Citrus Sinensis ID: 000726
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1329 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.203 | 0.289 | 0.381 | 3e-48 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.191 | 0.309 | 0.395 | 2e-45 | |
| A7J1T2 | 961 | Mitogen-activated protein | N/A | no | 0.185 | 0.257 | 0.394 | 5e-45 | |
| Q1HKZ5 | 959 | Mitogen-activated protein | yes | no | 0.185 | 0.257 | 0.387 | 1e-44 | |
| A7J1T0 | 961 | Mitogen-activated protein | N/A | no | 0.185 | 0.257 | 0.383 | 2e-44 | |
| O43283 | 966 | Mitogen-activated protein | yes | no | 0.185 | 0.255 | 0.387 | 2e-44 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.192 | 0.279 | 0.390 | 2e-44 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.198 | 0.109 | 0.397 | 3e-44 | |
| Q5R8X7 | 966 | Mitogen-activated protein | yes | no | 0.185 | 0.255 | 0.383 | 5e-44 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.188 | 0.194 | 0.384 | 8e-44 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 194 bits (494), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 110/288 (38%), Positives = 161/288 (55%), Gaps = 18/288 (6%)
Query: 1027 ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQE 1086
L + D+ +I N DL + +G G++G VYH W GT+VA+K+ F+G +
Sbjct: 653 VLDDADVGECEIPWN-DLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAA---- 707
Query: 1087 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 1146
EF E I+ +L HPNVV F G V P L+ VTEF+ GSL +L + H+D
Sbjct: 708 --LAEFRSEVRIMRRLRHPNVVFFLGAVTRPPN--LSIVTEFLPRGSLYRILHRPKSHID 763
Query: 1147 RRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
R+R+ +A+D A GM LH+ IVH DLK NLLV+ + KVGDFGLS++K N
Sbjct: 764 ERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNV----KVGDFGLSRLKHN 819
Query: 1205 TLVTG-GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 1263
T ++ GT WMAPE+L S +EK DV+SFG++LWE+ T P+ M+ ++G
Sbjct: 820 TFLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLRLPWRGMNPMQVVG 877
Query: 1264 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311
+ R +P D ++ +CW DP +RPSF ++ L+ ++
Sbjct: 878 AVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLN 925
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (471), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 108/273 (39%), Positives = 159/273 (58%), Gaps = 19/273 (6%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
DL +++G+G+FGTV+ +W G+DVA+K + + F ER+ EF RE I+ +L
Sbjct: 550 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-----HAERVN-EFLREVAIMKRL 603
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK--ERHLDRRKRLIIAMDAAFG 1160
HPN+V F G V P L+ VTE++ GSL +L LD R+RL +A D A G
Sbjct: 604 RHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 661
Query: 1161 MEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG-GVRGTLPW 1217
M YLH++N IVH DLK NLLV+ K + KV DFGLS++K +T ++ GT W
Sbjct: 662 MNYLHNRNPPIVHRDLKSPNLLVDKKYTV----KVCDFGLSRLKASTFLSSKSAAGTPEW 717
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
MAPE+L S +EK DV+SFG++LWE+ T ++P+ N++ ++ + R +P
Sbjct: 718 MAPEVLRDEPS--NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 775
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
+ + ++E CW +P RPSF I LR +
Sbjct: 776 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 808
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A7J1T2|M313A_XENLA Mitogen-activated protein kinase kinase kinase 13-A OS=Xenopus laevis GN=map3k13-a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 184 bits (466), Expect = 5e-45, Method: Compositional matrix adjust.
Identities = 107/271 (39%), Positives = 153/271 (56%), Gaps = 24/271 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E++ EL+ LGSG G V+ GK+RG +VAIK+++ EQ+ ++ L K
Sbjct: 167 EEISELQWLGSGAQGAVFLGKFRGEEVAIKKVR---------EQKETDIKH------LRK 211
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
L HPN++AF GV P L + E+ +G L VL + R + R + + A GM
Sbjct: 212 LKHPNIIAFKGVCTQAPCYCL--IMEYCAHGQLYEVLRAG-RKVSPRLLVDWSNGIASGM 268
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 1221
YLH I+H DLK N+LV D + K+ DFG SK + GT+ WMAPE
Sbjct: 269 NYLHLHKIIHRDLKSPNVLVTHTDTV----KISDFGTSKELSDKSTKMSFAGTVAWMAPE 324
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 1281
++ + VSEKVD++SFG++LWE+LTGE PY ++ AII G+ +N+L PVP C
Sbjct: 325 VIR--NEPVSEKVDIWSFGVLLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 382
Query: 1282 WRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312
+++LM+Q W P RPSF +I L + SA
Sbjct: 383 FKILMKQTWHSKPRNRPSFRQILMHLDIASA 413
|
May have a role in the JNK signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q1HKZ5|M3K13_MOUSE Mitogen-activated protein kinase kinase kinase 13 OS=Mus musculus GN=Map3k13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 183 bits (464), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 105/271 (38%), Positives = 149/271 (54%), Gaps = 24/271 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E++ EL+ LGSG G V+ GK+R +VAIK+++ EQ ++ R K
Sbjct: 165 EEISELQWLGSGAQGAVFLGKFRAEEVAIKKVR---------EQNETDIKHLR------K 209
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
L HPN++AF GV P + E+ +G L VL + R + R + + A GM
Sbjct: 210 LKHPNIIAFKGVCTQAP--CYCIIMEYCAHGQLYEVLRAG-RKITPRLLVDWSTGIASGM 266
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 1221
YLH I+H DLK N+LV D + K+ DFG SK + GT+ WMAPE
Sbjct: 267 NYLHLHKIIHRDLKSPNVLVTHTDAV----KISDFGTSKELSDKSTKMSFAGTVAWMAPE 322
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 1281
++ + VSEKVD++SFG+VLWE+LTGE PY ++ AII G+ +N+L PVP C
Sbjct: 323 VIR--NEPVSEKVDIWSFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 380
Query: 1282 WRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312
+++LM+Q W P RPSF + L + SA
Sbjct: 381 FKILMKQTWQSKPRNRPSFRQTLMHLDIASA 411
|
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|A7J1T0|M313B_XENLA Mitogen-activated protein kinase kinase kinase 13-B OS=Xenopus laevis GN=map3k13-b PE=2 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 104/271 (38%), Positives = 151/271 (55%), Gaps = 24/271 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E++ EL+ LGSG G V+ GK+RG +VAIK+++ EQ+ ++ R K
Sbjct: 169 EEISELQWLGSGAQGAVFLGKFRGEEVAIKKVR---------EQKETDIKHLR------K 213
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
L HPN++AF GV P + E+ G L VL + R + + + + A GM
Sbjct: 214 LKHPNIIAFKGVCTQAP--CYCILMEYCAQGQLYEVLRAG-RKVTPKLLVEWSTGIASGM 270
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 1221
YLH I+H DLK N+LV D + K+ DFG SK + GT+ WMAPE
Sbjct: 271 NYLHLHKIIHRDLKSPNVLVTHADTV----KISDFGTSKELSDKSTKMSFAGTVAWMAPE 326
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 1281
++ + VSEKVD++SFG++LWE+LTGE PY ++ AII G+ +N+L PVP C
Sbjct: 327 VIR--NEPVSEKVDIWSFGVLLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 384
Query: 1282 WRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312
+++LM+Q W P RPSF +I L + +A
Sbjct: 385 FKILMKQTWQSKPRNRPSFRQILMHLDIAAA 415
|
May have a role in the JNK signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|O43283|M3K13_HUMAN Mitogen-activated protein kinase kinase kinase 13 OS=Homo sapiens GN=MAP3K13 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 105/271 (38%), Positives = 149/271 (54%), Gaps = 24/271 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E++ EL+ LGSG G V+ GK+R +VAIK+++ EQ ++ R K
Sbjct: 166 EEISELQWLGSGAQGAVFLGKFRAEEVAIKKVR---------EQNETDIKHLR------K 210
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
L HPN++AF GV P + E+ +G L VL + R + R + + A GM
Sbjct: 211 LKHPNIIAFKGVCTQAP--CYCIIMEYCAHGQLYEVLRAG-RKITPRLLVDWSTGIASGM 267
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 1221
YLH I+H DLK N+LV D + K+ DFG SK + GT+ WMAPE
Sbjct: 268 NYLHLHKIIHRDLKSPNVLVTHTDAV----KISDFGTSKELSDKSTKMSFAGTVAWMAPE 323
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 1281
++ + VSEKVD++SFG+VLWE+LTGE PY ++ AII G+ +N+L PVP C
Sbjct: 324 VIR--NEPVSEKVDIWSFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 381
Query: 1282 WRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312
+++LM+Q W P RPSF + L + SA
Sbjct: 382 FKILMKQTWQSKPRNRPSFRQTLMHLDIASA 412
|
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (461), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 105/269 (39%), Positives = 151/269 (56%), Gaps = 13/269 (4%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I +L+ +LG GTFG VY G WRG+ VAIK+IK + ++ EF +E I
Sbjct: 657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKIN-----EDVNNQVLEEFRKELTI 711
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
LS+L HPN+V P L +TE++ GSL L SK+ ++ + +A+ A
Sbjct: 712 LSRLRHPNIVLLMAACTAPP--NLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIA 769
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
GM YLH ++H D+K NLL++ ++ IC DFGLSK+K + G+ WM
Sbjct: 770 QGMNYLHLSGVIHRDIKSLNLLLDEHMNVK-IC---DFGLSKLKSKSTEMTKSIGSPIWM 825
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278
+PELL G +EKVDV++FGI+LWE+ TGE PY+ + + + +LRPP+P
Sbjct: 826 SPELLMGED--YTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAW 883
Query: 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
+ L++ CW DP+ RPSFTEI L
Sbjct: 884 PYQLSHLIQACWHQDPLKRPSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 181 bits (459), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 114/287 (39%), Positives = 159/287 (55%), Gaps = 23/287 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I +LE + +G G FG V G WR TDVAIK I + F +SS + F E I
Sbjct: 2110 IDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSS-----LVMFQNEVGI 2164
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK--RLIIAMD 1156
LSKL HPNVV F G G VTE+M GSLR L L++ RL +A+D
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 1157 AAFGMEYLH--SKNIVHFDLKCDNLLVNLK-DPIRPI--------CKVGDFGLSKIK--R 1203
A GM YLH + I+H DL N+L++ DP P+ CK+ DFGLS++K +
Sbjct: 2225 IAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKMEQ 2284
Query: 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 1263
+ +T V G +P+MAPE+ G S+ SEK DV+S+G+VL+E+LT +EP +M +
Sbjct: 2285 ASQMTQSV-GCIPYMAPEVFKGDSN--SEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAH 2341
Query: 1264 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
+ RPP+P S+W+ ++ QCW +P RP+F +I L+ M
Sbjct: 2342 LAAYESYRPPIPLTTSSKWKEILTQCWDSNPDSRPTFKQIIVHLKEM 2388
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q5R8X7|M3K13_PONAB Mitogen-activated protein kinase kinase kinase 13 OS=Pongo abelii GN=MAP3K13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (458), Expect = 5e-44, Method: Compositional matrix adjust.
Identities = 104/271 (38%), Positives = 149/271 (54%), Gaps = 24/271 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E++ EL+ LGSG G V+ GK+R +VAIK+++ EQ ++ R K
Sbjct: 166 EEISELQWLGSGAQGAVFLGKFRAEEVAIKKVR---------EQNETDIKHLR------K 210
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
L HPN++AF GV P + E+ +G L VL + R + R + + A GM
Sbjct: 211 LKHPNIIAFKGVCTQAP--CYCIIMEYCAHGQLYEVLRAG-RKITPRLLVDWSTGIASGM 267
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 1221
YLH I+H DLK N+LV D + K+ DFG SK + GT+ W+APE
Sbjct: 268 NYLHLHKIIHRDLKSPNVLVTHTDAV----KISDFGTSKELSDKSTKMSFAGTVAWLAPE 323
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 1281
++ + VSEKVD++SFG+VLWE+LTGE PY ++ AII G+ +N+L PVP C
Sbjct: 324 VIR--NEPVSEKVDIWSFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 381
Query: 1282 WRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312
+++LM+Q W P RPSF + L + SA
Sbjct: 382 FKILMKQTWQSKPRNRPSFRQTLMHLDIASA 412
|
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 180 bits (456), Expect = 8e-44, Method: Compositional matrix adjust.
Identities = 103/268 (38%), Positives = 151/268 (56%), Gaps = 18/268 (6%)
Query: 1050 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109
+G G +G V+ G WRGT+VA+K + + +L + +E ++L KL HPN+V
Sbjct: 857 IGRGGYGQVFRGSWRGTEVAVKML------FNDNVNLKLISDLRKEVDLLCKLRHPNIVL 910
Query: 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN- 1168
F G + + VTE++ GSL ++LL + +D RL + D A GM YLHS+N
Sbjct: 911 FMGACTEPSSPCI--VTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYLHSRNP 968
Query: 1169 -IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS 1227
I+H DLK DNLLV+ D + KV DFGL+ +K +T + GT W+APE+L +
Sbjct: 969 IIIHRDLKTDNLLVD--DSWQ--VKVADFGLATVKSHTFA-KTMCGTTGWVAPEVL--AE 1021
Query: 1228 SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLME 1287
+EK DV+S+ IVLWE+LT PYA + ++ I + R P+P +C ++ LM
Sbjct: 1022 EGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSI-DRGERLPMPAWCPPKYAALMN 1080
Query: 1288 QCWAPDPVVRPSFTEIARRLRVMSAACQ 1315
+CW DP RPSF EI + M + Q
Sbjct: 1081 RCWETDPTHRPSFPEILPIMEGMISEFQ 1108
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1329 | ||||||
| 359472758 | 1338 | PREDICTED: uncharacterized protein LOC10 | 0.987 | 0.981 | 0.663 | 0.0 | |
| 449454768 | 1291 | PREDICTED: uncharacterized protein LOC10 | 0.962 | 0.990 | 0.591 | 0.0 | |
| 449503359 | 1291 | PREDICTED: LOW QUALITY PROTEIN: uncharac | 0.962 | 0.990 | 0.590 | 0.0 | |
| 449470682 | 1199 | PREDICTED: uncharacterized protein LOC10 | 0.893 | 0.989 | 0.571 | 0.0 | |
| 225462248 | 1207 | PREDICTED: uncharacterized protein LOC10 | 0.885 | 0.975 | 0.536 | 0.0 | |
| 255544604 | 1240 | serine/threonine protein kinase, putativ | 0.915 | 0.981 | 0.511 | 0.0 | |
| 255544602 | 1240 | serine/threonine protein kinase, putativ | 0.920 | 0.987 | 0.508 | 0.0 | |
| 356555219 | 1243 | PREDICTED: uncharacterized protein LOC10 | 0.920 | 0.983 | 0.505 | 0.0 | |
| 297737995 | 1238 | unnamed protein product [Vitis vinifera] | 0.631 | 0.677 | 0.656 | 0.0 | |
| 356528667 | 1245 | PREDICTED: uncharacterized protein LOC10 | 0.921 | 0.983 | 0.506 | 0.0 |
| >gi|359472758|ref|XP_002276237.2| PREDICTED: uncharacterized protein LOC100242423 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1730 bits (4480), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 886/1335 (66%), Positives = 1040/1335 (77%), Gaps = 22/1335 (1%)
Query: 1 MERNLGKGMMDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGG 60
MERNLG+ M+QQKNYEQVRY+ VE RNEG GSANQRF HDPSS INTN+RPPD++++
Sbjct: 1 MERNLGR-EMEQQKNYEQVRYNIVEARNEGLGSANQRFLHDPSSTINTNMRPPDFNITVA 59
Query: 61 VRPVLNYSIQTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSES 120
RPVLNYSIQTGEEFALEFM PRQHFVP+A GDPN++ Y LKG LG SHTGSES
Sbjct: 60 ARPVLNYSIQTGEEFALEFMN----PRQHFVPSASGDPNSATNYAVLKGFLGASHTGSES 115
Query: 121 GSDITMLNAAETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSGAS 180
G DI ML + E R QE ERK S HED+ YYDS+RSVPR SSRND RG GY SSGAS
Sbjct: 116 GPDIPMLTSVEKSRVQEFERKSSSVHEDKGYYDSVRSVPRISSRNDSSRGLHGYTSSGAS 175
Query: 181 D-SSRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQTHT 239
+ SS K KFLCSFGGKILPRPSDGKLRYVGGETRIIR+++DISWQ+L QK + IYNQ+HT
Sbjct: 176 ERSSTKFKFLCSFGGKILPRPSDGKLRYVGGETRIIRMNKDISWQDLMQKTMTIYNQSHT 235
Query: 240 IKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFSSADLEDTQLSLESM 299
IKYQLPGEDLDALVSVSCDEDLQNMMEECNVLED G+QK R+FLFSS+D +D Q L SM
Sbjct: 236 IKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDGGSQKLRLFLFSSSDFDDGQFGLGSM 295
Query: 300 EGDSEIQYVVAVNCMDLGSRKNSIALASASENNLDELLGLRVEREAGHIAAELAGSGATN 359
EGDSEIQYVVAVN MDL SRKNSI LAS S+NNLDELL L VERE G +A EL G
Sbjct: 296 EGDSEIQYVVAVNGMDLESRKNSIGLASTSDNNLDELLNLNVERETGRVATELPGPSTAP 355
Query: 360 LAYNASSSTIQSSQPVLVSSGSGYESNLQPYQGQRMQHISS---TLYPADGLPP---LDV 413
N SS +QSSQP++ + YESN +PYQGQ+M+H + ++P L LD
Sbjct: 356 STVNVHSSAVQSSQPLVPNFSGAYESNSKPYQGQKMRHGEAEQHQVFPVHHLESVHDLDG 415
Query: 414 KSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHA--DD 471
+++ P S + YGS P N+ GEN++ +P+ HG + +QGG AE++MYS H
Sbjct: 416 RNSVPFSVQFPYGYGSQPFNYGPFGENLVHMPL--HGHVTRQGGPAEDQMYSDVHVHVQG 473
Query: 472 SEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSEND 531
E A+E K K D+ + K+ E EK RSL+KEAS KE KIK D S+ K+NE++ IR E++
Sbjct: 474 LEVSAKEDKLKRDNSSQKMNEPEKNRSLEKEASVKEAKIKTDSSVQKMNELEKIRSLESE 533
Query: 532 HVVSSHSYVSSVSNYIPREEVSVVSSSPGI-VPSLLPSKSNKMAQEPIQNSMPLEAVNEG 590
H VSSH + SV NYIPR+E SVV+S+ I VP LLP K++K E +Q S P EAV++G
Sbjct: 534 HNVSSHPHDGSVPNYIPRDEASVVNSTADIGVPMLLP-KTSKKHLESVQISKPPEAVSDG 592
Query: 591 RKNN-DDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEKNRL 648
+ N + D F SGGAF+ G+GDSEA+PT SY + IP R +HSE+IPREQ E NRL
Sbjct: 593 KINTFNGDGHFHTSGGAFSPGYGDSEADPTEVSYPEQTLIPPRVFHSERIPREQAELNRL 652
Query: 649 SKSDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDG 708
SKSDDSFGSQFL+S SD S+ + ES+DKLH GN+ S++EQ+ + YTN + VEDG
Sbjct: 653 SKSDDSFGSQFLMSHTRSDVSQQVAESIDKLHGGNVTSQSEQAASSTTALYTNPKTVEDG 712
Query: 709 HAQLRKHKEFADKINKINSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSI 768
Q K+K+ AD I K+NSN SEDGL L KSE P S DD E+ +R+ KD ++
Sbjct: 713 LTQFEKYKDVADDIKKLNSNISEDGLGPKLLKSESKWPAPTSVDDHEIAGVRDGNKDPAV 772
Query: 769 NDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENS 828
+D EAAGL + TA+ GTS K +DS K + + W+E+A KNN ++ KG AQ +A EN
Sbjct: 773 SDREAAGLNNLTASQGTSSKPHDDSPSKPTGFHWDEMAVKKNNDDNTKGHAQPMAWTENP 832
Query: 829 VRAVSPGDSSIAVVSPEG-DILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVL 887
+R+V G+SS+ V +PEG DILIDINDRFPRDFLSDIF+KAR SE G+SP+HGDG L
Sbjct: 833 LRSVPGGESSVGVGAPEGGDILIDINDRFPRDFLSDIFSKARTSEGPPGISPLHGDGTGL 892
Query: 888 SWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKP 947
S N+ENH+P+ WS+F+ LAQ+EF RK VSLMDQDHLG+ S L NIEEG +DYS+PPLK
Sbjct: 893 SLNLENHEPKHWSFFQKLAQEEFIRKGVSLMDQDHLGYPSSLMNIEEGTPIDYSFPPLKS 952
Query: 948 DGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSE-VVNHRIQE 1006
DG + SRINF+E Q+ESSS+V P+T++ H DY S +K +ES+Q + + N R +
Sbjct: 953 DGVALGPMDSRINFEEEIQQESSSMVRPNTIDMHEDYDPSPVKRDESVQMDGMANPRTPD 1012
Query: 1007 SDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGT 1066
SDYEE + ++ G P VD +LG+ DISTLQIIKNEDLEEL+ELGSGTFGTVYHGKWRGT
Sbjct: 1013 SDYEEVKFEIQNTGAPFVDPSLGDIDISTLQIIKNEDLEELRELGSGTFGTVYHGKWRGT 1072
Query: 1067 DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVT 1126
DVAIKRIKKSCFTGRSSEQERLT+EFWREA+ILSKLHHPNVVAFYGVVQDGPGGTLATVT
Sbjct: 1073 DVAIKRIKKSCFTGRSSEQERLTVEFWREADILSKLHHPNVVAFYGVVQDGPGGTLATVT 1132
Query: 1127 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 1186
EFMVNGSLRHVL+SK+RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP
Sbjct: 1133 EFMVNGSLRHVLVSKDRHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 1192
Query: 1187 IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEI 1246
+RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSS+VSEKVDVFSFGIVLWEI
Sbjct: 1193 LRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSRVSEKVDVFSFGIVLWEI 1252
Query: 1247 LTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306
LTGEEPYA+MHYGAIIGGIVNNTLRPPVP +CDSEW+LLMEQCWAPDP+ RPSFTEIARR
Sbjct: 1253 LTGEEPYAHMHYGAIIGGIVNNTLRPPVPSYCDSEWKLLMEQCWAPDPIGRPSFTEIARR 1312
Query: 1307 LRVMSAACQTKSHGH 1321
LR MSAACQTK G+
Sbjct: 1313 LRAMSAACQTKPQGY 1327
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454768|ref|XP_004145126.1| PREDICTED: uncharacterized protein LOC101217445 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1442 bits (3734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 793/1341 (59%), Positives = 955/1341 (71%), Gaps = 62/1341 (4%)
Query: 1 MERNLGKGMMDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSM--S 58
MERN+ K +DQ NYEQ+R +++E RN+G GS NQR FHDPSSNI+TNIRPP+Y+M
Sbjct: 1 MERNVKKSTLDQPSNYEQIRLTSMEGRNQGLGSTNQRTFHDPSSNISTNIRPPEYNMLVV 60
Query: 59 GGVRPVLNYSIQTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGS 118
G P NYSIQTGEEFALEFMRERV + HFVP DP S YMDLKG+LGI H S
Sbjct: 61 GVASPGHNYSIQTGEEFALEFMRERVNAKHHFVPTNSPDPGVSTGYMDLKGMLGIPHASS 120
Query: 119 ESGSDITMLNAAETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSG 178
ESGS I MLN E Q ER G HE++S Y+SMR VPR SSRND+ R + SSG
Sbjct: 121 ESGSSIAMLNPVEKDHVQHFER-GSLPHEEKSSYNSMRFVPRASSRNDVSR-LHSFTSSG 178
Query: 179 ASDS-SRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQT 237
ASDS SRKVKFLCSFGGK++PRPSDGKLRYVGGETRIIRI++DISW L QK IY+Q
Sbjct: 179 ASDSTSRKVKFLCSFGGKVMPRPSDGKLRYVGGETRIIRITKDISWSNLLQKTSTIYDQV 238
Query: 238 HTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFSSADLEDTQLSLE 297
HTIKYQLPGEDLDALVSVSCDEDLQNMMEECN+ E+ G+ KPRMFLFS +DLED+Q+ +
Sbjct: 239 HTIKYQLPGEDLDALVSVSCDEDLQNMMEECNIPENGGSTKPRMFLFSISDLEDSQMGVG 298
Query: 298 SMEGDSEIQYVVAVNCMDLGSRKNSIALASASENNLDELLGLRVEREAGHIAAELAGSGA 357
S EG SEI+YV+AVN MDL SR+NS L + S NNLDELL L V E+G +A L+ +
Sbjct: 299 SAEGGSEIEYVIAVNGMDLSSRRNSTPLGNTSGNNLDELLALNVGLESGQVAP-LSDNMK 357
Query: 358 TNLAYNASSSTIQSSQPVLVSSGSGYESNLQPYQGQRMQH------ISSTLYPADGLPPL 411
++L + S QSSQ + +S SG +S+LQP GQ++Q S+ P P
Sbjct: 358 SSLTI--TPSFPQSSQTIWTNSSSGLKSSLQPLSGQKLQQGELGPPQPSSFRPMQSFPEK 415
Query: 412 DVKSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADD 471
K++ S QHDY + + AT ENV P+P +G L + SGFH D
Sbjct: 416 LGKTSVSSSIQSQHDYVLNTN--ATSVENVPPMP--------SKGYLNQHYPVSGFHTQD 465
Query: 472 SEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSEND 531
++ ++E K S + K+ E ++I+SL+KE S + ++KR+ SL KI+E + E++
Sbjct: 466 PDSSSREGKITEISTS-KLSEPDEIQSLEKEVSFNDAQMKRESSLHKIDEANESPNFEHE 524
Query: 532 HVVSSHSYVSSVSNYIPREEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR 591
VSS+ +SV NY + + V++S + SLL +K+NK Q+P S+ LEA NEG
Sbjct: 525 CGVSSNLNDASVLNYNTKG-MQVINSDTDVGSSLLLTKNNK-HQDPAPESVSLEASNEGN 582
Query: 592 KNNDDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEKNRLSK 650
+ +D +F +S TSG G S+A+ T FSY P +PQR +HSE+IPREQ E NRLSK
Sbjct: 583 RGTKED-KF-SSDELPTSGFGASKADETGFSYLEP-ILPQRVFHSERIPREQAELNRLSK 639
Query: 651 SDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHA 710
SDDSFGSQFL +Q SD S+ I ES + L GNM E+EQ V+ +K N Q +EDG
Sbjct: 640 SDDSFGSQFLRTQGNSDYSQTIIESAETLLDGNMTLESEQFVSSSKLPCGNHQTIEDGLE 699
Query: 711 QLRKHKEFADKINK-INSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSIN 769
K+K ADK +K +N +G DG SE++ + +K S
Sbjct: 700 PFEKYKTSADKNSKTMNISGEHDG-------SEVSDM--------------SNIKSPSAC 738
Query: 770 DEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSV 829
+EA GL H TA K+ E+S + E W E + N+GN+ + Q + + EN
Sbjct: 739 RKEAEGLAHLTAGEEVPDKHKEESLMGPLESGWIEGSTHNNHGNETQEQPEPSSLTENPG 798
Query: 830 RAVSPGDSSIAV-VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLS 888
+ + + + + S GDILIDINDRFPRDFLSDIF+KAR SENI+G++P+HG+GA LS
Sbjct: 799 KNATQVEPGVGIGTSEHGDILIDINDRFPRDFLSDIFSKARNSENISGINPLHGNGAGLS 858
Query: 889 WNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPD 948
NVENH+P+RWSYFRNLAQ+EF +DVSLMDQDHLGFSS L N+EEG TV+ +P L D
Sbjct: 859 VNVENHEPKRWSYFRNLAQEEFVGRDVSLMDQDHLGFSSSLGNVEEGGTVN-RFPLLNSD 917
Query: 949 GSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESD 1008
+ + S NFD+ Q ES + GPST + +Y+ S+LKGNE++ + + + +
Sbjct: 918 VGAIYEKESH-NFDDNIQPESRLLTGPSTTNLYTEYNSSQLKGNETMHEP--SSKSPQDE 974
Query: 1009 YEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDV 1068
+ +LD G+PLVD L +FDISTLQIIKNEDLEE +ELGSGTFGTVYHGKWRGTDV
Sbjct: 975 NVDAKLDGQDIGVPLVDFYLKDFDISTLQIIKNEDLEEQRELGSGTFGTVYHGKWRGTDV 1034
Query: 1069 AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1128
AIKRIKKSCFT RSSEQERLT+EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF
Sbjct: 1035 AIKRIKKSCFTCRSSEQERLTIEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1094
Query: 1129 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188
MVNGSLR+VLLSKER+LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP R
Sbjct: 1095 MVNGSLRNVLLSKERYLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPFR 1154
Query: 1189 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248
PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT
Sbjct: 1155 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1214
Query: 1249 GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
GEEPYANMHYGAIIGGIVNNTLRPPVP FCD +WRLLMEQCW+PDPV RPSFT+IARRLR
Sbjct: 1215 GEEPYANMHYGAIIGGIVNNTLRPPVPSFCDPDWRLLMEQCWSPDPVARPSFTDIARRLR 1274
Query: 1309 VMSAACQTKSHGHQVQNQVPK 1329
VMS A QT+S QNQ+PK
Sbjct: 1275 VMSTAAQTRS----PQNQMPK 1291
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449503359|ref|XP_004161963.1| PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC101223789 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1439 bits (3726), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 792/1341 (59%), Positives = 954/1341 (71%), Gaps = 62/1341 (4%)
Query: 1 MERNLGKGMMDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSM--S 58
MERN+ K +DQ NYEQ+R +++E RN+G GS NQR FHDPSSNI+TNIRPP+Y+M
Sbjct: 1 MERNVKKSTLDQPSNYEQIRLTSMEGRNQGLGSTNQRTFHDPSSNISTNIRPPEYNMLVV 60
Query: 59 GGVRPVLNYSIQTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGS 118
G P NYSIQTGEEFALEFMRERV + HFVP DP S YMDLKG+LGI H S
Sbjct: 61 GVASPGHNYSIQTGEEFALEFMRERVNAKHHFVPTNSPDPGVSTGYMDLKGMLGIPHASS 120
Query: 119 ESGSDITMLNAAETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSG 178
ESGS I MLN E Q ER G HE++S Y+SMR VPR SSRND+ R + SSG
Sbjct: 121 ESGSSIAMLNPVEKDHVQHFER-GSLPHEEKSSYNSMRFVPRASSRNDVSR-LHSFTSSG 178
Query: 179 ASDS-SRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQT 237
ASDS SRKVKFLCSFGGK++PRPSDGKLRYVGGETRIIRI++DISW L QK IY+Q
Sbjct: 179 ASDSTSRKVKFLCSFGGKVMPRPSDGKLRYVGGETRIIRITKDISWSNLLQKTSTIYDQV 238
Query: 238 HTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFSSADLEDTQLSLE 297
HTIKYQLPGEDLDALVSVSCDEDLQNMMEECN+ E+ G+ KPRMFLFS +DLED+Q+ +
Sbjct: 239 HTIKYQLPGEDLDALVSVSCDEDLQNMMEECNIPENGGSTKPRMFLFSISDLEDSQMGVG 298
Query: 298 SMEGDSEIQYVVAVNCMDLGSRKNSIALASASENNLDELLGLRVEREAGHIAAELAGSGA 357
S EG SEI+YV+AVN MDL SR+NS L + S NNLDELL L V E+G +A L+ +
Sbjct: 299 SAEGGSEIEYVIAVNGMDLSSRRNSTPLGNTSGNNLDELLALNVGLESGQVAP-LSDNMK 357
Query: 358 TNLAYNASSSTIQSSQPVLVSSGSGYESNLQPYQGQRMQH------ISSTLYPADGLPPL 411
++L + S QSSQ + +S SG +S+LQP GQ++Q S+ P P
Sbjct: 358 SSLTI--TPSFPQSSQTIWTNSSSGLKSSLQPLSGQKLQQGELGPPQPSSFRPMQSFPEK 415
Query: 412 DVKSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADD 471
K++ S QHDY + + AT ENV P+P +G L + SGFH D
Sbjct: 416 LGKTSVSSSIQSQHDYVLNTN--ATSVENVPPMP--------SKGYLNQHYPVSGFHTQD 465
Query: 472 SEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSEND 531
++ ++E K S + K+ E ++I+SL+KE S + ++KR+ SL KI+E + E++
Sbjct: 466 PDSSSREGKITEISTS-KLSEPDEIQSLEKEVSFNDAQMKRESSLHKIDEANESPNFEHE 524
Query: 532 HVVSSHSYVSSVSNYIPREEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR 591
VSS+ +SV NY + + V++S + SLL +K+NK Q+P S+ LEA NEG
Sbjct: 525 CGVSSNLNDASVLNYNTKG-MQVINSDTDVGSSLLLTKNNK-HQDPAPESVSLEASNEGN 582
Query: 592 KNNDDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEKNRLSK 650
+ +D +F +S TSG G S+A+ T FSY P +PQR +HSE+IPREQ E NRLSK
Sbjct: 583 RGTKED-KF-SSDELPTSGFGASKADETGFSYLEP-ILPQRVFHSERIPREQAELNRLSK 639
Query: 651 SDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHA 710
SDDSFGSQFL +Q SD S+ I ES + L GNM E+EQ V+ +K N Q +EDG
Sbjct: 640 SDDSFGSQFLRTQGNSDYSQTIIESAETLLDGNMTLESEQFVSSSKLPCGNHQTIEDGLE 699
Query: 711 QLRKHKEFADKINK-INSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSIN 769
K+K ADK +K +N +G DG SE++ + +K S
Sbjct: 700 PFEKYKTSADKNSKTMNISGEHDG-------SEVSDM--------------SNIKSPSAC 738
Query: 770 DEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSV 829
+EA GL H TA K+ E+S + E W E + N+GN+ + Q + + EN
Sbjct: 739 RKEAEGLAHLTAGEEVPDKHKEESLMGPLESGWIEGSTHNNHGNETQEQPEPSSLTENPG 798
Query: 830 RAVSPGDSSIAV-VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLS 888
+ + + + + S GDILIDINDRFPRDFLSDIF+KAR SENI+G++P+HG+GA LS
Sbjct: 799 KNATQVEPGVGIGTSEHGDILIDINDRFPRDFLSDIFSKARNSENISGINPLHGNGAGLS 858
Query: 889 WNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPD 948
NVENH+P+RWSYFRNLAQ+EF +DVSLMDQDHLGFSS L N+EEG TV+ +P L D
Sbjct: 859 VNVENHEPKRWSYFRNLAQEEFVGRDVSLMDQDHLGFSSSLGNVEEGGTVN-RFPLLNSD 917
Query: 949 GSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESD 1008
+ + S NFD+ Q ES + GPST + +Y+ S+LKGNE++ + + + +
Sbjct: 918 VGAIYEKESH-NFDDNIQPESRLLTGPSTTNLYTEYNSSQLKGNETMHEP--SSKSPQDE 974
Query: 1009 YEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDV 1068
+ +LD G+PLVD L +FDISTLQIIKNEDLEE +ELGSGTFGTVYHGKWRGTDV
Sbjct: 975 NVDAKLDGQDIGVPLVDFYLKDFDISTLQIIKNEDLEEQRELGSGTFGTVYHGKWRGTDV 1034
Query: 1069 AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1128
AIKRIKKSCFT RSSEQERLT+EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF
Sbjct: 1035 AIKRIKKSCFTCRSSEQERLTIEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1094
Query: 1129 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188
MVNGSLR+VLLSKER+LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP R
Sbjct: 1095 MVNGSLRNVLLSKERYLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPFR 1154
Query: 1189 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248
PICKVGDFGLSK KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT
Sbjct: 1155 PICKVGDFGLSKXKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1214
Query: 1249 GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
GEEPYANMHYGAIIGGIVNNTLRPPVP FCD +WRLLMEQCW+PDPV RPSFT+IARRLR
Sbjct: 1215 GEEPYANMHYGAIIGGIVNNTLRPPVPSFCDPDWRLLMEQCWSPDPVARPSFTDIARRLR 1274
Query: 1309 VMSAACQTKSHGHQVQNQVPK 1329
VMS A QT+S QNQ+PK
Sbjct: 1275 VMSTAAQTRS----PQNQMPK 1291
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449470682|ref|XP_004153045.1| PREDICTED: uncharacterized protein LOC101213632, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1264 bits (3272), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 712/1245 (57%), Positives = 869/1245 (69%), Gaps = 58/1245 (4%)
Query: 1 MERNLGKGMMDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSM--S 58
MERN+ K +DQ NYEQ+R +++E RN+G GS NQR FHDPSSNI+TNIRPP+Y+M
Sbjct: 1 MERNVKKSTLDQPSNYEQIRLTSMEGRNQGLGSTNQRTFHDPSSNISTNIRPPEYNMLVV 60
Query: 59 GGVRPVLNYSIQTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGS 118
G P NYSIQTGEEFALEFMRERV + HFVP DP S YMDLKG+LGI H S
Sbjct: 61 GVASPGHNYSIQTGEEFALEFMRERVNAKHHFVPTNSPDPGVSTGYMDLKGMLGIPHASS 120
Query: 119 ESGSDITMLNAAETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSG 178
ESGS I MLN E Q ER G HE++S Y+SMR VPR SSRND+ R + SSG
Sbjct: 121 ESGSSIAMLNPVEKDHVQHFER-GSLPHEEKSSYNSMRFVPRASSRNDVSR-LHSFTSSG 178
Query: 179 ASDS-SRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQT 237
ASDS SRKVKFLCSFGGK++PRPSDGKLRYVGGETRIIRI++DISW L QK IY+Q
Sbjct: 179 ASDSTSRKVKFLCSFGGKVMPRPSDGKLRYVGGETRIIRITKDISWSNLLQKTSTIYDQV 238
Query: 238 HTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFSSADLEDTQLSLE 297
HTIKYQLPGEDLDALVSVSCDEDLQNMMEECN+ E+ G+ KPRMFLFS +DLED+Q+ +
Sbjct: 239 HTIKYQLPGEDLDALVSVSCDEDLQNMMEECNIPENGGSTKPRMFLFSISDLEDSQMGVG 298
Query: 298 SMEGDSEIQYVVAVNCMDLGSRKNSIALASASENNLDELLGLRVEREAGHIAAELAGSGA 357
S EG SEI+YV+AVN MDL SR+NS L + S NNLDELL L V E+G +A L+ +
Sbjct: 299 SAEGGSEIEYVIAVNGMDLSSRRNSTPLGNTSGNNLDELLALNVGLESGQVAP-LSDNMK 357
Query: 358 TNLAYNASSSTIQSSQPVLVSSGSGYESNLQPYQGQRMQH------ISSTLYPADGLPPL 411
++L + S QSSQ + +S SG +S+LQP GQ++Q S+ P P
Sbjct: 358 SSLTI--TPSFPQSSQTIWTNSSSGLKSSLQPLSGQKLQQGELGPPQPSSFRPMQSFPEK 415
Query: 412 DVKSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADD 471
K++ S QHDY + + AT ENV P+P +G L + SGFH D
Sbjct: 416 LGKTSVSSSIQSQHDYVLNTN--ATSVENVPPMP--------SKGYLNQHYPVSGFHTQD 465
Query: 472 SEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSEND 531
++ ++E K S + K+ E ++I+SL+KE S + ++KR+ SL KI+E + E++
Sbjct: 466 PDSSSREGKITEISTS-KLSEPDEIQSLEKEVSFNDAQMKRESSLHKIDEANESPNFEHE 524
Query: 532 HVVSSHSYVSSVSNYIPREEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR 591
VSS+ +SV NY + + V++S + SLL +K+NK Q+P S+ LEA NEG
Sbjct: 525 CGVSSNLNDASVLNYNTKG-MQVINSDTDVGSSLLLTKNNKH-QDPAPESVSLEASNEGN 582
Query: 592 KNNDDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEKNRLSK 650
+ +D +F +S TSG G S+A+ T FSY P +PQR +HSE+IPREQ E NRLSK
Sbjct: 583 RGTKED-KF-SSDELPTSGFGASKADETGFSYLEP-ILPQRVFHSERIPREQAELNRLSK 639
Query: 651 SDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHA 710
SDDSFGSQFL +Q SD S+ I ES + L GNM E+EQ V+ +K N Q +EDG
Sbjct: 640 SDDSFGSQFLRTQGNSDYSQTIIESAETLLDGNMTLESEQFVSSSKLPCGNHQTIEDGLE 699
Query: 711 QLRKHKEFADKINK-INSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSIN 769
K+K ADK +K +N +G DG SE++ + +K S
Sbjct: 700 PFEKYKTSADKNSKTMNISGEHDG-------SEVSDM--------------SNIKSPSAC 738
Query: 770 DEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSV 829
+EA GL H TA K+ E+S + E W E + N+GN+ + Q + + EN
Sbjct: 739 RKEAEGLAHLTAGEEVPDKHKEESLMGPLESGWIEGSTHNNHGNETQEQPEPSSLTENPG 798
Query: 830 RAVSPGDSSIAV-VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLS 888
+ + + + + S GDILIDINDRFPRDFLSDIF+KAR SENI+G++P+HG+GA LS
Sbjct: 799 KNATQVEPGVGIGTSEHGDILIDINDRFPRDFLSDIFSKARNSENISGINPLHGNGAGLS 858
Query: 889 WNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPD 948
NVENH+P+RWSYFRNLAQ+EF +DVSLMDQDHLGFSS L N+EEG TV+ +P L D
Sbjct: 859 VNVENHEPKRWSYFRNLAQEEFVGRDVSLMDQDHLGFSSSLGNVEEGGTVN-RFPLLNSD 917
Query: 949 GSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESD 1008
+ + S NFD+ Q ES + GPST + +Y+ S+LKGNE++ + + + +
Sbjct: 918 VGAIYEKESH-NFDDNIQPESRLLTGPSTTNLYTEYNSSQLKGNETMHEP--SSKSPQDE 974
Query: 1009 YEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDV 1068
+ +LD G+PLVD L +FDISTLQIIKNEDLEE +ELGSGTFGTVYHGKWRGTDV
Sbjct: 975 NVDAKLDGQDIGVPLVDFYLKDFDISTLQIIKNEDLEEQRELGSGTFGTVYHGKWRGTDV 1034
Query: 1069 AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1128
AIKRIKKSCFT RSSEQERLT+EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF
Sbjct: 1035 AIKRIKKSCFTCRSSEQERLTIEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1094
Query: 1129 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188
MVNGSLR+VLLSKER+LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP R
Sbjct: 1095 MVNGSLRNVLLSKERYLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPFR 1154
Query: 1189 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233
PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK
Sbjct: 1155 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1199
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225462248|ref|XP_002263264.1| PREDICTED: uncharacterized protein LOC100257013 [Vitis vinifera] gi|147772468|emb|CAN65102.1| hypothetical protein VITISV_021043 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1229 bits (3180), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 700/1304 (53%), Positives = 854/1304 (65%), Gaps = 127/1304 (9%)
Query: 35 NQRFFHDPSSNINTNIRPPDYSMSGGVRPVLNYSIQTGEEFALEFMRERVIPRQHFVPNA 94
+Q F DP++ INT+ RPP+++ + V+PV NYSIQTGEEFALEFM +RV PR F+P+
Sbjct: 12 SQGFMLDPTTAINTDTRPPEFN-NLEVKPVRNYSIQTGEEFALEFMLDRVNPRNQFIPDT 70
Query: 95 YGDPNNSPVYMDLKGVLGISHTGSESGSDITMLNAAETGRAQELERKGPSGHEDRSYYDS 154
GDP+ P Y +LKG+LGI+HTGSESGSDI+ML E G +E ERK + +EDRSYY S
Sbjct: 71 AGDPHYVPKYTELKGILGINHTGSESGSDISMLTIVERG-PKEFERKNSALYEDRSYYGS 129
Query: 155 MRSVPRTSSRNDMGRGT-QGYASSGASDSSR-KVKFLCSFGGKILPRPSDGKLRYVGGET 212
++ VPRTSS +D RG GYASSGASDSS K+K LCSFGGKILPRPSDGKLRYVGGET
Sbjct: 130 VQLVPRTSSGHDSSRGVIHGYASSGASDSSSTKMKVLCSFGGKILPRPSDGKLRYVGGET 189
Query: 213 RIIRISRDISWQELTQKALAIYNQTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLE 272
RIIRI +DISWQEL QK L ++NQ H IKYQLPGEDLDALVSVSCDEDLQNMMEECN LE
Sbjct: 190 RIIRIRKDISWQELVQKTLMVFNQAHIIKYQLPGEDLDALVSVSCDEDLQNMMEECNELE 249
Query: 273 D-RGTQKPRMFLFSSADLEDTQLSLESMEGDSEIQYVVAVNCMDLGSRKNSI--ALASAS 329
D G++K RMFLFS++DL+D L+S +GDSEIQYVVAVN MD+GSRKNS L +S
Sbjct: 250 DGEGSKKLRMFLFSTSDLDDAYFGLDSTDGDSEIQYVVAVNGMDMGSRKNSTLHGLVGSS 309
Query: 330 ENNLDELLGLRVEREAGHIAAELAGSGATNLAYN-ASSSTIQSSQPVLVSSGSGYESNLQ 388
NNL +L G +ER A +A + G L STIQSSQP+L +S S YE++
Sbjct: 310 SNNLADLDGQNIERNATRVATDSVGISTLPLTGTIVPPSTIQSSQPILPNSSSAYEADPP 369
Query: 389 PYQGQRMQHISSTLYPADGLPPLDVKSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPI 448
Y GQ + H ++ + L + Y SH SN E+ +P+
Sbjct: 370 FYHGQMIYHGETSQHM------------------LHYGYPSHQSNCTPYQESTNLMPV-- 409
Query: 449 HGQLNQQGGLAEEKMYSGFHADDSEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQ 508
HG + QQ G AE + Y G D +EV
Sbjct: 410 HGLMTQQEGYAEGQPYIGLQVQDPSVLVKEVT---------------------------- 441
Query: 509 KIKRDHSLPKINEIDNIRRSENDHVVSSHSYVSSVSNYIPREEVSVVSSSPGIVPSLLPS 568
+K D S+ + N +NI S+ND ++ S V + IP EE V SS PS
Sbjct: 442 -LKNDASIQQENIPENISPSKNDCLIPSQPSDGEVMDRIPVEEALVSISSLDQFPSENKG 500
Query: 569 KSNKMAQEPIQNSMPLEAVNEGRKNNDDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSA 628
K +K P++ S ++A+N+ + D AS F + D + + SY P
Sbjct: 501 KHHK----PVEISSSVDAMNQAQVPKSDYDHHPASSSPFAPVYADPGSGLMDLSYLEPPV 556
Query: 629 IPQR-YHSEQIPREQTEK-NRLSKSDDSFGSQFLISQALSDGSK--PIRESVDKLHSGNM 684
+PQR Y+SE++PREQ E NRLSKSDDS GSQFLIS + SD K + ES DKL +GN+
Sbjct: 557 LPQRVYYSERVPREQAELLNRLSKSDDSLGSQFLISHSRSDIEKQDSVAESTDKLRNGNL 616
Query: 685 ASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFADKINKINSNGSEDGLQSSLGKSELT 744
A +TEQS+ S G++ +
Sbjct: 617 APQTEQSI--------------------------------------------STGEAMVE 632
Query: 745 QVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNE 804
+ K+ D T ++ + L ++ G P N S K+ +D E + E
Sbjct: 633 DMAVKA--DHGTTGTKDIPRKLLLHGTTEPGSELPAMNQVASVKHCQDPLSTPPELDQGE 690
Query: 805 IAA--IKNNGNDNKGQAQSLAQKENSVRAVSPGDSSIAVVSPE-GDILIDINDRFPRDFL 861
++ +N G AQ+ A SS+ V +PE GDILIDINDRFPRDFL
Sbjct: 691 MSGKDFTSNNTLGVGDAQTFAWT----------GSSVGVSTPEQGDILIDINDRFPRDFL 740
Query: 862 SDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQD 921
SDIF+KA + +S DGA LS N+EN +P+ WSYF+ LAQ F + DVSLMDQD
Sbjct: 741 SDIFSKAVHFADSPDISKPQKDGAGLSLNMENREPKHWSYFQKLAQGGFVQNDVSLMDQD 800
Query: 922 HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESS-SIVGPSTMET 980
HLGFSS LT +EE + Y + PL D ++ Q SRI+F E +Q+ES + + +
Sbjct: 801 HLGFSSVLTKVEEEVSKPYQFTPLMADEVLIGQLESRISFGEENQKESPPGRIAADSTDL 860
Query: 981 HPDYSRSELKGNESLQSE--VVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQI 1038
H DYS SE+K ++S+Q + + N R +S+ E+G+++ G P +D ++G+FDI+TLQI
Sbjct: 861 HSDYSPSEIKESDSVQFDRMIENLRTPDSEGEDGKMETKNIGRPPLDPSIGDFDINTLQI 920
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
IKNEDLEELKELGSGTFGTVYHGKWRG+DVAIKRIKK CFT RSSEQERLT+EFWREA+I
Sbjct: 921 IKNEDLEELKELGSGTFGTVYHGKWRGSDVAIKRIKKICFTSRSSEQERLTIEFWREADI 980
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
LSKLHHPNVVAFYGVV DGPG TLATVTE+MV+GSLRHVLL K+R+LDRRKRL+IAMDAA
Sbjct: 981 LSKLHHPNVVAFYGVVHDGPGATLATVTEYMVDGSLRHVLLRKDRYLDRRKRLLIAMDAA 1040
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
FGMEYLHSKNIVHFDLKCDNLLVNLKDP+RPICKVGDFGLSKIKRNTLV+GGVRGTLPWM
Sbjct: 1041 FGMEYLHSKNIVHFDLKCDNLLVNLKDPLRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 1100
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278
APELLNGSS+KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV+NTLRP VP C
Sbjct: 1101 APELLNGSSNKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVSNTLRPTVPSSC 1160
Query: 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQ 1322
D EWR LMEQCWAP+P VRPSFTEI RLRVMSAA QTK+ GH+
Sbjct: 1161 DPEWRTLMEQCWAPNPAVRPSFTEITGRLRVMSAAAQTKTPGHK 1204
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544604|ref|XP_002513363.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547271|gb|EEF48766.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1187 bits (3072), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 684/1336 (51%), Positives = 865/1336 (64%), Gaps = 119/1336 (8%)
Query: 1 MERNLGKGMMDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGG 60
MERNL M+ + + +Y + E +EG A Q F DP+S N N+R PD ++S
Sbjct: 1 MERNLNNIAMENSEVNKPFQYGSREPGHEGTSPAPQAFMLDPASIRNANMRIPDLNVSE- 59
Query: 61 VRPVLNYSIQTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSES 120
V+PV N+SIQTGEEFALEFMR+RV ++ +PN GDPN + Y++LKG+LGISHTGSES
Sbjct: 60 VKPV-NFSIQTGEEFALEFMRDRVNHKKPIIPNTVGDPNYATGYLELKGILGISHTGSES 118
Query: 121 GSDITMLNAAETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQG----YAS 176
GSDI+ML E G+ ++ ER S HE+R Y+S++SVP++S+ G G++G Y S
Sbjct: 119 GSDISMLTIVEKGQ-KDFERTNSSFHEERGNYESIQSVPQSSA----GYGSRGPPVGYTS 173
Query: 177 SGASDS-SRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYN 235
SG SDS S+K+K LCSFGGKILPRPSDGKLRYVGG+TRIIRI+RDISW EL QK LAIY+
Sbjct: 174 SGTSDSLSQKMKVLCSFGGKILPRPSDGKLRYVGGDTRIIRITRDISWMELKQKTLAIYD 233
Query: 236 QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRG-TQKPRMFLFSSADLEDTQL 294
Q H IKYQLPGEDLD+LVSVSCDEDL NMMEE N +EDRG +QK RMF+FS +DL+D Q
Sbjct: 234 QAHAIKYQLPGEDLDSLVSVSCDEDLLNMMEEWNEVEDRGGSQKLRMFIFSMSDLDDAQF 293
Query: 295 SLESMEGDSEIQYVVAVNCMDLGSRKNSI--ALASASENNLDELLGLRVEREAGHIAAEL 352
L S+E DSEIQYVVAVN MD+GSR+NS+ LAS+S NNLDEL L +++E +A
Sbjct: 294 GLSSVEADSEIQYVVAVNGMDIGSRRNSMLHGLASSSGNNLDELDRLNLDKETSRVATVS 353
Query: 353 AGSGATNLAYNASSSTIQSSQPVLVSSGSGYESNLQPYQGQRMQHISSTLYPADGLPPLD 412
G S+ ++QPV+ SS + YE++ YQG M H
Sbjct: 354 VGV----------STLPSTAQPVIRSSSNAYETHTPYYQGHLMDH--------------- 388
Query: 413 VKSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADDS 472
+ T HD H S F +++ +NQQGGL E + + F +S
Sbjct: 389 -RETQQFLLRNHHD-SFHHSPFEETPHSIL---------MNQQGGLNEGQPSTSFQVHNS 437
Query: 473 EACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSENDH 532
+ +E K K D+ + + E+ R L+K
Sbjct: 438 QILKKEEKPKFDASMQQEIDPERSRPLEKVYP---------------------------- 469
Query: 533 VVSSHSYVSSVSNYIPREEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR- 591
+P +E S+ G + SL PSK+ QE + S +AVN +
Sbjct: 470 --------------VPVDEASLAVGLQGDLHSL-PSKNEGWDQETEKVSSSADAVNSSQV 514
Query: 592 KNNDDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEK-NRLS 649
N+ +D AS G + +G+ D + + SY PS PQR Y+SE+IPREQ E NRLS
Sbjct: 515 PNSSEDGPCSASDGTYGTGNADPVSNLIDLSYLEPSVPPQRVYYSERIPREQAELLNRLS 574
Query: 650 KSDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGH 709
KSDDS G Q L S I ES +KL S N+AS + S + +KQ + + + DG
Sbjct: 575 KSDDSLGPQLLNS---------IAESTEKLSSSNLASHAKDSTSTSKQS-ADTRTINDGL 624
Query: 710 AQLRKHKEFADKINKINS--NGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLS 767
AQL+K KEFAD ++ +N + SED L+S + K D I D
Sbjct: 625 AQLQKFKEFADAVSLMNKKPSDSEDVLESGFKHPVSGNLADK--DSVHRDGILRGDSDTD 682
Query: 768 INDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKEN 827
A HP TS + D + SE E+ GN+N G + + E+
Sbjct: 683 YTTGIKAESEHPAGGKVTSVMHQMDPASIHSESTRAEMTGKDFTGNNNLGHSLPFSGIES 742
Query: 828 SVRAVSPGDSSIAV-VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAV 886
S + +S G S+ V + + DI +DINDRFPRDFLS+IF+ +E+ GVS MH DG
Sbjct: 743 SAKDISQGIPSVGVPATKQADITVDINDRFPRDFLSEIFSSGVFAED-PGVSTMHKDGVG 801
Query: 887 LSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLK 946
+S +++NH+P+ WSYF+ LAQ+ F ++DVSL+DQD +G S N EG Y + PL
Sbjct: 802 VSVHMKNHEPKHWSYFQKLAQEGFVQRDVSLIDQDSVGTPSAPAN-AEGDQKSYHFEPLT 860
Query: 947 PDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQ--SEVVNHRI 1004
D + S++NF E ++++ ++G + PD+ S++K +ES+Q + + N +
Sbjct: 861 -DVMSISHEYSQLNFGEDNKKDLPGVIGADSA-VLPDFGHSQVKDSESMQFGAMIENLKS 918
Query: 1005 QESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR 1064
+S YE +L+ G+P +D +L +FDI+TLQ+IKN+DLEEL+ELGSGTFGTVYHGKWR
Sbjct: 919 PDSVYEGAKLENRNVGLPPLDPSLVDFDINTLQVIKNDDLEELRELGSGTFGTVYHGKWR 978
Query: 1065 GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124
G+DVAIKR+KK CF+GRSSEQERLT EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT
Sbjct: 979 GSDVAIKRLKKICFSGRSSEQERLTSEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1038
Query: 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 1184
V E+MV+GSLRHVLL K+R+LDRRKRL+IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK
Sbjct: 1039 VAEYMVDGSLRHVLLKKDRYLDRRKRLLIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 1098
Query: 1185 DPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLW 1244
DP RPICKVGDFGLSKIKRNTLV+GGVRGTLPWMAPELLNGSS+KVSEKVDVFSFGIVLW
Sbjct: 1099 DPQRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLNGSSNKVSEKVDVFSFGIVLW 1158
Query: 1245 EILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIA 1304
EILTGEEPYANMHYGAIIGGIVNNTLRP +P CD+EW++LMEQCWAP+P RPSFTEIA
Sbjct: 1159 EILTGEEPYANMHYGAIIGGIVNNTLRPTIPSNCDAEWKMLMEQCWAPNPAARPSFTEIA 1218
Query: 1305 RRLRVMS-AACQTKSH 1319
RLRVMS AA QTK H
Sbjct: 1219 GRLRVMSIAAGQTKGH 1234
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544602|ref|XP_002513362.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547270|gb|EEF48765.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1156 bits (2991), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 675/1328 (50%), Positives = 857/1328 (64%), Gaps = 104/1328 (7%)
Query: 10 MDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGGVRPVLNYSI 69
M+Q +++V+Y+ E E A+ +P+S+ NTN+R PD + + V+PVLNYSI
Sbjct: 1 MEQSDVHKKVQYNAREPGRERFQPASHPILLEPASSRNTNMRLPDLN-APEVKPVLNYSI 59
Query: 70 QTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSESGSDITMLNA 129
QTGEEFALEFMR+RV ++ +PN+ G+PN+ +M+LKGVLG SH SE+GSDI+ML++
Sbjct: 60 QTGEEFALEFMRDRVNHKKPLIPNSLGNPNHGTSFMELKGVLGTSHIESENGSDISMLHS 119
Query: 130 AETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSGASDSSR-KVKF 188
E G ++ ER S +E++S Y+ + SVP+TS+ + GY+SS AS SS K+K
Sbjct: 120 VENG-PRKGERTNLSLYEEKSNYELVHSVPQTSAEYESRELLPGYSSSIASGSSSTKIKV 178
Query: 189 LCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGED 248
LCSFGG ILPRPSDGKLRYVGG+TRIIRISRDISWQEL QK AI NQ H IKYQLPGED
Sbjct: 179 LCSFGGTILPRPSDGKLRYVGGDTRIIRISRDISWQELKQKTFAICNQPHVIKYQLPGED 238
Query: 249 LDALVSVSCDEDLQNMMEECNVLEDR-GTQKPRMFLFSSADLEDTQLSLESMEGDSEIQY 307
LDALVSVSCDEDL+NMMEE ++DR G+QK RMFLFS +DLED Q L SMEGDSE+QY
Sbjct: 239 LDALVSVSCDEDLRNMMEEWIEVDDREGSQKLRMFLFSMSDLEDAQFGLGSMEGDSEVQY 298
Query: 308 VVAVNCMDLGSRKNSI--ALASASENNLDELLGLRVEREAGHIAAELAGSGATNLAYNAS 365
VVA+N MD+ SR+NSI L S+S NNL+EL GL ++RE A G + L
Sbjct: 299 VVAINGMDMRSRRNSILHGLGSSSGNNLNELDGLNIDRETSRAATASVGINTSPL----- 353
Query: 366 SSTIQSSQPVLVSSGSGYESNLQPYQGQRMQHISSTLYPADGLPPLDVKSTTPLSTPLQH 425
+ST QS+QP+L +S + +ES+ Y GQ M + + + AD ++
Sbjct: 354 TSTFQSAQPILQNSSTSHESHPHFYHGQMMDNRETQQFLAD----------------CRN 397
Query: 426 DYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADDSEACAQEVKQKIDS 485
D SN++ E IP +H NQQGG+ + +S F +S+ +EV+
Sbjct: 398 D----SSNYSAPKE--IPQSTSLHSLTNQQGGMNAGQSHSNFQVQNSQMLEKEVR----- 446
Query: 486 LADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSENDHVVSSHSYVSSVSN 545
I + +D I + H + +++ +
Sbjct: 447 ---PIPDGSVQHGID---------IGKSHPIERVSAV----------------------- 471
Query: 546 YIPREEVSV-VSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR-KNNDDDVRFQAS 603
P +E+SV V++ G + S+ PSK+ + S ++A++ N+ +D +F S
Sbjct: 472 --PVDEISVAVAAQEGALHSM-PSKNEGKQRGSESISFSVDAIDPVHVPNSCEDDQFSTS 528
Query: 604 GGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTE-KNRLSKSDDSFGSQFLI 661
F DS + + SY PSA PQR Y+SE+IPREQ E NRLSKSDDS GSQFLI
Sbjct: 529 SSIFGFDCADSVSNLIDLSYVEPSAPPQRVYYSERIPREQAELMNRLSKSDDSLGSQFLI 588
Query: 662 SQALSDGS--KPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFA 719
+ D + K S +KL N+ +TE A+ + Q + +G AQ +K+ E A
Sbjct: 589 PHSRPDIAEQKSTTASAEKLIQSNLLPQTEDPSTTAEPLLIDPQPI-NGLAQPQKYIELA 647
Query: 720 DKINKINSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHP 779
+ +N N S + V K+ DC ++ V++ A +P
Sbjct: 648 AP-DDVNDNDSVN-----------RNAVLKADHDCAAGNHKKPVEETG-----EARFGNP 690
Query: 780 TANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSVRAVSPGDSSI 839
A T G D ++ EI N+N G + + E+S VS I
Sbjct: 691 AAPQTTPGMYHRDPVSDHPGHKLGEITGKVFASNENVGYSLPYSLTESSTNDVSQEVPPI 750
Query: 840 AV-VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRR 898
V + GDI IDINDRFPRDFLS+IF++ ++E+ AGV+P+H DGA +S +ENH+P+
Sbjct: 751 FVSATKPGDISIDINDRFPRDFLSEIFSRGILTEDRAGVNPLHKDGAGMSVIMENHEPKH 810
Query: 899 WSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSR 958
WSYF+ LAQ+EF +KD SLMDQDHLG + +EG Y + LK +G M Q SR
Sbjct: 811 WSYFQKLAQEEFVQKDFSLMDQDHLGTPPLIAKFKEGDQNSYHFARLKTEGVSMDQKYSR 870
Query: 959 INFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVV--NHRIQESDYEEGRLDL 1016
NF EG+ ++ + + + + S +KG+ES+Q VV N + E E G LD
Sbjct: 871 PNFVEGTNQKVLAGLRAADSTILSGFDHSHVKGSESMQFGVVMDNLKTPEPRAEGGNLDN 930
Query: 1017 PTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKS 1076
+G+P V L++ +FDI TLQIIKNEDLEEL+ELGSGTFGTVYHGKWRG+DVAIKR+KK
Sbjct: 931 RNSGLPPVGLSVVDFDIDTLQIIKNEDLEELRELGSGTFGTVYHGKWRGSDVAIKRLKKI 990
Query: 1077 CFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRH 1136
CFTGRSSEQERLT+EFW EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE+MV+GSLRH
Sbjct: 991 CFTGRSSEQERLTIEFWHEAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEYMVDGSLRH 1050
Query: 1137 VLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
VLL K+R+LDRRKRL+IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP RPICKVGDF
Sbjct: 1051 VLLKKDRYLDRRKRLLIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPQRPICKVGDF 1110
Query: 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 1256
GLSKIKRNTLV+GGVRGTLPWMAPELLNG S+KVSEKVDVFSFGIVLWEILTGEEPYANM
Sbjct: 1111 GLSKIKRNTLVSGGVRGTLPWMAPELLNGGSNKVSEKVDVFSFGIVLWEILTGEEPYANM 1170
Query: 1257 HYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS-AACQ 1315
HYGAIIGGIVNNTLRP +P FCD EW+ LMEQCWAP+P RP+FTEIA RLR+MS AA Q
Sbjct: 1171 HYGAIIGGIVNNTLRPAIPNFCDPEWKRLMEQCWAPNPAARPAFTEIAGRLRIMSTAASQ 1230
Query: 1316 TKSHGHQV 1323
K GH+
Sbjct: 1231 NKGQGHKA 1238
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555219|ref|XP_003545932.1| PREDICTED: uncharacterized protein LOC100802996 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1127 bits (2914), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 666/1318 (50%), Positives = 838/1318 (63%), Gaps = 95/1318 (7%)
Query: 20 RYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGGVRPVLNYSIQTGEEFALEF 79
+Y+++E NE SA Q D ++ N RPP ++M+ +PVLNYSIQTGEEFALEF
Sbjct: 5 QYNSMEPNNEEFHSAPQLVPQDLRDGMHINARPPAFNMAEN-KPVLNYSIQTGEEFALEF 63
Query: 80 MRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSESGSDITMLNAAETGRAQELE 139
MR+RV R+ PN GDPN S YM+LKG+LG H GSESGSDI++L E G +E +
Sbjct: 64 MRDRVNLRKPAFPNVVGDPNYSTGYMELKGILG--HPGSESGSDISVLTKVEKG-PKEFD 120
Query: 140 RKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSGASDSS-RKVKFLCSFGGKILP 198
R+ S H+DRS Y S RS+PRTSS D R G ASS S+S+ K+K LCSFGG+ILP
Sbjct: 121 RRNSSQHQDRSNYGSARSIPRTSSNQDSYRVLHGTASSSVSESTPMKMKVLCSFGGRILP 180
Query: 199 RPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGEDLDALVSVSCD 258
RP DGKLRYVGGETRII I RDI + EL K L+IYN+TH IKYQLPGEDLDALVSVS D
Sbjct: 181 RPGDGKLRYVGGETRIISIRRDIRFHELMLKTLSIYNETHVIKYQLPGEDLDALVSVSSD 240
Query: 259 EDLQNMMEECNVLED-RGTQKPRMFLFSSADLEDTQLSLESMEGDSEIQYVVAVNCMDLG 317
EDL+NMMEEC+ L+ RG+ K R+FLFS DL+DTQ + SM+GDSEIQYVVAVN MD+G
Sbjct: 241 EDLRNMMEECHDLQGGRGSNKLRIFLFSLNDLDDTQFGIGSMDGDSEIQYVVAVNGMDMG 300
Query: 318 SRKNSIALA-SASENNLDELLGLRVEREAGHIAAELAGSGATNLAYNASSS-TIQSSQPV 375
SR NSI S S +NL EL ERE + + G ++L N S TIQSSQPV
Sbjct: 301 SRNNSILCGESGSTHNLHELNEQNNERETNRVLMDTFGVSGSSLTDNVKPSLTIQSSQPV 360
Query: 376 LVSSGSGYESNLQPYQGQRMQHISSTLYPADGLPPLDVKSTTPLSTPLQHDYGSHPSNFA 435
L S + YE++ Y ++H ++ YP LQH G PSN +
Sbjct: 361 LPISSNAYETHPLFYDDPVIRHGEASQYP------------------LQHGLG--PSNNS 400
Query: 436 TCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADDSEACAQEVKQKIDSLADKIKESEK 495
IP+ +P HG ++Q G + + + S S VK+K D+ + K
Sbjct: 401 AHNIQEIPVSMPTHGHVDQ-GIMNDGQASSELQVQISAMPETLVKRKGDNFIHTDNDPGK 459
Query: 496 IRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSENDHVVSSHSYVSSVSNYIPREEVSVV 555
+ L+ Q + + H+ +S S +
Sbjct: 460 VFPLEATYPIPSQPFEGN----------------------LHANLSEAS--------ATT 489
Query: 556 SSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR--KNNDDDVRFQASGGAFTSGHGD 613
+ S G+ P+L PSK+ Q+ S ++N + K+ +DD F S AF+ H D
Sbjct: 490 AISEGLHPAL-PSKNKGKHQQSEDASSLFSSMNPTQTPKSVEDDF-FTTSNDAFSRAHVD 547
Query: 614 SEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEK-NRLSKSDDSFGSQFLISQALSDGSKP 671
+E+ +FSY P +P R Y+SE+IPREQ + NR +KSDD+ GS L+S LSD S+
Sbjct: 548 AESNVIDFSYLEPPPLPNRVYYSERIPREQADLLNRSTKSDDAHGSHLLMSDLLSDFSQK 607
Query: 672 --IRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFADKINKINSNG 729
I ES D LHSGNM++ S + AK + + D Q +K+ D +K+NS
Sbjct: 608 NSITESSDILHSGNMSNLNMMSSSAAKPLQADGHTINDVLPQ--TYKQLPDTTSKVNS-- 663
Query: 730 SEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHPTANHGTSGKN 789
L V +S E K+ + ++ G H + S ++
Sbjct: 664 -----------KLLQHVNSESKQVLEDNKVSRNEDQVLSSENRTKGAEHLAFHRVPSVEH 712
Query: 790 PEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSVRAVSPGDSSIAVVSP-EGDI 848
++ + K + +E++ + + ND K Q+Q+ N+ + VS A P +GDI
Sbjct: 713 NQNLTSKLPDLNLSEVST-RESDNDTKVQSQTFPLTGNTGQDVSQEFPPEAKSRPTQGDI 771
Query: 849 LIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRRWSYFRNLAQD 908
LIDI DRFPRDFL D+F+KA ISE+ + + P+ D A LS N+ NH+P+RWSYF+NLA++
Sbjct: 772 LIDIEDRFPRDFLYDMFSKAIISEDSSSIGPLPTDRAGLSLNMGNHEPKRWSYFQNLAKE 831
Query: 909 EFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRE 968
F +VSL+DQD+LGFSS + ++EG + PL G + + S +N E SQ+
Sbjct: 832 GFD--NVSLIDQDNLGFSSAVRKVQEGDSKSQPSAPLPAAGVLAGHTESHLNVGEESQKN 889
Query: 969 SSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQ--ESDYEEGRLDLPTAGIPLVDL 1026
H Y S+LKGNE+ + V IQ ES+Y++G+ + P +
Sbjct: 890 VPVATKTEATIFHQKYEHSQLKGNENKNMDAVMENIQPQESEYQDGKDE------PRNVV 943
Query: 1027 ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQE 1086
G FD ST+Q IKNEDLEEL+ELGSGTFGTVYHGKWRG+DVAIKRIKKSCF GRSSEQE
Sbjct: 944 VAGEFDTSTVQFIKNEDLEELRELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQE 1003
Query: 1087 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 1146
RLT+EFWREA+ILSKLHHPNVVAFYGVVQDGPG TLATV E+MV+GSLR+VLL K+R+LD
Sbjct: 1004 RLTIEFWREADILSKLHHPNVVAFYGVVQDGPGATLATVAEYMVDGSLRNVLLRKDRYLD 1063
Query: 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206
RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP+RPICKVGDFGLSKIKRNTL
Sbjct: 1064 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPMRPICKVGDFGLSKIKRNTL 1123
Query: 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1266
V+GGVRGTLPWMAPELLNGSS+KVSEKVDVFSFGIVLWEILTG+EPYANMHYGAIIGGIV
Sbjct: 1124 VSGGVRGTLPWMAPELLNGSSNKVSEKVDVFSFGIVLWEILTGDEPYANMHYGAIIGGIV 1183
Query: 1267 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC-QTKSHGHQV 1323
NNTLRP +P +CD +W+ LMEQCWAP+P VRPSFTEIARRLRVMSAA Q K GH+
Sbjct: 1184 NNTLRPTIPSYCDLDWKTLMEQCWAPNPAVRPSFTEIARRLRVMSAAASQIKGQGHKA 1241
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297737995|emb|CBI27196.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1116 bits (2886), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 568/865 (65%), Positives = 668/865 (77%), Gaps = 26/865 (3%)
Query: 462 KMYSGFHADDSEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINE 521
K Y G EA +VK + K+ E EK RSL+KEAS KE KIK D S+ K+NE
Sbjct: 384 KPYQGQKMRHGEAEQHQVKSGSYASPWKMNEPEKNRSLEKEASVKEAKIKTDSSVQKMNE 443
Query: 522 IDNIRRSENDHVVSSHSYVSSVSNYIPREEVSVVSSSPGI-VPSLLPSKSNKMAQEPIQN 580
++ IR E++H VSSH + SV NYIPR+E SVV+S+ I VP LLP K++K E +Q
Sbjct: 444 LEKIRSLESEHNVSSHPHDGSVPNYIPRDEASVVNSTADIGVPMLLP-KTSKKHLESVQI 502
Query: 581 SMPLEAVNEGRKNN-DDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQI 638
S P EAV++G+ N + D F SGGAF+ G+GDSEA+PT SY + IP R +HSE+I
Sbjct: 503 SKPPEAVSDGKINTFNGDGHFHTSGGAFSPGYGDSEADPTEVSYPEQTLIPPRVFHSERI 562
Query: 639 PREQTEKNRLSKSDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQ 698
PREQ E NRLSKSDDSFGSQFL+S SD S+ + ES+DKLH GN+ S++EQ+ +
Sbjct: 563 PREQAELNRLSKSDDSFGSQFLMSHTRSDVSQQVAESIDKLHGGNVTSQSEQAASSTTAL 622
Query: 699 YTNLQKVEDGHAQLRKHKEFADKINKINSNGSEDGLQSSLGKSELTQVVPKSADDCEVTK 758
YTN + VEDG Q K+K+ AD I K+NSN SEDGL L KSE P S DD E+
Sbjct: 623 YTNPKTVEDGLTQFEKYKDVADDIKKLNSNISEDGLGPKLLKSESKWPAPTSVDDHEIAG 682
Query: 759 IRETVKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQ 818
+R+ KD +++D EAAGL + TA+ GTS K +DS K + + W+E+A
Sbjct: 683 VRDGNKDPAVSDREAAGLNNLTASQGTSSKPHDDSPSKPTGFHWDEMA------------ 730
Query: 819 AQSLAQKENSVRAVSPGDSSIAVVSPEG-DILIDINDRFPRDFLSDIFTKARISENIAGV 877
N +R+V G+SS+ V +PEG DILIDINDRFPRDFLSDIF+KAR SE G+
Sbjct: 731 --------NPLRSVPGGESSVGVGAPEGGDILIDINDRFPRDFLSDIFSKARTSEGPPGI 782
Query: 878 SPMHGDGAVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGAT 937
SP+HGDG LS N+ENH+P+ WS+F+ LAQ+EF RK VSLMDQDHLG+ S L NIEEG
Sbjct: 783 SPLHGDGTGLSLNLENHEPKHWSFFQKLAQEEFIRKGVSLMDQDHLGYPSSLMNIEEGTP 842
Query: 938 VDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQS 997
+DYS+PPLK DG + SRINF+E Q+ESSS+V P+T++ H DY S +K +ES+Q
Sbjct: 843 IDYSFPPLKSDGVALGPMDSRINFEEEIQQESSSMVRPNTIDMHEDYDPSPVKRDESVQM 902
Query: 998 E-VVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFG 1056
+ + N R +SDYEE + ++ G P VD +LG+ DISTLQIIKNEDLEEL+ELGSGTFG
Sbjct: 903 DGMANPRTPDSDYEEVKFEIQNTGAPFVDPSLGDIDISTLQIIKNEDLEELRELGSGTFG 962
Query: 1057 TVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116
TVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLT+EFWREA+ILSKLHHPNVVAFYGVVQD
Sbjct: 963 TVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWREADILSKLHHPNVVAFYGVVQD 1022
Query: 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKC 1176
GPGGTLATVTEFMVNGSLRHVL+SK+RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKC
Sbjct: 1023 GPGGTLATVTEFMVNGSLRHVLVSKDRHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKC 1082
Query: 1177 DNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDV 1236
DNLLVNLKDP+RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSS+VSEKVDV
Sbjct: 1083 DNLLVNLKDPLRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSRVSEKVDV 1142
Query: 1237 FSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVV 1296
FSFGIVLWEILTGEEPYA+MHYGAIIGGIVNNTLRPPVP +CDSEW+LLMEQCWAPDP+
Sbjct: 1143 FSFGIVLWEILTGEEPYAHMHYGAIIGGIVNNTLRPPVPSYCDSEWKLLMEQCWAPDPIG 1202
Query: 1297 RPSFTEIARRLRVMSAACQTKSHGH 1321
RPSFTEIARRLR MSAACQTK G+
Sbjct: 1203 RPSFTEIARRLRAMSAACQTKPQGY 1227
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528667|ref|XP_003532921.1| PREDICTED: uncharacterized protein LOC100799118 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1114 bits (2882), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 668/1318 (50%), Positives = 845/1318 (64%), Gaps = 93/1318 (7%)
Query: 20 RYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGGVRPVLNYSIQTGEEFALEF 79
+Y+++E RNE SA Q D ++ N RPP ++MS +PVLNYSIQTGEEFALEF
Sbjct: 5 QYNSMEPRNEEFHSAPQLVPQDLRDGMHINARPPPFNMSEN-KPVLNYSIQTGEEFALEF 63
Query: 80 MRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSESGSDITMLNAAETGRAQELE 139
MR+RV R+ PN GDPN S YM+LKG+LG H GSESGSDI++L E G +E +
Sbjct: 64 MRDRVNLRKPAFPNVVGDPNYSTGYMELKGILG--HPGSESGSDISVLTKVEKG-PKEFD 120
Query: 140 RKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSGASDSSR-KVKFLCSFGGKILP 198
R+ S H+DRS Y S +S+PR+SS D R G +SS S+S+ K+K LCSFGGKILP
Sbjct: 121 RRNSSQHQDRSNYGSAQSIPRSSSNQDSYRVLHGTSSSSVSESASMKMKVLCSFGGKILP 180
Query: 199 RPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGEDLDALVSVSCD 258
RPSDGKLRYVGGETRII I RDI + EL K +IYN+TH IKYQLPGEDLDALVSVS D
Sbjct: 181 RPSDGKLRYVGGETRIISIRRDIRFHELMLKTSSIYNETHVIKYQLPGEDLDALVSVSSD 240
Query: 259 EDLQNMMEECNVLED-RGTQKPRMFLFSSADLEDTQLSLESMEGDSEIQYVVAVNCMDLG 317
EDL+NMMEEC+ L+ R + K R+FL S DL+DTQ + SM+GDSEIQYVVAVN M +G
Sbjct: 241 EDLRNMMEECHDLQGGRESNKLRIFLLSMNDLDDTQFGIGSMDGDSEIQYVVAVNGMGMG 300
Query: 318 SRKNSIALA-SASENNLDELLGLRVEREAGHIAAELAGSGATNLAYNASSS-TIQSSQPV 375
SR NSI S S NNL EL G ERE + + G +++L N S IQSSQPV
Sbjct: 301 SRNNSILRGESGSTNNLHELNGHNNERETNRVLMDTFGVSSSSLTDNVKPSLAIQSSQPV 360
Query: 376 LVSSGSGYESNLQPYQGQRMQHISSTLYPADGLPPLDVKSTTPLSTPLQHDYGSHPSNFA 435
L S + YE++ Y Q + H ++ YP LQH G PSN +
Sbjct: 361 LPISSNAYETHPLFYDEQIIHHGEASHYP------------------LQHGLG--PSNNS 400
Query: 436 TCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADDSEACAQEVKQKIDSLADKIKESEK 495
IP+ +P HG +NQ G + + + S S VK+K D+ + K
Sbjct: 401 AHNLEEIPVSMPTHGLVNQ-GIMNDGQASSQLQVQISAMPETLVKRKGDNFIHTGNDPGK 459
Query: 496 IRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSENDHVVSSHSYVSSVSNYIPREEVSVV 555
+ L+ Q + + H+ +S S +
Sbjct: 460 VFPLEAPYPIPLQPFEGN----------------------LHANISDAS--------ATA 489
Query: 556 SSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR--KNNDDDVRFQASGGAFTSGHGD 613
+ S G+ P+L PSK+ Q+ S + ++N + K+ +DD F + AF+ H D
Sbjct: 490 AISEGLHPAL-PSKNKGKHQQSEDASSLISSMNPTQTPKSVEDDF-FTTATDAFSHAHVD 547
Query: 614 SEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEK-NRLSKSDDSFGSQFLISQALSDGSKP 671
+E+ +FSY P +P R Y+SE+IPREQ + NR +KSDD+ GS L+S LSD S+
Sbjct: 548 AESNVIDFSYLEPPPLPNRVYYSERIPREQADLLNRSTKSDDAHGSHLLMSDLLSDFSQK 607
Query: 672 --IRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFADKINKINSNG 729
I ES D LH+GN ++ S + K + ++DG A + +K+ D K+N
Sbjct: 608 NSITESTDMLHNGNTSNLNMMSSSAGKPLQADGHTIDDGFAPPQTYKQLPDTTIKVNPKL 667
Query: 730 SEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHPTANHGTSGKN 789
S+ SE QV+ +D +V++ + V LS ++ E G H + S +
Sbjct: 668 SQHV------NSESKQVL----EDNKVSRNEDQV--LS-SENETKGTEHLAFHQVPSVEQ 714
Query: 790 PEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSVRAVSPGDSSIAVVSP-EGDI 848
++ + K + E++ + + ND K Q+Q+ N+ + VS A P +GDI
Sbjct: 715 NQNLASKLPDLNLAEVST-RESDNDTKVQSQTFPLTGNTGQDVSQDFPPEAKSRPTQGDI 773
Query: 849 LIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRRWSYFRNLAQD 908
LIDI DRFPRDFL D+F+KA ISE+ + + P+ D A LS N++NH+P+RWSYF+NLA +
Sbjct: 774 LIDIEDRFPRDFLYDMFSKAIISEDSSSIGPLPTDRAGLSLNMDNHEPKRWSYFQNLALE 833
Query: 909 EFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRE 968
F +VSL+DQD+LGFSS + ++EG + P G + ++ S +N E +Q+
Sbjct: 834 GFD--NVSLIDQDNLGFSSAVRKVQEGDSKSQPSAPQPAGGVLAGRTDSHLNIGEENQKN 891
Query: 969 SSSIVGPSTMETHPDYSRSELKGNESLQSEVV--NHRIQESDYEEGRLDLPTAGIPLVDL 1026
H Y S+LKGNE+ + + N R QES+Y++ + + P +
Sbjct: 892 VPVATKTEASIFHQKYEHSQLKGNENKNMDAIMENIRPQESEYQDDKNE------PRNVV 945
Query: 1027 ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQE 1086
G FD ST+Q IKNEDLEEL+ELGSGTFGTVYHGKWRG+DVAIKRIKKSCF GRSSEQE
Sbjct: 946 VAGEFDTSTVQFIKNEDLEELRELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQE 1005
Query: 1087 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 1146
RLT+EFWREA+ILSKLHHPNVVAFYGVVQDGPG TLATVTEFMV+GSLR+VLL K+R+LD
Sbjct: 1006 RLTIEFWREADILSKLHHPNVVAFYGVVQDGPGATLATVTEFMVDGSLRNVLLRKDRYLD 1065
Query: 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206
RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL
Sbjct: 1066 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1125
Query: 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1266
V+GGVRGTLPWMAPELLNGSS+KVSEKVDVFSFGIVLWEILTG+EPYANMHYGAIIGGIV
Sbjct: 1126 VSGGVRGTLPWMAPELLNGSSNKVSEKVDVFSFGIVLWEILTGDEPYANMHYGAIIGGIV 1185
Query: 1267 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC-QTKSHGHQV 1323
NNTLRP +P +CD EW+ LMEQCWAP+P VRPSF EIARRLRVMSAA Q K GH+
Sbjct: 1186 NNTLRPTIPSYCDLEWKTLMEQCWAPNPAVRPSFAEIARRLRVMSAAASQIKGQGHKA 1243
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1329 | ||||||
| TAIR|locus:2044702 | 1257 | AT2G35050 [Arabidopsis thalian | 0.267 | 0.282 | 0.746 | 2.5e-307 | |
| TAIR|locus:2032895 | 1147 | AT1G16270 [Arabidopsis thalian | 0.271 | 0.314 | 0.740 | 4.7e-244 | |
| TAIR|locus:2093146 | 1117 | AT3G24715 [Arabidopsis thalian | 0.212 | 0.253 | 0.809 | 4.3e-172 | |
| TAIR|locus:2206350 | 1248 | AT1G79570 [Arabidopsis thalian | 0.497 | 0.529 | 0.531 | 7.4e-169 | |
| TAIR|locus:2197788 | 1042 | AT1G04700 [Arabidopsis thalian | 0.248 | 0.316 | 0.717 | 1.8e-164 | |
| TAIR|locus:2102787 | 1171 | AT3G46920 [Arabidopsis thalian | 0.219 | 0.249 | 0.715 | 2e-156 | |
| TAIR|locus:2174552 | 1054 | AT5G57610 [Arabidopsis thalian | 0.261 | 0.329 | 0.600 | 1.4e-146 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.190 | 0.330 | 0.427 | 9e-48 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.201 | 0.287 | 0.388 | 1.9e-42 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.197 | 0.254 | 0.4 | 3e-42 |
| TAIR|locus:2044702 AT2G35050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1395 (496.1 bits), Expect = 2.5e-307, Sum P(3) = 2.5e-307
Identities = 274/367 (74%), Positives = 306/367 (83%)
Query: 965 SQRESSSIVGPSTM---ETHPDYSRSELKGNESL--QSEVVNHRIQESDYEEGRLDLPTA 1019
S++ +SS + P PD S + ++ Q + +I+ ++ + L+ A
Sbjct: 893 SEKVASSQIHPQIHFDGNIKPDVSTITIPDLNTVDTQEDYSQSQIKGAESTDATLN---A 949
Query: 1020 GIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFT 1079
G+PL+D + + +LQ+IKN+DLEELKELGSGTFGTVYHGKWRGTDVAIKRIK+SCF
Sbjct: 950 GVPLIDFMAADSGMRSLQVIKNDDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKRSCFI 1009
Query: 1080 GRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL 1139
GRSSEQERLT EFW EAEILSKLHHPNV+AFYGVV+DGPGGTLATVTE+MVNGSLRHVLL
Sbjct: 1010 GRSSEQERLTSEFWHEAEILSKLHHPNVMAFYGVVKDGPGGTLATVTEYMVNGSLRHVLL 1069
Query: 1140 SKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199
S RHLDRRKRLIIAMDAAFGMEYLHSK+IVHFDLKCDNLLVNLKDP RPICKVGDFGLS
Sbjct: 1070 SN-RHLDRRKRLIIAMDAAFGMEYLHSKSIVHFDLKCDNLLVNLKDPARPICKVGDFGLS 1128
Query: 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 1259
KIKRNTLVTGGVRGTLPWMAPELL+GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG
Sbjct: 1129 KIKRNTLVTGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 1188
Query: 1260 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA-ACQTKS 1318
AIIGGIVNNTLRP VP +CD EWR+LMEQCWAPDP VRP+F EIARRLR MS+ A TK
Sbjct: 1189 AIIGGIVNNTLRPTVPNYCDPEWRMLMEQCWAPDPFVRPAFPEIARRLRTMSSSAVHTKP 1248
Query: 1319 HG--HQV 1323
H HQ+
Sbjct: 1249 HAVNHQI 1255
|
|
| TAIR|locus:2032895 AT1G16270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1400 (497.9 bits), Expect = 4.7e-244, Sum P(3) = 4.7e-244
Identities = 271/366 (74%), Positives = 306/366 (83%)
Query: 960 NFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTA 1019
+ ++G + V P T E D + ++ +E + V N R + + E+ + + A
Sbjct: 781 DMEDGGEIARLHQVAPLT-ENRVD-PQMKVTESEEFDAMVENLRTSDCEQEDEKSETRNA 838
Query: 1020 GIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFT 1079
G+P V +L ++D S LQII N+DLEELKELGSGTFGTVYHGKWRG+DVAIKRIKKSCF
Sbjct: 839 GLPPVGPSLADYDTSGLQIIMNDDLEELKELGSGTFGTVYHGKWRGSDVAIKRIKKSCFA 898
Query: 1080 GRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL 1139
GRSSEQERLT EFW EAEILSKLHHPNVVAFYGVV+DGPG TLATVTE+MV+GSLRHVL+
Sbjct: 899 GRSSEQERLTGEFWGEAEILSKLHHPNVVAFYGVVKDGPGATLATVTEYMVDGSLRHVLV 958
Query: 1140 SKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199
K+RHLDRRKRLIIAMDAAFGMEYLH+KNIVHFDLKCDNLLVNLKDP RPICKVGDFGLS
Sbjct: 959 RKDRHLDRRKRLIIAMDAAFGMEYLHAKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 1018
Query: 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 1259
KIKRNTLV+GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG
Sbjct: 1019 KIKRNTLVSGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 1078
Query: 1260 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC---QT 1316
AIIGGIVNNTLRP +P +CDS+WR+LME+CWAP+P RPSFTEIA RLRVMS A Q+
Sbjct: 1079 AIIGGIVNNTLRPTIPSYCDSDWRILMEECWAPNPTARPSFTEIAGRLRVMSTAATSNQS 1138
Query: 1317 KSHGHQ 1322
K H+
Sbjct: 1139 KPPAHK 1144
|
|
| TAIR|locus:2093146 AT3G24715 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1216 (433.1 bits), Expect = 4.3e-172, Sum P(4) = 4.3e-172
Identities = 229/283 (80%), Positives = 249/283 (87%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWRE 1095
LQIIKN DLE+L ELGSGT+GTVYHG WRGTDVAIKRI+ SCF GRSSEQERLT +FWRE
Sbjct: 828 LQIIKNADLEDLTELGSGTYGTVYHGTWRGTDVAIKRIRNSCFAGRSSEQERLTKDFWRE 887
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
A+ILS LHHPNVVAFYG+V DG GGTLATVTEFMVNGSLRH LL K+R LD RK++IIAM
Sbjct: 888 AQILSNLHHPNVVAFYGIVPDGTGGTLATVTEFMVNGSLRHALLKKDRLLDTRKKIIIAM 947
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
DAAFGMEYLHSKNIVHFDLKC+NLLVNL+DP RPICKVGD GLS+IKRNTLV+GGVRGTL
Sbjct: 948 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDLGLSRIKRNTLVSGGVRGTL 1007
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275
PWMAPELLNGSS++VSEKVDVFS+GI LWEILTGEEPYA+MH GAIIGGIV NTLRPP+P
Sbjct: 1008 PWMAPELLNGSSTRVSEKVDVFSYGISLWEILTGEEPYADMHCGAIIGGIVKNTLRPPIP 1067
Query: 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKS 1318
C EW+ LMEQCW+ DP RP FTEI RLR MS TKS
Sbjct: 1068 KSCSPEWKKLMEQCWSVDPDSRPPFTEITCRLRSMSMEVVTKS 1110
|
|
| TAIR|locus:2206350 AT1G79570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1642 (583.1 bits), Expect = 7.4e-169, P = 7.4e-169
Identities = 370/696 (53%), Positives = 458/696 (65%)
Query: 639 PREQTEKNRLSKSDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQ 698
PR+ T + D Q +S + D + +HS + ++ + + P +Q
Sbjct: 573 PRQNTTAKPATYRDAVITGQVPLS-GIEDQLSTSSSTYAPVHSDSESNLIDLNY-PEPEQ 630
Query: 699 YTNLQKVEDGHAQLRKHKEFADKINKINSNGSEDGLQSSLGKSELTQVVPKSADDCEVTK 758
+ Q+V R+ E ++++K +++ S + S + Q K A V K
Sbjct: 631 SS--QRVYCSERIPREQLELLNRLSKSDNSLSSQFVTSESPANTAQQDSGKEA----VGK 684
Query: 759 IRETVKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQ 818
+ K ++ND+ H T H E + E + I N + NK +
Sbjct: 685 SHDEFK--TVNDDAN----HHT--HKDVETIFEKVGVSDETLESEPLHKIVNPDDANKNR 736
Query: 819 AQSLAQKENSVRAVSPGDSSIAVVSPE------GDILIDINDRFPRDFLSDIFTKARISE 872
+ A E V +S +++++ V PE GDILIDINDRFPRDFLS+IF++A ISE
Sbjct: 737 VVNGADTEIGVSNLSHVNAAMSHVIPEEQASLQGDILIDINDRFPRDFLSEIFSQA-ISE 795
Query: 873 NIAGVSPMHGDGAVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNI 932
+ + V P DGA +S NV+NHD + WSYF+ LA+D+F ++DV ++DQ S +
Sbjct: 796 DTSTVRPYPHDGAAVSMNVQNHDRKNWSYFQQLAEDQFIQRDV-VLDQADSRIPSDRKDG 854
Query: 933 EEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 992
E + + Y PL DG + ++ + S G T P ++K
Sbjct: 855 GESSRLPY-VSPLSRDGISTNLANPQLTLGQDYGGNFSEKDGGGTGSIPPALENEQMKVT 913
Query: 993 ESLQ--SEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGN-FDISTLQIIKNEDLEELKE 1049
ES + + V N R +S+ ++ + + A +P LG+ FD S LQIIKNEDLEEL+E
Sbjct: 914 ESEEFGAMVENLRTPDSEPKDEKTETRHAALP----PLGSEFDYSGLQIIKNEDLEELRE 969
Query: 1050 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109
LGSGTFGTVYHGKWRG+DVAIKRIKKSCF GRSSEQERLT EFW EAEILSKLHHPNVVA
Sbjct: 970 LGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWGEAEILSKLHHPNVVA 1029
Query: 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNI 1169
FYGVV+DGPGGTLATVTE+MV+GSLRHVL+ K+RHLDRRKRLIIAMDAAFGMEYLHSKN
Sbjct: 1030 FYGVVKDGPGGTLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIAMDAAFGMEYLHSKNT 1089
Query: 1170 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229
VHFDLKCDNLLVNLKDP RPICKVGDFGLSKIKRNTLV+GGVRGTLPWMAPELLNGSSSK
Sbjct: 1090 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLNGSSSK 1149
Query: 1230 VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQC 1289
VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP +PGFCD EWR LME+C
Sbjct: 1150 VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPGFCDDEWRTLMEEC 1209
Query: 1290 WAPDPVVRPSFTEIARRLRVMSAAC---QTKSHGHQ 1322
WAP+P+ RPSFTEIA RLRVMS+A Q+K H+
Sbjct: 1210 WAPNPMARPSFTEIAGRLRVMSSAATSTQSKPSAHR 1245
|
|
| TAIR|locus:2197788 AT1G04700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1248 (444.4 bits), Expect = 1.8e-164, Sum P(3) = 1.8e-164
Identities = 244/340 (71%), Positives = 278/340 (81%)
Query: 979 ETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGR-LDLPTAGIPLVDLALGNFDISTLQ 1037
+ H Y+R + N +SE+ E Y++ R D + +V++ G I LQ
Sbjct: 709 DDHKSYTREKEITNADHESEM------EEKYKKSRNTDDSFSEAAMVEIEAG---IYGLQ 759
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
IIKN DLE+L ELGSGTFGTVY+GKWRGTDVAIKRIK SCF+G SSEQ R T +FWREA
Sbjct: 760 IIKNTDLEDLHELGSGTFGTVYYGKWRGTDVAIKRIKNSCFSGGSSEQARQTKDFWREAR 819
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
IL+ LHHPNVVAFYGVV DGPGGT+ATVTE+MVNGSLRHVL K+R LDRRK+L+I +D+
Sbjct: 820 ILANLHHPNVVAFYGVVPDGPGGTMATVTEYMVNGSLRHVLQRKDRLLDRRKKLMITLDS 879
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
AFGMEYLH KNIVHFDLKCDNLLVNL+DP RPICKVGDFGLS+IKRNTLV+GGVRGTLPW
Sbjct: 880 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPW 939
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
MAPELLNGSS++VSEKVDVFSFGIV+WEILTGEEPYAN+H GAIIGGIVNNTLRPPVP
Sbjct: 940 MAPELLNGSSNRVSEKVDVFSFGIVMWEILTGEEPYANLHCGAIIGGIVNNTLRPPVPER 999
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 1317
C++EWR LMEQCW+ DP VRPSFTEI RLR M+ A Q K
Sbjct: 1000 CEAEWRKLMEQCWSFDPGVRPSFTEIVERLRSMTVALQPK 1039
|
|
| TAIR|locus:2102787 AT3G46920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1132 (403.5 bits), Expect = 2.0e-156, Sum P(4) = 2.0e-156
Identities = 209/292 (71%), Positives = 241/292 (82%)
Query: 1029 GNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERL 1088
G+ + LQIIK+ DLEEL+ELGSGTFGTVYHGKWRGTDVAIKRI CF G+ SEQER+
Sbjct: 873 GSDSLDQLQIIKDSDLEELRELGSGTFGTVYHGKWRGTDVAIKRINDRCFAGKPSEQERM 932
Query: 1089 TLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR 1148
+FW EA+ L+ LHHPNVVAFYGVV D PGG++ATVTE+MVNGSLR+ L R+ DR
Sbjct: 933 IDDFWNEAQNLAGLHHPNVVAFYGVVLDSPGGSVATVTEYMVNGSLRNALQKNVRNFDRC 992
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT 1208
KR +IAMD AFGMEYLH K IVHFDLK DNLLVNL+DP RPICKVGD GLSK+K TL++
Sbjct: 993 KRQLIAMDIAFGMEYLHGKKIVHFDLKSDNLLVNLRDPHRPICKVGDLGLSKVKCQTLIS 1052
Query: 1209 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1268
GGVRGTLPWMAPELLNG+SS VSEKVDVFSFGIVLWE+ TGEEPYA++HYGAIIGGIV+N
Sbjct: 1053 GGVRGTLPWMAPELLNGTSSLVSEKVDVFSFGIVLWELFTGEEPYADLHYGAIIGGIVSN 1112
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHG 1320
TLRP +P FCD +W+LLME+CW+ +P RPSFTEI LR M+ +K G
Sbjct: 1113 TLRPQIPDFCDMDWKLLMERCWSAEPSERPSFTEIVNELRTMATKLPSKEQG 1164
|
|
| TAIR|locus:2174552 AT5G57610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1133 (403.9 bits), Expect = 1.4e-146, Sum P(2) = 1.4e-146
Identities = 209/348 (60%), Positives = 270/348 (77%)
Query: 970 SSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALG 1029
+++ G + ++ HP+ ++ +++ E +++E + Q+ + D P A
Sbjct: 708 AALEGAAEVKAHPEEAKDQVRP-ELVENESEHMNAQDEPEIDSDSDNPNNFKIEQTKAEA 766
Query: 1030 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLT 1089
LQ I+N+DLEE++ELG GT+G+VYHGKW+G+DVAIKRIK SCF G+ SE+ERL
Sbjct: 767 EAKSRGLQSIRNDDLEEIRELGHGTYGSVYHGKWKGSDVAIKRIKASCFAGKPSERERLI 826
Query: 1090 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
+FW+EA +LS LHHPNVV+FYG+V+DGP G+LATV EFMVNGSL+ L K+R +DRRK
Sbjct: 827 EDFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVAEFMVNGSLKQFLQKKDRTIDRRK 886
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
RLIIAMD AFGMEYLH KNIVHFDLKC+NLLVN++DP RPICK+GD GLSK+K+ TLV+G
Sbjct: 887 RLIIAMDTAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQKTLVSG 946
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1269
GVRGTLPWMAPELL+G S+ VSEK+DV+SFGIV+WE+LTGEEPYA+MH +IIGGIVNN
Sbjct: 947 GVRGTLPWMAPELLSGKSNMVSEKIDVYSFGIVMWELLTGEEPYADMHCASIIGGIVNNA 1006
Query: 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 1317
LRP +P +CD EW+ LME CW +P RPSFTEI+++LR M+AA K
Sbjct: 1007 LRPKIPQWCDPEWKGLMESCWTSEPTERPSFTEISQKLRTMAAAMNLK 1054
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 505 (182.8 bits), Expect = 9.0e-48, Sum P(3) = 9.0e-48
Identities = 115/269 (42%), Positives = 157/269 (58%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
EDL +++G G+ GTVYHG W G+DVA+K K ++ E + F +E ++ +
Sbjct: 485 EDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYS------EEIITSFKQEVSLMKR 538
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
L HPNV+ F G V P L VTEF+ GSL +L + LD R+R+ +A D A GM
Sbjct: 539 LRHPNVLLFMGAVAS-PQ-RLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGM 596
Query: 1162 EYLH--SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
YLH S I+H DLK NLLV+ + KV DFGLS+IK T +T RGT WMA
Sbjct: 597 NYLHHCSPPIIHRDLKSSNLLVDRNWTV----KVADFGLSRIKHETYLTTNGRGTPQWMA 652
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279
PE+L ++ EK DV+SFG+VLWE++T + P+ N++ +IG + R VP D
Sbjct: 653 PEVLRNEAA--DEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVD 710
Query: 1280 SEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
+W LME CW +P RPSF E+ +LR
Sbjct: 711 PQWIALMESCWHSEPQCRPSFQELMDKLR 739
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 481 (174.4 bits), Expect = 1.9e-42, Sum P(3) = 1.9e-42
Identities = 112/288 (38%), Positives = 163/288 (56%)
Query: 1028 LGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 1087
L + D+ +I N DL + +G G++G VYH W GT+VA+K+ F+G +
Sbjct: 654 LDDADVGECEIPWN-DLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAA----- 707
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR 1147
EF E I+ +L HPNVV F G V P L+ VTEF+ GSL +L + H+D
Sbjct: 708 -LAEFRSEVRIMRRLRHPNVVFFLGAVTRPPN--LSIVTEFLPRGSLYRILHRPKSHIDE 764
Query: 1148 RKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205
R+R+ +A+D A GM LH+ IVH DLK NLLV+ + KVGDFGLS++K NT
Sbjct: 765 RRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNV----KVGDFGLSRLKHNT 820
Query: 1206 LVTG-GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1264
++ GT WMAPE+L S +EK DV+SFG++LWE+ T P+ M+ ++G
Sbjct: 821 FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLRLPWRGMNPMQVVGA 878
Query: 1265 IVNNTLRPPVPGFCDSE-WRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311
+ R +P D R+++E CW DP +RPSF ++ L+ ++
Sbjct: 879 VGFQNRRLEIPKELDPVVGRIILE-CWQTDPNLRPSFAQLTEVLKPLN 925
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 496 (179.7 bits), Expect = 3.0e-42, Sum P(2) = 3.0e-42
Identities = 112/280 (40%), Positives = 162/280 (57%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE 1091
D+S +I+ E++ + +G G++G VY G W GT+VA+K+ TG + E E
Sbjct: 737 DVSDCEILW-EEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALE------E 789
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
F E I+ KL HPN+V F G V P L+ VTEF+ GSL ++ LD R+RL
Sbjct: 790 FRSEVRIMKKLRHPNIVLFMGAVTRPPN--LSIVTEFLPRGSLYRLIHRPNNQLDERRRL 847
Query: 1152 IIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
+A+DAA GM YLHS N IVH DLK NLLV+ K+ + +C DFGLS++K +T ++
Sbjct: 848 RMALDAARGMNYLHSCNPMIVHRDLKSPNLLVD-KNWVVKVC---DFGLSRMKHSTYLSS 903
Query: 1210 -GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1268
GT WMAPE+L + EK DV+S+G++LWE+ T ++P+ M+ ++G +
Sbjct: 904 KSTAGTAEWMAPEVLRNEPA--DEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQ 961
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
R +P F D L+ +CW D +RPSF EI L+
Sbjct: 962 HRRLDIPDFVDPAIADLISKCWQTDSKLRPSFAEIMASLK 1001
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00030137001 | SubName- Full=Chromosome chr1 scaffold_5, whole genome shotgun sequence; (782 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1329 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-79 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-77 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-77 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-71 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-61 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-59 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-51 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-48 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-47 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-45 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-45 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-45 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-44 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-44 | |
| cd06410 | 97 | cd06410, PB1_UP2, Uncharacterized protein 2 | 4e-44 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-44 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-43 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-42 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-42 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-41 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-40 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-40 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-40 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-40 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-39 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-39 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-38 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-37 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-37 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-37 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-37 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-37 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-37 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-37 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-36 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-35 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-35 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-34 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-34 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-34 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-33 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-32 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-32 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-32 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-32 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-32 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-31 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-31 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-30 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-29 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-29 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-29 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-29 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-29 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-29 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-29 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-29 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-28 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-28 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-28 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-28 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-28 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-27 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-27 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-27 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-26 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-26 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-26 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-26 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-25 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-24 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-24 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-24 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-24 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-23 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-21 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-20 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-20 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-20 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-20 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-20 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-19 | |
| pfam00564 | 84 | pfam00564, PB1, PB1 domain | 3e-19 | |
| smart00666 | 81 | smart00666, PB1, PB1 domain | 4e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-18 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-17 | |
| cd05992 | 81 | cd05992, PB1, The PB1 domain is a modular domain m | 1e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-16 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-15 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-15 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-15 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-14 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| COG2112 | 201 | COG2112, COG2112, Predicted Ser/Thr protein kinase | 4e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-04 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 260 bits (668), Expect = 5e-79
Identities = 112/278 (40%), Positives = 139/278 (50%), Gaps = 34/278 (12%)
Query: 1044 LEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
LE K+LG G FG VY G +G T VA+K +K+ +SE+ER EF EA
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-----ASEEERE--EFLEEAS 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
I+ KL HPN+V GV G L VTE+M G L L L + L +A+
Sbjct: 54 IMKKLSHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGT 1214
A GMEYL SKN VH DL N LV + K+ DFGLS+ GG +
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVTEN----LVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH----YGAIIGGIVNNT 1269
+ WMAPE L K + K DV+SFG++LWEI T GE+PY M + G
Sbjct: 168 IKWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG----- 220
Query: 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
R P P C E LM QCWA DP RP+F+E+ L
Sbjct: 221 YRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 255 bits (653), Expect = 5e-77
Identities = 111/274 (40%), Positives = 139/274 (50%), Gaps = 27/274 (9%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGT------DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
L K+LG G FG VY GK +G +VA+K +K+ SEQ+ EF REA
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-----SEQQIE--EFLREAR 53
Query: 1098 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
I+ KL HPNVV GV ++ P L V E+M G L L L L A+
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEP---LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQ 110
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GMEYL SKN +H DL N LV + K+ DFGLS+ + G LP
Sbjct: 111 IARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDFGLSRDLYDDDYYRKRGGKLP 166
Query: 1217 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
WMAPE L K + K DV+SFG++LWEI T GE+PY M ++ + N R P
Sbjct: 167 IRWMAPESLK--EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG-YRLP 223
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P C E LM QCWA DP RP+F+E+ L
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 254 bits (652), Expect = 6e-77
Identities = 106/274 (38%), Positives = 135/274 (49%), Gaps = 26/274 (9%)
Query: 1044 LEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
L K+LG G FG VY G +G +VA+K +K+ +SEQ+ EF REA
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-----ASEQQIE--EFLREAR 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMD 1156
I+ KL HPN+V GV + + V E+M G L L L L A+
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMI--VMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ 111
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GMEYL SKN +H DL N LV + K+ DFGLS+ + G LP
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 1217 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
WMAPE L K + K DV+SFG++LWEI T GEEPY M ++ + P
Sbjct: 168 IRWMAPESLK--EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK 225
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P C E LM QCWA DP RP+F+E+ L
Sbjct: 226 PPN-CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 4e-71
Identities = 104/279 (37%), Positives = 138/279 (49%), Gaps = 35/279 (12%)
Query: 1048 KELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K+LG G FG VY GK +G T+VA+K +K+ +SE+ER +F +EA ++ KL
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-----ASEEERK--DFLKEARVMKKL 53
Query: 1103 HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------ERHLDRRKRLII 1153
HPNVV GV ++ P L V E+M G L L + L + L
Sbjct: 54 GHPNVVRLLGVCTEEEP---LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV-TGGVR 1212
A+ A GMEYL SK VH DL N LV + K+ DFGLS+ +
Sbjct: 111 AIQIAKGMEYLASKKFVHRDLAARNCLVGED----LVVKISDFGLSRDVYDDDYYRKKTG 166
Query: 1213 GTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1269
G LP WMAPE L + K DV+SFG++LWEI T G PY + ++ +
Sbjct: 167 GKLPIRWMAPESLK--DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE-YLRKG 223
Query: 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
R P P +C E LM CW DP RP+F+E+ RL
Sbjct: 224 YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 1e-61
Identities = 86/263 (32%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E L++LG G+FG VY + + T VAIK IKK ++ER RE +IL KL
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK---KIKKDRER----ILREIKILKKL 54
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HPN+V Y V +D L V E+ G L +L + R + R + +E
Sbjct: 55 KHPNIVRLYDVFEDE--DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR-QILSALE 111
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPEL 1222
YLHSK IVH DLK +N+L++ + K+ DFGL++ GT +MAPE+
Sbjct: 112 YLHSKGIVHRDLKPENILLDEDGHV----KLADFGLARQLDPGEKLTTFVGTPEYMAPEV 167
Query: 1223 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLRPPVPGF-CDS 1280
L G + VD++S G++L+E+LTG+ P+ + I P P +
Sbjct: 168 LLG--KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP 225
Query: 1281 EWRLLMEQCWAPDPVVRPSFTEI 1303
E + L+ + DP R + E
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 2e-60
Identities = 94/270 (34%), Positives = 145/270 (53%), Gaps = 26/270 (9%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E L++LGSG+FGTVY K +GT VA+K +KK S++++ RE IL +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKR---SEKSKKDQ---TARREIRILRR 54
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
L HPN+V +D L V E+ G L LS+ L + IA+ G+
Sbjct: 55 LSHPNIVRLIDAFEDK--DHLYLVMEYCEGGDLFD-YLSRGGPLSEDEAKKIALQILRGL 111
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMA 1219
EYLHS I+H DLK +N+L++ + K+ DFGL+K +K ++ +T V GT +MA
Sbjct: 112 EYLHSNGIIHRDLKPENILLDEN----GVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMA 166
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279
PE+L G + KVDV+S G++L+E+LTG+ P++ + + ++ L PP+
Sbjct: 167 PEVLLG-GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL-QLIRRILGPPLEFDEP 224
Query: 1280 ------SEWRLLMEQCWAPDPVVRPSFTEI 1303
E + L+++C DP RP+ EI
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 8e-59
Identities = 89/257 (34%), Positives = 123/257 (47%), Gaps = 49/257 (19%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FGTVY + + T VAIK IKK + L E RE EIL KL+HPN+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE-------DSSSLLEELLREIEILKKLNHPNI 53
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 1167
V YGV +D L V E+ GSL+ +L E L + L I + G+EYLHS
Sbjct: 54 VKLYGVFEDENHLYL--VMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN 111
Query: 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLNGS 1226
I+H DLK +N+L++ + K+ DFGLSK + + + + GT +MAPE+L G
Sbjct: 112 GIIHRDLKPENILLDSDN---GKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG- 167
Query: 1227 SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLM 1286
SEK D++S G++L+E+ E + L+
Sbjct: 168 KGYYSEKSDIWSLGVILYEL---------------------------------PELKDLI 194
Query: 1287 EQCWAPDPVVRPSFTEI 1303
+ DP RPS EI
Sbjct: 195 RKMLQKDPEKRPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 5e-51
Identities = 98/273 (35%), Positives = 136/273 (49%), Gaps = 26/273 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I +++L+ +G G FG V G +RG VA+K +K ++ F EA +
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQA---------FLAEASV 53
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDA 1157
++ L HPN+V GVV G L VTE+M GSL L S+ R + ++L A+D
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP- 1216
GMEYL KN VH DL N+LV+ + KV DFGL+K + G LP
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDL----VAKVSDFGLAKEASQGQDS----GKLPV 163
Query: 1217 -WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 1274
W APE L K S K DV+SFGI+LWEI + G PY + ++ + R
Sbjct: 164 KWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEA 220
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P C E +M+ CW DP RP+F ++ +L
Sbjct: 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 8e-49
Identities = 95/272 (34%), Positives = 136/272 (50%), Gaps = 25/272 (9%)
Query: 1048 KELGSGTFGTVYHGKWRGT-----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K +G G FG V G+ + DVAIK +K S+++RL +F EA I+ +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-----SDKQRL--DFLTEASIMGQF 62
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HPN++ GVV + +TE+M NGSL L + + + + A GM+
Sbjct: 63 DHPNIIRLEGVVTKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN---TLVTGGVRGTLPWMA 1219
YL N VH DL N+LVN +CKV DFGLS+ + T T G + + W A
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNL----VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA 176
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278
PE + + K + DV+SFGIV+WE+++ GE PY +M +I + + R P P C
Sbjct: 177 PEAI--AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMDC 233
Query: 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
S LM CW D RP+F++I L M
Sbjct: 234 PSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-48
Identities = 87/266 (32%), Positives = 129/266 (48%), Gaps = 29/266 (10%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G+FG+VY + T +A+K ++ S + E LE RE ILS L HP
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA----LE--REIRILSSLQHP 59
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-----RRKRLIIAMDAAFG 1160
N+V +YG +D TL E++ GSL LL K L + R I+ G
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILE-----G 113
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---RNTLVTGGVRGTLPW 1217
+ YLHS IVH D+K N+LV+ + K+ DFG +K TG VRGT W
Sbjct: 114 LAYLHSNGIVHRDIKGANILVDSDG----VVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAIIGGIVNNTLRPPVPG 1276
MAPE++ G + D++S G + E+ TG+ P++ + A + I ++ P +P
Sbjct: 170 MAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227
Query: 1277 FCDSEWRLLMEQCWAPDPVVRPSFTE 1302
E + + +C DP RP+ E
Sbjct: 228 HLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-47
Identities = 95/270 (35%), Positives = 137/270 (50%), Gaps = 24/270 (8%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
+L LKELGSG FG V+ GKWRG DVAIK I++ G SE + F EA+++ K
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE----GAMSEDD-----FIEEAKVMMK 55
Query: 1102 LHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
L HPN+V YGV + P + VTE+M NG L + L ++ L L + D
Sbjct: 56 LSHPNLVQLYGVCTKQRP---IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEA 112
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT--GGVRGTLPWM 1218
MEYL S +H DL N LV + KV DFGL++ + T G + + W
Sbjct: 113 MEYLESNGFIHRDLAARNCLVGE----DNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA 168
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
PE+ + S+ S K DV+SFG+++WE+ + G+ PY ++ + R P
Sbjct: 169 PPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYRPKL 225
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
+E +M CW P RP+F ++ +L
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 96/268 (35%), Positives = 136/268 (50%), Gaps = 25/268 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L+ ++LG+G FG V+ G W G T VA+K +K + + F +EA+
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA---------FLQEAQ 53
Query: 1098 ILSKLHHPNVVAFYGVVQDG-PGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAM 1155
I+ KL H +V Y V + P + VTE+M GSL L S E + L + + +A
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEP---IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRG 1213
A GM YL S+N +H DL N+LV +CK+ DFGL+++ + T G +
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGEN----LVCKIADFGLARLIEDDEYTAREGAKF 166
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272
+ W APE N + + K DV+SFGI+L EI+T G PY M ++ + R
Sbjct: 167 PIKWTAPEAAN--YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRM 223
Query: 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSF 1300
P P C E LM QCW DP RP+F
Sbjct: 224 PRPPNCPEELYDLMLQCWDKDPEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 89/287 (31%), Positives = 140/287 (48%), Gaps = 31/287 (10%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLT 1089
L+I+K +LE++K LGSG FGTVY G W VAIK +++ T + +E L
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEIL- 57
Query: 1090 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLDRR 1148
EA +++ + HP+VV G+ + +T+ M G L +V K+ + +
Sbjct: 58 ----DEAYVMASVDHPHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQ 109
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNT 1205
L + A GM YL K +VH DL N+LV K P K+ DFGL+K+
Sbjct: 110 YLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--KTP--QHVKITDFGLAKLLDVDEKE 165
Query: 1206 LVTGGVRGTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIG 1263
G + + WMA E +L+ + K DV+S+G+ +WE++T G +PY + I
Sbjct: 166 YHAEGGKVPIKWMALESILHR---IYTHKSDVWSYGVTVWELMTFGAKPYEGIP-AVEIP 221
Query: 1264 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
++ R P P C + +++ +CW D RP+F E+ M
Sbjct: 222 DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 5e-45
Identities = 103/267 (38%), Positives = 143/267 (53%), Gaps = 25/267 (9%)
Query: 1048 KELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 1106
+++G G FG VY G + T+VA+K +C RS+ L +F +EAEIL + HPN
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TC---RSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 1107 VVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+V GV VQ P + V E + GSL L K+ L +K L +++DAA GMEYL
Sbjct: 54 IVKLIGVCVQKQP---IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL--VTGGVRGTLP--WMAPE 1221
SKN +H DL N LV + + K+ DFG+S+ + + V+ G +P W APE
Sbjct: 111 SKNCIHRDLAARNCLVGENN----VLKISDFGMSREEEGGIYTVSDG-LKQIPIKWTAPE 165
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 1280
LN + + + DV+S+GI+LWE + G+ PY M + + R P P C
Sbjct: 166 ALN--YGRYTSESDVWSYGILLWETFSLGDTPYPGMS-NQQTRERIESGYRMPAPQLCPE 222
Query: 1281 EWRLLMEQCWAPDPVVRPSFTEIARRL 1307
E LM QCWA DP RPSF+EI L
Sbjct: 223 EIYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 94/275 (34%), Positives = 135/275 (49%), Gaps = 25/275 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I ++ L++LG+G FG V+ G W T VA+K +K G ++ F EA+
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLK----PGTMDPKD-----FLAEAQ 53
Query: 1098 ILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAM 1155
I+ KL HP ++ Y V + P + VTE M GSL L R L + + +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEP---IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
A GM YL ++N +H DL N+LV + ICKV DFGL+++ + +
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENN----ICKVADFGLARVIKEDIYEAREGAKF 166
Query: 1216 P--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272
P W APE ++ S K DV+SFGI+L EI+T G PY M ++ V+ R
Sbjct: 167 PIKWTAPEAAL--YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-QQVDQGYRM 223
Query: 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P P C E +M CW DP RP+F + +L
Sbjct: 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 98/294 (33%), Positives = 138/294 (46%), Gaps = 44/294 (14%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTL 1090
+ E + ++ELG G+FG VY G +G T VAIK + +S +ER+
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-----NENASMRERI-- 54
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDG-PGGTLATVTEFMVNGSLRHVLLS---KERH-- 1144
EF EA ++ + + +VV GVV G P TL V E M G L+ L S + +
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSTGQP--TL-VVMELMAKGDLKSYLRSRRPEAENNP 111
Query: 1145 ----LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
+K + +A + A GM YL +K VH DL N +V K+GDFG+++
Sbjct: 112 GLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL----TVKIGDFGMTR 167
Query: 1201 -IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY--- 1253
I G +G LP WMAPE L + K DV+SFG+VLWE+ T E+PY
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESL--KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225
Query: 1254 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
+N + L P C + LM CW +P +RP+F EI L
Sbjct: 226 SNEEVLKFVID--GGHLDLPEN--CPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|99731 cd06410, PB1_UP2, Uncharacterized protein 2 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 4e-44
Identities = 57/98 (58%), Positives = 73/98 (74%), Gaps = 3/98 (3%)
Query: 189 LCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQTH--TIKYQLPG 246
LCS+GG+ILPRP DG+LRYVGGETRI+ + R IS++EL K ++ T+KYQLP
Sbjct: 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPD 60
Query: 247 EDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLF 284
EDLDAL+SVS DEDL+NMMEE + L + + R+FLF
Sbjct: 61 EDLDALISVSNDEDLKNMMEEYDRLSGG-SARLRVFLF 97
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. Length = 97 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 8e-44
Identities = 97/270 (35%), Positives = 134/270 (49%), Gaps = 24/270 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I +DL LKELG+G FG V +GKWRG DVAIK IK+ G SE E F EA+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDE-----FIEEAK 51
Query: 1098 ILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ KL H +V YGV + P + VTE+M NG L + L + + L + D
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRP---IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
GM YL SK +H DL N LV+ + KV DFGLS+ + T V P
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQG----CVKVSDFGLSRYVLDDEYTSSVGSKFP 164
Query: 1217 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
W PE+L SK S K DV++FG+++WE+ + G+ PY + + + LR
Sbjct: 165 VRWSPPEVLL--YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-LRLY 221
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P + +M CW RP+F ++
Sbjct: 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 91/272 (33%), Positives = 135/272 (49%), Gaps = 25/272 (9%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
E+ ++LGSG FG V+ G W+ VAIK +K S+ +F +E + L
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILK--------SDDLLKQQDFQKEVQALK 57
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAF 1159
+L H ++++ + V G + +TE M GSL L S E + L + +A A
Sbjct: 58 RLRHKHLISLFAVCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAE 115
Query: 1160 GMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLP 1216
GM YL +N +H DL N+LV +L +CKV DFGL++ IK + ++ +
Sbjct: 116 GMAYLEEQNSIHRDLAARNILVGEDL------VCKVADFGLARLIKEDVYLSSDKKIPYK 169
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 1275
W APE + S K DV+SFGI+L+E+ T G+ PY M+ + I R P P
Sbjct: 170 WTAPEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCP 226
Query: 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
C E +M +CWA +P RPSF + L
Sbjct: 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 95/273 (34%), Positives = 130/273 (47%), Gaps = 32/273 (11%)
Query: 1048 KELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
KELG G FG+V G + +VA+K +K+ + ++ EF REA ++++L
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ----EHIAAGKK---EFLREASVMAQL 53
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HP +V GV + G L V E G L L K R + +A A GM
Sbjct: 54 DHPCIVRLIGVCK-GEPLML--VMELAPLGPL-LKYLKKRREIPVSDLKELAHQVAMGMA 109
Query: 1163 YLHSKNIVHFDLKCDN-LLVNLKDPIRPICKVGDFGLSKIKRN-----TLVTGGVRGTLP 1216
YL SK+ VH DL N LLVN R K+ DFG+S+ T G R L
Sbjct: 110 YLESKHFVHRDLAARNVLLVN-----RHQAKISDFGMSRALGAGSDYYRATTAG-RWPLK 163
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 1275
W APE +N K S K DV+S+G+ LWE + G +PY M GA + ++ + R P P
Sbjct: 164 WYAPECIN--YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-GAEVIAMLESGERLPRP 220
Query: 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
C E +M CW P RP+F+E+ R
Sbjct: 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 85/272 (31%), Positives = 129/272 (47%), Gaps = 37/272 (13%)
Query: 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
E L+++G G FG VY + + G +VAIK IK ++E++ E +IL
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKII----NEIQILK 52
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
K HPN+V +YG L V EF GSL+ +L S + L + + + G
Sbjct: 53 KCKHPNIVKYYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-----RNTLVTGGVRGTL 1215
+EYLHS I+H D+K N+L+ + K+ DFGLS RNT+V GT
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTSDGEV----KLIDFGLSAQLSDTKARNTMV-----GTP 161
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275
WMAPE++NG K D++S GI E+ G+ PY+ + + I N P
Sbjct: 162 YWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN----GPP 215
Query: 1276 GFCDSEW-----RLLMEQCWAPDPVVRPSFTE 1302
G + E + +++C +P RP+ +
Sbjct: 216 GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 94/298 (31%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTL 1090
++ + + +ELG G FG V+ G+ VA+K +K++
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-------SNDARK 53
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH------ 1144
+F REAE+L+ H N+V FYGV + G V E+M +G L L S
Sbjct: 54 DFEREAELLTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKS 111
Query: 1145 -------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGD 1195
L + L IA+ A GM YL S++ VH DL N LV +L + K+GD
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL------VVKIGD 165
Query: 1196 FGLSK-IKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GE 1250
FG+S+ + G LP WM PE ++ K + + DV+SFG+VLWEI T G+
Sbjct: 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVVLWEIFTYGK 222
Query: 1251 EPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
+P+ + +I I L P C SE +M CW DP R + +I RL+
Sbjct: 223 QPWYGLSNEEVIECITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 88/288 (30%), Positives = 134/288 (46%), Gaps = 37/288 (12%)
Query: 1044 LEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
L+ +K+LG G FG V ++ G VA+K + S S+ F RE E
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-------FEREIE 58
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
IL L H N+V + GV + G +L + E++ +GSLR L ++ ++ L+ +
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGTL 1215
GM+YL S+ +H DL N+LV +D + K+ DFGL+K+ + G
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLV----KISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 1216 P--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN----- 1267
P W APE L +SK S DV+SFG+ L+E+ T G+ + + GI
Sbjct: 175 PIFWYAPECL--RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV 232
Query: 1268 ----NTLRP----PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
L+ P P C E LM+ CW +P RPSF ++ +
Sbjct: 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 87/267 (32%), Positives = 124/267 (46%), Gaps = 27/267 (10%)
Query: 1048 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K+LG G+FG V G+W + VA+K +K + + F +EA I+ L
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD-------FLKEAAIMHSL 53
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-LSKERHLDRRKRLIIAMDAAFGM 1161
H N++ YGVV P L VTE GSL L H A+ A GM
Sbjct: 54 DHENLIRLYGVVLTHP---LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGM 110
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGTLPW 1217
YL SK +H DL N+L+ D + K+GDFGL + + + ++ ++ W
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKV----KIGDFGLMRALPQNEDHYVMEEHLKVPFAW 166
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 1276
APE L + S DV+ FG+ LWE+ T GEEP+A + I+ I R P
Sbjct: 167 CAPESLR--TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPE 224
Query: 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
C + +M QCWA +P RP+F +
Sbjct: 225 ACPQDIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 2e-40
Identities = 95/276 (34%), Positives = 139/276 (50%), Gaps = 28/276 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I +L +KELGSG FG V+ GKWR VAIK I + G SE++ F EA+
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE----GAMSEED-----FIEEAK 51
Query: 1098 ILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ KL HP +V YGV Q P L VTEFM NG L + L ++ L + L + D
Sbjct: 52 VMMKLSHPKLVQLYGVCTQQKP---LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGT 1214
GMEYL + +H DL N LV+ + KV DFG+++ + + G +
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTG----VVKVSDFGMTRYVLDDEYTSSSGAKFP 164
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV--NNTLR 1271
+ W PE+ N SK S K DV+SFG+++WE+ T G+ P+ ++ I R
Sbjct: 165 VKWSPPEVFN--FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR 222
Query: 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P + + + ++ CW P RP+F E+ R +
Sbjct: 223 PKLA--SMTVYEVMY-SCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 4e-40
Identities = 90/268 (33%), Positives = 126/268 (47%), Gaps = 24/268 (8%)
Query: 1049 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 1106
+LG G +G VY G W+ VA+K +K E EF +EA ++ ++ HPN
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEAAVMKEIKHPN 63
Query: 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDAAFGMEYLH 1165
+V GV P +TEFM G+L L R ++ L +A + MEYL
Sbjct: 64 LVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRGTLPWMAPELL 1223
KN +H DL N LV + KV DFGLS++ T G + + W APE L
Sbjct: 122 KKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 177
Query: 1224 NGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 1282
+ +K S K DV++FG++LWEI T G PY + + ++ R P C +
Sbjct: 178 --AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKGYRMERPEGCPPKV 234
Query: 1283 RLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
LM CW +P RPSF EI + M
Sbjct: 235 YELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 98/274 (35%), Positives = 140/274 (51%), Gaps = 26/274 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ ++L+ L+ +G G FG V G +RG VA+K IK T ++ F EA +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQA---------FLAEASV 52
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMDA 1157
+++L H N+V GV+ + GG L VTE+M GSL L S+ R + L+ ++D
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP- 1216
MEYL + N VH DL N+LV+ + + KV DFGL+K +T T G LP
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASSTQDT----GKLPV 163
Query: 1217 -WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 1274
W APE L K S K DV+SFGI+LWEI + G PY + ++ V +
Sbjct: 164 KWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDA 220
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
P C +M+QCW D RPSF ++ +L
Sbjct: 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 92/274 (33%), Positives = 135/274 (49%), Gaps = 24/274 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I +L ++E+GSG FG V+ G W VAIK I++ G SE++ F EA+
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE----GAMSEED-----FIEEAQ 51
Query: 1098 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ KL HP +V YGV + P + V EFM +G L L ++ + L + +D
Sbjct: 52 VMMKLSHPKLVQLYGVCTERSP---ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
GM YL S N++H DL N LV + KV DFG+++ + T P
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQ----VVKVSDFGMTRFVLDDQYTSSTGTKFP 164
Query: 1217 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
W +PE+ S SK S K DV+SFG+++WE+ + G+ PY N ++ I N R
Sbjct: 165 VKWSSPEVF--SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLY 221
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P LM+ CW P RPSF+ + +L
Sbjct: 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 7e-39
Identities = 99/292 (33%), Positives = 144/292 (49%), Gaps = 39/292 (13%)
Query: 1044 LEELKELGSGTFGTV----YH--GKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
L+ +++LG G FG+V Y G VA+K+++ S ++E R +F RE E
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLR---DFEREIE 57
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
IL L H N+V + GV L V E++ GSLR L LD RK L+ A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVTGGVRG 1213
GMEYL SK VH DL N+LV ++ + K+GDFGL+K+ K V
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILVESENRV----KIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN--MHYGAIIGG------- 1264
+ W APE L SK S DV+SFG+VL+E+ T + + + ++G
Sbjct: 174 PIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI 231
Query: 1265 ------IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
++ N R P P C +E +M++CW DP RPSF+E+A ++ +
Sbjct: 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 78/260 (30%), Positives = 128/260 (49%), Gaps = 31/260 (11%)
Query: 1049 ELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 1106
+G G FG VY G G VAIK+I + + + E ++L L HPN
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEI----DLLKNLKHPN 60
Query: 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF------G 1160
+V + G ++ +L + E+ NGSLR ++ ++ + L+ A + G
Sbjct: 61 IVKYIGSIETS--DSLYIILEYAENGSLRQII---KKFGPFPESLV----AVYVYQVLQG 111
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMA 1219
+ YLH + ++H D+K N+L KD + K+ DFG++ K+ + V GT WMA
Sbjct: 112 LAYLHEQGVIHRDIKAANILTT-KD---GVVKLADFGVATKLNDVSKDDASVVGTPYWMA 167
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279
PE++ S S D++S G + E+LTG PY +++ A + IV + PP+P
Sbjct: 168 PEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGIS 224
Query: 1280 SEWRLLMEQCWAPDPVVRPS 1299
E + + QC+ DP +RP+
Sbjct: 225 PELKDFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 93/267 (34%), Positives = 136/267 (50%), Gaps = 24/267 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+ E L+ +K+LG+G FG V+ G + G T VAIK +K+ + + F EA
Sbjct: 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---------FLAEAN 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMD 1156
++ +L HP +V Y VV P + +TE+M NGSL L + E L K + +A
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ 110
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRGT 1214
A GM ++ KN +H DL+ N+LV+ CK+ DFGL+++ + T G +
Sbjct: 111 IAEGMAFIERKNYIHRDLRAANILVSET----LCCKIADFGLARLIEDNEYTAREGAKFP 166
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
+ W APE +N + + K DV+SFGI+L EI+T G PY M +I + R P
Sbjct: 167 IKWTAPEAINYGTFTI--KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMP 223
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSF 1300
P C E LM CW P RP+F
Sbjct: 224 RPDNCPEELYELMRLCWKEKPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 98/291 (33%), Positives = 142/291 (48%), Gaps = 36/291 (12%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQE 1086
D+S ++I EE+ +G+G FG V G+ R VAIK +K +G + +Q
Sbjct: 2 DVSCVKI------EEV--IGAGEFGEVCRGRLKLPGKREIFVAIKTLK----SGYTEKQR 49
Query: 1087 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 1146
R +F EA I+ + HPN++ GVV + +TEFM NG+L L +
Sbjct: 50 R---DFLSEASIMGQFDHPNIIHLEGVVTKSR--PVMIITEFMENGALDSFLRQNDGQFT 104
Query: 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----K 1202
+ + + A GM+YL N VH DL N+LVN +CKV DFGLS+
Sbjct: 105 VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN----LVCKVSDFGLSRFLEDDT 160
Query: 1203 RNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG 1259
+ T + G +P W APE + + K + DV+S+GIV+WE+++ GE PY +M
Sbjct: 161 SDPTYTSSLGGKIPIRWTAPEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218
Query: 1260 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
+I I + PP P C + LM CW D RP F +I L M
Sbjct: 219 DVINAIEQDYRLPP-PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 94/267 (35%), Positives = 138/267 (51%), Gaps = 24/267 (8%)
Query: 1048 KELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ +G G FG V+ G+ R T VA+K SC R + L +F +EA IL + HP
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVK----SC---RETLPPDLKAKFLQEARILKQYSHP 53
Query: 1106 NVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
N+V GV Q P + V E + G L ++ L ++ + + +AA GMEYL
Sbjct: 54 NIVRLIGVCTQKQP---IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL--VTGGVRGT-LPWMAPE 1221
SK+ +H DL N LV K+ + K+ DFG+S+ + + + TGG++ + W APE
Sbjct: 111 ESKHCIHRDLAARNCLVTEKNVL----KISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 1280
LN + S + DV+SFGI+LWE + G PYAN+ + +R P P C
Sbjct: 167 ALN--YGRYSSESDVWSFGILLWEAFSLGAVPYANLS-NQQTREAIEQGVRLPCPELCPD 223
Query: 1281 EWRLLMEQCWAPDPVVRPSFTEIARRL 1307
LME+CW DP RPSF+ + + L
Sbjct: 224 AVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 87/274 (31%), Positives = 132/274 (48%), Gaps = 36/274 (13%)
Query: 1050 LGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+G G FG VYHG +D A+K + R ++ E + +F +E I+ H
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN------RITDLEEVE-QFLKEGIIMKDFSH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMDAAFGMEY 1163
PNV++ G+ G L V +M +G LR+ + E H K LI + A GMEY
Sbjct: 56 PNVLSLLGICLPSEGSPL-VVLPYMKHGDLRN-FIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS---------KIKRNTLVTGGVRGT 1214
L SK VH DL N +++ + KV DFGL+ + +T G +
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTV----KVADFGLARDIYDKEYYSVHNHT----GAKLP 165
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
+ WMA E L + K + K DV+SFG++LWE++T G PY ++ I ++ R
Sbjct: 166 VKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLL 222
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P +C +M CW P P +RP+F+E+ R+
Sbjct: 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 90/277 (32%), Positives = 134/277 (48%), Gaps = 25/277 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
I+ ED+ + +G G FG VY G + VA+K K + +F
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------SPSVREKFL 55
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
+EA I+ + HP++V GV+ + P + V E G LR L + LD ++
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVITENP---VWIVMELAPLGELRSYLQVNKYSLDLASLILY 112
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
+ + + YL SK VH D+ N+LV+ D + K+GDFGLS+ + +G
Sbjct: 113 SYQLSTALAYLESKRFVHRDIAARNVLVSSPDCV----KLGDFGLSRYLEDESYYKASKG 168
Query: 1214 TLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1270
LP WMAPE +N + + DV+ FG+ +WEIL G +P+ + +IG I N
Sbjct: 169 KLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE- 225
Query: 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
R P+P C LM +CWA DP RP FTE+ +L
Sbjct: 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 7e-37
Identities = 82/285 (28%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
+ L+++G G G VY R T +VAIK+++ + + L + E I+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK------QNKELII---NEILIMKD 71
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
HPN+V +Y G L V E+M GSL ++ ++ + + + G+
Sbjct: 72 CKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVRGTL 1215
EYLHS+N++H D+K DN+L++ + K+ DFG + K KRN++V GT
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSV----KLADFGFAAQLTKEKSKRNSVV-----GTP 180
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV- 1274
WMAPE++ KVD++S GI+ E+ GE PY + I + PP+
Sbjct: 181 YWMAPEVI--KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PPLK 237
Query: 1275 -PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKS 1318
P E++ + +C DP RPS E+ + + AC +
Sbjct: 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP-FLKKACPKEE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 98/270 (36%), Positives = 136/270 (50%), Gaps = 30/270 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L+ +K+LG+G FG V+ G W G T VA+K +K + S F EA+
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---------FLEEAQ 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMD 1156
I+ KL H +V Y VV + P + VTE+M GSL L E R L + +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSKIKRNTLVTG--GVR 1212
A GM Y+ N +H DL+ N+LV L +CK+ DFGL+++ + T G +
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVGDGL------VCKIADFGLARLIEDNEYTARQGAK 164
Query: 1213 GTLPWMAPEL-LNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1270
+ W APE L G + + K DV+SFGI+L E++T G PY M+ ++ V
Sbjct: 165 FPIKWTAPEAALYG---RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-VERGY 220
Query: 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSF 1300
R P P C LM QCW DP RP+F
Sbjct: 221 RMPCPQDCPISLHELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 8e-37
Identities = 99/295 (33%), Positives = 138/295 (46%), Gaps = 44/295 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+ L+ELG G FG VY G+ G T VAIK +K++ + ++ EF +
Sbjct: 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-------AEPKVQQEFRQ 57
Query: 1095 EAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERH--------- 1144
EAE++S L HPN+V GV ++ P + E++ +G L L+ H
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQP---TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 1145 ------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
LD L IA+ A GMEYL S + VH DL N LV + K+ DFGL
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV----KISDFGL 170
Query: 1199 SK-IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYA 1254
S+ I + LP WM PE + K + + D++SFG+VLWEI + G +PY
Sbjct: 171 SRDIYSADYYRVQSKSLLPVRWMPPEAI--LYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228
Query: 1255 NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309
+I I + L P P C + LM +CW P RP F +I RLR
Sbjct: 229 GFSNQEVIEMIRSRQLL-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 93/288 (32%), Positives = 135/288 (46%), Gaps = 34/288 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
+ + + L+ LG G FG VY G +RG D VA+K + +SC SEQ+ +
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-----SEQDES--D 55
Query: 1092 FWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR--- 1147
F EA I+SK +H N+V GV + P + E M G L+ L +R
Sbjct: 56 FLMEALIMSKFNHQNIVRLIGVSFERLP---RFILLELMAGGDLKSFLRENRPRPERPSS 112
Query: 1148 ---RKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKR 1203
+ L A D A G +YL + +H D+ N L+ K P R + K+ DFG+++ I R
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR-VAKIADFGMARDIYR 171
Query: 1204 NTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG 1259
+ G R LP WM PE L+G + K DV+SFG++LWEI + G PY
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGI---FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
Query: 1260 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
++ + P G +R+ M CW P RP+F I R+
Sbjct: 229 EVMEFVTGGGRLDPPKGCPGPVYRI-MTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 92/272 (33%), Positives = 140/272 (51%), Gaps = 31/272 (11%)
Query: 1043 DLEEL---KELGSGTFGTVYHGKWRGTDVAIKRIKKSC-FTGRSSEQERLTLEFWREAEI 1098
+L++L + +G G FG V G++ G VA+K IK C T ++ F E +
Sbjct: 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK--CDVTAQA---------FLEETAV 52
Query: 1099 LSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++KLHH N+V GV+ +G L V E M G+L + L ++ R L +L+ ++D
Sbjct: 53 MTKLHHKNLVRLLGVILHNG----LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLD 108
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GMEYL SK +VH DL N+LV+ + KV DFGL+++ + + +
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVSEDG----VAKVSDFGLARVGSMGVDNS--KLPVK 162
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 1275
W APE L K S K DV+S+G++LWE+ + G PY M + V R P
Sbjct: 163 WTAPEALK--HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-VKECVEKGYRMEPP 219
Query: 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
C ++ +LM CW +P RPSF ++ +L
Sbjct: 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 80/272 (29%), Positives = 133/272 (48%), Gaps = 29/272 (10%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD---VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E +K++G G+FG VY + R +D +K I S SE+ER E +IL K
Sbjct: 3 EIIKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDLS----NMSEKEREDAL--NEVKILKK 55
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAA 1158
L+HPN++ +Y ++ G L V E+ G L + ++ + + L +
Sbjct: 56 LNHPNIIKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGTLPW 1217
++YLHS+ I+H D+K N+ + + K+GDFG+SK+ +T+ + V GT +
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNG----LVKLGDFGISKVLSSTVDLAKTVVGTPYY 169
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR---PPV 1274
++PEL + K D++S G VL+E+ T + P+ G + + L+ PP+
Sbjct: 170 LSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPF----EGENLLELALKILKGQYPPI 223
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306
P SE R L+ DP RPS +I +
Sbjct: 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 87/290 (30%), Positives = 134/290 (46%), Gaps = 45/290 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+L+E+ LG G FG V+ K +G + V +K ++K+ + E L EF R
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-------KDENLQSEFRR 57
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------SKERHLD 1146
E ++ KL H NVV G+ ++ + + E+ G L+ L K L
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---- 1202
++++ + A GM++L + VH DL N LV+ + KV LSK
Sbjct: 116 TKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR----EVKVSLLSLSKDVYNSE 171
Query: 1203 ----RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1257
RN L+ L W+APE + S K DV+SFG+++WE+ T GE P+ +
Sbjct: 172 YYKLRNALIP------LRWLAPEAV--QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223
Query: 1258 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
++ + L PVP C S LM +CWA +P RPSF+E+ L
Sbjct: 224 DEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 96/278 (34%), Positives = 137/278 (49%), Gaps = 33/278 (11%)
Query: 1050 LGSGTFGTVYHGKWRGTD--------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
LGSG FG VY G VA+K ++K +++QE+ EF +EA ++S
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-----ATDQEKK--EFLKEAHLMSN 55
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS--KERH----LDRRKRLIIAM 1155
+HPN+V GV + + E M G L L ER L ++ L I +
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP-ICKVGDFGLSK-IKRNTLVTGGVRG 1213
D A G YL + +H DL N LV+ K + K+GDFGL++ I ++ G
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 1214 TLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1269
LP WMAPE LL+G K + + DV+SFG+++WEILT G++PY ++ ++ V
Sbjct: 174 LLPVRWMAPESLLDG---KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ-HVTAG 229
Query: 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
R P C + LM CWA DP RP+F I L
Sbjct: 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 8e-35
Identities = 94/270 (34%), Positives = 134/270 (49%), Gaps = 26/270 (9%)
Query: 1048 KELGSGTFGTVYHG--KWRG---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K +G+G FG V+ G K G VAIK +K +E++R +F EA I+ +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-----YTEKQRQ--DFLSEASIMGQF 63
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
H N++ GVV + +TE+M NG+L L + + + + A GM+
Sbjct: 64 SHHNIIRLEGVVTKFKPAMI--ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMK 121
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN----TLVTGGVRGTLPWM 1218
YL N VH DL N+LVN CKV DFGLS++ + T T G + + W
Sbjct: 122 YLSDMNYVHRDLAARNILVNSN----LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
APE + + K + DV+SFGIV+WE+++ GE PY +M ++ I N+ R P P
Sbjct: 178 APEAI--AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMD 234
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
C S LM QCW D RP F +I L
Sbjct: 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 86/274 (31%), Positives = 125/274 (45%), Gaps = 35/274 (12%)
Query: 1042 EDLEELKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
DLE +K LG G+ G VY H K G A+K+I G +++L RE +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRH-KPTGKIYALKKIH---VDGDEEFRKQLL----RELKT 52
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L P VV YG G ++ V E+M GSL LL K + IA
Sbjct: 53 LRSCESPYVVKCYGAFYKE--GEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQIL 109
Query: 1159 FGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTGGV 1211
G++YLH+K +I+H D+K NLL+N K + K+ DFG+SK+ + NT V
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFV---- 161
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA---NMHYGAIIGGIVNN 1268
GT+ +M+PE + G S S D++S G+ L E G+ P+ + ++ I +
Sbjct: 162 -GTVTYMSPERIQGESY--SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG 218
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTE 1302
E+R + C DP RPS E
Sbjct: 219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-34
Identities = 92/270 (34%), Positives = 129/270 (47%), Gaps = 26/270 (9%)
Query: 1048 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K +G+G FG V G+ R VAIK +K G + +Q R +F EA I+ +
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK----AGYTEKQRR---DFLSEASIMGQF 62
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HPN++ GVV + VTE+M NGSL L + + + + A GM+
Sbjct: 63 DHPNIIHLEGVVTKSK--PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN----TLVTGGVRGTLPWM 1218
YL VH DL N+LVN +CKV DFGLS++ + T G + + W
Sbjct: 121 YLSDMGYVHRDLAARNILVNSN----LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
APE + + K + DV+S+GIV+WE+++ GE PY M +I I R P P
Sbjct: 177 APEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMD 233
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
C + LM CW D RP F +I L
Sbjct: 234 CPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 4e-34
Identities = 95/272 (34%), Positives = 133/272 (48%), Gaps = 28/272 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L +LG G FG V+ G W GT VAIK +K + F +EA+
Sbjct: 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---------FLQEAQ 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMD 1156
I+ KL H +V Y VV + P + VTEFM GSL L + ++L + + +A
Sbjct: 54 IMKKLRHDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQ 110
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSKIKRNTLVTG--GVR 1212
A GM Y+ N +H DL+ N+LV NL +CK+ DFGL+++ + T G +
Sbjct: 111 IADGMAYIERMNYIHRDLRAANILVGDNL------VCKIADFGLARLIEDNEYTARQGAK 164
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1271
+ W APE + + K DV+SFGI+L E++T G PY M ++ V R
Sbjct: 165 FPIKWTAPEA--ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-VERGYR 221
Query: 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P P C LM+ CW DP RP+F I
Sbjct: 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 7e-34
Identities = 95/269 (35%), Positives = 131/269 (48%), Gaps = 28/269 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L +LG G FG V+ G W GT VAIK +K + + F +EA+
Sbjct: 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---------FLQEAQ 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++ KL H +V Y VV + P + VTE+M GSL L + R +L+ +A
Sbjct: 54 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 110
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSKIKRNTLVTG--GVR 1212
A GM Y+ N VH DL+ N+LV NL +CKV DFGL+++ + T G +
Sbjct: 111 IASGMAYVERMNYVHRDLRAANILVGENL------VCKVADFGLARLIEDNEYTARQGAK 164
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1271
+ W APE + + K DV+SFGI+L E+ T G PY M ++ V R
Sbjct: 165 FPIKWTAPEA--ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYR 221
Query: 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSF 1300
P P C LM QCW +P RP+F
Sbjct: 222 MPCPPECPESLHDLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 74/259 (28%), Positives = 118/259 (45%), Gaps = 19/259 (7%)
Query: 1050 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109
LGSG+FG+VY G D +K+ + + +E +LSKL HPN+V
Sbjct: 8 LGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-----KRLIIAMDAAFGMEYL 1164
+ G ++ L E + GSL LL K R I+ G+EYL
Sbjct: 67 YLGTEREE--DNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQILL-----GLEYL 118
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLN 1224
H +N VH D+K N+LV+ + K+ DFG++K +G+ WMAPE++
Sbjct: 119 HDRNTVHRDIKGANILVDTNGVV----KLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 1225 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 1284
D++S G + E+ TG+ P++ + A + I + PP+P E +
Sbjct: 175 -QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233
Query: 1285 LMEQCWAPDPVVRPSFTEI 1303
+ +C DP +RP+ E+
Sbjct: 234 FILKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 89/278 (32%), Positives = 124/278 (44%), Gaps = 31/278 (11%)
Query: 1048 KELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K LG G FG+V G+ D VA+K +K T E EF EA +
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE------EFLSEAACMKDF 58
Query: 1103 HHPNVVAFYGV-VQDGPGGTLAT---VTEFMVNGSLRHVLLSKE-----RHLDRRKRLII 1153
HPNV+ GV + + + FM +G L LL L + L
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVR 1212
+D A GMEYL ++N +H DL N + L++ + +C V DFGLS KI G
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCM--LREDMT-VC-VADFGLSKKIYSGDYYRQGRI 174
Query: 1213 GTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1269
+P W+A E L + + K DV++FG+ +WEI T G+ PY + I + +
Sbjct: 175 AKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232
Query: 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
R P C E LM CW DP RP+FT++ L
Sbjct: 233 -RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 80/275 (29%), Positives = 128/275 (46%), Gaps = 41/275 (14%)
Query: 1042 EDLEELKE-LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
E++ ++ E LG G++G+VY + G VAIK + E++ + +E I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--------PVEEDLQEII--KEISI 51
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L + P +V +YG L V E+ GS+ ++ + L + I
Sbjct: 52 LKQCDSPYIVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTL 109
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTGGVR 1212
G+EYLHS +H D+K N+L+N + K+ DFG+S KRNT++
Sbjct: 110 KGLEYLHSNKKIHRDIKAGNILLNEEG----QAKLADFGVSGQLTDTMAKRNTVI----- 160
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272
GT WMAPE++ + K D++S GI E+ G+ PY+++H I I N +P
Sbjct: 161 GTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KP 215
Query: 1273 PVPGFCD-SEWRL----LMEQCWAPDPVVRPSFTE 1302
P P D +W +++C DP RPS +
Sbjct: 216 P-PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 84/276 (30%), Positives = 123/276 (44%), Gaps = 44/276 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E L+ +G G+FG VY + T+ VAIK I +E E ++ +E + L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-----EAEDEIEDIQ--QEIQFL 53
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
S+ P + +YG G L + E+ GS +L K LD I +
Sbjct: 54 SQCRSPYITKYYGSFLKG--SKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLL 109
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVRG 1213
G+EYLH + +H D+K N+L++ + + K+ DFG+S KRNT V G
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLSEEGDV----KLADFGVSGQLTSTMSKRNTFV-----G 160
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273
T WMAPE++ S EK D++S GI E+ GE P +++H ++ I N PP
Sbjct: 161 TPFWMAPEVI--KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--NPP 216
Query: 1274 V-------PGFCDSEWRLLMEQCWAPDPVVRPSFTE 1302
F D + C DP RPS E
Sbjct: 217 SLEGNKFSKPFKD-----FVSLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 90/268 (33%), Positives = 137/268 (51%), Gaps = 25/268 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E ++ +K+LG+G FG V+ G + T VA+K +K G S Q F EA
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP----GTMSVQA-----FLEEAN 53
Query: 1098 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAM 1155
++ L H +V Y VV ++ P + +TE+M GSL L S E +LI +
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEP---IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRG 1213
A GM Y+ KN +H DL+ N+LV+ + + +CK+ DFGL+++ + T G +
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS--ESL--MCKIADFGLARVIEDNEYTAREGAKF 166
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272
+ W APE +N S + K DV+SFGI+L+EI+T G+ PY M ++ + R
Sbjct: 167 PIKWTAPEAINFGSFTI--KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRM 223
Query: 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSF 1300
P C E +M+ CW RP+F
Sbjct: 224 PRMENCPDELYDIMKTCWKEKAEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 93/276 (33%), Positives = 131/276 (47%), Gaps = 30/276 (10%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+L K LG+G FG V G VA+K +K T SSE+E L E
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP---TAHSSEREALMSEL-- 89
Query: 1095 EAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLI 1152
+I+S L +H N+V G G G + +TE+ G L + L K E L L
Sbjct: 90 --KIMSHLGNHENIVNLLGACTIG--GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKR--NTLVTG 1209
+ A GM +L SKN +H DL N+L+ I K+ DFGL++ I N +V G
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK----IVKICDFGLARDIMNDSNYVVKG 201
Query: 1210 GVRGTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267
R + WMAPE + N + S DV+S+GI+LWEI + G PY M + ++
Sbjct: 202 NARLPVKWMAPESIFNCVYTFES---DVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK 258
Query: 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
R P +E +M+ CW DP+ RP+F +I
Sbjct: 259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 98/284 (34%), Positives = 139/284 (48%), Gaps = 41/284 (14%)
Query: 1050 LGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LG G FG+V + + D VA+K +K F+ SS+ E EF REA + + H
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIE----EFLREAACMKEFDH 60
Query: 1105 PNVVAFYGV-VQDGPGGTLA---TVTEFMVNGSLRHVLLSKER------HLDRRKRLIIA 1154
PNV+ GV ++ G L + FM +G L H L R L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL-HTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRG 1213
+D A GMEYL SKN +H DL N ++N +C V DFGLS KI G
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNEN---MTVC-VADFGLSKKIYSGDYYRQGCAS 175
Query: 1214 TLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH----YGAIIGGIV 1266
LP W+A E L + + + DV++FG+ +WEI+T G+ PYA + Y +I G
Sbjct: 176 KLPVKWLALESL--ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-- 231
Query: 1267 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
N L+ P C + LM QCW+P+P RPSF + +L ++
Sbjct: 232 -NRLKQPPD--CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 89/271 (32%), Positives = 126/271 (46%), Gaps = 30/271 (11%)
Query: 1049 ELGSGTFGTVYHG----KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
ELGSG FG V G + + DVAIK +K + ++ + E REAEI+ +L +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK-------NENEKSVRDEMMREAEIMHQLDN 54
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P +V GV + L V E G L L K+ + + + + GM+YL
Sbjct: 55 PYIVRMIGVCE---AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL 111
Query: 1165 HSKNIVHFDLKCDN-LLVNLKDPIRPICKVGDFGLSKI-----KRNTLVTGGVRGTLPWM 1218
KN VH DL N LLVN + K+ DFGLSK + G + L W
Sbjct: 112 EGKNFVHRDLAARNVLLVN-----QHYAKISDFGLSKALGADDSYYKARSAG-KWPLKWY 165
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
APE +N K S + DV+S+GI +WE + G++PY M ++ I R P
Sbjct: 166 APECIN--FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RLDCPAE 222
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
C E LM+ CW RP+F ++ R+R
Sbjct: 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 87/263 (33%), Positives = 127/263 (48%), Gaps = 22/263 (8%)
Query: 1050 LGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 1108
LG G FG V+ G + T VA+K K+ + L ++F EA IL + HPN+V
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIV 55
Query: 1109 AFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 1167
GV Q P + V E + G L K+ L ++ + A+DAA GM YL SK
Sbjct: 56 KLIGVCTQRQP---IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPELLNG 1225
N +H DL N LV + + K+ DFG+S+ + + + + +P W APE LN
Sbjct: 113 NCIHRDLAARNCLVGENN----VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN- 167
Query: 1226 SSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 1284
+ S + DV+S+GI+LWE + G PY M V R P C +
Sbjct: 168 -YGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRMSCPQKCPDDVYK 225
Query: 1285 LMEQCWAPDPVVRPSFTEIARRL 1307
+M++CW P RP F+E+ + L
Sbjct: 226 VMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 90/292 (30%), Positives = 136/292 (46%), Gaps = 41/292 (14%)
Query: 1044 LEELKELGSGTFGTV----YHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWR-EA 1096
L++++ LG G FG V Y GT VA+K +K+ C +Q W+ E
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-----GQQNT---SGWKKEI 57
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
IL L+H N+V + G + G L + E++ GSLR L + L+ + L+ A
Sbjct: 58 NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQ 115
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR--GT 1214
GM YLHS++ +H DL N+L++ + K+GDFGL+K VR G
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLLDNDR----LVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 1215 LP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN--MHYGAIIG---GIVN 1267
P W A E L +K S DV+SFG+ L+E+LT + + + +IG G +
Sbjct: 172 SPVFWYAVECLK--ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229
Query: 1268 ---------NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
+R P P C E +LM+ CW + RP+F + L+ M
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 84/270 (31%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 1048 KELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
ELGSG FGTV G ++ VA+K +K + L E REA ++ +L
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKND------NNDPALKDELLREANVMQQLD 54
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
+P +V G+ + + V E G L + L K +H+ + + + GM+Y
Sbjct: 55 NPYIVRMIGICE---AESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKY 110
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTLP--WMA 1219
L N VH DL N+L+ + K+ DFGLSK G P W A
Sbjct: 111 LEETNFVHRDLAARNVLLVTQH----YAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278
PE +N K S K DV+SFG+++WE + G++PY M G + ++ + R P C
Sbjct: 167 PECMN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-GNEVTQMIESGERMECPQRC 223
Query: 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
E LM+ CW RP F + RLR
Sbjct: 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 77/269 (28%), Positives = 130/269 (48%), Gaps = 22/269 (8%)
Query: 1050 LGSGTFGTVYHG--KWRGTDVAIKRIK-KSCFTGRSSEQERLTLEFWR-EAEILSKLHHP 1105
+G GT+G VY G +A+K+++ + GR +++ ++ R E E L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--IAMDAAFGMEY 1163
N+V + G + L+ E++ GS+ L + ++L+ G+ Y
Sbjct: 69 NIVQYLGF-ETTEE-YLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN---TLVTGGVRGTLPWMAP 1220
LHSK I+H DLK DNLLV+ ICK+ DFG+SK + ++G++ WMAP
Sbjct: 124 LHSKGILHRDLKADNLLVDADG----ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 1221 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP----G 1276
E+++ S S KVD++S G V+ E+ G P+++ A + + N PP+P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239
Query: 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
+ C+ +P RP+ E+ +
Sbjct: 240 NLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-30
Identities = 80/218 (36%), Positives = 114/218 (52%), Gaps = 22/218 (10%)
Query: 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 1105
L++LG G+FG VY + VA+K + K +S E ER F RE +IL+ L H P
Sbjct: 5 LRKLGEGSFGEVYLAR-DRKLVALKVLAKK-LESKSKEVER----FLREIQILASLNHPP 58
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLIIAMDAAFGMEY 1163
N+V Y QD L V E++ GSL +L R L + L I +EY
Sbjct: 59 NIVKLYDFFQDEGSLYL--VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-------GTLP 1216
LHSK I+H D+K +N+L+ D + K+ DFGL+K+ + T + GT
Sbjct: 117 LHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 1217 WMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPY 1253
+MAPE+L G S + S D++S GI L+E+LTG P+
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF 211
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 79/259 (30%), Positives = 117/259 (45%), Gaps = 25/259 (9%)
Query: 1050 LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G+FG V + + T A+K +KK + + + E ILS+++HP +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKK-----KKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR-RKRLIIAMDAAFGMEYLHS 1166
V + Q L V E+ G L LSKE R R A + +EYLHS
Sbjct: 56 VKLHYAFQTE--EKLYLVLEYAPGGELFS-HLSKEGRFSEERARFYAA-EIVLALEYLHS 111
Query: 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGGVRGTLPWMAPELLNG 1225
I++ DLK +N+L++ I K+ DFGL+K T GT ++APE+L G
Sbjct: 112 LGIIYRDLKPENILLDADGHI----KLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG 167
Query: 1226 SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV--PGFCDSEWR 1283
+ VD +S G++L+E+LTG+ P+ Y I L+ P+ P F E R
Sbjct: 168 --KGYGKAVDWWSLGVLLYEMLTGKPPF----YAEDRKEIYEKILKDPLRFPEFLSPEAR 221
Query: 1284 LLMEQCWAPDPVVRPSFTE 1302
L+ DP R
Sbjct: 222 DLISGLLQKDPTKRLGSGG 240
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 86/285 (30%), Positives = 134/285 (47%), Gaps = 27/285 (9%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKW--RGTD----VAIKRIKKSCFTGRSSEQERLTL 1090
+I+K +L +LK LGSG FGTV+ G W G VAIK I+ +GR + Q
Sbjct: 2 RILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQ----- 54
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
E + L H +V G+ PG +L VT+ GSL + LD ++
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL 111
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLV 1207
L + A GM YL +VH +L N+L LK I ++ DFG++ +
Sbjct: 112 LNWCVQIAKGMYYLEEHRMVHRNLAARNIL--LKSDS--IVQIADFGVADLLYPDDKKYF 167
Query: 1208 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1266
+ + WMA E + + + + DV+S+G+ +WE+++ G EPYA M + ++
Sbjct: 168 YSEHKTPIKWMALESIL--FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLL 224
Query: 1267 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311
R P C + ++M +CW D VRP+F E+A M+
Sbjct: 225 EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 88/267 (32%), Positives = 131/267 (49%), Gaps = 24/267 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L+ K+LG+G FG V+ + + T VA+K +K + + F EA
Sbjct: 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---------FLAEAN 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++ L H +V + VV P + +TEFM GSL L S E +LI +
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 110
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRGT 1214
A GM ++ +N +H DL+ N+LV+ +CK+ DFGL+++ + T G +
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVSAS----LVCKIADFGLARVIEDNEYTAREGAKFP 166
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
+ W APE +N S + K DV+SFGI+L EI+T G PY M +I + R P
Sbjct: 167 IKWTAPEAINFGSFTI--KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMP 223
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSF 1300
P C E +M +CW P RP+F
Sbjct: 224 RPENCPEELYNIMMRCWKNRPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 93/295 (31%), Positives = 135/295 (45%), Gaps = 56/295 (18%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTD----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
++ELG FG +Y G G D VAIK +K ++ Q+ EF +EA +++
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-----NNPQQ--WGEFQQEASLMA 62
Query: 1101 KLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERH--------------- 1144
+LHHPN+V GVV Q+ P + + E++ G L L+ + H
Sbjct: 63 ELHHPNIVCLLGVVTQEQP---VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 1145 -LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS---- 1199
LD L IA+ A GMEYL S VH DL N+L+ + + K+ D GLS
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV----KISDLGLSREIY 175
Query: 1200 -----KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1253
+++ +L+ + WM PE + K S D++SFG+VLWEI + G +PY
Sbjct: 176 SADYYRVQPKSLL------PIRWMPPEAI--MYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227
Query: 1254 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
+I + L P C LM +CW P RP F +I RLR
Sbjct: 228 YGFSNQEVIEMVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 97/295 (32%), Positives = 134/295 (45%), Gaps = 42/295 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
IK D+ ELG G FG V+ + VA+K +K++ SE R +
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESARQ--D 53
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS---KERHLDRR 1148
F REAE+L+ L H ++V FYGV +G L V E+M +G L L S + L
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 1149 K-----------RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197
+ L IA A GM YL S + VH DL N LV + K+GDFG
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG----LVVKIGDFG 167
Query: 1198 LSK-IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1253
+S+ I G R LP WM PE + K + + D++SFG+VLWEI T G++P+
Sbjct: 168 MSRDIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
Query: 1254 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
+ I I P C E +M+ CW +P R +I RL+
Sbjct: 226 YQLSNTEAIECITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 86/269 (31%), Positives = 122/269 (45%), Gaps = 24/269 (8%)
Query: 1050 LGSGTFGTVYHG-----KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LG+G FG + G R VAI ++ C S +Q R F EA L + H
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRR---GFLAEALTLGQFDH 65
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
N+V GV+ G T+ VTE+M NG+L L E L + + + A GM+YL
Sbjct: 66 SNIVRLEGVITRG--NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPEL 1222
VH L +LVN +CK+ F + ++ + + G P W APE
Sbjct: 124 SEMGYVHKGLAAHKVLVNSD----LVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 1223 LNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 1281
+ S DV+SFGIV+WE+++ GE PY +M +I V + R P P C +
Sbjct: 180 IQ--YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA-VEDGFRLPAPRNCPNL 236
Query: 1282 WRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
LM CW + RP F++I L M
Sbjct: 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 60/284 (21%)
Query: 1050 LGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLE-FWREAEILSKLHHPN 1106
+GSG+FG+VY G G +A+K+++ + S +++R L+ RE +L +L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 1107 VVAFYGVVQDG----------PGGTLATV-------TEFMVNGSLRHVLLSKERHLDRRK 1149
+V + G D PGG++A + E +V +R +L
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK---------- 117
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVT 1208
G+ YLH++ I+H D+K N+LV+ K I K+ DFG+S K++ N+L T
Sbjct: 118 ----------GLNYLHNRGIIHRDIKGANILVDNKGGI----KISDFGISKKLEANSLST 163
Query: 1209 G------GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAI 1261
++G++ WMAPE++ +S + K D++S G ++ E+LTG+ P+ + AI
Sbjct: 164 KTNGARPSLQGSVFWMAPEVVKQTSY--TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI 221
Query: 1262 --IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
IG P +P SE +E+ + D RP+ E+
Sbjct: 222 FKIGENA----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 97/295 (32%), Positives = 140/295 (47%), Gaps = 46/295 (15%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ E + L+ELG G+FG VY G R T VA+K + +S +S +ER+ E
Sbjct: 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-----ASLRERI--E 55
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS--------KER 1143
F EA ++ +VV GVV G TL V E M +G L+ L S R
Sbjct: 56 FLNEASVMKGFTCHHVVRLLGVVSKGQP-TL-VVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 1144 HLDRRKRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-I 1201
+ +I +A + A GM YL++K VH DL N +V + K+GDFG+++ I
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV----KIGDFGMTRDI 169
Query: 1202 KRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHY 1258
G +G LP WMAPE L + D++SFG+VLWEI + E+PY +
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGV--FTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227
Query: 1259 GAII-----GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
++ GG ++ P C LM CW +P +RP+F EI L+
Sbjct: 228 EQVLKFVMDGGYLDQ------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 98/305 (32%), Positives = 137/305 (44%), Gaps = 51/305 (16%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
IK D+ +ELG G FG V+ + VA+K +K R +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--------D 53
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL------------- 1138
F REAE+L+ L H ++V FYGV D G L V E+M +G L L
Sbjct: 54 FQREAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111
Query: 1139 --LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVG 1194
+ L + L IA A GM YL S++ VH DL N LV NL + K+G
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL------LVKIG 165
Query: 1195 DFGLSK-IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GE 1250
DFG+S+ + G LP WM PE + K + + DV+SFG++LWEI T G+
Sbjct: 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIFTYGK 223
Query: 1251 EPYANMHYGAIIGGIVNNTL--RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
+P+ + +I I + RP V C E +M CW +P R + EI + L
Sbjct: 224 QPWFQLSNTEVIECITQGRVLERPRV---CPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280
Query: 1309 VMSAA 1313
+ A
Sbjct: 281 ALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 93/304 (30%), Positives = 126/304 (41%), Gaps = 64/304 (21%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTL------------- 1090
L +++LG G FG V+ + D +K+ +++ L
Sbjct: 7 LNFVEKLGEGQFGEVHLCE---ADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 1091 -EFWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKE------ 1142
+F +E +ILS+L PN+ GV D P L + E+M NG L L
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPP---LCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 1143 ----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
+ L L +A A GM YL S N VH DL N LV I K+ DFG+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTI----KIADFGM 176
Query: 1199 SKIKRNTLVTGG---VRGTLP----WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-- 1248
S L + V+G P WMA E +L G K + K DV++FG+ LWEILT
Sbjct: 177 S----RNLYSSDYYRVQGRAPLPIRWMAWESVLLG---KFTTKSDVWAFGVTLWEILTLC 229
Query: 1249 GEEPYA---------NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPS 1299
E+PY N + G RPP C + LM +CW D RP+
Sbjct: 230 REQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPN---CPKDIYELMLECWRRDEEDRPT 286
Query: 1300 FTEI 1303
F EI
Sbjct: 287 FREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 95/295 (32%), Positives = 142/295 (48%), Gaps = 46/295 (15%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ E + +ELG G+FG VY G +G T VAIK + ++ +S +ER+ E
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-----ASMRERI--E 55
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR---- 1147
F EA ++ + + +VV GVV G TL + E M G L+ L S ++
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSQGQP-TL-VIMELMTRGDLKSYLRSLRPEMENNPVQ 113
Query: 1148 -----RKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-I 1201
+K + +A + A GM YL++ VH DL N +V + K+GDFG+++ I
Sbjct: 114 APPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV----KIGDFGMTRDI 169
Query: 1202 KRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHY 1258
G +G LP WM+PE L + DV+SFG+VLWEI T E+PY M
Sbjct: 170 YETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227
Query: 1259 GAII-----GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
++ GG+++ P C LM CW +P +RPSF EI ++
Sbjct: 228 EQVLRFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 83/268 (30%), Positives = 129/268 (48%), Gaps = 21/268 (7%)
Query: 1043 DLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
D E L ++G G+FG V+ K A+K+I S R E E EA +L+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE------EAIDEARVLA 54
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--IAMDAA 1158
KL ++ +Y D G L V E+ NG L H LL +R + + +
Sbjct: 55 KLDSSYIIRYYESFLDK--GKLNIVMEYAENGDL-HKLLKMQRGRPLPEDQVWRFFIQIL 111
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGGVRGTLPW 1217
G+ +LHSK I+H D+K NL ++ D + K+GD G++K+ NT + GT +
Sbjct: 112 LGLAHLHSKKILHRDIKSLNLFLDAYDNV----KIGDLGVAKLLSDNTNFANTIVGTPYY 167
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
++PEL +EK DV++ G+VL+E TG+ P+ + GA+I I+ PPV
Sbjct: 168 LSPELC--EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF-PPVSQM 224
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
+ L++QC D RP ++ R
Sbjct: 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 31/275 (11%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
N+ E + ELG G FG VY + + T + K E E +F E +ILS
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGL--FAAAKIIQIESEEELE----DFMVEIDILS 57
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
+ HPN+V Y L + EF G+L ++L ER L + +
Sbjct: 58 ECKHPNIVGLYEAYFYEN--KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVRGT 1214
+ +LHS ++H DLK N+L+ L + K+ DFG+S KR+T + GT
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDV----KLADFGVSAKNKSTLQKRDTFI-----GT 166
Query: 1215 LPWMAPELLNGSSSK---VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1271
WMAPE++ + K K D++S GI L E+ E P+ ++ ++ I+ +
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--E 224
Query: 1272 PPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
PP P S + ++ C DP RP+ E+
Sbjct: 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 88/287 (30%), Positives = 145/287 (50%), Gaps = 29/287 (10%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLT 1089
L+I+K +L+ +K LGSG FGTVY G W VAIK + ++ TG +
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TG-----PKAN 53
Query: 1090 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
+EF EA I++ + HP++V GV T+ VT+ M +G L + + ++ +
Sbjct: 54 VEFMDEALIMASMDHPHLVRLLGVCLS---PTIQLVTQLMPHGCLLDYVHEHKDNIGSQL 110
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNT 1205
L + A GM YL + +VH DL N+LV + + K+ DFGL+++ ++
Sbjct: 111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHV----KITDFGLARLLEGDEKEY 166
Query: 1206 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGG 1264
GG + + WMA E ++ K + + DV+S+G+ +WE++T G +PY + I
Sbjct: 167 NADGG-KMPIKWMALECIH--YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPD 222
Query: 1265 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311
++ R P P C + ++M +CW D RP F E+A M+
Sbjct: 223 LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 41/279 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E ++ +GSGT+G VY + T VAIK IK + +E +L
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-------LEPGDDFE-IIQQEISML 54
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ HPN+VA++G L V E+ GSL+ + L + + +
Sbjct: 55 KECRHPNIVAYFGSYLRR--DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KI-----KRNTLVTGGVRG 1213
G+ YLH +H D+K N+L+ + K+ DFG+S ++ KR + + G
Sbjct: 113 GLAYLHETGKIHRDIKGANILLTEDGDV----KLADFGVSAQLTATIAKRKSFI-----G 163
Query: 1214 TLPWMAPELL-NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272
T WMAPE+ K D+++ GI E+ + P ++H + I + P
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP 223
Query: 1273 PV--------PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P P F D +++C DP RP+ T++
Sbjct: 224 PKLKDKEKWSPVFHD-----FIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 92/308 (29%), Positives = 128/308 (41%), Gaps = 61/308 (19%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
+ + L K LG G FG V + G D VA+K +K +E++ +
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----TEKD--LSD 61
Query: 1092 FWREAEILSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVL----------- 1138
E E++ + H N++ GV Q+GP L V E+ +G+LR L
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGP---LYVVVEYAAHGNLRDFLRARRPPGEYAS 118
Query: 1139 ----LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194
E L ++ + A A GME+L SK +H DL N+LV + K+
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH----VMKIA 174
Query: 1195 DFGLSK-IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GE 1250
DFGL++ I G LP WMAPE L + + DV+SFG++LWEI T G
Sbjct: 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLLWEIFTLGG 232
Query: 1251 EPYANMHYGAIIGGIVNNTL--------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTE 1302
PY GI L R P C E LM CW P RP+F +
Sbjct: 233 SPYP---------GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQ 283
Query: 1303 IARRLRVM 1310
+ L M
Sbjct: 284 LVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 76/268 (28%), Positives = 118/268 (44%), Gaps = 19/268 (7%)
Query: 1045 EELKELGSGTFG--TVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
++ LG G FG T+Y + V K + T S ++ R L E ILS L
Sbjct: 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN---LTRLSEKERRDALN---EIVILSLL 56
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL-SKERHLDRRKRLIIAMDAAFGM 1161
HPN++A+Y D TL E+ G+L ++ K + + L +
Sbjct: 57 QHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGGVRGTLPWMAP 1220
Y+H I+H D+K N+ + I K+GDFG+SKI + V GT +M+P
Sbjct: 115 SYIHKAGILHRDIKTLNIFLTKAGLI----KLGDFGISKILGSEYSMAETVVGTPYYMSP 170
Query: 1221 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 1280
EL G K + K D+++ G VL+E+LT + + + ++ IV PV S
Sbjct: 171 ELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSS 227
Query: 1281 EWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
E L+ DP RP+ E+ +
Sbjct: 228 ELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 83/288 (28%), Positives = 130/288 (45%), Gaps = 45/288 (15%)
Query: 1044 LEELKELGSGTFGTVY------HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
L+ +++LG G FG V G G VA+K +K + +E E
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-------PESGGNHIADLKKEIE 58
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
IL L+H N+V + G+ + G + + EF+ +GSL+ L + ++ +++L A+
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI 118
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT---LVTGGVRG 1213
GM+YL S+ VH DL N+LV + + K+GDFGL+K I+ + V +
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVESEHQV----KIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG------AIIG---- 1263
+ W APE L SK DV+SFG+ L+E+LT Y + +IG
Sbjct: 175 PVFWYAPECL--IQSKFYIASDVWSFGVTLYELLT----YCDSESSPMTLFLKMIGPTHG 228
Query: 1264 --------GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
++ R P P C E LM +CW P R +F +
Sbjct: 229 QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-28
Identities = 83/283 (29%), Positives = 136/283 (48%), Gaps = 21/283 (7%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
L+I+K + +++K LGSG FGTVY G W G V I K R + + E
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEIL 57
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
EA +++ + +P+V G+ T+ +T+ M G L + + ++ + L
Sbjct: 58 DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 114
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVTG 1209
+ A GM YL + +VH DL N+LV K P K+ DFGL+K+ ++ G
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLGADEKEYHAEG 170
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1268
G + + WMA E + + + DV+S+G+ +WE++T G +PY + + I I+
Sbjct: 171 G-KVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEK 226
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311
R P P C + ++M +CW D RP F E+ M+
Sbjct: 227 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 91/273 (33%), Positives = 133/273 (48%), Gaps = 30/273 (10%)
Query: 1042 EDLEELKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+DLE L ELG+G G V H + G +A+K I+ + Q+++ RE +I
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLH-RPTGKIMAVKTIR---LEINEAIQKQIL----RELDI 52
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L K + P +V FYG + G ++ E+M GSL +L + + R IA+
Sbjct: 53 LHKCNSPYIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVL 110
Query: 1159 FGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
G+ YLH K I+H D+K N+LVN + I K+ DFG+S N+L V GT +
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQI----KLCDFGVSGQLVNSLAKTFV-GTSSY 165
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA--NMHYGAII---GGIVNNTLRP 1272
MAPE + G+ V K D++S G+ L E+ TG PY N I IVN P
Sbjct: 166 MAPERIQGNDYSV--KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP--P 221
Query: 1273 PV--PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P G +++ + C DP RPS+ E+
Sbjct: 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 80/265 (30%), Positives = 117/265 (44%), Gaps = 25/265 (9%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
+ G +G V+ K + T AIK IKK+ ++ + LT E +ILS+ P V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT-----ERDILSQAQSPYV 55
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 1167
V Y Q L V E++ G L LL LD I + +EYLHS
Sbjct: 56 VKLYYSFQGK--KNLYLVMEYLPGGDLAS-LLENVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLV------TGGVRGTLPWM 1218
I+H DLK DN+L++ + K+ DFGLSK ++R + + GT ++
Sbjct: 113 GIIHRDLKPDNILIDSNGHL----KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278
APE++ G S+ VD +S G +L+E L G P+ I I+N + P
Sbjct: 169 APEVILGQGH--SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEV 226
Query: 1279 DSEWRLLMEQCWAPDPVVRPSFTEI 1303
E L+ + PDP R I
Sbjct: 227 SDEAIDLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 69/218 (31%), Positives = 115/218 (52%), Gaps = 32/218 (14%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E++ ++G GT+G VY + + T VA+K+I+ +E+E + RE ++L KL
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRME------NEKEGFPITAIREIKLLQKL 55
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFM---VNGSLRHVL----LSKERHLDRRKRLIIAM 1155
HPN+V +V G++ V E+M + G L S+ + K+L+
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY--MKQLLE-- 111
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLV-TGGVR 1212
G++YLHS I+H D+K N+L+N + K+ DFGL++ KRN+ T V
Sbjct: 112 ----GLQYLHSNGILHRDIKGSNILINNDGVL----KLADFGLARPYTKRNSADYTNRVI 163
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
TL + PELL G +++ +VD++S G +L E+ G+
Sbjct: 164 -TLWYRPPELLLG-ATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 89/308 (28%), Positives = 133/308 (43%), Gaps = 68/308 (22%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWRE 1095
++E ++++G G FG V+ + G T VA+K +K+ +S + +F RE
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-----ASAD--MQADFQRE 58
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-------LSKERHLDRR 1148
A ++++ HPN+V GV G + + E+M G L L H
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 1149 KR--------------LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194
R L IA A GM YL + VH DL N LV + K+
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVV----KIA 172
Query: 1195 DFGLSKIKRNTLVTGGVRGT----LP--WMAPE--LLNGSSSKVSEKVDVFSFGIVLWEI 1246
DFGLS RN + + +P WM PE N + + + DV+++G+VLWEI
Sbjct: 173 DFGLS---RNIYSADYYKASENDAIPIRWMPPESIFYN----RYTTESDVWAYGVVLWEI 225
Query: 1247 LT-GEEPYANMHYGAII-----GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSF 1300
+ G +PY M + +I G +++ P C E LM CW+ P RPSF
Sbjct: 226 FSYGMQPYYGMAHEEVIYYVRDGNVLS------CPDNCPLELYNLMRLCWSKLPSDRPSF 279
Query: 1301 TEIARRLR 1308
I R L+
Sbjct: 280 ASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 19/224 (8%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
L+ +G G FG V + R T A+K + K + S + L E IL +L+H
Sbjct: 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL-----NERRILQELNH 59
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P +V + QD + V + ++ G LR+ L K + + + + I + +EYL
Sbjct: 60 PFLVNLWYSFQDEE--NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYL 116
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELL 1223
HSK I+H D+K DN+L++ + + DF ++ K+ +TL T GT +MAPE+L
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGH----VHITDFNIATKVTPDTLTTSTS-GTPGYMAPEVL 171
Query: 1224 NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1267
V+ VD +S G+ +E L G+ PY H I I
Sbjct: 172 CRQGYSVA--VDWWSLGVTAYECLRGKRPY-RGHSRTIRDQIRA 212
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 100/300 (33%), Positives = 137/300 (45%), Gaps = 50/300 (16%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
IK ED+ +G G FG V + + AIK +K+ +SE + +F
Sbjct: 4 IKFEDV-----IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-----ASENDHR--DFAG 51
Query: 1095 EAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-----------LSKE 1142
E E+L KL HHPN++ G ++ G L E+ G+L L +KE
Sbjct: 52 ELEVLCKLGHHPNIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKE 109
Query: 1143 R----HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDF 1196
L ++ L A D A GM+YL K +H DL N+LV NL K+ DF
Sbjct: 110 HGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL------ASKIADF 163
Query: 1197 GLSKIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1253
GLS+ + + G LP WMA E LN S + K DV+SFG++LWEI++ G PY
Sbjct: 164 GLSRGEE--VYVKKTMGRLPVRWMAIESLN--YSVYTTKSDVWSFGVLLWEIVSLGGTPY 219
Query: 1254 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313
M + + R P CD E LM QCW P RP F +I+ +L M A
Sbjct: 220 CGMTCAELYEKLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 26/268 (9%)
Query: 1048 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG G FG VY + G ++A+K++ +++E LE E ++L L H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVP-FDPDSPETKKEVNALE--CEIQLLKNLQHE 64
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGM 1161
+V +YG ++D TL+ E+M GS++ L + E + R I+ G+
Sbjct: 65 RIVQYYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE-----GV 117
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGTLPW 1217
EYLHS IVH D+K N+L + + K+GDFG SK I + V GT W
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNV----KLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
M+PE+++G K DV+S G + E+LT + P+A A I I P +P
Sbjct: 174 MSPEVISGEGY--GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSH 231
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
+ R + + + + RPS E+ R
Sbjct: 232 VSPDARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 96/305 (31%), Positives = 136/305 (44%), Gaps = 66/305 (21%)
Query: 1048 KELGSGTFGTV-----YHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
K LG G FG V + K R T VA+K +K++ SSE L EF +L
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELRDLLSEF----NLLK 58
Query: 1101 KLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVL-LSK----------------- 1141
+++HP+V+ YG QDGP L + E+ GSLR L S+
Sbjct: 59 QVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 1142 -----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
ER L + A + GM+YL +VH DL N+LV K+ DF
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR----KMKISDF 171
Query: 1197 GLSK--------IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEI 1246
GLS+ +KR+ +G +P WMA E L + + DV+SFG++LWEI
Sbjct: 172 GLSRDVYEEDSYVKRS-------KGRIPVKWMAIESL--FDHIYTTQSDVWSFGVLLWEI 222
Query: 1247 LT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
+T G PY + + ++ R P C E LM CW +P RP+F +I++
Sbjct: 223 VTLGGNPYPGIAPERLFN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
Query: 1306 RLRVM 1310
L M
Sbjct: 282 ELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 21/283 (7%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
++I+K +L+++K LGSG FGTVY G W G +V +I + R + + E
Sbjct: 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENV---KIPVAIKVLRENTSPKANKEIL 57
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGS-LRHVLLSKERHLDRRKRLI 1152
EA +++ + P V G+ T+ VT+ M G L +V +K+R + + L
Sbjct: 58 DEAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDR-IGSQDLLN 113
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTG 1209
+ A GM YL +VH DL N+LV K P K+ DFGL++ I
Sbjct: 114 WCVQIAKGMSYLEEVRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLDIDETEYHAD 169
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1268
G + + WMA E + + + + DV+S+G+ +WE++T G +PY + I ++
Sbjct: 170 GGKVPIKWMALESI--LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-AREIPDLLEK 226
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311
R P P C + ++M +CW D RP F E+ M+
Sbjct: 227 GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 94/285 (32%), Positives = 129/285 (45%), Gaps = 43/285 (15%)
Query: 1050 LGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 1104
+G G FG V + + D AIKR+K+ S + R +F E E+L KL HH
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHR---DFAGELEVLCKLGHH 67
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD----------------RR 1148
PN++ G + G L E+ +G+L L K R L+ +
Sbjct: 68 PNIINLLGACEHR--GYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT 1208
+ L A D A GM+YL K +H DL N+LV + K+ DFGLS+ + +
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN----YVAKIADFGLSRGQE--VYV 178
Query: 1209 GGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1265
G LP WMA E LN S + DV+S+G++LWEI++ G PY M + +
Sbjct: 179 KKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
Query: 1266 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
R P CD E LM QCW P RPSF +I L M
Sbjct: 237 PQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 94/287 (32%), Positives = 130/287 (45%), Gaps = 47/287 (16%)
Query: 1050 LGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 1104
+G G FG V + + D AIKR+K+ +S+ + +F E E+L KL HH
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDHR--DFAGELEVLCKLGHH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD----------------RR 1148
PN++ G + G L E+ +G+L L K R L+ +
Sbjct: 56 PNIINLLGACEHR--GYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQ 112
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSKIKRNTL 1206
+ L A D A GM+YL K +H DL N+LV N K+ DFGLS+ + +
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA------KIADFGLSRGQE--V 164
Query: 1207 VTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIG 1263
G LP WMA E LN S + DV+S+G++LWEI++ G PY M +
Sbjct: 165 YVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 222
Query: 1264 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
+ R P CD E LM QCW P RPSF +I L M
Sbjct: 223 KLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 96/300 (32%), Positives = 142/300 (47%), Gaps = 44/300 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
IK ++ +ELG G FG V+ + VA+K +K + R +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK--------D 53
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRH---------VLLSK- 1141
F REAE+L+ L H ++V FYGV + G L V E+M +G L VL+++
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 1142 --ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFG 1197
L + + L IA A GM YL S++ VH DL N LV NL + K+GDFG
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL------LVKIGDFG 165
Query: 1198 LSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1253
+S+ +T V G + WM PE + K + + DV+S G+VLWEI T G++P+
Sbjct: 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSLGVVLWEIFTYGKQPW 223
Query: 1254 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313
+ +I I + P C E LM CW +P +R + EI L+ ++ A
Sbjct: 224 YQLSNNEVIECITQGRVLQR-PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 81/289 (28%), Positives = 126/289 (43%), Gaps = 51/289 (17%)
Query: 1042 EDLEELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWR-EAEI 1098
+D E ++ +G G VY VAIKRI E+ + +++ R E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI--------DLEKCQTSVDELRKEVQA 52
Query: 1099 LSKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLIIA 1154
+S+ +HPNVV +Y VV D L V ++ GSL ++ S LD +
Sbjct: 53 MSQCNHPNVVKYYTSFVVGD----ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS----------KIKRN 1204
+ G+EYLHS +H D+K N+L+ + K+ DFG+S + R
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSV----KIADFGVSASLADGGDRTRKVRK 164
Query: 1205 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1264
T V GT WMAPE++ K D++SFGI E+ TG PY+ Y +
Sbjct: 165 TFV-----GTPCWMAPEVME-QVHGYDFKADIWSFGITAIELATGAAPYS--KYPPM--K 214
Query: 1265 IVNNTLRPPVPGF--------CDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
++ TL+ P +R ++ C DP RP+ E+ +
Sbjct: 215 VLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 35/288 (12%)
Query: 1030 NFDISTLQIIKNEDLEELKEL--GSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 1087
I+ ++ I+++D+++ + ++Y G + +V I+ KK +
Sbjct: 6 RSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKF-----HKGHKV 60
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYG----VVQDGPGGTLATVTEFMVNGSLRHVLLSKER 1143
L E + L ++ N++ YG +V D P +L + E+ G LR VL KE+
Sbjct: 61 LIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSL--ILEYCTRGYLREVL-DKEK 117
Query: 1144 HLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI- 1201
L + +L +A+D G+ L+ N + +L + LV K+ GL KI
Sbjct: 118 DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY----KLKIICHGLEKIL 173
Query: 1202 ------KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1255
N +V + + ++LN S+ + K D++S G+VLWEI TG+ P+ N
Sbjct: 174 SSPPFKNVNFMV---------YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
Query: 1256 MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ I I+N +P C E + ++E C + D + RP+ EI
Sbjct: 225 LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 73/271 (26%), Positives = 134/271 (49%), Gaps = 35/271 (12%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E+++ +G G FG V+ K V IK+I + ++ ERL + E ++L L
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP----VEQMTKDERLAAQ--NECQVLKLL 56
Query: 1103 HHPNVVAFYG----------VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
HPN++ +Y V++ PGGTLA + + LL ++ L +++
Sbjct: 57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQ-----KRCNSLLDEDTILHFFVQIL 111
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+A+ ++H+K I+H DLK N+L++ + + K+GDFG+SKI + V
Sbjct: 112 LAL------HHVHTKLILHRDLKTQNILLDKH---KMVVKIGDFGISKILSSKSKAYTVV 162
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272
GT +++PEL G ++K D+++ G VL+E+ + + + + A++ I++ T
Sbjct: 163 GTPCYISPELCEGKP--YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA- 219
Query: 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P+ + R L+ DP RP ++I
Sbjct: 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 79/266 (29%), Positives = 119/266 (44%), Gaps = 41/266 (15%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
++L ++G GT+G VY + + T VAIK+IK E E + RE ++L +L
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIK------LRFESEGIPKTALREIKLLKEL 55
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
+HPN++ V G L V EFM + L ++ ++R L G+
Sbjct: 56 NHPNIIKLLDVF--RHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTLPWMAP 1220
+ HS I+H DLK +NLL+N + + K+ DFGL++ T V T + AP
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVL----KLADFGLARSFGSPVRPYTHYV-VTRWYRAP 167
Query: 1221 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD- 1279
ELL G S VD++S G + E+L+ RP PG +
Sbjct: 168 ELLLG-DKGYSTPVDIWSVGCIFAELLSR---------------------RPLFPGKSEI 205
Query: 1280 SEWRLLMEQCWAPDPVVRPSFTEIAR 1305
+ + PDP V P FT +AR
Sbjct: 206 DQLFKIFRTLGTPDPEVWPKFTSLAR 231
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 31/216 (14%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E+L++LG GT+G VY + + T VA+K+I+ +E+E + RE +L +L
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD------NEEEGIPSTALREISLLKEL 55
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRL---IIAMDA 1157
HPN+V V+ L V E+ + L+ L + L K + ++
Sbjct: 56 KHPNIVKLLDVIHTE--RKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLR--- 109
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGT 1214
G+ Y HS I+H DLK N+L+N + K+ DFGL++ I T V T
Sbjct: 110 --GLAYCHSHRILHRDLKPQNILINRD----GVLKLADFGLARAFGIPLRTYTHEVV--T 161
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
L + APE+L G S S VD++S G + E++TG+
Sbjct: 162 LWYRAPEILLG-SKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 75/267 (28%), Positives = 120/267 (44%), Gaps = 22/267 (8%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
++LG+G F + Y + GT +A+K++ SSEQE + +E ++++L+HP
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYV--RNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+++ G + E+M GS+ H LLSK + G+ YLH
Sbjct: 64 HIIRMLGATCED--SHFNLFVEWMAGGSVSH-LLSKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-----SKIKRNTLVTGGVRGTLPWMAP 1220
I+H D+K NLL+ D ++ DFG +K G + GT+ +MAP
Sbjct: 121 ENQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 1221 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM----HYGAIIGGIVNNTLRPPVPG 1276
E+L G S DV+S G V+ E+ T + P+ H A+I I + T P +P
Sbjct: 178 EVLRGEQYGRS--CDVWSVGCVIIEMATAKPPWNAEKHSNHL-ALIFKIASATTAPSIPE 234
Query: 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
R + +C P RP E+
Sbjct: 235 HLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 80/262 (30%), Positives = 121/262 (46%), Gaps = 19/262 (7%)
Query: 1050 LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG GT+G VY + T V AIK I + R S + E E + S L H N+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHE---EIALHSYLKHRNI 67
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF--GMEYLH 1165
V + G D G E + GSL +L SK L ++ II G++YLH
Sbjct: 68 VQYLG--SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLN 1224
IVH D+K DN+LVN + K+ DFG SK + T GTL +MAPE+++
Sbjct: 126 DNQIVHRDIKGDNVLVN---TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID 182
Query: 1225 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLRPPVPGFCDSEWR 1283
D++S G + E+ TG+ P+ + A + + + P +P +E +
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK 242
Query: 1284 LLMEQCWAPDPVVRPSFTEIAR 1305
+ +C+ PDP R S ++ +
Sbjct: 243 NFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 24/225 (10%)
Query: 1050 LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V K + + A+K +KK ++ + E EIL + +HP +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEH-----IFSEKEILEECNHPFI 55
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK-RLIIAMDAAFGMEYLHS 1166
V Y +D + + E+ + G L +L D R IA EYLH+
Sbjct: 56 VKLYRTFKDKK--YIYMLMEYCLGGELWTIL-RDRGLFDEYTARFYIAC-VVLAFEYLHN 111
Query: 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226
+ I++ DLK +NLL++ + K+ DFG +K ++ T GT ++APE++
Sbjct: 112 RGIIYRDLKPENLLLDSNGYV----KLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNK 167
Query: 1227 SSKVSEKVDVFSFGIVLWEILTGEEPYAN------MHYGAIIGGI 1265
S VD +S GI+L+E+LTG P+ Y I+ G
Sbjct: 168 GYDFS--VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN 210
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-24
Identities = 91/295 (30%), Positives = 132/295 (44%), Gaps = 56/295 (18%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
++ELG FG VY G GT VAIK +K + L EF EA +
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMR 62
Query: 1100 SKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERH-------------- 1144
S+L HPN+V GVV ++ P L+ + + + L L+ + H
Sbjct: 63 SRLQHPNIVCLLGVVTKEQP---LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 1145 -LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL----- 1198
L+ + I A GME+L S ++VH DL N+LV K + K+ D GL
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV----KISDLGLFREVY 175
Query: 1199 ----SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1253
K+ N+L+ + WM+PE + K S D++S+G+VLWE+ + G +PY
Sbjct: 176 AADYYKLMGNSLLP------IRWMSPEAI--MYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
Query: 1254 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
+I I N + P P C + LM +CW P RP F +I RLR
Sbjct: 228 CGYSNQDVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 86/296 (29%), Positives = 130/296 (43%), Gaps = 47/296 (15%)
Query: 1048 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
K LG G FG V + G D VA+K +K + ++ + E E+
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-------DNATDKDLADLISEMEL 70
Query: 1099 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------------- 1141
+ + H N++ GV Q+GP L + E+ G+LR L ++
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGP---LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK- 1200
E L + + A A GMEYL S+ +H DL N+LV + + K+ DFGL++
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN----VMKIADFGLARG 183
Query: 1201 IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1257
+ G LP WMAPE L + + DV+SFGI++WEI T G PY +
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241
Query: 1258 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313
+ ++ R P C E +LM +CW P RP+F ++ L + AA
Sbjct: 242 VEELFK-LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 40/274 (14%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
L+ +G G +G VY GK T VA+K I + + ++ + RE +LS+L
Sbjct: 6 LELIGRGAYGAVYRGKHVPTGRVVALKIIN------LDTPDDDVS-DIQREVALLSQLRQ 58
Query: 1105 ---PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
PN+ +YG GP L + E+ GS+R L K + + +I + +
Sbjct: 59 SQPPNITKYYGSYLKGP--RLWIIMEYAEGGSVR--TLMKAGPIAEKYISVIIREVLVAL 114
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVRGTL 1215
+Y+H ++H D+K N+LV ++ +C DFG++ KR+T V GT
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVK-LC---DFGVAALLNQNSSKRSTFV-----GTP 165
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275
WMAPE++ K D++S GI ++E+ TG PY+++ + I + +P P
Sbjct: 166 YWMAPEVITEGKY-YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KP--P 220
Query: 1276 GFCDSEWRLLMEQ----CWAPDPVVRPSFTEIAR 1305
D+ + L+ + C +P R S E+ +
Sbjct: 221 RLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 97/307 (31%), Positives = 129/307 (42%), Gaps = 59/307 (19%)
Query: 1043 DLEELKE-LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTL----------- 1090
KE LG G FG V+ + G + K + K S Q L
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGME---KFMDKDFSLDVSGNQPVLVAVKMLREDANKN 61
Query: 1091 ---EFWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLS---KER 1143
+F +E +I+S+L PN++ V + P L +TE+M NG L L +E
Sbjct: 62 ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDP---LCMITEYMENGDLNQFLSRHEPQEA 118
Query: 1144 HLDRRKRLI-------IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
I +A A GM+YL S N VH DL N LV I K+ DF
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTI----KIADF 174
Query: 1197 GLSKIKRNTLVTGGV-----RGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT 1248
G+S RN L +G R LP WM+ E +L G + S DV++FG+ LWEILT
Sbjct: 175 GMS---RN-LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS---DVWAFGVTLWEILT 227
Query: 1249 --GEEPYANMHYGAII---GGIVNNTLRP---PVPGFCDSEWRLLMEQCWAPDPVVRPSF 1300
E+PY+ + +I G + R P P C LM CW + RPSF
Sbjct: 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF 287
Query: 1301 TEIARRL 1307
EI L
Sbjct: 288 QEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 79/286 (27%), Positives = 114/286 (39%), Gaps = 58/286 (20%)
Query: 1050 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQE------------RLTLEFWREAE 1097
LG GTF +Y G R +S QE R +L F+ A
Sbjct: 3 LGQGTFTNIYKGVLR---------VQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETAS 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
++S+L H ++V YGV + V E++ G L L ++ ++ +L +A
Sbjct: 54 LMSQLSHKHLVKLYGVCV-RDENIM--VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL 110
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR---PICKVGDFGLSKIKRNTLVTGGVRGT 1214
A + YL K +VH ++ N+LV P K+ D G I L
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG---IPITVLSREERVER 167
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEP------------YANMHYGAI 1261
+PW+APE + + ++ D +SFG L EI + GEEP Y + H
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH---- 223
Query: 1262 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
R P+P C L+ QCW DP RPSF I R L
Sbjct: 224 ---------RLPMPD-CAELANLIN-QCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 91/278 (32%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 1048 KELGSGTFGTVYHGKWRGTD----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
K LG G FG+V G+ D VA+K +K + T SE E +F EA + +
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT--RSEME----DFLSEAVCMKEFD 58
Query: 1104 HPNVVAFYGVVQDGPGG----TLATVTEFMVNGSLRHVLL-----SKERHLDRRKRLIIA 1154
HPNV+ GV + + FM +G L LL ++L + +
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRG 1213
D A GMEYL SK+ +H DL N ++N +C V DFGLS KI G
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNEN---MNVC-VADFGLSKKIYNGDYYRQGRIA 174
Query: 1214 TLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN-NT 1269
+P W+A E L + + K DV+SFG+ +WEI T G+ PY + I + N
Sbjct: 175 KMPVKWIAIESL--ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR 232
Query: 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
L+ P P D + LM CW +P RPSF + L
Sbjct: 233 LKQP-PDCLDGLYS-LMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 83/272 (30%), Positives = 130/272 (47%), Gaps = 25/272 (9%)
Query: 1048 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG G FG VY + G ++A+K+++ F S E + E ++L L H
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQ---FDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGM 1161
+V +YG ++D TL+ E M GS++ L S E + R I+ G+
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE-----GV 119
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG----GVRGTLPW 1217
YLHS IVH D+K N+ L+D + + K+GDFG SK + ++G V GT W
Sbjct: 120 SYLHSNMIVHRDIKGANI---LRDSVGNV-KLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
M+PE+++G K D++S G + E+LT + P+A A I I P +P
Sbjct: 176 MSPEVISGEG--YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309
R +++ + + +RPS E+ R V
Sbjct: 234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 96/309 (31%), Positives = 137/309 (44%), Gaps = 55/309 (17%)
Query: 1028 LGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 1087
LG + + + E L E G+ F + VA+K + R+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDG------QPVLVAVKML-------RADVTKT 59
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERH-- 1144
+F +E +I+S+L +PN++ GV V D P L +TE+M NG L L +E
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP---LCMITEYMENGDLNQFLSQREIEST 116
Query: 1145 ---------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
+ L +A+ A GM+YL S N VH DL N LV I K+ D
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTI----KIAD 172
Query: 1196 FGLSKIKRNTLVTGGV-----RGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEI- 1246
FG+S RN L +G R LP WMA E +L G + S DV++FG+ LWE+
Sbjct: 173 FGMS---RN-LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS---DVWAFGVTLWEMF 225
Query: 1247 -LTGEEPYANMHYGAII---GGIVNNTLRP---PVPGFCDSEWRLLMEQCWAPDPVVRPS 1299
L E+PY+ + +I G N R C S LM +CW+ D RP+
Sbjct: 226 TLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT 285
Query: 1300 FTEIARRLR 1308
F +I LR
Sbjct: 286 FNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 79/282 (28%), Positives = 125/282 (44%), Gaps = 53/282 (18%)
Query: 1047 LKELGSGTFGTVYHGKWRGTDV------AIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
++G GTFG VY ++ A+K I+ + E E ++L
Sbjct: 5 GNKIGGGTFGKVY----TAVNLDTGELMAVKEIRIQ------DNDPKTIKEIADEMKVLE 54
Query: 1101 KLHHPNVVAFYGV-VQDG---------PGGTLATVTEFMVNGSLRHVLLSKERHLDR-RK 1149
L HPN+V +YGV V GGTL + L H + E +
Sbjct: 55 LLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEEL--------LEHGRILDEHVIRVYTL 106
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVT 1208
+L+ G+ YLHS IVH D+K N+ ++ I K+GDFG + +K NT
Sbjct: 107 QLLE------GLAYLHSHGIVHRDIKPANIFLDHNGVI----KLGDFGCAVKLKNNTTTM 156
Query: 1209 G----GVRGTLPWMAPELLNGSSSKVSEK-VDVFSFGIVLWEILTGEEPYANMHYGAIIG 1263
G + GT +MAPE++ G K + D++S G V+ E+ TG+ P++ + I
Sbjct: 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216
Query: 1264 GIVNNTLRPPVPG--FCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
V +PP+P E + +++C DP RP+ +E+
Sbjct: 217 FHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 90/257 (35%), Positives = 118/257 (45%), Gaps = 59/257 (22%)
Query: 1091 EFWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
+F +E +ILS+L PN++ GV V + P L +TE+M NG L L S HLD ++
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDP---LCMITEYMENGDLNQFLSS--HHLDDKE 119
Query: 1150 R--------------------LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189
L +A+ A GM+YL S N VH DL N LV I
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTI-- 177
Query: 1190 ICKVGDFGLSKIKRNTLVTGGV-----RGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGI 1241
K+ DFG+S RN L G R LP WMA E +L G + S DV++FG+
Sbjct: 178 --KIADFGMS---RN-LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS---DVWAFGV 228
Query: 1242 VLWEILT--GEEPYANMHYGAII---GGIVNNT------LRPPVPGFCDSEWRLLMEQCW 1290
LWEIL E+PY + +I G + RPP C LM QCW
Sbjct: 229 TLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPP---CPQGLYELMLQCW 285
Query: 1291 APDPVVRPSFTEIARRL 1307
+ D RPSF++I L
Sbjct: 286 SRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 88/295 (29%), Positives = 130/295 (44%), Gaps = 48/295 (16%)
Query: 1048 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
K LG G FG V + G D VA+K +K S E+ + E E+
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK-------SDATEKDLSDLISEMEM 76
Query: 1099 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------------- 1141
+ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 77 MKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK- 1200
E L + + A A GMEYL SK +H DL N+LV + + K+ DFGL++
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN----VMKIADFGLARD 189
Query: 1201 IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1257
I G LP WMAPE L + + DV+SFG++LWEI T G PY +
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247
Query: 1258 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL-RVMS 1311
+ ++ R P C +E ++M CW P RP+F ++ L R+++
Sbjct: 248 VEELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 54/244 (22%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D + K +G G+F TV K + T+ AIK + K +E+ E E+L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVL 55
Query: 1100 SKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-KRLIIA--M 1155
++L HP ++ Y QD L V E+ NG L + K LD + R A +
Sbjct: 56 TRLNGHPGIIKLYYTFQDE--ENLYFVLEYAPNGELLQ-YIRKYGSLDEKCTRFYAAEIL 112
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-------------- 1201
A +EYLHSK I+H DLK +N+L++ I K+ DFG +K+
Sbjct: 113 LA---LEYLHSKGIIHRDLKPENILLDKDMHI----KITDFGTAKVLDPNSSPESNKGDA 165
Query: 1202 ------------KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
+ + V GT +++PELLN + + D+++ G +++++LTG
Sbjct: 166 TNIDSQIEKNRRRFASFV-----GTAEYVSPELLNEKPA--GKSSDLWALGCIIYQMLTG 218
Query: 1250 EEPY 1253
+ P+
Sbjct: 219 KPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 84/268 (31%), Positives = 125/268 (46%), Gaps = 25/268 (9%)
Query: 1048 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG G FG VY + G ++A K+++ F S E + E ++L L H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQ---FDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGM 1161
+V +YG ++D TL E+M GS++ L + E + R I+ GM
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE-----GM 119
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG-GVR---GTLPW 1217
YLHS IVH D+K N+L + + K+GDFG SK + ++G G+R GT W
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNV----KLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
M+PE+++G K DV+S G + E+LT + P+A A I I P +P
Sbjct: 176 MSPEVISGEG--YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSH 233
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
R + C + RPS E+ R
Sbjct: 234 ISEHARDFL-GCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 77/272 (28%), Positives = 123/272 (45%), Gaps = 24/272 (8%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER--LTLEFWREAEILS 1100
D E L+ +G G+FGTV + R +D I K+ + G +E+E+ L E IL
Sbjct: 1 DYEVLETIGKGSFGTVRKVR-RKSDGKILVWKEIDY-GNMTEKEKQQLVSEV----NILR 54
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKER-HLDRRKRLIIAMDA 1157
+L HPN+V +Y + D TL V E+ G L ++ KER +++ I
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 1158 AFGMEYLH-----SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGGV 1211
+ H ++H DLK N+ ++ K+GDFGL+KI ++
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDAN----NNVKLGDFGLAKILGHDSSFAKTY 170
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1271
GT +M+PE LN S EK D++S G +++E+ P+ + + I R
Sbjct: 171 VGTPYYMSPEQLNHMSY--DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR 228
Query: 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+P SE +++ DP RPS E+
Sbjct: 229 -RIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 79/268 (29%), Positives = 124/268 (46%), Gaps = 25/268 (9%)
Query: 1048 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG G FG VY + G ++A+K++ F S E + E ++L L H
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGM 1161
+V +YG ++D L+ E+M GS++ L + E R R I+ G+
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ-----GV 119
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG----GVRGTLPW 1217
YLHS IVH D+K N+L + + K+GDFG SK + ++G V GT W
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNV----KLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
M+PE+++G K DV+S + E+LT + P+A A I I +P +P
Sbjct: 176 MSPEVISGEG--YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
R ++Q + + RP+ + R
Sbjct: 234 VSDACRDFLKQIFVEEK-RRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 81/286 (28%), Positives = 120/286 (41%), Gaps = 53/286 (18%)
Query: 1046 ELKEL-GSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
EL E+ G GT+G VY + + T VAIK + E+E + E+ IL K
Sbjct: 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-----IEDEEEEIKEEY----NILRKY 59
Query: 1103 -HHPNVVAFYGV----VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR--LI--I 1153
+HPN+ FYG G L V E GS+ L+ R +R + I I
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYI 118
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK------IKRNTLV 1207
+ G+ YLH ++H D+K N+L+ + K+ DFG+S +RNT +
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEV----KLVDFGVSAQLDSTLGRRNTFI 174
Query: 1208 TGGVRGTLPWMAPELLNGSSS---KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1264
GT WMAPE++ + DV+S GI E+ G+ P +MH +
Sbjct: 175 -----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229
Query: 1265 IVNN---TLRPPVPGFCDSEWRLL----MEQCWAPDPVVRPSFTEI 1303
I N TL+ P W + +C + RP E+
Sbjct: 230 IPRNPPPTLKSP------ENWSKKFNDFISECLIKNYEQRPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 71/272 (26%), Positives = 131/272 (48%), Gaps = 30/272 (11%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E +K++G G+FG +Y K IK I + + E + +E +L+K+
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK------KEVILLAKM 56
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-------RHVLLSKERHLDRRKRLIIAM 1155
HPN+V F+ Q+ G L V E+ G L R VL S+++ L ++
Sbjct: 57 KHPNIVTFFASFQE--NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI---- 110
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGT 1214
+ G++++H + I+H D+K N+ ++ + K+GDFG+++ +++ + GT
Sbjct: 111 --SLGLKHIHDRKILHRDIKSQNIFLSKNG---MVAKLGDFGIARQLNDSMELAYTCVGT 165
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274
+++PE+ + + K D++S G VL+E+ T + P+ + ++ I P
Sbjct: 166 PYYLSPEICQ--NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS 223
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306
P F + R L+ Q + P RPS T I +R
Sbjct: 224 PNF-SRDLRSLISQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 39/220 (17%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ +K+LG GTFG+VY + + G VAIK++KK F S +E + L RE + L KL
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK-FY---SWEECMNL---REVKSLRKL 54
Query: 1103 -HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRK-RLIIAMDAAF 1159
HPN+V V ++ L V E+M G+L ++ K + R II
Sbjct: 55 NEHPNIVKLKEVFRE--NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ- 110
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--- 1216
G+ ++H H DLK +NLLV+ + + K+ DFGL++ +R P
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPE----VVKIADFGLAR---------EIRSRPPYTD 157
Query: 1217 -----WM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
W APE+L S+S S VD+++ G ++ E+ T
Sbjct: 158 YVSTRWYRAPEILLRSTS-YSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 83/295 (28%), Positives = 133/295 (45%), Gaps = 35/295 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
++NEDLE + +LG+G G+V K T + KK G S + L RE +I
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMA--KKVVHIGAKSSVRKQIL---RELQI 56
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ + P +V+FYG + + EFM GSL + K + IA+
Sbjct: 57 MHECRSPYIVSFYGAFLNEN--NICMCMEFMDCGSLDRI-YKKGGPIPVEILGKIAVAVV 113
Query: 1159 FGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
G+ YL++ + I+H D+K N+LVN + I K+ DFG+S N++ V GT +
Sbjct: 114 EGLTYLYNVHRIMHRDIKPSNILVNSRGQI----KLCDFGVSGELINSIADTFV-GTSTY 168
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA-----------NMHYGAIIGGIV 1266
M+PE + G K + K DV+S GI + E+ G+ P+A M ++ IV
Sbjct: 169 MSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226
Query: 1267 NNTLRPPVPGFCDSEW----RLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 1317
P P S++ R ++ C DP RP+ ++ + A +
Sbjct: 227 QE----PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 75/231 (32%), Positives = 107/231 (46%), Gaps = 53/231 (22%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
++ E+L + GT+G VY + + T VA+K++K E+E + RE IL
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK------MEKEKEGFPITSLREINIL 58
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
KL HPN+V VV G L + +MV + H L K L+ M F
Sbjct: 59 LKLQHPNIVTVKEVVV---GSNLDKI--YMVMEYVEHDL----------KSLMETMKQPF 103
Query: 1160 --------------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-----SK 1200
G+ +LH I+H DLK NLL+N R I K+ DFGL S
Sbjct: 104 LQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN----RGILKICDFGLAREYGSP 159
Query: 1201 IKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+K T LV TL + APELL G + + S +D++S G + E+LT +
Sbjct: 160 LKPYTQLVV-----TLWYRAPELLLG-AKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 3e-21
Identities = 80/272 (29%), Positives = 120/272 (44%), Gaps = 48/272 (17%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D E +K LG+G+FG V + +G+ A+K + K+ +Q L E IL
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV--KLKQVEHVL---NEKRIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL------II 1153
+ HP +V YG QD L V E++ G L HL + R
Sbjct: 56 QSIRHPFLVNLYGSFQDD--SNLYLVMEYVPGGELFS-------HLRKSGRFPEPVARFY 106
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN---TLVTGG 1210
A +EYLHS +IV+ DLK +NLL++ I K+ DFG +K + TL
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYI----KITDFGFAKRVKGRTYTLC--- 159
Query: 1211 VRGTLPWMAPELLNGSSSKVSEK-VDVFSFGIVLWEILTGEEPYA----NMHYGAIIGGI 1265
GT ++APE++ SK K VD ++ GI+++E+L G P+ Y I+ G
Sbjct: 160 --GTPEYLAPEII---LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
Query: 1266 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVR 1297
V P F + + L+ D R
Sbjct: 215 VR------FPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 4e-21
Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 44/221 (19%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E+ K+LG GT+ VY + + T VAIK+IK R ++ + RE ++L +L
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG---ERKEAKDGINFTALREIKLLQEL 59
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA-------M 1155
HPN++ V G + V EFM L V+ + K +++ M
Sbjct: 60 KHPNIIGLLDVF--GHKSNINLVFEFM-ETDLEKVI--------KDKSIVLTPADIKSYM 108
Query: 1156 DAAF-GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRN---TLV 1207
G+EYLHS I+H DLK +NLL+ + K+ DFGL++ R +V
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIASDG----VLKLADFGLARSFGSPNRKMTHQVV 164
Query: 1208 TGGVRGTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEIL 1247
T W APELL G+ VD++S G + E+L
Sbjct: 165 T-------RWYRAPELLFGARH-YGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ L +G G G V+ K R T VA+K++ R E + + RE + L
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKV-----ALRRLE-GGIPNQALREIKALQAC 56
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK-RLIIAMDAAFGM 1161
HP VV V G G V E+M L VL +ER L + + + M G+
Sbjct: 57 QHPYVVKLLDVFPHGSG--FVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK-GV 112
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRGTLPWM 1218
Y+H+ I+H DLK NLL++ + K+ DFGL+++ + L + V T +
Sbjct: 113 AYMHANGIMHRDLKPANLLISADG----VLKIADFGLARLFSEEEPRLYSHQV-ATRWYR 167
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
APELL G + K VD+++ G + E+L G
Sbjct: 168 APELLYG-ARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 8e-21
Identities = 80/268 (29%), Positives = 129/268 (48%), Gaps = 31/268 (11%)
Query: 1046 ELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
+L+ +G G+FG VY G T VAIK I E E + +E +LS+
Sbjct: 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
P + +YG G L + E++ GS +L K L+ I + G++Y
Sbjct: 61 SPYITRYYGSYLKG--TKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDY 116
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGTLPW 1217
LHS+ +H D+K N+L++ + + K+ DFG+ ++IKRNT V GT W
Sbjct: 117 LHSERKIHRDIKAANVLLSEQGDV----KLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
MAPE++ S+ K D++S GI E+ GE P +++H ++ I N+ P + G
Sbjct: 168 MAPEVIKQSAYDF--KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PPTLEGQ 224
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
++ +E C DP RP+ E+ +
Sbjct: 225 YSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 76/276 (27%), Positives = 131/276 (47%), Gaps = 41/276 (14%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD---VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D + LK+LG G++G+VY K R +D A+K + G S++ER + E IL
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVD----LGSMSQKERE--DAVNEIRIL 53
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI------- 1152
+ ++HPN++++ DG L V E+ G L + ++++LI
Sbjct: 54 ASVNHPNIISYKEAFLDG--NKLCIVMEYAPFGDLSKAI----SKRKKKRKLIPEQEIWR 107
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
I + G++ LH + I+H DLK N+L+ D + K+GD G+SK+ + +
Sbjct: 108 IFIQLLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLGISKVLKKNM-AKTQI 162
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY-----ANMHYGAIIGGIVN 1267
GT +MAPE+ G S K D++S G +L+E+ T P+ ++ Y + G
Sbjct: 163 GTPHYMAPEVWKGRP--YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY-KVQRGKY- 218
Query: 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
PP+P + + + P +RP+ +I
Sbjct: 219 ----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 38/276 (13%)
Query: 1053 GTFGTVYHGKWRGTDVAIKR--IKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 1110
GTFG +++G + K+ S Q L L+ E+ +L L H N++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ---ESCLLYGLSHQNILPI 73
Query: 1111 YGVVQDGPGGTLATVTEFMVNGSL-------RHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
V + + +M G+L R + + L ++ + +A+ A GM Y
Sbjct: 74 LHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGTLPWMA 1219
LH + ++H D+ N +++ + + K+ D LS+ + + L R + WMA
Sbjct: 133 LHKRGVIHKDIAARNCVIDEELQV----KITDNALSRDLFPMDYHCLGDNENR-PVKWMA 187
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANM------HYGAIIGGIVNNTLRP 1272
E L + + S DV+SFG++LWE++T G+ PY + Y + + R
Sbjct: 188 LESL--VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY-------LKDGYRL 238
Query: 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
P C E +M CWA DP RPSF+++ + L
Sbjct: 239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-20
Identities = 86/295 (29%), Positives = 129/295 (43%), Gaps = 48/295 (16%)
Query: 1048 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
K LG G FG V + G D VA+K +K ++ + E E+
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK-------DDATDKDLSDLVSEMEM 70
Query: 1099 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------------- 1141
+ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 71 MKMIGKHKNIINLLGACTQDGP---LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
E L + + A A GMEYL S+ +H DL N+LV + + K+ DFGL++
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN----VMKIADFGLARD 183
Query: 1202 KRNT-LVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1257
N G LP WMAPE L + + DV+SFG++LWEI T G PY +
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241
Query: 1258 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL-RVMS 1311
+ ++ R P C E ++M +CW P RP+F ++ L RV++
Sbjct: 242 VEELF-KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 81/296 (27%), Positives = 135/296 (45%), Gaps = 28/296 (9%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+LE + +GSG GTVY R T A+K I + ++ + + RE EIL
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-------YGNHEDTVRRQICREIEIL 126
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++HPNVV + + G + + EFM GSL ++ E+ L R I++
Sbjct: 127 RDVNHPNVVKCHDMFDHN--GEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS----- 179
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL--VTGGVRGTLPW 1217
G+ YLH ++IVH D+K NLL+N + K+ DFG+S+I T+ V GT+ +
Sbjct: 180 GIAYLHRRHIVHRDIKPSNLLINSAKNV----KIADFGVSRILAQTMDPCNSSV-GTIAY 234
Query: 1218 MAPELLNGSSSKVSEK---VDVFSFGIVLWEILTGEEPYANMHYG--AIIGGIVNNTLRP 1272
M+PE +N + + D++S G+ + E G P+ G A + + + P
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP 294
Query: 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQVQNQVP 1328
P E+R + C +P R S ++ + ++ A G + +P
Sbjct: 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLP 350
|
Length = 353 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-20
Identities = 82/297 (27%), Positives = 128/297 (43%), Gaps = 48/297 (16%)
Query: 1048 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
K LG G FG V + G D VA+K +K E+ + E E+
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEM 73
Query: 1099 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------------- 1141
+ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 74 MKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
+ + + + A GMEYL S+ +H DL N+LV + + K+ DFGL++
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN----VMKIADFGLARD 186
Query: 1202 KRNT-LVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1257
N G LP WMAPE L + + DV+SFG+++WEI T G PY +
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244
Query: 1258 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL-RVMSAA 1313
+ ++ R P C +E ++M CW P RP+F ++ L R+++
Sbjct: 245 VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 74/275 (26%), Positives = 119/275 (43%), Gaps = 33/275 (12%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRI--KKSCFTGRSSEQERLTLEFWREAEIL 1099
E + EL LG G G+V + + T I K+ T + + ++ L RE EI
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNT----GMIFALKTITTDPNPDLQKQIL---RELEIN 53
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHV---LLSKERHLDRRKRLIIAMD 1156
P +V +YG D ++ E+ GSL + + + + + IA
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAES 113
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
G+ YLHS+ I+H D+K N+L+ K + K+ DFG+S N+L G GT
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQV----KLCDFGVSGELVNSL-AGTFTGTSF 168
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY---ANMHYGAIIGGIVNNTLRPP 1273
+MAPE + G ++ DV+S G+ L E+ P+ G I +++ + P
Sbjct: 169 YMAPERIQGKPYSITS--DVWSLGLTLLEVAQNRFPFPPEGEPPLGPI--ELLSYIVNMP 224
Query: 1274 VPGFCDSE-----W----RLLMEQCWAPDPVVRPS 1299
P D W + ++QC DP RP+
Sbjct: 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 82/288 (28%), Positives = 130/288 (45%), Gaps = 36/288 (12%)
Query: 1032 DISTLQIIKNEDLEE----LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 1087
D ++ +D E+ L+E+G G+FG VY + T+ + IKK ++G+ S
Sbjct: 1 DPEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVA-IKKMSYSGKQSN--- 56
Query: 1088 LTLEFW----REAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKE 1142
E W +E L +L HPN + + G +++ T V E+ + GS +L +
Sbjct: 57 ---EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH---TAWLVMEYCL-GSASDILEVHK 109
Query: 1143 RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202
+ L + I A G+ YLHS +H D+K N+L L +P K+ DFG + +
Sbjct: 110 KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNIL--LTEP--GTVKLADFGSASLV 165
Query: 1203 R--NTLVTGGVRGTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 1259
N+ V GT WMAPE +L + KVDV+S GI E+ + P NM+
Sbjct: 166 SPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
Query: 1260 AIIGGIVNNTLRPPV--PGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
+ + I N P +R ++ C P RPS E+ +
Sbjct: 221 SALYHIAQN--DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 78/264 (29%), Positives = 130/264 (49%), Gaps = 18/264 (6%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
++ +G G++G V + R G IK++ +S +ER E +EA++LS+L H
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLR----NASRRERKAAE--QEAQLLSQLKH 58
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL-SKERHLDRRKRLIIAMDAAFGMEY 1163
PN+VA Y +G G L V F G L H L K + L + + + A ++Y
Sbjct: 59 PNIVA-YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGTLPWMAPEL 1222
LH K+I+H DLK N+ + + I KVGD G++++ N + + GT +M+PEL
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTN----IIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173
Query: 1223 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 1282
S+ + K DV++ G ++E+ T + + +++ I+ L PP+P E
Sbjct: 174 F--SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYSPEL 230
Query: 1283 RLLMEQCWAPDPVVRPSFTEIARR 1306
L+ + P RPS I R+
Sbjct: 231 GELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 4e-20
Identities = 72/282 (25%), Positives = 128/282 (45%), Gaps = 37/282 (13%)
Query: 1048 KELGSGTFGTVYHGK-WRGTDVA---IKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
E+G+G FG V G+ RG A +K ++ S ++ E+L F +E + +L+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-----ATPDEQLL--FLQEVQPYRELN 53
Query: 1104 HPNVVAFYG-VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL----DRRKRLIIAMDAA 1158
HPNV+ G ++ P V EF G L++ L S + + +A + A
Sbjct: 54 HPNVLQCLGQCIESIP---YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVA 110
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL--SKIKRNTLVTGGVRGT-L 1215
G+ +LH + +H DL N + + K+GD+GL + + +T L
Sbjct: 111 SGLLWLHQADFIHSDLALRNCQLTADLSV----KIGDYGLALEQYPEDYYITKDCHAVPL 166
Query: 1216 PWMAPELLNGSSS-----KVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV-NN 1268
W+APEL+ ++K +++S G+ +WE+ T ++PY ++ ++ +V
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ 226
Query: 1269 TLRPPVPGF---CDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
++ P P W +M+ CW DP RP+ E+ L
Sbjct: 227 DIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-20
Identities = 86/280 (30%), Positives = 128/280 (45%), Gaps = 41/280 (14%)
Query: 1045 EELKELGSGTFGTVYH--GKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E ++ +G GT+G VY K G+ A+K + S E + E+ IL L
Sbjct: 25 EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-----SDVDEEIEAEY----NILQSL 75
Query: 1103 -HHPNVVAFYGVVQDGP---GGTLATVTEFMVNGSLRHV---LLSKERHLDRRKRLIIAM 1155
+HPNVV FYG+ GG L V E GS+ + LL + LD I
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTG 1209
A G+++LH+ I+H D+K +N+L+ + + K+ DFG+S +++RNT V
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGV----KLVDFGVSAQLTSTRLRRNTSV-- 189
Query: 1210 GVRGTLPWMAPELL---NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1266
GT WMAPE++ + DV+S GI E+ G+ P +MH + I
Sbjct: 190 ---GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246
Query: 1267 NN---TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
N TL P +C + + QC D RPS T +
Sbjct: 247 RNPPPTLLHP-EKWCR-SFNHFISQCLIKDFEARPSVTHL 284
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 39/226 (17%)
Query: 1042 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKR--IKKSCFTGRSSEQERLTLEFWREAE 1097
L+ ++G G+ G V K G VA+K+ ++K Q+R L F E
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---------QQRRELLF-NEVV 68
Query: 1098 ILSKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
I+ HPN+V Y +V D L V EF+ G+L ++ + ++ + +A+
Sbjct: 69 IMRDYQHPNIVEMYSSYLVGD----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAV 124
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG----LSK--IKRNTLVTG 1209
A + +LH++ ++H D+K D++L+ + K+ DFG +SK +R +LV
Sbjct: 125 LKA--LSFLHAQGVIHRDIKSDSILLTSDGRV----KLSDFGFCAQVSKEVPRRKSLV-- 176
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1255
GT WMAPE++ S +VD++S GI++ E++ GE PY N
Sbjct: 177 ---GTPYWMAPEVI--SRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 74/255 (29%), Positives = 111/255 (43%), Gaps = 20/255 (7%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LK + G FG+VY K R T AIK +KKS ++ + + E A ++ +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN-QVTNVKAE---RAIMMIQGES 56
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P V Y Q L V E++ NG L+ L + G+E L
Sbjct: 57 PYVAKLYYSFQSK--DYLYLVMEYL-NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDL 113
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLN 1224
H + I+H D+K +NLL++ + K+ DFGLS RN L GT ++APE +
Sbjct: 114 HQRGIIHRDIKPENLLIDQTGHL----KLTDFGLS---RNGLENKKFVGTPDYLAPETIL 166
Query: 1225 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPGFCDSEW 1282
G + D +S G V++E L G P+ A+ I++ + P V FC E
Sbjct: 167 GVGD--DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEA 224
Query: 1283 RLLMEQCWAPDPVVR 1297
L+ + DP R
Sbjct: 225 VDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 6e-20
Identities = 76/267 (28%), Positives = 128/267 (47%), Gaps = 24/267 (8%)
Query: 1050 LGSGTFGTVYHG-KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 1108
LG G +GTVY G +G +A+K+++ ++E+E L+ E ++L L H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQ--EEVDLLKSLKHVNIV 65
Query: 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGMEYL 1164
+ G D T++ EF+ GS+ +L E + + I+ G+ YL
Sbjct: 66 QYLGTCLDD--NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-----GVAYL 118
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPI---C--KVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
H+ +VH D+K +N+++ I+ I C ++ GL N L + + GT WMA
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--MHGTPYWMA 176
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPGFC 1278
PE++N S K D++S G ++E+ TG+ P A+M A + I + L P +P
Sbjct: 177 PEVIN--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF 234
Query: 1279 DSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
+ + C D RPS ++ R
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 8e-20
Identities = 87/267 (32%), Positives = 132/267 (49%), Gaps = 31/267 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD---VAIKRIKKSCFTGRSSEQERLTLEFWRE 1095
+K ED ++ LG+G+FG V ++ D VAIKR +KS + +Q+++ F E
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS----KIIKQKQVDHVF-SE 81
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
+IL+ ++HP V YG +D L V EF++ G L + + A
Sbjct: 82 RKILNYINHPFCVNLYGSFKDE--SYLYLVLEFVIGGEF-FTFLRRNKRFPNDVGCFYAA 138
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
EYL S NIV+ DLK +NLL++ KD K+ DFG +K+ T + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLD-KD---GFIKMTDFGFAKVVDTRTYT--LCGTP 192
Query: 1216 PWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTGEEP-YAN---MHYGAIIGGIVNNTL 1270
++APE LLN K + D ++ GI ++EIL G P YAN + Y I+ GI+
Sbjct: 193 EYIAPEILLNVGHGKAA---DWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY--- 246
Query: 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVR 1297
P F D+ + LM++ + D R
Sbjct: 247 ---FPKFLDNNCKHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 9e-20
Identities = 79/272 (29%), Positives = 129/272 (47%), Gaps = 31/272 (11%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E +L+ +G G+FG V+ G T VAIK I E E + +E +L
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID-------LEEAEDEIEDIQQEITVL 56
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
S+ P V +YG G L + E++ GS +L + D + + +
Sbjct: 57 SQCDSPYVTKYYGSYLKG--TKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILK 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRG 1213
G++YLHS+ +H D+K N+L++ + + K+ DFG+ ++IKRNT V G
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEQGDV----KLADFGVAGQLTDTQIKRNTFV-----G 163
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273
T WMAPE++ S+ K D++S GI E+ GE P ++MH ++ I N P
Sbjct: 164 TPFWMAPEVIQQSA--YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPT 220
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
+ G ++ ++ C DP RP+ E+ +
Sbjct: 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-19
Identities = 59/168 (35%), Positives = 85/168 (50%), Gaps = 12/168 (7%)
Query: 1145 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203
LD L + A GM +L SKN +H DL N+L+ I K+ DFGL++ R
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR----ITKICDFGLARDIRN 266
Query: 1204 --NTLVTGGVRGTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG 1259
N +V G R + WMAPE + N + S DV+S+GI+LWEI + G PY M
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFES---DVWSYGILLWEIFSLGSSPYPGMPVD 323
Query: 1260 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
+ ++ R P SE +M+ CW DP+ RP+F +I + +
Sbjct: 324 SKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 19/223 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI- 1098
+DLE ++ELG G +G V + GT +A+KRI+ + S EQ+RL ++ +I
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDL----DIS 53
Query: 1099 LSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
+ + P V FYG + ++G V + ++ + V K + IA+
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVY-DKGLTIPEDILGKIAVSI 112
Query: 1158 AFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
+EYLHSK +++H D+K N+L+N ++ +C DFG+S +++ G P
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVK-LC---DFGISGYLVDSVAKTIDAGCKP 168
Query: 1217 WMAPELLN--GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1257
+MAPE +N + K DV+S GI + E+ TG PY +
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK 211
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 83/272 (30%), Positives = 124/272 (45%), Gaps = 25/272 (9%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
NE E + ELG G FG VY K + T A K I+ T E E ++ E EI
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE----TKSEEELE----DYMVEIEI 62
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L+ +HP +V G G L + EF G++ ++L +R L + +I
Sbjct: 63 LATCNHPYIVKLLGAFYWD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML 120
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT-GGVRGTLPW 1217
++YLHS I+H DLK N+L+ L I K+ DFG+S TL GT W
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGDI----KLADFGVSAKNVKTLQRRDSFIGTPYW 176
Query: 1218 MAPELLNGSSSKVSE---KVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274
MAPE++ + K + K D++S GI L E+ E P+ ++ ++ I + PP
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT 234
Query: 1275 ---PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P E+R ++ P RPS ++
Sbjct: 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-19
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 59/231 (25%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQER--LTLEFWREAEILS 1100
E+L +G GT+G VY + + VA+K+++ + ER + + RE +L
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVR--------MDNERDGIPISSLREITLLL 61
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF- 1159
L HPN+V VV G L ++ F+V L S L+ M F
Sbjct: 62 NLRHPNIVELKEVVV---GKHLDSI--FLVMEYCEQDLAS----------LLDNMPTPFS 106
Query: 1160 -------------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206
G++YLH I+H DLK NLL+ K K+ DFGL++
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG----CLKIADFGLAR------ 156
Query: 1207 VTGGVRG-------TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
G TL + APELL G + + +D+++ G +L E+L +
Sbjct: 157 TYGLPAKPMTPKVVTLWYRAPELLLG-CTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215996 pfam00564, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-19
Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 200 PSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQT-HTIKYQLPGEDLDALVSVSCD 258
KLRY GG R + +S IS++EL K + K + P ED D LVS++ D
Sbjct: 1 TVRVKLRYGGGIRRFLSVSPGISFEELRSKVEQRFGLDRVDFKLKYPDEDGD-LVSITSD 59
Query: 259 EDLQNMMEECNVLEDRGTQKPRMFLFSS 286
EDL+ +EE L G++ R+ +F +
Sbjct: 60 EDLEEAIEEARSL---GSKTLRLHVFPA 84
|
Length = 84 |
| >gnl|CDD|214770 smart00666, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 4e-19
Identities = 39/88 (44%), Positives = 56/88 (63%), Gaps = 10/88 (11%)
Query: 200 PSDGKLRYVGGETRIIRISRDISWQEL---TQKALAIYNQTHTIKYQLPGEDLDALVSVS 256
D KLRY GGETR + + RDIS+++L K + NQ+ T+KYQ ED D LVS++
Sbjct: 1 TVDVKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLT 56
Query: 257 CDEDLQNMMEECNVLEDRGTQKPRMFLF 284
DEDL+ +EE + L G++K R+ +F
Sbjct: 57 SDEDLEEAIEEYDSL---GSKKLRLHVF 81
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. Length = 81 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 6e-19
Identities = 82/284 (28%), Positives = 136/284 (47%), Gaps = 33/284 (11%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E +L+++G G+FG V+ G T VAIK I E E + +E +L
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-------LEEAEDEIEDIQQEITVL 56
Query: 1100 SKLHHPNVVAFYG-VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
S+ P V +YG ++D L + E++ GS +L + LD + I +
Sbjct: 57 SQCDSPYVTKYYGSYLKDT---KLWIIMEYLGGGSALDLL--EPGPLDETQIATILREIL 111
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVR 1212
G++YLHS+ +H D+K N+L++ + K+ DFG+ ++IKRNT V
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEHGEV----KLADFGVAGQLTDTQIKRNTFV----- 162
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272
GT WMAPE++ S+ K D++S GI E+ GE P++ +H ++ I N P
Sbjct: 163 GTPFWMAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PP 219
Query: 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 1316
+ G + +E C +P RP+ E+ + ++ A +T
Sbjct: 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKT 263
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 68/271 (25%), Positives = 121/271 (44%), Gaps = 18/271 (6%)
Query: 1047 LKELGSGTFGTVYHGKWR---GTDVAIKRI--KKSCFTGRSSEQERLTLEFWREAEILSK 1101
L+ LGSG FG VY + + +A+K I F E+++ + E I+ +
Sbjct: 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 1102 -LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDA 1157
L HPN+V +Y + L V + + L S K++ + I +
Sbjct: 65 QLRHPNIVRYYKTFLEN--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 1158 AFGMEYLH-SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
+ YLH K IVH DL +N+++ D + + DFGL+K K+ V GT+
Sbjct: 123 VLALRYLHKEKRIVHRDLTPNNIMLGEDDKV----TITDFGLAKQKQPESKLTSVVGTIL 178
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 1276
+ PE++ + EK DV++FG +L+++ T + P+ + + ++ IV P G
Sbjct: 179 YSCPEIVK--NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236
Query: 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
+ ++ C PD RP +++ +
Sbjct: 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 36/227 (15%)
Query: 1048 KELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLT----LEF--WREAEIL 1099
LG GT+G V G VAIK++K + ++ +L + F RE +I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 1100 SKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+++ H N++ V V+ G + V + M L+ V+ K R + + + I+ +
Sbjct: 75 NEIKHENIMGLVDVYVE---GDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-LQIL 129
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----------------IK 1202
G+ LH +H DL N+ +N K ICK+ DFGL++ ++
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKG----ICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 1203 RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
R +T V TL + APELL G + K VD++S G + E+LTG
Sbjct: 186 RREEMTSKVV-TLWYRAPELLMG-AEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 44/298 (14%)
Query: 1028 LGNFDISTLQIIKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQ 1085
LGNF I K++G G F VY G VA+K+++ + Q
Sbjct: 1 LGNFKI-------------EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ 47
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 1145
+ L +E ++L +L HPNV+ + + L V E G L ++ +H
Sbjct: 48 DCL-----KEIDLLKQLDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMI----KHF 96
Query: 1146 DRRKRLI-------IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
++KRLI + +E++HSK I+H D+K N+ + + K+GD GL
Sbjct: 97 KKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG----VVKLGDLGL 152
Query: 1199 SKI-KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--AN 1255
+ T + GT +M+PE ++ + K D++S G +L+E+ + P+
Sbjct: 153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF--KSDIWSLGCLLYEMAALQSPFYGDK 210
Query: 1256 MHYGAIIGGIVNNTLRPPVPGFCDS-EWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312
M+ ++ I PP+P S E R L+ +C PDP RP + + + + M A
Sbjct: 211 MNLYSLCKKIEKCDY-PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 41/280 (14%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E ++ +G GT+G V+ K G+ A+K + + E E IL L
Sbjct: 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---------HDIDEEIEAEYNILKAL 71
Query: 1103 H-HPNVVAFYGVVQDGP---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM--- 1155
HPNVV FYG+ G L V E GS+ ++ + +R + IIA
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTG 1209
+A G+++LH +H D+K +N+L+ + + K+ DFG+S +++RNT V
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGV----KLVDFGVSAQLTSTRLRRNTSV-- 185
Query: 1210 GVRGTLPWMAPELLNGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1266
GT WMAPE++ S + DV+S GI E+ G+ P A++H + I
Sbjct: 186 ---GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242
Query: 1267 NNTLRPPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
N PP P +E+ + +C D RP+ +++
Sbjct: 243 RNP--PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-18
Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 26/278 (9%)
Query: 1046 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+L+E+G G+FG VY + T+ + IKK ++G+ S ++ + +E + L ++ HP
Sbjct: 29 DLREIGHGSFGAVYFARDVRTNEVVA-IKKMSYSGKQSNEK--WQDIIKEVKFLQRIKHP 85
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
N + + G L V E+ + GS +L ++ L + I A G+ YLH
Sbjct: 86 NSIEYKGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTLPWMAPE-L 1222
S N++H D+K N+L L +P + K+ DFG + I N+ V GT WMAPE +
Sbjct: 143 SHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 1223 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 1282
L + KVDV+S GI E+ + P NM+ + + I N P +EW
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----SPTLQSNEW 249
Query: 1283 ----RLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 1316
R ++ C P RP+ E+ + + V+ +T
Sbjct: 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-18
Identities = 88/333 (26%), Positives = 129/333 (38%), Gaps = 88/333 (26%)
Query: 1048 KELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
K LG G FG V G + VA+K +K+ +SE + L E +IL
Sbjct: 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG---ATASEYKALMTEL----KILI 65
Query: 1101 KL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNG-------SLRHVLL------------- 1139
+ HH NVV G PGG L + E+ G S R
Sbjct: 66 HIGHHLNVVNLLGACTK-PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMK 124
Query: 1140 ---SKERHLDRR--------------KRLIIA-----------------------MDAAF 1159
K++ LD K L A
Sbjct: 125 QKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVAR 184
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT--LVTGGVRGTLP 1216
GME+L S+ +H DL N+L++ + + K+ DFGL++ I ++ + G R L
Sbjct: 185 GMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGDARLPLK 240
Query: 1217 WMAPELLNGSSSKV-SEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 1274
WMAPE + KV + + DV+SFG++LWEI + G PY + + R
Sbjct: 241 WMAPESI---FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA 297
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P + E +M CW +P RP+F+E+ L
Sbjct: 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 74/254 (29%), Positives = 112/254 (44%), Gaps = 23/254 (9%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V +++ T AIK +KK R E E L E R E + HP +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD-EVESLMCE-KRIFETANSERHPFL 64
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 1166
V + Q + V E+ G L H+ + + R A G++YLH
Sbjct: 65 VNLFACFQTE--DHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAA-CVVLGLQYLHE 119
Query: 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---RNTLVTGGVRGTLPWMAPELL 1223
IV+ DLK DNLL++ + + K+ DFGL K + T GT ++APE+L
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFV----KIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVL 173
Query: 1224 NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283
+S + VD + G++++E+L GE P+ + IVN+ P F E
Sbjct: 174 TETS--YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSREAI 229
Query: 1284 LLMEQCWAPDPVVR 1297
+M + +P R
Sbjct: 230 SIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-18
Identities = 69/241 (28%), Positives = 109/241 (45%), Gaps = 52/241 (21%)
Query: 1050 LGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
+G G G VY + VA+K+I++ SE L F REA+I + L HP +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDL-----SENPLLKKRFLREAKIAADLIHPGI 64
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNG-SLRHVL--------LSKERHLDRRKRLIIAMDAA 1158
V Y + DG T + G +L+ +L LSKE K + A +
Sbjct: 65 VPVYSICSDG---DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---EKTSVGAFLSI 118
Query: 1159 F-----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR---------- 1203
F +EY+HSK ++H DLK DN+L+ L + + D+G + K+
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEV----VILDWGAAIFKKLEEEDLLDID 174
Query: 1204 ---------NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1254
+ + G + GT +MAPE L G + SE D+++ G++L+++LT PY
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA--SESTDIYALGVILYQMLTLSFPYR 232
Query: 1255 N 1255
Sbjct: 233 R 233
|
Length = 932 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 67/272 (24%), Positives = 131/272 (48%), Gaps = 31/272 (11%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
++K++G G+FG K + G IK I S + + E+ R +E +LS +
Sbjct: 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR------KEVAVLSNM 56
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-------RHVLLSKERHLDRRKRLIIAM 1155
HPN+V + ++ G L V ++ G L R VL +++ LD ++ +A
Sbjct: 57 KHPNIVQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA- 113
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGT 1214
++++H + I+H D+K N+ + I K+GDFG++++ +T+ + GT
Sbjct: 114 -----LKHVHDRKILHRDIKSQNIFLTKDGTI----KLGDFGIARVLNSTVELARTCIGT 164
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274
+++PE+ + + K D+++ G VL+E+ T + + + ++ I+ + PPV
Sbjct: 165 PYYLSPEIC--ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPV 221
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306
+ R L+ Q + +P RPS I +
Sbjct: 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 4e-18
Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 38/220 (17%)
Query: 1047 LKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LK +GSG +G V K G VAIK+I + RE ++L L H
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKI------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 1105 PNVVAFYGVVQDGPG---GTLATVTEFMVNGSLRHVLLSKERHL--DRRKRLIIAMDAAF 1159
N++ +++ + VTE M + H ++ + L D + + +
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPLTDDHIQYFLYQI--LR 114
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKI-----KRNTLVTGGV- 1211
G++YLHS N++H DLK N+LVN + C K+ DFGL++ +T V
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVN-SN-----CDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 1212 -RGTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
R W APELL SSS+ ++ +D++S G + E+LT
Sbjct: 169 TR----WYRAPELL-LSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 5e-18
Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 1046 ELKELGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+L+E+G G+FG VY + R ++V IKK ++G+ S ++ + +E L KL H
Sbjct: 19 DLREIGHGSFGAVYFARDVRNSEVVA--IKKMSYSGKQSNEK--WQDIIKEVRFLQKLRH 74
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
PN + + G L V E+ + GS +L ++ L + + A G+ YL
Sbjct: 75 PNTIQYRGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGTLPWMAPE- 1221
HS N++H D+K N+L L +P + K+GDFG + I N V GT WMAPE
Sbjct: 132 HSHNMIHRDVKAGNIL--LSEP--GLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 1281
+L + KVDV+S GI E+ + P NM+ + + I N P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----SPALQSGH 238
Query: 1282 W----RLLMEQCWAPDPVVRPS 1299
W R ++ C P RP+
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 66/215 (30%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
EEL E+G G +GTVY + G VA+K+++ +E + L RE +L +L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP------LSEEGIPLSTLREIALLKQL 55
Query: 1103 ---HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHV------LLSK--ERHLDRRKRL 1151
HPN+V V T E + HV LSK + L
Sbjct: 56 ESFEHPNIVRLLDVCH-----GPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIK 110
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211
+ G+++LHS IVH DLK N+LV + K+ DFGL++I + V
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQV----KIADFGLARIYSFEMALTSV 166
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEI 1246
TL + APE+L SS VD++S G + E+
Sbjct: 167 VVTLWYRAPEVLLQSSYATP--VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-18
Identities = 81/275 (29%), Positives = 128/275 (46%), Gaps = 30/275 (10%)
Query: 1042 EDLEE----LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+D EE L E+G G+FG VY T+ + +KK ++G+ + ++ + +E +
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVA-VKKMSYSGKQTNEK--WQDIIKEVK 73
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
L +L HPN + + G L V E+ + GS +L ++ L + I A
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGA 130
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTL 1215
G+ YLHS N++H D+K N+L L +P + K+ DFG + N+ V GT
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASKSSPANSFV-----GTP 181
Query: 1216 PWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274
WMAPE +L + KVDV+S GI E+ + P NM+ + + I N
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND----S 237
Query: 1275 PGFCDSEW----RLLMEQCWAPDPVVRPSFTEIAR 1305
P +EW R ++ C P RP+ E+ R
Sbjct: 238 PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 8e-18
Identities = 72/221 (32%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 1040 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLE----FW 1093
K D E + LG+G+FG V K +GT AIK +KK +E L ++
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK---------REILKMKQVQHVA 66
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
+E IL +L HP +V QD + + EF+V G L L R + +
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH 124
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
A + EYLHSK+I++ DLK +NLL++ K + KV DFG + K+ T + G
Sbjct: 125 A-ELVLAFEYLHSKDIIYRDLKPENLLLDNKGHV----KVTDFGFA--KKVPDRTFTLCG 177
Query: 1214 TLPWMAPELLNGSSSKVSEK-VDVFSFGIVLWEILTGEEPY 1253
T ++APE++ SK K VD ++ G++L+E + G P+
Sbjct: 178 TPEYLAPEVIQ---SKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 8e-18
Identities = 83/272 (30%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E + ELG G FG VY + + T V A K I SE+E ++ E +IL+
Sbjct: 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK------SEEE--LEDYMVEIDILASC 59
Query: 1103 HHPNVV----AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
HPN+V AFY L + EF G++ V+L ER L + ++
Sbjct: 60 DHPNIVKLLDAFY------YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL 113
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPW 1217
+ YLH I+H DLK N+L L I K+ DFG+S K R GT W
Sbjct: 114 EALNYLHENKIIHRDLKAGNILFTLDGDI----KLADFGVSAKNTRTIQRRDSFIGTPYW 169
Query: 1218 MAPELLNGSSSK---VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274
MAPE++ +SK K DV+S GI L E+ E P+ ++ ++ I + PP
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT 227
Query: 1275 ---PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P SE++ +++C + R + T++
Sbjct: 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 78/258 (30%), Positives = 123/258 (47%), Gaps = 28/258 (10%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG G+FG V + +GT+ AIK +KK + E +E R L+ HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVE--RRVLALAW-EHP 56
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+ + Q L V E++ G L + S R + R R A + G+++LH
Sbjct: 57 FLTHLFCTFQTKE--HLFFVMEYLNGGDLMFHIQSSGRFDEARARFY-AAEIICGLQFLH 113
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTGGVRGTLPWMA 1219
K I++ DLK DN+L++ I K+ DFG+ K K +T GT ++A
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHI----KIADFGMCKENMNGEGKASTFC-----GTPDYIA 164
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279
PE+L G K +E VD +SFG++L+E+L G+ P+ + I+N+ RP P +
Sbjct: 165 PEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWIS 220
Query: 1280 SEWRLLMEQCWAPDPVVR 1297
E + + + + DP R
Sbjct: 221 KEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 74/267 (27%), Positives = 124/267 (46%), Gaps = 25/267 (9%)
Query: 1048 KELGSGTFGTVYHGKWRGTDVAIKRIK--KSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G+FGTVY K + A +R+K K G + E T++ +EA++LSKL HP
Sbjct: 6 QRLGKGSFGTVYLVKDKKAV-AEERLKVLKEIPVGELNPNE--TVQANQEAQLLSKLDHP 62
Query: 1106 NVVAFYG--VVQDGPGGTLATVTEFMVNGSLR---HVLLSKERHLDRRKRLIIAMDAAFG 1160
+V F+ + +D +TE+ L L + L + + G
Sbjct: 63 AIVKFHASFLERD----AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT--LVTGGVRGTLPWM 1218
+ Y+H + I+H DLK N+ + + K+GDFG+S++ + L T GT +M
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLK-----NNLLKIGDFGVSRLLMGSCDLAT-TFTGTPYYM 172
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278
+PE L K D++S G +L+E+ + ++ +++ IV P +P
Sbjct: 173 SPEAL--KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-TPSLPETY 229
Query: 1279 DSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
+ +M+ DP +RPS EI R
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-17
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 37/221 (16%)
Query: 1046 ELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
+++G G GTVY G +VAIK++ +Q + L E ++ +
Sbjct: 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-------QQPKKEL-IINEILVMRENK 74
Query: 1104 HPNVVAF---YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
HPN+V + Y V G L V E++ GSL V+ E +D + + +
Sbjct: 75 HPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQA 127
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGT 1214
+E+LHS ++H D+K DN+L+ + + K+ DFG + KR+T+V GT
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMV-----GT 178
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1255
WMAPE++ + KVD++S GI+ E++ GE PY N
Sbjct: 179 PYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 71/274 (25%), Positives = 124/274 (45%), Gaps = 35/274 (12%)
Query: 1050 LGSGTFGTVYHG---------KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
LG GTF ++ G + T+V +K + KS + F+ A ++S
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMS 54
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
+L H ++V YGV G + V E++ GSL L + ++ +L +A A+
Sbjct: 55 QLSHKHLVLNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWA 112
Query: 1161 MEYLHSKNIVHFDLKCDNLLV----NLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGT 1214
+ +L K + H ++ N+L+ + K P K+ D G+S + + L+
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-----R 167
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG-EEPYANMHYGAIIGGIVNNTLRPP 1273
+PW+ PE + + +S D +SFG LWEI +G ++P + + + + + P
Sbjct: 168 IPWVPPECIENPQN-LSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLP 225
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P + +E L+ QC +P RPSF I R L
Sbjct: 226 APKW--TELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 71/277 (25%), Positives = 129/277 (46%), Gaps = 36/277 (12%)
Query: 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K++G G F VY G VA+K+++ + + + +E ++L +L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-----KEIDLLKQLNHP 62
Query: 1106 NVVAFYG-VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-------IAMDA 1157
NV+ +Y ++D L V E G L ++ +H ++KRLI +
Sbjct: 63 NVIKYYASFIED---NELNIVLELADAGDLSRMI----KHFKKQKRLIPEKTVWKYFVQL 115
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLP 1216
+E++HS+ ++H D+K N+ + + K+GD GL + T + GT
Sbjct: 116 CSALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMHYGAIIGGIVNNTLRPPV 1274
+M+PE ++ + K D++S G +L+E+ + P+ M+ ++ I PP+
Sbjct: 172 YMSPERIHENGYNF--KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDYPPL 228
Query: 1275 PG-FCDSEWRLLMEQCWAPDPVVRPSFT---EIARRL 1307
P E R L+ C PDP RP T ++A+R+
Sbjct: 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 1043 DLEELKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCF-----TGRSSEQERLTLEF 1092
+ E L+ LG+G +G V+ G G A+K +KK+ T + ER LE
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
R L LH+ AF + L + +++ G L L +E + R+
Sbjct: 61 VRRCPFLVTLHY----AFQTDTK------LHLILDYVNGGELFTHLYQREHFTESEVRVY 110
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGG 1210
IA + +++LH I++ D+K +N+L++ + + + DFGLSK
Sbjct: 111 IA-EIVLALDHLHQLGIIYRDIKLENILLDSEGHV----VLTDFGLSKEFLAEEEERAYS 165
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1254
GT+ +MAPE++ G S + VD +S G++ +E+LTG P+
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 10/164 (6%)
Query: 1145 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--- 1201
LD L + A GM++L SKN +H D+ N+L+ + K+ DFGL++
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR----VAKICDFGLARDIMN 264
Query: 1202 KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGA 1260
N +V G R + WMAPE + V DV+S+GI+LWEI + G+ PY + +
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQS--DVWSYGILLWEIFSLGKSPYPGILVNS 322
Query: 1261 IIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIA 1304
+V + P F E +M+ CW +P RP+F++I+
Sbjct: 323 KFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 5e-17
Identities = 78/316 (24%), Positives = 123/316 (38%), Gaps = 67/316 (21%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
+++K LG G G V+ + +GT A+K + K R+ + LT E EIL+
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-----EQEILA 56
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF- 1159
L HP + Y Q L V ++ G L LL ++ K L A F
Sbjct: 57 TLDHPFLPTLYASFQTET--YLCLVMDYCPGGEL-FRLLQRQPG----KCLSEE-VARFY 108
Query: 1160 ------GMEYLHSKNIVHFDLKCDNLLV---------------NLKDPIRPICKVGDFGL 1198
+EYLH IV+ DLK +N+L+ P+ K G
Sbjct: 109 AAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 1199 SKIKRNTLVT------GGVR-----GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 1247
+ N++ + R GT ++APE+++G VD ++ GI+L+E+L
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH--GSAVDWWTLGILLYEML 226
Query: 1248 TGEEPYA----NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
G P+ + + I+ V PPV R L+ + DP
Sbjct: 227 YGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVK----DP--------- 273
Query: 1304 ARRLRVMSAACQTKSH 1319
++RL A + K H
Sbjct: 274 SKRLGSKRGAAEIKQH 289
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 40/219 (18%)
Query: 1046 ELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
+L++LG GT+ TVY G+ R T VA+K I G S RE ++ +L
Sbjct: 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA-------IREISLMKELK 56
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF---- 1159
H N+V + V+ L V E+M +++ + H R A+D
Sbjct: 57 HENIVRLHDVIH--TENKLMLVFEYMDKDLKKYM----DTHGVRG-----ALDPNTVKSF 105
Query: 1160 ------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGG 1210
G+ + H ++H DLK NLL+N + + K+ DFGL++ I NT
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLINKRGEL----KLADFGLARAFGIPVNTFSNEV 161
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
V TL + AP++L GS + S +D++S G ++ E++TG
Sbjct: 162 V--TLWYRAPDVLLGSRT-YSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 29/216 (13%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
D +++++G GT+G VY G+ + T VA+K+I+ SE+E + RE +L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR------LESEEEGVPSTAIREISLLK 54
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHV-LLSKERHLDRRKRLIIAMDAAF 1159
+L HPN+V V+ L + EF+ +++ L K +++D
Sbjct: 55 ELQHPNIVCLQDVLMQES--RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-------KIKRNTLVTGGVR 1212
G+ + HS+ ++H DLK NLL++ K I K+ DFGL+ ++ + +V
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVI----KLADFGLARAFGIPVRVYTHEVV----- 163
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248
TL + APE+L G S + S VD++S G + E+ T
Sbjct: 164 -TLWYRAPEVLLG-SPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-17
Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS-KLHH 1104
K LG G+FG V+ + +GT+ AIK +KK + + E +LS H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-----EKRVLSLAWEH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P + Y Q L V E++ G L + S + D + A + G+++L
Sbjct: 56 PFLTHLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFL 112
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPE 1221
HSK IV+ DLK DN+L++ I K+ DFG+ K N L T GT ++APE
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHI----KIADFGMC--KENMLGDAKTCTFCGTPDYIAPE 166
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
+L G K + VD +SFG++L+E+L G+ P+
Sbjct: 167 ILLG--QKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 7e-17
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 1051 GSGTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 1106
G GT+G VY K G + AIK+ K G + ++ RE +L +L H N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFK-----GDKEQYTGISQSACREIALLRELKHEN 63
Query: 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------SKERHLDRR--KRLIIAMD 1156
VV+ V + ++ + ++ H L +K + K L+ +
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI- 117
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT----GGVR 1212
G+ YLHS ++H DLK N+LV + P R + K+GD GL+++ L V
Sbjct: 118 -LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248
T+ + APELL G + ++ +D+++ G + E+LT
Sbjct: 177 VTIWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-17
Identities = 73/257 (28%), Positives = 124/257 (48%), Gaps = 23/257 (8%)
Query: 1047 LKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
LK LG G+FG V+ G G A+K +KK+ R + ++ E +IL++
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM------ERDILAE 54
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
++HP +V + Q G L + +F+ G L LSKE + A +
Sbjct: 55 VNHPFIVKLHYAFQTE--GKLYLILDFLRGGDL-FTRLSKEVMFTEEDVKFYLAELALAL 111
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAP 1220
++LHS I++ DLK +N+L++ + I K+ DFGLSK + GT+ +MAP
Sbjct: 112 DHLHSLGIIYRDLKPENILLDEEGHI----KLTDFGLSKESIDHEKKAYSFCGTVEYMAP 167
Query: 1221 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 1280
E++N ++ D +SFG++++E+LTG P+ + I+ L +P F
Sbjct: 168 EVVNRRGH--TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMPQFLSP 223
Query: 1281 EWRLLMEQCWAPDPVVR 1297
E + L+ + +P R
Sbjct: 224 EAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 9e-17
Identities = 68/221 (30%), Positives = 110/221 (49%), Gaps = 23/221 (10%)
Query: 1042 EDLEELKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
EDL++L E+G G FGTV H GT +A+KRI+ T EQ+RL ++ + +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKP-SGTIMAVKRIRS---TVDEKEQKRLLMDL--DV-V 56
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL----RHVLLSKERHLDRRKRLIIA 1154
+ P +V FYG + G E M + SL ++V + + IA
Sbjct: 57 MRSSDCPYIVKFYGALFRE--GDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIA 113
Query: 1155 MDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
+ + YL + I+H D+K N+L++ I K+ DFG+S +++ G
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLDRNGNI----KLCDFGISGQLVDSIAKTRDAG 169
Query: 1214 TLPWMAPELLNGSSSKVSE-KVDVFSFGIVLWEILTGEEPY 1253
P+MAPE ++ S+ + + DV+S GI L+E+ TG+ PY
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|99716 cd05992, PB1, The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-16
Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 202 DGKLRYVGGETRIIRISRDISWQELTQKALAIYN-QTHTIKYQLPGEDLDALVSVSCDED 260
K++Y G R + +SR IS+++L K + + K + P ED D LV++S DED
Sbjct: 2 RVKVKYGGEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYPDEDGD-LVTISSDED 60
Query: 261 LQNMMEECNVLEDRGTQKPRMFLF 284
L+ +EE G++K R+F+F
Sbjct: 61 LEEAIEEA---RRSGSKKLRLFVF 81
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. Length = 81 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+ ++G GT+G VY + + T VA+K+++ +E+E + RE +IL +L+H
Sbjct: 12 IGQIGEGTYGQVYKARDKDTGELVALKKVR------LDNEKEGFPITAIREIKILRQLNH 65
Query: 1105 PNVVAFYGVVQDGPG--------GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
N+V +V D G V E+M + L +L S H
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRG 1213
G+ Y H KN +H D+KC N+L+N K I K+ DFGL+++ + + T V
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQI----KLADFGLARLYNSEESRPYTNKVI- 179
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248
TL + PELL G + +DV+S G +L E+ T
Sbjct: 180 TLWYRPPELLLG-EERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-16
Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT--LVTGGVRGT 1214
A GME+L S+ +H DL N+L++ + + K+ DFGL++ I ++ + G R
Sbjct: 189 AKGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
L WMAPE + + DV+SFG++LWEI + G PY + + R
Sbjct: 245 LKWMAPETIFDRVYTIQS--DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P + E M CW +P RP+F+E+ L
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-16
Identities = 75/251 (29%), Positives = 122/251 (48%), Gaps = 19/251 (7%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
+G G+FG V + R T A+K I+K+ RS L E +L++++ P +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA-----ERTVLAQVNCPFI 55
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 1167
V Q L V F+ G L H L + R R R A + +E LH
Sbjct: 56 VPLKFSFQSP--EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLHKF 112
Query: 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGS 1226
N+++ DLK +N+L++ + I +C DFGL K+ ++ T GT ++APELL G
Sbjct: 113 NVIYRDLKPENILLDYQGHI-ALC---DFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 1227 SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLM 1286
++ VD ++ G++L+E+LTG P+ + + + I+ LR P GF D + + L+
Sbjct: 169 G--YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP-DGF-DRDAKDLL 224
Query: 1287 EQCWAPDPVVR 1297
+ DP R
Sbjct: 225 IGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 37/219 (16%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+++G G GTV+ G +VAIK+I + ++E + E ++ +L +P
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELII----NEILVMKELKNP 76
Query: 1106 NVVAF---YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
N+V F + V G L V E++ GSL V+ E +D + + + +E
Sbjct: 77 NIVNFLDSFLV-----GDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALE 129
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGTLP 1216
+LH+ ++H D+K DN+L+ + + K+ DFG + KR+T+V GT
Sbjct: 130 FLHANQVIHRDIKSDNVLLGMDGSV----KLTDFGFCAQITPEQSKRSTMV-----GTPY 180
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1255
WMAPE++ + KVD++S GI+ E++ GE PY N
Sbjct: 181 WMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 66/227 (29%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D E L +LG GTFG VY + G VA+K+I +E++ + RE +IL
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILM------HNEKDGFPITALREIKIL 61
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEF-MVNGSLRHVL---LSKER-HLDRRKRLIIA 1154
KL HPNVV + + P + MV + H L L L +
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYM 121
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVT 1208
+ G+ YLH +I+H D+K N+L++ + I K+ DFGL++
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQG----ILKIADFGLARPYDGPPPNPKGGGG 177
Query: 1209 GGVRG------TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
GG R T + PELL G + + VD++ G V E+ T
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 39/216 (18%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQ-ERLTLEFWREAEILSKL- 1102
L ++G GTF V + R G AIK +KK +S EQ L RE + L +L
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF---KSLEQVNNL-----REIQALRRLS 55
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HPN++ V+ D G LA V E M + +L ++ ++R L ++ ++
Sbjct: 56 PHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLD 114
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP------ 1216
++H I H D+K +N+L+ I K+ DFG + G+ P
Sbjct: 115 HMHRNGIFHRDIKPENILIKDD-----ILKLADFGSCR---------GIYSKPPYTEYIS 160
Query: 1217 --WM-APE-LLNGSSSKVSEKVDVFSFGIVLWEILT 1248
W APE LL + K+D+++ G V +EIL+
Sbjct: 161 TRWYRAPECLL--TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-16
Identities = 71/261 (27%), Positives = 108/261 (41%), Gaps = 50/261 (19%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKR------IKKSCFTGRSSEQERLTLEFWRE 1095
+D E+L ELG+G G V R + + + R IK + + RE
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN-----------QIIRE 49
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--- 1152
++L + + P +V FYG G ++ E M GSL VL ++ I
Sbjct: 50 LKVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVL--------KKAGRIPEN 99
Query: 1153 ----IAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207
I++ G+ YL K I+H D+K N+LVN R K+ DFG+S +++
Sbjct: 100 ILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMA 155
Query: 1208 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP--------YANMHYG 1259
V GT +M+PE L G+ V D++S G+ L E+ G P M
Sbjct: 156 NSFV-GTRSYMSPERLQGTHYTVQS--DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212
Query: 1260 AIIGGIVNNTLRPPVPGFCDS 1280
+ G + RP DS
Sbjct: 213 PVSEGEAKESHRPVSGHPPDS 233
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
++++++G GT+G VY + + G VA+K+I+ +E E + RE +L +L
Sbjct: 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKEL 55
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRR--KRLIIAMDAAF 1159
+HPN+V VV L V EF ++ L+ + S LD K + +
Sbjct: 56 NHPNIVRLLDVVHSE--NKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ-- 110
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG------ 1213
G+ Y HS ++H DLK NLL++ + + K+ DFGL++ VR
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLIDREGAL----KLADFGLARA-----FGVPVRTYTHEVV 161
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248
TL + APE+L GS S VD++S G + E++
Sbjct: 162 TLWYRAPEILLGSRQ-YSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-15
Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT--LVTGGVRGT 1214
A GME+L S+ +H DL N+L++ + + K+ DFGL++ I ++ + G R
Sbjct: 184 ARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 1215 LPWMAPELLNGSSSKV-SEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272
L WMAPE + KV + + DV+SFG++LWEI + G PY + + + R
Sbjct: 240 LKWMAPESI---FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P E +M CW DP RP+F+ + L
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 68/293 (23%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
DLE L E+GSGT G VY +++ G +A+K++++ TG E +R+ + +++
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRR---TGNKEENKRIL----MDLDVV 67
Query: 1100 SKLHH-PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI------ 1152
K H P +V YG F+ + + + LD+ + I
Sbjct: 68 LKSHDCPYIVKCYGY--------------FITDSDVFICMELMSTCLDKLLKRIQGPIPE 113
Query: 1153 -----IAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206
+ + + YL K ++H D+K N+L++ + K+ DFG+S L
Sbjct: 114 DILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNV----KLCDFGIS----GRL 165
Query: 1207 VTGGVR----GTLPWMAPELLNGSSSKVSEKV--DVFSFGIVLWEILTGEEPYAN--MHY 1258
V + G +MAPE ++ + DV+S GI L E+ TG+ PY N +
Sbjct: 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF 225
Query: 1259 GAIIGGIVNNTLRPPV--------PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
++ I+ PP P FC ++ C D RP + E+
Sbjct: 226 -EVLTKILQ--EEPPSLPPNEGFSPDFCS-----FVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 70/220 (31%), Positives = 102/220 (46%), Gaps = 35/220 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWR----E 1095
+D++ + LG G GTVY +A+K I +T+E + E
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-----------ITVELQKQIMSE 49
Query: 1096 AEILSKLHHPNVVAFYGV--VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
EIL K P ++ FYG V++ ++ TEFM GSL E L R I
Sbjct: 50 LEILYKCDSPYIIGFYGAFFVEN----RISICTEFMDGGSLDVYRKIPEHVLGR-----I 100
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
A+ G+ YL S I+H D+K N+LVN + + K+ DFG+S N++ V G
Sbjct: 101 AVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQV----KLCDFGVSTQLVNSIAKTYV-G 155
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
T +MAPE ++G + DV+S GI E+ G PY
Sbjct: 156 TNAYMAPERISGEQYGIHS--DVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 18/214 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+DLE +K +G+GTFG V+ + R A+K + EQ E +L
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH-----VHNEKRVL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++ HP ++ + D L + E++ G L L + R L A +
Sbjct: 56 KEVSHPFIIRLFWTEHDQ--RFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYASEIVC 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
+EYLHSK IV+ DLK +N+L++ + I K+ DFG +K R+ T + GT ++A
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHI----KLTDFGFAKKLRDRTWT--LCGTPEYLA 166
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
PE++ S ++ VD ++ GI+++E+L G P+
Sbjct: 167 PEVI--QSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 60/223 (26%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 1043 DLEELKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCF-----TGRSSEQERLTLEF 1092
+ E LK LG+G +G V+ G G A+K +KK+ T + ER LE
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
R++ L LH+ AF + L + +++ G L L +ER ++ ++
Sbjct: 61 IRQSPFLVTLHY----AFQTDTK------LHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGG 1210
+ +E+LH I++ D+K +N+L++ + + DFGLSK +
Sbjct: 111 SG-EIVLALEHLHKLGIIYRDIKLENILLDSNGHV----VLTDFGLSKEFHEDEVERAYS 165
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
GT+ +MAP+++ G + VD +S G++++E+LTG P+
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V + + T A K++ K R EQ L E +IL K+ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-----EKKILEKVSSRFI 55
Query: 1108 V----AFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGME 1162
V AF L V M G L+ H+ E + + A G+E
Sbjct: 56 VSLAYAFETKDD------LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLE 109
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPE 1221
+LH + IV+ DLK +N+L++ +R + D GL+ ++K + G GT +MAPE
Sbjct: 110 HLHQRRIVYRDLKPENVLLDDHGNVR----ISDLGLAVELKGGKKIKGRA-GTPGYMAPE 164
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
+L G S VD F+ G L+E++ G P+
Sbjct: 165 VLQGEVYDFS--VDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-15
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 1042 EDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E L+ ++G G+ G V K G VA+K++ +Q+R L F E I+
Sbjct: 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-------KQQRRELLF-NEVVIM 73
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
HH NVV Y G L V EF+ G+L ++ ++ + + +
Sbjct: 74 RDYHHENVVDMYNSYL--VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLR 129
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-SKIKRNTLVTGGVRGTLPWM 1218
+ YLH++ ++H D+K D++L+ I K+ DFG +++ + + GT WM
Sbjct: 130 ALSYLHNQGVIHRDIKSDSILLTSDGRI----KLSDFGFCAQVSKEVPKRKSLVGTPYWM 185
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1255
APE++ S +VD++S GI++ E++ GE PY N
Sbjct: 186 APEVI--SRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ-ERLTLEFWREAEILSK 1101
E L +G G +G V + + T VAIK+ K+S E ++ L RE ++L +
Sbjct: 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES----EDDEDVKKTAL---REVKVLRQ 56
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDAAF 1159
L H N+V + G L V E+ V +L +L + L + I + A
Sbjct: 57 LRHENIVNLKEAFRRK--GRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAI 113
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--- 1216
Y HS NI+H D+K +N+LV+ ++ +C DFG ++ + L
Sbjct: 114 A--YCHSHNIIHRDIKPENILVSESGVLK-LC---DFGFAR-----ALRARPASPLTDYV 162
Query: 1217 ---WM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
W APELL G ++ + VDV++ G ++ E+L GE
Sbjct: 163 ATRWYRAPELLVGDTN-YGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 8e-15
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 1104
K LG G+FG V + +GTD A+K +KK + +T E +L+ H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMT-----EKRVLALAGKH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
P + + Q L V E++ G L H+ + D + A + G+++
Sbjct: 56 PFLTQLHSCFQTKD--RLFFVMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQF 111
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWM 1218
LH + I++ DLK DN+L++ + K+ DFG+ K + GGV GT ++
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGH----IKIADFGMCKEG----ILGGVTTSTFCGTPDYI 163
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
APE+L+ + VD ++ G++L+E+L G+ P+
Sbjct: 164 APEILSYQPYGPA--VDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-15
Identities = 55/151 (36%), Positives = 77/151 (50%), Gaps = 12/151 (7%)
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKR--NTLVTGGVRGT 1214
A GME+L SKN VH DL N+L+ + + IC DFGL++ I R N + G
Sbjct: 249 ANGMEFLASKNCVHRDLAARNVLI-CEGKLVKIC---DFGLARDIMRDSNYISKGSTFLP 304
Query: 1215 LPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272
L WMAPE + N + +S DV+SFGI+LWEI T G PY + + R
Sbjct: 305 LKWMAPESIFNNLYTTLS---DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM 361
Query: 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P E +M++CW +RP F+++
Sbjct: 362 AKPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 68/278 (24%), Positives = 126/278 (45%), Gaps = 30/278 (10%)
Query: 1048 KELGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 1106
+E+G+G FG V + + T VA +K+ S EQ EF ++ + L HPN
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN----EFLQQGDPYRILQHPN 56
Query: 1107 VVAFYG-VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII---AMDAAFGME 1162
++ G V+ P V E+ G L+ L ++ H + L++ A + A G+
Sbjct: 57 ILQCLGQCVEAIP---YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL--SKIKRNTLVT-GGVRGTLPWMA 1219
++H N +H DL N + + KVGD+G+ S+ K + + T L W+A
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLTV----KVGDYGIGPSRYKEDYIETEDDKCVPLRWLA 169
Query: 1220 PELLNGSSSKV-----SEKVDVFSFGIVLWEIL-TGEEPYANMHYGAIIGGIVNNT---- 1269
PEL+ + ++ +V++ G+ LWE+ +PY+++ ++ ++ +
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL 229
Query: 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
+P + W +++ CW P R + E+ R L
Sbjct: 230 FKPQLELPYSERWYEVLQFCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPN 1106
LG G+FG V + + + A+K +KK + +T E ILS HP
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMT-----EKRILSLARNHPF 57
Query: 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 1166
+ Y Q L V EF VNG + K R D + A + + +LH
Sbjct: 58 LTQLYCCFQTPD--RLFFVMEF-VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD 114
Query: 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELLNG 1225
K I++ DLK DN+L++ + CK+ DFG+ K N T GT ++APE+L
Sbjct: 115 KGIIYRDLKLDNVLLDHEGH----CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 1226 SSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
S VD ++ G++L+E+L G P+
Sbjct: 171 MLYGPS--VDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-14
Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 30/269 (11%)
Query: 1043 DLEELKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQE-----RLTLEF 1092
+ E LK LG+G +G V+ G G A+K ++K+ ++ E R LE
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
R++ L LH+ AF + L + +++ G + L ++ + +
Sbjct: 61 VRQSPFLVTLHY----AFQTEAK------LHLILDYVSGGEMFTHLYQRD-NFSEDEVRF 109
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGG 1210
+ + +E+LH IV+ D+K +N+L++ + + + DFGLSK + T
Sbjct: 110 YSGEIILALEHLHKLGIVYRDIKLENILLDSEGHV----VLTDFGLSKEFLSEEKERTYS 165
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1270
GT+ +MAPE++ G + VD +S GI+++E+LTG P+ + L
Sbjct: 166 FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224
Query: 1271 R--PPVPGFCDSEWRLLMEQCWAPDPVVR 1297
+ PP P F E + L+ + DP R
Sbjct: 225 KCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-14
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 1044 LEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
LE ++G G+ G V K G VA+K + +Q+R L F E I+
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD-------LRKQQRRELLF-NEVVIMRD 74
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
H NVV Y G L + EF+ G+L ++ + L+ + + +
Sbjct: 75 YQHQNVVEMYKSYLVGE--ELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQAL 130
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-SKIKRNTLVTGGVRGTLPWMAP 1220
YLHS+ ++H D+K D++L+ L + K+ DFG ++I ++ + GT WMAP
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGRV----KLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 1221 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
E++ S + +VD++S GI++ E++ GE PY
Sbjct: 187 EVI--SRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 67/268 (25%), Positives = 125/268 (46%), Gaps = 20/268 (7%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
L+ +G G+FG + +D A+K I+ + + E R +EA +L+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSR------KEAVLLA 53
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLDRRKRLIIAMDAAF 1159
K+ HPN+VAF + G L V E+ G L + + L + + L +
Sbjct: 54 KMKHPNIVAFKESFE--ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-GTLPWM 1218
G++++H K ++H D+K N+ + + K+GDFG +++ + GT ++
Sbjct: 112 GVQHIHEKRVLHRDIKSKNIFLTQNGKV----KLGDFGSARLLTSPGAYACTYVGTPYYV 167
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278
PE+ + + K D++S G +L+E+ T + P+ + +I + + + P+P
Sbjct: 168 PPEIW--ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHY 224
Query: 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARR 1306
E R L++Q + +P RPS T I R
Sbjct: 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 74/258 (28%), Positives = 119/258 (46%), Gaps = 28/258 (10%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS-KLHH 1104
K LG G+FG V + +G A+K +KK + + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMV-----EKRVLALAWEN 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P + Y Q L V EF+ G L + K R D + A + G+++L
Sbjct: 56 PFLTHLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFL 112
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWMA 1219
HSK I++ DLK DN++++ I K+ DFG+ K V G R GT ++A
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHI----KIADFGMCKEN----VFGDNRASTFCGTPDYIA 164
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279
PE+L G K + VD +SFG++L+E+L G+ P+ + I +T P P +
Sbjct: 165 PEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PHYPRWIT 220
Query: 1280 SEWRLLMEQCWAPDPVVR 1297
E + ++E+ + DP R
Sbjct: 221 KESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 1045 EELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ ++ +GSG +G V G VAIK+I + + L RE +IL
Sbjct: 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKI------PHAFDVPTLAKRTLRELKILRHF 61
Query: 1103 HHPNVVAFYGVVQ--DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF- 1159
H N++A +++ + V + M L H++ S + + R F
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIR-------YFL 113
Query: 1160 -----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSK------IKRNTL 1206
G++Y+HS N++H DLK NLLVN +D C ++GDFG+++ +
Sbjct: 114 YQLLRGLKYIHSANVIHRDLKPSNLLVN-ED-----CELRIGDFGMARGLSSSPTEHKYF 167
Query: 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 1247
+T V T + APELL S + + +D++S G + E+L
Sbjct: 168 MTEYV-ATRWYRAPELLL-SLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 79/280 (28%), Positives = 122/280 (43%), Gaps = 40/280 (14%)
Query: 1046 ELKEL-GSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-H 1103
EL EL G+GT+G VY G+ T + IK TG E E +E +L K H
Sbjct: 9 ELVELVGNGTYGQVYKGRHVKTG-QLAAIKVMDVTGDEEE------EIKQEINMLKKYSH 61
Query: 1104 HPNVVAFYGV-VQDGPGGT---LATVTEFMVNGSLRHVLL-SKERHLDRRKRLIIAMDAA 1158
H N+ +YG ++ P G L V EF GS+ ++ +K L I +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTGGVR 1212
G+ +LH ++H D+K N+L+ + K+ DFG+S +RNT +
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEV----KLVDFGVSAQLDRTVGRRNTFI----- 172
Query: 1213 GTLPWMAPELL---NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1269
GT WMAPE++ + K D++S GI E+ G P +MH + I N
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN- 231
Query: 1270 LRPPVPGFCDSEW----RLLMEQCWAPDPVVRPSFTEIAR 1305
P P +W + +E C + RP+ ++ +
Sbjct: 232 ---PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 35/277 (12%)
Query: 1048 KELGSGTFGTVYHGK----WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
KE+G+G FG V G+ + V +K ++ S +S QE++ +F EA+ L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS-----ASVQEQM--KFLEEAQPYRSLQ 53
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH----LDRRKRLIIAMDAAF 1159
H N++ G + L V EF G L+ L S + D +A + A
Sbjct: 54 HSNLLQCLGQCTEVTPYLL--VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS--KIKRNTLVTGGVRGT-LP 1216
G+ +LH N +H DL N L+ + K+GD+GLS K K + VT L
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLTADLTV----KIGDYGLSHNKYKEDYYVTPDQLWVPLR 167
Query: 1217 WMAPELLNGSSSKV-----SEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV-NNT 1269
W+APEL++ + +++ +V+S G+ +WE+ G +PY ++ ++ V
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227
Query: 1270 LRPPVPGF---CDSEWRLLMEQCWAPDPVVRPSFTEI 1303
L+ P P W +M+ CW P RPS E+
Sbjct: 228 LKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 68/233 (29%), Positives = 104/233 (44%), Gaps = 31/233 (13%)
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-HLD 1146
+ L F+ A ++S++ H ++ +GV G + V EF+ +G L V L KE+ +
Sbjct: 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIM--VEEFVEHGPL-DVCLRKEKGRVP 115
Query: 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV---NLKDPIRPICKVGDFGLS--KI 1201
++ +A A + YL KN+VH ++ N+L+ L + P K+ D G+S +
Sbjct: 116 VAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL 175
Query: 1202 KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEI-------LTGEEPYA 1254
R V +PW+APE + G +S +S D +SFG L EI L P
Sbjct: 176 SREERVE-----RIPWIAPECVPGGNS-LSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229
Query: 1255 NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
+ R P P C E L+ QC +P RPSF I R L
Sbjct: 230 KERF-------YEKKHRLPEPS-C-KELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 1047 LKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+++G G GTVY G +VAIK++ + +Q+ E ++ + +
Sbjct: 24 FEKIGQGASGTVYTAIDIATGQEVAIKQM--------NLQQQPKKELIINEILVMRENKN 75
Query: 1105 PNVVAF---YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
PN+V + Y V G L V E++ GSL V+ E +D + + + +
Sbjct: 76 PNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQAL 128
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGTL 1215
++LHS ++H D+K DN+L+ + + K+ DFG + KR+T+V GT
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMV-----GTP 179
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1255
WMAPE++ + KVD++S GI+ E++ GE PY N
Sbjct: 180 YWMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 30/219 (13%)
Query: 1040 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
K E +L +LG GT+ TV+ G+ + T+ VA+K I R +E RE
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVS 55
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
+L L H N+V + ++ TL V E++ + L+ L + + I
Sbjct: 56 LLKNLKHANIVTLHDIIHTERCLTL--VFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQL 112
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-------RNTLVTGG 1210
G+ Y H + I+H DLK NLL+N K + K+ DFGL++ K N +V
Sbjct: 113 LRGLSYCHKRKILHRDLKPQNLLINEKGEL----KLADFGLARAKSVPTKTYSNEVV--- 165
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
TL + P++L G S++ S +D++ G +L+E+ TG
Sbjct: 166 ---TLWYRPPDVLLG-STEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 70/231 (30%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E +K + +G +G VY + + T A+K+I K R+ Q+ E +IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-----ERDIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ +P VV+ + + L V E++ G +L + R+ A +
Sbjct: 56 TFAENPFVVSMFCSFETKR--HLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVL 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGG------ 1210
+EYLH+ IVH DLK DNLL+ I K+ DFGLSKI T + G
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGHI----KLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 1211 -------VRGTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
V GT ++APE +L K VD ++ GI+L+E L G P+
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 1046 ELKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
+L+ +G G FG V + G +VAIK+I K T +++ +RE ++L L
Sbjct: 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRT------YRELKLLKHLR 67
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
H N+++ + P + VTE + G+ H LL R L+++ G++Y
Sbjct: 68 HENIISLSDIFIS-PLEDIYFVTELL--GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKY 123
Query: 1164 LHSKNIVHFDLKCDNLLVN----LKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
+HS +VH DLK N+L+N LK IC DFGL++I+ + TG V T + A
Sbjct: 124 VHSAGVVHRDLKPSNILINENCDLK-----IC---DFGLARIQDPQM-TGYV-STRYYRA 173
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
PE++ + K +VD++S G + E+L G+
Sbjct: 174 PEIML-TWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-14
Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 28/199 (14%)
Query: 1065 GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124
G +VAIK ++ + E+E F RE + ++L+HPN+VA + P G L
Sbjct: 3 GHEVAIKLLRTD-----APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFA 56
Query: 1125 VTEFMVNGSLRHVL-----LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 1179
V E++ +LR VL L +++ A+ A H++ IVH DLK N+
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACA------HNQGIVHRDLKPQNI 110
Query: 1180 LVNLKDPIRPICKVGDFGLS-------KIKRNTLV-TGGVRGTLPWMAPELLNGSSSKVS 1231
+V+ +RP KV DFG+ TL T V GT + APE L G V+
Sbjct: 111 MVSQTG-VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP--VT 167
Query: 1232 EKVDVFSFGIVLWEILTGE 1250
D++++G++ E LTG+
Sbjct: 168 PNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-14
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 1040 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
K E +L +LG GT+ TVY G+ + TD VA+K I R +E RE
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI-------RLEHEEGAPCTAIREVS 56
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
+L L H N+V + ++ +L V E++ + L+ L ++ +
Sbjct: 57 LLKDLKHANIVTLHDIIHTEK--SLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL 113
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVTGGVRGTLP 1216
G+ Y H + ++H DLK NLL+N + + K+ DFGL++ K T TL
Sbjct: 114 LRGLNYCHRRKVLHRDLKPQNLLINERGEL----KLADFGLARAKSIPTKTYSNEVVTLW 169
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
+ P++L G S+ S ++D++ G + +E+ TG
Sbjct: 170 YRPPDILLG-STDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 35/220 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E+++++G GT+G VY + R T+ +A+K+I+ E E + RE +L
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR------LEQEDEGVPSTAIREISLL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD------RRKRLII 1153
++ H N+V VV L V E++ L ++H+D + RLI
Sbjct: 56 KEMQHGNIVRLQDVVHSEK--RLYLVFEYLD--------LDLKKHMDSSPDFAKNPRLIK 105
Query: 1154 AM--DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVT 1208
G+ Y HS ++H DLK NLL+ D K+ DFGL++ I T
Sbjct: 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLI---DRRTNALKLADFGLARAFGIPVRTFTH 162
Query: 1209 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248
V TL + APE+L GS S VD++S G + E++
Sbjct: 163 EVV--TLWYRAPEILLGSRH-YSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-14
Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
D + L ++G G +G V+ K + T VA+KR+KKS + + LT E +IL+
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLT-----ERDILT 56
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDAA 1158
+V QD LA E++ G R LL+ L + + M A
Sbjct: 57 TTKSEWLVKLLYAFQDDEYLYLAM--EYVPGGDFR-TLLNNLGVLSEDHARFYMAEMFEA 113
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGTL 1215
++ LH +H DLK +N L++ I K+ DFGLSK N++V G+
Sbjct: 114 --VDALHELGYIHRDLKPENFLIDASGHI----KLTDFGLSKGIVTYANSVV-----GSP 162
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1254
+MAPE+L G VD +S G +L+E L G P++
Sbjct: 163 DYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V + R T A K+++K R E L E +IL K++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-----EKQILEKVNSRFV 62
Query: 1108 V--AFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
V A+ +D L V M G L+ H+ D + + A + G+E L
Sbjct: 63 VSLAYAYETKDA----LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELL 1223
H + IV+ DLK +N+L++ IR + D GL+ +I + G V GT+ +MAPE++
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIR----ISDLGLAVEIPEGETIRGRV-GTVGYMAPEVV 173
Query: 1224 NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
+ + + D + G +++E++ G+ P+
Sbjct: 174 K--NERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 7e-14
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 1047 LKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+++G G GTVY G +VAI+++ + +Q+ E ++ + +
Sbjct: 25 FEKIGQGASGTVYTAMDVATGQEVAIRQM--------NLQQQPKKELIINEILVMRENKN 76
Query: 1105 PNVVAF---YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
PN+V + Y V G L V E++ GSL V+ E +D + + + +
Sbjct: 77 PNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQAL 129
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGTL 1215
E+LHS ++H D+K DN+L+ + + K+ DFG + KR+T+V GT
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMV-----GTP 180
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1255
WMAPE++ + KVD++S GI+ E++ GE PY N
Sbjct: 181 YWMAPEVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-14
Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 38/274 (13%)
Query: 1044 LEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
L+ ++G G+ G V K G VA+K++ +Q+R L F E I+
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-------KQQRRELLF-NEVVIMRD 73
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
H NVV Y G L V EF+ G+L ++ + ++ + +A+ A +
Sbjct: 74 YQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV 131
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-SKIKRNTLVTGGVRGTLPWMAP 1220
LH++ ++H D+K D++L+ + K+ DFG +++ + + GT WMAP
Sbjct: 132 --LHAQGVIHRDIKSDSILLTHDGRV----KLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
Query: 1221 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---------TLR 1271
EL+ S +VD++S GI++ E++ GE PY N + I +N +
Sbjct: 186 ELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVS 243
Query: 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
P + GF D RLL+ DP R + E+ +
Sbjct: 244 PSLKGFLD---RLLVR-----DPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 8e-14
Identities = 72/255 (28%), Positives = 111/255 (43%), Gaps = 23/255 (9%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG GTFG V + + T A+K +KK + LT E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLQNTRHP 55
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+ A Q L V E+ NG LS+ER + + + YLH
Sbjct: 56 FLTALKYSFQTH--DRLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH 112
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKR-NTLVTGGVRGTLPWMAPEL 1222
S ++V+ DLK +NL+++ I K+ DFGL K I T+ T GT ++APE+
Sbjct: 113 SCDVVYRDLKLENLMLDKDGHI----KITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 166
Query: 1223 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 1282
L + VD + G+V++E++ G P+ N + + I+ +R P E
Sbjct: 167 LE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEA 222
Query: 1283 RLLMEQCWAPDPVVR 1297
+ L+ DP R
Sbjct: 223 KSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 9e-14
Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 53/248 (21%)
Query: 1031 FDISTLQIIKNEDLEELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQER 1087
FD+ + L +G G +G V H K G VAIK+I S F E +
Sbjct: 1 FDVG-------PRYQNLSYIGEGAYGMVCSATH-KPTGVKVAIKKI--SPF-----EHQT 45
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSK 1141
RE +IL + H N++ +++ + + V E M L ++ ++
Sbjct: 46 FCQRTLREIKILRRFKHENIIGILDIIR---PPSFESFNDVYIVQELM-ETDLYKLIKTQ 101
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN----LKDPIRPICKVGDFG 1197
D + + + G++Y+HS N++H DLK NLL+N LK IC DFG
Sbjct: 102 HLSNDHIQYFLYQI--LRGLKYIHSANVLHRDLKPSNLLLNTNCDLK-----IC---DFG 151
Query: 1198 LSKIKRNTLVTGGVRGTLP------WM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
L+ R G L W APE++ +S ++ +D++S G +L E+L+
Sbjct: 152 LA---RIADPEHDHTGFLTEYVATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNR 207
Query: 1251 EPYANMHY 1258
+ Y
Sbjct: 208 PLFPGKDY 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 32/217 (14%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ L +GSG +G V T VAIK++ + S+ + T +RE +L +
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ---SAIHAKRT---YRELRLLKHM 71
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
H NV+ V P +L VT M L +++ ++ D + L+ +
Sbjct: 72 DHENVIGLLDVFT--PASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQI- 127
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGT 1214
G++Y+HS I+H DLK N+ VN +D C K+ DFGL++ + +TG V T
Sbjct: 128 -LRGLKYIHSAGIIHRDLKPSNIAVN-ED-----CELKILDFGLAR-HTDDEMTGYV-AT 178
Query: 1215 LPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ APE +LN ++ VD++S G ++ E+LTG+
Sbjct: 179 RWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 25/233 (10%)
Query: 1048 KELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG GTFG V K G A+K ++K + +T E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-----ESRVLQNTRHP 55
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+ A Q L V E+ NG LS+ER + + +EYLH
Sbjct: 56 FLTALKYAFQTH--DRLCFVMEY-ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 112
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWMAP 1220
S+++V+ D+K +NL+++ I K+ DFGL K ++ G GT ++AP
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHI----KITDFGLCK----EGISDGATMKTFCGTPEYLAP 164
Query: 1221 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273
E+L + VD + G+V++E++ G P+ N + + I+ +R P
Sbjct: 165 EVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-13
Identities = 52/152 (34%), Positives = 76/152 (50%), Gaps = 12/152 (7%)
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRGT 1214
A GME+L SKN VH DL N+L+ I K+ DFGL++ N + G
Sbjct: 247 ARGMEFLASKNCVHRDLAARNVLLAQGK----IVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 1215 LPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272
+ WMAPE + + + +S DV+S+GI+LWEI + G PY M + + + R
Sbjct: 303 VKWMAPESIFDNLYTTLS---DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359
Query: 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIA 1304
P E +M +CW +P RPSF ++
Sbjct: 360 AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 46/227 (20%)
Query: 1040 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
K E ++L +LG G++ TVY G+ + T VA+K I R +E REA
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEI-------RLEHEEGAPFTAIREAS 55
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
+L L H N+V + ++ TL V E++ L + ++D ++M
Sbjct: 56 LLKDLKHANIVTLHDIIHTKK--TLTLVFEYL------DTDLKQ--YMDDCGG-GLSMHN 104
Query: 1158 A--F------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK------- 1202
F G+ Y H + ++H DLK NLL++ + + K+ DFGL++ K
Sbjct: 105 VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGEL----KLADFGLARAKSVPSKTY 160
Query: 1203 RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
N +V TL + P++L G S++ S +D++ G + +E+ TG
Sbjct: 161 SNEVV------TLWYRPPDVLLG-STEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V + R T A K++ K R + + E IL+K+H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-----EKRILAKVHSRFI 55
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERH--LDRRKRLIIAMDAAFGMEYL 1164
V+ Q L V M G LR H+ E + + G+E+L
Sbjct: 56 VSLAYAFQTKT--DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELL 1223
H + I++ DLK +N+L++ +R + D GL+ ++K T G GT +MAPELL
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVR----ISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169
Query: 1224 NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
G S VD F+ G+ L+E++ P+
Sbjct: 170 QGEEYDFS--VDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 69/242 (28%), Positives = 109/242 (45%), Gaps = 19/242 (7%)
Query: 1048 KELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K +G G+FG V K + A+K ++K + EQ+ + E +L + HP
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK-EQKHIMAE---RNVLLKNVKHP 56
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+V + Q L V ++ VNG L +ER + A + A + YLH
Sbjct: 57 FLVGLHYSFQTAD--KLYFVLDY-VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMAPELL 1223
S NI++ DLK +N+L++ + + + DFGL K I+ + T GT ++APE+L
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVV----LTDFGLCKEGIEHSK-TTSTFCGTPEYLAPEVL 168
Query: 1224 NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283
VD + G VL+E+L G P+ + + I+N LR P S
Sbjct: 169 R--KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK-PNISVSARH 225
Query: 1284 LL 1285
LL
Sbjct: 226 LL 227
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-13
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 1040 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
K E +L++LG GT+ TV+ G+ + T+ VA+K I R +E RE
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVS 56
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
+L L H N+V + +V TL V E++ + L+ + + I
Sbjct: 57 LLKDLKHANIVTLHDIVHTDKSLTL--VFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQI 113
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVTGGVRGTLP 1216
G+ Y H + ++H DLK NLL+N + + K+ DFGL++ K T TL
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLINERGEL----KLADFGLARAKSVPTKTYSNEVVTLW 169
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
+ P++L G SS+ S ++D++ G + +E+ +G
Sbjct: 170 YRPPDVLLG-SSEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-13
Identities = 66/257 (25%), Positives = 120/257 (46%), Gaps = 36/257 (14%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLT 1089
I+ L++ K ED + +K +G G FG V + + + A+K + K RS +
Sbjct: 34 KITKLRM-KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSD-----S 87
Query: 1090 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
FW E +I++ + +V + QD L V E+M G L +++ + + +
Sbjct: 88 AFFWEERDIMAHANSEWIVQLHYAFQDDK--YLYMVMEYMPGGDLVNLMSNYDIPEKWAR 145
Query: 1150 ----RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205
+++A+DA +HS +H D+K DN+L++ + K+ DFG + +K +
Sbjct: 146 FYTAEVVLALDA------IHSMGFIHRDVKPDNMLLDKSGHL----KLADFG-TCMKMDA 194
Query: 1206 LVTGGVR-----GTLPWMAPELL--NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 1258
G VR GT +++PE+L G + D +S G+ L+E+L G+ P+
Sbjct: 195 --NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252
Query: 1259 GAIIGGIVN--NTLRPP 1273
I++ N+L P
Sbjct: 253 VGTYSKIMDHKNSLTFP 269
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E ++ +G+GT+G VY G+ G AIK + + E+E + LE +L K
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEI----NMLKK 68
Query: 1102 L-HHPNVVAFYGV-VQDGPGG---TLATVTEFMVNGSLRHVLL-SKERHLDRRKRLIIAM 1155
HH N+ +YG ++ P G L V EF GS+ ++ +K L I
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTG 1209
+ G+ +LH+ ++H D+K N+L+ + K+ DFG+S +RNT +
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEV----KLVDFGVSAQLDRTVGRRNTFI-- 182
Query: 1210 GVRGTLPWMAPELL---NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1266
GT WMAPE++ + + D++S GI E+ G P +MH + I
Sbjct: 183 ---GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239
Query: 1267 NNTLRPPVPGFCDSEWRL----LMEQCWAPDPVVRPS 1299
N P P +W +E C + + RPS
Sbjct: 240 RN----PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPS 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 69/222 (31%), Positives = 105/222 (47%), Gaps = 37/222 (16%)
Query: 1047 LKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
LK LG G +G V+ G G A+K +KK+ R+ + T E IL
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKD---TAHTKAERNILEA 56
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA--- 1158
+ HP +V Q G G L + E++ G L HL+R I D A
Sbjct: 57 VKHPFIVDLIYAFQTG--GKLYLILEYLSGGELF-------MHLEREG--IFMEDTACFY 105
Query: 1159 -----FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGV 1211
+E+LH + I++ DLK +N+L++ + + K+ DFGL K I T VT
Sbjct: 106 LSEISLALEHLHQQGIIYRDLKPENILLDAQGHV----KLTDFGLCKESIHEGT-VTHTF 160
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
GT+ +MAPE+L S + VD +S G +++++LTG P+
Sbjct: 161 CGTIEYMAPEIL--MRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-13
Identities = 67/233 (28%), Positives = 113/233 (48%), Gaps = 39/233 (16%)
Query: 1046 ELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
+L+ LG G+ G V+ D VA+K+I T S + L RE +I+ +L
Sbjct: 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKI---VLTDPQSVKHAL-----REIKIIRRLD 60
Query: 1104 HPNVVAFYGVVQDGPGGT-----LATVTEF--------MVNGSLRHVLLSKERHLDRRKR 1150
H N+V Y V+ GP G+ + ++TE + L +L + + R
Sbjct: 61 HDNIVKVYEVL--GPSGSDLTEDVGSLTELNSVYIVQEYMETDLA-NVLEQGPLSEEHAR 117
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRN 1204
L G++Y+HS N++H DLK N+ +N +D + K+GDFGL++I +
Sbjct: 118 LF-MYQLLRGLKYIHSANVLHRDLKPANVFINTED---LVLKIGDFGLARIVDPHYSHKG 173
Query: 1205 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1257
L G V T + +P LL S + ++ +D+++ G + E+LTG+ +A H
Sbjct: 174 YLSEGLV--TKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS-KLHH 1104
K LG G+FG V + +GTD AIK +KK +T E IL+ H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMT-----EKRILALAAKH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P + A + Q L V E+ VNG + + R D + A + + +L
Sbjct: 56 PFLTALHCCFQTKD--RLFFVMEY-VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELL 1223
H +++ DLK DN+L++ + CK+ DFG+ K N + T GT ++APE+L
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGH----CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL 168
Query: 1224 NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
S VD ++ G++++E++ G+ P+
Sbjct: 169 QELEYGPS--VDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
++++++G GT+G VY + + G VA+K+I+ +E E + RE +L +L
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLLKEL 56
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF--- 1159
+HPN+V V+ L V EF+ H L K + + + ++
Sbjct: 57 NHPNIVKLLDVIHT--ENKLYLVFEFL------HQDLKKFMDASPLSGIPLPLIKSYLFQ 108
Query: 1160 ---GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRG 1213
G+ + HS ++H DLK NLL+N + I K+ DFGL++ + T V
Sbjct: 109 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAI----KLADFGLARAFGVPVRTYTHEVV-- 162
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248
TL + APE+L G S VD++S G + E++T
Sbjct: 163 TLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-13
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+K++D E + ELG+G G V + + + + + R K + + + ++ RE ++
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMAR-KLIHLEIKPAIRNQII----RELQV 56
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L + + P +V FYG G ++ E M GSL V L + + + +++
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQV-LKEAKRIPEEILGKVSIAVL 113
Query: 1159 FGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
G+ YL K+ I+H D+K N+LVN + I K+ DFG+S +++ V GT +
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVNSRGEI----KLCDFGVSGQLIDSMANSFV-GTRSY 168
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
M+PE L G+ V D++S G+ L E+ G P
Sbjct: 169 MSPERLQGTHYSVQS--DIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K++G G F VY VA+K+++ + Q+ + +E ++L +L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV-----KEIDLLKQLNHP 62
Query: 1106 NVVAFY-GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-------IAMDA 1157
NV+ + ++D L V E G L ++ ++ ++KRLI +
Sbjct: 63 NVIKYLDSFIEDN---ELNIVLELADAGDLSQMI----KYFKKQKRLIPERTVWKYFVQL 115
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLP 1216
+E++HS+ ++H D+K N+ + + K+GD GL + T + GT
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN--MHYGAIIGGIVNNTLRPPV 1274
+M+PE ++ + K D++S G +L+E+ + P+ M+ ++ I PP+
Sbjct: 172 YMSPERIHENGYNF--KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPPL 228
Query: 1275 PGFCDSE-WRLLMEQCWAPDPVVRPSFT---EIARRLRV 1309
P SE R L+ C PDP RP +IA+++ V
Sbjct: 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 8e-13
Identities = 66/229 (28%), Positives = 101/229 (44%), Gaps = 17/229 (7%)
Query: 1048 KELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG GTFG V K G A+K +KK + LT E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLKNTRHP 55
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+ + Q L V E+ VNG LS+ER + + ++YLH
Sbjct: 56 FLTSLKYSFQTK--DRLCFVMEY-VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH 112
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-GTLPWMAPELLN 1224
S IV+ DLK +NL+++ I K+ DFGL K T GT ++APE+L
Sbjct: 113 SGKIVYRDLKLENLMLDKDGHI----KITDFGLCKEGITDAATMKTFCGTPEYLAPEVL- 167
Query: 1225 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273
+ VD + G+V++E++ G P+ N + + I+ ++ P
Sbjct: 168 -EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E+L+++G GT+GTV+ K R T VA+KR++ + E + RE +L +L
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKEL 56
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
H N+V Y V+ TL V E+ + L+ S +D G+
Sbjct: 57 KHKNIVRLYDVLHSDKKLTL--VFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG------TLP 1216
+ HS N++H DLK NLL+N + K+ DFGL+ R + VR TL
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGEL----KLADFGLA---RAFGIP--VRCYSAEVVTLW 164
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
+ P++L G+ S +D++S G + E+ P
Sbjct: 165 YRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 30/216 (13%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E + E+G G +GTVY + G VA+K ++ + ++ L L RE +L +L
Sbjct: 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQ------TNEDGLPLSTVREVALLKRL 56
Query: 1103 H---HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA- 1158
HPN+V V T T E V HV +LD+ + +
Sbjct: 57 EAFDHPNIVRLMDVC-----ATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK 111
Query: 1159 -------FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211
G+++LH+ IVH DLK +N+LV + K+ DFGL++I + V
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQV----KLADFGLARIYSCQMALTPV 167
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 1247
TL + APE+L S + VD++S G + E+
Sbjct: 168 VVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ----ERLTLEFWREA 1096
D L LG G+FG V + +GTD AIK +KK + E+ L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 1097 EILSKLHH--PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA 1154
L++LH + Y V++ GG L ++ V KE H + A
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMY--------QIQQVGRFKEPH-----AVFYA 107
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVTGGVRG 1213
+ A G+ +LHSK I++ DLK DN++++ + I K+ DFG+ K + + T G
Sbjct: 108 AEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHI----KIADFGMCKENMWDGVTTKTFCG 163
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
T ++APE++ + + VD ++FG++L+E+L G+ P+
Sbjct: 164 TPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
+ + LG G FG V + R T A KR++K R E L E +IL K
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-----EKQILEK 56
Query: 1102 LHHPNVV--AFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAA 1158
++ VV A+ +D L V M G L+ H+ + + L A +
Sbjct: 57 VNSQFVVNLAYAYETKDA----LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEIL 112
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPW 1217
G+E LH +N V+ DLK +N+L++ IR + D GL+ KI + G V GT+ +
Sbjct: 113 CGLEDLHRENTVYRDLKPENILLDDYGHIR----ISDLGLAVKIPEGESIRGRV-GTVGY 167
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
MAPE+LN +S D + G +++E++ G+ P+
Sbjct: 168 MAPEVLNNQRYTLSP--DYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-12
Identities = 66/247 (26%), Positives = 106/247 (42%), Gaps = 48/247 (19%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D E +K +G G FG V+ + + T A+K ++KS R Q E +IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKR--NQIAH---VRAERDIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA-MDAA 1158
+ P +V Y QD L V E+M G L ++L+ K+ + R IA + A
Sbjct: 56 ADADSPWIVKLYYSFQDE--EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---------------IKR 1203
++ +H +H D+K DN+L++ I K+ DFGL K
Sbjct: 114 --LDSVHKLGFIHRDIKPDNILIDADGHI----KLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 1204 NTLVTGGVR---------------GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248
VR GT ++APE+L G+ + D +S G++L+E+L
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP--YGLECDWWSLGVILYEMLY 225
Query: 1249 GEEPYAN 1255
G P+ +
Sbjct: 226 GFPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-12
Identities = 74/255 (29%), Positives = 111/255 (43%), Gaps = 22/255 (8%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG GTFG V K + T A+K +KK + LT E +L HP
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-----ENRVLQNSRHP 55
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+ A Q L V E+ NG LS+ER + + ++YLH
Sbjct: 56 FLTALKYSFQTH--DRLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 112
Query: 1166 S-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMAPEL 1222
S KN+V+ DLK +NL+++ I K+ DFGL K IK + GT ++APE+
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHI----KITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 167
Query: 1223 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 1282
L + VD + G+V++E++ G P+ N + + I+ +R P E
Sbjct: 168 L--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEA 223
Query: 1283 RLLMEQCWAPDPVVR 1297
+ L+ DP R
Sbjct: 224 KSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 30/226 (13%)
Query: 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
K + E+L++LG G++ TVY GK + G VA+K I R E+E REA
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-------RLQEEEGTPFTAIREAS 55
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
+L L H N+V + ++ TL V E+ V+ L + L +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKE--TLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-------RNTLVTGG 1210
G+ Y+H + I+H DLK NLL++ + K+ DFGL++ K N +V
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLISDTGEL----KLADFGLARAKSVPSHTYSNEVV--- 165
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 1256
TL + P++L G S++ S +D++ G + E++ G + M
Sbjct: 166 ---TLWYRPPDVLLG-STEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 74/276 (26%), Positives = 119/276 (43%), Gaps = 29/276 (10%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+++E L ELG G +G+VY R T V A+K I R E + E +IL
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI-------RLELDESKFNQIIMELDIL 53
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIAMDA 1157
K P +V FYG G + E+M GSL + + I
Sbjct: 54 HKAVSPYIVDFYGAFFI--EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV 111
Query: 1158 AFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
G+++L + NI+H D+K N+LVN ++ +C DFG+S +L + G
Sbjct: 112 VKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVK-LC---DFGVSGNLVASLAKTNI-GCQS 166
Query: 1217 WMAPELLNGSSSK----VSEKVDVFSFGIVLWEILTGEEPYANMHYGAI---IGGIVNNT 1269
+MAPE + + + DV+S G+ + E+ G PY Y I + IV+
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226
Query: 1270 LRPP-VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIA 1304
PP +P + + + +C P RP++ ++
Sbjct: 227 --PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E+L+++G GT+G VY + + T VA+K+ T ++E + RE +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK------TRLEMDEEGIPPTALREISLL 54
Query: 1100 SKLHH-PNVVAFYGVV---QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
L +V V + +L V E++ + L+ + S R R
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 1156 DAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNT- 1205
+ G+ + H ++H DLK NLLV D + + K+ D GL + +K T
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 1206 -LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+V TL + APE+L GS+ S VD++S G + E+ +
Sbjct: 171 EIV------TLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-12
Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 59/230 (25%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
L++LG G +G V W+ D VA+K+I + F + Q +RE L
Sbjct: 12 LQKLGKGAYGIV----WKAIDRRTKEVVALKKIFDA-FRNATDAQRT-----FREIMFLQ 61
Query: 1101 KL-HHPNVVAFYGVVQDGPGGTLATVTEFM---VNGSLRHVLLSKERHLDRRKRLII--- 1153
+L HPN+V V++ + V E+M ++ +R +L ++ H KR I+
Sbjct: 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANIL-EDVH----KRYIMYQL 116
Query: 1154 --AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTG 1209
A+ +Y+HS N++H DLK N+L+N C K+ DFGL++ +L
Sbjct: 117 LKAL------KYIHSGNVIHRDLKPSNILLNSD------CRVKLADFGLAR----SLSEL 160
Query: 1210 GVRGTLPWM----------APELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
P + APE+L G S++ ++ VD++S G +L E+L G
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLG-STRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 29/223 (13%)
Query: 1048 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
K + K T VA+K+I S +E L L +E +L HPN+
Sbjct: 8 KCFEDLMIVHLAKHKPTNTLVAVKKINLD-----SCSKEDLKLLQ-QEIITSRQLQHPNI 61
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM---DAAFGMEYL 1164
+ + L V+ M GS L K + L IA D ++Y+
Sbjct: 62 LPYVTSFIVD--SELYVVSPLMAYGSCE--DLLKTHFPEGLPELAIAFILKDVLNALDYI 117
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-------KIKRNTLVTGGVRGT--- 1214
HSK +H +K ++L + KV GL KR +V + +
Sbjct: 118 HSKGFIHRSVKASHIL------LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1257
LPW++PE+L + +EK D++S GI E+ G P+ +M
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 73/248 (29%), Positives = 114/248 (45%), Gaps = 27/248 (10%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K +G G+FG V K + G A+K ++K R EQ+ + E +L + HP
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK-EQKHIMAE---RNVLLKNVKHP 56
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+V + Q L V +F VNG L +ER + A + A + YLH
Sbjct: 57 FLVGLHYSFQTTE--KLYFVLDF-VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGTLPWMAPEL 1222
S NIV+ DLK +N+L++ + + + DFGL K + +T T GT ++APE+
Sbjct: 114 SINIVYRDLKPENILLDSQGHV----VLTDFGLCKEGIAQSDTTTT--FCGTPEYLAPEV 167
Query: 1223 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV---PGFCD 1279
+ VD + G VL+E+L G P+ Y + + +N L P+ PG
Sbjct: 168 IR--KQPYDNTVDWWCLGAVLYEMLYGLPPF----YCRDVAEMYDNILHKPLVLRPGASL 221
Query: 1280 SEWRLLME 1287
+ W +L E
Sbjct: 222 TAWSILEE 229
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 16/215 (7%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+K++D E++ ELG+G G V+ + + + + R K + + + ++ RE ++
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMAR-KLIHLEIKPAIRNQII----RELQV 56
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L + + P +V FYG G ++ E M GSL V L K + + +++
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQV-LKKAGRIPEQILGKVSIAVI 113
Query: 1159 FGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
G+ YL K+ I+H D+K N+LVN + I K+ DFG+S +++ V GT +
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVNSRGEI----KLCDFGVSGQLIDSMANSFV-GTRSY 168
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
M+PE L G+ V D++S G+ L E+ G P
Sbjct: 169 MSPERLQGTHYSVQS--DIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
L++LG G++ TVY G R G VA+K I +E + REA +L L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKT-------EEGVPFTAIREASLLKGLKH 62
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
N+V + ++ TL V E+M + L ++ L + G+ Y+
Sbjct: 63 ANIVLLHDIIHTKE--TLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR---NTLVTGGVRGTLPWMAPE 1221
H ++I+H DLK NLL++ + K+ DFGL++ K T + V TL + P+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGEL----KLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1254
+L G++ S +D++ G + E+L G+ +
Sbjct: 174 VLLGATDYSSA-LDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 6e-12
Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 21/175 (12%)
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA 1154
EA +L ++HP+V+ + G T + + + L L + R L + LII
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAI-TCMVLPHY--SSDLYTYLTKRSRPLPIDQALIIE 163
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGT 1214
G+ YLH++ I+H D+K +N+ +N D +C +GD G ++ G+ GT
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVD---QVC-IGDLGAAQFPVVAPAFLGLAGT 219
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL------------TGEEPYANMH 1257
+ APE+L + K + K D++S GIVL+E+L T EE + H
Sbjct: 220 VETNAPEVL--ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCH 272
|
Length = 357 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-12
Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 18/228 (7%)
Query: 1048 KELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K +G G+FG V + + + A+K ++K + E+ ++ +L + HP
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMS----ERNVLLKNVKHP 56
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+V + Q L V +++ G L + L + L+ R R A + A + YLH
Sbjct: 57 FLVGLHFSFQTA--DKLYFVLDYINGGELFYHLQRERCFLEPRARFY-AAEIASALGYLH 113
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMAPELL 1223
S NIV+ DLK +N+L++ + I + DFGL K I+ N T GT ++APE+L
Sbjct: 114 SLNIVYRDLKPENILLDSQGHI----VLTDFGLCKENIEHNG-TTSTFCGTPEYLAPEVL 168
Query: 1224 NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1271
+ VD + G VL+E+L G P+ + + + I+N L+
Sbjct: 169 H--KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ 214
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-12
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 19/221 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+K ED E +K +G G FG V + + T A+K + K RS + FW E
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD-----SAFFWEER 94
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
+I++ + P VV + QD L V E+M G L + L+S ++ R A +
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDR--YLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTA-E 150
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVR-GT 1214
++ +HS +H D+K DN+L++ + K+ DFG K+ + +V GT
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHL----KLADFGTCMKMNKEGMVRCDTAVGT 206
Query: 1215 LPWMAPELL--NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
+++PE+L G + D +S G+ L+E+L G+ P+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-11
Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 24/212 (11%)
Query: 1046 ELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
+LK++GSG +GTV R G VAIK++ R + E +RE +L +
Sbjct: 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLKHMK 72
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMV----NGSLRHVLLSKER-HLDRRKRLIIAMDAA 1158
H NV+ V P +L +F + G+ L+ E+ DR + L+ M
Sbjct: 73 HENVIGLLDVFT--PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM--L 128
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
G++Y+H+ I+H DLK NL VN + K+ DFGL++ + ++ +TG V T +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCEL----KILDFGLAR-QTDSEMTGYVV-TRWYR 182
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
APE++ + ++ VD++S G ++ E+LTG+
Sbjct: 183 APEVIL-NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 31/220 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHG---KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ E + E+G G +G V+ K G VA+KR++ + +E + L RE +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTIREVAV 54
Query: 1099 LSKLH---HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR-------R 1148
L L HPNVV + V T E + HV +LD+
Sbjct: 55 LRHLETFEHPNVVRLFDVCT-----VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 109
Query: 1149 KRLIIAMDAAF-GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207
+ + M G+++LHS +VH DLK N+LV I K+ DFGL++I +
Sbjct: 110 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI----KLADFGLARIYSFQMA 165
Query: 1208 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 1247
V TL + APE+L SS + VD++S G + E+
Sbjct: 166 LTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQE----RLTLEFWRE 1095
E E+L ++G G++G V+ + R G VAIK+ F SE + ++ L RE
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK-----FV--ESEDDPVIKKIAL---RE 50
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
+L +L HPN+V V + L V E+ + ++ + L R + I
Sbjct: 51 IRMLKQLKHPNLVNLIEVFRRKR--KLHLVFEY-CDHTVLNELEKNPRGVPEHLIKKIIW 107
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR--- 1212
+ + H N +H D+K +N+L+ + I K+ DFG ++I L G
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILITKQGQI----KLCDFGFARI----LTGPGDDYTD 159
Query: 1213 --GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
T + APELL G ++ VDV++ G V E+LTG+
Sbjct: 160 YVATRWYRAPELLVG-DTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
D L LG G+FG V + +GTD AIK +KK + + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMV-----EKRVLA 55
Query: 1101 KLHHPN-VVAFYGVVQDGPGGTLATVTEFMVNGSL----RHVLLSKERHLDRRKRLIIAM 1155
P + + Q L V E++ G L + V KE H + A
Sbjct: 56 LPGKPPFLTQLHSCFQTM--DRLYFVMEYVNGGDLMYHIQQVGKFKEPH-----AVFYAA 108
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-GT 1214
+ A G+ +LHSK I++ DLK DN++++ + I K+ DFG+ K T GT
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHI----KIADFGMCKENIFGGKTTRTFCGT 164
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
++APE++ + + VD ++FG++L+E+L G+ P+
Sbjct: 165 PDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E E L +G G++G V K + T VAIK+ +S + + + RE +L
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLES------EDDKMVKKIAMREIRML 54
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH----LDRRKRLIIAM 1155
+L H N+V V + L V EF+ H +L LD +
Sbjct: 55 KQLRHENLVNLIEVFRRKK--RLYLVFEFV-----DHTVLDDLEKYPNGLDESRVRKYLF 107
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGG----- 1210
G+E+ HS NI+H D+K +N+LV+ + K+ DFG ++ TL G
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFAR----TLAAPGEVYTD 159
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
T + APELL G +K VD+++ G ++ E+LTGE
Sbjct: 160 YVATRWYRAPELLVG-DTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E+L ++G GTFG V+ + + T VA+K++ +E+E + RE +IL L
Sbjct: 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITALREIKILQLL 68
Query: 1103 HHPNVVAFYGVV------QDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRKRLII 1153
H NVV + + G+ V EF + LLS + L K+++
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVKFTLSEIKKVMK 126
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLV 1207
+ G+ Y+H I+H D+K N+L+ KD I K+ DFGL SK +
Sbjct: 127 MLLN--GLYYIHRNKILHRDMKAANILIT-KD---GILKLADFGLARAFSLSKNSKPNRY 180
Query: 1208 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248
T V TL + PELL G +D++ G ++ E+ T
Sbjct: 181 TNRVV-TLWYRPPELLLGERD-YGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 74/282 (26%), Positives = 109/282 (38%), Gaps = 47/282 (16%)
Query: 1048 KELGSGTFGTVYHGKWR----------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+ LG GT +Y G + IK I K ++L F+ A
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVL----DPSHRDISLAFFETAS 56
Query: 1098 ILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ ++ H ++V YGV V+D V EF+ G L + K L + +A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVEN---IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQ 113
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLV---NLKDPIRPICKVGDFG--LSKIKRNTLVTGGV 1211
A + YL K++VH ++ N+L+ + P K+ D G ++ + R V
Sbjct: 114 LASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE--- 170
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEI-LTGEEPYANM-------HYGAIIG 1263
+PW+APE + S +S D +SFG LWEI GE P + Y
Sbjct: 171 --RIPWIAPECVE-DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG--- 224
Query: 1264 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
P C E LM C DP RP F I R
Sbjct: 225 -----QCMLVTPS-CK-ELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 16/229 (6%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K +G G+FG V K + G+ A+K ++K + EQ + E +L L HP
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAE---RNVLLKNLKHP 56
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+V + Q L V ++ VNG L +ER + A + A + YLH
Sbjct: 57 FLVGLHYSFQTAE--KLYFVLDY-VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH 113
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELLN 1224
S NI++ DLK +N+L++ + + + DFGL K T GT ++APE+L
Sbjct: 114 SLNIIYRDLKPENILLDSQGHV----VLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLR 169
Query: 1225 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273
VD + G VL+E+L G P+ + + I++ L+ P
Sbjct: 170 --KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 4e-11
Identities = 64/242 (26%), Positives = 105/242 (43%), Gaps = 18/242 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E LK +G G FG V K + D A+K + K R+ T F E ++L
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE-----TACFREERDVL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ + + QD L V ++ V G L +L E L +
Sbjct: 56 VNGDNQWITTLHYAFQDE--NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVI 113
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG--LSKIKRNTLVTGGVRGTLPW 1217
++ +H + VH D+K DN+L+++ IR + DFG L ++ T+ + GT +
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMDMNGHIR----LADFGSCLKLMEDGTVQSSVAVGTPDY 169
Query: 1218 MAPELLNG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274
++PE+L K + D +S G+ ++E+L GE P+ G I+N+ R
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 229
Query: 1275 PG 1276
P
Sbjct: 230 PA 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-11
Identities = 66/231 (28%), Positives = 113/231 (48%), Gaps = 26/231 (11%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLT 1089
I LQ+ K ED + +K +G G FG V + + + A+K + K RS +
Sbjct: 34 KIRKLQM-KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD-----S 87
Query: 1090 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
FW E +I++ + P VV + QD L V E+M G L + L+S ++
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFCAFQDDK--YLYMVMEYMPGGDLVN-LMSNYDVPEKWA 144
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
+ A + ++ +HS ++H D+K DN+L++ + K+ DFG + +K + TG
Sbjct: 145 KFYTA-EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL----KLADFG-TCMKMDE--TG 196
Query: 1210 GVR-----GTLPWMAPELL--NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
VR GT +++PE+L G + D +S G+ L+E+L G+ P+
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 1047 LKELGSGTFGTV----YHGKWRGTDVAIKRI----KKSCFTGRSSEQERLTLEFWREAEI 1098
+KELG G +G V VAIK+I K R+ + +L L +R
Sbjct: 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKL-LRHFRG--- 60
Query: 1099 LSKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
H N+ Y +V G L E M L ++ S + D + I
Sbjct: 61 -----HKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFI-YQ 113
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGG 1210
G++Y+HS N++H DLK NLLVN ++ IC DFGL+ + +T
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELK-IC---DFGLARGFSENPGENAGFMTEY 169
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
V T + APE++ S ++ +DV+S G +L E+L
Sbjct: 170 V-ATRWYRAPEIML-SFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-11
Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 40/224 (17%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
D+E + +G G FG V W TD VA+K++ F S + RE
Sbjct: 1 DVEPDRPIGYGAFGVV----WSVTDPRDGKRVALKKMPN-VFQNLVSCKRVF-----REL 50
Query: 1097 EILSKLHHPNVVAFYGVVQD---GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
++L H NV++ ++Q P + VTE M L +++S + ++ +
Sbjct: 51 KMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFL 109
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL--------SKIKRNT 1205
G++YLHS I+H D+K NLLVN + + IC DFGL SK
Sbjct: 110 -YQILRGLKYLHSAGILHRDIKPGNLLVN-SNCVLKIC---DFGLARVEEPDESKHMTQE 164
Query: 1206 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
+VT R APE+L GS S VD++S G + E+L
Sbjct: 165 VVTQYYR------APEILMGSRHYTS-AVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V + R T A K+++K R E L E IL K++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-----EKRILEKVNSRFV 62
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 1166
V+ + L V M G L+ H+ D ++ + A + G+E L
Sbjct: 63 VSLAYAYETKDA--LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELLNG 1225
+ IV+ DLK +N+L++ + IR + D GL+ +I V G V GT+ +MAPE++N
Sbjct: 121 ERIVYRDLKPENILLDDRGHIR----ISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINN 175
Query: 1226 SSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
S D + G +++E++ G+ P+
Sbjct: 176 EKYTFSP--DWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 1050 LGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V K G A K++ K +S E+ L E EIL K++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-----EKEILEKVNSPFI 55
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 1166
V + L V M G L+ H+ ER L+ + + + G+ +LHS
Sbjct: 56 VNLAYAFESKT--HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113
Query: 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226
+IV+ D+K +N+L++ + C++ D GL+ ++ GT +MAPE+L
Sbjct: 114 MDIVYRDMKPENVLLDDQGN----CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE 169
Query: 1227 SSKVSEKVDVFSFGIVLWEILTGEEPYAN 1255
VD F+ G ++E++ G P+ +
Sbjct: 170 PYSYP--VDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V + R T A K+++K R E L E +IL K++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-----EKQILEKVNSRFV 62
Query: 1108 V--AFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
V A+ +D L V M G L+ H+ E + + + A + G+E L
Sbjct: 63 VSLAYAYETKDA----LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELL 1223
H + IV+ DLK +N+L++ IR + D GL+ + + G V GT+ +MAPE++
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIR----ISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVV 173
Query: 1224 NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
S D ++ G +L+E++ G+ P+
Sbjct: 174 KNERYTFSP--DWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 7e-11
Identities = 41/118 (34%), Positives = 63/118 (53%), Gaps = 12/118 (10%)
Query: 1138 LLSKERHLDRRK-RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN-LKDPIRPICKVGD 1195
LL KE L + + II + LH NI+H D+K +N+L + KD I +C D
Sbjct: 99 LLKKEGKLSEAEVKKII-RQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIY-LC---D 153
Query: 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
+GL KI T GTL + +PE + G + VS D ++ G++ +E+LTG+ P+
Sbjct: 154 YGLCKI-IGT--PSCYDGTLDYFSPEKIKGHNYDVS--FDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 8e-11
Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K +G G +G V K T+ VAIK+I + F R + L RE ++L L H
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANA-FDNRIDAKRTL-----REIKLLRHLDHE 64
Query: 1106 NVVAFYGVVQDGPGGTLA-----TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
NV+A ++ P A V E M + L ++ S + D + + G
Sbjct: 65 NVIAIKDIMP--PPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFL-YQLLRG 120
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRG----T 1214
++Y+HS N++H DLK NLL+N C K+ DFGL+ R T G T
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNAN------CDLKICDFGLA---RTTSEKGDFMTEYVVT 171
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ APELL + S+ + +DV+S G + E+L +
Sbjct: 172 RWYRAPELLL-NCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 1042 EDLEELKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E ++ +GSGT+G VY + G AIK IK + Q+ + + +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIM--------M 60
Query: 1100 SKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
H N+VA++G + +D L EF GSL+ + L + ++ +
Sbjct: 61 KDCKHSNIVAYFGSYLRRD----KLWICMEFCGGGSLQDI-YHVTGPLSESQIAYVSRET 115
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK------IKRNTLVTGGV 1211
G+ YLHSK +H D+K N+L+ + K+ DFG+S KR + +
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLTDNGHV----KLADFGVSAQITATIAKRKSFI---- 167
Query: 1212 RGTLPWMAPELLN-GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1270
GT WMAPE+ ++ D+++ GI E+ + P ++H + + +
Sbjct: 168 -GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226
Query: 1271 RPP 1273
+PP
Sbjct: 227 QPP 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-10
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL---SKLHH 1104
+G GTFG VY + + T A+K + K + + E IL
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIG-----ERNILVRTLLDES 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P +V Q L VT++M G L L + R + R + IA + +E+L
Sbjct: 56 PFIVGLKFSFQTD--SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHL 112
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMAPEL 1222
H +IV+ DLK +N+L++ I +C DFGLSK + N T GT ++APE+
Sbjct: 113 HKYDIVYRDLKPENILLDATGHI-ALC---DFGLSKANLTDNKT-TNTFCGTTEYLAPEV 167
Query: 1223 LNGSSSKVSEKVDVFSFGIVLWEILTGEEP---------YANMHYGAI 1261
L ++ VD +S G++++E+ G P Y N+ +G +
Sbjct: 168 LL-DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV 214
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-10
Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 18/241 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D E +K +G G FG V K + T+ A+K + K R+ T F E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAE-----TACFREERNVL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ + QD L V ++ V G L +L E L +
Sbjct: 56 VNGDCQWITTLHYAFQDE--NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL 113
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG--LSKIKRNTLVTGGVRGTLPW 1217
+ +H + VH D+K DN+L+++ IR + DFG L + T+ + GT +
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIR----LADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 1218 MAPELLNGSSS---KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274
++PE+L K + D +S G+ ++E+L GE P+ G I+N+ R
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 229
Query: 1275 P 1275
P
Sbjct: 230 P 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 24/218 (11%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ----ERLTLEFWREA 1096
D L LG G+FG V + +GTD AIK +KK + E+ L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
L++LH F V + L V E++ G L + + + + + A +
Sbjct: 61 PFLTQLHS----CFQTVDR------LYFVMEYVNGGDLMY-HIQQVGKFKEPQAVFYAAE 109
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVTGGVRGTL 1215
+ G+ +LH + I++ DLK DN++++ + I K+ DFG+ K + + T GT
Sbjct: 110 ISVGLFFLHRRGIIYRDLKLDNVMLDSEGHI----KIADFGMCKEHMVDGVTTRTFCGTP 165
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
++APE++ + + VD +++G++L+E+L G+ P+
Sbjct: 166 DYIAPEII--AYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 45/146 (30%), Positives = 78/146 (53%), Gaps = 18/146 (12%)
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTLP 1216
+ ++HSK+++H D+K N+L+ + K+GDFG SK+ T V+ V GT
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNG----LVKLGDFGFSKMYAAT-VSDDVGRTFCGTPY 210
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR---PP 1273
++APE+ S+K D+FS G++L+E+LT + P+ G + +++ TL P
Sbjct: 211 YVAPEIWR--RKPYSKKADMFSLGVLLYELLTLKRPFD----GENMEEVMHKTLAGRYDP 264
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPS 1299
+P E + ++ + DP RPS
Sbjct: 265 LPPSISPEMQEIVTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-09
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 1049 ELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
++G GT+G VY K + D A+K+I E +++ RE +L +L H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----------EGTGISMSACREIALLRELKH 57
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------SKERHLDRRKRLIIAMD 1156
PNV++ V + + ++ L H++ K L R +
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT----GGVR 1212
G+ YLH+ ++H DLK N+LV + P R K+ D G +++ + L V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
T + APELL G + ++ +D+++ G + E+LT E
Sbjct: 177 VTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-09
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 1049 ELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
++G GT+G VY K + G D +K+ TG +++ RE +L +L HPNV
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-------ISMSACREIALLRELKHPNV 60
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------SKERHLDRRKRLIIAMDAAF 1159
+A V + + ++ L H++ K L R +
Sbjct: 61 IALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT----GGVRGTL 1215
G+ YLH+ ++H DLK N+LV + P R K+ D G +++ + L V T
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ APELL G + ++ +D+++ G + E+LT E
Sbjct: 180 WYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE---ILSKLHH 1104
+G G++ V + + T A+K IKK + E + W + E + +H
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVN----DDEDID---WVQTEKHVFETASNH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL------IIAMDAA 1158
P +V + Q L V EF+ G L H+ R+++L + + +
Sbjct: 56 PFLVGLHSCFQTE--SRLFFVIEFVSGGDLMF-------HMQRQRKLPEEHARFYSAEIS 106
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPW 1217
+ +LH + I++ DLK DN+L++ + I K+ D+G+ K R T GT +
Sbjct: 107 LALNFLHERGIIYRDLKLDNVLLDAEGHI----KLTDYGMCKEGIRPGDTTSTFCGTPNY 162
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
+APE+L G S VD ++ G++++E++ G P+
Sbjct: 163 IAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 1047 LKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LK++GSG +G+V K G VAIK++ R + E +RE +L + H
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLS------RPFQSEIFAKRAYRELTLLKHMQH 73
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER--HLDRRKRLIIAMDAAFGME 1162
NV+ V + +F + L K L K + G++
Sbjct: 74 ENVIGLLDVFTSAV--SGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGTLPWMAP 1220
Y+HS I+H DLK NL VN +D C K+ DFGL++ + +TG V T + AP
Sbjct: 132 YIHSAGIIHRDLKPGNLAVN-ED-----CELKILDFGLAR-HADAEMTGYVV-TRWYRAP 183
Query: 1221 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 1258
E++ + ++ VD++S G ++ E+LTG+ + Y
Sbjct: 184 EVIL-NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-09
Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 12/154 (7%)
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA 1154
EA +L +L HP V+A V G G T + ++ L L ++ R L + +A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVG-GLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTAVA 266
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG---LSKIKRNTLVTGGV 1211
++Y+H + I+H D+K +N+LVN + IC +GDFG ++ +T G+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE---DIC-LGDFGAACFARGSWSTPFHYGI 322
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWE 1245
GT+ APE+L G S VD++S G+V++E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPS--VDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-09
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE---ILSKLHH 1104
+G G++ V + + T+ A+K +KK ++ E + W + E +H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELV----NDDEDID---WVQTEKHVFEQASNH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P +V + Q L V E+ VNG + ++R L + + + + YL
Sbjct: 56 PFLVGLHSCFQTE--SRLFFVIEY-VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 112
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELL 1223
H + I++ DLK DN+L++ + I K+ D+G+ K R T GT ++APE+L
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHI----KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 1224 NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
G S VD ++ G++++E++ G P+
Sbjct: 169 RGEDYGFS--VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 64/230 (27%), Positives = 104/230 (45%), Gaps = 40/230 (17%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVA-----------IKRIKKSCFTGRSSEQERLTL 1090
+D E LK +G G FG V K + T +KR + +CF +ER L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACF-----REERDVL 55
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK--ERHLDRR 1148
+ ++ LH+ AF QD L V ++ V G L LLSK +R +
Sbjct: 56 VN-GDRRWITNLHY----AF----QD--ENNLYLVMDYYVGGDLL-TLLSKFEDRLPEDM 103
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG--LSKIKRNTL 1206
R +A + ++ +H VH D+K DN+L++ IR + DFG L + T+
Sbjct: 104 ARFYLA-EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIR----LADFGSCLRLLADGTV 158
Query: 1207 VTGGVRGTLPWMAPELLN---GSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
+ GT +++PE+L + + D +S G+ ++E+L GE P+
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 1034 STLQIIKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLE 1091
ST ++K ++LK +GSG G V G +VA+K++ R + +
Sbjct: 15 STFTVLKR--YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL------SRPFQNQTHAKR 66
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRK 1149
+RE +L ++H N+++ V P +L + + L L + H LD +
Sbjct: 67 AYRELVLLKCVNHKNIISLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVIHMELDHER 124
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
+ G+++LHS I+H DLK N++V + K+ DFGL++ +
Sbjct: 125 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL----KILDFGLARTACTNFMMT 180
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
T + APE++ G K E VD++S G ++ E++ G
Sbjct: 181 PYVVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-08
Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 16/151 (10%)
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP--ICKVGDFGLSKIKRNTL---VTGGVRG 1213
++ +HS+ ++H DLK N+ + P I K+GDFG SK +++ V G
Sbjct: 180 LALDEVHSRKMMHRDLKSANIF------LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP- 1272
T ++APEL + S+K D++S G++L+E+LT P+ I+ ++ P
Sbjct: 234 TPYYLAPELW--ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291
Query: 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P P S + L++ + +P +RP+ ++
Sbjct: 292 PCP--VSSGMKALLDPLLSKNPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-08
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 14/165 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E+ +K + G FG VY G K A+K +KK+ ++ + R+A L
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQA---ERDALAL 60
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
SK P +V Y +Q L V E+++ G ++ LL + D + + A
Sbjct: 61 SK--SPFIVHLYYSLQSANNVYL--VMEYLIGGDVKS-LLHIYGYFDEEMAVKYISEVAL 115
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
++YLH I+H DLK DN+L++ + I K+ DFGLSK+ N
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLISNEGHI----KLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 28/226 (12%)
Query: 1042 EDLEELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
E + L +GSG +G+V Y + R VA+K++ + +S R T +RE +
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLR-QKVAVKKLSRPF---QSLIHARRT---YRELRL 67
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEF-----MVNGSLRHVLLSKERHLDRRKRLII 1153
L + H NV+ V P ++ E ++ L +++ ++ + + LI
Sbjct: 68 LKHMKHENVIGLLDVFT--PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIY 125
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
+ G++Y+HS I+H DLK N+ VN +R + DFGL++ + + +TG V
Sbjct: 126 QL--LRGLKYIHSAGIIHRDLKPSNVAVNEDCELR----ILDFGLAR-QADDEMTGYV-A 177
Query: 1214 TLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 1258
T + APE +LN ++ VD++S G ++ E+L G+ + Y
Sbjct: 178 TRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-08
Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 1034 STLQIIKNEDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE 1091
ST ++K + LK +GSG G V + G +VAIK++ + F + +
Sbjct: 10 STFTVLKR--YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP-FQNVTHAKRA---- 62
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHL 1145
+RE ++ ++H N++ V P +L V E M + +L V+ H
Sbjct: 63 -YRELVLMKLVNHKNIIGLLNVFT--PQKSLEEFQDVYLVMELM-DANLCQVIQMDLDH- 117
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKR 1203
+R L+ M G+++LHS I+H DLK N++V C K+ DFGL++
Sbjct: 118 ERMSYLLYQM--LCGIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAG 169
Query: 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
+ + T + APE++ G K E VD++S G ++ E++ G
Sbjct: 170 TSFMMTPYVVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 62/249 (24%), Positives = 109/249 (43%), Gaps = 45/249 (18%)
Query: 1042 EDLEELKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D E ++ +GSGT+G VY + G A+K IK S Q+ E ++
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ--------EIFMV 60
Query: 1100 SKLHHPNVVAFYG----------VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
+ H N+VA++G ++ GG+L + + V G L + ++
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI--YHVTGPLSELQIA--------- 109
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-SKIKRNTLVT 1208
+ + G+ YLHSK +H D+K N+L+ + K+ DFG+ +KI
Sbjct: 110 --YVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDV----KLADFGVAAKITATIAKR 163
Query: 1209 GGVRGTLPWMAPELL----NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1264
GT WMAPE+ NG +++ D+++ GI E+ + P ++H +
Sbjct: 164 KSFIGTPYWMAPEVAAVEKNGGYNQL---CDIWAVGITAIELAELQPPMFDLHPMRALFL 220
Query: 1265 IVNNTLRPP 1273
+ + +PP
Sbjct: 221 MSKSNFQPP 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-08
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 33/216 (15%)
Query: 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
+G G++G V G VAIK+I F S L RE ++L L HP++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRIL-----REIKLLRLLRHPDI 61
Query: 1108 VAFYGVV--------QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
V ++ +D + V E M S H ++ L
Sbjct: 62 VEIKHIMLPPSRREFKD-----IYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN-----TLVTGGVRGT 1214
++Y+H+ N+ H DLK N+L N ++ IC DFGL+++ N T V T
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLK-IC---DFGLARVAFNDTPTAIFWTDYV-AT 169
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ APEL SK + +D++S G + E+LTG+
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-08
Identities = 78/308 (25%), Positives = 128/308 (41%), Gaps = 63/308 (20%)
Query: 1041 NEDLEELKE---LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWRE 1095
N+ L LKE + G G Y GK + +K I +S +
Sbjct: 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV-----NSIPSSEIADM--- 737
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLII 1153
KL HPN+V G+ + G L + E++ +L VL LS ER RRK I
Sbjct: 738 ----GKLQHPNIVKLIGLCRSEKGAYL--IHEYIEGKNLSEVLRNLSWER---RRK---I 785
Query: 1154 AMDAAFGMEYLH---SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGG 1210
A+ A + +LH S +V +L + ++++ KD P ++ GL ++
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD--EPHLRLSLPGLLCTDTKCFISSA 843
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN--- 1267
++APE + ++EK D++ FG++L E+LTG+ P A+ +G + G IV
Sbjct: 844 ------YVAPE--TRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFG-VHGSIVEWAR 893
Query: 1268 ---------NTLRPPVPGFCDSEWRLLME------QCWAPDPVVRPSFTEIARRLRV--- 1309
+ P + G ++E C A DP RP ++ + L
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
Query: 1310 MSAACQTK 1317
S++C T
Sbjct: 954 SSSSCVTG 961
|
Length = 968 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-08
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 30/218 (13%)
Query: 1042 EDLEELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
E + L +GSG +G+V + K G VA+K++ + +S + T +RE +
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPF---QSIIHAKRT---YRELRL 69
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
L + H NV+ V P +L VT M L +++ ++ D + LI
Sbjct: 70 LKHMKHENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 126
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ G++Y+HS +I+H DLK NL VN + K+ DFGL++ + + G
Sbjct: 127 YQI--LRGLKYIHSADIIHRDLKPSNLAVNEDCEL----KILDFGLARHTDDEMT--GYV 178
Query: 1213 GTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
T + APE +LN + VD++S G ++ E+LTG
Sbjct: 179 ATRWYRAPEIMLNWMHYNQT--VDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 9e-08
Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 20/218 (9%)
Query: 1034 STLQIIKNEDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE 1091
ST ++K + LK +GSG G V + +VAIK++ R + +
Sbjct: 11 STFTVLKR--YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKR 62
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK--ERHLDRRK 1149
+RE ++ ++H N+++ V P +L + + L L + + LD +
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVIQMELDHER 120
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
+ G+++LHS I+H DLK N++V + K+ DFGL++ + +
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL----KILDFGLARTAGTSFMMT 176
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 1247
T + APE++ G K E VD++S G ++ E++
Sbjct: 177 PYVVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-07
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 1042 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D E +K +G G FG V K G A+K+++KS + EQ E +IL
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK--EQ---VAHVRAERDIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++ +P VV Y QD L + E++ G + +L+ K+ + R IA +
Sbjct: 56 AEADNPWVVKLYYSFQDE--NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETIL 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
++ +H +H D+K DNLL++ K I K+ DFGL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHI----KLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 25/168 (14%)
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--IAMDAAFGM 1161
HPN++ + V G L ++ FM GS LL + LI I A G+
Sbjct: 58 HPNIMTSWTVFT--TGSWLWVISPFMAYGSANS-LLKTYFPEGMSEALIGNILFGALRGL 114
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR--------- 1212
YLH +H ++K ++L++ D + V GLS + +LV G +
Sbjct: 115 NYLHQNGYIHRNIKASHILIS-GDGL-----VSLSGLSHL--YSLVRNGQKAKVVYDFPQ 166
Query: 1213 ---GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1257
LPW++PELL + K D++S GI E+ TG P+ +M
Sbjct: 167 FSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 1181
L V E+ VNG + ++R L A + + +LH + I++ DLK DN+L+
Sbjct: 71 LFLVIEY-VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL 129
Query: 1182 NLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFG 1240
+ I K+ D+G+ K T GT ++APE+L G S VD ++ G
Sbjct: 130 DADGHI----KLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS--VDWWALG 183
Query: 1241 IVLWEILTGEEPY 1253
++++E++ G P+
Sbjct: 184 VLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-07
Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVN--GSLRHVLLSKERHLDRRKRLI 1152
EA IL ++HP+++ G T T ++ + + L+ +R++ L
Sbjct: 133 EAHILRAINHPSIIQLKGTF------TYNKFTCLILPRYKTDLYCYLAAKRNIAICDILA 186
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP--ICKVGDFGLS----KIKRNTL 1206
I ++YLH I+H D+K +N+ +N P +C +GDFG + I N
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFIN-----HPGDVC-LGDFGAACFPVDINANKY 240
Query: 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEE 1251
G GT+ APELL + VD++S GIVL+E+ T +
Sbjct: 241 Y--GWAGTIATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 36/200 (18%)
Query: 1099 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA-- 1154
+SKL +HPN+V + + D L VT FM GS + ++ + +D L IA
Sbjct: 52 VSKLFNHPNIVPYRATFIADN---ELWVVTSFMAYGSAKDLICT--HFMDGMSELAIAYI 106
Query: 1155 -MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN-TLVTGGVR 1212
++Y+H VH +K ++L+++ G LS ++ N +++ G R
Sbjct: 107 LQGVLKALDYIHHMGYVHRSVKASHILISVD---------GKVYLSGLRSNLSMINHGQR 157
Query: 1213 G------------TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 1260
LPW++PE+L + K D++S GI E+ G P+ +M
Sbjct: 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217
Query: 1261 IIGGIVNNTLRPPVPGFCDS 1280
++ +N T VP D+
Sbjct: 218 MLLEKLNGT----VPCLLDT 233
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 1050 LGSGTFGTVYHGKWRGT-DV-AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
+G G FG V + + T D+ A+K +KKS + F E +ILS + P +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKS-----VLLAQETVSFFEEERDILSISNSPWI 63
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 1167
QD L V E+ G L +L E D + + +H
Sbjct: 64 PQLQYAFQDK--DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVR-GTLPWMAPELLNG 1225
VH D+K +N+L++ I K+ DFG + ++ N +V + GT ++APE+L
Sbjct: 122 GYVHRDIKPENVLIDRTGHI----KLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 1226 --SSSKVSEKV--DVFSFGIVLWEILTGEEPYA 1254
K + V D +S G++ +E++ G P+
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-07
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 1034 STLQIIKNEDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE 1091
ST ++K + LK +GSG G V + +VAIK++ R + +
Sbjct: 18 STFTVLKR--YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS------RPFQNQTHAKR 69
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK--ERHLDRRK 1149
+RE ++ ++H N++ V P +L + + L L + + LD +
Sbjct: 70 AYRELVLMKCVNHKNIIGLLNVFT--PQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 127
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
+ G+++LHS I+H DLK N++V + K+ DFGL++ + +
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL----KILDFGLARTAGTSFMMT 183
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
T + APE++ G K E VD++S G ++ E++ G
Sbjct: 184 PYVVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 39/129 (30%), Positives = 67/129 (51%), Gaps = 14/129 (10%)
Query: 1129 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188
++NG H LS+ ++ A + G+E++H++ +V+ DLK N+L++ +R
Sbjct: 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 137
Query: 1189 PICKVGDFGL----SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLW 1244
+ D GL SK K + V GT +MAPE+L ++ S D FS G +L+
Sbjct: 138 ----ISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGTAYDSS-ADWFSLGCMLF 187
Query: 1245 EILTGEEPY 1253
++L G P+
Sbjct: 188 KLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 39/129 (30%), Positives = 65/129 (50%), Gaps = 14/129 (10%)
Query: 1129 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188
++NG H LS+ + A + G+E++H++ +V+ DLK N+L++ +R
Sbjct: 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 137
Query: 1189 PICKVGDFGL----SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLW 1244
+ D GL SK K + V GT +MAPE+L + S D FS G +L+
Sbjct: 138 ----ISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLF 187
Query: 1245 EILTGEEPY 1253
++L G P+
Sbjct: 188 KLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 54/253 (21%)
Query: 1042 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E LK +G G FG V K G A+K ++K+ E+E++ E +IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML----EKEQVG-HIRAERDIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ VV + QD L + EF+ G + +L+ K+ + + IA +
Sbjct: 56 VEADSLWVVKMFYSFQDKL--NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVL 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-------------------- 1199
++ +H +H D+K DNLL++ K + K+ DFGL
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHV----KLSDFGLCTGLKKAHRTEFYRNLNHSLP 168
Query: 1200 -----------------KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIV 1242
K R L V GT ++APE+ + ++ D +S G++
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTV-GTPDYIAPEVF--MQTGYNKLCDWWSLGVI 225
Query: 1243 LWEILTGEEPYAN 1255
++E+L G P+ +
Sbjct: 226 MYEMLIGYPPFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-06
Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 54/253 (21%)
Query: 1042 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D E LK +G G FG V K G A+K ++K+ E+E++ E +IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML----EKEQVA-HIRAERDIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ VV + QD L + EF+ G + +L+ K+ + + IA +
Sbjct: 56 VEADGAWVVKMFYSFQDKR--NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVL 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-------------------- 1199
++ +H +H D+K DNLL++ K + K+ DFGL
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHV----KLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
Query: 1200 -----------------KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIV 1242
K R L V GT ++APE+ + ++ D +S G++
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVF--MQTGYNKLCDWWSLGVI 225
Query: 1243 LWEILTGEEPYAN 1255
++E+L G P+ +
Sbjct: 226 MYEMLIGYPPFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 6e-06
Identities = 59/238 (24%), Positives = 108/238 (45%), Gaps = 35/238 (14%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSE--QERLTLEFWREAEILS 1100
+ E +K++G+G FG V+ K + T + C+ S +ER + E ++
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQ------EFFCWKAISYRGLKEREKSQLVIEVNVMR 67
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLR------HVLLSK-ERH--LDRRKRL 1151
+L H N+V + + L + EF G L + + K E H +D ++L
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127
Query: 1152 IIAMDAAFGM-EYLHSKNIVHFDLKCDNLLV---------------NLKDPIRPICKVGD 1195
+ A+ + + + + ++H DLK N+ + NL RPI K+GD
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG--RPIAKIGD 185
Query: 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
FGLSK + GT + +PELL + +K D+++ G +++E+ +G+ P+
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-05
Identities = 58/261 (22%), Positives = 102/261 (39%), Gaps = 72/261 (27%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTDV----AIKRIKKSCFTGRSS----EQERLTLEFWREA 1096
++K +G G FG V R D A+K ++K+ R+ + ER
Sbjct: 4 VKIKTIGIGAFGEVCLV--RKVDTNALYAMKTLRKADVLMRNQAAHVKAER--------- 52
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
+IL++ + VV Y QD L V +++ G + +L+ + R IA +
Sbjct: 53 DILAEADNEWVVKLYYSFQDK--DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-E 109
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------------------ 1198
+E +H +H D+K DN+L++ I K+ DFGL
Sbjct: 110 LTCAIESVHKMGFIHRDIKPDNILIDRDGHI----KLTDFGLCTGFRWTHDSKYYQKGDH 165
Query: 1199 ---------------SKIKRNTLVTGGVR-----------GTLPWMAPELLNGSSSKVSE 1232
+ + L R GT ++APE+L + ++
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQ 223
Query: 1233 KVDVFSFGIVLWEILTGEEPY 1253
D +S G++L+E+L G+ P+
Sbjct: 224 LCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E L +G G +G V + + T VAIK+ K S E E + RE ++L
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS------EENEEVKETTLRELKMLRT 56
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL-----DRRKRLIIAMD 1156
L N+V + G L V E++ +++L E ++ + I +
Sbjct: 57 LKQENIVELKEAFRRR--GKLYLVFEYVE----KNMLELLEEMPNGVPPEKVRSYIYQLI 110
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A + + H +IVH D+K +NLL++ D + K+ DFG ++ L G
Sbjct: 111 KA--IHWCHKNDIVHRDIKPENLLISHND----VLKLCDFGFAR----NLSEGSNANYTE 160
Query: 1217 WMA------PELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
++A PELL G+ + VD++S G +L E+ G+
Sbjct: 161 YVATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-05
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 1042 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED +K +G G FG V K G A+K + KS ++++L E ++L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS----EMFKKDQLA-HVKAERDVL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++ P VV+ Y QD L + EF+ G L +L+ + + R +A +
Sbjct: 56 AESDSPWVVSLYYSFQDA--QYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVL 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199
+E +H +H D+K DN+L++ I K+ DFGLS
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHI----KLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 32/126 (25%), Positives = 49/126 (38%), Gaps = 18/126 (14%)
Query: 1132 GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191
SL +L + R L+ + + + + LH + L + L+ L
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL-------- 52
Query: 1192 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEE 1251
G K T R +MAPE++ G S +EK D++S GI L+E L E
Sbjct: 53 ----DGSVAFK--TPEQS--RPDPYFMAPEVIQGQS--YTEKADIYSLGITLYEALDYEL 102
Query: 1252 PYANMH 1257
PY
Sbjct: 103 PYNEER 108
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-04
Identities = 59/258 (22%), Positives = 104/258 (40%), Gaps = 64/258 (24%)
Query: 1046 ELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
++K LG G FG V T A+K ++K R+ E +IL++
Sbjct: 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ-----VAHVKAERDILAEAD 59
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
+ VV Y QD L V +++ G + +L+ E + R IA + +E
Sbjct: 60 NEWVVKLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIES 116
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL----------------SKIKRNTL- 1206
+H +H D+K DN+L++L I K+ DFGL S I+++++
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHI----KLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 1207 -------------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVD 1235
+ + GT ++APE+L ++ D
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCD 230
Query: 1236 VFSFGIVLWEILTGEEPY 1253
+S G++L+E+L G+ P+
Sbjct: 231 WWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-04
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 14/94 (14%)
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG-----TL 1215
+ Y+HSK I H DLK NLL+ DP K+ DFG +K N L G R +
Sbjct: 183 LAYIHSKFICHRDLKPQNLLI---DPNTHTLKLCDFGSAK---NLL--AGQRSVSYICSR 234
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
+ APEL+ G+++ + +D++S G ++ E++ G
Sbjct: 235 FYRAPELMLGATNYTTH-IDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-04
Identities = 41/172 (23%), Positives = 79/172 (45%), Gaps = 19/172 (11%)
Query: 1087 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLS 1140
R ++ E L +L+H N++ +++ + T + FM + +
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW---- 260
Query: 1141 KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
K+R L ++ R I+ +EY+H K ++H D+K +N+ +N I +GDFG +
Sbjct: 261 KDRPLLKQTRAIMKQLLC-AVEYIHDKKLIHRDIKLENIFLNCDGKI----VLGDFGTAM 315
Query: 1201 IKRNTLVTG--GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
G GT+ +PE+L G E D++S G++L ++L+ +
Sbjct: 316 PFEKEREAFDYGWVGTVATNSPEILAGDG--YCEITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 29/72 (40%), Positives = 35/72 (48%), Gaps = 13/72 (18%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
L KEL GT VY G+WRG +VA+K R + R LE +EA+IL L
Sbjct: 24 LRVEKELAKGTTSVVYLGEWRGGEVALKV--------RRRDSPRRNLE--KEAKILEILA 73
Query: 1104 HPNV---VAFYG 1112
V V FYG
Sbjct: 74 GEGVTPEVYFYG 85
|
Length = 201 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-04
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 40/213 (18%)
Query: 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 1106
L L G+ G V+ G + K I K+ G++ RE +IL + H
Sbjct: 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG---------REIDILKTISHRA 147
Query: 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---------LSKERHLDRRKRLIIAMDA 1157
++ + T MV + L L E+ + ++RL+ A+
Sbjct: 148 IINLIHAYRWKS-------TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEAL-- 198
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS---KIKRNTLVTGGVRGT 1214
YLH + I+H D+K +N+ ++ +P + +GDFG + +T G GT
Sbjct: 199 ----AYLHGRGIIHRDVKTENIFLD--EPENAV--LGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 1247
L +PELL + K D++S G+VL+E+
Sbjct: 251 LETNSPELL--ALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1329 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06410 | 97 | PB1_UP2 Uncharacterized protein 2. The PB1 domain | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.64 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.58 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.17 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.14 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.98 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.95 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.85 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.84 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.8 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| smart00666 | 81 | PB1 PB1 domain. Phox and Bem1p domain, present in | 98.7 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.63 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.59 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.31 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.29 | |
| PF00564 | 84 | PB1: PB1 domain; InterPro: IPR000270 The Phox and | 98.15 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.07 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.06 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.0 | |
| cd05992 | 81 | PB1 The PB1 domain is a modular domain mediating s | 97.98 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.86 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.85 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.81 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.79 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.71 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.58 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.57 | |
| cd06407 | 82 | PB1_NLP A PB1 domain is present in NIN like protei | 97.5 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.4 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.38 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.32 | |
| cd06405 | 79 | PB1_Mekk2_3 The PB1 domain is present in the two m | 97.06 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.0 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.97 | |
| cd06408 | 86 | PB1_NoxR The PB1 domain is present in the Epichloe | 96.9 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.78 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.73 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.61 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.44 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.35 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.3 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.16 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.13 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.88 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.84 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.79 | |
| cd06404 | 83 | PB1_aPKC PB1 domain is an essential modular domain | 95.64 | |
| cd06401 | 81 | PB1_TFG The PB1 domain found in TFG protein, an on | 95.32 | |
| cd06396 | 81 | PB1_NBR1 The PB1 domain is an essential part of NB | 95.24 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.06 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.94 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.78 | |
| PLN02236 | 344 | choline kinase | 94.67 | |
| cd06398 | 91 | PB1_Joka2 The PB1 domain is present in the Nicotia | 94.67 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.47 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.33 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.06 | |
| cd06397 | 82 | PB1_UP1 Uncharacterized protein 1. The PB1 domain | 93.82 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.33 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.53 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=413.78 Aligned_cols=271 Identities=49% Similarity=0.812 Sum_probs=239.5
Q ss_pred cccccccCeeEEEEecccCcEEEEEEEECCce-EEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Q 000726 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTD-VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1329)
Q Consensus 1036 l~iI~~edYellkvLGqGaFGtVYKA~~kGr~-VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif 1114 (1329)
.+.+...++.+.+.||+|+||+||+|.|+|+. ||||++....... +. ..+|.+|+.+|.+++|||||+++|+|
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~-----~~-~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDD-----ES-RKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcCh-----HH-HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34566777777888999999999999999999 9999998654332 11 67899999999999999999999999
Q ss_pred ccCCCCeEEEEEEeccCCchhhhhhc-ccccCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCCcceEeccCCCCCCcEE
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRKRLIIAMDAAFGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm~GGSL~d~L~~-kek~Lse~qrlkIA~QIAsALaYLHs~G-IIHRDLKPeNILLDsdGni~~~VK 1192 (1329)
.+.+. .++||||||++|+|.++++. ....+++..++.|+.+|++||.|||+++ |||||||++|||++.++ .++|
T Consensus 109 ~~~~~-~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~---~~~K 184 (362)
T KOG0192|consen 109 TSPPG-SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG---KTLK 184 (362)
T ss_pred cCCCC-ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC---CEEE
Confidence 88542 68999999999999999987 4778999999999999999999999999 99999999999999765 4789
Q ss_pred EeecCCcccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC
Q 000726 1193 VGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1271 (1329)
Q Consensus 1193 LsDFGLAr~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr 1271 (1329)
|+|||+++..... .......||+.|||||++.+....++.|+||||||++||||+||+.||...........++....+
T Consensus 185 I~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 185 IADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR 264 (362)
T ss_pred ECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC
Confidence 9999999876543 233346799999999999954456899999999999999999999999999998888888889999
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcc
Q 000726 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 1316 (1329)
Q Consensus 1272 ~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q~ 1316 (1329)
++++..+++.+..||.+||..||..||+|.+++..|+.+......
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999999999999999876553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=407.05 Aligned_cols=275 Identities=28% Similarity=0.340 Sum_probs=233.6
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif 1114 (1329)
+....+.|.+.+.||+|+||.|-+|.. +|+.||||++.+........ .........+|+++|++|+|||||+++++|
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~-~~~~~~~v~~EieILkkL~HP~IV~~~d~f 245 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR-AIAKTRDVQNEIEILKKLSHPNIVRIKDFF 245 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc-cccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence 344567889999999999999999987 48899999999877665443 111223457999999999999999999999
Q ss_pred ccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
.... ..|+||||++||.|.+.+... +.+.+.....+++||+.|+.|||++||+||||||+|||+..+. ....+||+
T Consensus 246 ~~~d--s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~-e~~llKIt 321 (475)
T KOG0615|consen 246 EVPD--SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA-EDCLLKIT 321 (475)
T ss_pred ecCC--ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC-cceEEEec
Confidence 9866 889999999999999999654 4578888899999999999999999999999999999998764 45789999
Q ss_pred ecCCcccccCcccccCCCCCCcccCccccccCCCCCC-hhhHHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHhcCCCC
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVS-EKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRP 1272 (1329)
Q Consensus 1195 DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S-~KSDVWSLGVLLyELLTGk~PF~~~~~~e-ll~qIve~~lr~ 1272 (1329)
|||+|+...+.....++|||+.|.|||++.+....+. .++|+|||||+||-+++|.+||....... ..+++....+..
T Consensus 322 DFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 322 DFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred ccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 9999999888888889999999999999986554444 48999999999999999999998776655 677777766543
Q ss_pred --CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcc
Q 000726 1273 --PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 1316 (1329)
Q Consensus 1273 --~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q~ 1316 (1329)
+....++++..+||.+||..||++|||+.|+|+|.|.-.+.|..
T Consensus 402 ~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 402 GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 33456799999999999999999999999999999988665543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=406.38 Aligned_cols=298 Identities=36% Similarity=0.576 Sum_probs=247.1
Q ss_pred hHHHhhhcccccccccCCCCCCCCCCccccccCCCCc-cccccccccCeeEEEEecccCcEEEEEEEECCc-eEEEEEEe
Q 000726 997 SEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDI-STLQIIKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIK 1074 (1329)
Q Consensus 997 sesvn~~i~e~d~~e~~l~Lp~s~~pL~d~al~~fDl-s~l~iI~~edYellkvLGqGaFGtVYKA~~kGr-~VAVKiLK 1074 (1329)
.++++++.........++..+....... .+...+. ...+.+..+.+++++.||+|-||.||+|.|++. +||||.++
T Consensus 162 ~~lv~~~~~~~~gl~~~l~~p~~~~~~~--~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik 239 (468)
T KOG0197|consen 162 QQLVNYYSKNADGLCTRLRDPCSKQGHT--KPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIK 239 (468)
T ss_pred HHHHhhhhccCcchhhcccCchhccCCC--CCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEe
Confidence 3455555555555554444443321110 0111111 456788889999999999999999999999877 89999998
Q ss_pred ccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEEeccCCchhhhhhc-ccccCCHHHHHHH
Q 000726 1075 KSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRKRLII 1153 (1329)
Q Consensus 1075 ks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~-kek~Lse~qrlkI 1153 (1329)
...+. ...|.+|+++|++|+|+|||+++++|..+. .++||||||+.|+|.++|.. .+..+...+.+.|
T Consensus 240 ~~~m~---------~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~ 308 (468)
T KOG0197|consen 240 EGSMS---------PEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDF 308 (468)
T ss_pred ccccC---------hhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEEEecccCcHHHHhhhcCCCccchHHHHHH
Confidence 75433 256889999999999999999999998854 79999999999999999986 4577999999999
Q ss_pred HHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccC--cccccCCCCCCcccCccccccCCCCCC
Q 000726 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN--TLVTGGVRGTLPWMAPELLNGSSSKVS 1231 (1329)
Q Consensus 1154 A~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~--~~~ss~~~GTp~YmAPEvL~Gs~~~~S 1231 (1329)
+.|||+||+||+++++|||||.+.||||+.+. .|||+|||+|+.... .....+..-...|.|||.+. ...++
T Consensus 309 a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~----~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~--~~~FS 382 (468)
T KOG0197|consen 309 AAQIAEGMAYLESKNYIHRDLAARNILVDEDL----VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALN--YGKFS 382 (468)
T ss_pred HHHHHHHHHHHHhCCccchhhhhhheeeccCc----eEEEcccccccccCCCceeecCCCCCCceecCHHHHh--hCCcc
Confidence 99999999999999999999999999999664 689999999995433 22334445667899999999 67799
Q ss_pred hhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1232 EKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1232 ~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.|+|||||||+||||+| |+.||..+...+++.. ++.+++++.|..||+.+.+||..||+.+|++||||+.+...|..+
T Consensus 383 ~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 383 SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred cccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999 9999999999988865 678899999999999999999999999999999999999999988
Q ss_pred HHHh
Q 000726 1311 SAAC 1314 (1329)
Q Consensus 1311 ~aa~ 1314 (1329)
....
T Consensus 462 ~~~~ 465 (468)
T KOG0197|consen 462 FTST 465 (468)
T ss_pred hhcc
Confidence 7644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=389.95 Aligned_cols=258 Identities=33% Similarity=0.487 Sum_probs=223.1
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.+..++++.++.||+|..|+|||+.++ ++-+|+|++... .++...+++.+|+++++.++||+||++||.|.
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-------~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-------IDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 355668888999999999999999995 777999999532 23455688999999999999999999999998
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
.... .+.|+||||.+|+|..++... +.+++...-+|+.+|++||.|||+ ++||||||||+||||+..|.+ |||
T Consensus 148 ~~~~-~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeV----Kic 221 (364)
T KOG0581|consen 148 SNGE-EISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEV----KIC 221 (364)
T ss_pred eCCc-eEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCE----Eec
Confidence 8543 599999999999999988544 669999999999999999999996 899999999999999988754 999
Q ss_pred ecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCC-----ChhHHHHHHHhcC
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-----HYGAIIGGIVNNT 1269 (1329)
Q Consensus 1195 DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~-----~~~ell~qIve~~ 1269 (1329)
|||.++...+. ..+++.||..|||||.+.+. .|+.++||||||++++||++|+.||... ...+++..|+.+.
T Consensus 222 DFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 222 DFGVSGILVNS-IANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP 298 (364)
T ss_pred cccccHHhhhh-hcccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC
Confidence 99999976665 56778899999999999964 5788899999999999999999999874 5566777777654
Q ss_pred CCCCCCC-CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1270 LRPPVPG-FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1270 lr~~ips-~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
. +.+|. .+++++++|+.+||++||.+||++.|+++|.+-...
T Consensus 299 p-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 299 P-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred C-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 4 34444 499999999999999999999999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=395.63 Aligned_cols=252 Identities=30% Similarity=0.453 Sum_probs=225.7
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
.+|...+.||+|+|+.||.+++ +|..||+|++.+..+... .......+|+++.+.|+|||||+++++|++..
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-----~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~- 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP-----KQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN- 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc-----chHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-
Confidence 5799999999999999999998 589999999988655433 23456778999999999999999999999976
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+|||.|+|..++|.+++. +.+.+++.+++.++.||+.||.|||+++|||||||..|+|++.+ ..|||+|||+|
T Consensus 92 -nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~----~~VKIgDFGLA 165 (592)
T KOG0575|consen 92 -NVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN----MNVKIGDFGLA 165 (592)
T ss_pred -ceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc----CcEEeccccee
Confidence 9999999999999999886 66789999999999999999999999999999999999999955 45799999999
Q ss_pred cccc-CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1200 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 r~~~-~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
.... ......+.||||.|+|||++. ....+..+||||+||+||-||.|++||......+.+..+....+. +|..+
T Consensus 166 t~le~~~Erk~TlCGTPNYIAPEVl~--k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--~P~~l 241 (592)
T KOG0575|consen 166 TQLEYDGERKKTLCGTPNYIAPEVLN--KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--MPSHL 241 (592)
T ss_pred eeecCcccccceecCCCcccChhHhc--cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc--ccccc
Confidence 9765 446777899999999999998 445678899999999999999999999999899999888877664 45588
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
+.+.++||.++|++||.+|||+.+|+.+-+.
T Consensus 242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 242 SAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 9999999999999999999999999998876
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=381.88 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=221.7
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
..+|.+.+.||+|+||+||+|+++ +..||||.+.+... ......-+..|+.+|+.++|||||++++++...+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD 82 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence 357888889999999999999984 78899999976532 2334455778999999999999999999999865
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCC--CcEEEeec
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR--PICKVGDF 1196 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~--~~VKLsDF 1196 (1329)
++|||||||.||+|.++++.++ .+++..+..++.||+.||++||+++||||||||+||||+...... ..+||+||
T Consensus 83 --~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 83 --FIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred --eEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 9999999999999999997654 689999999999999999999999999999999999999763233 78999999
Q ss_pred CCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-CCCCC
Q 000726 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPPVP 1275 (1329)
Q Consensus 1197 GLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l-r~~ip 1275 (1329)
|+|+...+.......||++.|||||++. ..+|+-|+|+||+|++||+|++|+.||...+..+++..+..... .+.++
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~--~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~ 237 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIM--SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP 237 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHH--hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh
Confidence 9999988888888899999999999998 56789999999999999999999999999998888876655443 33445
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1276 s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
..++..+.+++...++.++.+|.++.+...+.-
T Consensus 238 ~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~ 270 (429)
T KOG0595|consen 238 AELSNPLRELLISLLQRNPKDRISFEDFFDHPF 270 (429)
T ss_pred hhccCchhhhhhHHHhcCccccCchHHhhhhhh
Confidence 566777889999999999999998887765543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=374.06 Aligned_cols=256 Identities=31% Similarity=0.457 Sum_probs=221.8
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.+..++|+++++||+|+||+||+++. +++-+|+|++++...... ........|..+|..++||+||+++-.|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-----~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-----KEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-----hhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 56678999999999999999999987 477799999998765432 22455678999999999999999999999
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
+.. .+|||+||+.||.|...|. +++.+++..+..++.+|+.||.|||++|||||||||+|||+|.+|+ ++|+|
T Consensus 96 t~~--kLylVld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH----i~LtD 168 (357)
T KOG0598|consen 96 TEE--KLYLVLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH----IKLTD 168 (357)
T ss_pred cCC--eEEEEEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc----EEEec
Confidence 865 9999999999999999985 4567899999999999999999999999999999999999998875 59999
Q ss_pred cCCccc-ccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC
Q 000726 1196 FGLSKI-KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1196 FGLAr~-~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~i 1274 (1329)
||+++. ......+.++|||+.|||||++.+ ..++..+|+||||+++|||++|.+||...+.......+.... ....
T Consensus 169 FgL~k~~~~~~~~t~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~ 245 (357)
T KOG0598|consen 169 FGLCKEDLKDGDATRTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLP 245 (357)
T ss_pred cccchhcccCCCccccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCC
Confidence 999994 444455667899999999999994 578999999999999999999999999999888888887765 2345
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCC----CHHHHHHHHH
Q 000726 1275 PGFCDSEWRLLMEQCWAPDPVVRP----SFTEIARRLR 1308 (1329)
Q Consensus 1275 ps~~S~eL~DLIkrCLqkDPeERP----TaeELLq~Le 1308 (1329)
+..++.+.+++++++|+.||++|. ++.+|..|..
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hpf 283 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPF 283 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcc
Confidence 566899999999999999999995 6777766643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=360.17 Aligned_cols=262 Identities=29% Similarity=0.490 Sum_probs=211.3
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCcee
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVV 1108 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~k-------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIV 1108 (1329)
+.+..++|++.++||+|+||.||+|.+. ++.||||+++... .......+.+|+.+|..+ +||||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv 74 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-------TASEHKALMSELKILIHIGNHLNVV 74 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-------chHHHHHHHHHHHHHHHhccCccee
Confidence 4567789999999999999999999752 3569999986431 112235688999999999 899999
Q ss_pred eEecccccCCCCeEEEEEEeccCCchhhhhhccc----------------------------------------------
Q 000726 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------------------------------- 1142 (1329)
Q Consensus 1109 KL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------------------------------------------- 1142 (1329)
+++++|... ...+++||||+++|+|.+++....
T Consensus 75 ~~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (338)
T cd05102 75 NLLGACTKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST 153 (338)
T ss_pred eEEeEecCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccccc
Confidence 999988654 346899999999999998885421
Q ss_pred ---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCc--
Q 000726 1143 ---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT-- 1205 (1329)
Q Consensus 1143 ---------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~-- 1205 (1329)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 154 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~----~~kl~DfG~a~~~~~~~~ 229 (338)
T cd05102 154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPD 229 (338)
T ss_pred CcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC----cEEEeecccccccccCcc
Confidence 2477888899999999999999999999999999999999765 4699999999753221
Q ss_pred -ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1206 -LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1206 -~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
.......++..|+|||++. ...++.++|||||||+||||++ |..||............+........+..+++.+.
T Consensus 230 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (338)
T cd05102 230 YVRKGSARLPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIY 307 (338)
T ss_pred hhcccCCCCCccccCcHHhh--cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 1122334567899999997 3457889999999999999997 99999876554444444444445555677899999
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1284 DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=350.90 Aligned_cols=265 Identities=26% Similarity=0.374 Sum_probs=220.9
Q ss_pred cccccccCeeEE--EEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecc
Q 000726 1036 LQIIKNEDLEEL--KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1329)
Q Consensus 1036 l~iI~~edYell--kvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gi 1113 (1329)
++.+..++++.. ..||+|++|.||+|.++|+.||||+++... .........|.+|+.+|++++||||++++++
T Consensus 12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 12 IKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFH-----KGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred ceecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccc-----cccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 344444444444 679999999999999999999999997532 1223345678899999999999999999999
Q ss_pred ccc--CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEeccCCCCCCc
Q 000726 1114 VQD--GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPI 1190 (1329)
Q Consensus 1114 f~e--~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~-GIIHRDLKPeNILLDsdGni~~~ 1190 (1329)
+.+ .....+++||||+++|+|.+++.. ...+++...+.++.+++.||.|||+. +++||||||+|||++.++ .
T Consensus 87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~----~ 161 (283)
T PHA02988 87 IIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY----K 161 (283)
T ss_pred EEecccCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC----c
Confidence 876 333478999999999999999865 35688999999999999999999984 999999999999999776 4
Q ss_pred EEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC
Q 000726 1191 CKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1270 (1329)
Q Consensus 1191 VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l 1270 (1329)
+||+|||+++...... ....++..|+|||++.+....++.++|||||||++|||++|+.||......+....++....
T Consensus 162 ~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 239 (283)
T PHA02988 162 LKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN 239 (283)
T ss_pred EEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC
Confidence 6999999987543322 23457899999999975445689999999999999999999999998887777777766666
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1271 r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
+...+..++..+.+|+.+||+.||.+|||+.+++..|..++.
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 667776789999999999999999999999999999998753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=367.58 Aligned_cols=261 Identities=29% Similarity=0.457 Sum_probs=224.2
Q ss_pred ccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQ 1115 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~ 1115 (1329)
.....|.+.+.||+|+||+|++|.+ ++..||||++.+....... ......+.+|+.+++.++ ||||++++.++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 4567899999999999999999987 5789999988765332111 112334558999999999 999999999999
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccC-CCCCCcEEEe
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK-DPIRPICKVG 1194 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsd-Gni~~~VKLs 1194 (1329)
... .+++||||+.+|+|.+++.. ..++.+..+..++.||++|++|||++||+||||||+|||++.+ ++ +||+
T Consensus 91 t~~--~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~----~Kl~ 163 (370)
T KOG0583|consen 91 TPT--KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN----LKLS 163 (370)
T ss_pred cCC--eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC----EEEe
Confidence 876 69999999999999999987 6778999999999999999999999999999999999999987 54 5999
Q ss_pred ecCCcccc-cCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 000726 1195 DFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1195 DFGLAr~~-~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ 1273 (1329)
|||++... .........+||+.|+|||++.+....-+.++||||+||+||.|++|+.||.......+...+....+ .
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~--~ 241 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF--K 241 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc--c
Confidence 99999977 45566678899999999999997542336899999999999999999999999887777777665544 4
Q ss_pred CCCCC-cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1274 VPGFC-DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1274 ips~~-S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
+|..+ +.+++.|+.+||..||.+|+|+.+++.+.|...
T Consensus 242 ~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 242 IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 56677 999999999999999999999999999988876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=362.67 Aligned_cols=259 Identities=25% Similarity=0.435 Sum_probs=216.3
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
..+..+|+++++||+|.||.||++++ +|..||.|.+.-.. -+.........|+.+|++|+|||||++|++-.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~------md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f 88 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM------MDAKARQDCVKEISLLKQLNHPNIVQYYAHSF 88 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh------ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh
Confidence 34456899999999999999999987 58889999887322 23445677889999999999999999999443
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHH--CC--eeecCCCCcceEeccCCCCC
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHS--KN--IVHFDLKCDNLLVNLKDPIR 1188 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs--~G--IIHRDLKPeNILLDsdGni~ 1188 (1329)
..+..-++||||||..|+|.+.+.. +.+.+++..+|+++.|+++||.+||. .. |+||||||.||+|+.+|
T Consensus 89 ~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g--- 165 (375)
T KOG0591|consen 89 IEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG--- 165 (375)
T ss_pred hccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC---
Confidence 3333358999999999999998843 34679999999999999999999998 45 99999999999999777
Q ss_pred CcEEEeecCCcccccC-cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 000726 1189 PICKVGDFGLSKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1189 ~~VKLsDFGLAr~~~~-~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve 1267 (1329)
.|||+|||+++.... ........|||.||+||++. ...|+.++|||||||++|||+.-++||.+....++...|..
T Consensus 166 -vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~--~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q 242 (375)
T KOG0591|consen 166 -VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIH--ESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ 242 (375)
T ss_pred -ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHh--cCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc
Confidence 469999999997654 34455778999999999999 45688999999999999999999999999988888877766
Q ss_pred cCCCCCCC-CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1268 NTLRPPVP-GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1268 ~~lr~~ip-s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
..+ +++| ..++..+.+||..|+..||+.||+...++..+..
T Consensus 243 gd~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 243 GDY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 544 4455 6789999999999999999999986555555544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.65 Aligned_cols=254 Identities=20% Similarity=0.305 Sum_probs=205.5
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCe
Q 000726 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~ 1121 (1329)
|+..+.||+|+||.||++.+ +++.||||.+...... .......+.+|+.+++.++|+||+++++++.+.. .
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~--~ 74 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD--A 74 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-----hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--e
Confidence 77889999999999999987 4788999998754321 1122345778999999999999999999988754 8
Q ss_pred EEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1122 LATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1122 L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.++||||+++++|..++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++ .++|+|||++.
T Consensus 75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~----~~kl~Dfg~~~ 150 (285)
T cd05631 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG----HIRISDLGLAV 150 (285)
T ss_pred EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC----CEEEeeCCCcE
Confidence 99999999999998877543 34689999999999999999999999999999999999998765 46999999998
Q ss_pred cccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh--cCCCCCCCCCC
Q 000726 1201 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN--NTLRPPVPGFC 1278 (1329)
Q Consensus 1201 ~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve--~~lr~~ips~~ 1278 (1329)
............||..|+|||++.+ ..++.++|||||||+||+|++|+.||...........+.. .......+..+
T Consensus 151 ~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd05631 151 QIPEGETVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKF 228 (285)
T ss_pred EcCCCCeecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccC
Confidence 6543333345568999999999984 4578899999999999999999999987544322211111 11223445667
Q ss_pred cHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPS-----FTEIARRLRVM 1310 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPT-----aeELLq~Le~L 1310 (1329)
+..+.+|+.+||+.||.+||+ +.+++++.+..
T Consensus 229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~ 265 (285)
T cd05631 229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265 (285)
T ss_pred CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence 899999999999999999997 89999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=361.87 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=215.7
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
..+|...+.||+|+||.||++... |...|||.+.... . .. ...+.+|+.+|++++|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~----~---~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED----S---PT-SESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc----c---hh-HHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 346778889999999999999985 6889999987541 1 11 566789999999999999999999754433
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecc-CCCCCCcEEEeecC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL-KDPIRPICKVGDFG 1197 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDs-dGni~~~VKLsDFG 1197 (1329)
...++++|||+++|+|.+++...+..+++..+..++.||++||+|||++||+||||||+||||+. ++ .+||+|||
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~----~~KlaDFG 163 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG----DVKLADFG 163 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC----eEEeccCc
Confidence 23689999999999999999776657999999999999999999999999999999999999997 34 46999999
Q ss_pred CcccccC----cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHhcCCCC
Q 000726 1198 LSKIKRN----TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN-MHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1198 LAr~~~~----~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~-~~~~ell~qIve~~lr~ 1272 (1329)
+++.... ........||+.|||||++.. ......++|||||||++.||+||+.||.. ......+..+......+
T Consensus 164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P 242 (313)
T KOG0198|consen 164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP 242 (313)
T ss_pred cccccccccccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC
Confidence 9986552 122335679999999999984 22233589999999999999999999987 44444455555555566
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
.+|..++.+.++|+.+|++.+|++|||+.++|.|++.....
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 88899999999999999999999999999999999886543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=345.46 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=211.3
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||+|.++ ++.||||++...... .......+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-----RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR- 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence 46889999999999999999985 788999999753211 1223456788999999999999999999988754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 75 -~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~----~kl~Dfg~~ 148 (291)
T cd05612 75 -FLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH----IKLTDFGFA 148 (291)
T ss_pred -eEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC----EEEEecCcc
Confidence 899999999999999988643 46899999999999999999999999999999999999997664 699999998
Q ss_pred ccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCc
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S 1279 (1329)
....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... ..++..++
T Consensus 149 ~~~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~ 222 (291)
T cd05612 149 KKLRDRT--WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRHLD 222 (291)
T ss_pred hhccCCc--ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--cCCCccCC
Confidence 8554322 23568999999999984 456889999999999999999999998887776666665543 34556678
Q ss_pred HHHHHHHHHhhcCCCCCCCC-----HHHHHHHHHHH
Q 000726 1280 SEWRLLMEQCWAPDPVVRPS-----FTEIARRLRVM 1310 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERPT-----aeELLq~Le~L 1310 (1329)
..+.+||++||+.||.+||+ +.++++|.|..
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence 99999999999999999995 99999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=382.21 Aligned_cols=261 Identities=38% Similarity=0.667 Sum_probs=233.1
Q ss_pred cccccccccCeeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecc
Q 000726 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1329)
Q Consensus 1034 s~l~iI~~edYellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gi 1113 (1329)
..+|.|.-+....++-||.|+.|.||+|++.++.||||.++.. -..+++-|++|+||||+.|.|+
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------------kETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------------KETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------------hhhhHHHHHhccCcceeeEeee
Confidence 4577888888888899999999999999999999999987521 1246788999999999999999
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
|...+ ++|||||||..|.|...|. .++.+.......|..+||.||.|||.+.|||||||.-||||..+. .|||
T Consensus 181 CtqsP--cyCIiMEfCa~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d----~VKI 253 (904)
T KOG4721|consen 181 CTQSP--CYCIIMEFCAQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD----VVKI 253 (904)
T ss_pred ecCCc--eeEEeeeccccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc----eEEe
Confidence 99977 9999999999999999985 456788889999999999999999999999999999999999665 4699
Q ss_pred eecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ 1273 (1329)
+|||-++......+...++||..|||||+++ ....++|+|||||||+|||||||..||...+...++..+-.+.+.++
T Consensus 254 sDFGTS~e~~~~STkMSFaGTVaWMAPEvIr--nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp 331 (904)
T KOG4721|consen 254 SDFGTSKELSDKSTKMSFAGTVAWMAPEVIR--NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP 331 (904)
T ss_pred ccccchHhhhhhhhhhhhhhhHhhhCHHHhh--cCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc
Confidence 9999999776666777899999999999999 56789999999999999999999999998887777777777888899
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhccCC
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKS 1318 (1329)
Q Consensus 1274 ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q~~s 1318 (1329)
+|..|++.|+-||++||+..|..||+|.+++.||..+...+....
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~t 376 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTT 376 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhccc
Confidence 999999999999999999999999999999999998876655443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=333.83 Aligned_cols=256 Identities=32% Similarity=0.561 Sum_probs=211.5
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC-----CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k-----Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gi 1113 (1329)
+...+|++.+.||+|+||.||+|.++ +..||+|.++.... ......+.+|+.+++.++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-------DKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-------HHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 45678999999999999999999863 45799999875321 1223568899999999999999999999
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
+.... ..++||||+++++|.+++......+++..++.++.||+.||+|||++|++||||||+|||++.++ .+++
T Consensus 75 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~----~~~l 148 (266)
T cd05064 75 ITRGN--TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL----VCKI 148 (266)
T ss_pred EecCC--CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC----cEEE
Confidence 98754 89999999999999999876666789999999999999999999999999999999999998765 4699
Q ss_pred eecCCcccccCccc--ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC
Q 000726 1194 GDFGLSKIKRNTLV--TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1270 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~--ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~l 1270 (1329)
+|||.+........ .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||...........+ ....
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~ 225 (266)
T cd05064 149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGF 225 (266)
T ss_pred CCCcccccccccchhcccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCC
Confidence 99998764322211 112234678999999873 567889999999999999875 99999887766655554 3444
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1271 r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
..+.+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 5566778899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=350.38 Aligned_cols=252 Identities=28% Similarity=0.390 Sum_probs=212.5
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
..++|++.+.||+|+||.||+|+++ ++.||||+++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-----KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 4578999999999999999999984 678999999753211 122345688999999999999999999999875
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
. .+++||||+.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 91 ~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~----~kl~Dfg 163 (329)
T PTZ00263 91 N--RVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH----VKVTDFG 163 (329)
T ss_pred C--EEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC----EEEeecc
Confidence 4 899999999999999988643 46889999999999999999999999999999999999997764 5999999
Q ss_pred CcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 000726 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277 (1329)
Q Consensus 1198 LAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~ 1277 (1329)
++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ..++..
T Consensus 164 ~~~~~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~p~~ 237 (329)
T PTZ00263 164 FAKKVPDRT--FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNW 237 (329)
T ss_pred CceEcCCCc--ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--cCCCCC
Confidence 998654322 23568999999999984 456889999999999999999999998877666666665543 445667
Q ss_pred CcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLRV 1309 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERPT-----aeELLq~Le~ 1309 (1329)
++..+.+||.+||+.||.+||+ +.+++.|.+.
T Consensus 238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f 274 (329)
T PTZ00263 238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274 (329)
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence 8999999999999999999986 7999988764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=370.94 Aligned_cols=257 Identities=29% Similarity=0.398 Sum_probs=221.4
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEeccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVV 1114 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif 1114 (1329)
.....+|.+.+.||+|+|++|++|+. .++.+|||++.+.... .+...+.+.+|..+|.+| .||.|++||-.|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Ii-----ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYII-----KEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHH-----hhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 34457899999999999999999988 4788999999765332 344456677899999999 899999999999
Q ss_pred ccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
++.. .+|+|+||+++|+|.+++... +.+++.....++.+|+.||+|||++|||||||||+|||+|.++++ ||+
T Consensus 144 QD~~--sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhi----kIT 216 (604)
T KOG0592|consen 144 QDEE--SLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHI----KIT 216 (604)
T ss_pred eccc--ceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcE----EEe
Confidence 9866 899999999999999999654 679999999999999999999999999999999999999988754 999
Q ss_pred ecCCcccccCccc------------c--cCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH
Q 000726 1195 DFGLSKIKRNTLV------------T--GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 1260 (1329)
Q Consensus 1195 DFGLAr~~~~~~~------------s--s~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~e 1260 (1329)
|||.|+....... . ..+.||..|.+||++. ....+..+|+|+|||+||.|+.|.+||.....--
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~--~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl 294 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN--DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL 294 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhc--CCCCCcccchHHHHHHHHHHhcCCCCCccccHHH
Confidence 9999986432211 1 3477999999999998 4567889999999999999999999999988877
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1261 IIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1261 ll~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.++.|+.- ..+++...++.+.+|++++|..||.+|+|..+|.+|+.-.
T Consensus 295 iFqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~ 342 (604)
T KOG0592|consen 295 IFQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE 342 (604)
T ss_pred HHHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence 78777764 4467788899999999999999999999999999887543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=349.56 Aligned_cols=253 Identities=28% Similarity=0.423 Sum_probs=211.9
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||+|++. ++.||||+++..... .......+.+|+.++..++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-----KRNQIAHVRAERDILADADSPWIVKLYYSFQDEE- 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhcCCCCccchhhheecCC-
Confidence 46899999999999999999985 888999999864321 1123456788999999999999999999998755
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 75 -~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~----~kL~Dfg~~ 148 (350)
T cd05573 75 -HLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH----IKLADFGLC 148 (350)
T ss_pred -eEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC----EEeecCCCC
Confidence 899999999999999998655 56899999999999999999999999999999999999997764 599999998
Q ss_pred ccccCcc------------------------------cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhC
Q 000726 1200 KIKRNTL------------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249 (1329)
Q Consensus 1200 r~~~~~~------------------------------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTG 1249 (1329)
....... ......||+.|+|||++.+ ..++.++|||||||+||+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccC
Confidence 7543322 2234568999999999984 4678899999999999999999
Q ss_pred CCCCCCCChhHHHHHHHh--cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCC-HHHHHHHHHH
Q 000726 1250 EEPYANMHYGAIIGGIVN--NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPS-FTEIARRLRV 1309 (1329)
Q Consensus 1250 k~PF~~~~~~ell~qIve--~~lr~~ips~~S~eL~DLIkrCLqkDPeERPT-aeELLq~Le~ 1309 (1329)
+.||...........+.. .....+....+++.+.+||.+||. +|.+||+ +.+++++.+-
T Consensus 227 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 227 FPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred CCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 999998877666666665 333333334469999999999997 9999999 9999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=346.67 Aligned_cols=253 Identities=25% Similarity=0.309 Sum_probs=209.4
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
.+|++.+.||+|+||.||+|++. ++.||||+++..... .......+.+|+.++..++||||+++++++....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE- 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-
Confidence 36899999999999999999984 788999999864221 1223456788999999999999999999998755
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~----~kL~Dfg~a 148 (333)
T cd05600 75 -YLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH----IKLTDFGLS 148 (333)
T ss_pred -EEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC----EEEEeCcCC
Confidence 89999999999999999854 346889999999999999999999999999999999999997764 699999999
Q ss_pred ccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC----
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP---- 1275 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ip---- 1275 (1329)
..... ......||+.|+|||++.+ ..++.++|||||||+||||++|..||......+....+.........+
T Consensus 149 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 224 (333)
T cd05600 149 KGIVT--YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224 (333)
T ss_pred ccccc--ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCc
Confidence 75443 2334569999999999984 367889999999999999999999998877666555544322211111
Q ss_pred --CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1276 --GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1276 --s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
..++.++.++|.+||..+|.+||++.+++++.+..
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~ 261 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK 261 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence 14588999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=348.34 Aligned_cols=246 Identities=27% Similarity=0.361 Sum_probs=205.1
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEE
Q 000726 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LV 1125 (1329)
+.||+|+||.||++++ .++.||||+++..... .......+.+|+.+++.++||||+++++++.... .+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-----AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--RLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--EEEEE
Confidence 3699999999999987 4788999999864221 2233456778999999999999999999998755 89999
Q ss_pred EEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc-C
Q 000726 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-N 1204 (1329)
Q Consensus 1126 MEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~-~ 1204 (1329)
|||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++... .
T Consensus 74 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~----~kl~DfG~a~~~~~~ 148 (323)
T cd05571 74 MEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH----IKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC----EEEeeCCCCcccccC
Confidence 999999999988854 456899999999999999999999999999999999999997664 6999999987432 2
Q ss_pred cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHH
Q 000726 1205 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 1284 (1329)
Q Consensus 1205 ~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~D 1284 (1329)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.... ..++..++..+.+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~ 224 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKS 224 (323)
T ss_pred CCcccceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHH
Confidence 222334569999999999984 457889999999999999999999998877666666555443 3456678999999
Q ss_pred HHHHhhcCCCCCCC-----CHHHHHHHHHH
Q 000726 1285 LMEQCWAPDPVVRP-----SFTEIARRLRV 1309 (1329)
Q Consensus 1285 LIkrCLqkDPeERP-----TaeELLq~Le~ 1309 (1329)
||.+||+.||++|| ++.++++|.+-
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~h~~f 254 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHcCCCc
Confidence 99999999999999 89999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=336.57 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=202.3
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++.+.||.|+||.||+|.++ +..||+|+++...... ....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------APCTAIREVSLLKNLKHANIVTLHDIIHTER 76 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC-------cchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 467999999999999999999884 6789999997542211 1234678999999999999999999998754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+. ++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 77 --~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~----~kl~DfG~ 149 (288)
T cd07871 77 --CLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE----LKLADFGL 149 (288)
T ss_pred --eEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC----EEECcCcc
Confidence 8999999996 5898888666667899999999999999999999999999999999999997764 59999999
Q ss_pred cccccC-cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-------
Q 000726 1199 SKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL------- 1270 (1329)
Q Consensus 1199 Ar~~~~-~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l------- 1270 (1329)
+..... ........+++.|+|||++.+ ...++.++|||||||++|+|++|+.||......+.+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 150 ARAKSVPTKTYSNEVVTLWYRPPDVLLG-STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228 (288)
T ss_pred eeeccCCCccccCceecccccChHHhcC-CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 875332 222234457899999999874 34578899999999999999999999987665544433221100
Q ss_pred -------------CC--------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1271 -------------RP--------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1271 -------------r~--------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.+ .....++.++.+||.+||+.||.+|||++|+++|.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 00 001235788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.63 Aligned_cols=254 Identities=33% Similarity=0.492 Sum_probs=201.7
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC------------------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHh
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR------------------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k------------------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~ 1101 (1329)
...+|++.++||+|+||.||+|.+. +..||||+++... .......|.+|+.+|++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~ 75 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-------NKNARNDFLKEVKILSR 75 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-------CHHHHHHHHHHHHHHhh
Confidence 4568999999999999999999752 2359999987532 12234578899999999
Q ss_pred cCCCceeeEecccccCCCCeEEEEEEeccCCchhhhhhccc------------------ccCCHHHHHHHHHHHHHHHHH
Q 000726 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE------------------RHLDRRKRLIIAMDAAFGMEY 1163 (1329)
Q Consensus 1102 LrHPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke------------------k~Lse~qrlkIA~QIAsALaY 1163 (1329)
++||||+++++++.+.. ..++||||+.+++|.+++.... ..+++..++.++.||+.||+|
T Consensus 76 l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 153 (304)
T cd05096 76 LKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY 153 (304)
T ss_pred cCCCCeeEEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 99999999999998754 7899999999999998884321 246788899999999999999
Q ss_pred HHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHH
Q 000726 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFG 1240 (1329)
Q Consensus 1164 LHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLG 1240 (1329)
||++||+||||||+|||++.++ .+||+|||+++...... ......++..|+|||++.+ ..++.++||||||
T Consensus 154 lH~~~ivH~dlkp~Nill~~~~----~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG 227 (304)
T cd05096 154 LSSLNFVHRDLATRNCLVGENL----TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--GKFTTASDVWAFG 227 (304)
T ss_pred HHHCCccccCcchhheEEcCCc----cEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--CCCCchhhhHHHH
Confidence 9999999999999999999765 46999999987542211 1223345788999999873 4578899999999
Q ss_pred HHHHHHHh--CCCCCCCCChhHHHHHHHh---c---CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1241 IVLWEILT--GEEPYANMHYGAIIGGIVN---N---TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1241 VLLyELLT--Gk~PF~~~~~~ell~qIve---~---~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
|++|||++ +..||...........+.. . ......+..++..+.+|+.+||+.+|.+|||+.+|.+.|+
T Consensus 228 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 228 VTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 99999987 5678877665554433221 1 1122234567899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=371.55 Aligned_cols=254 Identities=28% Similarity=0.444 Sum_probs=219.6
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEeccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVV 1114 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif 1114 (1329)
.+..++|.++++||+|.||+|++++.+ ++.+|||++|+...-.++. ....+.|..++... +||.|+.++..|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~-----Ve~~~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE-----VESLMCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc-----HHHHHHHHHHHHHhccCCeEeeccccc
Confidence 567789999999999999999999985 5669999999876654332 34566788888777 599999999999
Q ss_pred ccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
++.. ++++||||+.||++..+ .+...+++..+..++..|+.||.|||++||||||||.+|||+|.+|. +||+
T Consensus 439 QT~~--~l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh----~kiA 510 (694)
T KOG0694|consen 439 QTKE--HLFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH----VKIA 510 (694)
T ss_pred ccCC--eEEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc----EEec
Confidence 9966 99999999999994433 35567999999999999999999999999999999999999998875 5999
Q ss_pred ecCCcccc-cCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 000726 1195 DFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1195 DFGLAr~~-~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ 1273 (1329)
|||+++.. .....++++|||+.|||||++. ...|+.++|+|||||+|||||.|+.||.+.+.+++...|+.....
T Consensus 511 DFGlcKe~m~~g~~TsTfCGTpey~aPEil~--e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~-- 586 (694)
T KOG0694|consen 511 DFGLCKEGMGQGDRTSTFCGTPEFLAPEVLT--EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR-- 586 (694)
T ss_pred ccccccccCCCCCccccccCChhhcChhhhc--cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC--
Confidence 99999953 3555778899999999999999 456899999999999999999999999999999999999887654
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHH
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLR 1308 (1329)
Q Consensus 1274 ips~~S~eL~DLIkrCLqkDPeERPT-----aeELLq~Le 1308 (1329)
.|.+++.+...+|+++|.++|++|.. +.+|..|..
T Consensus 587 yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpF 626 (694)
T KOG0694|consen 587 YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPF 626 (694)
T ss_pred CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCc
Confidence 46689999999999999999999964 567766653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.92 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=206.5
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
+.|+.+.++|+|+||+||+|++ +|+-||||.|.. .+++....+-.+||+.+|++|+|+|+|.++.+|...
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~E------sedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-- 73 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVE------SEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-- 73 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeecc------CCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc--
Confidence 4577788999999999999998 488899999974 233455566678999999999999999999999874
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
+.++||+|||+ .++.+.+.....-++...+.++++|++.|+.|||++++|||||||+||||+.+|. +||||||+|
T Consensus 74 rklhLVFE~~d-hTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv----vKLCDFGFA 148 (396)
T KOG0593|consen 74 RKLHLVFEYCD-HTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV----VKLCDFGFA 148 (396)
T ss_pred ceeEEEeeecc-hHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc----EEeccchhh
Confidence 48999999994 6666667666667899999999999999999999999999999999999998774 599999999
Q ss_pred cccc-CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh-----------
Q 000726 1200 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN----------- 1267 (1329)
Q Consensus 1200 r~~~-~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve----------- 1267 (1329)
+... +....+....|.+|.|||.+.| ...|+..+||||+||++.||++|.+.|++...-+.+..|..
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvG-DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVG-DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcc-cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 9765 4445556678999999999997 45688999999999999999999999998766544332221
Q ss_pred ---c-----CCCCCCC----------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1268 ---N-----TLRPPVP----------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1268 ---~-----~lr~~ip----------s~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
. +.+.+.+ ..++.-+.+|++.||+.||.+|++-++++.|-
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 1 1112211 12456688999999999999999999998764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=367.57 Aligned_cols=259 Identities=29% Similarity=0.369 Sum_probs=218.7
Q ss_pred ccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQ 1115 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~ 1115 (1329)
+..++|.++++||.|+||.||+|+- .+..||||.+|+...+ ..+. .-+||+..|++|+ |||||++.+++.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s----~ee~---~nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS----WEEC---MNLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc----HHHH---HHHHHHHHHHhcCCCCcchhhHHHhh
Confidence 3457899999999999999999987 4788999999876533 2222 2368999999998 999999999998
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
+... .+++||||| ..+|.+++..+.+.+++..+..|+.||++||+|+|++|+.||||||+||||... ..+||+|
T Consensus 80 d~~~-~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~----~~iKiaD 153 (538)
T KOG0661|consen 80 DNDR-ILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN----DVIKIAD 153 (538)
T ss_pred ccCc-eEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc----ceeEecc
Confidence 8643 899999999 699999999999999999999999999999999999999999999999999853 3579999
Q ss_pred cCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-------
Q 000726 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN------- 1268 (1329)
Q Consensus 1196 FGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~------- 1268 (1329)
||+|+........+....|.+|.|||++.. .+.|+.++||||+||+++|+.+-++.|++....+.+.+|+.-
T Consensus 154 FGLARev~SkpPYTeYVSTRWYRAPEvLLr-s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~ 232 (538)
T KOG0661|consen 154 FGLAREVRSKPPYTEYVSTRWYRAPEVLLR-SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKD 232 (538)
T ss_pred cccccccccCCCcchhhhcccccchHHhhh-ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccc
Confidence 999998777666677789999999999985 566899999999999999999999999998776655544321
Q ss_pred ------------CCCCC---------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1269 ------------TLRPP---------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1269 ------------~lr~~---------ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
+++.+ +...++.++.++|.+|++.||.+|||+.+++++..-..
T Consensus 233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 01111 11236888999999999999999999999999876543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=352.23 Aligned_cols=259 Identities=33% Similarity=0.511 Sum_probs=210.7
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCcee
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVV 1108 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~k-------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIV 1108 (1329)
+.+..++|++.+.||+|+||.||+|++. +..||||+++.... ......+.+|+.+|+.+ +||||+
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~Ei~il~~l~~HpnIv 102 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-------LTEREALMSELKVLSYLGNHINIV 102 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-------cHHHHHHHHHHHHHHHhcCCccee
Confidence 3556778999999999999999999752 45799999874321 11235678899999999 899999
Q ss_pred eEecccccCCCCeEEEEEEeccCCchhhhhhccc----------------------------------------------
Q 000726 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------------------------------- 1142 (1329)
Q Consensus 1109 KL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------------------------------------------- 1142 (1329)
+++++|.... ..++|||||++|+|.+++....
T Consensus 103 ~l~~~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 180 (375)
T cd05104 103 NLLGACTVGG--PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVP 180 (375)
T ss_pred eeeeeeccCC--cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccc
Confidence 9999998855 7899999999999998885421
Q ss_pred ----------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1143 ----------------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1143 ----------------------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~----~~kl~ 256 (375)
T cd05104 181 TKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR----ITKIC 256 (375)
T ss_pred cccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC----cEEEe
Confidence 2478888999999999999999999999999999999998654 46999
Q ss_pred ecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC
Q 000726 1195 DFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1270 (1329)
Q Consensus 1195 DFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~l 1270 (1329)
|||++....... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||............+....
T Consensus 257 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~ 334 (375)
T cd05104 257 DFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY 334 (375)
T ss_pred cCccceeccCcccccccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc
Confidence 999997543221 1122335667999999984 457889999999999999998 8999987765555555556555
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1271 r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
+...+...+.++.+|+.+||+.||++||++.+|++.|+..
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 5556667789999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=334.99 Aligned_cols=255 Identities=25% Similarity=0.320 Sum_probs=200.1
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++.+.||+|+||.||+|++ +++.||||+++..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-------GTPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-------ccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 46799999999999999999998 4788999998753211 11234678999999999999999999998755
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+ .++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 77 --~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~----~kl~Dfg~ 149 (303)
T cd07869 77 --TLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE----LKLADFGL 149 (303)
T ss_pred --eEEEEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC----EEECCCCc
Confidence 899999999 57888887666667899999999999999999999999999999999999997664 59999999
Q ss_pred cccccC-cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHh---cCC---
Q 000726 1199 SKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVN---NTL--- 1270 (1329)
Q Consensus 1199 Ar~~~~-~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~-ell~qIve---~~l--- 1270 (1329)
+..... ........+++.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+.. ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 150 ARAKSVPSHTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228 (303)
T ss_pred ceeccCCCccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence 874322 2222345688999999998742 34688999999999999999999999875432 22211111 000
Q ss_pred ---------------CCCCC---------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1271 ---------------RPPVP---------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1271 ---------------r~~ip---------s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
....+ ...+..+.+|+.+||+.||.+|||+.++++|.+-.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~ 292 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence 00000 11346788999999999999999999999988753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=352.28 Aligned_cols=261 Identities=31% Similarity=0.508 Sum_probs=213.1
Q ss_pred cccccccCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCce
Q 000726 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNV 1107 (1329)
Q Consensus 1036 l~iI~~edYellkvLGqGaFGtVYKA~~k-------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNI 1107 (1329)
.+.+..++|++.+.||+|+||.||+|.+. +..||||+++.... ......+.+|+.+++.+ +|+||
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l~~h~nI 104 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-------TDEREALMSELKILSHLGQHKNI 104 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-------HHHHHHHHHHHHHHHhhccCCce
Confidence 34566778999999999999999999863 24699999975321 11235678999999999 89999
Q ss_pred eeEecccccCCCCeEEEEEEeccCCchhhhhhccc---------------------------------------------
Q 000726 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE--------------------------------------------- 1142 (1329)
Q Consensus 1108 VKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke--------------------------------------------- 1142 (1329)
|+++++|.... .+++|||||++++|.+++....
T Consensus 105 v~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (374)
T cd05106 105 VNLLGACTHGG--PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV 182 (374)
T ss_pred eeEeeEecCCC--CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence 99999998754 8999999999999998875321
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1143 ------------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1143 ------------------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~----~~kL~DfGl 258 (374)
T cd05106 183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR----VAKICDFGL 258 (374)
T ss_pred ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC----eEEEeecee
Confidence 2478888999999999999999999999999999999998654 469999999
Q ss_pred cccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCC
Q 000726 1199 SKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1199 Ar~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~i 1274 (1329)
++...... ......++..|+|||++. ...++.++|||||||++|+|++ |+.||.....................
T Consensus 259 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 336 (374)
T cd05106 259 ARDIMNDSNYVVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR 336 (374)
T ss_pred eeeccCCcceeeccCCCCccceeCHHHhc--CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC
Confidence 97543221 112233566799999997 4457889999999999999997 99999877665555555666666666
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1275 ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
+..+++++.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 7778999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=336.95 Aligned_cols=260 Identities=30% Similarity=0.577 Sum_probs=213.6
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC--Cc----eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k--Gr----~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
++...+|++.+.||+|+||.||+|++. +. .||||+++... ......++.+|+.+++.++||||++++
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~ 75 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRLL 75 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 456678999999999999999999873 33 38999886421 122345688899999999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
++|... ..++|+||+++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +
T Consensus 76 g~~~~~---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~----~ 148 (316)
T cd05108 76 GICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH----V 148 (316)
T ss_pred EEEcCC---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc----E
Confidence 998764 467999999999999999776667899999999999999999999999999999999999987653 6
Q ss_pred EEeecCCcccccCccc---ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 000726 1192 KVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~~~---ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve 1267 (1329)
||+|||+++....... .....++..|+|||++. ...++.++|||||||++|||++ |..||........ ..++.
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~ 225 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILE 225 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhc--cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHh
Confidence 9999999985432221 12233467899999997 4567899999999999999998 9999987665443 34455
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 000726 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 1314 (1329)
Q Consensus 1268 ~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~ 1314 (1329)
.....+.+..++..+.+++.+||+.+|.+||++.+++..|..+....
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 55566666778899999999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=322.46 Aligned_cols=249 Identities=36% Similarity=0.632 Sum_probs=205.9
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC-CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
.++|++.+.||+|+||.||++.++ +..+|+|.++..... ...+.+|+.+|+.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQK- 72 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---------HHHHHHHHHHHHHCCCCCceeEEEEEccCC-
Confidence 467899999999999999999985 457999987643211 245788999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|.+++......+++..++.++.|++.||+|||++||+|+||||+||+++.++ .+||+|||++
T Consensus 73 -~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~----~~kl~d~g~~ 147 (256)
T cd05114 73 -PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG----VVKVSDFGMT 147 (256)
T ss_pred -CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC----eEEECCCCCc
Confidence 79999999999999998865555689999999999999999999999999999999999998665 4699999998
Q ss_pred ccccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 000726 1200 KIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1200 r~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips 1276 (1329)
....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |+.||...........+... .....+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~ 224 (256)
T cd05114 148 RYVLDDEYTSSSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-FRLYRPK 224 (256)
T ss_pred cccCCCceeccCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCCCC
Confidence 7543221 1122335668999999974 457889999999999999999 99999887766666655443 3344456
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
..+..+.+++.+||+.+|.+||++.++++.|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 6788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=328.80 Aligned_cols=254 Identities=37% Similarity=0.620 Sum_probs=208.8
Q ss_pred cccCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEec
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~kG-------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~G 1112 (1329)
..++|++.+.||+|+||.||+|.+.+ ..||+|.++... .......|.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 75 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-------EPKVQQEFRQEAELMSDLQHPNIVCLLG 75 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-------CHHHHHHHHHHHHHHHhcCCcccceEEE
Confidence 34678889999999999999998743 459999886431 1223456889999999999999999999
Q ss_pred ccccCCCCeEEEEEEeccCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCc
Q 000726 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCD 1177 (1329)
Q Consensus 1113 if~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPe 1177 (1329)
++.... ..+++|||+++++|.+++.... ..+++..++.++.||+.||+|||+++|+|+||||+
T Consensus 76 ~~~~~~--~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05048 76 VCTKEQ--PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAAR 153 (283)
T ss_pred EEcCCC--ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccc
Confidence 988744 7899999999999999885431 45788899999999999999999999999999999
Q ss_pred ceEeccCCCCCCcEEEeecCCcccccCc---ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCC
Q 000726 1178 NLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1253 (1329)
Q Consensus 1178 NILLDsdGni~~~VKLsDFGLAr~~~~~---~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF 1253 (1329)
|||++.++ .++|+|||++...... .......+++.|+|||.+. ...++.++|||||||++|||++ |..||
T Consensus 154 Nil~~~~~----~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDv~slG~il~el~~~g~~p~ 227 (283)
T cd05048 154 NCLVGEGL----TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEIFSYGLQPY 227 (283)
T ss_pred eEEEcCCC----cEEECCCcceeeccccccccccCCCcccccccCHHHhc--cCcCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 99999765 4699999998743221 1222344678899999987 3457899999999999999998 99999
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1254 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1254 ~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
......+....+.. ......+..++..+.+|+.+||+.+|.+||++.+|+++|+.
T Consensus 228 ~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 228 YGFSNQEVIEMIRS-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCHHHHHHHHHc-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 88777666655443 33445667889999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.44 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=207.7
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||+|++. ++.||||+++..... .......+.+|+.+|+.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-----EKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN- 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-
Confidence 46899999999999999999984 788999999753211 1233456778999999999999999999998855
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~----~kl~Dfg~~ 148 (364)
T cd05599 75 -YLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH----IKLSDFGLC 148 (364)
T ss_pred -eEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC----EEEeecccc
Confidence 899999999999999988654 46899999999999999999999999999999999999997764 599999998
Q ss_pred ccccCcc---------------------------------------cccCCCCCCcccCccccccCCCCCChhhHHHHHH
Q 000726 1200 KIKRNTL---------------------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFG 1240 (1329)
Q Consensus 1200 r~~~~~~---------------------------------------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLG 1240 (1329)
....... ......||+.|+|||++. ...++.++||||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG 226 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL--QTGYNKECDWWSLG 226 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc--CCCCCCeeeeecch
Confidence 6432110 011245899999999997 44578899999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhcCCCCCCCC---HHHHHHHHHH
Q 000726 1241 IVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP--GFCDSEWRLLMEQCWAPDPVVRPS---FTEIARRLRV 1309 (1329)
Q Consensus 1241 VLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ip--s~~S~eL~DLIkrCLqkDPeERPT---aeELLq~Le~ 1309 (1329)
|++|||++|..||...........+.........+ ..+++.+.++|.+|+. +|.+|++ +.+++.+.+.
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~ 299 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence 99999999999998887766666665443333333 3468999999999996 8999987 9999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=336.50 Aligned_cols=257 Identities=25% Similarity=0.322 Sum_probs=199.5
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC--
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP-- 1118 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~-- 1118 (1329)
+|++.+.||+|+||.||+|.++ +..||||+++..... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc------chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 5889999999999999999874 788999998743211 112346789999999999999999999875432
Q ss_pred -CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1119 -GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1119 -dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
...+++||||| +++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 75 ~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~----~kL~Dfg 148 (338)
T cd07859 75 EFKDIYVVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK----LKICDFG 148 (338)
T ss_pred CCceEEEEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc----EEEccCc
Confidence 13589999999 5788887754 346899999999999999999999999999999999999997664 6999999
Q ss_pred CcccccCc----ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh------
Q 000726 1198 LSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN------ 1267 (1329)
Q Consensus 1198 LAr~~~~~----~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve------ 1267 (1329)
+++..... .......||+.|+|||++.+....++.++|||||||++|+|++|+.||...........+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99743221 11234568999999999875445678899999999999999999999976543222111100
Q ss_pred --------------------cCCCCCC---CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1268 --------------------NTLRPPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1268 --------------------~~lr~~i---ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
....... -..+++.+.+++.+||+.||.+|||+.+++++.+-..
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 0000000 1235678899999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=323.64 Aligned_cols=255 Identities=36% Similarity=0.626 Sum_probs=211.5
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC-----CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k-----Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif 1114 (1329)
..++|++.+.||+|+||.||+|.+. ...||||+++... .......|.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-------SDKQRLDFLTEASIMGQFDHPNIIRLEGVV 74 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-------ChHHHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence 3567899999999999999999984 2369999886432 122345688999999999999999999998
Q ss_pred ccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
.... ..++||||+++++|.+++......+++..++.++.|++.||+|||+++|+|+||||+|||++.++ .++|+
T Consensus 75 ~~~~--~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~----~~~l~ 148 (266)
T cd05033 75 TKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL----VCKVS 148 (266)
T ss_pred ecCC--ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC----CEEEC
Confidence 7754 78999999999999999876666789999999999999999999999999999999999999765 46999
Q ss_pred ecCCcccccC---cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC
Q 000726 1195 DFGLSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1270 (1329)
Q Consensus 1195 DFGLAr~~~~---~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~l 1270 (1329)
|||++..... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+. ...
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~ 225 (266)
T cd05033 149 DFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGY 225 (266)
T ss_pred ccchhhcccccccceeccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCC
Confidence 9999986531 111112234678999999873 457889999999999999998 999998777666655544 334
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1271 r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
..+.+..++..+.+++.+||+.+|.+||++.+|+++|..+
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 4556677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=338.02 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=206.9
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
+..++|++.+.||+|+||.||++++. +..||+|+++... .......+.+|+++|+.++||||+++++++..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 34578999999999999999999985 6779999987531 12334578899999999999999999999987
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~-GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
.. .+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~----~kl~D 147 (331)
T cd06649 75 DG--EISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE----IKLCD 147 (331)
T ss_pred CC--EEEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc----EEEcc
Confidence 54 89999999999999998854 34589999999999999999999986 6999999999999997764 69999
Q ss_pred cCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHH----------
Q 000726 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI---------- 1265 (1329)
Q Consensus 1196 FGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qI---------- 1265 (1329)
||++...... ......|++.|+|||++.+ ..++.++|||||||+||||++|+.||......+....+
T Consensus 148 fg~~~~~~~~-~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224 (331)
T ss_pred Cccccccccc-ccccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccC
Confidence 9998754332 2234568999999999984 45788999999999999999999999765443322111
Q ss_pred ------------------------------------HhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1266 ------------------------------------VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1266 ------------------------------------ve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
............++.++.+||.+||+.||++|||+.+|+++.|.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 01100111112467889999999999999999999999999986
Q ss_pred HHH
Q 000726 1310 MSA 1312 (1329)
Q Consensus 1310 L~a 1312 (1329)
...
T Consensus 305 ~~~ 307 (331)
T cd06649 305 KRS 307 (331)
T ss_pred hhc
Confidence 543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=349.15 Aligned_cols=255 Identities=29% Similarity=0.439 Sum_probs=212.9
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEECC---ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecc
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRG---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~kG---r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gi 1113 (1329)
..+..++|++.+.||+|+||.||+|.+++ ..||||++...... .......+.+|+.+++.++||||++++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 34567789999999999999999998742 56999999753211 12234567889999999999999999999
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
+.+.. .+++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 100 ~~~~~--~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~----ikL 172 (340)
T PTZ00426 100 FKDES--YLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF----IKM 172 (340)
T ss_pred EEeCC--EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC----EEE
Confidence 98854 89999999999999998854 346899999999999999999999999999999999999987664 599
Q ss_pred eecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ 1273 (1329)
+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+..... .
T Consensus 173 ~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--~ 246 (340)
T PTZ00426 173 TDFGFAKVVDTR--TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--Y 246 (340)
T ss_pred ecCCCCeecCCC--cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--C
Confidence 999999865432 234569999999999984 4468899999999999999999999988776666666655433 3
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHHH
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLRV 1309 (1329)
Q Consensus 1274 ips~~S~eL~DLIkrCLqkDPeERP-----TaeELLq~Le~ 1309 (1329)
++..++..+.++|++||+.+|.+|+ +++++++|.|-
T Consensus 247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 4567789999999999999999995 89999998764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=343.81 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=204.5
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEE
Q 000726 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LV 1125 (1329)
+.||+|+||.||++++ .+..||+|+++..... .+.....+.+|+.+++.++||||++++++|.... .+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--EEEEE
Confidence 3699999999999987 4788999999864321 2233456778999999999999999999998754 89999
Q ss_pred EEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc-cC
Q 000726 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RN 1204 (1329)
Q Consensus 1126 MEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~-~~ 1204 (1329)
|||+++++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++... ..
T Consensus 74 ~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~----~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 74 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH----IKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC----EEecccHHhccccCC
Confidence 999999999888754 346899999999999999999999999999999999999997664 599999998743 22
Q ss_pred cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHH
Q 000726 1205 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 1284 (1329)
Q Consensus 1205 ~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~D 1284 (1329)
........||+.|+|||++.+ ..++.++|||||||+||+|++|+.||...........+..... .++..+++.+.+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~ 224 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFPRTLSPEAKS 224 (323)
T ss_pred CCccccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence 222334569999999999974 4578899999999999999999999988777666666554433 345678999999
Q ss_pred HHHHhhcCCCCCCC-----CHHHHHHHHHH
Q 000726 1285 LMEQCWAPDPVVRP-----SFTEIARRLRV 1309 (1329)
Q Consensus 1285 LIkrCLqkDPeERP-----TaeELLq~Le~ 1309 (1329)
+|.+||+.||.+|| ++.+++++.|.
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~h~~~ 254 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHcCCCc
Confidence 99999999999998 89999987644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.38 Aligned_cols=252 Identities=24% Similarity=0.271 Sum_probs=198.6
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||+++++ ++.||||+++..... +.....+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN------EEVKETTLRELKMLRTLKQENIVELKEAFRRRG- 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc------ccchhhHHHHHHHHHhCCCccccchhhhEecCC-
Confidence 36899999999999999999985 677999999754221 222356778999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||++++.+..+. .....+++..++.++.||+.||.|||+.+|+||||||+|||++.++. +||+|||++
T Consensus 74 -~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~----~kl~Dfg~~ 147 (287)
T cd07848 74 -KLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV----LKLCDFGFA 147 (287)
T ss_pred -EEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc----EEEeeccCc
Confidence 899999999877665443 34456899999999999999999999999999999999999997664 699999999
Q ss_pred ccccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc---------
Q 000726 1200 KIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--------- 1268 (1329)
Q Consensus 1200 r~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~--------- 1268 (1329)
....... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred ccccccccccccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 8543221 2223468999999999974 44788999999999999999999999876543332221110
Q ss_pred ----------CCCCC-----------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1269 ----------TLRPP-----------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1269 ----------~lr~~-----------ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
....+ ....++..+.+||++||+.||++|||+.++++|.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 00000 01135778999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.48 Aligned_cols=254 Identities=27% Similarity=0.344 Sum_probs=198.6
Q ss_pred cCeeEEEEecccCcEEEEEEEEC---CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc---CCCceeeEecccc
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k---Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L---rHPNIVKL~Gif~ 1115 (1329)
.+|++.+.||+|+||.||+|++. ++.||||+++....... ....+.+|+.+++.+ .||||++++++|.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------MPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC------chHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 36889999999999999999873 56799999876432211 123345666666665 6999999999875
Q ss_pred c---CCCCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1116 D---GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1116 e---~~dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
. .....+++||||+. ++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~----~ 149 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ----I 149 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC----E
Confidence 2 12346899999995 6888888543 345899999999999999999999999999999999999997664 6
Q ss_pred EEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC
Q 000726 1192 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1271 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr 1271 (1329)
||+|||++.............||+.|+|||++.+ ..++.++|||||||++|||++|++||......+.+..+......
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~ 227 (290)
T cd07862 150 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227 (290)
T ss_pred EEccccceEeccCCcccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 9999999986554444445668999999999974 45788999999999999999999999887665555444321100
Q ss_pred C-------------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1272 P-------------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1272 ~-------------------------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
+ .....++..+.+++.+||+.||++|||+.++++|.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~ 289 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence 0 011235778899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=362.08 Aligned_cols=260 Identities=28% Similarity=0.374 Sum_probs=219.4
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.+..++|+++++||+|+||.||+|+. +|..+|+|++++..+.. .....-++.|..+|....+|+||++|-.|+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~-----~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK-----KNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh-----hhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 45778999999999999999999987 58889999999865432 233455778999999999999999999999
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
+.. ++||||||++||++..+|... ..|++..+..++.+++.||..||+.|+|||||||+|+|||..|++ ||+|
T Consensus 212 D~~--~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHi----KLSD 284 (550)
T KOG0605|consen 212 DKE--YLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHI----KLSD 284 (550)
T ss_pred CCC--eeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCE----eecc
Confidence 966 999999999999999998654 568999999999999999999999999999999999999988755 9999
Q ss_pred cCCcccccC-----------------------ccc-------------------------ccCCCCCCcccCccccccCC
Q 000726 1196 FGLSKIKRN-----------------------TLV-------------------------TGGVRGTLPWMAPELLNGSS 1227 (1329)
Q Consensus 1196 FGLAr~~~~-----------------------~~~-------------------------ss~~~GTp~YmAPEvL~Gs~ 1227 (1329)
|||+..... ... .....|||.|||||++.+.
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k- 363 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK- 363 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-
Confidence 999852100 000 0023499999999999954
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC--CCCCCCcHHHHHHHHHhhcCCCCCCC---CHHH
Q 000726 1228 SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--PVPGFCDSEWRLLMEQCWAPDPVVRP---SFTE 1302 (1329)
Q Consensus 1228 ~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~--~ips~~S~eL~DLIkrCLqkDPeERP---TaeE 1302 (1329)
.|+..+|+|||||||||||.|.+||...+..+.+..++...... +....++++..+||.+||. ||++|. .++|
T Consensus 364 -gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 364 -GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred -CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 47888999999999999999999999999999999988876433 3445578999999999999 999995 6999
Q ss_pred HHHHHHHHHH
Q 000726 1303 IARRLRVMSA 1312 (1329)
Q Consensus 1303 LLq~Le~L~a 1312 (1329)
|.+|.+--..
T Consensus 442 IK~HPfF~~v 451 (550)
T KOG0605|consen 442 IKKHPFFKGV 451 (550)
T ss_pred HhcCCccccC
Confidence 9988876543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=367.07 Aligned_cols=263 Identities=35% Similarity=0.575 Sum_probs=221.0
Q ss_pred ccccccccCeeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Q 000726 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1329)
Q Consensus 1035 ~l~iI~~edYellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif 1114 (1329)
..|.|..+++.+...||+|.||+||+|.|.| +||||++.....+ .+ ..+.|+.|+.+|++-+|.||+-+.|+|
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt-----~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPT-----PE-QLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCC-----HH-HHHHHHHHHHHHhhcchhhheeeehhh
Confidence 5678889999999999999999999999976 6899999865322 22 568899999999999999999999999
Q ss_pred ccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
.... ++||+.||+|.+|+.+++..+..++..+.+.|++||++||.|||.++|||||||..||++..++ .|||+
T Consensus 458 ~~p~---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~----kVkIg 530 (678)
T KOG0193|consen 458 MNPP---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL----KVKIG 530 (678)
T ss_pred cCCc---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC----cEEEe
Confidence 9865 4999999999999999998888999999999999999999999999999999999999999664 56999
Q ss_pred ecCCcccccC---cccccCCCCCCcccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC
Q 000726 1195 DFGLSKIKRN---TLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1270 (1329)
Q Consensus 1195 DFGLAr~~~~---~~~ss~~~GTp~YmAPEvL~G-s~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l 1270 (1329)
|||++..... ........|...|||||+++. ....|+..+|||||||++|||++|..||.....+.++. ++..++
T Consensus 531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif-mVGrG~ 609 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-MVGRGY 609 (678)
T ss_pred cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE-Eecccc
Confidence 9999985322 222233457888999999963 34568999999999999999999999999444444433 344443
Q ss_pred CC-C---CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1271 RP-P---VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1271 r~-~---ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
.. . ....++.++++|+..||..++++||.|.+|+..|+.+..
T Consensus 610 l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 610 LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 22 2 234678899999999999999999999999998887765
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=329.97 Aligned_cols=247 Identities=38% Similarity=0.672 Sum_probs=201.8
Q ss_pred eEEEEecccCcEEEEEEEEC------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1045 EELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1045 ellkvLGqGaFGtVYKA~~k------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.+.+.||.|.||.||+|.++ +..|+||+++... .......|.+|++.+++++||||+++++++....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-------SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-------SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-------ccccceeeeecccccccccccccccccccccccc
Confidence 46789999999999999997 5679999995421 2223567889999999999999999999999544
Q ss_pred CCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
..++||||+++++|.+++... ...+++..++.|+.||+.||+|||+++|+|++|++.|||++.++ .+||+|||
T Consensus 75 --~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~----~~Kl~~f~ 148 (259)
T PF07714_consen 75 --PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG----QVKLSDFG 148 (259)
T ss_dssp --SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT----EEEEESTT
T ss_pred --cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----cccccccc
Confidence 689999999999999999776 56799999999999999999999999999999999999999765 56999999
Q ss_pred CcccccC---cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCC
Q 000726 1198 LSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1198 LAr~~~~---~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ 1273 (1329)
++..... ............|+|||.+.+ ..++.++||||||+++|||++ |+.||...........+ ....+.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~ 225 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLP 225 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETT
T ss_pred ccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc-cccccce
Confidence 9986521 112233446778999999984 347999999999999999999 78999888777766666 5555566
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1274 ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
.+..++..+.++|.+||..+|.+||++.+|++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 7778999999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=339.40 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=203.4
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHH---HhcCCCceeeEecccccCC
Q 000726 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL---SKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeIL---k~LrHPNIVKL~Gif~e~~ 1118 (1329)
|++.+.||+|+||.||++.++ ++.||||++++.... .......+.+|+.++ +.++||||+++++++....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-----ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 678899999999999999884 778999999864321 112234455565554 5668999999999998755
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
.+++||||+++++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 76 --~~~lv~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~----~kL~Dfg~ 147 (324)
T cd05589 76 --HVCFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF----VKIADFGL 147 (324)
T ss_pred --EEEEEEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc----EEeCcccC
Confidence 8999999999999988874 346899999999999999999999999999999999999997764 59999999
Q ss_pred ccccc-CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 000726 1199 SKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277 (1329)
Q Consensus 1199 Ar~~~-~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~ 1277 (1329)
+.... .........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..... ..+..
T Consensus 148 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--~~p~~ 223 (324)
T cd05589 148 CKEGMGFGDRTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV--RYPRF 223 (324)
T ss_pred CccCCCCCCcccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCC
Confidence 87432 2222345679999999999984 4578899999999999999999999998877777666655433 34567
Q ss_pred CcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 1308 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERP-----TaeELLq~Le 1308 (1329)
++..+.++|.+||+.||.+|| ++.+++++.+
T Consensus 224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~ 259 (324)
T cd05589 224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259 (324)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence 899999999999999999999 6888888764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=339.32 Aligned_cols=244 Identities=27% Similarity=0.384 Sum_probs=203.2
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEE
Q 000726 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1329)
Q Consensus 1050 LGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVME 1127 (1329)
||+|+||.||++.+. ++.||||+++..... .......+.+|+.+|+.++||||+++++++.... .+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-----SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE--KLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--eEEEEEc
Confidence 799999999999984 678999999753211 2223456788999999999999999999998754 8999999
Q ss_pred eccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc-Ccc
Q 000726 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTL 1206 (1329)
Q Consensus 1128 Ym~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~-~~~ 1206 (1329)
|+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++... ...
T Consensus 74 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~----~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 74 FINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH----IALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc----EEEEECcccccCccCCC
Confidence 9999999998864 346899999999999999999999999999999999999997764 6999999987432 222
Q ss_pred cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 000726 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLM 1286 (1329)
Q Consensus 1207 ~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLI 1286 (1329)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... ..++..+++.+.+++
T Consensus 149 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 224 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--LRFPDGFDRDAKDLL 224 (312)
T ss_pred ccccccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--CCCCCcCCHHHHHHH
Confidence 3344679999999999984 457889999999999999999999998877777666665543 345567889999999
Q ss_pred HHhhcCCCCCCC---CHHHHHHHHHH
Q 000726 1287 EQCWAPDPVVRP---SFTEIARRLRV 1309 (1329)
Q Consensus 1287 krCLqkDPeERP---TaeELLq~Le~ 1309 (1329)
.+||+.||.+|| ++.+++.|.+.
T Consensus 225 ~~~L~~dp~~R~~~~~~~e~l~hp~~ 250 (312)
T cd05585 225 IGLLSRDPTRRLGYNGAQEIKNHPFF 250 (312)
T ss_pred HHHcCCCHHHcCCCCCHHHHHcCCCc
Confidence 999999999997 57888887653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=321.54 Aligned_cols=254 Identities=33% Similarity=0.575 Sum_probs=210.1
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC-CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
.+..++|++.++||+|+||.||+|.+. +..||+|.++.... ....+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---------SVQAFLEEANLMKTLQHDKLVRLYAVVTK 72 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---------hHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 466789999999999999999999874 56799998764211 13567889999999999999999999877
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
.. ..++||||+++++|.+++... ...+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|+|
T Consensus 73 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~----~~~l~d 146 (261)
T cd05072 73 EE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL----MCKIAD 146 (261)
T ss_pred CC--CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC----cEEECC
Confidence 54 789999999999999988653 35688899999999999999999999999999999999999765 469999
Q ss_pred cCCcccccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC
Q 000726 1196 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1196 FGLAr~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~ 1272 (1329)
||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+. .....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~ 223 (261)
T cd05072 147 FGLARVIEDNEYTAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRM 223 (261)
T ss_pred CccceecCCCceeccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 99998654322 1122345678999999874 457889999999999999998 999998776666555543 33444
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
+....++..+.+++.+||..+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 5556788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=344.25 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=204.1
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||+||++.+. ++.||||++++... ........+.+|+.++..++|+||+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~- 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-----LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL- 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 47899999999999999999884 77899999975321 12233456778999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++|||||++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~----~vkL~DFGla 148 (363)
T cd05628 75 -NLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG----HVKLSDFGLC 148 (363)
T ss_pred -eEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC----CEEEeeccCc
Confidence 899999999999999998653 5689999999999999999999999999999999999999766 4699999998
Q ss_pred ccccCcc------------------------------------cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHH
Q 000726 1200 KIKRNTL------------------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVL 1243 (1329)
Q Consensus 1200 r~~~~~~------------------------------------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLL 1243 (1329)
+...... .....+||+.|+|||++.+ ..++.++|||||||+|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil 226 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIM 226 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHH
Confidence 7432110 0123569999999999984 4578899999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhcC--CCCCCCCHHHHHHHHH
Q 000726 1244 WEILTGEEPYANMHYGAIIGGIVNNTLRPPVP--GFCDSEWRLLMEQCWAP--DPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1244 yELLTGk~PF~~~~~~ell~qIve~~lr~~ip--s~~S~eL~DLIkrCLqk--DPeERPTaeELLq~Le 1308 (1329)
|||++|+.||...........+........++ ..+++.+.++|.+|+.. ++..||++.+|++|.+
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~ 295 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPF 295 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCC
Confidence 99999999998877777776666533222233 34688999999986542 3334689999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=343.79 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=202.6
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
..++|+.++.||+|+||.||++++. ++.||||++.... .+.....+.+|+.+++.++|+||+++++++...
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-------EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-------cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 3467888899999999999999984 7889999986431 223345788999999999999999999999875
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
. .+++||||+++++|.... ...+..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 145 ~--~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~----~kL~DfG 213 (353)
T PLN00034 145 G--EIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN----VKIADFG 213 (353)
T ss_pred C--eEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC----EEEcccc
Confidence 4 899999999999986543 3567778899999999999999999999999999999997664 6999999
Q ss_pred CcccccCcc-cccCCCCCCcccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHH--HHHhcCCC
Q 000726 1198 LSKIKRNTL-VTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG--GIVNNTLR 1271 (1329)
Q Consensus 1198 LAr~~~~~~-~ss~~~GTp~YmAPEvL~Gs---~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~--qIve~~lr 1271 (1329)
++....... ......||..|+|||++... ....+.++|||||||+||||++|+.||.......... ........
T Consensus 214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 293 (353)
T PLN00034 214 VSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP 293 (353)
T ss_pred cceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC
Confidence 998543321 22345689999999998531 2234568999999999999999999997433222111 11122233
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1272 ~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
...+..++.++.+||.+||+.||++|||+.++++|.|....
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 44556788999999999999999999999999999887654
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.19 Aligned_cols=246 Identities=27% Similarity=0.377 Sum_probs=204.1
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEE
Q 000726 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LV 1125 (1329)
+.||+|+||.||++++ +++.||||+++..... .+.....+.+|+.+++.++||||+++++++.... .+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 73 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-----AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD--RLCFV 73 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--EEEEE
Confidence 3699999999999987 4788999999864321 2233456788999999999999999999998754 89999
Q ss_pred EEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc-C
Q 000726 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-N 1204 (1329)
Q Consensus 1126 MEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~-~ 1204 (1329)
|||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++... .
T Consensus 74 ~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~----~kL~DfG~~~~~~~~ 148 (328)
T cd05593 74 MEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH----IKITDFGLCKEGITD 148 (328)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc----EEEecCcCCccCCCc
Confidence 999999999888754 356899999999999999999999999999999999999997664 5999999987532 2
Q ss_pred cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHH
Q 000726 1205 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 1284 (1329)
Q Consensus 1205 ~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~D 1284 (1329)
........||+.|+|||++.+ ..++.++|||||||+||+|++|+.||...........+.... ..++..++.++.+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~ 224 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKS 224 (328)
T ss_pred ccccccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--ccCCCCCCHHHHH
Confidence 222334569999999999984 457889999999999999999999998877666655544332 3456678999999
Q ss_pred HHHHhhcCCCCCCC-----CHHHHHHHHHH
Q 000726 1285 LMEQCWAPDPVVRP-----SFTEIARRLRV 1309 (1329)
Q Consensus 1285 LIkrCLqkDPeERP-----TaeELLq~Le~ 1309 (1329)
||.+||+.||.+|+ ++.+++++.|.
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 254 (328)
T cd05593 225 LLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254 (328)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence 99999999999997 89999988653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=364.63 Aligned_cols=250 Identities=28% Similarity=0.451 Sum_probs=214.4
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
..|...++||+|+.|.||.+.. ++..||||.+....-.. ..-++.|+.+|+..+|+|||.+++-|...+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--------keLilnEi~Vm~~~~H~NiVnfl~Sylv~d- 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--------KELLLNEILVMRDLHHPNIVNFLDSYLVGD- 343 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--------hhhhHHHHHHHHhccchHHHHHHHHhcccc-
Confidence 4577778999999999999987 46779999997654321 134678999999999999999999887754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+|.|||||++|+|.+.+. ...+++.++..|+++++.||+|||.+||+|||||.+|||++.+|. +||+|||++
T Consensus 344 -eLWVVMEym~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~----vKltDFGFc 416 (550)
T KOG0578|consen 344 -ELWVVMEYMEGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS----VKLTDFGFC 416 (550)
T ss_pred -eeEEEEeecCCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc----EEEeeeeee
Confidence 8999999999999999884 345899999999999999999999999999999999999998886 599999999
Q ss_pred ccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC-CCCCCCCC
Q 000726 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPPVPGF 1277 (1329)
Q Consensus 1200 r~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~-lr~~ips~ 1277 (1329)
..+.... ......||++|||||++. ...|+.++||||||++++||+-|++||-.......+..+..++ .....+..
T Consensus 417 aqi~~~~~KR~TmVGTPYWMAPEVvt--rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~k 494 (550)
T KOG0578|consen 417 AQISEEQSKRSTMVGTPYWMAPEVVT--RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEK 494 (550)
T ss_pred eccccccCccccccCCCCccchhhhh--hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccc
Confidence 8655433 445677999999999998 5668999999999999999999999998766666655555443 34556778
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
+++.|++|+.+||+.|+.+|+++.|||+|...
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 99999999999999999999999999999876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=368.28 Aligned_cols=255 Identities=28% Similarity=0.398 Sum_probs=225.8
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
.-|++.+-||.|+-|.|-+|++ +|+.+|||++.+.... .+.....+.+|+.+|+.+.|||++++|++|++..
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-----s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~- 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-----SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ- 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccccc-----ccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-
Confidence 3478889999999999999998 6999999999876321 1223356779999999999999999999999865
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+|+|.||+++|.|.+++..++ ++++..+.+++.||+.|+.|||..+||||||||+|+|+|..++ +||+|||+|
T Consensus 86 -~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n----IKIADFGMA 159 (786)
T KOG0588|consen 86 -HLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN----IKIADFGMA 159 (786)
T ss_pred -eEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC----Eeeecccee
Confidence 9999999999999999997654 5888889999999999999999999999999999999998775 499999999
Q ss_pred ccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCc
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S 1279 (1329)
....+.....+-||++.|+|||++.|..|+ +.++||||.|||||.||+|+.||++.....++.++....+. +|..++
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYd-G~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~--MPs~Is 236 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYD-GRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE--MPSNIS 236 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCC-CCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc--CCCcCC
Confidence 987777777788999999999999987665 77899999999999999999999988888888887766654 458899
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1280 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.+.++||.+||..||+.|.|+++|++|+|-..
T Consensus 237 ~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 237 SEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred HHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 99999999999999999999999999998753
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.25 Aligned_cols=255 Identities=35% Similarity=0.617 Sum_probs=211.1
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.+...+|++.+.||+|+||.||+|.++ ++.||+|+++... .....+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---------hHHHHHHHHHHHHHhCCCCChhheEEEEc
Confidence 355678999999999999999999884 7789999986421 11346788999999999999999999988
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
... .+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||++.++ .+||+
T Consensus 73 ~~~--~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~----~~kl~ 146 (263)
T cd05052 73 REP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVA 146 (263)
T ss_pred CCC--CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC----cEEeC
Confidence 754 7899999999999999886533 4589999999999999999999999999999999999998765 46999
Q ss_pred ecCCcccccCcccc--cCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCC
Q 000726 1195 DFGLSKIKRNTLVT--GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1271 (1329)
Q Consensus 1195 DFGLAr~~~~~~~s--s~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr 1271 (1329)
|||++......... ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||...........+ .....
T Consensus 147 df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~ 223 (263)
T cd05052 147 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKGYR 223 (263)
T ss_pred CCccccccccceeeccCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCC
Confidence 99999865432211 12234567999999873 457889999999999999998 99999877665554443 44455
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1272 ~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
...+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 666778899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.06 Aligned_cols=254 Identities=35% Similarity=0.609 Sum_probs=210.3
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC-CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
.+..++|++.+.||+|++|.||+|.+. ++.||||.++.... ....+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---------DPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---------cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence 355678999999999999999999874 56799999875321 12457889999999999999999999887
Q ss_pred CCCCeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
.. ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+|||++.++. ++|+|
T Consensus 73 ~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----~~l~d 146 (261)
T cd05068 73 EE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI----CKVAD 146 (261)
T ss_pred CC--CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC----EEECC
Confidence 54 7899999999999999986543 56899999999999999999999999999999999999997764 59999
Q ss_pred cCCcccccCccc--ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC
Q 000726 1196 FGLSKIKRNTLV--TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1196 FGLAr~~~~~~~--ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~ 1272 (1329)
||++........ ......+..|+|||++.+ ..++.++|||||||++|+|++ |+.||...........+. .....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~ 223 (261)
T cd05068 147 FGLARVIKEDIYEAREGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRM 223 (261)
T ss_pred cceEEEccCCcccccCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 999985542211 112223457999999873 457889999999999999999 999998877666665543 33445
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
+.+..++..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 5666788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=342.15 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=220.8
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
...++|+.++.||.|+||.|.+++.+ |..+|+|++++...- ..........|..+|+.+.||+++++++.|.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV-----klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV-----KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH-----HHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 44578889999999999999999884 778999999875322 23344556789999999999999999999988
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.. .+++||||++||.|..+++.. +++++..+..++.||+.||+|||+++|++|||||+|||+|.+|.+ ||+||
T Consensus 116 ~~--~lymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~i----KitDF 188 (355)
T KOG0616|consen 116 NS--NLYMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHI----KITDF 188 (355)
T ss_pred CC--eEEEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcE----EEEec
Confidence 55 999999999999999999644 568999999999999999999999999999999999999988865 99999
Q ss_pred CCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 000726 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1197 GLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips 1276 (1329)
|+|+..... +.+.||||.|+|||++. ...+..++|+|||||++|||+.|.+||.......+.+.|+...+. +|.
T Consensus 189 GFAK~v~~r--T~TlCGTPeYLAPEii~--sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--fP~ 262 (355)
T KOG0616|consen 189 GFAKRVSGR--TWTLCGTPEYLAPEIIQ--SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--FPS 262 (355)
T ss_pred cceEEecCc--EEEecCCccccChHHhh--cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--CCc
Confidence 999876554 45689999999999999 566788999999999999999999999999999999999987654 567
Q ss_pred CCcHHHHHHHHHhhcCCCCCC-----CCHHHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVR-----PSFTEIARRLRVM 1310 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeER-----PTaeELLq~Le~L 1310 (1329)
..+..+++|++.+|+.|-.+| ....+|..|.|.-
T Consensus 263 ~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~ 301 (355)
T KOG0616|consen 263 YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFK 301 (355)
T ss_pred ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccc
Confidence 889999999999999999999 3556777777654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=376.27 Aligned_cols=267 Identities=37% Similarity=0.604 Sum_probs=230.8
Q ss_pred cccccccccCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCc
Q 000726 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 1106 (1329)
Q Consensus 1034 s~l~iI~~edYellkvLGqGaFGtVYKA~~k-------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPN 1106 (1329)
..+..++..+..+.+.||+|+||+||+|+.. ..-||||.+|.. ....+..+|.||+++|..++|||
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-------a~~~~~~dF~REaeLla~l~H~n 550 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-------AENQARQDFRREAELLAELQHPN 550 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-------ccHHHHHHHHHHHHHHHhccCCC
Confidence 3456788899999999999999999999874 234999999853 23345688999999999999999
Q ss_pred eeeEecccccCCCCeEEEEEEeccCCchhhhhhccc-------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Q 000726 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFD 1173 (1329)
Q Consensus 1107 IVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke-------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRD 1173 (1329)
||+|+|+|.+++ .+++|+|||..|+|.++|.... .+++..+.+.||.|||.||.||-++.++|||
T Consensus 551 IVrLlGVC~~~~--P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRD 628 (774)
T KOG1026|consen 551 IVRLLGVCREGD--PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRD 628 (774)
T ss_pred eEEEEEEEccCC--eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccc
Confidence 999999999966 8999999999999999996432 2388899999999999999999999999999
Q ss_pred CCCcceEeccCCCCCCcEEEeecCCccc-ccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-C
Q 000726 1174 LKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-G 1249 (1329)
Q Consensus 1174 LKPeNILLDsdGni~~~VKLsDFGLAr~-~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-G 1249 (1329)
|-..|+||.+ ...|||+|||+++. +..+. ......-..+|||||.+. .++|+.++|||||||+|||+++ |
T Consensus 629 LATRNCLVge----~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl--y~kFTteSDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 629 LATRNCLVGE----NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL--YGKFTTESDVWSFGVVLWEIFSYG 702 (774)
T ss_pred hhhhhceecc----ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh--cCcccchhhhhhhhhhhhhhhccc
Confidence 9999999984 46789999999984 32221 111223467899999998 7789999999999999999999 9
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcc
Q 000726 1250 EEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 1316 (1329)
Q Consensus 1250 k~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q~ 1316 (1329)
+.||.+..+.+++..+..... .+.|..||.++++||..||+.+|.+||+|.||-..|+.+..+...
T Consensus 703 ~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 703 KQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred cCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 999999999999998887777 899999999999999999999999999999999999998766543
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.68 Aligned_cols=255 Identities=30% Similarity=0.460 Sum_probs=211.2
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
+.|.+.+.||+|++|.||++.. .++.||||.++..... .........+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS---PETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc---hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-
Confidence 4578889999999999999987 4788999998754321 112233467889999999999999999999998865
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++
T Consensus 78 -~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~----~~l~dfg~~ 151 (263)
T cd06625 78 -TLSIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN----VKLGDFGAS 151 (263)
T ss_pred -eEEEEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC----EEEeecccc
Confidence 89999999999999988854 346889999999999999999999999999999999999997664 699999998
Q ss_pred ccccCcccc----cCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 000726 1200 KIKRNTLVT----GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275 (1329)
Q Consensus 1200 r~~~~~~~s----s~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ip 1275 (1329)
......... ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.........+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229 (263)
T ss_pred eeccccccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC
Confidence 754322111 23457889999999985 347889999999999999999999998766655555555555566677
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1276 s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
..++..+.++|.+||..+|.+|||+.+++++.+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred ccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 788999999999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=345.94 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=203.8
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
.|++++.||+|+||+||+|++. ++.||||+++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-----NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--
Confidence 5889999999999999999884 678999999754221 2233456889999999999999999999998755
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++ .+||+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~----~~kL~DFGl~~ 149 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG----HIKLTDFGLCT 149 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC----CEEEeeCcCCc
Confidence 899999999999999988643 4588999999999999999999999999999999999999765 46999999975
Q ss_pred cccCc------------------------------------------------ccccCCCCCCcccCccccccCCCCCCh
Q 000726 1201 IKRNT------------------------------------------------LVTGGVRGTLPWMAPELLNGSSSKVSE 1232 (1329)
Q Consensus 1201 ~~~~~------------------------------------------------~~ss~~~GTp~YmAPEvL~Gs~~~~S~ 1232 (1329)
..... .......||+.|+|||++.+ ..++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~ 227 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQ 227 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCC
Confidence 32100 00123469999999999984 45788
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC--CCCCCCCCcHHHHHHHHHh--hcCCCCCCCCHHHHHHHHH
Q 000726 1233 KVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL--RPPVPGFCDSEWRLLMEQC--WAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1233 KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l--r~~ips~~S~eL~DLIkrC--LqkDPeERPTaeELLq~Le 1308 (1329)
++|||||||++|||++|..||...........+..... ..+....+++++.+||.+| +..++..||++.+++.|.+
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence 99999999999999999999988776655555554322 2233335789999999984 4556666999999999976
Q ss_pred H
Q 000726 1309 V 1309 (1329)
Q Consensus 1309 ~ 1309 (1329)
-
T Consensus 308 f 308 (381)
T cd05626 308 F 308 (381)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=353.40 Aligned_cols=255 Identities=35% Similarity=0.557 Sum_probs=199.9
Q ss_pred cCeeEEEEecccCcEEEEEEEECC-ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~kG-r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+.|...+.||+|+||.||+|...+ +.||||.+...... . .++|.+|+.+|.+++|||||+|+|||.+...
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~------~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ------G--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE- 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc------c--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence 566667789999999999999964 88999977643211 0 3459999999999999999999999998542
Q ss_pred eEEEEEEeccCCchhhhhhcccc-cCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAMDAAFGMEYLHSKN---IVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek-~Lse~qrlkIA~QIAsALaYLHs~G---IIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
..+||+|||++|+|.++++.... .++|..+++|+.++|+||+|||... |||||||++|||+|.+. .+||+||
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~----~aKlsDF 221 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF----NAKLSDF 221 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC----CEEccCc
Confidence 58999999999999999987766 8999999999999999999999854 99999999999999654 5699999
Q ss_pred CCcccccC-cccccCC-CCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---h---hHHHHHHHhc
Q 000726 1197 GLSKIKRN-TLVTGGV-RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---Y---GAIIGGIVNN 1268 (1329)
Q Consensus 1197 GLAr~~~~-~~~ss~~-~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~---~---~ell~qIve~ 1268 (1329)
|+|+.... ....... .||.+|+|||++. .+..+.|+||||||++|+||++|+.+.+... . .+.....+..
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~--~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYAS--TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhc--cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99976543 2222222 7999999999998 4678999999999999999999998887532 1 1111111111
Q ss_pred C-----CCCCCC-CCCc-----HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1269 T-----LRPPVP-GFCD-----SEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1269 ~-----lr~~ip-s~~S-----~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
. ..+.+. ..+. ..+..+..+|++.+|.+||++.+|++.|+.+.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 1 111111 2222 23556778999999999999999999885543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=361.03 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=214.2
Q ss_pred cccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
..+.|+.+++||+|+||.||+|++ +|+.||+|.++..... +.+.....||+.+|++|+||||++|.+++.+.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~------~~~~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK------EGFPITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC------CcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 345688889999999999999998 5788999999865332 33455677999999999999999999999987
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
..+.+|+|+||| ..+|..++...+-.|++.++..++.||+.||+|||.+||+|||||.+|||||.+|.. ||+|||
T Consensus 189 ~~~siYlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~L----KiaDFG 263 (560)
T KOG0600|consen 189 LSGSIYLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVL----KIADFG 263 (560)
T ss_pred CCceEEEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCE----Eecccc
Confidence 667999999999 689999988777889999999999999999999999999999999999999988754 999999
Q ss_pred CcccccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC----
Q 000726 1198 LSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR---- 1271 (1329)
Q Consensus 1198 LAr~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr---- 1271 (1329)
+|+++.... ..+...-|.+|.|||++.|. ..|+.++|+||.||||.||++|++.|.+.+.-+.+..|.+-.-.
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 999765433 34455679999999999984 56899999999999999999999999998877666655432100
Q ss_pred ----CCCC-------------------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1272 ----PPVP-------------------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1272 ----~~ip-------------------s~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
..+| ...+....+|+..+|..||.+|.|+.++|..-
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE 401 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence 0011 12467788999999999999999999987654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=346.46 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=204.9
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++++.||+|+||.||++.+ +++.||||++.+... ........+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~- 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-----FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ- 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 4688999999999999999988 478899999875321 12233456788999999999999999999998755
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~----~kl~DfGla 148 (377)
T cd05629 75 -YLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH----IKLSDFGLS 148 (377)
T ss_pred -eeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC----EEEeecccc
Confidence 89999999999999998864 356889999999999999999999999999999999999997664 699999998
Q ss_pred ccccCcc------------------------------------------------cccCCCCCCcccCccccccCCCCCC
Q 000726 1200 KIKRNTL------------------------------------------------VTGGVRGTLPWMAPELLNGSSSKVS 1231 (1329)
Q Consensus 1200 r~~~~~~------------------------------------------------~ss~~~GTp~YmAPEvL~Gs~~~~S 1231 (1329)
+...... ......||+.|+|||++.+ ..++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~ 226 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCC
Confidence 6321100 0012468999999999974 4578
Q ss_pred hhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhcCCCCCC---CCHHHHHHH
Q 000726 1232 EKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG--FCDSEWRLLMEQCWAPDPVVR---PSFTEIARR 1306 (1329)
Q Consensus 1232 ~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips--~~S~eL~DLIkrCLqkDPeER---PTaeELLq~ 1306 (1329)
.++|||||||+||||++|..||...........+.........+. .++.++.+||.+||. +|.+| +++.+++.+
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 899999999999999999999988776666666554333333333 478999999999997 66665 699999999
Q ss_pred HHH
Q 000726 1307 LRV 1309 (1329)
Q Consensus 1307 Le~ 1309 (1329)
.+.
T Consensus 306 p~~ 308 (377)
T cd05629 306 PFF 308 (377)
T ss_pred CCc
Confidence 764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=329.75 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=206.6
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
.|++.+.||+|+||.||++.+ +++.||||++...... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-----hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--
Confidence 378889999999999999987 4788999999753221 1222345678999999999999999999998755
Q ss_pred eEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|..++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG----HIRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC----CEEEeeCCCc
Confidence 8999999999999998875433 4689999999999999999999999999999999999999765 4699999998
Q ss_pred ccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh--cCCCCCCCCC
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN--NTLRPPVPGF 1277 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve--~~lr~~ips~ 1277 (1329)
.............|+..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.. .......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05605 150 VEIPEGETIRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227 (285)
T ss_pred eecCCCCccccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcc
Confidence 86543333344568999999999973 4578899999999999999999999987654332222211 1122334556
Q ss_pred CcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLRVM 1310 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERP-----TaeELLq~Le~L 1310 (1329)
++..+.+|+.+||+.||.+|| ++.+++.+.|..
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence 789999999999999999999 899999986665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=341.82 Aligned_cols=262 Identities=30% Similarity=0.506 Sum_probs=211.6
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCcee
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVV 1108 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~k-------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIV 1108 (1329)
|.+..++|++.+.||+|+||.||+|.+. ++.||||+++.... ......+.+|+.++.++ +|+||+
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~E~~~~~~l~~h~niv 74 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-------ASEYKALMTELKILIHIGHHLNVV 74 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-------HHHHHHHHHHHHHHHhhccCcchh
Confidence 4567789999999999999999999753 35799999864321 12235677899999999 899999
Q ss_pred eEecccccCCCCeEEEEEEeccCCchhhhhhccc----------------------------------------------
Q 000726 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------------------------------- 1142 (1329)
Q Consensus 1109 KL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------------------------------------------- 1142 (1329)
+++++|... ...++++|||+++++|.+++....
T Consensus 75 ~~~~~~~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (337)
T cd05054 75 NLLGACTKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL 153 (337)
T ss_pred heeeeEecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence 999988653 347889999999999998875321
Q ss_pred --------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCc---
Q 000726 1143 --------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT--- 1205 (1329)
Q Consensus 1143 --------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~--- 1205 (1329)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||++......
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~----~vkL~DfG~a~~~~~~~~~ 229 (337)
T cd05054 154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDY 229 (337)
T ss_pred hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC----cEEEeccccchhcccCcch
Confidence 2578999999999999999999999999999999999999765 4699999999854221
Q ss_pred ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHH
Q 000726 1206 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 1284 (1329)
Q Consensus 1206 ~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~D 1284 (1329)
.......++..|+|||++. ...++.++|||||||+||||++ |..||......+.+...+....+...+..+++.+.+
T Consensus 230 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 230 VRKGDARLPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYS 307 (337)
T ss_pred hhccCCCCCccccCcHHhc--CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHH
Confidence 1122334567899999997 4567889999999999999998 999998755444444445555555566678899999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1285 LMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1285 LIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
++.+||+.+|++||++.+|+++|..+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=363.10 Aligned_cols=250 Identities=30% Similarity=0.486 Sum_probs=217.7
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|.+.+.||+|+||.||||+.+ .+.||+|.+.+... .+...+.+.+|+++++.++|||||.++++|++..
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr------~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~- 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR------NEKELKNLRQEVRILRSLKHPNIVEMLESFETSA- 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC------chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-
Confidence 56778889999999999999885 56799999976432 2344567889999999999999999999999866
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++|+||+.| +|..++. .+..++++.+..|+.+++.||.|||+++|+|||+||.|||++..|. +||||||+|
T Consensus 75 -~~~vVte~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~----~KlcdFg~A 147 (808)
T KOG0597|consen 75 -HLWVVTEYAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT----LKLCDFGLA 147 (808)
T ss_pred -eEEEEehhhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc----eeechhhhh
Confidence 89999999965 9999885 4567999999999999999999999999999999999999997764 599999999
Q ss_pred cccc-CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1200 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 r~~~-~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
+... +........|||.|||||++. .+.|+..+|+|||||++|||++|++||-.....++...|..+...++. ..
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~--e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~--~~ 223 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVE--EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS--TA 223 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHc--CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc--cc
Confidence 9543 445566788999999999999 456888999999999999999999999887777778888777665543 67
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
+..+..|+..+|.+||.+|.+..+++.|..-
T Consensus 224 S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~ 254 (808)
T KOG0597|consen 224 SSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW 254 (808)
T ss_pred cHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence 8999999999999999999999999988654
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=354.03 Aligned_cols=256 Identities=22% Similarity=0.247 Sum_probs=201.3
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.....+|++.+.||+|+||.||+|.+ .++.||||++.... ....+|+.+|+.++|||||++++++.
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~ 129 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYY 129 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEe
Confidence 34456899999999999999999988 47789999885421 12346999999999999999988764
Q ss_pred cC------CCCeEEEEEEeccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCC
Q 000726 1116 DG------PGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 1186 (1329)
Q Consensus 1116 e~------~dg~L~LVMEYm~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGn 1186 (1329)
.. ...++++||||++ ++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 130 ~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~ 208 (440)
T PTZ00036 130 TECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH 208 (440)
T ss_pred ecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC
Confidence 32 1235779999996 567666532 3456899999999999999999999999999999999999986542
Q ss_pred CCCcEEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 000726 1187 IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1266 (1329)
Q Consensus 1187 i~~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIv 1266 (1329)
.+||+|||+++............||+.|+|||++.+ ...++.++|||||||+||||++|.+||.+....+.+..++
T Consensus 209 ---~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 209 ---TLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG-ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred ---ceeeeccccchhccCCCCcccCCCCcCccCHHHhcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 479999999986544333344568999999999875 2357889999999999999999999998766544433332
Q ss_pred hcC---------------------------CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1267 NNT---------------------------LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1267 e~~---------------------------lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
... +...++...+.++.+||.+||+.||.+|||+.+++.|.+-.
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 210 00112345678999999999999999999999999998864
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.89 Aligned_cols=258 Identities=31% Similarity=0.581 Sum_probs=210.2
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE--CCc----eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~--kGr----~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
.+...+|++.+.||+|+||+||+|++ +++ .||||+++... .......+.+|+.+++.+.||||++++
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-------SPKANKEILDEAYVMAGVGSPYVCRLL 75 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-------CHHHHHHHHHHHHHHHhcCCCCCceEE
Confidence 45677899999999999999999987 343 48999886432 122345688899999999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
+++... ..+++|||+++++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++. +
T Consensus 76 ~~~~~~---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~----~ 148 (279)
T cd05109 76 GICLTS---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH----V 148 (279)
T ss_pred EEEcCC---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc----E
Confidence 998753 467899999999999999766667899999999999999999999999999999999999986653 6
Q ss_pred EEeecCCcccccCccc---ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 000726 1192 KVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~~~---ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve 1267 (1329)
||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.......... .+.
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~ 225 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLE 225 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHH
Confidence 9999999985432211 112234678999999973 457889999999999999998 999998765554443 344
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1268 ~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
.....+.+..++..+.+++.+||+.||++||++.+++..|..+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 444455566789999999999999999999999999999877644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.13 Aligned_cols=257 Identities=23% Similarity=0.392 Sum_probs=206.3
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||+|++ +++.||||.++..... .......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-----DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN- 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-----CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-
Confidence 5789999999999999999987 5788999988653221 1233456888999999999999999999988754
Q ss_pred CeEEEEEEeccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1120 GTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
..++||||+++++|..++.. ....+++..++.++.||+.||+|||+++++|+||||+|||++.++. ++|+||
T Consensus 76 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~----~~l~d~ 150 (267)
T cd08228 76 -ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV----VKLGDL 150 (267)
T ss_pred -eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC----EEECcc
Confidence 88999999999999887743 2345789999999999999999999999999999999999987654 699999
Q ss_pred CCcccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHhcCCCCC
Q 000726 1197 GLSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--GAIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1197 GLAr~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~--~ell~qIve~~lr~~ 1273 (1329)
|++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... ......+........
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL 228 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC
Confidence 9987543322 2223458889999999974 4468899999999999999999999965432 233333222222222
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1274 ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
....++..+.+++.+||+.+|.+||++.++++.|+.++
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 23457788999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.09 Aligned_cols=256 Identities=22% Similarity=0.284 Sum_probs=210.5
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||++.+ .++.||||+++..... .......+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~- 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPWIPQLQYAFQDKD- 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence 3688999999999999999988 4788999999864221 2233456788999999999999999999988754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++.++. +||+|||++
T Consensus 75 -~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~----~kL~Dfg~a 149 (330)
T cd05601 75 -NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH----IKLADFGSA 149 (330)
T ss_pred -eEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC----EEeccCCCC
Confidence 899999999999999999766567999999999999999999999999999999999999997664 599999999
Q ss_pred ccccCcc--cccCCCCCCcccCccccccC----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC-
Q 000726 1200 KIKRNTL--VTGGVRGTLPWMAPELLNGS----SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP- 1272 (1329)
Q Consensus 1200 r~~~~~~--~ss~~~GTp~YmAPEvL~Gs----~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~- 1272 (1329)
....... ......||+.|+|||++... ...++.++|||||||++|+|++|+.||...........+.......
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 229 (330)
T cd05601 150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229 (330)
T ss_pred eECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC
Confidence 7543222 22234689999999998632 2346789999999999999999999998877766666655433222
Q ss_pred -CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1273 -PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1273 -~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
+....++..+.+|+.+||+ +|.+|||+.+++.|.+-
T Consensus 230 ~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~ 266 (330)
T cd05601 230 FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF 266 (330)
T ss_pred CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence 2233578999999999998 99999999999988764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=347.35 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=212.1
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
+..++|++.+.||+|+||.||++++. ++.||||++++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 45678999999999999999999884 778999999753211 11223446789999999999999999999887
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.. .+++||||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 115 ~~--~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~----~kL~Df 186 (370)
T cd05596 115 DK--YLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH----LKLADF 186 (370)
T ss_pred CC--EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC----EEEEec
Confidence 55 89999999999999998853 35788889999999999999999999999999999999997764 699999
Q ss_pred CCcccccCcc--cccCCCCCCcccCccccccCC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC
Q 000726 1197 GLSKIKRNTL--VTGGVRGTLPWMAPELLNGSS--SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1197 GLAr~~~~~~--~ss~~~GTp~YmAPEvL~Gs~--~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~ 1272 (1329)
|++....... ......||+.|+|||++.+.. ..++.++|||||||+||||++|+.||...........+.......
T Consensus 187 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05596 187 GTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred cceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC
Confidence 9997543221 223457999999999987432 347889999999999999999999999887776666666544333
Q ss_pred CCCC--CCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHHHH
Q 000726 1273 PVPG--FCDSEWRLLMEQCWAPDPVV--RPSFTEIARRLRV 1309 (1329)
Q Consensus 1273 ~ips--~~S~eL~DLIkrCLqkDPeE--RPTaeELLq~Le~ 1309 (1329)
..+. .++..+.++|.+||+.+|.+ |+++.+++.|.+.
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~ 307 (370)
T cd05596 267 TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307 (370)
T ss_pred CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence 3333 57899999999999999987 9999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=338.14 Aligned_cols=252 Identities=26% Similarity=0.412 Sum_probs=202.9
Q ss_pred CeeEEEEecccCcEEEEEEEE-----CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEeccccc
Q 000726 1043 DLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~-----kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e 1116 (1329)
+|++.+.||+|+||.||+++. +++.||+|++++.... ........+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV----QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh----hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 488999999999999999876 3678999999754221 1122345677899999999 59999999999887
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.. .+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 77 ~~--~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~----~kl~Df 149 (332)
T cd05614 77 EA--KLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH----VVLTDF 149 (332)
T ss_pred CC--EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC----EEEeeC
Confidence 54 899999999999999988643 46899999999999999999999999999999999999997764 699999
Q ss_pred CCcccccC--cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHhcCC
Q 000726 1197 GLSKIKRN--TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTL 1270 (1329)
Q Consensus 1197 GLAr~~~~--~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~----~ell~qIve~~l 1270 (1329)
|+++.... ........||+.|+|||++.+ ...++.++|||||||+||||++|..||..... ......+. ..
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~ 226 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KC 226 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcC-CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cC
Confidence 99875322 222234569999999999974 23467889999999999999999999964322 22222222 23
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 1308 (1329)
Q Consensus 1271 r~~ips~~S~eL~DLIkrCLqkDPeERP-----TaeELLq~Le 1308 (1329)
...++..++..+.+++.+||+.||.+|| ++++++++.|
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 3455667899999999999999999999 8889998875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.04 Aligned_cols=250 Identities=31% Similarity=0.500 Sum_probs=208.7
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||+|++|.||++.+ +++.|++|.+...... ......+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN------RREREEAIDEARVLAKLDSSYIIRYYESFLDKG-- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC------HHHHHHHHHHHHHHHhcCCCCeehheeeeccCC--
Confidence 478889999999999999988 4788999998753221 233457889999999999999999999998754
Q ss_pred eEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|.+++... ...+++..++.++.+++.||.|||++||+|+||||+||+++.++. ++|+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~----~~l~df~~~ 148 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN----VKIGDLGVA 148 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC----EEEcccccc
Confidence 899999999999999998664 457899999999999999999999999999999999999997654 599999998
Q ss_pred ccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 r~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
...... .......+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...........+... ....++..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG-VFPPVSQMY 225 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCcccc
Confidence 854332 22234468889999999984 45788999999999999999999999887765555554443 344455678
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
+..+.+++.+||+.+|++||++.+++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 254 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence 89999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.10 Aligned_cols=255 Identities=34% Similarity=0.559 Sum_probs=206.2
Q ss_pred cccccCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeE
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 1110 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~kG-------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL 1110 (1329)
.+..++|++.+.||+|+||.||+|.+++ ..||||+++... ......++.+|+.+++.++||||+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~iv~~ 74 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 3556789999999999999999998743 469999875321 11223568899999999999999999
Q ss_pred ecccccCCCCeEEEEEEeccCCchhhhhhccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe
Q 000726 1111 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 1181 (1329)
Q Consensus 1111 ~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILL 1181 (1329)
++++.... ..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+|||+
T Consensus 75 ~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~ 152 (277)
T cd05062 75 LGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 152 (277)
T ss_pred EEEEcCCC--CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE
Confidence 99987754 7899999999999999885422 235778899999999999999999999999999999999
Q ss_pred ccCCCCCCcEEEeecCCcccccCccc---ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCC
Q 000726 1182 NLKDPIRPICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1257 (1329)
Q Consensus 1182 DsdGni~~~VKLsDFGLAr~~~~~~~---ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~ 1257 (1329)
+.++ .++|+|||++........ .....++..|+|||++.+ ..++.++|||||||++|||++ |..||....
T Consensus 153 ~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 153 AEDF----TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred cCCC----CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9765 469999999874322111 112235678999999973 457889999999999999999 789998877
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1258 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1258 ~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.......+.... ....+..++..+.+++.+||+.+|.+|||+.+++++|+
T Consensus 227 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 227 NEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 766665554433 34456678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.96 Aligned_cols=251 Identities=36% Similarity=0.616 Sum_probs=206.7
Q ss_pred cccCeeEEEEecccCcEEEEEEEECCc-eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~kGr-~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
..++|++.+.||+|+||.||++.+.+. .+|||.++..... ...+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---------HHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 356799999999999999999998654 5999988643211 245788999999999999999999987754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+.+++|.+++......+++..++.++.||+.||+|||++|++|+||||.|||++.++ .+||+|||.
T Consensus 73 --~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~----~~kl~d~g~ 146 (256)
T cd05113 73 --PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG----CVKVSDFGL 146 (256)
T ss_pred --CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC----CEEECCCcc
Confidence 78999999999999999866555789999999999999999999999999999999999998665 469999999
Q ss_pred cccccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCC
Q 000726 1199 SKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 1275 (1329)
Q Consensus 1199 Ar~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ip 1275 (1329)
+....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+.. ..+...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 223 (256)
T cd05113 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRP 223 (256)
T ss_pred ceecCCCceeecCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-CCCCCCC
Confidence 87443221 1122335678999999974 447889999999999999998 9999987776655555443 3444455
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1276 s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
...+..+.+++.+||+.+|.+||++.+|+..|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 667899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=337.67 Aligned_cols=246 Identities=28% Similarity=0.414 Sum_probs=203.3
Q ss_pred EEecccCcEEEEEEEE-----CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeE
Q 000726 1048 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~-----kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L 1122 (1329)
+.||+|+||.||+++. .++.||||+++..... ........+.+|+.+|+.++||||+++++++.... .+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV----RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG--KL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH----hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC--eE
Confidence 5799999999999976 3677999999754221 11222345678999999999999999999998754 89
Q ss_pred EEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 000726 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
++||||+.+++|.+++.. ...+.+..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~----~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH----VKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC----EEEeeCcCCeec
Confidence 999999999999998854 345788889999999999999999999999999999999997764 699999998742
Q ss_pred -cCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHH
Q 000726 1203 -RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 1281 (1329)
Q Consensus 1203 -~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~e 1281 (1329)
..........||+.|+|||++.+ ..++.++|||||||+||||++|+.||...........+.... ..++..+++.
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~ 226 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--LNLPPYLTPE 226 (323)
T ss_pred ccCCCcccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHH
Confidence 22222334569999999999984 446789999999999999999999998877766666665443 3456678999
Q ss_pred HHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 000726 1282 WRLLMEQCWAPDPVVRP-----SFTEIARRLR 1308 (1329)
Q Consensus 1282 L~DLIkrCLqkDPeERP-----TaeELLq~Le 1308 (1329)
+.++|.+||+.+|.+|| ++.+++.+.+
T Consensus 227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred HHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 99999999999999999 8999999865
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=335.23 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=205.2
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCC-ceeeEecccccCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP-NVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHP-NIVKL~Gif~e~~d 1119 (1329)
+|++++.||+|+||.||+|+++ ++.||||++++.... .......+..|..++..+.|+ +|+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-----QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD- 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-
Confidence 5889999999999999999985 567999999864321 122345677899999999765 6888988887754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~----~kL~Dfg~~ 148 (324)
T cd05587 75 -RLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH----IKIADFGMC 148 (324)
T ss_pred -EEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC----EEEeecCcc
Confidence 899999999999999888543 46889999999999999999999999999999999999997764 699999998
Q ss_pred cccc-CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1200 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 r~~~-~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... ...+..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~~~~~ 224 (324)
T cd05587 149 KENIFGGKTTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSL 224 (324)
T ss_pred eecCCCCCceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCC
Confidence 7422 2222334568999999999984 456889999999999999999999999887777776665443 3456678
Q ss_pred cHHHHHHHHHhhcCCCCCCCCH-----HHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSF-----TEIARRLR 1308 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTa-----eELLq~Le 1308 (1329)
+..+.+++.+||..+|.+|++. .+++++.+
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~ 259 (324)
T cd05587 225 SKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAF 259 (324)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCC
Confidence 9999999999999999999976 78877743
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.62 Aligned_cols=249 Identities=36% Similarity=0.638 Sum_probs=205.4
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC-CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
..+|++.+.||+|+||.||++.+. +..+|||+++..... ...+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR- 72 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-
Confidence 456888999999999999999885 457999998643221 235778999999999999999999987754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~----~kl~dfg~~ 147 (256)
T cd05059 73 -PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV----VKVSDFGLA 147 (256)
T ss_pred -ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc----EEECCcccc
Confidence 889999999999999998765567899999999999999999999999999999999999997664 699999998
Q ss_pred ccccCccc--ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 000726 1200 KIKRNTLV--TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1200 r~~~~~~~--ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips 1276 (1329)
+....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+ ....+...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~ 224 (256)
T cd05059 148 RYVLDDQYTSSQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-SAGYRLYRPK 224 (256)
T ss_pred eecccccccccCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH-HcCCcCCCCC
Confidence 75432211 111223457999999984 457889999999999999999 89999877665555443 3444555666
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
.++..+.+++.+||+.+|.+|||+.++++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 7899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=345.16 Aligned_cols=253 Identities=22% Similarity=0.276 Sum_probs=204.6
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++++.||+|+||.||++++. ++.||||++.+.... .......+.+|+.+|+.++||||+++++.+.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-----MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD- 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 36899999999999999999884 778999998653211 1223456778999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++|||||++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~----~ikL~DFG~a 148 (376)
T cd05598 75 -NLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG----HIKLTDFGLC 148 (376)
T ss_pred -EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC----CEEEEeCCCC
Confidence 899999999999999998643 4688999999999999999999999999999999999999766 4699999997
Q ss_pred ccccCc--------------------------------------------ccccCCCCCCcccCccccccCCCCCChhhH
Q 000726 1200 KIKRNT--------------------------------------------LVTGGVRGTLPWMAPELLNGSSSKVSEKVD 1235 (1329)
Q Consensus 1200 r~~~~~--------------------------------------------~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSD 1235 (1329)
...... .......||+.|+|||++.+ ..++.++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 226 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCD 226 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCccee
Confidence 522100 00123469999999999984 45788999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHhhcCCCCCCC---CHHHHHHHHHH
Q 000726 1236 VFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPGFCDSEWRLLMEQCWAPDPVVRP---SFTEIARRLRV 1309 (1329)
Q Consensus 1236 VWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~--ips~~S~eL~DLIkrCLqkDPeERP---TaeELLq~Le~ 1309 (1329)
||||||+||||++|+.||......+....+........ ....++..+.++|.+|+ .+|.+|+ ++.+++.|.+.
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~ 304 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFF 304 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCc
Confidence 99999999999999999988776665555544332222 23457899999999976 5999999 99999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.58 Aligned_cols=252 Identities=36% Similarity=0.612 Sum_probs=208.6
Q ss_pred cccccCeeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
.+...+|++.+.||+|+||.||++..++..||+|.++... ....+.+|+.++++++|+|++++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 3556789999999999999999999999999999986421 134678899999999999999999976433
Q ss_pred CCCeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
....++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+||
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~----~kl~df 146 (256)
T cd05082 72 -KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV----AKVSDF 146 (256)
T ss_pred -CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc----EEecCC
Confidence 236899999999999999986543 34889999999999999999999999999999999999997764 599999
Q ss_pred CCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCC
Q 000726 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 1275 (1329)
Q Consensus 1197 GLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ip 1275 (1329)
|++....... ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...........+ ........+
T Consensus 147 g~~~~~~~~~--~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~ 221 (256)
T cd05082 147 GLTKEASSTQ--DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAP 221 (256)
T ss_pred ccceeccccC--CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hcCCCCCCC
Confidence 9987543222 22335668999999873 457889999999999999997 99999877665555443 333445566
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1276 s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
..+++.+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 6789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=325.62 Aligned_cols=259 Identities=35% Similarity=0.543 Sum_probs=208.8
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--Cc--eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccc
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr--~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~ 1115 (1329)
+++|++.+.||+|+||.||+|.++ +. .+++|.++... .......+.+|+.++.++ +||||+++++++.
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-------SENDHRDFAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-------CHHHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence 468999999999999999999874 32 47888876321 112235688899999999 7999999999987
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceE
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLL 1180 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~ke---------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNIL 1180 (1329)
... ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 74 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil 151 (297)
T cd05089 74 NRG--YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVL 151 (297)
T ss_pred cCC--cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEE
Confidence 754 7899999999999999985422 34888999999999999999999999999999999999
Q ss_pred eccCCCCCCcEEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChh
Q 000726 1181 VNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG 1259 (1329)
Q Consensus 1181 LDsdGni~~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ 1259 (1329)
++.++ .+||+|||++..............+..|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 152 l~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~ 225 (297)
T cd05089 152 VGENL----ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA 225 (297)
T ss_pred ECCCC----eEEECCcCCCccccceeccCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 98765 459999999864332212222223567999999873 457889999999999999997 99999887776
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1260 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1260 ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
.....+. .....+.+..++..+.+|+.+||+.+|.+||++.++++.|..+.....
T Consensus 226 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 226 ELYEKLP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 6655543 344555667789999999999999999999999999999988765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=321.23 Aligned_cols=257 Identities=32% Similarity=0.573 Sum_probs=207.7
Q ss_pred ccccCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~kG-------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
+..++|.+.+.||+|++|.||+|.+.+ ..||+|.+.... .......|.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------SEQDESDFLMEALIMSKFNHQNIVRLI 75 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 456789999999999999999999853 458888775321 122235688899999999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhccc------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCC
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 1185 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdG 1185 (1329)
+++.+.. ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++++|+||||+|||++.++
T Consensus 76 ~~~~~~~--~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 76 GVSFERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG 153 (277)
T ss_pred EEEccCC--CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC
Confidence 9887754 7789999999999999885542 2589999999999999999999999999999999999998765
Q ss_pred CCCCcEEEeecCCcccccCccc---ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 000726 1186 PIRPICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI 1261 (1329)
Q Consensus 1186 ni~~~VKLsDFGLAr~~~~~~~---ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~el 1261 (1329)
. ...+||+|||+++....... ......+..|+|||++. ...++.++|||||||++|+|++ |..||........
T Consensus 154 ~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~ 230 (277)
T cd05036 154 P-GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL--DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230 (277)
T ss_pred C-CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHh--cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 3 34689999999985432211 11222356799999997 4457899999999999999997 9999988766655
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1262 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1262 l~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
...+ ........+..++..+.+++.+||+.+|++||++.+|+++|.
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 MEFV-TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHH-HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 5443 333344556778899999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.32 Aligned_cols=254 Identities=34% Similarity=0.571 Sum_probs=206.1
Q ss_pred cccCeeEEEEecccCcEEEEEEEE------CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecc
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~------kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gi 1113 (1329)
..++|++.+.||+|+||+||+|.+ .+..||+|.++... .......+.+|+.+++.++||||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 75 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-------NPQQWGEFQQEASLMAELHHPNIVCLLGV 75 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCCeeeEEEE
Confidence 456789999999999999999985 24679999987421 11223567889999999999999999999
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhcc----------------cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCc
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSK----------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCD 1177 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~k----------------ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPe 1177 (1329)
+.... ..++||||+++++|.+++... ...+++.+++.++.||+.||+|||++||+|+||||+
T Consensus 76 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05090 76 VTQEQ--PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAAR 153 (283)
T ss_pred EecCC--ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccc
Confidence 88755 789999999999999988432 124788899999999999999999999999999999
Q ss_pred ceEeccCCCCCCcEEEeecCCcccccCc---ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCC
Q 000726 1178 NLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1253 (1329)
Q Consensus 1178 NILLDsdGni~~~VKLsDFGLAr~~~~~---~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF 1253 (1329)
|||++.++ .+||+|||+++..... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||
T Consensus 154 nili~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~ 227 (283)
T cd05090 154 NILIGEQL----HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPY 227 (283)
T ss_pred eEEEcCCC----cEEeccccccccccCCcceecccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 99999665 4699999999754221 12223345678999999974 457889999999999999998 99999
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1254 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1254 ~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
...........+ ......+.+..++..+.+++.+||+.+|.+||++.+|+++|..
T Consensus 228 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 228 YGFSNQEVIEMV-RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 876655544443 3334455667789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.79 Aligned_cols=253 Identities=34% Similarity=0.599 Sum_probs=211.2
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC-CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
...+|++.+.||.|+||.||+|.+. +..+|+|+++... ......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--------LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--------hhhHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence 3467888999999999999999985 5779999987532 112345778999999999999999999998755
Q ss_pred CCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++ .+||+|||
T Consensus 76 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~----~~kl~d~g 149 (261)
T cd05148 76 --PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL----VCKVADFG 149 (261)
T ss_pred --CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc----eEEEcccc
Confidence 789999999999999999653 35689999999999999999999999999999999999999765 46999999
Q ss_pred CcccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCC
Q 000726 1198 LSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 1275 (1329)
Q Consensus 1198 LAr~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ip 1275 (1329)
++....... ......++..|+|||.+. ...++.++|||||||++|+|++ |+.||......+....+. ...+.+.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 226 (261)
T cd05148 150 LARLIKEDVYLSSDKKIPYKWTAPEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCP 226 (261)
T ss_pred chhhcCCccccccCCCCceEecCHHHHc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCC
Confidence 997543221 112333567899999987 3457889999999999999998 899998877666665544 44556667
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1276 s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
..+++.+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 7889999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=354.61 Aligned_cols=268 Identities=28% Similarity=0.394 Sum_probs=224.1
Q ss_pred ccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChH------HHHHHHHHHHHHHHHHhcCCCceeeE
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSE------QERLTLEFWREAEILSKLHHPNVVAF 1110 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e------~E~~~keFlrEIeILk~LrHPNIVKL 1110 (1329)
....+|++.+.||+|.||+|-+|.. .++.||||++.+..+.....- ...-.....+|+.+|++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4457899999999999999999998 478899999976543221111 01123468899999999999999999
Q ss_pred ecccccCCCCeEEEEEEeccCCchhhhhhccccc-CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCC
Q 000726 1111 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1329)
Q Consensus 1111 ~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~-Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~ 1189 (1329)
+.+..+.....+|||+|||..|.+...- .... +++.++++++.+++.||+|||.+|||||||||+|+||+++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g---- 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG---- 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC----
Confidence 9999998888999999999888765432 3344 89999999999999999999999999999999999999876
Q ss_pred cEEEeecCCcccc------cCcccccCCCCCCcccCccccccC--CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH
Q 000726 1190 ICKVGDFGLSKIK------RNTLVTGGVRGTLPWMAPELLNGS--SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI 1261 (1329)
Q Consensus 1190 ~VKLsDFGLAr~~------~~~~~ss~~~GTp~YmAPEvL~Gs--~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~el 1261 (1329)
+|||+|||.+... ..........|||.|+|||.+.+. ....+.+.|||||||+||.|+.|+.||......+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 4699999998744 112222336699999999999752 23357789999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1262 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1262 l~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
...|+...+..+....+.+.+++||++||.+||+.|.+..+|..|+|....
T Consensus 328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 999999888776666788999999999999999999999999999998754
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.53 Aligned_cols=253 Identities=36% Similarity=0.595 Sum_probs=207.4
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEec
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k-------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~G 1112 (1329)
...+|.+.+.||+|+||.||+|.+. +..||||+++... .......+.+|+++|+.++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-------SNDARKDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-------CHHHHHHHHHHHHHHHhcCCCCchheee
Confidence 3567888899999999999999863 3569999987431 1223467889999999999999999999
Q ss_pred ccccCCCCeEEEEEEeccCCchhhhhhccc-------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcce
Q 000726 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE-------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 1179 (1329)
Q Consensus 1113 if~e~~dg~L~LVMEYm~GGSL~d~L~~ke-------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNI 1179 (1329)
++.... ..++||||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 76 ~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~ni 153 (280)
T cd05049 76 VCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNC 153 (280)
T ss_pred EEecCC--CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceE
Confidence 998854 8999999999999999986432 3478889999999999999999999999999999999
Q ss_pred EeccCCCCCCcEEEeecCCcccccCc---ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCC
Q 000726 1180 LVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYAN 1255 (1329)
Q Consensus 1180 LLDsdGni~~~VKLsDFGLAr~~~~~---~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~ 1255 (1329)
|++.++ .++|+|||++...... .......+++.|+|||++. ...++.++|||||||++|+|++ |..||..
T Consensus 154 li~~~~----~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 154 LVGYDL----VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred EEcCCC----eEEECCcccceecccCcceecCCCCcccceecChhhhc--cCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 999765 4699999998743221 1122334577899999998 4557889999999999999998 9999987
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1256 MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1256 ~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.........+... .....+..++..+.+++.+||+.||.+||++.++++.|.
T Consensus 228 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 228 LSNEEVIECITQG-RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 7766666555433 333445678899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=378.67 Aligned_cols=264 Identities=36% Similarity=0.637 Sum_probs=228.6
Q ss_pred cccccccCeeEEEEecccCcEEEEEEEEC---Cc----eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCcee
Q 000726 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR---GT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 1108 (1329)
Q Consensus 1036 l~iI~~edYellkvLGqGaFGtVYKA~~k---Gr----~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIV 1108 (1329)
++.+.++..++.+.||+|+||.||.|+.. +. .||||.++... .+....+|++|..+|++++|||||
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-------~~~~~~~Fl~Ea~~m~~f~HpNiv 758 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-------SEQEVSDFLKEALLMSKFDHPNIV 758 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCccee
Confidence 66788899999999999999999999984 33 38888887532 234457899999999999999999
Q ss_pred eEecccccCCCCeEEEEEEeccCCchhhhhhcc------cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec
Q 000726 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN 1182 (1329)
Q Consensus 1109 KL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~k------ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLD 1182 (1329)
+++|+|.+. +..+|++|||++|+|..+|+.. ...++....+.|+.+||+|+.||+++++|||||.+.|+|++
T Consensus 759 ~liGv~l~~--~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~ 836 (1025)
T KOG1095|consen 759 SLIGVCLDS--GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD 836 (1025)
T ss_pred eEEEeecCC--CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec
Confidence 999999883 4789999999999999999876 56799999999999999999999999999999999999999
Q ss_pred cCCCCCCcEEEeecCCcc-cccCcc-cccCC-CCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 000726 1183 LKDPIRPICKVGDFGLSK-IKRNTL-VTGGV-RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHY 1258 (1329)
Q Consensus 1183 sdGni~~~VKLsDFGLAr-~~~~~~-~ss~~-~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~ 1258 (1329)
.. ..|||+|||+|+ .+.... ..... .-...|||||.+. .+.++.|+|||||||+|||++| |..||.....
T Consensus 837 ~~----r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~--d~iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 837 ER----RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK--DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred cc----CcEEEcccchhHhhhhchheeccCccccceecCCHHHHh--hcccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 55 578999999999 333222 11222 3346899999999 5789999999999999999999 9999999999
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1259 GAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1259 ~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
.+++.-++... +++.|..|+..++++|.+||+.+|++||+|..|++.+..+.....
T Consensus 911 ~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 911 FEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 99888777777 999999999999999999999999999999999998888765443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=360.38 Aligned_cols=269 Identities=38% Similarity=0.621 Sum_probs=234.9
Q ss_pred ccccccccCeeEEEEecccCcEEEEEEEEC---C--ce-EEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCcee
Q 000726 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWR---G--TD-VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 1108 (1329)
Q Consensus 1035 ~l~iI~~edYellkvLGqGaFGtVYKA~~k---G--r~-VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIV 1108 (1329)
..|++..++..+.++||+|+||.||+|+++ + .. ||||..+... ...+....+|++|+++++.++|||||
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-----~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-----ELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-----cccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 346777788888899999999999999984 2 13 8999987532 22456678999999999999999999
Q ss_pred eEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCC
Q 000726 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188 (1329)
Q Consensus 1109 KL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~ 1188 (1329)
++||++.... .++||||+|.||+|.++|......++..+...++.+.+.||+|||++++|||||-++|+|++.++
T Consensus 225 r~yGVa~~~~--Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~--- 299 (474)
T KOG0194|consen 225 RFYGVAVLEE--PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG--- 299 (474)
T ss_pred EEEEEEcCCC--ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC---
Confidence 9999998865 89999999999999999987777799999999999999999999999999999999999999654
Q ss_pred CcEEEeecCCcccccCccccc-CCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 000726 1189 PICKVGDFGLSKIKRNTLVTG-GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1266 (1329)
Q Consensus 1189 ~~VKLsDFGLAr~~~~~~~ss-~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIv 1266 (1329)
.+||+|||+++......... ...-...|+|||.+. ...++.++|||||||++||+++ |..||.+....+....++
T Consensus 300 -~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~--~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~ 376 (474)
T KOG0194|consen 300 -VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLN--TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV 376 (474)
T ss_pred -eEEeCccccccCCcceeeccccccCcceecChhhhc--cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH
Confidence 46999999998654333332 223567899999998 5578999999999999999999 889999999999999998
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcc
Q 000726 1267 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 1316 (1329)
Q Consensus 1267 e~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q~ 1316 (1329)
...++.+.+...+..+..++.+||..+|++||+|.++.+.|+.+......
T Consensus 377 ~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 377 KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 99999999999999999999999999999999999999999999876553
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.64 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=197.3
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEE
Q 000726 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1329)
Q Consensus 1050 LGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVME 1127 (1329)
||+|+||+||++.+. ++.||||++...... .......+..|+.+++.++|+||+++++++.... .+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-----KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT--DLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-----hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC--eEEEEEe
Confidence 799999999999874 778999998754221 1222356778999999999999999999888754 8999999
Q ss_pred eccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 000726 1128 FMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204 (1329)
Q Consensus 1128 Ym~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~ 1204 (1329)
|+++++|..++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++. ++|+|||++.....
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~----~~l~dfg~~~~~~~ 149 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN----VRISDLGLAVELKD 149 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----EEEeeCccceecCC
Confidence 9999999877743 2356899999999999999999999999999999999999987654 69999999875432
Q ss_pred c-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH----HHHHHHhcCCCCCCCCCCc
Q 000726 1205 T-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA----IIGGIVNNTLRPPVPGFCD 1279 (1329)
Q Consensus 1205 ~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~e----ll~qIve~~lr~~ips~~S 1279 (1329)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+... ....+..++
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 225 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFS 225 (280)
T ss_pred CCccccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCC
Confidence 2 22334568999999999984 457889999999999999999999997654322 22222211 223455688
Q ss_pred HHHHHHHHHhhcCCCCCCC-----CHHHHHHHHHHH
Q 000726 1280 SEWRLLMEQCWAPDPVVRP-----SFTEIARRLRVM 1310 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERP-----TaeELLq~Le~L 1310 (1329)
..+.+++.+||+.||.+|| +++++++|.|.-
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~ 261 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR 261 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhh
Confidence 9999999999999999999 789999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=318.93 Aligned_cols=255 Identities=35% Similarity=0.587 Sum_probs=208.9
Q ss_pred cccccCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeE
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 1110 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~kG-------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL 1110 (1329)
.+..++|++.+.||+|+||.||++.+++ ..||+|.+.... .......+.+|+.+++.++||||+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~ 74 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-------SMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-------CHHHHHHHHHHHHHHHhCCCCceeEE
Confidence 3567789999999999999999998752 569999975321 11223567889999999999999999
Q ss_pred ecccccCCCCeEEEEEEeccCCchhhhhhccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe
Q 000726 1111 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 1181 (1329)
Q Consensus 1111 ~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILL 1181 (1329)
++++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+|||+
T Consensus 75 ~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill 152 (277)
T cd05032 75 LGVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV 152 (277)
T ss_pred EEEEcCCC--CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE
Confidence 99988754 8899999999999999885422 246788999999999999999999999999999999999
Q ss_pred ccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCC
Q 000726 1182 NLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1257 (1329)
Q Consensus 1182 DsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~ 1257 (1329)
+.++. +||+|||+++...... ......++..|+|||.+. ...++.++|||||||++|||++ |..||....
T Consensus 153 ~~~~~----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 153 AEDLT----VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK--DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred cCCCC----EEECCcccchhhccCcccccCCCCCccccccCHHHHh--cCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 97764 5999999987433221 122334678899999987 3457889999999999999998 999998777
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1258 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1258 ~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.......+. .......+..++..+.+++.+||+.+|.+|||+.+++..|+
T Consensus 227 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 227 NEEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 666655554 44445567778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=336.13 Aligned_cols=246 Identities=25% Similarity=0.407 Sum_probs=203.7
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
++||+|+||.||+|++. ++.||||++++.... .+.....+..|..++..+ +||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~--~~~l 73 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-----QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--RLFF 73 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--eEEE
Confidence 36999999999999985 578999999764221 122234567788888866 7999999999998754 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc-
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~- 1203 (1329)
||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 74 v~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~----~kL~Dfg~~~~~~~ 148 (321)
T cd05591 74 VMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH----CKLADFGMCKEGIL 148 (321)
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC----EEEeecccceeccc
Confidence 9999999999988854 356899999999999999999999999999999999999997764 6999999987432
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..... ..+..++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~ 224 (321)
T cd05591 149 NGVTTTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--LYPVWLSKEAV 224 (321)
T ss_pred CCccccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 2222344568999999999984 4578899999999999999999999998887777776665443 34556889999
Q ss_pred HHHHHhhcCCCCCCC-------CHHHHHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRP-------SFTEIARRLRV 1309 (1329)
Q Consensus 1284 DLIkrCLqkDPeERP-------TaeELLq~Le~ 1309 (1329)
+++.+||+.||.+|| ++.+++++.+.
T Consensus 225 ~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~ 257 (321)
T cd05591 225 SILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257 (321)
T ss_pred HHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence 999999999999999 89999988753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=343.37 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=204.1
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
.|++++.||+|+||.||+|++. ++.||||++.+... ........+.+|+.+++.++||||+++++.+.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-- 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-- 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--
Confidence 5889999999999999999984 67899999875321 12334457889999999999999999999998754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.+++|||||++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|. +||+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~----~kL~DFGla~ 149 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH----IKLTDFGLCT 149 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC----EEEeECCCCc
Confidence 899999999999999988643 46889999999999999999999999999999999999997764 6999999975
Q ss_pred cccC------------------------------------------------cccccCCCCCCcccCccccccCCCCCCh
Q 000726 1201 IKRN------------------------------------------------TLVTGGVRGTLPWMAPELLNGSSSKVSE 1232 (1329)
Q Consensus 1201 ~~~~------------------------------------------------~~~ss~~~GTp~YmAPEvL~Gs~~~~S~ 1232 (1329)
.... ........||+.|+|||++.+ ..++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~ 227 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQ 227 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCC
Confidence 2110 000123468999999999984 45788
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhcCCCCCCCC---HHHHHHHH
Q 000726 1233 KVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV--PGFCDSEWRLLMEQCWAPDPVVRPS---FTEIARRL 1307 (1329)
Q Consensus 1233 KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~i--ps~~S~eL~DLIkrCLqkDPeERPT---aeELLq~L 1307 (1329)
++|||||||+||||++|+.||...........+......... ...+++++.++|.+|+ .+|.+|++ +.+++.|.
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp 306 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHP 306 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCC
Confidence 999999999999999999999887766666555543333323 3457899999998876 59999987 99999886
Q ss_pred HH
Q 000726 1308 RV 1309 (1329)
Q Consensus 1308 e~ 1309 (1329)
+.
T Consensus 307 ~f 308 (382)
T cd05625 307 FF 308 (382)
T ss_pred Cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=336.83 Aligned_cols=246 Identities=28% Similarity=0.431 Sum_probs=203.2
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+.||+|+||.||+|+++ ++.||||++++.... .+.....+..|..++..+ +||||+++++++.... .+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-----QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD--RLFF 73 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC--EEEE
Confidence 36999999999999984 678999999764221 122334567888888876 6999999999998755 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc-
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~- 1203 (1329)
||||+++++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus 74 v~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~----~kL~DfG~~~~~~~ 148 (320)
T cd05590 74 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH----CKLADFGMCKEGIF 148 (320)
T ss_pred EEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc----EEEeeCCCCeecCc
Confidence 99999999999887543 56899999999999999999999999999999999999997764 5999999987432
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... ...+..++..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (320)
T cd05590 149 NGKTTSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLSQDAV 224 (320)
T ss_pred CCCcccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 2223344569999999999984 457889999999999999999999999888777776665543 334567899999
Q ss_pred HHHHHhhcCCCCCCCCH------HHHHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRPSF------TEIARRLRV 1309 (1329)
Q Consensus 1284 DLIkrCLqkDPeERPTa------eELLq~Le~ 1309 (1329)
+++++||+.||.+||++ ++++.|.+-
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f 256 (320)
T cd05590 225 DILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256 (320)
T ss_pred HHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence 99999999999999998 888887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=327.13 Aligned_cols=257 Identities=25% Similarity=0.342 Sum_probs=204.3
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|.+.+.||+|+||.||+|++. ++.||||.++...... ....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 77 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIVHTDK 77 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-------cchhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence 467999999999999999999884 6779999997543211 1234668999999999999999999998754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||++ ++|..++......+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 78 --~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~----~kl~Dfg~ 150 (309)
T cd07872 78 --SLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE----LKLADFGL 150 (309)
T ss_pred --eEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC----EEECcccc
Confidence 8999999996 5888888666666899999999999999999999999999999999999997664 69999999
Q ss_pred cccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC--------
Q 000726 1199 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-------- 1269 (1329)
Q Consensus 1199 Ar~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~-------- 1269 (1329)
+...... .......+++.|+|||++.+ ...++.++|||||||++|+|++|+.||......+....+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 151 ARAKSVPTKTYSNEVVTLWYRPPDVLLG-SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred ceecCCCccccccccccccccCCHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 8753322 22223457899999999874 3457889999999999999999999998766544333222100
Q ss_pred -------------CCC-------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1270 -------------LRP-------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1270 -------------lr~-------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
... .....++.++.++|.+||+.||.+|||+.+++.+.|-...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 000 0112367889999999999999999999999998887543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=335.72 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=199.4
Q ss_pred cccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
...+|++.+.||+|+||.||++.+ .+..||||+++.... .......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ------NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ 92 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc------chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 347899999999999999999987 478899999975421 122345677899999999999999999988643
Q ss_pred CC----CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1118 PG----GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1118 ~d----g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
.. ..+++||||+. ++|...+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||
T Consensus 93 ~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~----~kl 164 (359)
T cd07876 93 KSLEEFQDVYLVMELMD-ANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKI 164 (359)
T ss_pred CCccccceeEEEEeCCC-cCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC----EEE
Confidence 21 35799999995 45665553 24788899999999999999999999999999999999997764 699
Q ss_pred eecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh------
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN------ 1267 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve------ 1267 (1329)
+|||+++............+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+..
T Consensus 165 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 165 LDFGLARTACTNFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ecCCCccccccCccCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 99999975443333344568999999999984 4578899999999999999999999986654322211111
Q ss_pred ----------------cCCCC------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1268 ----------------NTLRP------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1268 ----------------~~lr~------------------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
..... ......+..+.+||.+||+.||++|||+.|++.|.|..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 00000 01112457789999999999999999999999998864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.84 Aligned_cols=245 Identities=39% Similarity=0.659 Sum_probs=207.3
Q ss_pred EEecccCcEEEEEEEEC-----CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeE
Q 000726 1048 KELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k-----Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L 1122 (1329)
+.||+|+||.||++.+. +..||||+++..... .....+.+|+.+++.++|+||+++++++... ..+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~ 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE-------EERKDFLKEARVMKKLGHPNVVRLLGVCTEE--EPL 71 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch-------hHHHHHHHHHHHHhhcCCCChheeeeeecCC--Cce
Confidence 36999999999999985 667999998754221 1346788999999999999999999999874 489
Q ss_pred EEEEEeccCCchhhhhhcc--------cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1123 ATVTEFMVNGSLRHVLLSK--------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~d~L~~k--------ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+++|+|+||||+||+++.++. ++|+
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~----~~l~ 147 (262)
T cd00192 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV----VKIS 147 (262)
T ss_pred EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc----EEEc
Confidence 9999999999999999765 467899999999999999999999999999999999999997754 5999
Q ss_pred ecCCcccccCc---ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC
Q 000726 1195 DFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1270 (1329)
Q Consensus 1195 DFGLAr~~~~~---~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~l 1270 (1329)
|||.+...... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+.. ..
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~ 224 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GY 224 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CC
Confidence 99999854432 22334557889999999984 367899999999999999999 6999988877666655544 44
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1271 r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
....+..++..+.+++.+||+.+|.+||++.+++++|+
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 55667778999999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=338.98 Aligned_cols=246 Identities=28% Similarity=0.376 Sum_probs=203.3
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEE
Q 000726 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LV 1125 (1329)
+.||+|+||.||++.+ +++.||||++++.... .......+.+|+.+++.++||||+++++++.... .+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~--~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC--EEEEE
Confidence 3699999999999987 4788999999864321 1223456778999999999999999999988754 89999
Q ss_pred EEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc-
Q 000726 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1329)
Q Consensus 1126 MEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~- 1203 (1329)
|||+++++|..++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++. +||+|||++....
T Consensus 74 ~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~----~kL~Dfg~~~~~~~ 148 (325)
T cd05594 74 MEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH----IKITDFGLCKEGIK 148 (325)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC----EEEecCCCCeecCC
Confidence 999999999888754 3568999999999999999999997 79999999999999997764 6999999987432
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
.........||+.|+|||++.+ ..++.++|||||||+||+|++|..||...........+.... ..++..+++++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~ 224 (325)
T cd05594 149 DGATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAK 224 (325)
T ss_pred CCcccccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 2222234569999999999974 457889999999999999999999998877666665554433 334567899999
Q ss_pred HHHHHhhcCCCCCCC-----CHHHHHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRP-----SFTEIARRLRV 1309 (1329)
Q Consensus 1284 DLIkrCLqkDPeERP-----TaeELLq~Le~ 1309 (1329)
+|+.+||+.||.+|+ ++.++++|.+.
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 255 (325)
T cd05594 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255 (325)
T ss_pred HHHHHHhhcCHHHhCCCCCCCHHHHhcCCCc
Confidence 999999999999996 99999988654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=322.59 Aligned_cols=258 Identities=36% Similarity=0.582 Sum_probs=211.8
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k-------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
|.+.+|.+.+.||+|+||.||++.+. +..+|+|.++.. .......+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--------SDNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--------CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 45678999999999999999999752 345899988642 122345688999999999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhccc------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcce
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 1179 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNI 1179 (1329)
+++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+||
T Consensus 74 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Ni 151 (288)
T cd05093 74 GVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 151 (288)
T ss_pred EEEecCC--ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence 9998754 8999999999999999885432 2489999999999999999999999999999999999
Q ss_pred EeccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCC
Q 000726 1180 LVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYAN 1255 (1329)
Q Consensus 1180 LLDsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~ 1255 (1329)
|++.++ .++|+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||..
T Consensus 152 li~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 152 LVGENL----LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred EEccCC----cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999766 46999999987442211 1122335778999999974 457889999999999999998 9999988
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1256 MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1256 ~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
.........+.... ....+..++..+.+|+.+||+.+|.+|||+.+++..|+.+...
T Consensus 226 ~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 226 LSNNEVIECITQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 77766666555433 3344556789999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=321.00 Aligned_cols=253 Identities=32% Similarity=0.528 Sum_probs=201.5
Q ss_pred eeEEEEecccCcEEEEEEEE------CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1044 LEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~------kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
|++.+.||+|+||+||++.+ .+..||+|+++.... ......+.+|+.+|+.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-------QQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 38889999999999998764 356799999875321 12235678899999999999999999988765
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
....+++||||+++++|.+++.. ..+++.+++.++.|++.||.|||+++|+|+||||+|||++.++ .++|+|||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~~l~dfg 152 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR----LVKIGDFG 152 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC----cEEEeecc
Confidence 55578999999999999998854 3589999999999999999999999999999999999998765 46999999
Q ss_pred CcccccCccc----ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh--------------
Q 000726 1198 LSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-------------- 1259 (1329)
Q Consensus 1198 LAr~~~~~~~----ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~-------------- 1259 (1329)
++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccch
Confidence 9875433211 112235667999999873 45788999999999999999999998543211
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1260 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1260 ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
......+......+.+..++..+.+++.+||+.+|++|||+.+++..|+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111222233344556678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=334.95 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=205.0
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~~d 1119 (1329)
+|++.+.||+|+||.||+|++. ++.||||++++.... .+.....+..|..++..+ .|++|+++++++....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD- 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-
Confidence 5788999999999999999985 568999999864321 122234566788888777 5899999999988754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~----~kL~DfG~~ 148 (323)
T cd05616 75 -RLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH----IKIADFGMC 148 (323)
T ss_pred -EEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc----EEEccCCCc
Confidence 899999999999999888543 46899999999999999999999999999999999999997764 599999998
Q ss_pred cccc-CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1200 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 r~~~-~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..... ..+..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 224 (323)
T cd05616 149 KENMWDGVTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--AYPKSM 224 (323)
T ss_pred eecCCCCCccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCcC
Confidence 7432 2223345679999999999984 4578899999999999999999999998887777776665443 445678
Q ss_pred cHHHHHHHHHhhcCCCCCCCCH-----HHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSF-----TEIARRL 1307 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTa-----eELLq~L 1307 (1329)
+.++.+++.+||+.+|.+|++. .+++.+.
T Consensus 225 s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~ 258 (323)
T cd05616 225 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 258 (323)
T ss_pred CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCC
Confidence 9999999999999999999974 7777663
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=327.90 Aligned_cols=261 Identities=34% Similarity=0.550 Sum_probs=208.7
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEEC--Cce--EEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEe
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFY 1111 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~k--Gr~--VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~ 1111 (1329)
+.+.+++|++.+.||+|+||.||+|.++ +.. +|+|.++... .......+.+|+.++.++ +||||++++
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~ 74 (303)
T cd05088 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLL 74 (303)
T ss_pred CccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-------CHHHHHHHHHHHHHHHHhcCCCCcceEE
Confidence 3567789999999999999999999874 443 5777665321 122345678899999999 899999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCC
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKC 1176 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKP 1176 (1329)
+++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 75 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp 152 (303)
T cd05088 75 GACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 152 (303)
T ss_pred EEECCCC--CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccch
Confidence 9998754 8999999999999999886432 2578999999999999999999999999999999
Q ss_pred cceEeccCCCCCCcEEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCC
Q 000726 1177 DNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYAN 1255 (1329)
Q Consensus 1177 eNILLDsdGni~~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~ 1255 (1329)
+|||++.++ .+||+|||++.............++..|+|||++.+ ..++.++|||||||+||||++ |..||..
T Consensus 153 ~Nili~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~ 226 (303)
T cd05088 153 RNILVGENY----VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226 (303)
T ss_pred heEEecCCC----cEEeCccccCcccchhhhcccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCccc
Confidence 999999765 459999999864322212222234667999999874 447889999999999999998 9999987
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1256 MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1256 ~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
....+....+ ........+..++..+.+|+.+||+.+|.+||++.+++..|..+...
T Consensus 227 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 227 MTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred CChHHHHHHH-hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 7665554443 33334445556789999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=313.71 Aligned_cols=251 Identities=37% Similarity=0.629 Sum_probs=210.6
Q ss_pred ccccCeeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
+...+|++.+.||.|+||.||++...++.||||.++.... ...++.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence 4567889999999999999999999999999999975321 3467889999999999999999999988744
Q ss_pred CCeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++. ++|+|||
T Consensus 74 --~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~----~~l~d~g 147 (256)
T cd05039 74 --PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV----AKVSDFG 147 (256)
T ss_pred --CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC----EEEcccc
Confidence 7899999999999999986544 36899999999999999999999999999999999999997664 5999999
Q ss_pred CcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 000726 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1198 LAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips 1276 (1329)
.+........ ....+..|+|||.+. ...++.++|||||||++|+|++ |..||...........+. .......+.
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~ape~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 222 (256)
T cd05039 148 LAKEASQGQD--SGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPE 222 (256)
T ss_pred cccccccccc--cCCCcccccCchhhc--CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCcc
Confidence 9986533222 233466799999987 3457889999999999999997 999998776655544433 334445566
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
.+++.+.+++.+||..+|.+||++.+++++|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 788999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=314.35 Aligned_cols=244 Identities=35% Similarity=0.641 Sum_probs=199.5
Q ss_pred EecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEE
Q 000726 1049 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVT 1126 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVM 1126 (1329)
.||+|+||.||+|++ .++.||+|.+.... .......+.+|+.+++.++||||+++++++.... ..++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 72 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIVM 72 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--CeEEEE
Confidence 699999999999988 57889999876321 1223456889999999999999999999998754 789999
Q ss_pred EeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCcc
Q 000726 1127 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206 (1329)
Q Consensus 1127 EYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~ 1206 (1329)
||+++++|.+++......+++..++.++.|++.||+|||++||+|+||||.|||++.++ .+||+|||++.......
T Consensus 73 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~----~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 73 ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN----VLKISDFGMSREEEDGV 148 (252)
T ss_pred eeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC----cEEECccccCccccccc
Confidence 99999999999876556789999999999999999999999999999999999998765 36999999987533221
Q ss_pred cc---cCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHH
Q 000726 1207 VT---GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 1282 (1329)
Q Consensus 1207 ~s---s~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL 1282 (1329)
.. .....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||........... +........+..++..+
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 225 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-IEQGVRLPCPELCPDAV 225 (252)
T ss_pred ccccCCCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH-HHcCCCCCCcccCCHHH
Confidence 11 11123456999999873 457889999999999999998 8999977665544433 33344556667789999
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1283 RLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1283 ~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.+++.+||+.+|.+|||+.++++.|+
T Consensus 226 ~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 226 YRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 99999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=321.46 Aligned_cols=258 Identities=36% Similarity=0.573 Sum_probs=211.0
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k-------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
++..+|.+.+.||+|+||.||++++. +..+++|.++... ......+.+|+.++++++|+||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--------LAARKDFQREAELLTNLQHEHIVKFY 73 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--------HHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 34567999999999999999999863 2348888875321 22235688999999999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCC
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKC 1176 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKP 1176 (1329)
+++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 74 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 151 (291)
T cd05094 74 GVCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLAT 151 (291)
T ss_pred EEEccCC--ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCc
Confidence 9998754 7999999999999999985432 3478999999999999999999999999999999
Q ss_pred cceEeccCCCCCCcEEEeecCCcccccCc---ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCC
Q 000726 1177 DNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEP 1252 (1329)
Q Consensus 1177 eNILLDsdGni~~~VKLsDFGLAr~~~~~---~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~P 1252 (1329)
+|||++.++ .++|+|||++...... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 152 ~Nil~~~~~----~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 225 (291)
T cd05094 152 RNCLVGANL----LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQP 225 (291)
T ss_pred ceEEEccCC----cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999765 4699999999754321 11223446788999999884 457889999999999999999 9999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1253 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1253 F~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
|...........+.. ......+..++..+.+++.+||+.+|.+||++.+|++.|..+...
T Consensus 226 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 226 WFQLSNTEVIECITQ-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCCHHHHHHHHhC-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 988776666555433 333344566789999999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=320.23 Aligned_cols=258 Identities=31% Similarity=0.553 Sum_probs=208.4
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE--CCce----EEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTD----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~--kGr~----VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
.+...+|++.+.||+|+||+||+|.+ .++. |++|.+... .......++..|+.+++.+.||||++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~~~~~l~~l~h~~iv~~~ 75 (279)
T cd05111 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-------SGRQTFQEITDHMLAMGSLDHAYIVRLL 75 (279)
T ss_pred cCCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-------cchHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 34567889999999999999999998 3443 666665321 1123345677888899999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
+++... ..+++|||+++++|.+++......+++..++.|+.||+.||+|||+++++|+||||+|||++.++ .+
T Consensus 76 ~~~~~~---~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~----~~ 148 (279)
T cd05111 76 GICPGA---SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS----IV 148 (279)
T ss_pred EEECCC---ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC----cE
Confidence 987542 57889999999999999977667799999999999999999999999999999999999998665 46
Q ss_pred EEeecCCcccccCc---ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 000726 1192 KVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~---~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve 1267 (1329)
||+|||+++..... .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||......... .++.
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~ 225 (279)
T cd05111 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLE 225 (279)
T ss_pred EEcCCccceeccCCCcccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHH
Confidence 99999999754221 12223456778999999973 457899999999999999998 99999877655433 3344
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1268 ~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
.......+..++..+.+++.+||..+|.+|||+.++++.|..+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 226 KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 445555566788899999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=345.39 Aligned_cols=260 Identities=30% Similarity=0.480 Sum_probs=211.5
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCcee
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVV 1108 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~kG-------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIV 1108 (1329)
+.+..++|++.++||+|+||.||+|++.+ ..||||+++... .......+.+|+.+|+++. ||||+
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~Ei~~l~~l~~HpnIv 104 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-------RSSEKQALMSELKIMTHLGPHLNIV 104 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhcCCCCCee
Confidence 35667889999999999999999998732 359999986432 1222356889999999996 99999
Q ss_pred eEecccccCCCCeEEEEEEeccCCchhhhhhccc----------------------------------------------
Q 000726 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------------------------------- 1142 (1329)
Q Consensus 1109 KL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------------------------------------------- 1142 (1329)
+++++|.+.. .+++|||||++|+|.+++....
T Consensus 105 ~l~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (400)
T cd05105 105 NLLGACTKSG--PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQ 182 (400)
T ss_pred eEEEEEccCC--ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccc
Confidence 9999998754 8999999999999998875421
Q ss_pred -------------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Q 000726 1143 -------------------------------------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFD 1173 (1329)
Q Consensus 1143 -------------------------------------------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRD 1173 (1329)
..+++..++.++.||+.||+|||+++|+|+|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~d 262 (400)
T cd05105 183 ADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRD 262 (400)
T ss_pred ccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 2367888899999999999999999999999
Q ss_pred CCCcceEeccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-C
Q 000726 1174 LKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-G 1249 (1329)
Q Consensus 1174 LKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-G 1249 (1329)
|||+|||++.++ .+||+|||+++...... ......++..|+|||++.+ ..++.++|||||||+||+|++ |
T Consensus 263 ikp~Nill~~~~----~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g 336 (400)
T cd05105 263 LAARNVLLAQGK----IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLG 336 (400)
T ss_pred CChHhEEEeCCC----EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCC
Confidence 999999998654 46999999997542211 1223346778999999974 457889999999999999997 9
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1250 EEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1250 k~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
..||............+....+...+..++..+.+++.+||+.+|++||++.+|.+.|+.+.
T Consensus 337 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 337 GTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred CCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 99998766555544455555566667788999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.41 Aligned_cols=245 Identities=29% Similarity=0.467 Sum_probs=198.7
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHh-cCCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~-LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+.||+|+||.||+|+++ ++.||||+++..... .+.....+..|..++.. ++||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-----EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE--HLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEE
Confidence 36999999999999985 567999999864321 11223345566677765 48999999999988754 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc-
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~- 1203 (1329)
||||+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus 74 v~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~----~kL~Dfg~a~~~~~ 148 (316)
T cd05592 74 VMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH----IKIADFGMCKENMN 148 (316)
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC----EEEccCcCCeECCC
Confidence 99999999999888543 46899999999999999999999999999999999999997664 6999999997432
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... ...++..++..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 224 (316)
T cd05592 149 GEGKASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWISKEAK 224 (316)
T ss_pred CCCccccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHH
Confidence 2233345679999999999984 45788999999999999999999999988777666665443 3445667899999
Q ss_pred HHHHHhhcCCCCCCCCHH-HHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRPSFT-EIARRLR 1308 (1329)
Q Consensus 1284 DLIkrCLqkDPeERPTae-ELLq~Le 1308 (1329)
+++.+||+.+|.+||++. +++++.+
T Consensus 225 ~ll~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05592 225 DCLSKLFERDPTKRLGVDGDIRQHPF 250 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHcCcc
Confidence 999999999999999875 6766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=316.07 Aligned_cols=245 Identities=33% Similarity=0.557 Sum_probs=201.0
Q ss_pred EecccCcEEEEEEEE----CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEE
Q 000726 1049 ELGSGTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~----kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+||+|+||.||+|.+ .+..+|||+++... ........+.+|+.+++.+.||||+++++++... ..++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN------NDPALKDELLREANVMQQLDNPYIVRMIGICEAE---SWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---CcEE
Confidence 589999999999976 35679999986432 1233456788999999999999999999988643 5789
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~ 1204 (1329)
||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||.|||++.++ .+||+|||++.....
T Consensus 73 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~----~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 73 VMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH----YAKISDFGLSKALGA 147 (257)
T ss_pred EEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC----eEEECCCccccccCC
Confidence 9999999999998854 34689999999999999999999999999999999999999765 469999999875432
Q ss_pred ccc----ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCc
Q 000726 1205 TLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279 (1329)
Q Consensus 1205 ~~~----ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips~~S 1279 (1329)
... .....++..|+|||.+. ...++.++|||||||++|||++ |..||...........+ ......+.+..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~ 224 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-ESGERMECPQRCP 224 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhc--cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCC
Confidence 211 11223457899999987 3457789999999999999998 99999877665555444 3444566777889
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1280 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.++.++|.+||+.||.+||++.+|...|+..
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=321.13 Aligned_cols=259 Identities=32% Similarity=0.545 Sum_probs=211.5
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCcee
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVV 1108 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~kG-------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIV 1108 (1329)
..+..++|++.+.||+|+||.||++.+.+ ..+|+|.++... .......+.+|+.+++++ +|+||+
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i~ 79 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNII 79 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-------CHHHHHHHHHHHHHHHhhcCCCCee
Confidence 45677889999999999999999998742 468999887431 112235688999999999 799999
Q ss_pred eEecccccCCCCeEEEEEEeccCCchhhhhhcc---------------cccCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Q 000726 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK---------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFD 1173 (1329)
Q Consensus 1109 KL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~k---------------ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRD 1173 (1329)
++++++.... .+++||||+++++|..++... ...+++..++.++.||+.||+|||+++|+|||
T Consensus 80 ~~~~~~~~~~--~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~d 157 (293)
T cd05053 80 NLLGVCTQEG--PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRD 157 (293)
T ss_pred eEEEEEcCCC--CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 9999987754 799999999999999988532 34688999999999999999999999999999
Q ss_pred CCCcceEeccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-C
Q 000726 1174 LKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-G 1249 (1329)
Q Consensus 1174 LKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-G 1249 (1329)
|||+|||++.++ .+||+|||+++...... ......++..|+|||++. ...++.++|||||||++|||++ |
T Consensus 158 lkp~Nil~~~~~----~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g 231 (293)
T cd05053 158 LAARNVLVTEDH----VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLG 231 (293)
T ss_pred cceeeEEEcCCC----eEEeCccccccccccccceeccCCCCCCccccCHHHhc--cCCcCcccceeehhhHHHHHhcCC
Confidence 999999998765 46999999998543321 111223456799999987 3457889999999999999998 9
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1250 EEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1250 k~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
..||......+....+ ........+..++..+.+|+.+||..+|.+|||+.++++.|..+.
T Consensus 232 ~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 232 GSPYPGIPVEELFKLL-KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 9999887666655443 334455566678899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=343.72 Aligned_cols=259 Identities=23% Similarity=0.353 Sum_probs=210.8
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
+..++|++.+.||+|+||.||++++. ++.||+|++++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 34578999999999999999999984 678999999753211 11223457789999999999999999999987
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.. .+++||||+++++|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+||
T Consensus 115 ~~--~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~----~kL~DF 186 (370)
T cd05621 115 DK--YLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH----LKLADF 186 (370)
T ss_pred CC--EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC----EEEEec
Confidence 54 89999999999999998853 35789999999999999999999999999999999999997664 699999
Q ss_pred CCcccccCcc--cccCCCCCCcccCccccccCC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC
Q 000726 1197 GLSKIKRNTL--VTGGVRGTLPWMAPELLNGSS--SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1197 GLAr~~~~~~--~ss~~~GTp~YmAPEvL~Gs~--~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~ 1272 (1329)
|++....... ......||+.|+|||++.+.. ..++.++|||||||+||+|++|+.||...........+.......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc
Confidence 9998643221 223567999999999997532 336789999999999999999999998887776666666544333
Q ss_pred CCCC--CCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHHHHH
Q 000726 1273 PVPG--FCDSEWRLLMEQCWAPDPVV--RPSFTEIARRLRVM 1310 (1329)
Q Consensus 1273 ~ips--~~S~eL~DLIkrCLqkDPeE--RPTaeELLq~Le~L 1310 (1329)
..+. .++..+.+++.+||..++.+ |+++.++++|.|--
T Consensus 267 ~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~ 308 (370)
T cd05621 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308 (370)
T ss_pred CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence 3333 46889999999999855543 89999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=315.49 Aligned_cols=253 Identities=36% Similarity=0.617 Sum_probs=208.2
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC-CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
.+..++|++.+.||+|+||.||++.+. +..||+|.++..... ...+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---------PESFLEEAQIMKKLRHDKLVQLYAVVSE 72 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---------HHHHHHHHHHHHhcCCCceEEEEeEECC
Confidence 456778999999999999999999875 567999998753221 1357889999999999999999998754
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
. ..++||||+++++|.+++... ...+++..++.++.+++.||+|||+++|+|+||||+||+++.++ .++|+|
T Consensus 73 ~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~----~~~l~d 145 (260)
T cd05070 73 E---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL----VCKIAD 145 (260)
T ss_pred C---CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc----eEEeCC
Confidence 2 578999999999999988653 34589999999999999999999999999999999999999765 469999
Q ss_pred cCCcccccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC
Q 000726 1196 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1196 FGLAr~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~ 1272 (1329)
||++....... ......++..|+|||.+. ...++.++|||||||++|+|++ |..||......+....+. .....
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~ 222 (260)
T cd05070 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRM 222 (260)
T ss_pred ceeeeeccCcccccccCCCCCccccChHHHh--cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 99997543221 112233556799999987 3457889999999999999999 899998877666555543 34455
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
+.+...+..+.+|+.+||.++|.+|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 6667788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=336.18 Aligned_cols=244 Identities=28% Similarity=0.411 Sum_probs=201.8
Q ss_pred EEecccCcEEEEEEEE-----CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeE
Q 000726 1048 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~-----kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L 1122 (1329)
+.||+|+||.||++.. .++.||||+++..... ......+.+|+.+|++++||||+++++++.+.. .+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK------VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--KL 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--EE
Confidence 5799999999999875 3678999999864221 122345678999999999999999999998754 89
Q ss_pred EEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 000726 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 74 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~----~kL~Dfg~~~~~ 148 (318)
T cd05582 74 YLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH----IKLTDFGLSKES 148 (318)
T ss_pred EEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc----EEEeeccCCccc
Confidence 999999999999998854 346899999999999999999999999999999999999997764 599999998754
Q ss_pred cCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHH
Q 000726 1203 RNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 1281 (1329)
Q Consensus 1203 ~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~e 1281 (1329)
... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... ..++..++..
T Consensus 149 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~~~~~~ 224 (318)
T cd05582 149 IDHEKKAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPE 224 (318)
T ss_pred CCCCCceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHH
Confidence 332 23334678999999999984 456789999999999999999999998877766666655443 3456678899
Q ss_pred HHHHHHHhhcCCCCCCCC-----HHHHHHHHH
Q 000726 1282 WRLLMEQCWAPDPVVRPS-----FTEIARRLR 1308 (1329)
Q Consensus 1282 L~DLIkrCLqkDPeERPT-----aeELLq~Le 1308 (1329)
+.+||.+||+.||.+||+ +.+++.+.+
T Consensus 225 ~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~ 256 (318)
T cd05582 225 AQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256 (318)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence 999999999999999999 666776643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=316.13 Aligned_cols=255 Identities=35% Similarity=0.584 Sum_probs=208.4
Q ss_pred cccccCeeEEEEecccCcEEEEEEEECC-ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~kG-r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
.+..++|++.++||+|+||.||+|++.+ ..||||+++..... ...+.+|+.++++++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 72 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVSE 72 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---------HHHHHHHHHHHHhCCCCCcceEEEEECC
Confidence 3556789999999999999999998854 46999998753211 2357889999999999999999998754
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
. ..++||||+++++|.+++... ...+++..+..++.|++.||+|||+++|+|+||||+|||++.++. ++|+|
T Consensus 73 ~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~----~~L~d 145 (262)
T cd05071 73 E---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV----CKVAD 145 (262)
T ss_pred C---CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc----EEecc
Confidence 2 578999999999999998653 345789999999999999999999999999999999999997654 59999
Q ss_pred cCCcccccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC
Q 000726 1196 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1196 FGLAr~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~ 1272 (1329)
||.+....... ......++..|+|||++. ...++.++|||||||++|+|++ |..||...........+. .....
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~ 222 (262)
T cd05071 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRM 222 (262)
T ss_pred CCceeeccccccccccCCcccceecCHhHhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCC
Confidence 99997543222 112334667899999987 4457889999999999999999 888998877666555443 33344
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
+.+..++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 455678899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=314.81 Aligned_cols=253 Identities=36% Similarity=0.611 Sum_probs=209.7
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE-CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~-kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
.+..++|++.++||+|+||.||+|.. .++.||+|.+...... ...+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 72 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---------PEAFLAEANLMKQLQHPRLVRLYAVVTQ 72 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---------HHHHHHHHHHHHhcCCcCeeeEEEEEcc
Confidence 46678899999999999999999987 4678999998753221 2457889999999999999999998753
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
...++||||+.+++|.+++... ...+++.+++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~----~~~l~d 145 (260)
T cd05067 73 ---EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL----CCKIAD 145 (260)
T ss_pred ---CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC----CEEEcc
Confidence 2689999999999999988543 35689999999999999999999999999999999999999765 469999
Q ss_pred cCCcccccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC
Q 000726 1196 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1196 FGLAr~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~ 1272 (1329)
||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...........+ ......
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~ 222 (260)
T cd05067 146 FGLARLIEDNEYTAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-ERGYRM 222 (260)
T ss_pred CcceeecCCCCcccccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-HcCCCC
Confidence 99987544211 1223345678999999873 446789999999999999999 99999877766655443 344555
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
+.+..++..+.+++.+||..+|.+||++.+++..|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 6677788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=331.68 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=204.0
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
+..++|++.+.||+|+||.||++.+. +..+|+|+++... .......+.+|+++++.++||||++++++|..
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 34578999999999999999999985 6779999887532 12234568899999999999999999999988
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~-GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
.. .+++||||+++++|.+++.. ...+++..+..++.+++.||.|||++ +|+|+||||+|||++.++. +||+|
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~----~kL~D 147 (333)
T cd06650 75 DG--EISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCD 147 (333)
T ss_pred CC--EEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC----EEEee
Confidence 54 89999999999999998854 34588999999999999999999975 7999999999999997664 69999
Q ss_pred cCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHH----------
Q 000726 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI---------- 1265 (1329)
Q Consensus 1196 FGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qI---------- 1265 (1329)
||++...... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (333)
T cd06650 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224 (333)
T ss_pred CCcchhhhhh-ccccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence 9998754322 2234568999999999984 45788999999999999999999999754432221100
Q ss_pred ---------------------------------HhcCCCCCC-CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1266 ---------------------------------VNNTLRPPV-PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1266 ---------------------------------ve~~lr~~i-ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
+.....+.. ....+.++.+|+.+||+.||++|||+.+++.+.+.-.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 000111111 1235788999999999999999999999999887643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=347.85 Aligned_cols=248 Identities=21% Similarity=0.358 Sum_probs=206.1
Q ss_pred cCeeEEEEecccCcEEEEEEEEC---CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k---Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
..|.+.+.||+|+||.||+|... +..||+|.+... .......+.+|+.+|+.++|||||+++++|....
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--------DERQAAYARSELHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence 34999999999999999999873 456888876432 1222345678999999999999999999998754
Q ss_pred CCeEEEEEEeccCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~k---ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
.++|||||+++++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|
T Consensus 139 --~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~----~~kL~D 212 (478)
T PTZ00267 139 --KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGD 212 (478)
T ss_pred --EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC----cEEEEe
Confidence 899999999999999887532 34688999999999999999999999999999999999999766 469999
Q ss_pred cCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC
Q 000726 1196 FGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1196 FGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~ 1272 (1329)
||+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+..... .
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-~ 289 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-D 289 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C
Confidence 99998543321 2344569999999999984 5678999999999999999999999988777776666655433 3
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~ 1306 (1329)
+.+..++..+.++|.+||+.+|++||++.+++.+
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 4556788999999999999999999999999865
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.10 Aligned_cols=262 Identities=31% Similarity=0.528 Sum_probs=212.2
Q ss_pred cccccCeeEEEEecccCcEEEEEEEECC---------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCce
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNV 1107 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~kG---------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNI 1107 (1329)
.+..++|.+.+.||+|+||.||++.+.+ ..+|+|+++... .+.....+.+|+.+++.+ +||||
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~h~~i 86 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKNI 86 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-------ChHHHHHHHHHHHHHHHhcCCCCE
Confidence 4556789999999999999999998632 359999987431 112235678899999999 79999
Q ss_pred eeEecccccCCCCeEEEEEEeccCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeec
Q 000726 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 1172 (1329)
Q Consensus 1108 VKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHR 1172 (1329)
+++++++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++|++||
T Consensus 87 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 87 INLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred eeEEEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999998754 8999999999999999986432 247889999999999999999999999999
Q ss_pred CCCCcceEeccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-
Q 000726 1173 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT- 1248 (1329)
Q Consensus 1173 DLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT- 1248 (1329)
||||+|||++.++ .++|+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 165 dlkp~Nill~~~~----~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 165 DLAARNVLVTEDN----VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred cccHHheEEcCCC----cEEECCCcccccccccchhhccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcC
Confidence 9999999999765 46999999987543211 1111224568999999974 457889999999999999998
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1249 GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1249 Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
|..||......+.... +......+.+..++..+.+++.+||..+|.+||++.++++.|+.+.....
T Consensus 239 g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 239 GGSPYPGVPVEELFKL-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred CCCCCCcCCHHHHHHH-HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 8899977665554443 34444556667789999999999999999999999999999999876644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=314.01 Aligned_cols=254 Identities=32% Similarity=0.495 Sum_probs=204.5
Q ss_pred eeEEEEecccCcEEEEEEEEC-----CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1044 LEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~k-----Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
|++.+.||+|+||.||+|.+. +..||||+++.... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH------TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC------CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 456788999999999999873 25699999875321 1223456889999999999999999999876543
Q ss_pred C----CeEEEEEEeccCCchhhhhhcc-----cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCC
Q 000726 1119 G----GTLATVTEFMVNGSLRHVLLSK-----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1329)
Q Consensus 1119 d----g~L~LVMEYm~GGSL~d~L~~k-----ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~ 1189 (1329)
. ...++||||+++++|..++... ...+++..+..++.|++.||+|||+++|+||||||+||+++.++
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~---- 150 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM---- 150 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC----
Confidence 1 2478999999999999887432 23689999999999999999999999999999999999998765
Q ss_pred cEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 000726 1190 ICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1265 (1329)
Q Consensus 1190 ~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qI 1265 (1329)
.+||+|||+++...... ......++..|+|||.+. ...++.++|||||||++|||++ |..||......+....+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05035 151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228 (273)
T ss_pred eEEECCccceeeccccccccccccccCCccccCHhhcc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 46999999998543221 111223567899999987 4457889999999999999999 99999887766665544
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1266 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1266 ve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.. ......+..++..+.+++.+||+.||.+||++.++++.|..+
T Consensus 229 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RH-GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred Hc-CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 43 334556677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.58 Aligned_cols=255 Identities=36% Similarity=0.574 Sum_probs=202.8
Q ss_pred cCeeEEEEecccCcEEEEEEEE------CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~------kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.+|++.+.||+|+||.||++.+ .+..||||.++... ......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 75 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--------AEHLRDFEREIEILKSLQHDNIVKYKGVCY 75 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCeeEEEEEEc
Confidence 4788999999999999999875 36789999986431 223457889999999999999999999876
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
......+++||||+++++|.+++......+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~----~~~l~d 151 (284)
T cd05081 76 SAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN----RVKIGD 151 (284)
T ss_pred cCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC----eEEECC
Confidence 5444578999999999999999866556689999999999999999999999999999999999998765 469999
Q ss_pred cCCcccccCccc----ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh------------
Q 000726 1196 FGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG------------ 1259 (1329)
Q Consensus 1196 FGLAr~~~~~~~----ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~------------ 1259 (1329)
||++........ .....++..|+|||++.+ ..++.++|||||||++|||++|..++......
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05081 152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQ 229 (284)
T ss_pred CcccccccCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccc
Confidence 999985432211 111123456999999974 45788999999999999999987765432211
Q ss_pred ---HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1260 ---AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1260 ---ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
..+...+......+.+..++..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 011123333444455667889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=343.72 Aligned_cols=260 Identities=24% Similarity=0.350 Sum_probs=217.6
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.+..++|++..+||.|..++||+|++ ++..||||++..+... .....+.+|+..++.++||||++++..|.
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-------~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-------NDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-------hhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 45568999999999999999999998 4788999999764321 12567889999999999999999999998
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
.+. .+|+||.||.+|++.+.+...- .-+++..+..|++++++||.|||++|.||||||+.||||+.+|.+ ||+
T Consensus 95 v~~--~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~V----kLa 168 (516)
T KOG0582|consen 95 VDS--ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTV----KLA 168 (516)
T ss_pred ecc--eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcE----EEc
Confidence 865 8999999999999999996542 348999999999999999999999999999999999999988864 999
Q ss_pred ecCCcccc-cCcc----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 000726 1195 DFGLSKIK-RNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1269 (1329)
Q Consensus 1195 DFGLAr~~-~~~~----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~ 1269 (1329)
|||..-.. .... ....+.||++|||||++......|+.|+||||||++..||.+|..||.......++...+.+.
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~ 248 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND 248 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 99986532 1111 115567999999999977667789999999999999999999999999988877766555554
Q ss_pred CCCC--------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1270 LRPP--------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1270 lr~~--------ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.... .....+..+++++..||++||.+|||+.+++++-+.-
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk 297 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFK 297 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHh
Confidence 3211 1223567899999999999999999999999886654
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=315.64 Aligned_cols=257 Identities=24% Similarity=0.436 Sum_probs=206.6
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||++.+ .++.+|||.+..... ........+.+|+.+++.+.||||+++++++....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-----MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN- 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-----hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-
Confidence 4677888999999999999997 578899998875321 12333467889999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1120 GTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
..+++|||+++++|.+++.. ....+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+||
T Consensus 76 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~----~~~l~df 150 (267)
T cd08229 76 -ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG----VVKLGDL 150 (267)
T ss_pred -eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC----CEEECcc
Confidence 89999999999999988753 234689999999999999999999999999999999999998765 4699999
Q ss_pred CCcccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHhcCCCCC
Q 000726 1197 GLSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--AIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1197 GLAr~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~--ell~qIve~~lr~~ 1273 (1329)
|++....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||...... .....+........
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 228 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCC
Confidence 9987543322 2234468899999999974 45788999999999999999999999654332 22223222222222
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1274 ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.+..++..+.+++.+||+.+|.+|||+.+|++.+..++
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 33457889999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=318.71 Aligned_cols=253 Identities=26% Similarity=0.326 Sum_probs=196.0
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc---CCCceeeEecccccC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L---rHPNIVKL~Gif~e~ 1117 (1329)
+|++.+.||+|+||+||+|+++ ++.||||.++........ ...+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL------PLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC------chHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 4888999999999999999984 778999998764322211 12344566666655 799999999987643
Q ss_pred C---CCeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1118 P---GGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1118 ~---dg~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
. ...+++||||+. ++|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~----~kl 149 (288)
T cd07863 75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ----VKL 149 (288)
T ss_pred cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC----EEE
Confidence 2 246899999996 58888775433 45899999999999999999999999999999999999997764 599
Q ss_pred eecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC----
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT---- 1269 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~---- 1269 (1329)
+|||++.............+|..|+|||++.+ ..++.++|||||||++|+|++|++||........+..+....
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07863 150 ADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227 (288)
T ss_pred CccCccccccCcccCCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence 99999986554433344568999999999974 457889999999999999999999997766554443332210
Q ss_pred --------------CC-------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1270 --------------LR-------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1270 --------------lr-------~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.. ......++..+.+++.+||+.||.+|||+.+++.+.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~ 287 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 00 0011245778899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=315.94 Aligned_cols=254 Identities=35% Similarity=0.605 Sum_probs=208.2
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--C---ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--G---r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
..+|++.+.||+|+||.||+|++. + ..+|+|.++.... ......+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-------EKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-------HHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 467889999999999999999873 2 3589998864321 123457888999999999999999999987
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
... ..++||||+++++|.+++......+++..++.++.|++.||+|||+++++|+||||+|||++.++ .++|+|
T Consensus 76 ~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~----~~~l~d 149 (267)
T cd05066 76 KSK--PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL----VCKVSD 149 (267)
T ss_pred cCC--ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC----eEEeCC
Confidence 754 88999999999999999976666789999999999999999999999999999999999998665 469999
Q ss_pred cCCcccccCccc----ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC
Q 000726 1196 FGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1270 (1329)
Q Consensus 1196 FGLAr~~~~~~~----ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~l 1270 (1329)
||++........ .....++..|+|||.+.+ ..++.++|+|||||++|++++ |..||......+....+.. ..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~ 226 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-GY 226 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-CC
Confidence 999875432211 111223567999999973 457889999999999999887 9999987766555554443 34
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1271 r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
+.+.+..++..+.+++.+||+.+|.+||++.++++.|..+
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 5556667889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=333.19 Aligned_cols=261 Identities=31% Similarity=0.522 Sum_probs=209.2
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE-------CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceee
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW-------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVA 1109 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~-------kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVK 1109 (1329)
....++|++.+.||+|+||.||+|.+ .++.||||+++.... ......+.+|+.+|.++ +||||++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~ 75 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLNVVN 75 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-------hHHHHHHHHHHHHHHhccCCccHhh
Confidence 45677899999999999999999975 256799999974321 12235678899999999 6899999
Q ss_pred EecccccCCCCeEEEEEEeccCCchhhhhhccc-----------------------------------------------
Q 000726 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----------------------------------------------- 1142 (1329)
Q Consensus 1110 L~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke----------------------------------------------- 1142 (1329)
+++++... ...+++||||+++++|.+++....
T Consensus 76 ~~~~~~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (343)
T cd05103 76 LLGACTKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVE 154 (343)
T ss_pred hcceeecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccC
Confidence 99988653 347889999999999998875321
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 000726 1143 -------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1329)
Q Consensus 1143 -------------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~ 1203 (1329)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~----~~kl~dfg~~~~~~ 230 (343)
T cd05103 155 EKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIY 230 (343)
T ss_pred CCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC----cEEEEecccccccc
Confidence 2367888899999999999999999999999999999999665 46999999987532
Q ss_pred Cc---ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCc
Q 000726 1204 NT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279 (1329)
Q Consensus 1204 ~~---~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips~~S 1279 (1329)
.. .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||............+........+..++
T Consensus 231 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (343)
T cd05103 231 KDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 308 (343)
T ss_pred cCcchhhcCCCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCC
Confidence 21 11222335677999999873 457889999999999999997 9999987654444444455555556666788
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1280 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
+.+.+++.+||+.+|.+||++.+|+++|+.+..
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=334.20 Aligned_cols=246 Identities=23% Similarity=0.374 Sum_probs=198.4
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
++||+|+||.||++++. ++.||||++++.... .......+.+|..++..+ +||||+++++++.+.. .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~--~~~l 73 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-----DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES--RLFF 73 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC--EEEE
Confidence 36999999999999984 678999999864322 122345577899999988 7999999999998754 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc-c
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-R 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~-~ 1203 (1329)
||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.. .
T Consensus 74 v~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~----~kL~Dfg~~~~~~~ 148 (329)
T cd05588 74 VIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH----IKLTDYGMCKEGIR 148 (329)
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC----EEECcCcccccccc
Confidence 9999999999888754 356899999999999999999999999999999999999997664 699999998742 2
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--------h-hHHHHHHHhcCCCCCC
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH--------Y-GAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~--------~-~ell~qIve~~lr~~i 1274 (1329)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... . ......+... ...+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 224 (329)
T cd05588 149 PGDTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRI 224 (329)
T ss_pred CCCccccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCC
Confidence 2223344679999999999984 457889999999999999999999996321 1 1122333333 2345
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCC------HHHHHHHHHH
Q 000726 1275 PGFCDSEWRLLMEQCWAPDPVVRPS------FTEIARRLRV 1309 (1329)
Q Consensus 1275 ps~~S~eL~DLIkrCLqkDPeERPT------aeELLq~Le~ 1309 (1329)
+..++..+.++|.+||+.||.+|++ +.++++|.|.
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~ 265 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence 6678899999999999999999987 7899888665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=333.22 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=200.0
Q ss_pred cccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
..++|++.+.||+|+||.||++.+ .++.||||+++.... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc------ChHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence 346899999999999999999987 478899999875321 122345677899999999999999999987643
Q ss_pred C----CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1118 P----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1118 ~----dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
. ....++||||+. ++|...+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~----~kl 160 (355)
T cd07874 89 KSLEEFQDVYLVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKI 160 (355)
T ss_pred ccccccceeEEEhhhhc-ccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC----EEE
Confidence 2 135799999995 56666653 34788999999999999999999999999999999999997664 699
Q ss_pred eecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-----
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN----- 1268 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~----- 1268 (1329)
+|||+++............+|..|+|||++.+ ..++.++|||||||++|+|++|+.||........+..++..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred eeCcccccCCCccccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999986554444445678999999999984 45788999999999999999999999876543332221110
Q ss_pred -----------------CCC------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1269 -----------------TLR------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1269 -----------------~lr------------------~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
... .......+..+.+||.+||+.||.+|||+.+++++.|.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 000 001112356789999999999999999999999997663
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.79 Aligned_cols=246 Identities=28% Similarity=0.430 Sum_probs=199.3
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+.||+|+||.||+|+++ ++.||||+++...... +.....+..|..++..+ +||||+++++++.+.. .+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-----DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE--HLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC--EEEE
Confidence 36999999999999984 6789999998643211 11233456677788754 8999999999998754 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc-
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~- 1203 (1329)
||||+.+++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||++....
T Consensus 74 v~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~----~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 74 VMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG----HIKIADFGMCKENVF 148 (316)
T ss_pred EECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC----CEEeCccCCCeeccc
Confidence 9999999999988854 34689999999999999999999999999999999999999766 46999999987421
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+... ....+..++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 224 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESK 224 (316)
T ss_pred CCCceeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHH
Confidence 1222344679999999999984 45788999999999999999999999887776666655433 2345667899999
Q ss_pred HHHHHhhcCCCCCCCCH-HHHHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRPSF-TEIARRLRV 1309 (1329)
Q Consensus 1284 DLIkrCLqkDPeERPTa-eELLq~Le~ 1309 (1329)
++|.+||+.||.+||++ .++++|.+.
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~~h~~f 251 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIRGHPFF 251 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHcCCCc
Confidence 99999999999999998 477766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.31 Aligned_cols=245 Identities=34% Similarity=0.585 Sum_probs=201.1
Q ss_pred EecccCcEEEEEEEEC----CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEE
Q 000726 1049 ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~k----Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
.||+|+||.||+|.+. +..||||+++... .......+.+|+.++++++||||+++++++... ..++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~---~~~l 71 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE---ALML 71 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC---CeEE
Confidence 3899999999999874 3459999886431 123345688999999999999999999988542 6899
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~ 1204 (1329)
||||+++++|.+++......+++..++.++.||+.||+|||++|++|+||||+|||++.++ .+||+|||++.....
T Consensus 72 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~----~~kl~dfg~~~~~~~ 147 (257)
T cd05115 72 VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH----YAKISDFGLSKALGA 147 (257)
T ss_pred EEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC----cEEeccCCccccccC
Confidence 9999999999999876566789999999999999999999999999999999999998665 469999999874322
Q ss_pred cc----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCc
Q 000726 1205 TL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279 (1329)
Q Consensus 1205 ~~----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips~~S 1279 (1329)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||........... +........+..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 224 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF-IEQGKRLDCPAECP 224 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-HHCCCCCCCCCCCC
Confidence 11 1111223578999999873 457889999999999999996 9999988776665543 34445566777889
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1280 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
+++.++|.+||..+|++||++.+|.+.|+.+
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.64 Aligned_cols=254 Identities=35% Similarity=0.609 Sum_probs=207.6
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--C---ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--G---r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
..+|++.+.||+|+||.||+|.+. + ..||||+++... .+.....|..|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCcCcceEEEEEC
Confidence 356889999999999999999884 3 259999986431 1233467889999999999999999999987
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
+.. ..++||||+++++|.+++......+++.+++.++.|++.||+|||++|++|+||||+|||++.++ .++|+|
T Consensus 76 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~----~~kl~d 149 (269)
T cd05065 76 KSR--PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL----VCKVSD 149 (269)
T ss_pred CCC--ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC----cEEECC
Confidence 754 78999999999999999876666789999999999999999999999999999999999998654 469999
Q ss_pred cCCcccccCcccc----cCCC--CCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhc
Q 000726 1196 FGLSKIKRNTLVT----GGVR--GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1268 (1329)
Q Consensus 1196 FGLAr~~~~~~~s----s~~~--GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~ 1268 (1329)
||++......... .... .+..|+|||.+. ...++.++|||||||++|||++ |..||...........+. .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~ 226 (269)
T cd05065 150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-Q 226 (269)
T ss_pred CccccccccCccccccccccCCCcceeecCHhHhc--cCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-c
Confidence 9998754322111 1111 235799999997 4457889999999999999987 999998777666555543 3
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1269 ~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
....+.+..++..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 344555667889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=331.43 Aligned_cols=246 Identities=24% Similarity=0.409 Sum_probs=202.7
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+.||+|+||+||++.++ +..||||++++.... .......+.+|..++..+ +||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-----QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFF 73 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEE
Confidence 36999999999999984 678999999864321 122234567888899887 6999999999998754 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc-c
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-R 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~-~ 1203 (1329)
||||+++++|..++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||++... .
T Consensus 74 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~----~kl~Dfg~~~~~~~ 148 (318)
T cd05570 74 VMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH----IKIADFGMCKEGIL 148 (318)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc----EEecccCCCeecCc
Confidence 99999999999887543 46899999999999999999999999999999999999997764 699999998742 2
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
........+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..... ..+..++..+.
T Consensus 149 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (318)
T cd05570 149 GGVTTSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV--RYPRWLSKEAK 224 (318)
T ss_pred CCCcccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--CCCCcCCHHHH
Confidence 2222334568999999999984 4578899999999999999999999988777666665554433 34567889999
Q ss_pred HHHHHhhcCCCCCCCCH-----HHHHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRPSF-----TEIARRLRV 1309 (1329)
Q Consensus 1284 DLIkrCLqkDPeERPTa-----eELLq~Le~ 1309 (1329)
+||.+||+.||.+||++ .+++.+.|.
T Consensus 225 ~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~ 255 (318)
T cd05570 225 SILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255 (318)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHhcCCCc
Confidence 99999999999999999 999887544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.48 Aligned_cols=253 Identities=32% Similarity=0.463 Sum_probs=200.5
Q ss_pred eEEEEecccCcEEEEEEEECC--c--eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC--
Q 000726 1045 EELKELGSGTFGTVYHGKWRG--T--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP-- 1118 (1329)
Q Consensus 1045 ellkvLGqGaFGtVYKA~~kG--r--~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~-- 1118 (1329)
.+.+.||+|+||.||+|++.. . .||||.++.... .......+.+|+.+++.++|+||+++++++....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC------TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence 456789999999999999853 2 589998875421 1223467888999999999999999999764321
Q ss_pred --CCeEEEEEEeccCCchhhhhhc-----ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1119 --GGTLATVTEFMVNGSLRHVLLS-----KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1119 --dg~L~LVMEYm~GGSL~d~L~~-----kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
....++||||+++++|..++.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~ 151 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM----NV 151 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC----CE
Confidence 1246899999999999888742 224578999999999999999999999999999999999998665 46
Q ss_pred EEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 000726 1192 KVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve 1267 (1329)
||+|||+++...... ......+++.|+|||.+. ...++.++|||||||++|+|++ |..||...........+..
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 229 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLA--DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHcc--CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999998543221 112223567899999998 4457889999999999999999 8999987766555554443
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1268 ~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
......+..++..+.++|.+||+.+|.+|||+.+|++.|+.+
T Consensus 230 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 -GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 333344567889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.29 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=204.8
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
.|+..+.||+|+||+||++.+. ++.||+|++...... .......+.+|+.+|+.++|+||+++++.+....
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-----KRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--
Confidence 3677889999999999999984 778999998754221 1222345678999999999999999999888754
Q ss_pred eEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|..++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~----~~kl~Dfg~~ 149 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG----HIRISDLGLA 149 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC----CEEEecCCcc
Confidence 8999999999999998876543 4689999999999999999999999999999999999998765 4699999998
Q ss_pred ccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc--CCCCCCCCC
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--TLRPPVPGF 1277 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~--~lr~~ips~ 1277 (1329)
.............|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+... ......+..
T Consensus 150 ~~~~~~~~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05632 150 VKIPEGESIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227 (285)
T ss_pred eecCCCCcccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCcc
Confidence 75433333334568999999999974 45788999999999999999999999876554333222211 112234456
Q ss_pred CcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLRVM 1310 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERPT-----aeELLq~Le~L 1310 (1329)
++..+.+|+.+||+.+|.+||+ +.+++.+.+-.
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhh
Confidence 7889999999999999999999 88998886553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=344.59 Aligned_cols=259 Identities=29% Similarity=0.383 Sum_probs=226.3
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccccC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~e~ 1117 (1329)
...|++.+.||+|.||+||+++.+ |+.+|+|++++....... ....+.+|+.+|+++. |||||.+++.|.+.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-----~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-----DREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-----cHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 457889999999999999999984 788999999886554221 2356789999999998 99999999999986
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
. .+++|||+|.||.|.+.+... .+++..+..++.||+.+++|||+.||+||||||+|+|+.........+|++|||
T Consensus 109 ~--~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 109 D--SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred C--eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 6 899999999999999999766 499999999999999999999999999999999999998765444578999999
Q ss_pred CcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC--CC
Q 000726 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VP 1275 (1329)
Q Consensus 1198 LAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~--ip 1275 (1329)
++............+||+.|+|||++. ...|+..+||||+|+++|.|++|.+||...........+....+... ..
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~--~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w 262 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLG--GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW 262 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhc--CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc
Confidence 999877766677889999999999998 45688999999999999999999999999988887777776655333 33
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1276 s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
..++..++++|+.||..||.+|+|+.++++|+|..
T Consensus 263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~ 297 (382)
T KOG0032|consen 263 DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK 297 (382)
T ss_pred cccCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence 45689999999999999999999999999998843
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=324.18 Aligned_cols=258 Identities=31% Similarity=0.516 Sum_probs=212.0
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceee
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVA 1109 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k-------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVK 1109 (1329)
.+.+++|.+.+.||+|+||.||++.+. +..||||+++.... ......+.+|+.+++++ +||||++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~iv~ 103 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-------SSEREALMSELKIMSHLGNHENIVN 103 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-------hHHHHHHHHHHHHHHhccCCCCcce
Confidence 466778999999999999999999752 34699998874321 12345688999999999 7999999
Q ss_pred EecccccCCCCeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCC
Q 000726 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188 (1329)
Q Consensus 1110 L~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~ 1188 (1329)
+++++.... ..++||||+.+++|..++.... ..+++.++..++.||+.||.|||+++|+|+||||+|||++.++
T Consensus 104 ~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--- 178 (302)
T cd05055 104 LLGACTIGG--PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--- 178 (302)
T ss_pred EEEEEecCC--ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC---
Confidence 999988754 7999999999999999986533 3489999999999999999999999999999999999998654
Q ss_pred CcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 000726 1189 PICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGG 1264 (1329)
Q Consensus 1189 ~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~q 1264 (1329)
.++|+|||++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........
T Consensus 179 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~ 255 (302)
T cd05055 179 -IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255 (302)
T ss_pred -eEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH
Confidence 46999999987543221 1222345678999999873 457889999999999999998 9999987766655555
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1265 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1265 Ive~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.+........+...+..+.+++.+||..+|++|||+.++++.|..+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 5555555556667789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=321.26 Aligned_cols=253 Identities=34% Similarity=0.546 Sum_probs=205.3
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecc
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k-------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gi 1113 (1329)
..+|++.+.||+|+||.||+|.+. +..||||+++... .......+.+|+.++..++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 345777788999999999999874 3569999987431 12234568889999999999999999999
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhcc---------------cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcc
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSK---------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDN 1178 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~k---------------ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeN 1178 (1329)
+.... ..++++||+.+++|..++... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 77 ~~~~~--~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~N 154 (283)
T cd05091 77 VTKEQ--PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN 154 (283)
T ss_pred EcCCC--ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhh
Confidence 98755 789999999999999887422 1347888899999999999999999999999999999
Q ss_pred eEeccCCCCCCcEEEeecCCcccccCc---ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCC
Q 000726 1179 LLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYA 1254 (1329)
Q Consensus 1179 ILLDsdGni~~~VKLsDFGLAr~~~~~---~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~ 1254 (1329)
||++.++. +||+|||+++..... .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 155 il~~~~~~----~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 155 VLVFDKLN----VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred eEecCCCc----eEecccccccccccchheeeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 99986653 699999998743221 11223345778999999873 457889999999999999998 888998
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1255 NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1255 ~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
..........+... ...+.+..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 229 ~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 229 GYSNQDVIEMIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 87766665554443 3445667889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.34 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=208.5
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||.|+||.||++.+ .+..||+|+++..... ......+..|+.+++.++||||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT------EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 478889999999999999987 4678999998754221 22345678899999999999999999988765556
Q ss_pred eEEEEEEeccCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHH-----HCCeeecCCCCcceEeccCCCCCCcEE
Q 000726 1121 TLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLH-----SKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~k---ek~Lse~qrlkIA~QIAsALaYLH-----s~GIIHRDLKPeNILLDsdGni~~~VK 1192 (1329)
..+++|||+++++|.+++... ...+++..++.++.||+.||+||| +.+|+|+||+|+||+++.++ .+|
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~----~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN----NVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC----CEE
Confidence 789999999999999988543 457899999999999999999999 88999999999999999765 459
Q ss_pred EeecCCcccccCccc-ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC
Q 000726 1193 VGDFGLSKIKRNTLV-TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1271 (1329)
Q Consensus 1193 LsDFGLAr~~~~~~~-ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr 1271 (1329)
|+|||++........ .....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||...........+ .....
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~ 227 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-KEGKF 227 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH-hcCCC
Confidence 999999986543322 334568999999999974 44788999999999999999999999887655444443 33444
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1272 ~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
...+..++..+.+++.+||+.+|.+||++.+|+++.
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~ 263 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence 456677889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=314.09 Aligned_cols=251 Identities=37% Similarity=0.517 Sum_probs=200.7
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCe
Q 000726 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~ 1121 (1329)
|++.+.||+|+||+||++... +..||+|++.... ..........+|+.+++.++||||+++++++.... .
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~ 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE------IEEEEREENIREIKILRRLRHPNIVQILDVFQDDN--Y 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--E
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc------ccccccchhhhhhhccccccccccccccccccccc--c
Confidence 788999999999999999995 4579999998642 22222334456999999999999999999998844 8
Q ss_pred EEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1122 L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
.++||||+++++|.+++. ....+++..++.++.||+.||+|||+++|+|+||||+|||++.++. ++|+|||.+..
T Consensus 73 ~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~----~~l~Dfg~~~~ 147 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE----VKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE----EEESSGTTTEE
T ss_pred cccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccc----ccccccccccc
Confidence 999999999889999986 4567899999999999999999999999999999999999996654 59999999875
Q ss_pred c-cCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---HHHHHHHhcCCCCCCC--
Q 000726 1202 K-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVNNTLRPPVP-- 1275 (1329)
Q Consensus 1202 ~-~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~---ell~qIve~~lr~~ip-- 1275 (1329)
. ..........++..|+|||++.. ...++.++||||||+++|+|++|..||...... ................
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 148 LSENNENFNPFVGTPEYMAPEVLQQ-GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp STSTTSEBSSSSSSGGGSCHHHHTT-TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence 2 33334445678999999999872 345788999999999999999999999887322 2222222111111111
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1276 s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
......+.+++.+||+.||.+||++.+++++.|
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 112488999999999999999999999998764
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.88 Aligned_cols=245 Identities=28% Similarity=0.390 Sum_probs=198.4
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHH-HHHhcCCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE-ILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIe-ILk~LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+.||+|+||+||+|++ +++.||||++.+.... .......+..|.. +++.++||||+++++++.+.. ..++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~--~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-----KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD--KLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC--EEEE
Confidence 3699999999999998 4788999999754221 1122234555554 567899999999999998754 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc-c
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-R 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~-~ 1203 (1329)
||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++... .
T Consensus 74 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~----~kl~Dfg~~~~~~~ 148 (323)
T cd05575 74 VLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH----VVLTDFGLCKEGIE 148 (323)
T ss_pred EEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc----EEEeccCCCccccc
Confidence 9999999999988854 456899999999999999999999999999999999999997764 599999998743 2
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+..... ..+..++..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (323)
T cd05575 149 HSKTTSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKPNISVSAR 224 (323)
T ss_pred CCCccccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 2223344569999999999984 4578899999999999999999999988777776666655433 33456789999
Q ss_pred HHHHHhhcCCCCCCCCH----HHHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRPSF----TEIARRLR 1308 (1329)
Q Consensus 1284 DLIkrCLqkDPeERPTa----eELLq~Le 1308 (1329)
++|.+||+.||.+||++ .+++.+.+
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~~il~~~~ 253 (323)
T cd05575 225 HLLEGLLQKDRTKRLGAKDDFLEIKNHVF 253 (323)
T ss_pred HHHHHHhhcCHHhCCCCCCCHHHHHcCCC
Confidence 99999999999999987 57777654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.48 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=206.9
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||+|.+. ++.||+|.++...... ......+.+|+.++++++|+||+++++++....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~- 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-----AKARQDCLKEIDLLKQLDHPNVIKYLASFIENN- 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-----hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence 57899999999999999999984 8889999987533221 222456889999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1120 GTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
..++||||+++++|..++.. ....+++.+++.++.+++.||+|||+.||+|+||+|+||+++.++. ++|+||
T Consensus 76 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~----~~l~d~ 150 (267)
T cd08224 76 -ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV----VKLGDL 150 (267)
T ss_pred -eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc----EEEecc
Confidence 88999999999999988753 2345899999999999999999999999999999999999997764 599999
Q ss_pred CCcccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHhcCCCCC
Q 000726 1197 GLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--GAIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1197 GLAr~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~--~ell~qIve~~lr~~ 1273 (1329)
|++...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......+.. ....+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 227 (267)
T cd08224 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPP 227 (267)
T ss_pred ceeeeccCCCcccceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCC
Confidence 998754322 12233458889999999873 4578899999999999999999999965432 222222222 22333
Q ss_pred CCC-CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1274 VPG-FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1274 ips-~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.+. .++..+.++|.+||..+|.+|||+.+|++.|+.++
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 333 67889999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=337.79 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=204.9
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||++++. ++.||||+++..... .......+.+|+.++..++||||+++++.+.+..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-----EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR- 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 46889999999999999999884 778999999753211 1233456778999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++. ++|+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~----vkL~DfG~~ 148 (360)
T cd05627 75 -NLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH----VKLSDFGLC 148 (360)
T ss_pred -EEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC----EEEeeccCC
Confidence 899999999999999988643 46899999999999999999999999999999999999997664 599999998
Q ss_pred ccccCcc------------------------------------cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHH
Q 000726 1200 KIKRNTL------------------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVL 1243 (1329)
Q Consensus 1200 r~~~~~~------------------------------------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLL 1243 (1329)
....... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil 226 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIM 226 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceecccccee
Confidence 6332110 0123469999999999984 4578899999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhcCCCCCCC---CHHHHHHHHH
Q 000726 1244 WEILTGEEPYANMHYGAIIGGIVNNTLRPPVP--GFCDSEWRLLMEQCWAPDPVVRP---SFTEIARRLR 1308 (1329)
Q Consensus 1244 yELLTGk~PF~~~~~~ell~qIve~~lr~~ip--s~~S~eL~DLIkrCLqkDPeERP---TaeELLq~Le 1308 (1329)
|||++|+.||...........+........++ ..++..+.++|.+|+ .+|.+|+ ++.++++|.+
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCC
Confidence 99999999998887777666665433322233 246889999999977 4999998 5889999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=339.32 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=209.5
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.+..++|++.+.||+|+||.||+++++ ++.||+|++.+.... .......+.+|+.+++.++||||+++++.+.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 345678999999999999999999984 678999998753211 1222345778999999999999999999998
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
+.. .+++||||+++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 114 ~~~--~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~----ikL~D 185 (371)
T cd05622 114 DDR--YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH----LKLAD 185 (371)
T ss_pred cCC--EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC----EEEEe
Confidence 754 89999999999999998853 35788899999999999999999999999999999999997664 69999
Q ss_pred cCCcccccCc--ccccCCCCCCcccCccccccCC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC
Q 000726 1196 FGLSKIKRNT--LVTGGVRGTLPWMAPELLNGSS--SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1271 (1329)
Q Consensus 1196 FGLAr~~~~~--~~ss~~~GTp~YmAPEvL~Gs~--~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr 1271 (1329)
||++...... .......||+.|+|||++.+.. ..++.++|||||||+||||++|..||...........+......
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 9999854322 1223567999999999997432 23788999999999999999999999887776666666654332
Q ss_pred CCC--CCCCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHHHH
Q 000726 1272 PPV--PGFCDSEWRLLMEQCWAPDPVV--RPSFTEIARRLRV 1309 (1329)
Q Consensus 1272 ~~i--ps~~S~eL~DLIkrCLqkDPeE--RPTaeELLq~Le~ 1309 (1329)
... ...++..+.++|.+||..++.+ |+++.+++++++.
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 266 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 333 3457899999999999844433 7899999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=345.30 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=226.5
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
..+|++.+.||+|.||.|-+|.. .|+.||||.+++.... ++.-...+.+|+++|..|+||||+.+|.+|++.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk-----deqDlvhIRREIeIMSsLNHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK-----DEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc-----cHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence 45788999999999999999976 4899999999886544 2333456789999999999999999999999866
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
.+.|||||..+|.|++++... +.+++..+..|++||++|+.|||+++++|||||.+|||+|.++++ ||+|||+
T Consensus 127 --KIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~Ni----KIADFGL 199 (668)
T KOG0611|consen 127 --KIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNI----KIADFGL 199 (668)
T ss_pred --eEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCe----eeeccch
Confidence 899999999999999999654 569999999999999999999999999999999999999998876 9999999
Q ss_pred cccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1199 Ar~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
+-.+.......++||++.|.+||++.|..+. ++.+|.||||++||-|+.|..||++.+...++.+|....++.+. -
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~-GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~ 275 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYK-GPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---T 275 (668)
T ss_pred hhhhccccHHHHhcCCcccCCccccCCCCCC-CCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---C
Confidence 9988888888899999999999999986654 77899999999999999999999999988888888887776543 3
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
+....-||++||..+|++|.|+++|..|.|.-
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 55678899999999999999999999999863
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.56 Aligned_cols=248 Identities=25% Similarity=0.421 Sum_probs=205.5
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||+|+||.||++++. +..+|+|.++.... ......+.+|+.+++.++|+||+++++.+.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-------SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--
Confidence 4788999999999999999884 77899999864321 122456778999999999999999999998754
Q ss_pred eEEEEEEeccCCchhhhhhc-ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLS-KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~-kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++. ++|+|||++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~----~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK----VKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc----EEEcccCcc
Confidence 89999999999999988754 3356889999999999999999999999999999999999997664 599999998
Q ss_pred ccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 r~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
...... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...........+... ...+.+..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 224 (255)
T cd08219 148 RLLTSPGAYACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG-SYKPLPSHY 224 (255)
T ss_pred eeecccccccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC-CCCCCCccc
Confidence 754322 22234568889999999974 45788999999999999999999999887666555554433 334456678
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARR 1306 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~ 1306 (1329)
+..+.+++.+||+.||.+||++.+++..
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 8999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.28 Aligned_cols=254 Identities=37% Similarity=0.614 Sum_probs=210.2
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC-CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
.+..++|++.+.||+|+||.||++.++ +..||||.+...... ..++.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---------PEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---------HHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 356789999999999999999999875 467999998753211 2457889999999999999999999876
Q ss_pred CCCCeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
.. ..++||||+++++|.+++.... ..+++..+..++.+|+.||.|||+++|+|+||||+||+++.++. ++|+|
T Consensus 73 ~~--~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~----~~l~d 146 (261)
T cd05034 73 EE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV----CKIAD 146 (261)
T ss_pred CC--ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC----EEECc
Confidence 44 7899999999999999986543 56899999999999999999999999999999999999997754 59999
Q ss_pred cCCcccccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC
Q 000726 1196 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1196 FGLAr~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~ 1272 (1329)
||++....... .......+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...........+. .....
T Consensus 147 ~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~ 223 (261)
T cd05034 147 FGLARLIEDDEYTAREGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRM 223 (261)
T ss_pred cccceeccchhhhhhhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 99987543211 1112234568999999984 457889999999999999998 999998877666665544 33445
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
+.+..++..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 5566678999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=333.22 Aligned_cols=254 Identities=23% Similarity=0.299 Sum_probs=200.7
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++.+.||+|+||.||++.+ .++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc------CchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 46899999999999999999987 477899999875321 1222356778999999999999999999876432
Q ss_pred ----CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1119 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1119 ----dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
...+++||||+. ++|...+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~~kL~ 168 (364)
T cd07875 97 SLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKIL 168 (364)
T ss_pred cccccCeEEEEEeCCC-CCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC----cEEEE
Confidence 235799999995 56766663 3478889999999999999999999999999999999999766 46999
Q ss_pred ecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC---
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 1271 (1329)
Q Consensus 1195 DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr--- 1271 (1329)
|||+++............+|..|+|||++.+ ..++.++|||||||+||+|++|+.||........+..++.....
T Consensus 169 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (364)
T cd07875 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246 (364)
T ss_pred eCCCccccCCCCcccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9999986554444445668999999999984 45788999999999999999999999876654443333221000
Q ss_pred -----------------C--------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1272 -----------------P--------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1272 -----------------~--------------------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
+ ......+..+++||.+||+.||.+|||+.++++|.|-.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 0 00111346789999999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.20 Aligned_cols=256 Identities=36% Similarity=0.612 Sum_probs=208.5
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC--Cc---eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GT---DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k--Gr---~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gi 1113 (1329)
|...+|+..+.||+|+||.||+|.+. +. .+|||.++... .......+.+|+.+++.++||||++++++
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-------TEKQRQDFLSEASIMGQFSHHNIIRLEGV 74 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Confidence 34567888999999999999999874 33 58999886431 12224568899999999999999999999
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
+.... ..++||||+++++|..++......+++..+..++.|++.||+|||+.|++|+||||+|||++.++ .+||
T Consensus 75 ~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~----~~kl 148 (268)
T cd05063 75 VTKFK--PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL----ECKV 148 (268)
T ss_pred EccCC--CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC----cEEE
Confidence 98754 78999999999999999876666789999999999999999999999999999999999998665 4699
Q ss_pred eecCCcccccCccc----ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhc
Q 000726 1194 GDFGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1268 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~----ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~ 1268 (1329)
+|||++........ ......+..|+|||++. ...++.++|||||||++|||++ |..||...........+..
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~- 225 (268)
T cd05063 149 SDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA--YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND- 225 (268)
T ss_pred CCCccceecccccccceeccCCCcCceecCHHHhh--cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-
Confidence 99999874432111 11112345799999987 3457889999999999999997 9999987766665555543
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1269 ~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
....+.+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 226 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 345555667889999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=317.15 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=202.8
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.....+|++.+.||+|+||.||+|++ .++.||||+++.... .....+.+|+.+++.++||||+++++.+.
T Consensus 5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~ii~~~~~~~ 76 (267)
T cd06646 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--------DDFSLIQQEIFMVKECKHCNIVAYFGSYL 76 (267)
T ss_pred cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--------chHHHHHHHHHHHHhcCCCCeeeeeEEEE
Confidence 34456899999999999999999997 467899999864311 11234678999999999999999999998
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
... .+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+|+||+|+||+++.++. ++|+|
T Consensus 77 ~~~--~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~----~~l~d 149 (267)
T cd06646 77 SRE--KLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD----VKLAD 149 (267)
T ss_pred eCC--EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC----EEECc
Confidence 754 899999999999999988543 46899999999999999999999999999999999999987664 59999
Q ss_pred cCCcccccCc-ccccCCCCCCcccCccccccC-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 000726 1196 FGLSKIKRNT-LVTGGVRGTLPWMAPELLNGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1196 FGLAr~~~~~-~~ss~~~GTp~YmAPEvL~Gs-~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ 1273 (1329)
||++...... .......++..|+|||.+.+. ...++.++|||||||++|+|++|+.||...........+.......+
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd06646 150 FGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP 229 (267)
T ss_pred CccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC
Confidence 9998754322 122345688999999998532 34467899999999999999999999965543332222222222221
Q ss_pred C---CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1274 V---PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1274 i---ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
. ...++..+.++|.+||+.+|++||++.+++++|+
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 1 2346789999999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.68 Aligned_cols=254 Identities=32% Similarity=0.520 Sum_probs=206.7
Q ss_pred CeeEEEEecccCcEEEEEEEECC-------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1043 DLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~kG-------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
+|++.+.||+|+||.||+|.+.. ..+|+|.++.... ......+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-------SSELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-------HHHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 36778899999999999998742 4588888864321 122356889999999999999999999988
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcc-----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCeeec
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSK-----------------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 1172 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~k-----------------------ek~Lse~qrlkIA~QIAsALaYLHs~GIIHR 1172 (1329)
... ..++||||+.+++|.+++... ...+++..++.++.|++.||+|||+++|+||
T Consensus 74 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~ 151 (290)
T cd05045 74 QDG--PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151 (290)
T ss_pred cCC--CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehh
Confidence 754 789999999999999887431 1357889999999999999999999999999
Q ss_pred CCCCcceEeccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-
Q 000726 1173 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT- 1248 (1329)
Q Consensus 1173 DLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT- 1248 (1329)
||||+|||+++++ .+||+|||+++...... ......++..|+|||.+. ...++.++|||||||++|+|++
T Consensus 152 dikp~nill~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~~l~el~t~ 225 (290)
T cd05045 152 DLAARNVLVAEGR----KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTL 225 (290)
T ss_pred hhhhheEEEcCCC----cEEeccccccccccCccchhcccCCCCCccccCHHHHc--cCCcchHhHHHHHHHHHHHHHhc
Confidence 9999999998765 46999999987432211 122334567899999987 3457899999999999999998
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1249 GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1249 Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
|..||.......... ........+.+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 226 g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 226 GGNPYPGIAPERLFN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCCCCHHHHHH-HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 999998776655544 344455566677889999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.46 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=192.8
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEE
Q 000726 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1329)
Q Consensus 1050 LGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVME 1127 (1329)
||+|+||.||+++.. |+.||+|.+....... ......+..|+++++.++||||+++++++.... .+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~--~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-----KSGEKMALLEKEILEKVNSPFIVNLAYAFESKT--HLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-----chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC--eEEEEEe
Confidence 799999999999874 7889999986532211 111234557999999999999999999998754 8999999
Q ss_pred eccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCcc
Q 000726 1128 FMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206 (1329)
Q Consensus 1128 Ym~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~ 1206 (1329)
|+++++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++.......
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~----~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN----CRLSDLGLAVELKDGK 149 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC----EEEeeceeeeecCCCc
Confidence 999999988875433 45889999999999999999999999999999999999997664 5999999987654433
Q ss_pred cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHhcCCCCCCCCCCcHHH
Q 000726 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG----AIIGGIVNNTLRPPVPGFCDSEW 1282 (1329)
Q Consensus 1207 ~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~----ell~qIve~~lr~~ips~~S~eL 1282 (1329)
......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ............. ....++.++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 226 (277)
T cd05607 150 TITQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEES 226 (277)
T ss_pred eeeccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHH
Confidence 3334568999999999984 34788999999999999999999999754322 2222222222211 123578999
Q ss_pred HHHHHHhhcCCCCCCCCHHH----HHHHHHH
Q 000726 1283 RLLMEQCWAPDPVVRPSFTE----IARRLRV 1309 (1329)
Q Consensus 1283 ~DLIkrCLqkDPeERPTaeE----LLq~Le~ 1309 (1329)
.+|+.+||+.||.+||++.+ ++.|.|.
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 99999999999999999954 4455444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.21 Aligned_cols=258 Identities=33% Similarity=0.599 Sum_probs=210.7
Q ss_pred ccccCeeEEEEecccCcEEEEEEEECC-----ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~kG-----r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gi 1113 (1329)
+...+|.+.+.||+|+||.||+|.+.. ..||||.+.... .......+.+|+.+++.+.||||++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 75 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------SPSVREKFLQEAYIMRQFDHPHIVKLIGV 75 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCchhceeEE
Confidence 445678999999999999999998742 358999886431 12234578899999999999999999998
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
+.+. ..++||||+++++|.+++......+++..++.++.+|+.||+|||+++++|+||||+|||++.++ .++|
T Consensus 76 ~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~----~~~l 148 (270)
T cd05056 76 ITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD----CVKL 148 (270)
T ss_pred EcCC---CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC----CeEE
Confidence 8753 46899999999999999976555689999999999999999999999999999999999999765 4699
Q ss_pred eecCCcccccCccc--ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC
Q 000726 1194 GDFGLSKIKRNTLV--TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1270 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~--ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~l 1270 (1329)
+|||++........ .....++..|+|||.+. ...++.++|||||||++|+|++ |..||......+....+ ....
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-~~~~ 225 (270)
T cd05056 149 GDFGLSRYLEDESYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-ENGE 225 (270)
T ss_pred ccCceeeecccccceecCCCCccccccChhhhc--cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HcCC
Confidence 99999875433221 11223456799999987 3457889999999999999996 99999887766555443 3334
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1271 r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
..+.+..++..+.+++.+||..+|.+|||+.+++..|..+...
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 4556677899999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=330.80 Aligned_cols=245 Identities=29% Similarity=0.443 Sum_probs=199.0
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHh-cCCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~-LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+.||+|+||+||+|+++ ++.||||+++..... .+.....+..|..++.. ++||||+++++++.+.. .+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~--~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE--NLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC--EEEE
Confidence 36999999999999985 577999999864321 11123445667778876 48999999999998754 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc-
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~- 1203 (1329)
||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 74 v~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~----~kl~Dfg~~~~~~~ 148 (316)
T cd05619 74 VMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH----IKIADFGMCKENML 148 (316)
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC----EEEccCCcceECCC
Confidence 9999999999998854 346889999999999999999999999999999999999997664 6999999987421
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ...+..++..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (316)
T cd05619 149 GDAKTCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAK 224 (316)
T ss_pred CCCceeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHH
Confidence 2222334568999999999984 457889999999999999999999998877766665554333 334567889999
Q ss_pred HHHHHhhcCCCCCCCCHH-HHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRPSFT-EIARRLR 1308 (1329)
Q Consensus 1284 DLIkrCLqkDPeERPTae-ELLq~Le 1308 (1329)
+++.+||+.+|.+||++. +++++.+
T Consensus 225 ~li~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05619 225 DILVKLFVREPERRLGVKGDIRQHPF 250 (316)
T ss_pred HHHHHHhccCHhhcCCChHHHHcCcc
Confidence 999999999999999996 7777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.89 Aligned_cols=249 Identities=34% Similarity=0.639 Sum_probs=205.6
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC-CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
..+|++.+.||+|+||.||++.+. ++.+|||+++..... ...+.+|++++++++||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---------EEDFIEEAQVMMKLSHPKLVQLYGVCTERS- 72 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---------HHHHHHHHHHHHhCCCCCeeeEEEEEccCC-
Confidence 457899999999999999999885 778999988753221 235778999999999999999999987754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|.+++......+++..++.++.+++.+|+|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~----~~~l~d~g~~ 147 (256)
T cd05112 73 -PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ----VVKVSDFGMT 147 (256)
T ss_pred -ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC----eEEECCCcce
Confidence 78999999999999999876666789999999999999999999999999999999999998665 4699999998
Q ss_pred ccccCccc--ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 000726 1200 KIKRNTLV--TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1200 r~~~~~~~--ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips 1276 (1329)
........ .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||...........+.. ..+...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 224 (256)
T cd05112 148 RFVLDDQYTSSTGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFRLYKPR 224 (256)
T ss_pred eecccCcccccCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-CCCCCCCC
Confidence 74432211 122335678999999974 457889999999999999998 9999987766555554432 23344455
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
..+..+.+|+.+||+.+|.+||++.+++++|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 6789999999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.20 Aligned_cols=262 Identities=29% Similarity=0.512 Sum_probs=212.5
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC---------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCce
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNV 1107 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k---------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNI 1107 (1329)
.+...+|.+.+.||+|+||.||++++. +..||+|.++... .......+.+|+.+++.+ +||||
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i 83 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNI 83 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-------chHHHHHHHHHHHHHHhhccCCCc
Confidence 456778999999999999999999752 2358999886431 122245688999999999 89999
Q ss_pred eeEecccccCCCCeEEEEEEeccCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeec
Q 000726 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 1172 (1329)
Q Consensus 1108 VKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHR 1172 (1329)
+++++++.... ..++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||
T Consensus 84 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 84 INLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred hheeEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 99999998754 8899999999999999986431 347888899999999999999999999999
Q ss_pred CCCCcceEeccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-
Q 000726 1173 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT- 1248 (1329)
Q Consensus 1173 DLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT- 1248 (1329)
||||+|||++.++ .+||+|||+++...... ......++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 162 dlkp~Nili~~~~----~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 162 DLAARNVLVTENN----VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred ccccceEEEcCCC----cEEECCCccceecccccccccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcC
Confidence 9999999998665 46999999998543221 1222335678999999974 457889999999999999998
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1249 GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1249 Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
|..||......+....+ ....+...+..++..+.+++.+||+.+|.+||++.++++.|..+.....
T Consensus 236 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 236 GGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred CCCCcccCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 88899887766665544 3344455566789999999999999999999999999999998866543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.91 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=205.6
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++.+.||.|+||.||++.+. ++.+|+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--------DDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--------hhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 468999999999999999999884 67799999975321 12467789999999999999999999988754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
.++++|||+.+++|.+++......+++..++.++.|++.||+|||+++|+|+||+|+||+++.++. ++|+|||+
T Consensus 74 --~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~----~~l~d~g~ 147 (262)
T cd06613 74 --KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD----VKLADFGV 147 (262)
T ss_pred --EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC----EEECcccc
Confidence 899999999999999988665567899999999999999999999999999999999999997764 59999999
Q ss_pred cccccCcc-cccCCCCCCcccCccccccC-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC---C
Q 000726 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP---P 1273 (1329)
Q Consensus 1199 Ar~~~~~~-~ss~~~GTp~YmAPEvL~Gs-~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~---~ 1273 (1329)
+....... ......++..|+|||.+.+. ...++.++|||||||++|+|++|+.||...........+....+.. .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 148 SAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLK 227 (262)
T ss_pred chhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcccc
Confidence 87543321 22345688899999998742 1257889999999999999999999998766554444333332221 1
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306 (1329)
Q Consensus 1274 ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~ 1306 (1329)
....++.++.+++.+||..+|.+|||+.+|+.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 223457889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=330.52 Aligned_cols=257 Identities=23% Similarity=0.299 Sum_probs=206.3
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||++++. ++.||||++.+... ........+.+|+.++..++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-----LKRAETACFREERDVLVNGDRRWITNLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-
Confidence 47899999999999999999984 77899999975311 11223455788999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||++
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~----~kl~Dfg~~ 149 (331)
T cd05597 75 -NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH----IRLADFGSC 149 (331)
T ss_pred -eEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC----EEEEECCce
Confidence 899999999999999999765667899999999999999999999999999999999999987664 599999998
Q ss_pred ccccCcc--cccCCCCCCcccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC
Q 000726 1200 KIKRNTL--VTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1200 r~~~~~~--~ss~~~GTp~YmAPEvL~Gs---~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~i 1274 (1329)
....... ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||......+....+........+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQF 229 (331)
T ss_pred eecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccC
Confidence 7543221 22234689999999998632 234678999999999999999999999887666665555543322222
Q ss_pred ---CCCCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHHHH
Q 000726 1275 ---PGFCDSEWRLLMEQCWAPDPVV--RPSFTEIARRLRV 1309 (1329)
Q Consensus 1275 ---ps~~S~eL~DLIkrCLqkDPeE--RPTaeELLq~Le~ 1309 (1329)
...++..+.++|.+||..++.. |+++.+++.|.|.
T Consensus 230 ~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 230 PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 2347899999999988664443 7899999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=321.30 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=204.7
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
.|+..+.||+|+||.||++.+. ++.||||.+...... .......+.+|+.+++.++|++|+++++.+....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-----chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--
Confidence 3677889999999999999984 678999998754322 1222345678999999999999999999988754
Q ss_pred eEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++. ++|+|||++
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~----~~l~Dfg~~ 149 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH----IRISDLGLA 149 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC----EEEeeccce
Confidence 8999999999999998885433 45899999999999999999999999999999999999997654 699999998
Q ss_pred ccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---HHHHHHHhcCCCCCCCC
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~---ell~qIve~~lr~~ips 1276 (1329)
.............|+..|+|||++. ...++.++|||||||++|+|++|+.||...... ........ ......+.
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (285)
T cd05630 150 VHVPEGQTIKGRVGTVGYMAPEVVK--NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSE 226 (285)
T ss_pred eecCCCccccCCCCCccccChHHHc--CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCc
Confidence 7543333333456899999999998 455788999999999999999999999765432 11222211 12233455
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLRVM 1310 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPT-----aeELLq~Le~L 1310 (1329)
.+++.+.+|+.+||+.||.+||| +.+++++.+-.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 67889999999999999999999 89999988765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.91 Aligned_cols=254 Identities=34% Similarity=0.538 Sum_probs=204.4
Q ss_pred cccCeeEEEEecccCcEEEEEEEECC------------------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHh
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWRG------------------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~kG------------------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~ 1101 (1329)
...+|++.+.||+|+||.||++.+.. ..||+|.+.... .......+.+|+.+++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~ 75 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-------SDNAREDFLKEVKILSR 75 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-------CHHHHHHHHHHHHHHHh
Confidence 35678999999999999999988642 348999887532 12345678899999999
Q ss_pred cCCCceeeEecccccCCCCeEEEEEEeccCCchhhhhhccc----------ccCCHHHHHHHHHHHHHHHHHHHHCCeee
Q 000726 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 1171 (1329)
Q Consensus 1102 LrHPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke----------k~Lse~qrlkIA~QIAsALaYLHs~GIIH 1171 (1329)
++||||+++++++.... ..++||||+++++|..++.... ..+++..++.++.|++.||+|||++||+|
T Consensus 76 l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H 153 (296)
T cd05051 76 LSDPNIARLLGVCTVDP--PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVH 153 (296)
T ss_pred cCCCCEeEEEEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 99999999999998754 8899999999999999886543 26899999999999999999999999999
Q ss_pred cCCCCcceEeccCCCCCCcEEEeecCCcccccCc---ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 000726 1172 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248 (1329)
Q Consensus 1172 RDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~---~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT 1248 (1329)
+||||+|||++.++ .++|+|||++...... .......++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 154 ~dlkp~Nili~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 154 RDLATRNCLVGKNY----TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred cccchhceeecCCC----ceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHh
Confidence 99999999999775 4699999998743221 12223446778999999874 457889999999999999998
Q ss_pred --CCCCCCCCChhHHHHHHHhc------CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1249 --GEEPYANMHYGAIIGGIVNN------TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1249 --Gk~PF~~~~~~ell~qIve~------~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
+..||........+...... ....+.+..++.++.+++.+||+.+|.+|||+.+|++.|+
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 228 LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 77888776665555443322 1122334557789999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=314.58 Aligned_cols=255 Identities=26% Similarity=0.372 Sum_probs=203.9
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~ 1117 (1329)
.+.|++.+.||+|+||.||+|.+. ++.||||++..... ....+.+|+.+++++ +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---------EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 346777889999999999999884 67899999875311 123567889999998 699999999998653
Q ss_pred C----CCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEE
Q 000726 1118 P----GGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1118 ~----dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VK 1192 (1329)
. ...+++||||+.+++|.+++... ...+++..+..++.|++.||+|||+++|+|+||||+||+++.++. ++
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~----~~ 151 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE----VK 151 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC----EE
Confidence 2 23689999999999999988653 356899999999999999999999999999999999999997664 69
Q ss_pred EeecCCcccccCc-ccccCCCCCCcccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 000726 1193 VGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1268 (1329)
Q Consensus 1193 LsDFGLAr~~~~~-~~ss~~~GTp~YmAPEvL~Gs---~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~ 1268 (1329)
|+|||++...... .......|+..|+|||++.+. ...++.++|||||||++|+|++|..||...............
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~ 231 (272)
T cd06637 152 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 231 (272)
T ss_pred EccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC
Confidence 9999998754322 223345689999999998632 235778999999999999999999999766554444333333
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1269 ~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
..+......++..+.+|+.+||..+|.+|||+.+++++.|
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 3333344567889999999999999999999999998754
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.28 Aligned_cols=252 Identities=36% Similarity=0.614 Sum_probs=206.2
Q ss_pred ccccCeeEEEEecccCcEEEEEEEECC-ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~kG-r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
+..++|.+.+.||+|++|.||++.+.+ ..+|+|.+..... ....+.+|+.+++.+.|+|++++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---------MPEAFLQEAQIMKKLRHDKLVPLYAVVSE- 72 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---------cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 445679999999999999999999854 4699998764311 12457789999999999999999998754
Q ss_pred CCCeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
...++||||+.+++|.+++.... ..+++..+..++.|++.||+|||+.||+|+||||+||++++++ .++|+||
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~----~~~l~df 146 (260)
T cd05069 73 --EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL----VCKIADF 146 (260)
T ss_pred --CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC----eEEECCC
Confidence 25789999999999999986533 4578999999999999999999999999999999999999765 4699999
Q ss_pred CCcccccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCC
Q 000726 1197 GLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1197 GLAr~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ 1273 (1329)
|++....... ......++..|+|||.+. ...++.++|||||||++|+|++ |..||...........+. .....+
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~ 223 (260)
T cd05069 147 GLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMP 223 (260)
T ss_pred ccceEccCCcccccCCCccchhhCCHHHhc--cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 9997543221 112234567899999987 3457889999999999999999 999998877666555543 334445
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1274 ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
.+...+..+.+++.+||+++|.+||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.67 Aligned_cols=245 Identities=27% Similarity=0.368 Sum_probs=197.2
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHH-HHHhcCCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE-ILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIe-ILk~LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
++||+|+||.||+|++. ++.||||++.+.... .......+.+|.. +++.++||||+++++++.+.. ..++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-----KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--EEEE
Confidence 36999999999999984 678999999754221 1122334555554 578899999999999988755 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc-c
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-R 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~-~ 1203 (1329)
||||+++++|...+.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++. +||+|||++... .
T Consensus 74 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~----~kl~Dfg~~~~~~~ 148 (321)
T cd05603 74 VLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH----VVLTDFGLCKEGVE 148 (321)
T ss_pred EEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC----EEEccCCCCccCCC
Confidence 9999999999887753 456889999999999999999999999999999999999997764 599999998743 2
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
.........||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+.... ..++...+..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (321)
T cd05603 149 PEETTSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP--LQLPGGKTVAAC 224 (321)
T ss_pred CCCccccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 2223344568999999999974 457889999999999999999999998877766666665543 345566788999
Q ss_pred HHHHHhhcCCCCCCCCH----HHHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRPSF----TEIARRLR 1308 (1329)
Q Consensus 1284 DLIkrCLqkDPeERPTa----eELLq~Le 1308 (1329)
+++.+||+.+|.+||++ .+++++++
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05603 225 DLLVGLLHKDQRRRLGAKADFLEIKNHVF 253 (321)
T ss_pred HHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence 99999999999999865 46666544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=348.66 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=211.5
Q ss_pred cccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
...+|++.+.||+|+||+||++.+ +++.||||++...... +.....+.+|+.++..++|+||++++..+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS------EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 356899999999999999999987 5789999999764321 22345678899999999999999998876532
Q ss_pred CC------CeEEEEEEeccCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCC
Q 000726 1118 PG------GTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188 (1329)
Q Consensus 1118 ~d------g~L~LVMEYm~GGSL~d~L~~k---ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~ 1188 (1329)
.. ..+++||||+++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~--- 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG--- 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC---
Confidence 21 2478999999999999988543 34689999999999999999999999999999999999999765
Q ss_pred CcEEEeecCCcccccCc---ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 000726 1189 PICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1265 (1329)
Q Consensus 1189 ~~VKLsDFGLAr~~~~~---~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qI 1265 (1329)
.+||+|||+++..... ......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||........+..+
T Consensus 181 -~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 181 -LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred -CEEEEecccCeeccccccccccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 4699999999754321 12234579999999999984 45789999999999999999999999887776666665
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1266 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1266 ve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.... ..+.+..+++.+.+++.+||+.+|.+||++.+++.+.+
T Consensus 258 ~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~ 299 (496)
T PTZ00283 258 LAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPI 299 (496)
T ss_pred hcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence 5443 33466778999999999999999999999999998754
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.18 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=210.6
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEec
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~G 1112 (1329)
+..++|++.+.||+|+||.||+|.+. +..|++|.++... .......+.+|+.+++.++|+||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-------SEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45788999999999999999999984 3669999876321 2233466788999999999999999999
Q ss_pred ccccCCCCeEEEEEEeccCCchhhhhhccc-------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCC
Q 000726 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE-------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 1185 (1329)
Q Consensus 1113 if~e~~dg~L~LVMEYm~GGSL~d~L~~ke-------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdG 1185 (1329)
++... ....+++++|+++++|..++.... ..+++..++.++.||+.||+|||+++++|+||||+|||++.++
T Consensus 76 ~~~~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~ 154 (280)
T cd05043 76 VCIED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL 154 (280)
T ss_pred EEecC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC
Confidence 87654 236789999999999999885432 4589999999999999999999999999999999999998665
Q ss_pred CCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 000726 1186 PIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI 1261 (1329)
Q Consensus 1186 ni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~el 1261 (1329)
.+||+|||+++...... ......++..|+|||++.+ ..++.++|||||||++||+++ |+.||........
T Consensus 155 ----~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 228 (280)
T cd05043 155 ----QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228 (280)
T ss_pred ----cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH
Confidence 46999999997542211 1122345678999999973 457899999999999999999 9999987655554
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1262 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1262 l~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
... +........+..+++.+.+++.+||..+|++|||+.++++.|..+...
T Consensus 229 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 229 AAY-LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHH-HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 433 334444455566789999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.22 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=188.9
Q ss_pred EEecccCcEEEEEEEEC----CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEE
Q 000726 1048 KELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k----Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~ 1123 (1329)
++||+|+||+||+|++. ++.||||.++.... ...+.+|+.+|++++||||+++++++.......++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 57999999999999863 46799999864321 13466899999999999999999998765566899
Q ss_pred EEEEeccCCchhhhhhcc--------cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1124 TVTEFMVNGSLRHVLLSK--------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1124 LVMEYm~GGSL~d~L~~k--------ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
+||||+ +++|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.....+||+|
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 999998 46777766321 235889999999999999999999999999999999999965544455789999
Q ss_pred cCCcccccCc----ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---------HHH
Q 000726 1196 FGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---------AII 1262 (1329)
Q Consensus 1196 FGLAr~~~~~----~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~---------ell 1262 (1329)
||+++..... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|++||...... ..+
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcC-CCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHH
Confidence 9999754322 12234568999999999975 234788999999999999999999999643221 111
Q ss_pred HHHHhc-----------------------CC-CC------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 000726 1263 GGIVNN-----------------------TL-RP------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306 (1329)
Q Consensus 1263 ~qIve~-----------------------~l-r~------------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~ 1306 (1329)
..+... .. .. ......+..+.+||.+||+.||.+|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 235 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111000 00 00 0001234668899999999999999999999987
Q ss_pred HH
Q 000726 1307 LR 1308 (1329)
Q Consensus 1307 Le 1308 (1329)
.|
T Consensus 315 p~ 316 (317)
T cd07868 315 PY 316 (317)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.11 Aligned_cols=253 Identities=37% Similarity=0.582 Sum_probs=206.2
Q ss_pred ccccCeeEEEEecccCcEEEEEEEE-------CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKW-------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~-------kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
+.+.+|.+.++||+|+||.||++.. .+..+|+|.++.. .......+.+|+.+++.++|+||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--------SESARQDFQREAELLTVLQHQHIVRFY 73 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--------CHHHHHHHHHHHHHHhcCCCCCCceEE
Confidence 4567889999999999999999974 2456899987642 123345788999999999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhccc--------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCc
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE--------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCD 1177 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke--------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPe 1177 (1329)
+++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+
T Consensus 74 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 151 (280)
T cd05092 74 GVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATR 151 (280)
T ss_pred EEEecCC--ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHh
Confidence 9988754 7899999999999999886432 24788999999999999999999999999999999
Q ss_pred ceEeccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCC
Q 000726 1178 NLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1253 (1329)
Q Consensus 1178 NILLDsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF 1253 (1329)
|||++.++ .+||+|||++....... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus 152 nil~~~~~----~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~ 225 (280)
T cd05092 152 NCLVGQGL----VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPW 225 (280)
T ss_pred hEEEcCCC----CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99998655 46999999987432211 1122335678999999874 457889999999999999998 99999
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1254 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1254 ~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
...........+... .....+..+++.+.+|+.+||+.||.+||++.+|++.|+
T Consensus 226 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 226 YQLSNTEAIECITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ccCCHHHHHHHHHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 877666655554433 334455678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.34 Aligned_cols=245 Identities=36% Similarity=0.607 Sum_probs=204.1
Q ss_pred EEecccCcEEEEEEEEC---Cc--eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeE
Q 000726 1048 KELGSGTFGTVYHGKWR---GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k---Gr--~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L 1122 (1329)
+.||+|++|.||+|.+. ++ .||||.+...... .....+.+|+.++++++||||+++++++.. ...
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 70 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPL 70 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeE
Confidence 36899999999999873 22 5899998764321 445678899999999999999999999887 378
Q ss_pred EEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1123 ATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+|||++.++ .+||+|||++..
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~----~~kl~dfg~~~~ 146 (257)
T cd05040 71 MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD----KVKIGDFGLMRA 146 (257)
T ss_pred EEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC----EEEecccccccc
Confidence 99999999999999987654 5689999999999999999999999999999999999999775 469999999875
Q ss_pred ccCcc----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 000726 1202 KRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1202 ~~~~~----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips 1276 (1329)
..... ......++..|+|||++. ...++.++|||||||++|+|++ |..||......+....+.........+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
T cd05040 147 LPQNEDHYVMEEHLKVPFAWCAPESLR--TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPE 224 (257)
T ss_pred ccccccceecccCCCCCceecCHHHhc--ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCc
Confidence 43211 112244678899999987 3457889999999999999998 9999988777766666554444555566
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 77899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=329.92 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=207.5
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||+++++ ++.||+|++.+... ........+..|+.++..++|+||+++++.+.+..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-----LKRAETACFREERDVLVNGDNQWITTLHYAFQDEN- 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-
Confidence 47899999999999999999985 56799999865311 11222345778999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++.++. +||+|||++
T Consensus 75 -~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~----~kL~DfG~a 149 (332)
T cd05623 75 -NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH----IRLADFGSC 149 (332)
T ss_pred -EEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC----EEEeecchh
Confidence 899999999999999999765667899999999999999999999999999999999999997664 699999998
Q ss_pred ccccC--cccccCCCCCCcccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC
Q 000726 1200 KIKRN--TLVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1200 r~~~~--~~~ss~~~GTp~YmAPEvL~Gs---~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~i 1274 (1329)
..... ........||+.|+|||++.+. ...++.++|||||||+||||++|+.||...........+.....+...
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (332)
T cd05623 150 LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 229 (332)
T ss_pred eecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC
Confidence 74322 2222345699999999998632 235688999999999999999999999888777777666654433333
Q ss_pred C---CCCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHHH
Q 000726 1275 P---GFCDSEWRLLMEQCWAPDPVV--RPSFTEIARRLR 1308 (1329)
Q Consensus 1275 p---s~~S~eL~DLIkrCLqkDPeE--RPTaeELLq~Le 1308 (1329)
+ ..++..+.+|+.+||..++.. |+++.++++|.+
T Consensus 230 p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 230 PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 3 357899999999999765444 689999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=307.24 Aligned_cols=252 Identities=28% Similarity=0.443 Sum_probs=205.6
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
.|++.+.||.|++|.||++.+. ++.||||.+..... .......+.+|+.++++++|+|++++++.+... ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA------SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CC
Confidence 4889999999999999999874 67899999875322 122345678899999999999999999887543 34
Q ss_pred eEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++... ...+++.+++.++.+++.+|+|||++||+|+||||+||+++.++ .++|+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~----~~~l~df~~~ 149 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN----IIKVGDLGIA 149 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC----cEEEecccce
Confidence 689999999999999988653 34689999999999999999999999999999999999998665 4699999998
Q ss_pred ccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 r~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
...... .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... .....+..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 226 (257)
T cd08223 150 RVLENQCDMASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG-KLPPMPKDY 226 (257)
T ss_pred EEecccCCccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CCCCCcccc
Confidence 754322 22233458899999999974 45778999999999999999999999877665555444433 233455678
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
++.+.+++.+||+.+|.+||++.+++.+.+
T Consensus 227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 227 SPELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 899999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=307.09 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=208.8
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||+|+||.||++.+ .+..+|||.+...... ......+.+|+.+|+.++||||+++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT------KDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc------cHHHHHHHHHHHHHhhCCCCchhheeeeEecCC--
Confidence 478899999999999999887 4678999998754322 122456889999999999999999999887644
Q ss_pred eEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|.+++.... ..+++..+..++.+++.+|+|||++||+|+||+|+||+++.++ ..++|+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~---~~~~l~d~~~~ 149 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK---MVVKIGDFGIS 149 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEEccCCCc
Confidence 8999999999999999996543 4589999999999999999999999999999999999998654 24799999999
Q ss_pred ccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCc
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S 1279 (1329)
.............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+... ...+++..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 226 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-TFAPISDRYS 226 (256)
T ss_pred eecCCCccccccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-CCCCCCCCcC
Confidence 86554433344568889999999973 45788999999999999999999999887666555544433 2344566788
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1280 SEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
..+.+++.+||+.+|.+|||+.+++.+.
T Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~p 254 (256)
T cd08220 227 PDLRQLILSMLNLDPSKRPQLSQIMAQP 254 (256)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.17 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=205.8
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCC-ChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGR-SSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~-s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
|.+.+.||+|++|.||+|.+ .++.||||.+........ ..........+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD-- 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--
Confidence 66778999999999999987 467899999876533322 1122344567889999999999999999999988754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..++||||+++++|..++... ..+++..+..++.|++.||+|||++|++|+||+|+|||++.++. ++|+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~----~~l~dfg~~~ 154 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG----IKISDFGISK 154 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC----EEecccCCCc
Confidence 889999999999999988543 56889999999999999999999999999999999999987654 5999999987
Q ss_pred cccCcc-------cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 000726 1201 IKRNTL-------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1201 ~~~~~~-------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ 1273 (1329)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~ 231 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPE 231 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCc
Confidence 543111 1112357889999999974 4567899999999999999999999987655444443332 34455
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1274 ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
.+..++..+.++|.+||+.+|.+||++.+++++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 265 (267)
T cd06628 232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHP 265 (267)
T ss_pred CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCC
Confidence 6677899999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.01 Aligned_cols=257 Identities=29% Similarity=0.417 Sum_probs=207.8
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
...+.|++++.||+|+||.||++++. +..||+|++... .......+.+|+.+++.++||||+++++.+..
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--------SEEELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 34467999999999999999999984 678999998642 12234668889999999999999999999877
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.. ..++||||+++++|..++......+++..++.++.|++.+|.|||+++|+||||||+||+++.++. ++|+||
T Consensus 81 ~~--~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~----~kl~df 154 (292)
T cd06644 81 DG--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD----IKLADF 154 (292)
T ss_pred CC--eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC----EEEccC
Confidence 44 899999999999998887666667899999999999999999999999999999999999987654 699999
Q ss_pred CCcccccC-cccccCCCCCCcccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-C
Q 000726 1197 GLSKIKRN-TLVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-R 1271 (1329)
Q Consensus 1197 GLAr~~~~-~~~ss~~~GTp~YmAPEvL~Gs---~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l-r 1271 (1329)
|++..... ........++..|+|||++.+. ...++.++|||||||++|+|++|..||...........+..... .
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (292)
T cd06644 155 GVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234 (292)
T ss_pred ccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc
Confidence 99864322 1222344578899999998531 33467899999999999999999999977655444444332221 2
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1272 ~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
...+..++..+.++|.+||..+|++||++.+++++.+.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 272 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV 272 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 23345678899999999999999999999999988764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.92 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=208.6
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|+.++.||.|+||.||.++. ++..+++|.+...... ......+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS------EKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc------hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC--
Confidence 488999999999999998877 4788999998654221 223456789999999999999999999998854
Q ss_pred eEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.++++|||+++++|.+++... ...+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++. +||+|||++
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~----~kl~d~~~~ 148 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL----IKLGDFGIS 148 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC----EEECcCcce
Confidence 899999999999999998654 456899999999999999999999999999999999999997664 699999998
Q ss_pred ccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 r~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+..... .+.+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 225 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY-TPVVSVY 225 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-CCCcccc
Confidence 7543322 2334568999999999974 3467889999999999999999999988776666665554433 3344667
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
+..+.+++.+||..+|.+||++.+++++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=329.36 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=203.1
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccccCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~e~~d 1119 (1329)
+|+..+.||+|+||.||+|+++ ++.||||++++.... .......+..|..++..+. |++|+++++++.+..
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD- 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-
Confidence 4778899999999999999884 778999999864221 1222345677888888885 577888998887754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 75 -~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~----ikL~Dfg~~ 148 (323)
T cd05615 75 -RLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH----IKIADFGMC 148 (323)
T ss_pred -EEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC----EEEeccccc
Confidence 899999999999999888543 46899999999999999999999999999999999999997764 599999998
Q ss_pred cccc-CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1200 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 r~~~-~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..... ..+..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--~~p~~~ 224 (323)
T cd05615 149 KEHMVDGVTTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--SYPKSL 224 (323)
T ss_pred cccCCCCccccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCccC
Confidence 7432 2222334568999999999984 4578899999999999999999999998877777766665443 445678
Q ss_pred cHHHHHHHHHhhcCCCCCCCC-----HHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPS-----FTEIARRL 1307 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPT-----aeELLq~L 1307 (1329)
+..+.+++.+||+.+|.+|++ ..+++++.
T Consensus 225 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~ 258 (323)
T cd05615 225 SKEAVSICKGLMTKHPSKRLGCGPEGERDIREHA 258 (323)
T ss_pred CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCc
Confidence 899999999999999999997 46666663
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=325.61 Aligned_cols=256 Identities=28% Similarity=0.344 Sum_probs=212.1
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
.+|..+++||+|.||+||+|++ +|+.||||.++.....++- ....+||+.+|+.++|+||+.++++|....
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi------~~talREIK~Lqel~h~nIi~LiD~F~~~~- 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI------NRTALREIKLLQELKHPNIIELIDVFPHKS- 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc------cHHHHHHHHHHHHccCcchhhhhhhccCCC-
Confidence 4677888999999999999998 5889999999976544332 346789999999999999999999998855
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+.||+||| ..+|...+..+...++..++..++.++++||+|||.+.|+||||||.|+||+++|. +||+|||+|
T Consensus 75 -~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~----lKiADFGLA 148 (318)
T KOG0659|consen 75 -NLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ----LKIADFGLA 148 (318)
T ss_pred -ceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc----EEeecccch
Confidence 899999999 58999999888889999999999999999999999999999999999999998875 599999999
Q ss_pred ccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC--------
Q 000726 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-------- 1270 (1329)
Q Consensus 1200 r~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l-------- 1270 (1329)
+...... ......-|.+|.|||.+.| ...|+..+||||.||++.||+-+.+-|++...-+.+..+....-
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfG-sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFG-SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhcc-chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 9654322 2222357999999999998 46688999999999999999999998988776555443332100
Q ss_pred -------------CCC-----CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1271 -------------RPP-----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1271 -------------r~~-----ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.+. +-..++.++.+|+.+||..||.+|+++.|++++-.--.
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 000 11235677899999999999999999999998876543
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.98 Aligned_cols=254 Identities=28% Similarity=0.400 Sum_probs=206.4
Q ss_pred CeeEEEEecccCcEEEEEEEE-CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCe
Q 000726 1043 DLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~-kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~ 1121 (1329)
+|++.+.||+|+||.||+|.. +++.+|||.++..... ..........+.+|+.+++.++|+||+++++++.+.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN--VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN--T 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc--hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC--e
Confidence 477788999999999999987 5778999998754322 1223344567889999999999999999999998754 8
Q ss_pred EEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1122 L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++. ++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~----~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI----IKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe----EEeccchhhHh
Confidence 99999999999999998543 45789999999999999999999999999999999999997664 69999999874
Q ss_pred ccC-------cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-CCCCC
Q 000726 1202 KRN-------TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPP 1273 (1329)
Q Consensus 1202 ~~~-------~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~-~lr~~ 1273 (1329)
... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+... .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC
Confidence 321 111223458889999999984 45678999999999999999999999876554443333322 33445
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1274 ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
.+..++..+.++|.+||+.+|.+||++.+++.+.
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 263 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHD 263 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 6677899999999999999999999999998764
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.03 Aligned_cols=256 Identities=25% Similarity=0.353 Sum_probs=203.6
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
..++|++.+.||.|+||.||+|.++ ++.||+|.++...... ....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-------chhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 4578999999999999999999884 6789999987543211 123466899999999999999999999875
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
. ..++||||+. ++|..++......+++..+..++.||+.||+|||++||+|+||||+|||++.++. ++|+|||
T Consensus 77 ~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~----~kl~dfg 149 (301)
T cd07873 77 K--SLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE----LKLADFG 149 (301)
T ss_pred C--eEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc----EEECcCc
Confidence 4 8999999996 6898888766667899999999999999999999999999999999999997664 6999999
Q ss_pred CcccccC-cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC-------
Q 000726 1198 LSKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT------- 1269 (1329)
Q Consensus 1198 LAr~~~~-~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~------- 1269 (1329)
++..... ........+++.|+|||++.+ ...++.++|||||||++|+|++|+.||......+....+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 228 (301)
T cd07873 150 LARAKSIPTKTYSNEVVTLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228 (301)
T ss_pred chhccCCCCCcccccceeecccCcHHHhC-CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 9875332 112223457889999999874 3346789999999999999999999998766544332221100
Q ss_pred ---------C-CC-----------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1270 ---------L-RP-----------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1270 ---------l-r~-----------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
. .. .....+++.+.+||.+||+.||.+|||+.+++++.|..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~ 290 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 0 00 01124678899999999999999999999999988763
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=306.85 Aligned_cols=244 Identities=34% Similarity=0.623 Sum_probs=200.9
Q ss_pred EecccCcEEEEEEEEC-CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEE
Q 000726 1049 ELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVME 1127 (1329)
.||+|+||.||+|... ++.+|+|+++... .......+.+|+.+++.++||||+++++++.... ..++|||
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 72 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVME 72 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEE
Confidence 6999999999999874 6779999886432 1223346889999999999999999999998754 7899999
Q ss_pred eccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCccc
Q 000726 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207 (1329)
Q Consensus 1128 Ym~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~ 1207 (1329)
|+++++|.+++......+++..++.++.+++.+|.|||++|++|+||||+||+++.++ .+||+|||++........
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~----~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN----VLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC----eEEECCCccceecccccc
Confidence 9999999999876666789999999999999999999999999999999999998765 469999999874332211
Q ss_pred --ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHH
Q 000726 1208 --TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 1284 (1329)
Q Consensus 1208 --ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~D 1284 (1329)
.....++..|+|||++. ...++.++|||||||++|+|++ |..||...........+ ....+...+..++..+.+
T Consensus 149 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALN--YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV-EKGYRMSCPQKCPDDVYK 225 (250)
T ss_pred ccCCCCCCcccccCHHHhc--cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHH
Confidence 11223456799999997 3457889999999999999998 99999887666555443 344455566678899999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1285 LMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1285 LIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
++.+||+.+|.+||++.++++.|.
T Consensus 226 li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 226 VMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=316.96 Aligned_cols=256 Identities=29% Similarity=0.448 Sum_probs=210.2
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++.+.||.|+||.||++.++ +..||+|+++.. .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--------SEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence 356888999999999999999984 678999998643 1223456889999999999999999999998754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+++++|.+++......+++..++.++.|++.+|.|||+++|+|+||+|+||+++.++. ++|+|||+
T Consensus 76 --~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~----~~l~d~g~ 149 (280)
T cd06611 76 --KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD----VKLADFGV 149 (280)
T ss_pred --eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC----EEEccCcc
Confidence 899999999999999998766677999999999999999999999999999999999999997654 69999998
Q ss_pred cccccC-cccccCCCCCCcccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-CCC
Q 000726 1199 SKIKRN-TLVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPP 1273 (1329)
Q Consensus 1199 Ar~~~~-~~~ss~~~GTp~YmAPEvL~Gs---~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l-r~~ 1273 (1329)
+..... ........+++.|+|||.+... ...++.++|||||||++|+|++|+.||...........+..... ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (280)
T cd06611 150 SAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD 229 (280)
T ss_pred chhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC
Confidence 864322 2222334588999999998532 23467799999999999999999999988766555544433221 223
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1274 ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.+..++..+.+++.+||+.+|.+||++.+++++.|..
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 266 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhc
Confidence 3456789999999999999999999999999997754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=315.83 Aligned_cols=258 Identities=33% Similarity=0.546 Sum_probs=206.7
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeE
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 1110 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k-------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL 1110 (1329)
.+..++|++.+.||+|+||.||+|.++ +..||||.++... .......+.+|+.+++.++||||+++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~ 74 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-------SLRERIEFLNEASVMKGFTCHHVVRL 74 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-------CHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 456789999999999999999998753 3469999876321 11123457889999999999999999
Q ss_pred ecccccCCCCeEEEEEEeccCCchhhhhhccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe
Q 000726 1111 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 1181 (1329)
Q Consensus 1111 ~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILL 1181 (1329)
++++.... ..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 75 ~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili 152 (288)
T cd05061 75 LGVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV 152 (288)
T ss_pred EEEEcCCC--CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE
Confidence 99988754 7899999999999999986422 234667888999999999999999999999999999999
Q ss_pred ccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCC
Q 000726 1182 NLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1257 (1329)
Q Consensus 1182 DsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~ 1257 (1329)
+.++ .++|+|||+++...... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||....
T Consensus 153 ~~~~----~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 153 AHDF----TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred cCCC----cEEECcCCccccccccccccccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9765 46999999987432211 1112234677999999873 457889999999999999998 788998877
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1258 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1258 ~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
..+....+.... ....+..+++.+.+++.+||+.+|.+|||+.++++.|+...
T Consensus 227 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 227 NEQVLKFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 666655554432 23445567899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=320.32 Aligned_cols=264 Identities=30% Similarity=0.520 Sum_probs=212.6
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEEC---------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCc
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 1106 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~k---------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPN 1106 (1329)
+.+..++|.+.+.||+|+||.||++++. ...+|+|+++.... ......+.+|+.+++.+ +|||
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~ 79 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-------DKDLADLISEMELMKLIGKHKN 79 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhccCCCC
Confidence 3566789999999999999999999752 34589998864311 12245678899999999 6999
Q ss_pred eeeEecccccCCCCeEEEEEEeccCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeee
Q 000726 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 1171 (1329)
Q Consensus 1107 IVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------------k~Lse~qrlkIA~QIAsALaYLHs~GIIH 1171 (1329)
|+++++++.... .+++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|
T Consensus 80 iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H 157 (314)
T cd05099 80 IINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIH 157 (314)
T ss_pred eeeEEEEEccCC--ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 999999987744 7899999999999999985431 35788999999999999999999999999
Q ss_pred cCCCCcceEeccCCCCCCcEEEeecCCcccccCccc---ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 000726 1172 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248 (1329)
Q Consensus 1172 RDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~---ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT 1248 (1329)
|||||+|||++.++ .+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 158 ~dlkp~Nill~~~~----~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~ 231 (314)
T cd05099 158 RDLAARNVLVTEDN----VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFT 231 (314)
T ss_pred ccccceeEEEcCCC----cEEEccccccccccccccccccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHh
Confidence 99999999998766 469999999975432111 111224467999999873 457889999999999999999
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcc
Q 000726 1249 -GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 1316 (1329)
Q Consensus 1249 -Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q~ 1316 (1329)
|..||...........+.. ......+..++..+.+++.+||..+|.+||++.++++.|+.+......
T Consensus 232 ~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 232 LGGSPYPGIPVEELFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred CCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 8999988766665554433 334455667889999999999999999999999999999998765543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.36 Aligned_cols=256 Identities=30% Similarity=0.525 Sum_probs=202.9
Q ss_pred cCeeEEEEecccCcEEEEEEEE------CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~------kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.-|++++.||+|+||.||++.+ .+..||||.++... .......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------GGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3467889999999999999975 25679999986431 1223456889999999999999999999987
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
.......++||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~----~~~l~d 152 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH----QVKIGD 152 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC----CEEECC
Confidence 7544578999999999999999865555689999999999999999999999999999999999998765 369999
Q ss_pred cCCcccccCcc----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh-------------
Q 000726 1196 FGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY------------- 1258 (1329)
Q Consensus 1196 FGLAr~~~~~~----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~------------- 1258 (1329)
||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++++.|+.....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM 230 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc
Confidence 99998543221 1223456778999999874 4578899999999999999998766422110
Q ss_pred -hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1259 -GAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1259 -~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
..............+.+..++..+.+|+.+||+.+|.+||++.++++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0111122233334455667889999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=312.12 Aligned_cols=258 Identities=32% Similarity=0.573 Sum_probs=212.6
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC--Cc----eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k--Gr----~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
++...+|++.+.||+|+||.||+|.+. +. .||+|.++.... .....++.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~ 75 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-------PKANKEILDEAYVMASVDHPHVVRLL 75 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 456788999999999999999999873 32 489998765321 23345688999999999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
+++.. ...++||||+++++|.+++......+++..++.++.||+.||+|||+++|+|+||||+|||++.++ .+
T Consensus 76 ~~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~----~~ 148 (279)
T cd05057 76 GICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ----HV 148 (279)
T ss_pred EEEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC----eE
Confidence 99876 378999999999999999977666799999999999999999999999999999999999998665 46
Q ss_pred EEeecCCcccccCccc---ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 000726 1192 KVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~~~---ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve 1267 (1329)
||+|||+++....... .....++..|+|||.+. ...++.++|||||||++|||++ |..||......+....+.
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~- 225 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL--HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE- 225 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhh--cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-
Confidence 9999999975432211 11222456799999987 4557889999999999999998 999998877666554443
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1268 ~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
.....+.+..++..+.+++.+||..+|.+||++.++++.|..+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 226 KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 344455566788999999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=329.92 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=207.1
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||+++++ ++.||||++.+... ........+.+|..++..+.|+||+++++++.+..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~- 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-----LKRAETACFREERNVLVNGDCQWITTLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 47899999999999999999884 67799999875311 12223345778999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|..++......+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 75 -~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~----~kl~DfG~a 149 (331)
T cd05624 75 -YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH----IRLADFGSC 149 (331)
T ss_pred -EEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC----EEEEeccce
Confidence 899999999999999999765667899999999999999999999999999999999999997664 699999998
Q ss_pred ccccCcc--cccCCCCCCcccCccccccCC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC
Q 000726 1200 KIKRNTL--VTGGVRGTLPWMAPELLNGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1200 r~~~~~~--~ss~~~GTp~YmAPEvL~Gs~---~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~i 1274 (1329)
....... ......||+.|+|||++.+.. ..++.++|||||||+||+|++|+.||...........+.....+.+.
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05624 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 229 (331)
T ss_pred eeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccC
Confidence 7543322 222356999999999987421 34678999999999999999999999887766666666554433333
Q ss_pred C---CCCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHHH
Q 000726 1275 P---GFCDSEWRLLMEQCWAPDPVV--RPSFTEIARRLR 1308 (1329)
Q Consensus 1275 p---s~~S~eL~DLIkrCLqkDPeE--RPTaeELLq~Le 1308 (1329)
+ ..++..+.+++.+||...+.+ |+++.++++|.+
T Consensus 230 p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 230 PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 3 346889999999999876544 468999998864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.14 Aligned_cols=249 Identities=31% Similarity=0.568 Sum_probs=197.8
Q ss_pred EecccCcEEEEEEEEC-----CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEE
Q 000726 1049 ELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~k-----Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~ 1123 (1329)
.||+|+||.||+|.+. ...||||.+.... .......+.+|+.+++.++||||+++++++... ++..+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~ 73 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPL 73 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccC-------CHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcE
Confidence 6899999999999863 2469999875321 122345678899999999999999999977543 24678
Q ss_pred EEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 000726 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1329)
Q Consensus 1124 LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~ 1203 (1329)
+||||+.+++|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 74 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~----~~kl~dfg~~~~~~ 149 (262)
T cd05058 74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF----TVKVADFGLARDIY 149 (262)
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC----cEEECCcccccccc
Confidence 99999999999999876555678888899999999999999999999999999999999765 46999999987432
Q ss_pred Cc-----ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 000726 1204 NT-----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277 (1329)
Q Consensus 1204 ~~-----~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips~ 1277 (1329)
.. .......++..|+|||.+. ...++.++|||||||++|||++ |.+||...........+ ........+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 226 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEY 226 (262)
T ss_pred CCcceeecccccCcCCccccChhHhc--cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCCCCCc
Confidence 21 1112334677899999987 3457889999999999999999 56677766555544433 33334445566
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
++..+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 78999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=329.76 Aligned_cols=244 Identities=27% Similarity=0.379 Sum_probs=195.3
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHH-HHHHhcCCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREA-EILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEI-eILk~LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+.||+|+||+||++++. ++.||+|++.+.... .......+..|. .+++.++||||+++++++.... .+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~--~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL-----KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH-----hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC--eEEE
Confidence 36999999999999984 567999999753221 111123344444 4567889999999999998754 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc-
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~- 1203 (1329)
||||+++++|..++.. ...+.+..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 74 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~----~kl~DfG~a~~~~~ 148 (325)
T cd05602 74 VLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH----IVLTDFGLCKENIE 148 (325)
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC----EEEccCCCCccccc
Confidence 9999999999998864 345788888999999999999999999999999999999997664 5999999987432
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..... ..+..++..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (325)
T cd05602 149 HNGTTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLKPNITNSAR 224 (325)
T ss_pred CCCCcccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--CCCCCCCHHHH
Confidence 2223345679999999999984 4578899999999999999999999988777776666655433 34456789999
Q ss_pred HHHHHhhcCCCCCCCCHH----HHHHHH
Q 000726 1284 LLMEQCWAPDPVVRPSFT----EIARRL 1307 (1329)
Q Consensus 1284 DLIkrCLqkDPeERPTae----ELLq~L 1307 (1329)
+++.+||+.+|.+||++. ++++++
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~~i~~~~ 252 (325)
T cd05602 225 HLLEGLLQKDRTKRLGAKDDFMEIKNHI 252 (325)
T ss_pred HHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence 999999999999999875 555554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.18 Aligned_cols=248 Identities=34% Similarity=0.628 Sum_probs=206.4
Q ss_pred cccCeeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
...+|++.+.||+|+||.||++...++.||+|.++... ....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 71 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-- 71 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--
Confidence 44678999999999999999999999999999986421 124678899999999999999999988653
Q ss_pred CeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++.++ .++|+|||+
T Consensus 72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~----~~kl~Dfg~ 146 (254)
T cd05083 72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG----VAKVSDFGL 146 (254)
T ss_pred -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC----cEEECCCcc
Confidence 4689999999999999986543 3588999999999999999999999999999999999998765 469999999
Q ss_pred cccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 000726 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277 (1329)
Q Consensus 1199 Ar~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips~ 1277 (1329)
+....... .....+..|+|||.+. ...++.++|||||||++|+|++ |+.||...........+ ....+...+..
T Consensus 147 ~~~~~~~~--~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 221 (254)
T cd05083 147 ARVGSMGV--DNSKLPVKWTAPEALK--HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-EKGYRMEPPEG 221 (254)
T ss_pred ceeccccC--CCCCCCceecCHHHhc--cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-hCCCCCCCCCc
Confidence 87543221 2233456799999987 3457889999999999999998 99999887766555443 33455555667
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 88999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.41 Aligned_cols=255 Identities=32% Similarity=0.509 Sum_probs=201.5
Q ss_pred ccccCeeEEEEecccCcEEEEEEEECC----------------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWRG----------------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~kG----------------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L 1102 (1329)
+...+|++.+.||+|+||.||++++.+ ..||||.++.... ......|.+|+++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~ei~~l~~l 74 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-------KTARNDFLKEIKIMSRL 74 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-------HHHHHHHHHHHHHHHhC
Confidence 345789999999999999999987632 2489998864321 22345688999999999
Q ss_pred CCCceeeEecccccCCCCeEEEEEEeccCCchhhhhhccc-----------ccCCHHHHHHHHHHHHHHHHHHHHCCeee
Q 000726 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-----------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 1171 (1329)
Q Consensus 1103 rHPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke-----------k~Lse~qrlkIA~QIAsALaYLHs~GIIH 1171 (1329)
+|+||+++++++.... ..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||++|++|
T Consensus 75 ~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H 152 (295)
T cd05097 75 KNPNIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVH 152 (295)
T ss_pred CCCCcCeEEEEEcCCC--ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeec
Confidence 9999999999998754 8899999999999999885432 23688899999999999999999999999
Q ss_pred cCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 000726 1172 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248 (1329)
Q Consensus 1172 RDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT 1248 (1329)
+||||+|||++.++ .+||+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 153 ~dlkp~Nill~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 153 RDLATRNCLVGNHY----TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred cccChhhEEEcCCC----cEEecccccccccccCcceeccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHH
Confidence 99999999999665 46999999987432211 1222335678999999873 457899999999999999998
Q ss_pred --CCCCCCCCChhHHHHHHHh------cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1249 --GEEPYANMHYGAIIGGIVN------NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1249 --Gk~PF~~~~~~ell~qIve------~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
+..||...........+.. .......+..++..+.+|+.+||+.+|.+||++.+|++.|+
T Consensus 227 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 227 LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 6778877665554443321 11122334457899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=309.15 Aligned_cols=256 Identities=30% Similarity=0.424 Sum_probs=206.6
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
.+|++.+.||+|+||.||++.+ +++.||||.+...... .........+.+|+.+++++.||||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES---PETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC---cccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 5788999999999999999987 4788999988643211 1122334678889999999999999999998876544
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..+++||||+++++|.+++... ..+++..++.++.|++.||+|||+++|+|+||||+|||++.++ .++|+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~----~~~l~Dfg~~ 153 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG----NVKLGDFGAS 153 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC----CEEECcCccc
Confidence 5788999999999999988643 4578899999999999999999999999999999999999765 4699999998
Q ss_pred ccccCc----ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 000726 1200 KIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275 (1329)
Q Consensus 1200 r~~~~~----~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ip 1275 (1329)
...... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.....................+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP 231 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCc
Confidence 743321 11223458889999999974 457889999999999999999999998765555554444444445556
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1276 s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
...+..+.+++.+||. +|.+||++.+++++.+
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence 6678889999999995 8999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=339.63 Aligned_cols=261 Identities=30% Similarity=0.477 Sum_probs=214.3
Q ss_pred cccccccCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCce
Q 000726 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNV 1107 (1329)
Q Consensus 1036 l~iI~~edYellkvLGqGaFGtVYKA~~kG-------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNI 1107 (1329)
.+.+..++|.+.+.||+|+||.||+|++.+ +.||||+++.... ......+.+|+.+|.++. ||||
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~E~~~l~~l~~H~ni 103 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-------SSEKQALMSELKIMSHLGPHLNI 103 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-------hhHHHHHHHHHHHHHhcCCCCCe
Confidence 367788899999999999999999998743 4699999975321 112346789999999997 9999
Q ss_pred eeEecccccCCCCeEEEEEEeccCCchhhhhhccc---------------------------------------------
Q 000726 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE--------------------------------------------- 1142 (1329)
Q Consensus 1108 VKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke--------------------------------------------- 1142 (1329)
|+++++|.... .+++||||+.+|+|.+++....
T Consensus 104 v~~~~~~~~~~--~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (401)
T cd05107 104 VNLLGACTKGG--PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDM 181 (401)
T ss_pred EEEEEEEccCC--CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccccc
Confidence 99999998754 7999999999999999885421
Q ss_pred ----------------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCee
Q 000726 1143 ----------------------------------------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIV 1170 (1329)
Q Consensus 1143 ----------------------------------------------------k~Lse~qrlkIA~QIAsALaYLHs~GII 1170 (1329)
..+++..++.++.||+.||+|||+++|+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 261 (401)
T cd05107 182 SKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV 261 (401)
T ss_pred CCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcC
Confidence 2357778889999999999999999999
Q ss_pred ecCCCCcceEeccCCCCCCcEEEeecCCcccccCc---ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHH
Q 000726 1171 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 1247 (1329)
Q Consensus 1171 HRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~---~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELL 1247 (1329)
||||||+|||++.++ .+||+|||+++..... .......++..|+|||.+.+ ..++.++|||||||++|||+
T Consensus 262 Hrdlkp~NiLl~~~~----~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l 335 (401)
T cd05107 262 HRDLAARNVLICEGK----LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIF 335 (401)
T ss_pred cccCCcceEEEeCCC----EEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHH
Confidence 999999999998654 5699999999754221 11223346788999999974 45788999999999999999
Q ss_pred h-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1248 T-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1248 T-Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
+ |..||......+.....+....+...+..++..+.+|+.+||..+|.+||++.+|+..|+.+.
T Consensus 336 ~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 336 TLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 8 899998766555555555556666677788999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.59 Aligned_cols=254 Identities=32% Similarity=0.555 Sum_probs=205.7
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k-------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
+...+|++.+.||+|+||.||++.+. +..||||+++... .......+.+|+.+++++.||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~iv~~~ 74 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDHPNIVKLL 74 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-------CHHHHHHHHHHHHHHHhcCCCchheEE
Confidence 34578999999999999999999873 4679999986432 122345688999999999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhccc---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCee
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIV 1170 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------------------k~Lse~qrlkIA~QIAsALaYLHs~GII 1170 (1329)
+++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++++
T Consensus 75 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~ 152 (288)
T cd05050 75 GVCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV 152 (288)
T ss_pred EEEcCCC--ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9998754 7899999999999999985321 2478888999999999999999999999
Q ss_pred ecCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHH
Q 000726 1171 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 1247 (1329)
Q Consensus 1171 HRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELL 1247 (1329)
||||||+|||++.++. ++|+|||++....... .......+..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 153 H~dl~p~nil~~~~~~----~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~ 226 (288)
T cd05050 153 HRDLATRNCLVGENMV----VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIF 226 (288)
T ss_pred cccccHhheEecCCCc----eEECccccceecccCccccccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHH
Confidence 9999999999987664 5999999987432211 1122234567999999873 45788999999999999999
Q ss_pred h-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1248 T-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1248 T-Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
+ |..||......+....+.... ..+.+..++..+.+|+.+||+.+|.+|||+.|+++.|+
T Consensus 227 ~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 227 SYGMQPYYGMAHEEVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred hCCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 8 888998776666655544333 33445678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=331.38 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=200.0
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC-
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG- 1119 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d- 1119 (1329)
+|++.+.||+|+||.||++.+ +++.||||++..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ------NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc------chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 467889999999999999997 478899999864311 12224567899999999999999999999876431
Q ss_pred --CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1120 --GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1120 --g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
..+++||||+. ++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~----~~kL~Dfg 148 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC----VLKICDFG 148 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC----CEEecccc
Confidence 26899999995 677777643 45689999999999999999999999999999999999999765 46999999
Q ss_pred CcccccCc--ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh--------
Q 000726 1198 LSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN-------- 1267 (1329)
Q Consensus 1198 LAr~~~~~--~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve-------- 1267 (1329)
++...... .......+++.|+|||++.+. ..++.++|||||||++|||++|+.||........+..+..
T Consensus 149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227 (372)
T ss_pred ceeecccCccccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 99754322 112234578899999999853 3468899999999999999999999987665443332211
Q ss_pred ---------------cCCCC-------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1268 ---------------NTLRP-------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1268 ---------------~~lr~-------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
..... ......++.+.+||.+||+.||.+|||+.+++.+.|..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 292 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhC
Confidence 11111 12234578899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=372.24 Aligned_cols=358 Identities=23% Similarity=0.306 Sum_probs=240.9
Q ss_pred ccccCCCccccCCCCccccCCcCCCCCCCCCCCCCCCcCcccCccccCCCCCccCCCCCC-CCCCCcccccccCc-c---
Q 000726 920 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTME-THPDYSRSELKGNE-S--- 994 (1329)
Q Consensus 920 qLs~~LP~~Lg~L~~L~~LdLS~N~LS~~Gs~IP~sg~~~nL~~lSftgNsiLcgPssl~-~~P~lqKs~LaGN~-S--- 994 (1329)
++++.+|..|++++.|+.|++++|+|+ |. +|..+.+..+...++.+|+.+|++.... ..+...... .... .
T Consensus 558 ~l~~~~p~~l~~l~~L~~l~ls~N~l~--~~-~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~-~~~~~~~~~ 633 (968)
T PLN00113 558 QLSGEIPKNLGNVESLVQVNISHNHLH--GS-LPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK-TPSWWFYIT 633 (968)
T ss_pred cccccCChhHhcCcccCEEeccCCcce--ee-CCCcchhcccChhhhcCCccccCCccccCCCCCccccc-cceeeeehh
Confidence 678999999999999999999999999 95 9999999999999999999999865321 111111000 0000 0
Q ss_pred -------hhhHHH--hhhccccc-ccccCCCCCCCCCCccccccCCCCccccccc----cccCeeEEEEecccCcEEEEE
Q 000726 995 -------LQSEVV--NHRIQESD-YEEGRLDLPTAGIPLVDLALGNFDISTLQII----KNEDLEELKELGSGTFGTVYH 1060 (1329)
Q Consensus 995 -------Lqsesv--n~~i~e~d-~~e~~l~Lp~s~~pL~d~al~~fDls~l~iI----~~edYellkvLGqGaFGtVYK 1060 (1329)
+...++ ..+..... ....+....... +....++......+ ....+...++||+|+||.||+
T Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~ 708 (968)
T PLN00113 634 CTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGT-----WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYK 708 (968)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhccccccccccccc-----ccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEE
Confidence 000000 00000000 000000000000 00000110000000 113466778899999999999
Q ss_pred EEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEEeccCCchhhhh
Q 000726 1061 GKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 1138 (1329)
Q Consensus 1061 A~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L 1138 (1329)
|++ .+..||||.++.... ....|++++++++|||||+++++|.+.. ..++|||||++++|.+++
T Consensus 709 ~~~~~~~~~vavK~~~~~~~------------~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv~Ey~~~g~L~~~l 774 (968)
T PLN00113 709 GKSIKNGMQFVVKEINDVNS------------IPSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLIHEYIEGKNLSEVL 774 (968)
T ss_pred EEECCCCcEEEEEEccCCcc------------ccHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEEEeCCCCCcHHHHH
Confidence 997 478899998864211 1123577899999999999999998754 789999999999999998
Q ss_pred hcccccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCcccccCCCCCC
Q 000726 1139 LSKERHLDRRKRLIIAMDAAFGMEYLH---SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215 (1329)
Q Consensus 1139 ~~kek~Lse~qrlkIA~QIAsALaYLH---s~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~ss~~~GTp 1215 (1329)
. .++|..+..|+.||+.||+||| +.+|+||||||+||+++.++.. ++. |+........ ....+|+
T Consensus 775 ~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~----~~~-~~~~~~~~~~---~~~~~t~ 842 (968)
T PLN00113 775 R----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP----HLR-LSLPGLLCTD---TKCFISS 842 (968)
T ss_pred h----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCce----EEE-eccccccccC---CCccccc
Confidence 4 3789999999999999999999 6699999999999999976543 443 5554322111 1235789
Q ss_pred cccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh--HHH---HHH---------HhcCCCC--CCCCCCc
Q 000726 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--AII---GGI---------VNNTLRP--PVPGFCD 1279 (1329)
Q Consensus 1216 ~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~--ell---~qI---------ve~~lr~--~ips~~S 1279 (1329)
.|+|||++. ...++.++|||||||++|||++|+.||...... ... ... ++..... ..+....
T Consensus 843 ~y~aPE~~~--~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (968)
T PLN00113 843 AYVAPETRE--TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEI 920 (968)
T ss_pred cccCccccc--CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHH
Confidence 999999998 455789999999999999999999998542211 111 000 0000000 0111123
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 000726 1280 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 1314 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~ 1314 (1329)
.++.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus 921 ~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 921 VEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 45778999999999999999999999999886533
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=311.12 Aligned_cols=254 Identities=33% Similarity=0.570 Sum_probs=207.0
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEec
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k-------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~G 1112 (1329)
..++|++.+.||+|+||.||+|+++ ...|++|.+... ..+.....+.+|+.++++++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 75 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-------KDENLQSEFRRELDMFRKLSHKNVVRLLG 75 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-------cchHHHHHHHHHHHHHHhcCCcceeeeEE
Confidence 4578899999999999999999873 345899887532 12234567889999999999999999999
Q ss_pred ccccCCCCeEEEEEEeccCCchhhhhhccc--------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccC
Q 000726 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE--------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 1184 (1329)
Q Consensus 1113 if~e~~dg~L~LVMEYm~GGSL~d~L~~ke--------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsd 1184 (1329)
++.+.. ..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+++|+|+||||+|||++.+
T Consensus 76 ~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~ 153 (275)
T cd05046 76 LCREAE--PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ 153 (275)
T ss_pred EECCCC--cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC
Confidence 988754 7899999999999999986433 158999999999999999999999999999999999999976
Q ss_pred CCCCCcEEEeecCCcccccC--cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 000726 1185 DPIRPICKVGDFGLSKIKRN--TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI 1261 (1329)
Q Consensus 1185 Gni~~~VKLsDFGLAr~~~~--~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~el 1261 (1329)
+. ++|+|||++..... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||........
T Consensus 154 ~~----~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~ 227 (275)
T cd05046 154 RE----VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227 (275)
T ss_pred Cc----EEEcccccccccCcccccccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH
Confidence 64 59999999864321 112223345677999999873 446789999999999999998 8889977666666
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1262 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1262 l~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
...+.........+..++..+.+++.+||+.+|.+||++.+++..|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 228 LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 65555444444556678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.16 Aligned_cols=255 Identities=28% Similarity=0.412 Sum_probs=206.1
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
+.|++.+.||+|+||.||++.+. +..+++|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~- 75 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--------SEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN- 75 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--------CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-
Confidence 34677889999999999999985 567888888532 1223456788999999999999999999988754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|..++......+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++
T Consensus 76 -~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~----~kl~dfg~~ 150 (282)
T cd06643 76 -NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD----IKLADFGVS 150 (282)
T ss_pred -EEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC----EEEcccccc
Confidence 899999999999998888665667999999999999999999999999999999999999987664 699999998
Q ss_pred ccccC-cccccCCCCCCcccCcccccc---CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-CCCCCC
Q 000726 1200 KIKRN-TLVTGGVRGTLPWMAPELLNG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPV 1274 (1329)
Q Consensus 1200 r~~~~-~~~ss~~~GTp~YmAPEvL~G---s~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~-~lr~~i 1274 (1329)
..... ........++..|+|||++.. ....++.++|||||||++|+|++|..||...........+... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd06643 151 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQ 230 (282)
T ss_pred ccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCC
Confidence 64322 122234568899999999852 1334678999999999999999999999876655444443332 223334
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1275 ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
+..++..+.++|.+||+.+|.+||++.+++++.+..
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 266 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT 266 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence 556789999999999999999999999999887643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=330.32 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=196.6
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+.||+|+||.||+++++ ++.||+|++++..... ......+.+|+.++..+ +||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFF 73 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-----hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC--EEEE
Confidence 36999999999999984 6789999998653221 12234567888888876 7999999999998755 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc-
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~- 1203 (1329)
||||+++++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 74 v~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~----~kL~DfG~~~~~~~ 148 (329)
T cd05618 74 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH----IKLTDYGMCKEGLR 148 (329)
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC----EEEeeCCccccccC
Confidence 9999999999887754 356899999999999999999999999999999999999997764 5999999987432
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---------hhHHHHHHHhcCCCCCC
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---------YGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~---------~~ell~qIve~~lr~~i 1274 (1329)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+... ...+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~ 224 (329)
T cd05618 149 PGDTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRI 224 (329)
T ss_pred CCCccccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCC
Confidence 2222344679999999999984 457889999999999999999999995311 11122223332 3345
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCC------HHHHHHHHHH
Q 000726 1275 PGFCDSEWRLLMEQCWAPDPVVRPS------FTEIARRLRV 1309 (1329)
Q Consensus 1275 ps~~S~eL~DLIkrCLqkDPeERPT------aeELLq~Le~ 1309 (1329)
+..++..+.++|.+||+.||.+||+ +.++++|.+.
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f 265 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence 6778899999999999999999998 5788888643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=347.68 Aligned_cols=255 Identities=28% Similarity=0.470 Sum_probs=224.4
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|..++++|+|+||.+++++++ ++.+++|.+.....+.+ ......+|+.+++++.|||||.+++.|.+..
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~------~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~- 76 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP------ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG- 76 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch------hhHHHHHHHHHHHhccCCCeeeeccchhcCC-
Confidence 57888999999999999998875 56799999987654432 2236678999999999999999999998854
Q ss_pred CeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++|||+||+||+|.+.+..+. ..+++..++.|+.||+.|+.|||++.|+|||||+.||+++.++. |+|+|||+
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~----VkLgDfGl 152 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK----VKLGDFGL 152 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc----eeecchhh
Confidence 23999999999999999997655 67999999999999999999999999999999999999998764 49999999
Q ss_pred cccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 000726 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277 (1329)
Q Consensus 1199 Ar~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~ 1277 (1329)
|+...... ......||+.||+||++. ...|..|+|||||||++|||++-+++|...+...++..++... -.+++..
T Consensus 153 aK~l~~~~~~a~tvvGTp~YmcPEil~--d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ 229 (426)
T KOG0589|consen 153 AKILNPEDSLASTVVGTPYYMCPEILS--DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSM 229 (426)
T ss_pred hhhcCCchhhhheecCCCcccCHHHhC--CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCcc
Confidence 99877665 667788999999999999 4567899999999999999999999999999888888877665 4677889
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
++.+++.+|+.||..+|..||++.+||.++-..
T Consensus 230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 230 YSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 999999999999999999999999999985554
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=310.30 Aligned_cols=255 Identities=31% Similarity=0.435 Sum_probs=206.6
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
.|+..+.||+|+||.||++.+ +++.||+|+++..... .........+.+|+.+++.++||||+++++++.+....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES---PETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC---chhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCC
Confidence 577788999999999999987 4788999998754322 12233456788999999999999999999998765455
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.++++|||+++++|.+++... ..+++...+.++.||+.||+|||+++|+|+||+|+||+++.++ .++|+|||++.
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~----~~~l~dfg~~~ 154 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG----NVKLGDFGASK 154 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC----CEEEccCCCcc
Confidence 889999999999999988643 4588999999999999999999999999999999999998765 46999999987
Q ss_pred cccCc----ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 000726 1201 IKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1201 ~~~~~----~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips 1276 (1329)
..... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..................+.++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 232 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCch
Confidence 43221 11122457889999999974 4578899999999999999999999987765555555444444555666
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.+++.+.+++ +||..+|.+||++.+|+.|.+
T Consensus 233 ~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~ 263 (266)
T cd06651 233 HISEHARDFL-GCIFVEARHRPSAEELLRHPF 263 (266)
T ss_pred hcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence 7788899999 677789999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.39 Aligned_cols=254 Identities=28% Similarity=0.464 Sum_probs=207.9
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|+..+.||+|++|.||+|.+. ++.|++|.+....... ..+.....+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ---TGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED-- 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccc---cchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC--
Confidence 3667788999999999999884 7889999987532211 12334567889999999999999999999988754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.+++||||+++++|.+++... ..+++..++.++.||+.||+|||+.||+|+||+|+||+++.++ .+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~----~~kl~d~~~~~ 150 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG----VVKLADFGMAK 150 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEccCccce
Confidence 899999999999999988543 4588999999999999999999999999999999999999765 46999999987
Q ss_pred cccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcH
Q 000726 1201 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 1280 (1329)
Q Consensus 1201 ~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~ 1280 (1329)
............++..|+|||.+.... .++.++|+|||||++|+|++|..||...........+........++..+++
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd06632 151 QVVEFSFAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229 (258)
T ss_pred eccccccccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCH
Confidence 654433334556889999999987422 3788999999999999999999999776644444444433344456667889
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1281 EWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1281 eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
.+.+++.+||+.+|.+||++.+++.+.
T Consensus 230 ~~~~li~~~l~~~p~~Rp~~~~~l~~~ 256 (258)
T cd06632 230 EAKDFILKCLQRDPSLRPTAAELLEHP 256 (258)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhcCC
Confidence 999999999999999999999998764
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=366.62 Aligned_cols=265 Identities=22% Similarity=0.328 Sum_probs=213.3
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
+...+|++++.||+|+||+||++.+. +..||+|++...... +.....|..|+.+|+.|+|||||+++++|..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~------e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK------EREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 44578999999999999999999984 567999998754321 2234568899999999999999999999876
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHC-------CeeecCCCCcceEeccCC-
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSK-------NIVHFDLKCDNLLVNLKD- 1185 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~k---ek~Lse~qrlkIA~QIAsALaYLHs~-------GIIHRDLKPeNILLDsdG- 1185 (1329)
.....++|||||+++++|..++... ...+++..++.|+.||+.||+|||+. +||||||||+||||+...
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 5556899999999999999988542 35689999999999999999999984 499999999999997532
Q ss_pred ------------CCCCcEEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCC
Q 000726 1186 ------------PIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253 (1329)
Q Consensus 1186 ------------ni~~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF 1253 (1329)
.....+||+|||++.............||+.|+|||++.+....++.++||||||||||+|++|..||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 12345899999999865444444456799999999999765566789999999999999999999999
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1254 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1254 ~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
........+...+......++ ..++..+.+||.+||+.+|.+||++.+++.+.+..
T Consensus 244 ~~~~~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 765544433333333332222 34688999999999999999999999999876543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=361.58 Aligned_cols=261 Identities=34% Similarity=0.601 Sum_probs=231.5
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEEC--C---ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~k--G---r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
..|......+.++||.|.||.||+|+++ | ..||||.+|... .+....+|+.|+.||-+..||||++|.
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-------tekqrrdFL~EAsIMGQFdHPNIIrLE 696 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIRLE 696 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-------cHHHHhhhhhhhhhcccCCCCcEEEEE
Confidence 3577778899999999999999999984 3 349999998642 345567899999999999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
|++.... .++||+|||++|+|..+|+..+..+++.++..|+++|+.||.||-+.+++||||.++||||+. ++.|
T Consensus 697 GVVTks~--PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs----nLvC 770 (996)
T KOG0196|consen 697 GVVTKSK--PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS----NLVC 770 (996)
T ss_pred EEEecCc--eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc----ceEE
Confidence 9998865 899999999999999999999889999999999999999999999999999999999999994 4689
Q ss_pred EEeecCCcccccCcc----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 000726 1192 KVGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1266 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~~----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIv 1266 (1329)
|++|||+++...+.. .+.+-+-..+|.|||.+. ..+++.++||||||++|||.++ |..||-.+.+.+++.. +
T Consensus 771 KVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa--~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-I 847 (996)
T KOG0196|consen 771 KVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-I 847 (996)
T ss_pred EeccccceeecccCCCccccccCCccceeecChhHhh--hcccCchhhccccceEEEEecccCCCcccccchHHHHHH-H
Confidence 999999999764433 111222357899999998 7889999999999999999998 9999999999999876 5
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1267 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1267 e~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
+..++++.|..|+..|.+||..||++|..+||.|.+|+..|.++...
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 67889999999999999999999999999999999999999998643
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.45 Aligned_cols=252 Identities=28% Similarity=0.336 Sum_probs=196.7
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||+|++|.||+|++ ++..||||+++..... +.....+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE------EGVPSTAIREISLLKELQHPNIVCLQDVLMQES-- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc------CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--
Confidence 478899999999999999988 4788999998753211 112345678999999999999999999998754
Q ss_pred eEEEEEEeccCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~ke--k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
.+++||||+. ++|..++.... ..+++..++.++.||+.||.|||+++|+|+||||+|||++.++. ++|+|||+
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~----~~l~dfg~ 147 (285)
T cd07861 73 RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV----IKLADFGL 147 (285)
T ss_pred eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc----EEECcccc
Confidence 8999999996 68888775432 56899999999999999999999999999999999999997764 59999999
Q ss_pred cccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC--------
Q 000726 1199 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-------- 1269 (1329)
Q Consensus 1199 Ar~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~-------- 1269 (1329)
+...... .......+++.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226 (285)
T ss_pred eeecCCCcccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 8743321 112233468899999998753 346789999999999999999999997654432222111100
Q ss_pred -------------------CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1270 -------------------LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1270 -------------------lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
........+++++.++|.+||+.||.+|||+.+|+.+.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~ 284 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence 000112346888999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=316.75 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=211.3
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|++|.||+|... ++.||||.+...... .......+.+|+++++.++||||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-----KRNKVKRVLTEQEILATLDHPFLPTLYASFQTET- 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-----hHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-
Confidence 36889999999999999999984 688999999764221 1234466889999999999999999999988754
Q ss_pred CeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+.+++|.+++... ...+++..+..++.||+.||+|||++|++|+||||+||+++.++. ++|+|||+
T Consensus 75 -~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~----~~l~dfg~ 149 (316)
T cd05574 75 -YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH----IMLSDFDL 149 (316)
T ss_pred -EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC----EEEeecch
Confidence 899999999999999988643 356899999999999999999999999999999999999997764 59999999
Q ss_pred cccccCcc------------------------------cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 000726 1199 SKIKRNTL------------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248 (1329)
Q Consensus 1199 Ar~~~~~~------------------------------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT 1248 (1329)
+....... ......|+..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhh
Confidence 86432110 1112357889999999984 456889999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCC----HHHHHHHHHHHH
Q 000726 1249 GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPS----FTEIARRLRVMS 1311 (1329)
Q Consensus 1249 Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPT----aeELLq~Le~L~ 1311 (1329)
|+.||........+..+.......+.....+..+.+++.+||+.+|++||+ +.+++.+.|...
T Consensus 228 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 228 GTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred CCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 999998877776666666554444333347899999999999999999999 999999876543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=330.19 Aligned_cols=246 Identities=25% Similarity=0.360 Sum_probs=198.7
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc---CCCceeeEecccccCCCCeEEE
Q 000726 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1050 LGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L---rHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
||+|+||+||+|++. ++.||||++.+.... .+.....+..|..++..+ .||||++++.++.+.. .+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~--~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-----AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS--DLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-----hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC--eEEE
Confidence 799999999999884 788999999753211 122234455677777665 6999999999998755 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc-c
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-R 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~-~ 1203 (1329)
||||+++++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||++... .
T Consensus 74 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~----~kl~Dfg~a~~~~~ 148 (330)
T cd05586 74 VTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH----IALCDFGLSKANLT 148 (330)
T ss_pred EEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC----EEEecCCcCcCCCC
Confidence 9999999999988854 456899999999999999999999999999999999999997764 599999998743 2
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
........+||+.|+|||++.+ ...++.++|||||||+||+|++|+.||...........+.......+ ...++..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~ 226 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLD-EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-KNVLSDEGR 226 (330)
T ss_pred CCCCccCccCCccccCHHHHcC-CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC-CccCCHHHH
Confidence 2223345679999999999874 23468899999999999999999999988777666666554443332 234688999
Q ss_pred HHHHHhhcCCCCCCC----CHHHHHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRP----SFTEIARRLRV 1309 (1329)
Q Consensus 1284 DLIkrCLqkDPeERP----TaeELLq~Le~ 1309 (1329)
+++.+||+.||.+|| ++.+++++.+.
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~h~~~ 256 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhcCccc
Confidence 999999999999998 78899887664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.70 Aligned_cols=249 Identities=29% Similarity=0.415 Sum_probs=198.9
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||+|.+ ++..||||++..... .....++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-------VELQKQIMSELEILYKCDSPYIIGFYGAFFVEN- 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-
Confidence 3678889999999999999987 477899999875321 123356889999999999999999999998855
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|..+. .+++..+..++.|++.||.|||++||+|+||||+|||++.++. ++|+|||++
T Consensus 73 -~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~----~~l~dfg~~ 142 (279)
T cd06619 73 -RISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ----VKLCDFGVS 142 (279)
T ss_pred -EEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC----EEEeeCCcc
Confidence 889999999999886542 4678889999999999999999999999999999999997664 699999998
Q ss_pred ccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-------HHHHHHHhcCCCC
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-------AIIGGIVNNTLRP 1272 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~-------ell~qIve~~lr~ 1272 (1329)
....... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.......
T Consensus 143 ~~~~~~~-~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (279)
T cd06619 143 TQLVNSI-AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV 219 (279)
T ss_pred eeccccc-ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC
Confidence 7543322 234568999999999984 45788999999999999999999999653221 1122222221111
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
......++.+.+++.+||+.+|.+||++.+++++.|...
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 122346788999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=307.76 Aligned_cols=253 Identities=34% Similarity=0.567 Sum_probs=207.9
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC-CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
.+..++|++.+.||+|+||.||++.+. +..+|+|.++.. ......+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence 456789999999999999999999874 567999987642 1123567889999999999999999999876
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
...+++|||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~----~~~l~d 145 (260)
T cd05073 73 ---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIAD 145 (260)
T ss_pred ---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC----cEEECC
Confidence 2678999999999999998653 34578889999999999999999999999999999999998665 469999
Q ss_pred cCCcccccCc--ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC
Q 000726 1196 FGLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1196 FGLAr~~~~~--~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~ 1272 (1329)
||++...... .......++..|+|||++.+ ..++.++|+|||||++|+|++ |..||...........+ ......
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~ 222 (260)
T cd05073 146 FGLARVIEDNEYTAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRM 222 (260)
T ss_pred CcceeeccCCCcccccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hCCCCC
Confidence 9998754321 11222335677999999973 457889999999999999998 99999887666555443 344445
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
+.+...+..+.+++.+||+.+|.+||++.++++.|..
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 5566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=339.19 Aligned_cols=259 Identities=28% Similarity=0.404 Sum_probs=221.6
Q ss_pred cccccCeeEEEEecccCcEEEEEEEECC--ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~kG--r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.+..++|++++.||+|.-|+||+++.++ ..+|+|++.+..+.. +....+...|.+||+.++||.|+.||..|+
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-----rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe 147 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-----RKKLKRAQTEREILSLLDHPFLPTLYASFE 147 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-----hhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence 4455678888999999999999999976 679999998865542 334566778999999999999999999999
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
... +.|||||||+||+|..+++.+ ++.+++..+..++.+|+-||+|||..|||+|||||+||||.++|++ -|+
T Consensus 148 t~~--~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHI----MLs 221 (459)
T KOG0610|consen 148 TDK--YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHI----MLS 221 (459)
T ss_pred ccc--eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcE----Eee
Confidence 866 999999999999999988665 4679999999999999999999999999999999999999988865 899
Q ss_pred ecCCcccc-------c---------------------------C-c----------------------ccccCCCCCCcc
Q 000726 1195 DFGLSKIK-------R---------------------------N-T----------------------LVTGGVRGTLPW 1217 (1329)
Q Consensus 1195 DFGLAr~~-------~---------------------------~-~----------------------~~ss~~~GTp~Y 1217 (1329)
||.++... . . . ...+.+.||..|
T Consensus 222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY 301 (459)
T KOG0610|consen 222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY 301 (459)
T ss_pred eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence 99986410 0 0 0 111235599999
Q ss_pred cCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCC
Q 000726 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVR 1297 (1329)
Q Consensus 1218 mAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeER 1297 (1329)
+|||++.|.. -+.++|||+|||+||||+.|..||.+....+.+..++.+....+-...++..+++||+++|.+||.+|
T Consensus 302 lAPEvI~G~G--HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 302 LAPEVIRGEG--HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred ccceeeecCC--CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence 9999999753 46789999999999999999999999999999999999888766666788999999999999999999
Q ss_pred CC----HHHHHHHHHH
Q 000726 1298 PS----FTEIARRLRV 1309 (1329)
Q Consensus 1298 PT----aeELLq~Le~ 1309 (1329)
.. +.||.+|..-
T Consensus 380 lg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 380 LGSKRGAAEIKRHPFF 395 (459)
T ss_pred hccccchHHhhcCccc
Confidence 87 8999887643
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=310.53 Aligned_cols=256 Identities=33% Similarity=0.554 Sum_probs=206.7
Q ss_pred cCeeEEEEecccCcEEEEEEEEC------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
++|++.+.||+|+||.||++.+. +..||||+++.... ......|.+|+.+++.+.|+||+++++++.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~ 76 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-------EQHRSDFEREIEILRTLDHENIVKYKGVCE 76 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc-------hHHHHHHHHHHHHHHhCCCCChheEEeeee
Confidence 56778899999999999999874 56799999875421 133467889999999999999999999887
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
.......++||||+++++|.+++......+++..++.++.|++.||+|||++||+|+||||+|||++.++ .++|+|
T Consensus 77 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~----~~~l~d 152 (284)
T cd05038 77 KPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED----LVKISD 152 (284)
T ss_pred cCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC----CEEEcc
Confidence 6444578999999999999999976665799999999999999999999999999999999999999765 469999
Q ss_pred cCCcccccCccc----ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh------------
Q 000726 1196 FGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG------------ 1259 (1329)
Q Consensus 1196 FGLAr~~~~~~~----ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~------------ 1259 (1329)
||++........ .....++..|+|||.+.+ ..++.++|||||||++|||++|..||......
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM 230 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccc
Confidence 999986542111 112234567999999874 45788999999999999999999998653221
Q ss_pred --HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1260 --AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1260 --ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
......+....+.+.+..++..+.+++.+||+.+|.+|||+.+|+++|..+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 231 IVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 112233344444555667789999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=307.00 Aligned_cols=245 Identities=35% Similarity=0.584 Sum_probs=200.2
Q ss_pred EEecccCcEEEEEEEEC--C---ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeE
Q 000726 1048 KELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k--G---r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L 1122 (1329)
++||+|+||.||+|.+. + ..+|+|.++..... ....++.+|+.+++.+.|+||+++++++... ..
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~ 70 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------AGKKEFLREASVMAQLDHPCIVRLIGVCKGE---PL 70 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC---ce
Confidence 36999999999999873 2 56999998754221 2345788999999999999999999987642 57
Q ss_pred EEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 000726 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
++||||+++++|.+++.... .+++..++.++.|++.+|+|||.++++|+||||+|||++.++. +||+|||+++..
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~----~kl~df~~~~~~ 145 (257)
T cd05060 71 MLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ----AKISDFGMSRAL 145 (257)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc----EEecccccccee
Confidence 89999999999999986543 6899999999999999999999999999999999999997664 599999998754
Q ss_pred cCccc----ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 000726 1203 RNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277 (1329)
Q Consensus 1203 ~~~~~----ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips~ 1277 (1329)
..... .....++..|+|||.+. ...++.++|||||||++|+|++ |..||......+....+. .....+.+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 222 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECIN--YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEE 222 (257)
T ss_pred ecCCcccccccCccccccccCHHHhc--CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCC
Confidence 32211 11112346799999997 4457889999999999999998 999998877665554443 3344566677
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
++..+.++|.+||..+|.+||++.+|++.|+.+
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=311.35 Aligned_cols=246 Identities=36% Similarity=0.584 Sum_probs=197.7
Q ss_pred EecccCcEEEEEEEEC--Cc--eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccCCCCeEE
Q 000726 1049 ELGSGTFGTVYHGKWR--GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLA 1123 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~k--Gr--~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~~dg~L~ 1123 (1329)
.||+|+||.||+|++. +. .+|+|.++... .......+.+|+.++.++ +||||+++++++.... ..+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~ 72 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLY 72 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC--Cce
Confidence 5899999999999984 33 46888876421 112235678899999999 7999999999998754 789
Q ss_pred EEEEeccCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCC
Q 000726 1124 TVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188 (1329)
Q Consensus 1124 LVMEYm~GGSL~d~L~~ke---------------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~ 1188 (1329)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+|||++.++
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~--- 149 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--- 149 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC---
Confidence 9999999999999885432 2478999999999999999999999999999999999999765
Q ss_pred CcEEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 000726 1189 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1189 ~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve 1267 (1329)
.+||+|||++..............+..|+|||++. ...++.++|||||||++|||++ |..||...........+.
T Consensus 150 -~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~- 225 (270)
T cd05047 150 -VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 225 (270)
T ss_pred -eEEECCCCCccccchhhhccCCCCccccCChHHHc--cCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-
Confidence 46999999986332221112223456799999987 3457889999999999999997 999998776666555443
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1268 ~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.....+.+..++..+.+++.+||+.+|.+|||+.+++..|..+
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 226 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 3344455666789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=328.96 Aligned_cols=244 Identities=27% Similarity=0.362 Sum_probs=196.5
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHH-HHHhcCCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE-ILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIe-ILk~LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+.||+|+||+||++++ +++.||||++.+.... .......+.+|.. +++.++||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~--~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-----NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE--KLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC--EEEE
Confidence 3699999999999988 4788999999764221 1222344555654 467789999999999988754 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc-c
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-R 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~-~ 1203 (1329)
||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++... .
T Consensus 74 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~----~kL~DfG~~~~~~~ 148 (325)
T cd05604 74 VLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH----VVLTDFGLCKEGIA 148 (325)
T ss_pred EEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC----EEEeecCCcccCCC
Confidence 9999999999888753 456899999999999999999999999999999999999997764 599999998743 2
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..... ..+...+..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 224 (325)
T cd05604 149 QSDTTTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--VLRPGASLTAW 224 (325)
T ss_pred CCCCcccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--cCCCCCCHHHH
Confidence 2223344569999999999984 4578899999999999999999999988777776666655432 23345788999
Q ss_pred HHHHHhhcCCCCCCCCHH----HHHHHH
Q 000726 1284 LLMEQCWAPDPVVRPSFT----EIARRL 1307 (1329)
Q Consensus 1284 DLIkrCLqkDPeERPTae----ELLq~L 1307 (1329)
+++.+||+.+|.+||++. +++++.
T Consensus 225 ~ll~~ll~~~p~~R~~~~~~~~~i~~h~ 252 (325)
T cd05604 225 SILEELLEKDRQRRLGAKEDFLEIQEHP 252 (325)
T ss_pred HHHHHHhccCHHhcCCCCCCHHHHhcCC
Confidence 999999999999999764 666654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=326.45 Aligned_cols=245 Identities=22% Similarity=0.376 Sum_probs=197.0
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+.||+|+||.||++.+. ++.||||++++.... .+.....+.+|+.++.++ +||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~l 73 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-----DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS--RLFL 73 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC--EEEE
Confidence 36999999999999884 678999999864321 223345677899999888 6999999999998755 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc-c
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-R 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~-~ 1203 (1329)
||||+++++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.. .
T Consensus 74 v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~----~kl~Dfg~~~~~~~ 148 (327)
T cd05617 74 VIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH----IKLTDYGMCKEGLG 148 (327)
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC----EEEeccccceeccC
Confidence 9999999999887753 356899999999999999999999999999999999999997764 699999998742 2
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC------h-hHHHHHHHhcCCCCCCCC
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH------Y-GAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~------~-~ell~qIve~~lr~~ips 1276 (1329)
........+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.... . ......+... ...++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~ 224 (327)
T cd05617 149 PGDTTSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPR 224 (327)
T ss_pred CCCceecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCC
Confidence 2223345679999999999984 457889999999999999999999995321 1 1223333332 234566
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCC------HHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPS------FTEIARRLR 1308 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPT------aeELLq~Le 1308 (1329)
.++..+.+++.+||+.||.+|++ +.+++.|.+
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~ 262 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF 262 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCC
Confidence 78899999999999999999997 568887754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=311.18 Aligned_cols=251 Identities=30% Similarity=0.452 Sum_probs=206.7
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||.|++|.||++.+ .++.||+|++..... ......+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-------EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS- 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-------chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-
Confidence 3677888999999999999998 477899999875321 122345778999999999999999999988754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++|+||+++++|.+++... .+++..++.++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~----~~l~d~g~~ 145 (274)
T cd06609 73 -KLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD----VKLADFGVS 145 (274)
T ss_pred -eEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC----EEEcccccc
Confidence 899999999999999998643 7899999999999999999999999999999999999998764 599999999
Q ss_pred ccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC-
Q 000726 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF- 1277 (1329)
Q Consensus 1200 r~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~- 1277 (1329)
+..... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+... .....+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 222 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNK 222 (274)
T ss_pred eeecccccccccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccc
Confidence 865433 22334568889999999984 34789999999999999999999999876654444333332 23333334
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
++..+.+++.+||..+|++|||+++++++.+-.
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~ 255 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKFIK 255 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhhChhhc
Confidence 788999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.90 Aligned_cols=250 Identities=30% Similarity=0.473 Sum_probs=206.0
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++.+.||+|+||.||++.+. +..+++|.++... ....+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----------DLQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 357888899999999999999985 6789999986421 1467889999999999999999999998754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
.++++|||+.+++|.+++......+++..++.++.|++.||.|||+.+|+|+||+|.||+++.++ .++|+|||+
T Consensus 72 --~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~----~~~l~dfg~ 145 (256)
T cd06612 72 --DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG----QAKLADFGV 145 (256)
T ss_pred --cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC----cEEEccccc
Confidence 89999999999999999876667789999999999999999999999999999999999999766 469999999
Q ss_pred cccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC-CCCCCCC
Q 000726 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPPVPG 1276 (1329)
Q Consensus 1199 Ar~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~-lr~~ips 1276 (1329)
+....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... .....+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd06612 146 SGQLTDTMAKRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPE 223 (256)
T ss_pred chhcccCccccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchh
Confidence 88544322 2233457889999999874 457889999999999999999999998765544333322211 1222334
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.++..+.+++.+||+.+|.+|||+.+++.+.|
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 56789999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=340.15 Aligned_cols=256 Identities=20% Similarity=0.258 Sum_probs=194.7
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC------CCceeeEe
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH------HPNVVAFY 1111 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr------HPNIVKL~ 1111 (1329)
...+|++.++||+|+||+||+|.+. ++.||||+++... .....+..|+.+++.++ |.+|++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---------hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 4578999999999999999999884 6779999996421 11233445666666654 45689999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCCC---
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPI--- 1187 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGni--- 1187 (1329)
++|... ...+++||+++ +++|.+++... ..+++..+..|+.||+.||.|||+ .|||||||||+|||++.++..
T Consensus 198 ~~~~~~-~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNE-TGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcC-CceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 988754 34789999998 78888887543 568999999999999999999998 599999999999999876531
Q ss_pred ---------CCcEEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh
Q 000726 1188 ---------RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 1258 (1329)
Q Consensus 1188 ---------~~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~ 1258 (1329)
...+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||.....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccCccc--cccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 235899999988643222 234679999999999984 4578899999999999999999999987665
Q ss_pred hHHHHHHHhcCC-------------------------CCC--------------C-CCCCcHHHHHHHHHhhcCCCCCCC
Q 000726 1259 GAIIGGIVNNTL-------------------------RPP--------------V-PGFCDSEWRLLMEQCWAPDPVVRP 1298 (1329)
Q Consensus 1259 ~ell~qIve~~l-------------------------r~~--------------i-ps~~S~eL~DLIkrCLqkDPeERP 1298 (1329)
.+.+..+..... ... . .....+.+.+||.+||+.||.+||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 433322211000 000 0 001245678999999999999999
Q ss_pred CHHHHHHHHHHHH
Q 000726 1299 SFTEIARRLRVMS 1311 (1329)
Q Consensus 1299 TaeELLq~Le~L~ 1311 (1329)
|+.|+++|.|...
T Consensus 431 ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 431 NARQMTTHPYVLK 443 (467)
T ss_pred CHHHHhcCccccc
Confidence 9999999988754
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=311.28 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=202.3
Q ss_pred ccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~ 1115 (1329)
...++|++.+.||+|+||.||++.+ .++.+|+|+++... .....+.+|+.+++.+ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---------DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---------chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3567899999999999999999988 47789999876421 1123466789999999 6999999999874
Q ss_pred c---CCCCeEEEEEEeccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCC
Q 000726 1116 D---GPGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1329)
Q Consensus 1116 e---~~dg~L~LVMEYm~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~ 1189 (1329)
. ......++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++|+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--- 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--- 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC---
Confidence 2 123478999999999999987742 2356889999999999999999999999999999999999997764
Q ss_pred cEEEeecCCcccccCc-ccccCCCCCCcccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 000726 1190 ICKVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1265 (1329)
Q Consensus 1190 ~VKLsDFGLAr~~~~~-~~ss~~~GTp~YmAPEvL~Gs---~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qI 1265 (1329)
++|+|||++...... .......|++.|+|||++... ...++.++|||||||++|+|++|+.||............
T Consensus 163 -~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~ 241 (286)
T cd06638 163 -VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241 (286)
T ss_pred -EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence 699999998754322 222344689999999998532 234688999999999999999999999876544433322
Q ss_pred HhcC-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1266 VNNT-LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1266 ve~~-lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.... .....+..++..+.++|.+||+.+|.+|||+.+|+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 2211 122234456788999999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=317.23 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=188.0
Q ss_pred EEecccCcEEEEEEEEC----CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEE
Q 000726 1048 KELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k----Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~ 1123 (1329)
.+||+|+||.||+|++. +..||+|.++.... ...+.+|+.+|+.++||||+++++++.......++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVW 76 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence 57999999999999874 36799998864321 13467899999999999999999998765556889
Q ss_pred EEEEeccCCchhhhhhcc--------cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1124 TVTEFMVNGSLRHVLLSK--------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1124 LVMEYm~GGSL~d~L~~k--------ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
+||||+. ++|..++... ...+++..++.++.||+.||.|||+++|+||||||+|||+..++.....+||+|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 9999985 5777666321 235788999999999999999999999999999999999965544456789999
Q ss_pred cCCcccccCcc----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---------HHH
Q 000726 1196 FGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---------AII 1262 (1329)
Q Consensus 1196 FGLAr~~~~~~----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~---------ell 1262 (1329)
||+++...... ......+|+.|+|||++.+ ...++.++|||||||++|||++|++||...... ...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcC-CCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence 99998543221 1234468899999999874 244688999999999999999999999643211 000
Q ss_pred HHHHhc-----------------------CC-C------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 000726 1263 GGIVNN-----------------------TL-R------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306 (1329)
Q Consensus 1263 ~qIve~-----------------------~l-r------------~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~ 1306 (1329)
..+... .. . .......+..+.+|+.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000 00 0 00011234568899999999999999999999987
Q ss_pred HH
Q 000726 1307 LR 1308 (1329)
Q Consensus 1307 Le 1308 (1329)
.|
T Consensus 315 p~ 316 (317)
T cd07867 315 PY 316 (317)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.86 Aligned_cols=252 Identities=27% Similarity=0.342 Sum_probs=196.2
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||+|+||.||+|.+ +|+.||+|.++..... +.....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLYDVLHSDK-- 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc------ccCccchhHHHHHHHhcCCCCeeeHHHHhccCC--
Confidence 478889999999999999998 4788999999754221 112245678999999999999999999998754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.+++||||+. ++|..++......+++..++.++.||+.||.|||+++|+|+||||+||+++.++. ++|+|||++.
T Consensus 73 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~----~~l~dfg~~~ 147 (284)
T cd07839 73 KLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE----LKLADFGLAR 147 (284)
T ss_pred ceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc----EEECccchhh
Confidence 8999999995 6888877655567999999999999999999999999999999999999997664 5999999987
Q ss_pred cccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHhc----------
Q 000726 1201 IKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN-MHYGAIIGGIVNN---------- 1268 (1329)
Q Consensus 1201 ~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~-~~~~ell~qIve~---------- 1268 (1329)
..... .......++..|+|||++.+ ...++.++|||||||++|+|++|..||.. ......+..+...
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhC-CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 54322 12223457889999999875 23468899999999999999999888533 3322222221110
Q ss_pred --------CCCC---------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1269 --------TLRP---------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1269 --------~lr~---------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.... .....++..+.++|.+||+.||.+|||+.+++.+.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 0000 011236788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=320.84 Aligned_cols=264 Identities=30% Similarity=0.509 Sum_probs=213.1
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEEC---------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCc
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 1106 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~k---------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPN 1106 (1329)
+.+...+|++.+.||+|+||.||++++. ...||+|+++... .......+.+|+.+++++ +|||
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-------TDKDLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-------CHHHHHHHHHHHHHHHhhcCCCC
Confidence 3455668999999999999999999763 1258999886421 122346788999999999 7999
Q ss_pred eeeEecccccCCCCeEEEEEEeccCCchhhhhhcc---------------cccCCHHHHHHHHHHHHHHHHHHHHCCeee
Q 000726 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK---------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVH 1171 (1329)
Q Consensus 1107 IVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~k---------------ek~Lse~qrlkIA~QIAsALaYLHs~GIIH 1171 (1329)
|++++++|.... .+++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+|
T Consensus 80 iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH 157 (334)
T cd05100 80 IINLLGACTQDG--PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH 157 (334)
T ss_pred eeeeeEEEccCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 999999998754 789999999999999988542 234788899999999999999999999999
Q ss_pred cCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 000726 1172 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248 (1329)
Q Consensus 1172 RDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT 1248 (1329)
|||||+|||++.++ .+||+|||+++...... ......++..|+|||++. ...++.++|||||||+||||++
T Consensus 158 ~dlkp~Nill~~~~----~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~ 231 (334)
T cd05100 158 RDLAARNVLVTEDN----VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFT 231 (334)
T ss_pred cccccceEEEcCCC----cEEECCcccceecccccccccccCCCcCceEcCHHHhc--cCCcCchhhhHHHHHHHHHHHh
Confidence 99999999998765 46999999987543321 111223456799999997 3457889999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcc
Q 000726 1249 -GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 1316 (1329)
Q Consensus 1249 -Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q~ 1316 (1329)
|..||...........+. .....+.+..++..+.+++.+||+.+|.+||++.+++..|+.+......
T Consensus 232 ~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 232 LGGSPYPGIPVEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred cCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 899998877666655443 3444556667889999999999999999999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=308.19 Aligned_cols=256 Identities=27% Similarity=0.393 Sum_probs=204.7
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEeccccc
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e 1116 (1329)
.+++|++.+.||+|++|.||+|.++ ++.+++|++..... ....+.+|+.+++++ .|+||+++++++..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---------EEEEIKEEYNILRKYSNHPNIATFYGAFIK 74 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---------hHHHHHHHHHHHHHhcCCCChheEEEEEEe
Confidence 3578999999999999999999984 67799999875311 234678999999998 69999999999865
Q ss_pred CC----CCeEEEEEEeccCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCC
Q 000726 1117 GP----GGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1329)
Q Consensus 1117 ~~----dg~L~LVMEYm~GGSL~d~L~~k---ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~ 1189 (1329)
.. ...+++||||+++++|.+++... ...+++..++.++.|++.||.|||+++++|+||+|+||+++.++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--- 151 (275)
T cd06608 75 KNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--- 151 (275)
T ss_pred cCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe---
Confidence 33 34689999999999999887543 357899999999999999999999999999999999999997654
Q ss_pred cEEEeecCCcccccCc-ccccCCCCCCcccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 000726 1190 ICKVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1265 (1329)
Q Consensus 1190 ~VKLsDFGLAr~~~~~-~~ss~~~GTp~YmAPEvL~Gs---~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qI 1265 (1329)
++|+|||++...... .......++..|+|||++... ...++.++|||||||+||+|++|..||...........+
T Consensus 152 -~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 230 (275)
T cd06608 152 -VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230 (275)
T ss_pred -EEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh
Confidence 699999998754322 222345588999999998532 244678999999999999999999999866555544444
Q ss_pred HhcCC-CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1266 VNNTL-RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1266 ve~~l-r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
..... ....+..++..+.+|+.+||..||.+|||+.+++++.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 231 PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 33322 11222336789999999999999999999999998754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=334.71 Aligned_cols=247 Identities=25% Similarity=0.302 Sum_probs=194.0
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
+...+|++++.||+|+||.||+|.+. ++.||||.... ..+.+|+.+|+.++||||++++++|..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------------~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------------GGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 45578999999999999999999984 77899996431 235689999999999999999999987
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.. ..++|||++ .++|..++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 155 ~~--~~~lv~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~----vkL~DF 226 (391)
T PHA03212 155 NK--FTCLILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD----VCLGDF 226 (391)
T ss_pred CC--eeEEEEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC----EEEEeC
Confidence 54 889999999 57888877543 46889999999999999999999999999999999999997764 599999
Q ss_pred CCcccccC--cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-------hhHHHHHHH-
Q 000726 1197 GLSKIKRN--TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-------YGAIIGGIV- 1266 (1329)
Q Consensus 1197 GLAr~~~~--~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~-------~~ell~qIv- 1266 (1329)
|+++.... ........||+.|+|||++.+ ..++.++|||||||+||||++|..||.... ....+..++
T Consensus 227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~ 304 (391)
T PHA03212 227 GAACFPVDINANKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304 (391)
T ss_pred CcccccccccccccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence 99974322 122234579999999999984 457899999999999999999998764321 011111111
Q ss_pred -------------------------hcCCCCC--CC-----CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1267 -------------------------NNTLRPP--VP-----GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1267 -------------------------e~~lr~~--ip-----s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
......+ .+ ..++.++.+||.+||+.||.+|||+.|++++.+.
T Consensus 305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 0000000 00 1245679999999999999999999999998885
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=324.63 Aligned_cols=256 Identities=23% Similarity=0.314 Sum_probs=200.9
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++++.||+|+||.||+|.+ .+..||||+++... ........+.+|+.+|+.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF------QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh------hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 36799999999999999999987 46789999986532 11223455778999999999999999999886432
Q ss_pred ----CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1119 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1119 ----dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
....+++|+++ +++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~----~kl~ 160 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE----LRIL 160 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC----EEEc
Confidence 13578999988 788887774 346899999999999999999999999999999999999997764 5999
Q ss_pred ecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC---
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 1271 (1329)
Q Consensus 1195 DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr--- 1271 (1329)
|||++...... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||........+..+......
T Consensus 161 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 161 DFGLARQADDE--MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred CCccceecCCC--cCCccccccccCchHhcC-CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999865432 234568999999999874 245788999999999999999999999876544333322211000
Q ss_pred ------------------CC--------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1272 ------------------PP--------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1272 ------------------~~--------ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
.. .....++.+.+|+.+||+.||.+|||+.+++.|.+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00 012345678899999999999999999999999887643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=316.69 Aligned_cols=259 Identities=33% Similarity=0.618 Sum_probs=209.5
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE--CCc----eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~--kGr----~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
.+..++|+..+.||+|+||.||++.+ .+. .||+|.+.... ......++.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~niv~~~ 75 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-------GPKANVEFMDEALIMASMDHPHLVRLL 75 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 46678899999999999999999987 343 46888775421 122234688999999999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
+++... ..++++||+++++|.+++......+++..++.++.||+.||+|||+++|+|+||||+|||++.++. +
T Consensus 76 ~~~~~~---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~----~ 148 (303)
T cd05110 76 GVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH----V 148 (303)
T ss_pred EEEcCC---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc----e
Confidence 998753 467899999999999998766667899999999999999999999999999999999999987653 6
Q ss_pred EEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 000726 1192 KVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve 1267 (1329)
||+|||+++...... ......++..|+|||.+. ...++.++|||||||++|||++ |..||......... .++.
T Consensus 149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~ 225 (303)
T cd05110 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH--YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLE 225 (303)
T ss_pred EEccccccccccCcccccccCCCccccccCCHHHhc--cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHH
Confidence 999999998543221 122234567899999987 3457889999999999999997 99999876544433 3344
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1268 ~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
.....+.+..++..+.+++.+||..+|++||++.++++.|+.+...
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 226 KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 4444555667889999999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=318.05 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=204.6
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||++.+. +..+|+|.++... .......+.+|++++++++||||++++++|....
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG- 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-
Confidence 36889999999999999999884 6779999886431 1223456888999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.++. ++|+|||+
T Consensus 73 -~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~----~~l~dfg~ 146 (308)
T cd06615 73 -EISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGV 146 (308)
T ss_pred -EEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc----EEEccCCC
Confidence 899999999999999998644 568899999999999999999997 58999999999999997654 69999999
Q ss_pred cccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh-----------
Q 000726 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN----------- 1267 (1329)
Q Consensus 1199 Ar~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve----------- 1267 (1329)
+...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 147 SGQLIDS-MANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred ccccccc-ccccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 8754322 2234568899999999874 3467899999999999999999999865443222111100
Q ss_pred ------------------------cCCCCCCC-CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhccC
Q 000726 1268 ------------------------NTLRPPVP-GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 1317 (1329)
Q Consensus 1268 ------------------------~~lr~~ip-s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q~~ 1317 (1329)
....+..+ ..++.++.+++.+||..+|++|||+.+++.+.|.........
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~ 298 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEV 298 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccccc
Confidence 00011111 135778999999999999999999999999999876544433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=307.29 Aligned_cols=249 Identities=29% Similarity=0.431 Sum_probs=198.7
Q ss_pred EEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEE
Q 000726 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
...||+|+||.||+|.+. +..||+|.+.... ......+.+|+.+++.++|+||+++++++.... ..++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 82 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--------SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG--FFKI 82 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC--------HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC--EEEE
Confidence 457999999999999874 5679999886431 122356789999999999999999999998754 8999
Q ss_pred EEEeccCCchhhhhhcccccC--CHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 000726 1125 VTEFMVNGSLRHVLLSKERHL--DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~L--se~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
||||+++++|.+++......+ ++..+..++.||+.||+|||++||+||||||+||+++.+. ..++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~---~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS---GVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC---CeEEEecchhheec
Confidence 999999999999987654445 8888899999999999999999999999999999998532 24799999998754
Q ss_pred cC-cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHhcCCCCCCCCCCcH
Q 000726 1203 RN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI-IGGIVNNTLRPPVPGFCDS 1280 (1329)
Q Consensus 1203 ~~-~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~el-l~qIve~~lr~~ips~~S~ 1280 (1329)
.. ........++..|+|||++.+....++.++||||||+++|+|++|..||........ ............++..+++
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA 239 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence 32 112223457889999999875455578899999999999999999999976433221 1111122233455667889
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1281 EWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1281 eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.+.+++.+||+.+|.+|||+.+++.+.|
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 9999999999999999999999998754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=313.21 Aligned_cols=249 Identities=28% Similarity=0.434 Sum_probs=209.2
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||++.+. ++.||||+++..... .......+.+|++++++++||||+++++++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-----KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS- 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-
Confidence 46899999999999999999984 688999999753221 1223456889999999999999999999998755
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|.|||++.++. +||+|||++
T Consensus 75 -~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~----~kl~dfg~~ 148 (290)
T cd05580 75 -NLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFA 148 (290)
T ss_pred -eEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC----EEEeeCCCc
Confidence 899999999999999988654 56899999999999999999999999999999999999997764 699999998
Q ss_pred ccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCc
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S 1279 (1329)
...... .....+++.|+|||.+.+ ...+.++||||||+++|+|++|..||...........+... ...++..++
T Consensus 149 ~~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~ 222 (290)
T cd05580 149 KRVKGR--TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KVRFPSFFS 222 (290)
T ss_pred cccCCC--CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CccCCccCC
Confidence 865433 234568899999999874 45678999999999999999999999877765555555433 334566678
Q ss_pred HHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 000726 1280 SEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 1308 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERP-----TaeELLq~Le 1308 (1329)
..+.+++.+||+.+|.+|+ ++++++.+.+
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 9999999999999999999 8899998876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=312.31 Aligned_cols=260 Identities=26% Similarity=0.423 Sum_probs=208.5
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++++.||+|+||.||++.+. +..||+|.++... .+.....+.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-------DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG- 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-
Confidence 46888999999999999999985 7889999986431 1222356889999999999999999999988754
Q ss_pred CeEEEEEEeccCCchhhhhhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSK--ERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~k--ek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.+++||||+++++|..++... ...+++..+..++.+|+.||.|||. .+|+|+||||+|||++.++ .++|+||
T Consensus 73 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~----~~~l~df 147 (286)
T cd06622 73 -AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG----QVKLCDF 147 (286)
T ss_pred -eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC----CEEEeec
Confidence 899999999999998887543 2368999999999999999999997 5999999999999999765 4699999
Q ss_pred CCcccccCcccccCCCCCCcccCccccccC----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHH--HhcCC
Q 000726 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGS----SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI--VNNTL 1270 (1329)
Q Consensus 1197 GLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs----~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qI--ve~~l 1270 (1329)
|++....... .....++..|+|||.+.+. ...++.++|||||||++|+|++|+.||...........+ .....
T Consensus 148 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd06622 148 GVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226 (286)
T ss_pred CCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC
Confidence 9987543222 2234578899999998642 224578999999999999999999999765443332221 11223
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1271 r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
...++..++..+.+||.+||+.+|.+||++.+++.+.|.......
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 344556689999999999999999999999999999887665544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=314.04 Aligned_cols=254 Identities=31% Similarity=0.514 Sum_probs=200.3
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC------------------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHh
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR------------------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k------------------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~ 1101 (1329)
..++|++.+.||+|+||.||++.+. +..||||+++... .......+.+|+.+++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~E~~~l~~ 75 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-------NKNARNDFLKEIKIMSR 75 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHh
Confidence 3567999999999999999998643 2358999886431 12334578899999999
Q ss_pred cCCCceeeEecccccCCCCeEEEEEEeccCCchhhhhhccc----------ccCCHHHHHHHHHHHHHHHHHHHHCCeee
Q 000726 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 1171 (1329)
Q Consensus 1102 LrHPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke----------k~Lse~qrlkIA~QIAsALaYLHs~GIIH 1171 (1329)
++|+||+++++++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+|
T Consensus 76 l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H 153 (296)
T cd05095 76 LKDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVH 153 (296)
T ss_pred CCCCCcceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 99999999999998754 7899999999999999885432 24677889999999999999999999999
Q ss_pred cCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 000726 1172 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248 (1329)
Q Consensus 1172 RDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT 1248 (1329)
+||||+|||++.++ .++|+|||++....... ......++..|++||...+ ..++.++|||||||++|||++
T Consensus 154 ~dlkp~Nili~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~ 227 (296)
T cd05095 154 RDLATRNCLVGKNY----TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILT 227 (296)
T ss_pred ccCChheEEEcCCC----CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHH
Confidence 99999999998665 46999999987542221 1122334678999998773 457889999999999999998
Q ss_pred --CCCCCCCCChhHHHHHHHh------cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1249 --GEEPYANMHYGAIIGGIVN------NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1249 --Gk~PF~~~~~~ell~qIve------~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
|..||......+....... .....+.+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred hCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7788876655444332211 11122344567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=307.11 Aligned_cols=258 Identities=26% Similarity=0.459 Sum_probs=208.0
Q ss_pred CeeEEEEecccCcEEEEEEEEC---CceEEEEEEeccccCCCC--hHHHHHHHHHHHHHHHHHh-cCCCceeeEeccccc
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRS--SEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k---Gr~VAVKiLKks~~sd~s--~e~E~~~keFlrEIeILk~-LrHPNIVKL~Gif~e 1116 (1329)
.|++.+.||+|+||.||++.+. ++.+|||.+......... ........++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3677788999999999999985 467999998754322211 1223344567789988875 799999999999987
Q ss_pred CCCCeEEEEEEeccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCCCCCcEE
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGni~~~VK 1192 (1329)
.. ..++||||+++++|.+++.. ....+++..++.++.|++.+|.|||+ .+++|+||+|+|||++.++ .++
T Consensus 81 ~~--~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~----~~~ 154 (269)
T cd08528 81 ND--RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD----KVT 154 (269)
T ss_pred CC--eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC----cEE
Confidence 54 89999999999999887733 34568999999999999999999996 7899999999999999765 469
Q ss_pred EeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC
Q 000726 1193 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1193 LsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~ 1272 (1329)
|+|||++.............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+......+
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc
Confidence 999999986544433345568899999999984 457889999999999999999999998776666655555544443
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.....++..+.++|.+||+.||.+||++.++..++.
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 334467899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=330.64 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=226.3
Q ss_pred cccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
..++|++.++||+|.|+.||++.+ +|+.+|+|++....++.. -.+++.+|+.+-+.|+|||||+++..+.+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~------~~e~l~rEarIC~~LqHP~IvrL~~ti~~- 81 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQE- 81 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc------cHHHHHHHHHHHHhcCCCcEeehhhhhcc-
Confidence 346788888999999999999877 588899999987666543 23567789999999999999999998877
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
.++.|+|+|+|.|++|...+..+ ...++..+-..++||+++|.|||.++|||||+||+|+|+.+.... .-+||+|||
T Consensus 82 -~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~-A~vKL~~FG 158 (355)
T KOG0033|consen 82 -ESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKG-AAVKLADFG 158 (355)
T ss_pred -cceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCC-Cceeecccc
Confidence 45999999999999998777554 457888888999999999999999999999999999999766543 457999999
Q ss_pred CcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC--
Q 000726 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP-- 1275 (1329)
Q Consensus 1198 LAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ip-- 1275 (1329)
+|..........++.|||.|||||+++ ...|+..+|||+.||+||-|+.|++||.+.+...+.+++....+..+.+
T Consensus 159 vAi~l~~g~~~~G~~GtP~fmaPEvvr--kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w 236 (355)
T KOG0033|consen 159 LAIEVNDGEAWHGFAGTPGYLSPEVLK--KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW 236 (355)
T ss_pred eEEEeCCccccccccCCCcccCHHHhh--cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc
Confidence 999888777888999999999999999 5668889999999999999999999999988889999998887765543
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1276 s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
..++++.++|+++||..||.+|.|+.|.|+|.|--
T Consensus 237 ~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 237 DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 45799999999999999999999999999999864
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=309.41 Aligned_cols=252 Identities=27% Similarity=0.356 Sum_probs=202.9
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||+|++|.||+|.+ .++.||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE------GGIPNQALREIKALQACQHPYVVKLLDVFPHGS-- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc------chhhHHHHHHHHHHHhCCCCCCcceeeEEecCC--
Confidence 588899999999999999998 4788999999764322 122356789999999999999999999998754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..++||||+ +++|.+++......+++.+++.++.||+.+|+|||++||+|+||||+||+++.++ .++|+|||++.
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~----~~~l~dfg~~~ 147 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG----VLKIADFGLAR 147 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC----cEEEeeeeecc
Confidence 899999999 9999999876667799999999999999999999999999999999999999765 46999999988
Q ss_pred cccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC------
Q 000726 1201 IKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP------ 1272 (1329)
Q Consensus 1201 ~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~------ 1272 (1329)
...... ......++..|+|||++.+ ...++.++|||||||++|+|++|.+||........+..+......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYG-ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred cccCCCCCccccccCcccccCceeeec-cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHh
Confidence 543322 2234468899999999874 3346889999999999999999988887665444333322210000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1273 ----------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1273 ----------------------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
......+..+.+++.+||+.+|.+||++.+++.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 011235688999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=308.17 Aligned_cols=259 Identities=29% Similarity=0.471 Sum_probs=205.4
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCC--hHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRS--SEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s--~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
+|.+.+.||+|+||.||+|.. +++.||||.++........ .........+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477888999999999999987 4788999998653222111 112334457888999999999999999999988754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++ .++|+|||+
T Consensus 82 --~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~----~~~l~d~~~ 154 (272)
T cd06629 82 --YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG----ICKISDFGI 154 (272)
T ss_pred --ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC----eEEEeeccc
Confidence 899999999999999988654 5689999999999999999999999999999999999999765 469999999
Q ss_pred cccccCc---ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 000726 1199 SKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275 (1329)
Q Consensus 1199 Ar~~~~~---~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ip 1275 (1329)
+...... .......++..|+|||.+......++.++|+||||+++|+|++|..||...........+.........+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP 234 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCC
Confidence 8754321 1122345788999999987544457889999999999999999999997655544443333232222222
Q ss_pred ----CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1276 ----GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1276 ----s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
..++..+.+++.+||.++|.+||++.+++++.+
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 345889999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=342.91 Aligned_cols=298 Identities=32% Similarity=0.550 Sum_probs=244.4
Q ss_pred hhHHHhhhcccccccccCCCCCCCCCCcccc-ccCCCCccccccccccCeeEEEEecccCcEEEEEEEEC--CceEEEEE
Q 000726 996 QSEVVNHRIQESDYEEGRLDLPTAGIPLVDL-ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKR 1072 (1329)
Q Consensus 996 qsesvn~~i~e~d~~e~~l~Lp~s~~pL~d~-al~~fDls~l~iI~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKi 1072 (1329)
..+++.|.....+.+-..+-.|.....-... ... -...-|.+.+.+..+.++||-|.||.||.|.|+ ...||||.
T Consensus 222 LaELVHHHStvADGLittLhYPApK~nKptvygvS--Pn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKt 299 (1157)
T KOG4278|consen 222 LAELVHHHSTVADGLITTLHYPAPKKNKPTVYGVS--PNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT 299 (1157)
T ss_pred HHHHHhhccccccceeEeeeccCccCCCCceeeec--CCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhh
Confidence 3455666666666655555444432221111 111 112457788889999999999999999999996 46699999
Q ss_pred EeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEEeccCCchhhhhhcccc-cCCHHHHH
Q 000726 1073 IKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-HLDRRKRL 1151 (1329)
Q Consensus 1073 LKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek-~Lse~qrl 1151 (1329)
+|.. -+...+|++|+.+|+.++|||+|+|+|+|.... .+|||+|||..|+|.++|....+ .++....+
T Consensus 300 LKED---------tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep--PFYIiTEfM~yGNLLdYLRecnr~ev~avvLl 368 (1157)
T KOG4278|consen 300 LKED---------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP--PFYIITEFMCYGNLLDYLRECNRSEVPAVVLL 368 (1157)
T ss_pred hhhc---------chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC--CeEEEEecccCccHHHHHHHhchhhcchhHHH
Confidence 8743 334678999999999999999999999999866 89999999999999999977653 46777888
Q ss_pred HHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCcc--cccCCCCCCcccCccccccCCCC
Q 000726 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSK 1229 (1329)
Q Consensus 1152 kIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~ 1229 (1329)
.|+.||.+||.||..+++|||||.+.|+|+..+. .||++|||++++..... ...+......|.|||-+. ...
T Consensus 369 yMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh----iVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLA--yNt 442 (1157)
T KOG4278|consen 369 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH----IVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA--YNT 442 (1157)
T ss_pred HHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc----eEEeeccchhhhhcCCceecccCccCcccccCccccc--ccc
Confidence 9999999999999999999999999999998553 57999999999765433 334555678899999997 566
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1230 VSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1230 ~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
++.|+|||+|||+|||+.| |..||.+.+...++ .+++..++++-|..|++.+++||++||+.+|.+||+|.|+-+.++
T Consensus 443 FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 443 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 8999999999999999999 99999998876665 467889999999999999999999999999999999999999998
Q ss_pred HHHHH
Q 000726 1309 VMSAA 1313 (1329)
Q Consensus 1309 ~L~aa 1313 (1329)
.+...
T Consensus 522 tmf~~ 526 (1157)
T KOG4278|consen 522 TMFSS 526 (1157)
T ss_pred HHhcc
Confidence 87643
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.06 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=200.2
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++.+.||+|+||.||++++ .++.||||+++.... .....+.+|+.+++.++||||+++++.+....
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--------EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--------hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 45778888999999999999988 477899999875311 11235678999999999999999999988754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+++++|.+++... ..+++.+++.++.|++.||.|||++||+|+||||+||+++.++. ++|+|||+
T Consensus 80 --~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~----~~l~dfg~ 152 (267)
T cd06645 80 --KLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH----VKLADFGV 152 (267)
T ss_pred --EEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC----EEECccee
Confidence 899999999999999988543 46899999999999999999999999999999999999997664 69999999
Q ss_pred cccccCc-ccccCCCCCCcccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC--
Q 000726 1199 SKIKRNT-LVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV-- 1274 (1329)
Q Consensus 1199 Ar~~~~~-~~ss~~~GTp~YmAPEvL~G-s~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~i-- 1274 (1329)
+...... .......|+..|+|||++.. ....++.++|||||||++|+|++|..||...................+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06645 153 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK 232 (267)
T ss_pred eeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc
Confidence 8743322 12234468999999999742 1334678999999999999999999998765543333333222222211
Q ss_pred -CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1275 -PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1275 -ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
...++..+.+++.+||+.+|++||++.+|+++.
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~ 266 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHP 266 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence 124678899999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=347.78 Aligned_cols=252 Identities=29% Similarity=0.448 Sum_probs=212.7
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
....|+.+++||+|.||.||+|.+. ++.||+|++..... +.....+.+|+.+|..++++||.++|+.+..+
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-------~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-------EDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhc-------chhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 3456777889999999999999984 77899999986532 33355677899999999999999999999886
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
. .++++||||.||++.+.+.. +..+++..+..|+++++.||.|||.++.+|||||+.|||+..+|. |||+|||
T Consensus 84 ~--~LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~----vkl~Dfg 156 (467)
T KOG0201|consen 84 T--KLWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD----VKLADFG 156 (467)
T ss_pred c--cHHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc----EEEEecc
Confidence 6 89999999999999999854 344588888889999999999999999999999999999997764 5999999
Q ss_pred CcccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 000726 1198 LSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1198 LAr~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips 1276 (1329)
.+....... ....+.||+.|||||++. ...|+.|+||||||++.+||++|.+||...+....+..|-+ ...+.+..
T Consensus 157 Va~ql~~~~~rr~tfvGTPfwMAPEVI~--~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-~~PP~L~~ 233 (467)
T KOG0201|consen 157 VAGQLTNTVKRRKTFVGTPFWMAPEVIK--QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-SAPPRLDG 233 (467)
T ss_pred eeeeeechhhccccccccccccchhhhc--cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-CCCCcccc
Confidence 998654432 336788999999999999 45689999999999999999999999998887554443333 33344556
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.+++.+++|+..||.+||+.||++.++++|-.
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLKHKF 265 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHH
Confidence 78999999999999999999999999988743
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.59 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=204.9
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
..+|++.+.||+|+||.||++.+ .+..||+|.+...... ....+.+|+.+++.+.|+||+++++.+....
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--------~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 35799999999999999999987 4778999998753211 1245778999999999999999999988754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+++++|.+++.. ..+++.++..++.|++.||+|||++||+|+||||+|||++.++ .++|+|||+
T Consensus 91 --~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~----~~kl~dfg~ 162 (296)
T cd06654 91 --ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGF 162 (296)
T ss_pred --EEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC----CEEECcccc
Confidence 89999999999999998843 4578999999999999999999999999999999999998765 469999999
Q ss_pred cccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC-CCCCCCC
Q 000726 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPPVPG 1276 (1329)
Q Consensus 1199 Ar~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~-lr~~ips 1276 (1329)
+....... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.... .....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06654 163 CAQITPEQSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (296)
T ss_pred chhccccccccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCcc
Confidence 87533221 1223468899999999974 456789999999999999999999997765543333222222 1223345
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.++..+.+++.+||..+|.+||++.+++++.+...
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 67889999999999999999999999999877543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=308.81 Aligned_cols=253 Identities=26% Similarity=0.332 Sum_probs=198.9
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|++|.||++.++ ++.||+|++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP------VIKKIALREIRMLKQLKHPNLVNLIEVFRRKR- 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc------cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-
Confidence 46889999999999999999984 7889999987542111 11245678999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||++++.|..++. ....+++..++.++.||+.+|+|||++||+|+||||+||+++.++ .++|+|||++
T Consensus 74 -~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~~l~dfg~~ 147 (286)
T cd07847 74 -KLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG----QIKLCDFGFA 147 (286)
T ss_pred -EEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC----cEEECccccc
Confidence 8999999998887776654 344689999999999999999999999999999999999999766 4699999999
Q ss_pred ccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc----------
Q 000726 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---------- 1268 (1329)
Q Consensus 1200 r~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~---------- 1268 (1329)
....... ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||......+....+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 8543322 22234578899999998742 34678999999999999999999999876554333222110
Q ss_pred ---------CCCCCC----------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1269 ---------TLRPPV----------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1269 ---------~lr~~i----------ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
....+. ...++..+.+|+.+||+.+|++||++.+++.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~ 285 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence 000000 1235788999999999999999999999987753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.27 Aligned_cols=253 Identities=32% Similarity=0.485 Sum_probs=208.9
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|+..+.||+|++|.||+|.+. ++.|++|++...... ......+.+|+.++++++||||+++++.+......
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS------EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 4778899999999999999985 788999998764321 23356788999999999999999999998875335
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..++||||+.+++|.+++.... .+++..++.++.|++.+|+|||+.+++|+||+|+||+++.++. ++|+|||.+.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~----~~l~d~~~~~ 149 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV----VKLADFGCAK 149 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC----EEEcccccEE
Confidence 8999999999999999886544 7899999999999999999999999999999999999997654 5999999998
Q ss_pred cccCccc---ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhcCCCCCCCC
Q 000726 1201 IKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1201 ~~~~~~~---ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~-~ell~qIve~~lr~~ips 1276 (1329)
....... .....++..|+|||.+.+ ...+.++||||||+++|+|++|..||..... ......+........++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCc
Confidence 6544332 334568899999999974 3478899999999999999999999987652 222223332234455667
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.++..+.+++.+||+.+|.+||++.+++.+.+
T Consensus 228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQHPF 259 (260)
T ss_pred ccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence 77999999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=310.06 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=202.2
Q ss_pred cccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEeccccc
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e 1116 (1329)
..+.|++.+.||+|+||.||+|.+ .++.||+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---------DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 346788889999999999999998 46789999986421 1224567889999998 69999999999853
Q ss_pred C----CCCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1117 G----PGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1117 ~----~dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
. ....++++|||+++++|.+++... ...+++..++.++.||+.||+|||+++|+|+||+|+||+++.++. +
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~----~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE----V 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----E
Confidence 2 234789999999999999988643 345788889999999999999999999999999999999997664 6
Q ss_pred EEeecCCcccccCc-ccccCCCCCCcccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 000726 1192 KVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~-~~ss~~~GTp~YmAPEvL~Gs---~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve 1267 (1329)
+|+|||++...... .......++..|+|||++... ...++.++|||||||++|+|++|..||...........+..
T Consensus 161 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 240 (282)
T cd06636 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240 (282)
T ss_pred EEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh
Confidence 99999998754321 122345688999999998531 24567899999999999999999999976654443333333
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1268 ~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
..........++..+.++|.+||+.||.+|||+.+|+++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 22222233457899999999999999999999999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.30 Aligned_cols=242 Identities=29% Similarity=0.452 Sum_probs=191.9
Q ss_pred EecccCcEEEEEEEEC--------------------------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc
Q 000726 1049 ELGSGTFGTVYHGKWR--------------------------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~k--------------------------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L 1102 (1329)
.||+|+||.||+|.+. ...||+|++... .......+.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------HRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------HHHHHHHHHHHHHHHhcC
Confidence 4999999999998752 124888887532 223345688899999999
Q ss_pred CCCceeeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec
Q 000726 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN 1182 (1329)
Q Consensus 1103 rHPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLD 1182 (1329)
+||||+++++++.... ..++||||+++++|..++......+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 74 ~h~niv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 74 SHIHLAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCCCeeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 9999999999998755 78999999999999998876566789999999999999999999999999999999999998
Q ss_pred cCCCC---CCcEEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHH-hCCCCCCCCCh
Q 000726 1183 LKDPI---RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL-TGEEPYANMHY 1258 (1329)
Q Consensus 1183 sdGni---~~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELL-TGk~PF~~~~~ 1258 (1329)
..+.. ...+|++|||++...... ....++..|+|||.+.+. ..++.++|||||||++|||+ +|..||.....
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred ccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 65421 235799999987643221 123467889999998743 45789999999999999995 69999977654
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1259 GAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1259 ~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
..... ..... ...+......+.++|.+||+.+|.+|||+.+|++.|
T Consensus 228 ~~~~~-~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEKER-FYEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHH-HHHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 44322 22222 223334567899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.26 Aligned_cols=253 Identities=29% Similarity=0.492 Sum_probs=203.3
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||+|+||.||++.+ .++.||||.++.... .+.....+..|+.+++.++|+||+++++++....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN------DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc------chHHHHHHHHHHHHHHhCCCCChhheeeeEecCC--
Confidence 578889999999999999987 477899999975421 1344567889999999999999999999987754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..++|+||+++++|.+++... ..+++..+..|+.+++.||.|||++||+|+||+|+||+++.++ .+||+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~----~~kl~d~g~~~ 147 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG----VIKLGDFGCAV 147 (264)
T ss_pred EEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEccccccc
Confidence 899999999999999988643 4578999999999999999999999999999999999999765 46999999987
Q ss_pred cccCccc-----ccCCCCCCcccCccccccCC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC
Q 000726 1201 IKRNTLV-----TGGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1201 ~~~~~~~-----ss~~~GTp~YmAPEvL~Gs~-~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~i 1274 (1329)
....... .....++..|+|||++.+.. ..++.++|||||||++|+|++|+.||.....................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 227 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPI 227 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCC
Confidence 5432211 11345788999999997533 34788999999999999999999999765433222222222333334
Q ss_pred CCC--CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1275 PGF--CDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1275 ps~--~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
+.. ++..+.+++.+||+.+|.+||++.+++.+.|
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 228 PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 443 4899999999999999999999999987643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=320.55 Aligned_cols=253 Identities=21% Similarity=0.359 Sum_probs=195.1
Q ss_pred EEEEeccc--CcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCe
Q 000726 1046 ELKELGSG--TFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1046 llkvLGqG--aFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~ 1121 (1329)
++++||+| +|++||++.++ ++.||||+++.... .......+.+|+.+++.++||||++++++|.... .
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~ 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--E 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--E
Confidence 45679999 78999999884 78899999875422 1223345678999999999999999999998855 8
Q ss_pred EEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1122 LATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1122 L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++. ++++||+.+.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~----~~l~~~~~~~ 149 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK----VYLSGLRSNL 149 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc----EEEcccchhh
Confidence 99999999999999988543 345899999999999999999999999999999999999997664 5899998654
Q ss_pred cccCc-c-------cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC-
Q 000726 1201 IKRNT-L-------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR- 1271 (1329)
Q Consensus 1201 ~~~~~-~-------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr- 1271 (1329)
..... . ......++..|+|||++.+....++.++|||||||++|||++|+.||..................
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 229 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccc
Confidence 22110 0 11123466789999999754456789999999999999999999999765443332221111000
Q ss_pred -------------------------------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1272 -------------------------------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1272 -------------------------------------------~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.+....+++.+.+|+.+||+.||++|||+.+++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 0011234678999999999999999999999999877
Q ss_pred HH
Q 000726 1309 VM 1310 (1329)
Q Consensus 1309 ~L 1310 (1329)
-.
T Consensus 310 f~ 311 (327)
T cd08227 310 FK 311 (327)
T ss_pred hh
Confidence 54
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.66 Aligned_cols=251 Identities=24% Similarity=0.423 Sum_probs=207.3
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||+|+||.||++.. .++.||||.+...... .....++.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS------PKEREESRKEVAVLSNMKHPNIVQYQESFEENG-- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC------hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC--
Confidence 488899999999999999987 4788999998753221 122356789999999999999999999998754
Q ss_pred eEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+.+++|.+++... ...+++.+++.++.|++.||.|||+++++|+||+|+|||++.++. ++|+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~----~~l~d~~~~ 148 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT----IKLGDFGIA 148 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC----EEEeeccce
Confidence 899999999999999988653 235789999999999999999999999999999999999987654 699999998
Q ss_pred ccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 r~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
....... ......+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||......+....+.... ..+.+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-YPPVSSHY 225 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC-CCCCcccC
Confidence 7543321 1223457888999999874 457789999999999999999999998776666665554433 34456678
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
+..+.++|.+||+.+|.+||++.+++++.+
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence 899999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.91 Aligned_cols=247 Identities=41% Similarity=0.669 Sum_probs=203.8
Q ss_pred eEEEEecccCcEEEEEEEECC------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1045 EELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1045 ellkvLGqGaFGtVYKA~~kG------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
++.+.||.|+||.||++.+.. ..||+|+++.... ......+..|+.+++.++|+||+++++++.+..
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-------EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE 74 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-------hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 456789999999999999854 6799999865321 113457888999999999999999999998754
Q ss_pred CCeEEEEEEeccCCchhhhhhccccc-CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~-Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
..+++|||+++++|.+++...... +++..+..++.|++.||+|||+.+++|+||||+||+++.++ .++|+|||
T Consensus 75 --~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~----~~~l~dfg 148 (258)
T smart00219 75 --PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDFG 148 (258)
T ss_pred --eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC----eEEEcccC
Confidence 899999999999999998654444 89999999999999999999999999999999999999776 46999999
Q ss_pred CcccccCccccc--CCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCC
Q 000726 1198 LSKIKRNTLVTG--GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1198 LAr~~~~~~~ss--~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~i 1274 (1329)
++.......... ...+++.|+|||.+. ...++.++|||||||++|+|++ |..||...........+.. ......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~--~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 225 (258)
T smart00219 149 LSRDLYDDDYYKKKGGKLPIRWMAPESLK--DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPK 225 (258)
T ss_pred CceecccccccccccCCCcccccChHHhc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCC
Confidence 997544321111 223678999999986 4557889999999999999998 8899987666666555443 344555
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1275 ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
+..++..+.+++.+||..+|.+|||+.++++.|
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 667899999999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=307.64 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=206.3
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||.|+||.||++.++ +..||+|++...... .......+.+|++++++++||||+++++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-----EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-----chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 4788999999999999999985 788999999754221 2234567889999999999999999999998755
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..++||||+.+++|..++... ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++. ++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~----~~l~d~~~~~ 148 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH----VHITDFNIAT 148 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC----EEEeeccccc
Confidence 899999999999999988654 57899999999999999999999999999999999999997764 5999999988
Q ss_pred cccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHhcCCCCCCCCCC
Q 000726 1201 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--GAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1201 ~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~--~ell~qIve~~lr~~ips~~ 1278 (1329)
............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ...+...... .....+..+
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (258)
T cd05578 149 KVTPDTLTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATW 225 (258)
T ss_pred ccCCCccccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccC
Confidence 6544433445668889999999974 3478899999999999999999999987663 2222222221 344556678
Q ss_pred cHHHHHHHHHhhcCCCCCCCCH--HHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSF--TEIARRL 1307 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTa--eELLq~L 1307 (1329)
+..+.++|.+||+.+|.+||++ .+++.+.
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~ 256 (258)
T cd05578 226 STEAIDAINKLLERDPQKRLGDNLKDLKNHP 256 (258)
T ss_pred cHHHHHHHHHHccCChhHcCCccHHHHhcCC
Confidence 8999999999999999999999 8777653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.22 Aligned_cols=246 Identities=28% Similarity=0.482 Sum_probs=190.2
Q ss_pred EecccCcEEEEEEEEC----CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEE
Q 000726 1049 ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~k----Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
.||+|+||.||+|.+. +..+|+|.++.... ......+.+|+.+++.++||||+++++++.+.. ..++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 72 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-------VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLL 72 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--CcEE
Confidence 5899999999999874 34589998764321 112346888999999999999999999988754 7899
Q ss_pred EEEeccCCchhhhhhccc----ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1125 VTEFMVNGSLRHVLLSKE----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~ke----k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+++++|+||||+||+++.++ .+||+|||++.
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~----~~kL~dfg~~~ 148 (269)
T cd05087 73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL----TVKIGDYGLSH 148 (269)
T ss_pred EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC----cEEECCccccc
Confidence 999999999999986432 2456777888999999999999999999999999999998654 46999999987
Q ss_pred cccCcc---cccCCCCCCcccCccccccCC-----CCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhc-CC
Q 000726 1201 IKRNTL---VTGGVRGTLPWMAPELLNGSS-----SKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN-TL 1270 (1329)
Q Consensus 1201 ~~~~~~---~ss~~~GTp~YmAPEvL~Gs~-----~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~-~l 1270 (1329)
...... ......++..|+|||++.+.. ..++.++|||||||++|||++ |..||......+.....+.. ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL 228 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC
Confidence 433221 122345678899999986422 135789999999999999996 99999876655543332222 11
Q ss_pred C---CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1271 R---PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1271 r---~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
. +......+..+.+++.+|| .+|.+|||+.+|+..|.
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 2222346788999999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=328.04 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=193.9
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.+....|++.+.||+|+||.||+|.+. +..||+|+.... ....|+.+++.++||||+++++++.
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------------~~~~E~~~l~~l~h~~iv~~~~~~~ 127 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------------TTLIEAMLLQNVNHPSVIRMKDTLV 127 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------------ccHHHHHHHHhCCCCCCcChhheEE
Confidence 344567999999999999999999985 567999975432 1245888999999999999999998
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
... ..++|||++ .++|..++......+++..++.|+.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 128 ~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~----~kl~D 200 (357)
T PHA03209 128 SGA--ITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ----VCIGD 200 (357)
T ss_pred eCC--eeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC----EEEec
Confidence 755 889999999 57888888776778999999999999999999999999999999999999997664 69999
Q ss_pred cCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCC-CCCChh---------HHHHHH
Q 000726 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY-ANMHYG---------AIIGGI 1265 (1329)
Q Consensus 1196 FGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF-~~~~~~---------ell~qI 1265 (1329)
||++.............||+.|+|||++.+ ..++.++|||||||+||||+++..++ ...... ..+..+
T Consensus 201 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~ 278 (357)
T PHA03209 201 LGAAQFPVVAPAFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278 (357)
T ss_pred CccccccccCcccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHH
Confidence 999975443333345669999999999984 45789999999999999999855544 321110 011111
Q ss_pred Hhc-CC-C-----------------------CCC-------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1266 VNN-TL-R-----------------------PPV-------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1266 ve~-~l-r-----------------------~~i-------ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
+.. .. . .+. ...++..+.+||.+||+.||.+|||+.|+++|.|-
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f 354 (357)
T PHA03209 279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354 (357)
T ss_pred HHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence 100 00 0 000 01345677889999999999999999999998764
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=320.07 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=222.9
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
-..++|++.+.||+|-||.||+|+.+ +--||+|++.++... ......++.+|+++...|+||||+++|++|.+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~-----~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL-----KTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH-----HhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 34578889999999999999999985 456999999875422 23345678899999999999999999999998
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
.. .+||++||...|.|...|... ...+++...+.++.|++.||.|||.++||||||||+|+|++.+|.. ||+|
T Consensus 94 ~~--riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~l----kiAd 167 (281)
T KOG0580|consen 94 SK--RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGEL----KIAD 167 (281)
T ss_pred cc--eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCe----eccC
Confidence 65 899999999999999999643 3568999999999999999999999999999999999999988765 9999
Q ss_pred cCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 000726 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275 (1329)
Q Consensus 1196 FGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ip 1275 (1329)
||-+.... .....+.|||..|++||+..+ ...+..+|+|++|++.||++.|.+||......+....+..-.+ .+|
T Consensus 168 fGwsV~~p-~~kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~--~~p 242 (281)
T KOG0580|consen 168 FGWSVHAP-SNKRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL--KFP 242 (281)
T ss_pred CCceeecC-CCCceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc--cCC
Confidence 99886544 444457899999999999984 5578899999999999999999999999888888888776544 445
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1276 s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
..++....++|.+|+.++|.+|....+++.|.|-..
T Consensus 243 ~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 243 STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 788999999999999999999999999999998653
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.27 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=205.7
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|+..+.||+|++|.||++.. +++.||+|+++..... ....+.....+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT--SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCC--chhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--
Confidence 367778999999999999987 5788999998754322 1223445678899999999999999999999998755
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++. .++|+|||++.
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~---~~~l~dfg~~~ 152 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ---RLRIADFGAAA 152 (268)
T ss_pred eEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEEccccccc
Confidence 88999999999999998854 346889999999999999999999999999999999999986653 47999999987
Q ss_pred cccCcc-----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---HHHHHHHhcCCCC
Q 000726 1201 IKRNTL-----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVNNTLRP 1272 (1329)
Q Consensus 1201 ~~~~~~-----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~---ell~qIve~~lr~ 1272 (1329)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... .....+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC
Confidence 543221 1123457889999999874 45688999999999999999999999654332 2222222333445
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
..+..+++.+.+++.+||..+|.+||++.+++++.+
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~ 266 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV 266 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence 566678899999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.81 Aligned_cols=241 Identities=30% Similarity=0.473 Sum_probs=190.6
Q ss_pred EecccCcEEEEEEEECCc------------eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1049 ELGSGTFGTVYHGKWRGT------------DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~kGr------------~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
.||+|+||.||+|.+... .|++|+++... .....+.+|+.+++.++||||+++++++..
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---------RDSLAFFETASLMSQLSHKHLVKLYGVCVR 72 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccch---------hhHHHHHHHHHHHHcCCCcchhheeeEEec
Confidence 699999999999998533 37777765321 114678889999999999999999998876
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCC---CCCcEEE
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP---IRPICKV 1193 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGn---i~~~VKL 1193 (1329)
. ..++||||+++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++. ....+||
T Consensus 73 -~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 73 -D--ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred -C--CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence 3 578999999999999998765557899999999999999999999999999999999999987651 1235799
Q ss_pred eecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~ 1272 (1329)
+|||++..... .....++..|+|||++.+....++.++|||||||++|+|++ |..||............. .....
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~ 225 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRL 225 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCC
Confidence 99999885433 12234677899999998543467899999999999999999 688887664333222222 22112
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
+......+.+++.+||..+|.+|||+.++++.|
T Consensus 226 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 226 --PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 222237899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.28 Aligned_cols=244 Identities=40% Similarity=0.672 Sum_probs=200.5
Q ss_pred EecccCcEEEEEEEEC-CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEE
Q 000726 1049 ELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVME 1127 (1329)
+||+|+||.||++.+. ++.||+|+++.... ......+.+|+.++++++|+||+++++++.... ..++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e 72 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-------PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVME 72 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCC-------HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEEE
Confidence 6999999999999985 78899998875321 123456889999999999999999999988754 8899999
Q ss_pred eccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCccc
Q 000726 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207 (1329)
Q Consensus 1128 Ym~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~ 1207 (1329)
|+++++|.+++......+++..++.++.+++.+|+|||+++++||||||+|||++.++ .++|+|||++........
T Consensus 73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~----~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN----VLKISDFGMSREEEGGIY 148 (251)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC----cEEEeeccccccccCCcc
Confidence 9999999999876556789999999999999999999999999999999999999766 469999999875432111
Q ss_pred c---cCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1208 T---GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1208 s---s~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
. .....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+ ........+..++..+.
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 225 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIY 225 (251)
T ss_pred eeccccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-hcCCCCCCCccCCHHHH
Confidence 1 11223567999999874 457889999999999999999 88999777655444433 33344555667889999
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1284 DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
+++.+||..+|.+||++.+|++.|.
T Consensus 226 ~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 226 RLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHhccChhhCcCHHHHHHHhh
Confidence 9999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.12 Aligned_cols=251 Identities=25% Similarity=0.290 Sum_probs=197.2
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccccCCCC
Q 000726 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~e~~dg 1120 (1329)
|++.+.||+|+||.||++.+ +++.||+|+++...... . .....+|+.+++++. |+||+++++++.+...+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~----~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL----E---QVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc----h---hhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 56788999999999999987 47889999987542211 1 123457888899885 99999999999876446
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.+++||||+. ++|.+.+......+++..++.++.||+.||+|||++|++|+||+|+||+++. + .+||+|||++.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~----~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D----ILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C----CeEEEeccccc
Confidence 8999999995 6888888665567899999999999999999999999999999999999997 4 46999999998
Q ss_pred cccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC-----------
Q 000726 1201 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----------- 1269 (1329)
Q Consensus 1201 ~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~----------- 1269 (1329)
............++..|+|||++.. ...++.++|||||||++|||++|..||...+..+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLT-DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhc-CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 6544333334457889999998753 2346789999999999999999999998766544332221100
Q ss_pred -----CCCCC-----------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1270 -----LRPPV-----------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1270 -----lr~~i-----------ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
..... ...++..+.++|.+||+++|.+||++.+++.+.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 00000 1245789999999999999999999999998754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.04 Aligned_cols=246 Identities=27% Similarity=0.416 Sum_probs=205.5
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEE
Q 000726 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1329)
Q Consensus 1050 LGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVME 1127 (1329)
||.|++|.||++.++ ++.||||++.+.... .......+.+|+.+++.++||||+++++++.+.. ..++|||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-----ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK--YIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-----hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC--ccEEEEe
Confidence 689999999999996 788999999764322 1223456889999999999999999999988754 8999999
Q ss_pred eccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCccc
Q 000726 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207 (1329)
Q Consensus 1128 Ym~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~ 1207 (1329)
|+++++|.+++... ..+++..+..++.||+.||+|||+++++|+||+|.||+++.++. ++|+|||++........
T Consensus 74 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~----~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 74 YCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFAKKLKSGQK 148 (262)
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC----EEEeeCCcccccCcccc
Confidence 99999999998643 45899999999999999999999999999999999999997664 69999999986544323
Q ss_pred ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--hhHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 000726 1208 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH--YGAIIGGIVNNTLRPPVPGFCDSEWRLL 1285 (1329)
Q Consensus 1208 ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~--~~ell~qIve~~lr~~ips~~S~eL~DL 1285 (1329)
.....++..|++||.+.+ ..++.++|+||||+++|+|++|..||.... .......+.........+..++..+.++
T Consensus 149 ~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05572 149 TWTFCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL 226 (262)
T ss_pred cccccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 334568899999999873 457889999999999999999999998766 4455555554444556666678999999
Q ss_pred HHHhhcCCCCCCCC-----HHHHHHHHHH
Q 000726 1286 MEQCWAPDPVVRPS-----FTEIARRLRV 1309 (1329)
Q Consensus 1286 IkrCLqkDPeERPT-----aeELLq~Le~ 1309 (1329)
|.+||+.+|.+||+ +.|++++.|.
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 255 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKKHKWF 255 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhcChhh
Confidence 99999999999999 9999998774
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.64 Aligned_cols=248 Identities=35% Similarity=0.583 Sum_probs=198.6
Q ss_pred EecccCcEEEEEEEECC--------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1049 ELGSGTFGTVYHGKWRG--------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~kG--------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
.||+|+||.||+|++.. ..+|||.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-- 72 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-------hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--
Confidence 59999999999998742 4689998764311 122356888999999999999999999987754
Q ss_pred eEEEEEEeccCCchhhhhhcc------cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCC-CCCCcEEE
Q 000726 1121 TLATVTEFMVNGSLRHVLLSK------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PIRPICKV 1193 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~k------ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdG-ni~~~VKL 1193 (1329)
..++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+++|+||||+|||++.++ .....++|
T Consensus 73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEE
Confidence 789999999999999998642 23478899999999999999999999999999999999998765 12336799
Q ss_pred eecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcC
Q 000726 1194 GDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1269 (1329)
Q Consensus 1194 sDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~ 1269 (1329)
+|||++....... ......++..|+|||++. ...++.++|||||||++|+|++ |..||...........+ ...
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~ 229 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL--DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-TAG 229 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHc--cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-hcC
Confidence 9999987432211 112233567899999997 4457889999999999999998 99999876665544433 333
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1270 lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.....+..++..+.++|.+||+.+|.+||++.+|++.|+
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 344555678899999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.65 Aligned_cols=253 Identities=29% Similarity=0.426 Sum_probs=204.7
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||.|+||+||+|.+ .+..+|+|++...... .....+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ-------TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc-------hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-
Confidence 4688999999999999999987 4678999998653221 13466889999999999999999999888754
Q ss_pred CeEEEEEEeccCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~ke--k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
..++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+|+||+|+||+++.++. ++|+|||
T Consensus 73 -~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~----~~l~df~ 147 (267)
T cd06610 73 -ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS----VKIADFG 147 (267)
T ss_pred -EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC----EEEcccc
Confidence 8999999999999999986532 46899999999999999999999999999999999999997654 5999999
Q ss_pred CcccccCcc-----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC-
Q 000726 1198 LSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR- 1271 (1329)
Q Consensus 1198 LAr~~~~~~-----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr- 1271 (1329)
++....... ......++..|+|||++... ..++.++|+|||||++|+|++|+.||..................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (267)
T cd06610 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPS 226 (267)
T ss_pred hHHHhccCccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCC
Confidence 987443221 12334588999999998743 35788999999999999999999999877665544444433211
Q ss_pred CCC---CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1272 PPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1272 ~~i---ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
... ...++..+.+++.+||+.||++||++.+|+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 111 1246788999999999999999999999998753
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.47 Aligned_cols=242 Identities=27% Similarity=0.434 Sum_probs=190.4
Q ss_pred EecccCcEEEEEEEEC--------------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Q 000726 1049 ELGSGTFGTVYHGKWR--------------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~k--------------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif 1114 (1329)
.||+|+||.||+|.+. ...|++|++... .+.....+.+|+.+++.++||||+++++++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~ 73 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--------HRDISLAFFETASMMRQVSHKHIVLLYGVC 73 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--------hhhHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 5899999999999853 124788876532 223345688899999999999999999998
Q ss_pred ccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCC---CCCcE
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP---IRPIC 1191 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGn---i~~~V 1191 (1329)
.... ..++||||+++++|..++......+++..++.++.||+.||+|||+++|+||||||+|||++.++. ....+
T Consensus 74 ~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 74 VRDV--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred ecCC--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCcee
Confidence 8754 778999999999998888766667899999999999999999999999999999999999986553 12347
Q ss_pred EEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHH-hCCCCCCCCChhHHHHHHHhcCC
Q 000726 1192 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL-TGEEPYANMHYGAIIGGIVNNTL 1270 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELL-TGk~PF~~~~~~ell~qIve~~l 1270 (1329)
+++|||++...... ....++..|+|||.+.. ...++.++|||||||+||||+ +|..||......+.. .......
T Consensus 152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~ 226 (262)
T cd05077 152 KLSDPGIPITVLSR---QECVERIPWIAPECVED-SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQC 226 (262)
T ss_pred EeCCCCCCccccCc---ccccccccccChhhhcC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCc
Confidence 99999998644221 23457888999998863 345788999999999999998 588888765443322 2222221
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1271 r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
. .....+.++.+||.+||+.||.+||++.+|++++
T Consensus 227 ~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1 2223467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=295.03 Aligned_cols=248 Identities=32% Similarity=0.524 Sum_probs=204.5
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|+..+.||+|++|.||++.+. +..+++|++..... .....+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-- 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 4778899999999999999985 78899999975321 23467889999999999999999999988754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..+++|||+++++|.+++......+++..+..++.|++.+|.|||.+|++|+||+|.||+++.++ .++|+|||.+.
T Consensus 71 ~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~----~~~l~d~~~~~ 146 (253)
T cd05122 71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG----EVKLIDFGLSA 146 (253)
T ss_pred eEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC----eEEEeeccccc
Confidence 88999999999999999876556789999999999999999999999999999999999999765 46999999988
Q ss_pred cccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC--CCC
Q 000726 1201 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP--GFC 1278 (1329)
Q Consensus 1201 ~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ip--s~~ 1278 (1329)
............++..|+|||.+.+ ..++.++||||||+++|+|++|..||............... .....+ ..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 223 (253)
T cd05122 147 QLSDTKARNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPGLRNPEKW 223 (253)
T ss_pred cccccccccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCCcCccccc
Confidence 6544332334568899999999984 34788999999999999999999999876544444333322 222222 234
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
+..+.+++.+||+.||.+|||+.+++++.
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~~ 252 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKHP 252 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 88999999999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=309.61 Aligned_cols=242 Identities=29% Similarity=0.500 Sum_probs=193.0
Q ss_pred EecccCcEEEEEEEEC---------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1049 ELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~k---------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
.||+|+||.||+|.+. ...||+|.+... .......+..|+.+++.+.||||+++++++....
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 72 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD- 72 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch--------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-
Confidence 5999999999999873 223788876432 1233456788999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCC----CCcEEEee
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI----RPICKVGD 1195 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni----~~~VKLsD 1195 (1329)
..++||||+++++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++.. ...++++|
T Consensus 73 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 73 -ESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred -CcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 7899999999999999997666678999999999999999999999999999999999999876532 23579999
Q ss_pred cCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHhcCCCCCC
Q 000726 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG-EEPYANMHYGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1196 FGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTG-k~PF~~~~~~ell~qIve~~lr~~i 1274 (1329)
||++...... ....++..|+|||++.+ ...++.++|||||||++|+|++| ..||.......... .... ...+
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~--~~~~ 224 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIEN-PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED--RHQL 224 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccC-CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--cccC
Confidence 9998754322 23457889999999974 23468899999999999999998 46665544433322 2222 2334
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1275 ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
+...+..+.+|+.+||+.+|.+|||+.++++.|
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 555678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.25 Aligned_cols=245 Identities=27% Similarity=0.514 Sum_probs=190.2
Q ss_pred EecccCcEEEEEEEEC-C---ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEE
Q 000726 1049 ELGSGTFGTVYHGKWR-G---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~k-G---r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
.||+|+||.||+|... + ..+|+|.+.... .......+.+|+.+++.++|+||+++++.+.... ..++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~--~~~l 72 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYLL 72 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC--ceEE
Confidence 5999999999999763 2 357777664321 1223456888999999999999999999988754 7999
Q ss_pred EEEeccCCchhhhhhccc----ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1125 VTEFMVNGSLRHVLLSKE----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~ke----k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
||||+++++|.+++.... ...++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||++.
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~----~kl~dfg~~~ 148 (269)
T cd05042 73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS----VKIGDYGLAL 148 (269)
T ss_pred EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc----EEEecccccc
Confidence 999999999999986533 23467788899999999999999999999999999999997664 5999999986
Q ss_pred cccCc---ccccCCCCCCcccCccccccC-----CCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC-
Q 000726 1201 IKRNT---LVTGGVRGTLPWMAPELLNGS-----SSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL- 1270 (1329)
Q Consensus 1201 ~~~~~---~~ss~~~GTp~YmAPEvL~Gs-----~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~l- 1270 (1329)
..... .......++..|+|||++... ...++.++|||||||++|||++ |..||......+.+...+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 228 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc
Confidence 43221 112233456789999997531 2346889999999999999999 8889987766555544433321
Q ss_pred ---CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1271 ---RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1271 ---r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
.+..+..++..+.+++..|| .||++|||+.+|++.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 12234467888999999999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.78 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=207.9
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
.|+..+.||.|+||.||+|.+. +..||||+++.... ......+.+|+.+++.+.||||+++++++.+..
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-- 75 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--
Confidence 4667788999999999999884 67899999875321 223467889999999999999999999998754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..++||||+++++|.+++.. ..+++.++..++.|++.||+|||+++++|+||+|+||+++.++. ++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~----~~l~dfg~~~ 149 (277)
T cd06640 76 KLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD----VKLADFGVAG 149 (277)
T ss_pred EEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC----EEEcccccce
Confidence 89999999999999998853 45889999999999999999999999999999999999997664 5999999987
Q ss_pred cccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCc
Q 000726 1201 IKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279 (1329)
Q Consensus 1201 ~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S 1279 (1329)
...... ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+ .....+..+..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 226 (277)
T cd06640 150 QLTDTQIKRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFS 226 (277)
T ss_pred eccCCccccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhhh
Confidence 543221 2233457889999999873 45788999999999999999999999876655444332 2233344555678
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 000726 1280 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 1314 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~ 1314 (1329)
..+.+++.+||+.+|.+||++.+++.+.+......
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 89999999999999999999999999987655443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.43 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=199.3
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHH-HHhcCCCceeeEecccccCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI-LSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeI-Lk~LrHPNIVKL~Gif~e~~ 1118 (1329)
++|++.+.||+|+||.||++++. |+.||||+++..... .....+..|+.+ ++.++||||+++++++....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-------QEQKRLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-------HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 36889999999999999999984 788999998764221 112344455554 56678999999999998754
Q ss_pred CCeEEEEEEeccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs~-GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
..++||||++ ++|.+++.. ....+++..++.++.||+.||+|||++ +++||||||+|||++.++ .+||+
T Consensus 74 --~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~----~~kl~ 146 (283)
T cd06617 74 --DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG----QVKLC 146 (283)
T ss_pred --cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC----CEEEe
Confidence 7999999995 677766643 234689999999999999999999998 999999999999999766 46999
Q ss_pred ecCCcccccCcccccCCCCCCcccCccccccC--CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhcCCC
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS--SSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAIIGGIVNNTLR 1271 (1329)
Q Consensus 1195 DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs--~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~-~ell~qIve~~lr 1271 (1329)
|||++.............++..|+|||.+.+. ...++.++|+|||||++|+|++|+.||..... .+.+...... ..
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~ 225 (283)
T cd06617 147 DFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-PS 225 (283)
T ss_pred ecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-CC
Confidence 99998865433333335588899999998642 13467899999999999999999999975332 2223333322 22
Q ss_pred CCC-CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1272 PPV-PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1272 ~~i-ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
... ...++..+.++|.+||..+|.+||++.+++.+.+.....
T Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 222 235789999999999999999999999999988776543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=311.44 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=207.4
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
+.+|++.+.||.|++|.||++.+ .++.||||.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--------KKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--------hHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 35799999999999999999987 4788999998643211 1245778999999999999999999998754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
.+++||||+++++|..++.. ..+++.++..++.+++.||+|||++|++|+||||+||+++.++. ++|+|||+
T Consensus 90 --~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~----~kl~dfg~ 161 (296)
T cd06655 90 --ELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS----VKLTDFGF 161 (296)
T ss_pred --eEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----EEEccCcc
Confidence 89999999999999998843 45899999999999999999999999999999999999987664 69999999
Q ss_pred cccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC-CCCCCCC
Q 000726 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPPVPG 1276 (1329)
Q Consensus 1199 Ar~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~-lr~~ips 1276 (1329)
+....... ......++..|+|||.+. ...++.++|||||||++|+|++|+.||...........+.... .....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06655 162 CAQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239 (296)
T ss_pred chhcccccccCCCcCCCccccCcchhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcc
Confidence 87543221 223345888999999987 3457889999999999999999999998776554444333222 1223455
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.+++.+.++|.+||..+|.+||++.+++.+-+...
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 67889999999999999999999999999988753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=302.73 Aligned_cols=255 Identities=29% Similarity=0.408 Sum_probs=209.3
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
.+|++.+.||+|+||.||++.+ +++.||+|.+...... .........+.+|+.++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS---QETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc---chhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 5788999999999999999987 4788999987543211 1123345678899999999999999999999877655
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..+++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++. ++|+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~----~~l~dfg~~ 153 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN----VKLGDFGAS 153 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC----EEECccccc
Confidence 6789999999999999988643 35889999999999999999999999999999999999997654 599999999
Q ss_pred ccccCc----ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 000726 1200 KIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275 (1329)
Q Consensus 1200 r~~~~~----~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ip 1275 (1329)
...... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+........++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p 231 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCC
Confidence 754321 11123458889999999984 456889999999999999999999998776666555555555566677
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1276 s~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
..+++.+.+++.+||+ +|..||++.+++.|+
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 7889999999999999 579999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.24 Aligned_cols=269 Identities=24% Similarity=0.312 Sum_probs=230.6
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~~d 1119 (1329)
.|.-.+.||.|..++|-++.+ +|..+|+|++.........+...+...+-.+|+.+|+++ .||+|+++.++|+...
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s- 96 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA- 96 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc-
Confidence 455667899999999998877 478899999987666555555666777788999999998 6999999999999865
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
++++|+|.|+.|.|.++|... -.+++.....|..|+.+|++|||.+.|+||||||+|||++++-+ +||+|||++
T Consensus 97 -F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~----i~isDFGFa 170 (411)
T KOG0599|consen 97 -FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN----IKISDFGFA 170 (411)
T ss_pred -hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc----eEEecccee
Confidence 999999999999999999643 45899999999999999999999999999999999999997765 499999999
Q ss_pred ccccCcccccCCCCCCcccCccccc----cCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLN----GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~----Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ip 1275 (1329)
+...........||||+|+|||.+. .....|+..+|+||+|++||-|+.|++||-.....-++..+....+....|
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 9888777777899999999999985 235678999999999999999999999997766556666677766654444
Q ss_pred --CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhccCC
Q 000726 1276 --GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKS 1318 (1329)
Q Consensus 1276 --s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q~~s 1318 (1329)
..++...++||.+||+.||.+|.|++|+|.|.+......+...
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r 295 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR 295 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence 4568899999999999999999999999999999877766544
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=311.51 Aligned_cols=264 Identities=24% Similarity=0.306 Sum_probs=207.4
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
..++|++.+.||+|+||.||+|.+. ++.||+|+++...... .....+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD------GIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC------CCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 3568999999999999999999984 7889999997543221 1122456799999999999999999998765
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
....+++||||+. ++|..++......+++..++.++.||+.||+|||++|++|+||||+|||++.++ .+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~----~~kL~dfg 153 (309)
T cd07845 79 HLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG----CLKIADFG 153 (309)
T ss_pred CCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----CEEECccc
Confidence 5457899999995 588888765556789999999999999999999999999999999999999766 46999999
Q ss_pred CcccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC------
Q 000726 1198 LSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL------ 1270 (1329)
Q Consensus 1198 LAr~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l------ 1270 (1329)
++...... .......++..|+|||++.+ ...++.++|||||||++|+|++|+.||........+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 154 LARTYGLPAKPMTPKVVTLWYRAPELLLG-CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred eeeecCCccCCCCcccccccccChhhhcC-CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 99854432 11222335788999999874 23468899999999999999999999987776555444332100
Q ss_pred -------------CCC-C--------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1271 -------------RPP-V--------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1271 -------------r~~-i--------ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
... . ....++.+.++|.+||+.||.+|||+.+++.+.|-....+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 000 0 01247888999999999999999999999999887644444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.25 Aligned_cols=252 Identities=25% Similarity=0.448 Sum_probs=205.9
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||+|+||.||++.++ +..||+|.+....... .....+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV------KEKEASKKEVILLAKMKHPNIVTFFASFQENG-- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc------hhhHHHHHHHHHHHhCCCCChhhhhheeccCC--
Confidence 4788999999999999999984 6789999987532211 12345678999999999999999999988754
Q ss_pred eEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++. .++|+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~---~~~l~d~~~~ 149 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM---VAKLGDFGIA 149 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC---eEEecccccc
Confidence 8999999999999999886533 35799999999999999999999999999999999999987653 4699999998
Q ss_pred ccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 r~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
....... ......|++.|+|||++. ...++.++|+|||||++|+|++|..||...........+.... ..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQ--NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-FAPISPNF 226 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-CCCCCCCC
Confidence 7544322 222345888999999987 3457889999999999999999999998766655555544333 33444567
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
+..+.+++.+||..+|++|||+.+++++.|
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 227 SRDLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=298.04 Aligned_cols=250 Identities=32% Similarity=0.511 Sum_probs=207.2
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||+|++|.||++++. ++.|+||++...... .....+.+|+.++..++|+||+++++++....
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-------EFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-- 72 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC--
Confidence 6888999999999999999984 788999998754211 33467889999999999999999999998754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++... ..+++..++.++.|++.+|+|||+ .+++|+||+|+||+++.++. ++|+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~----~~l~df~~~ 147 (264)
T cd06623 73 EISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE----VKIADFGIS 147 (264)
T ss_pred eEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC----EEEccCccc
Confidence 899999999999999998644 568999999999999999999999 99999999999999997664 599999998
Q ss_pred ccccCcccc-cCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhcCCCCCCC
Q 000726 1200 KIKRNTLVT-GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---YGAIIGGIVNNTLRPPVP 1275 (1329)
Q Consensus 1200 r~~~~~~~s-s~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~---~~ell~qIve~~lr~~ip 1275 (1329)
......... ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.... .......+. .......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 224 (264)
T cd06623 148 KVLENTLDQCNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLP 224 (264)
T ss_pred eecccCCCcccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCC
Confidence 854332222 23457889999999874 467889999999999999999999997763 333344433 33334444
Q ss_pred CC-CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1276 GF-CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1276 s~-~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
.. ++..+.+++.+||..+|.+||++.+++++.+.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~ 259 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHH
Confidence 55 78999999999999999999999999998665
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.01 Aligned_cols=251 Identities=28% Similarity=0.453 Sum_probs=204.1
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
.|+..+.||+|+||.||+|.+ .+..||||+++... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT-- 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-------chHHHHHHHHHHHHHHcCCCCccHhhhcccccCC--
Confidence 455667899999999999987 46789999986431 1223457889999999999999999999998754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++. ++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~----~~l~dfg~~~ 149 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD----VKLADFGVAG 149 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC----EEEccccccc
Confidence 89999999999999988843 46889999999999999999999999999999999999997654 6999999987
Q ss_pred cccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCc
Q 000726 1201 IKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279 (1329)
Q Consensus 1201 ~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S 1279 (1329)
...... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+ ...........++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 226 (277)
T cd06642 150 QLTDTQIKRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-PKNSPPTLEGQYS 226 (277)
T ss_pred cccCcchhhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-hcCCCCCCCcccC
Confidence 543322 2223457889999999984 45788999999999999999999999765544433332 2223334455678
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1280 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
..+.+++.+||+.+|.+||++.+++.+.+...
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 89999999999999999999999999887553
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=296.65 Aligned_cols=250 Identities=30% Similarity=0.517 Sum_probs=209.6
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||.|+||.||++.+. +..||+|++..... .......+.+|+++++.++|||++++++.+... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~ 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM------SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--G 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC------ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--C
Confidence 4788899999999999999985 78899999875322 123345678899999999999999999998875 4
Q ss_pred eEEEEEEeccCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1121 TLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~k---ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
..++||||+++++|..++... ...+++..++.++.+++.||.|||++|++|+||+|+||+++.++. ++|+|||
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~----~~l~d~~ 148 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL----VKLGDFG 148 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc----EEECCcc
Confidence 899999999999999988654 367899999999999999999999999999999999999997654 5999999
Q ss_pred CcccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 000726 1198 LSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1198 LAr~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips 1276 (1329)
++....... ......+++.|+|||.+. ...++.++||||||+++|+|++|+.||............... ...+++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 225 (258)
T cd08215 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQ--NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG-QYPPIPS 225 (258)
T ss_pred ceeecccCcceecceeeeecccChhHhc--cCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC-CCCCCCC
Confidence 998544332 223346888999999987 345788999999999999999999999887766655554433 3455666
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
.++..+.+++.+||..+|.+|||+.+++.+.
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 256 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQSP 256 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCC
Confidence 7889999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=304.91 Aligned_cols=250 Identities=34% Similarity=0.515 Sum_probs=203.9
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||.|++|.||++.++ ++.||+|.+..... .....++.+|+.+++.+.||||+++++.+....
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-------EAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-- 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-------hHHHHHHHHHHHHHHHCCCCchhhhheeeecCC--
Confidence 5677788999999999999985 77899999875421 123456789999999999999999999988754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+.+++|.+++......+++..+..++.|++.+|+|||+ .+++|+||||+||+++.++. ++|+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~----~~l~d~g~~ 148 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ----IKLCDFGVS 148 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC----EEEeecccc
Confidence 8999999999999999986654678999999999999999999999 99999999999999997654 699999998
Q ss_pred ccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-----hhHHHHHHHhcCCCCCC
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-----YGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~-----~~ell~qIve~~lr~~i 1274 (1329)
.......... ..++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... .......+... ..+..
T Consensus 149 ~~~~~~~~~~-~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 224 (265)
T cd06605 149 GQLVNSLAKT-FVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-PPPRL 224 (265)
T ss_pred hhhHHHHhhc-ccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-CCCCC
Confidence 7543322222 568889999999974 467889999999999999999999997642 22223333222 22233
Q ss_pred CCC-CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1275 PGF-CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1275 ps~-~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
+.. ++..+.++|.+||..+|.+|||+.+++.+.|.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 333 78899999999999999999999999988765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=309.64 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=204.6
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
.+|++.+.||+|+||.||++.+. ++.||||.+..... ........+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-----ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR- 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-
Confidence 36889999999999999999985 67899999875421 12233456788999999999999999999988754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+++++|.+++... ..+++..+..++.|++.||+|||+++++||||||+|||++.++ .++|+|||++
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~----~~~l~dfg~~ 148 (305)
T cd05609 75 -HLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG----HIKLTDFGLS 148 (305)
T ss_pred -EEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC----CEEEeeCCCc
Confidence 899999999999999998554 4689999999999999999999999999999999999998765 4699999998
Q ss_pred ccccCc----------------ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 000726 1200 KIKRNT----------------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 1263 (1329)
Q Consensus 1200 r~~~~~----------------~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~ 1263 (1329)
+..... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+....+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 631100 01112347888999999873 457899999999999999999999998877776666
Q ss_pred HHHhcCCCCC-CCCCCcHHHHHHHHHhhcCCCCCCCC---HHHHHHHHHH
Q 000726 1264 GIVNNTLRPP-VPGFCDSEWRLLMEQCWAPDPVVRPS---FTEIARRLRV 1309 (1329)
Q Consensus 1264 qIve~~lr~~-ips~~S~eL~DLIkrCLqkDPeERPT---aeELLq~Le~ 1309 (1329)
.+.......+ ....++..+.++|.+||+.+|++||+ +.+++++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 227 QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 6555433222 22357899999999999999999998 5777777553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=311.95 Aligned_cols=255 Identities=30% Similarity=0.467 Sum_probs=205.1
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
..++|++.+.||+|+||+||++.+. ++.||+|++.... .+.....+.+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-------KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-------cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 4567888899999999999999985 7889999986431 122345788999999999999999999999886
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
. .+++||||+++++|..++.. ...+++..+..++.+++.+|.|||+ .+++|+||||+||+++.++ .++|+||
T Consensus 76 ~--~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~----~~~l~d~ 148 (284)
T cd06620 76 N--NICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG----QIKLCDF 148 (284)
T ss_pred C--EEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC----cEEEccC
Confidence 4 89999999999999888754 3568999999999999999999997 6899999999999998765 4699999
Q ss_pred CCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-----------HHHHHH
Q 000726 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-----------AIIGGI 1265 (1329)
Q Consensus 1197 GLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~-----------ell~qI 1265 (1329)
|++....... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+
T Consensus 149 gl~~~~~~~~-~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd06620 149 GVSGELINSI-ADTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225 (284)
T ss_pred Ccccchhhhc-cCccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence 9986432221 224568999999999874 46788999999999999999999999764431 222222
Q ss_pred HhcCCCCCCC-CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1266 VNNTLRPPVP-GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1266 ve~~lr~~ip-s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
.... ...++ ..++..+.+|+.+||+.||.+|||+.+++++++.+..
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 226 VQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 2222 12222 2367889999999999999999999999998777654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.82 Aligned_cols=255 Identities=28% Similarity=0.424 Sum_probs=205.2
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
..|+..+.||+|+||.||++.+ .++.||+|++...... .......+.+|+.+++.++||||++++++|....
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~- 88 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH- 88 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-----cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-
Confidence 4588889999999999999987 4788999998643211 1223456889999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+. ++|.+++......+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++. ++|+|||++
T Consensus 89 -~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~----~kL~dfg~~ 162 (307)
T cd06607 89 -TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT----VKLADFGSA 162 (307)
T ss_pred -eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC----EEEeecCcc
Confidence 7899999995 6777776555567899999999999999999999999999999999999997764 599999998
Q ss_pred ccccCcccccCCCCCCcccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~G-s~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
...... ....++..|+|||++.+ ....++.++||||||+++|+|++|..||...........+.........+..+
T Consensus 163 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (307)
T cd06607 163 SLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW 239 (307)
T ss_pred eecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhh
Confidence 754332 23457889999999853 23457889999999999999999999998776555444433332222223346
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
+..+.++|.+||+.+|.+||++.+++.+.+...
T Consensus 240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 788999999999999999999999999877543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.29 Aligned_cols=252 Identities=29% Similarity=0.354 Sum_probs=197.9
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||+|.++ ++.||+|++...... ......+.+|+++++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD------KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK- 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc------chhhHHHHHHHHHHHhcCCcchhhHHHhcccCC-
Confidence 46889999999999999999984 788999998653221 122345778999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|..+... ...+++..++.++.||+.||+|||+.+|+|+||+|+||+++.++ .++|+|||++
T Consensus 74 -~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~----~~~l~dfg~~ 147 (286)
T cd07846 74 -RLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFA 147 (286)
T ss_pred -eEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC----cEEEEeeeee
Confidence 89999999998888776543 34589999999999999999999999999999999999999766 4599999998
Q ss_pred ccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc----------
Q 000726 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---------- 1268 (1329)
Q Consensus 1200 r~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~---------- 1268 (1329)
...... .......++..|+|||++.+ ...++.++|||||||++|+|++|++||......+....+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVG-DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhcc-ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 754322 22233457889999999874 234678999999999999999999999765543322221110
Q ss_pred ---------CC-CC---------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1269 ---------TL-RP---------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1269 ---------~l-r~---------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
.. .. .....++..+.+++.+||+.+|.+||++.+++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 284 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCC
Confidence 00 00 01124578899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=349.81 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=212.9
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC-C-ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecc-
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-G-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGV- 1113 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k-G-r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gi- 1113 (1329)
.|...++++.+.|.+|||+.||+|++. + ..||+|++... ++.....+.+|+.+|+.|. |+|||.+++.
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--------de~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--------DEEALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--------CHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 566678899999999999999999984 3 78999988642 4666778899999999997 9999999993
Q ss_pred ccc--CCC--CeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCCcceEeccCCC
Q 000726 1114 VQD--GPG--GTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDP 1186 (1329)
Q Consensus 1114 f~e--~~d--g~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~G--IIHRDLKPeNILLDsdGn 1186 (1329)
... ... -.++|.||||.+|.|.++|..+. ..|++.++++|+.++++|+++||... |||||||-+||||+.+|+
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence 221 111 35789999999999999997543 45999999999999999999999987 999999999999998875
Q ss_pred CCCcEEEeecCCcccccCcc-ccc---------CCCCCCcccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCC
Q 000726 1187 IRPICKVGDFGLSKIKRNTL-VTG---------GVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1255 (1329)
Q Consensus 1187 i~~~VKLsDFGLAr~~~~~~-~ss---------~~~GTp~YmAPEvL~G-s~~~~S~KSDVWSLGVLLyELLTGk~PF~~ 1255 (1329)
+||||||-|+...... ... ..-.|+.|+|||++.- ....+++|+|||||||+||-||....||..
T Consensus 185 ----~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 185 ----YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE 260 (738)
T ss_pred ----EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence 5999999998432211 110 1226899999999851 234579999999999999999999999987
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1256 MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1256 ~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
... ..|+...+..+....++..|.+||+.||+.||.+||++-+++.++..+...
T Consensus 261 sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 261 SGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred Ccc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 532 345666676666678899999999999999999999999999999888653
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.15 Aligned_cols=254 Identities=28% Similarity=0.380 Sum_probs=201.4
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||+|.++ ++.+|||.++..... +.....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence 46888899999999999999985 778999999754322 2223456789999999999999999999877644
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
...++||||+. ++|.+++......+++..++.++.||+.||+|||++||+|+||||+|||++.++ .++|+|||++
T Consensus 79 ~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~----~~~l~d~g~~ 153 (293)
T cd07843 79 DKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG----ILKICDFGLA 153 (293)
T ss_pred CcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC----cEEEeecCce
Confidence 58999999996 588888866556789999999999999999999999999999999999999765 4699999998
Q ss_pred ccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc----------
Q 000726 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---------- 1268 (1329)
Q Consensus 1200 r~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~---------- 1268 (1329)
...... .......+++.|+|||.+.+. ..++.++|||||||++|+|++|..||...........+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred eeccCCccccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 854332 222334578899999998742 33678999999999999999999999766544433322110
Q ss_pred -------------------CCCCCCCCC-CcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1269 -------------------TLRPPVPGF-CDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1269 -------------------~lr~~ips~-~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
.....++.. +++.+.++|.+||+.+|++|||+.|++.+-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~ 291 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCC
Confidence 001112222 578899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=326.73 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=197.4
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC----CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k----Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gi 1113 (1329)
.+...+|.+++.||+|+||.||++... +..||||.+... ..+.+|+.+|+.++||||++++++
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------~~~~~E~~il~~l~h~~iv~~~~~ 154 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------KTPGREIDILKTISHRAIINLIHA 154 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------ccHHHHHHHHHhcCCCCccceeee
Confidence 344568999999999999999999764 456899987542 124579999999999999999999
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
+.... ..++|||++ .++|..++ .....+++..++.|+.||+.||.|||++||+||||||+|||++.++. ++|
T Consensus 155 ~~~~~--~~~lv~e~~-~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~----~~l 226 (392)
T PHA03207 155 YRWKS--TVCMVMPKY-KCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN----AVL 226 (392)
T ss_pred EeeCC--EEEEEehhc-CCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC----EEE
Confidence 88754 899999998 57888888 34467899999999999999999999999999999999999997664 599
Q ss_pred eecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---HHHHHHHh
Q 000726 1194 GDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVN 1267 (1329)
Q Consensus 1194 sDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~---ell~qIve 1267 (1329)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... ..+..++.
T Consensus 227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~ 304 (392)
T PHA03207 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304 (392)
T ss_pred ccCccccccCcccccccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH
Confidence 9999987543221 2234569999999999984 45788999999999999999999999654321 11111111
Q ss_pred -------------------------cCCCCC--CC-----CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1268 -------------------------NTLRPP--VP-----GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1268 -------------------------~~lr~~--ip-----s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
...+.+ .+ ..++.++.++|.+||..||.+|||+.+++.+.+...
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 305 CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred HhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 000110 11 234677899999999999999999999999987754
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.95 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=204.4
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
.+|++.+.||+|+||.||++.. .++.||||.+...... ....+.+|+.+++.++|+||+++++++....
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 89 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVGD- 89 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 6799999999999999999987 4788999998643211 1244678999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+++++|.+++.. ..+++.++..++.|++.+|.|||+.||+|+||||+|||++.++. ++|+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~----~~l~Dfg~~ 162 (297)
T cd06656 90 -ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFC 162 (297)
T ss_pred -EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----EEECcCccc
Confidence 89999999999999998843 45789999999999999999999999999999999999997664 699999998
Q ss_pred ccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-CCCCCCCCC
Q 000726 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPGF 1277 (1329)
Q Consensus 1200 r~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~-~lr~~ips~ 1277 (1329)
....... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+... ......+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccc
Confidence 7543221 2223458889999999984 45688999999999999999999999765443322222221 112223456
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
++..+.+++.+||+.+|.+||++.+++++.+....
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 78889999999999999999999999998776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.03 Aligned_cols=259 Identities=27% Similarity=0.337 Sum_probs=215.8
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|+.+.+|++|+||+||+|+++ ++.||+|.++...- .+.+....+||+.+|.+++|||||.+-.++...+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke------k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE------KEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc------cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 467999999999999999999985 66799999987542 2334456789999999999999999999998877
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
-..+|+||||| ..+|...+....+++...++..+..|+++|++|||.+.|+|||||++|+|++..|. +||+|||+
T Consensus 149 ~d~iy~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~----lKiaDFGL 223 (419)
T KOG0663|consen 149 MDKIYIVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI----LKIADFGL 223 (419)
T ss_pred cceeeeeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc----EEecccch
Confidence 77899999999 57898888877788999999999999999999999999999999999999997774 59999999
Q ss_pred cccccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC--------
Q 000726 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-------- 1269 (1329)
Q Consensus 1199 Ar~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~-------- 1269 (1329)
|+.+.... ..+...-|.+|.|||++.| ...|+..+|+||+|||+.||+++++.|.+....+.+..|+..-
T Consensus 224 AR~ygsp~k~~T~lVVTLWYRaPELLLG-~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 224 AREYGSPLKPYTPLVVTLWYRAPELLLG-AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hhhhcCCcccCcceEEEeeecCHHHhcC-CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 99876542 3344567999999999998 4568999999999999999999999999887766555443210
Q ss_pred ---------------------CCCCCCCC-CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1270 ---------------------LRPPVPGF-CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1270 ---------------------lr~~ips~-~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
++..++.. +++.-.+|+..+|..||.+|.|+.+.|++=+..-
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 00111111 4578889999999999999999999998876553
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.61 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=201.8
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC---CCceeeEecccccC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr---HPNIVKL~Gif~e~ 1117 (1329)
.|+..+.||+|+||.||+|.+ .++.||||+++.... ......+.+|+.+++.+. |||++++++++...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-------DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 366778899999999999998 478899999865321 122346778999999986 99999999998875
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
. ..++||||+++++|.+++.. ..+++..++.++.|++.+|.|||+.||+|+||+|+||+++.++ .++|+|||
T Consensus 75 ~--~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~----~~~l~dfg 146 (277)
T cd06917 75 P--RLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG----NVKLCDFG 146 (277)
T ss_pred C--EEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC----CEEEccCC
Confidence 4 89999999999999998854 3689999999999999999999999999999999999999765 46999999
Q ss_pred CcccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 000726 1198 LSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1198 LAr~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips 1276 (1329)
++...... .......|+..|+|||.+.+ ...++.++|||||||++|+|++|..||...........+... ....++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 224 (277)
T cd06917 147 VAALLNQNSSKRSTFVGTPYWMAPEVITE-GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLED 224 (277)
T ss_pred ceeecCCCccccccccCCcceeCHHHhcc-CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCc
Confidence 98754332 22233468889999999864 234678999999999999999999999876554433322221 1222222
Q ss_pred -CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1277 -FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1277 -~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.++..+.+++.+||+.+|.+||++.+++.+.|...
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 225 NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 37789999999999999999999999999877644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=305.13 Aligned_cols=255 Identities=30% Similarity=0.434 Sum_probs=202.7
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~ 1117 (1329)
.++|++.+.||+|+||.||++.. .++.+|+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 57799999999999999999988 47789999986421 1123466788899988 799999999998753
Q ss_pred C---CCeEEEEEEeccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1118 P---GGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1118 ~---dg~L~LVMEYm~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
+ ....++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+|+|+||||+||+++.++. +
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~----~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG----V 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC----E
Confidence 2 2468999999999999988753 3456899999999999999999999999999999999999987664 6
Q ss_pred EEeecCCcccccCc-ccccCCCCCCcccCccccccCC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 000726 1192 KVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~-~~ss~~~GTp~YmAPEvL~Gs~---~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve 1267 (1329)
||+|||++...... .......++..|+|||++.... ..++.++|||||||++|+|++|+.||...........+..
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 99999998754322 1223446888999999986322 2357899999999999999999999987765554444332
Q ss_pred cCC-CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1268 NTL-RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1268 ~~l-r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
... ....+..++..+.++|.+||+.+|++||++.+++++.+
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~ 289 (291)
T cd06639 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289 (291)
T ss_pred CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence 221 22224456788999999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=307.55 Aligned_cols=258 Identities=27% Similarity=0.325 Sum_probs=202.4
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||+|++|.||+|.+. ++.||||.++....... .......+..|+.+++.++|+||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA---KDGINFTALREIKLLQELKHPNIIGLLDVFGHKS-- 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc---cchhhHHHHHHHHHHhhcCCCCChhhhheeecCC--
Confidence 4778899999999999999984 78899999986543211 1223345678999999999999999999998844
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..++||||+ +++|..++......+++..++.++.||++||.|||++||+|+||+|+|||++.++. ++|+|||++.
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~----~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV----LKLADFGLAR 150 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC----EEEccceeee
Confidence 899999999 89999998655447899999999999999999999999999999999999997664 6999999998
Q ss_pred cccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC--------
Q 000726 1201 IKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-------- 1271 (1329)
Q Consensus 1201 ~~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr-------- 1271 (1329)
...... ......++..|+|||.+.+ ...++.++|||||||++|+|++|.+||........+..+......
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFG-ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhC-CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 554321 2223346788999999864 345688999999999999999998888765544333332211000
Q ss_pred -------------C-----CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1272 -------------P-----PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1272 -------------~-----~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
. ......+..+.++|.+||+.+|.+|||+.+++.+-|-..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 0 011234678999999999999999999999999766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=309.32 Aligned_cols=259 Identities=25% Similarity=0.330 Sum_probs=197.7
Q ss_pred CeeEEEEecccCcEEEEEEEE----CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~----kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.|++.+.||+|+||.||+|.+ .+..||||.++..... .+.....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-----YTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-----ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 478889999999999999998 3578999999864211 1112345678999999999999999999998874
Q ss_pred CCeEEEEEEeccCCchhhhhhcc----cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSK----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~k----ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
...+++||||++ ++|..++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.....+||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 468999999996 4666655322 23688999999999999999999999999999999999999866556678999
Q ss_pred ecCCcccccCcc----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH---------H
Q 000726 1195 DFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA---------I 1261 (1329)
Q Consensus 1195 DFGLAr~~~~~~----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~e---------l 1261 (1329)
|||++....... ......++..|+|||++.+ ...++.++|||||||+||+|++|+.||....... .
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 999988543221 2234467889999999874 2346889999999999999999999997544321 0
Q ss_pred HHHHHh------------------------cCCCCCCC-----------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 000726 1262 IGGIVN------------------------NTLRPPVP-----------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306 (1329)
Q Consensus 1262 l~qIve------------------------~~lr~~ip-----------s~~S~eL~DLIkrCLqkDPeERPTaeELLq~ 1306 (1329)
+..++. .......+ ...+..+.+++.+||+.||.+|||+.+++.+
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111000 00011111 1456778999999999999999999999987
Q ss_pred HH
Q 000726 1307 LR 1308 (1329)
Q Consensus 1307 Le 1308 (1329)
.+
T Consensus 314 ~~ 315 (316)
T cd07842 314 PY 315 (316)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=303.11 Aligned_cols=252 Identities=28% Similarity=0.447 Sum_probs=206.4
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
-|++.+.||.|+||.||+|.+ .+..||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-- 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC--
Confidence 467788999999999999987 46789999886431 1223456889999999999999999999998755
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..++||||+.+++|..++.. ..+++..+..++.+++.+|.|||++|++|+||+|+||+++.++. ++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~----~~l~dfg~~~ 149 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE----VKLADFGVAG 149 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC----EEEeecccce
Confidence 89999999999999988853 46889999999999999999999999999999999999997664 6999999987
Q ss_pred cccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCc
Q 000726 1201 IKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279 (1329)
Q Consensus 1201 ~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S 1279 (1329)
..... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+ ........+..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 226 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-PKNNPPTLEGNYS 226 (277)
T ss_pred ecccchhhhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-hcCCCCCCCcccC
Confidence 54322 12233457889999999873 45678999999999999999999999876654444433 2333444556788
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1280 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
..+.+++.+||+.+|.+||++.+++.+.+....
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 999999999999999999999999998766544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=304.10 Aligned_cols=252 Identities=26% Similarity=0.353 Sum_probs=194.1
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
..+|.+.+.||+|+||.||+|.+ ++..||||+++...... ....+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 76 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-------VPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-------CcHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence 36799999999999999999987 47889999987543211 1234568999999999999999999998754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+. ++|..++......+++..+..++.||+.||+|||++||+|+||||+|||++.++. ++|+|||+
T Consensus 77 --~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~----~~l~Dfg~ 149 (291)
T cd07870 77 --TLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE----LKLADFGL 149 (291)
T ss_pred --eEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc----EEEecccc
Confidence 8999999995 7777777555556788889999999999999999999999999999999997664 69999999
Q ss_pred cccccC-cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhc--------
Q 000726 1199 SKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNN-------- 1268 (1329)
Q Consensus 1199 Ar~~~~-~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~-ell~qIve~-------- 1268 (1329)
++.... ........+++.|+|||++.+. ..++.++|||||||++|+|++|..||...... +.+..+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 150 ARAKSIPSQTYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred ccccCCCCCCCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 874322 1122334578899999998742 34678899999999999999999999765432 111111100
Q ss_pred --------CC-----CCCCC---------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1269 --------TL-----RPPVP---------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1269 --------~l-----r~~ip---------s~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
.+ ....+ ...+..+.+++.+||+.||.+|||+.+++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~ 289 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHP 289 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCC
Confidence 00 00000 11256889999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=310.91 Aligned_cols=255 Identities=28% Similarity=0.441 Sum_probs=208.5
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
..|...+.||+|+||.||++.+ .+..||||++..... ........+.+|+.+++.++|||++++++++....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 98 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-----QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH- 98 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-----CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-
Confidence 4477888999999999999987 467899999865321 12233457889999999999999999999998755
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+. ++|.+.+......+++..+..++.+|+.||.|||+++|+|+||+|+||+++.++ .++|+|||++
T Consensus 99 -~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~----~~kl~dfg~~ 172 (317)
T cd06635 99 -TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG----QVKLADFGSA 172 (317)
T ss_pred -eEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC----CEEEecCCCc
Confidence 7899999996 578777765566789999999999999999999999999999999999998765 4699999998
Q ss_pred ccccCcccccCCCCCCcccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~G-s~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
...... ....++..|+|||++.. ....++.++|||||||++|+|++|+.||...........+............+
T Consensus 173 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (317)
T cd06635 173 SIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW 249 (317)
T ss_pred cccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccc
Confidence 754322 23458889999999742 23457889999999999999999999998776655555555544434444567
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
+..+.+++.+||+.+|.+||++.+++.+++.+.
T Consensus 250 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred cHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 889999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.93 Aligned_cols=253 Identities=29% Similarity=0.433 Sum_probs=201.5
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|+..+.||.|++|.||++.+ .++.+|+|.+..... ......+.+|+++++.++||||++++++|.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-------PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-------hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 3688999999999999999998 467899999875311 1234568899999999999999999999876555
Q ss_pred CeEEEEEEeccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1120 GTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
..+++||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+++|+||+|.||+++.++ .++|+||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~----~~~l~df 149 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG----QVKLCDF 149 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC----eEEEeec
Confidence 678999999999999887642 345688999999999999999999999999999999999998765 3699999
Q ss_pred CCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-----hhHHHHHHHhcCCC
Q 000726 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-----YGAIIGGIVNNTLR 1271 (1329)
Q Consensus 1197 GLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~-----~~ell~qIve~~lr 1271 (1329)
|++........ ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ..+....+... ..
T Consensus 150 g~~~~~~~~~~-~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 225 (287)
T cd06621 150 GVSGELVNSLA-GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PN 225 (287)
T ss_pred ccccccccccc-ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-Cc
Confidence 99874332211 23457889999999873 457889999999999999999999997652 12222222221 11
Q ss_pred CCCC------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1272 PPVP------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1272 ~~ip------s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
...+ ..+++.+.+++.+||..+|.+|||+.+++++.|.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 1111 2346789999999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=304.19 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=195.7
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++.+.||+|++|.||+|.++ ++.||||.+....... ....+.+|+.+++.++|+||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-------APFTAIREASLLKDLKHANIVTLHDIIHTKK 76 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-------CchhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence 467999999999999999999884 7889999987543211 1124568999999999999999999998754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+. ++|.+++......+++..+..++.||+.||.|||+++|+|+||||+|||++.++. +||+|||+
T Consensus 77 --~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~----~kl~dfg~ 149 (291)
T cd07844 77 --TLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE----LKLADFGL 149 (291)
T ss_pred --eEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC----EEECcccc
Confidence 8999999996 5899888766667899999999999999999999999999999999999997764 69999999
Q ss_pred cccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhc---C----
Q 000726 1199 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGIVNN---T---- 1269 (1329)
Q Consensus 1199 Ar~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~-~~ell~qIve~---~---- 1269 (1329)
+...... .......++..|+|||++.+ ...++.++|||||||++|+|++|+.||.... ..+.+..+... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 150 ARAKSVPSKTYSNEVVTLWYRPPDVLLG-STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228 (291)
T ss_pred ccccCCCCccccccccccccCCcHHhhc-CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence 8743221 11122346788999999874 2346789999999999999999999997654 22221111100 0
Q ss_pred ------------CC------C---CCCCCCc--HHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1270 ------------LR------P---PVPGFCD--SEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1270 ------------lr------~---~ips~~S--~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.. . ....... ..+.+++.+||+.+|.+|||+.+++.+.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~ 290 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 00 0 0001123 77889999999999999999999987643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=334.41 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=224.7
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
-|.+.+-||+|.|.+|-+|++ +|..||||++.+..+ +....-.+.+|+.||+.++|||||++|.+..+..
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl------D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT-- 90 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL------DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT-- 90 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc------chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc--
Confidence 366778899999999999987 899999999987543 2333456789999999999999999999998865
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.+|||+|+-.+|+|.+++...+.-+.+..+.+++.||+.|+.|||+..++||||||+||.+-.. .+.|||.|||++-
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK---lGlVKLTDFGFSN 167 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK---LGLVKLTDFGFSN 167 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee---cCceEeeeccccc
Confidence 8999999999999999999888889999999999999999999999999999999999998743 2468999999998
Q ss_pred cccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcH
Q 000726 1201 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 1280 (1329)
Q Consensus 1201 ~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~ 1280 (1329)
.+.........||+..|-|||++.|..+. .+++||||||||||-|++|++||......+.+..|++.. ..+|..++.
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYD-APAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK--YtvPshvS~ 244 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYD-APAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK--YTVPSHVSK 244 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccC-CcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc--ccCchhhhH
Confidence 87777777888999999999999987665 578999999999999999999999888888777776654 457888999
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1281 EWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1281 eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
+.++||..||..||.+|.+.++|...-|.-
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq 274 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQ 274 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence 999999999999999999999999887754
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=303.64 Aligned_cols=252 Identities=26% Similarity=0.326 Sum_probs=197.3
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|+..+.||.|++|.||+|.+ ++..||||.++...... .....+.+|++++++++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------GVPSTAIREISLLKELNHPNIVKLLDVIHTEN-- 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc------ccchHHHHHHHHHHhcCCCCCcchhhhcccCC--
Confidence 478899999999999999988 47889999887543221 12246778999999999999999999998754
Q ss_pred eEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+. ++|..++... ...+++..++.++.||+.||+|||+++++|+||+|+||+++.++. +||+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~----~~l~dfg~~ 147 (284)
T cd07860 73 KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA----IKLADFGLA 147 (284)
T ss_pred cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC----EEEeeccch
Confidence 8999999995 6888877543 356899999999999999999999999999999999999997764 599999998
Q ss_pred ccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC-------
Q 000726 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR------- 1271 (1329)
Q Consensus 1200 r~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr------- 1271 (1329)
...... .......++..|+|||++.+. ..++.++|||||||++|+|++|+.||...........+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 148 RAFGVPVRTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred hhcccCccccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 754322 122233467889999998742 33578899999999999999999999776544333322211000
Q ss_pred --------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1272 --------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1272 --------------------~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
......++..+.++|.+||+.||.+|||+.+++.+.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 283 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence 0011235788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=302.50 Aligned_cols=252 Identities=26% Similarity=0.335 Sum_probs=198.4
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|+||.||+|.+. ++.||||+++.... .......+.+|+++++.++|+||+++++++....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED------DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG- 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc------cccchhHHHHHHHHHHhcCCCCeeehhheEEECC-
Confidence 36899999999999999999884 67899999875322 1223456789999999999999999999998744
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||++++.+..+. .....+++..++.++.||+.||.|||+++++|+||+|+||+++.++ .+||+|||++
T Consensus 74 -~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~----~~kl~d~g~~ 147 (288)
T cd07833 74 -RLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG----VLKLCDFGFA 147 (288)
T ss_pred -EEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----CEEEEeeecc
Confidence 899999999876555444 4445689999999999999999999999999999999999999765 4699999998
Q ss_pred ccccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc---------
Q 000726 1200 KIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--------- 1268 (1329)
Q Consensus 1200 r~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~--------- 1268 (1329)
....... ......++..|+|||++.+. ..++.++||||||+++|+|++|+.||...........+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 8644332 22345578899999999853 25788999999999999999999999765443322211110
Q ss_pred -------CC---C-----------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1269 -------TL---R-----------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1269 -------~l---r-----------~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
.. . ...+..++..+.+||++||..+|++||++.+++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 286 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP 286 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCC
Confidence 00 0 011233578899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.64 Aligned_cols=259 Identities=26% Similarity=0.346 Sum_probs=207.6
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc---
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD--- 1116 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e--- 1116 (1329)
..|..++.||+|+||.|+.+.+ +|+.||||.+... ......+++.+||+.+|+.++|+||+.+++++..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~------F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP------FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh------hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 4555578999999999999988 4788999988632 2234556788999999999999999999999876
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.....+|+|+|+| +.+|...+. .++.++..++..+++||++||.|+|+.+|+||||||.|+|++.+.. +|||||
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~----lKI~DF 169 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD----LKICDF 169 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC----EEeccc
Confidence 2335789999999 678888774 4455999999999999999999999999999999999999997654 499999
Q ss_pred CCcccccC---cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh------
Q 000726 1197 GLSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN------ 1267 (1329)
Q Consensus 1197 GLAr~~~~---~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve------ 1267 (1329)
|+|+.... ....+....|.+|.|||++.. ...|+..+||||+||+|.||++|++.|.+.+.-..+..++.
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 99997643 223244567999999999964 56789999999999999999999999988765433322211
Q ss_pred -----------------c-CCCCCCC-----CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1268 -----------------N-TLRPPVP-----GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1268 -----------------~-~lr~~ip-----s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
. +..+..+ ...++...+|+.+||..||.+|+|++|++.|+-...-.
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 1 1111111 25678899999999999999999999999998665433
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=296.35 Aligned_cols=245 Identities=31% Similarity=0.435 Sum_probs=199.7
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEE
Q 000726 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1329)
Q Consensus 1050 LGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVME 1127 (1329)
||.|+||.||++++. ++.+++|++..... ........+.+|+.++++++||||+++++.+.... ..++|||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-----IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--NLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-----hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc--EEEEEEe
Confidence 689999999999985 78899999875422 12344567889999999999999999999987754 8999999
Q ss_pred eccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCcc-
Q 000726 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL- 1206 (1329)
Q Consensus 1128 Ym~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~- 1206 (1329)
|+++++|.+++.... .+++..++.++.||+.||+|||+++++|+||+|+||+++.++. ++|+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~----~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 74 YLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH----LKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC----EEEEecccchhcccCcc
Confidence 999999999886543 6899999999999999999999999999999999999997764 5999999987432221
Q ss_pred --------cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1207 --------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1207 --------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
......++..|+|||.+.+ ...+.++||||||+++|+|++|..||...........+.......+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEV 226 (265)
T ss_pred cccccccccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccC
Confidence 2233457889999999874 346889999999999999999999998877776666655533333322234
Q ss_pred cHHHHHHHHHhhcCCCCCCCCH---HHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSF---TEIARRLR 1308 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTa---eELLq~Le 1308 (1329)
+..+.+++.+||+.+|.+|||+ .+++.+.+
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 8999999999999999999999 76666544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.87 Aligned_cols=254 Identities=33% Similarity=0.528 Sum_probs=199.7
Q ss_pred eeEEEEecccCcEEEEEEEEC-----CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1044 LEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~k-----Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
|.+.+.||+|+||.||+|.++ +..||||+++..... .....++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS------SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC------hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 456778999999999999863 567999999754321 222456789999999999999999999876432
Q ss_pred C----CeEEEEEEeccCCchhhhhhcc-----cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCC
Q 000726 1119 G----GTLATVTEFMVNGSLRHVLLSK-----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1329)
Q Consensus 1119 d----g~L~LVMEYm~GGSL~d~L~~k-----ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~ 1189 (1329)
. ...+++++|+.+++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~---- 150 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM---- 150 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC----
Confidence 1 1347899999999998876422 13578899999999999999999999999999999999998655
Q ss_pred cEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 000726 1190 ICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1265 (1329)
Q Consensus 1190 ~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qI 1265 (1329)
.+||+|||+++...... ......+++.|++||.+. ...++.++|||||||++|+|++ |+.||...........+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05074 151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLA--DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228 (273)
T ss_pred CEEECcccccccccCCcceecCCCccCchhhcCHhHHh--cCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 46999999988543211 112223567899999987 4456889999999999999999 89999877665554444
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1266 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1266 ve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
... .....+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 229 ~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKG-NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 332 23334456788999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=306.49 Aligned_cols=261 Identities=24% Similarity=0.389 Sum_probs=204.2
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEeccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVV 1114 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif 1114 (1329)
.+..++|++.+.||+|+||.||++.+. ++.||||+++..... .....+.+|+.++.++. ||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-------EENKRILMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-------HHHHHHHHHHHHHHhccCCCchHhhheee
Confidence 456788999999999999999999996 888999999754211 12345666777676664 99999999999
Q ss_pred ccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
.+.. ..++||||+ +++|..++......+++..+..++.||+.||+|||+ .||+||||+|+||+++.++ .+||
T Consensus 84 ~~~~--~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~----~~kL 156 (296)
T cd06618 84 ITDS--DVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG----NVKL 156 (296)
T ss_pred ecCC--eEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC----CEEE
Confidence 8755 899999998 456776665545678999999999999999999997 5999999999999998665 4699
Q ss_pred eecCCcccccCcccccCCCCCCcccCccccccCC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcCC
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS--SKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNNTL 1270 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~--~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~-ell~qIve~~l 1270 (1329)
+|||++.............++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||...... +.+..+.....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (296)
T cd06618 157 CDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP 236 (296)
T ss_pred CccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC
Confidence 9999987544333333345788899999987532 44788999999999999999999999764332 33333333321
Q ss_pred -CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1271 -RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1271 -r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
..+....++.++.+|+.+||..+|.+||++.+++.+.+....
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 122223468899999999999999999999999999886543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=294.25 Aligned_cols=249 Identities=27% Similarity=0.469 Sum_probs=206.4
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||+|++|.||++.+. +..+|||.++..... ......+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS------QKEREDAVNEIRILASVNHPNIISYKEAFLDGN-- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc------HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC--
Confidence 4788999999999999999874 678999998754322 222456778999999999999999999988754
Q ss_pred eEEEEEEeccCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1121 TLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~k---ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
..++||||+++++|..++... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .+||+|||
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~----~~kl~d~g 148 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLG 148 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC----cEEEeecc
Confidence 899999999999999988542 24689999999999999999999999999999999999999755 46999999
Q ss_pred CcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 000726 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277 (1329)
Q Consensus 1198 LAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~ 1277 (1329)
++...... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+. .....+.+..
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 224 (256)
T cd08530 149 ISKVLKKN-MAKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPI 224 (256)
T ss_pred chhhhccC-CcccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchh
Confidence 99865443 2233457889999999974 456789999999999999999999998877655544443 3334445567
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
++.++.+++.+||+.+|.+||++.++++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 889999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=299.27 Aligned_cols=253 Identities=27% Similarity=0.369 Sum_probs=200.4
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCe
Q 000726 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~ 1121 (1329)
|++.+.||.|++|.||+|.+. ++.+|||+++.... .......+.+|+.+++.+.|+|++++++++.......
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE------KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc------cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 567889999999999999985 68899999986531 1222356778999999999999999999998753358
Q ss_pred EEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1122 L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
.++||||++ ++|..++......+++..++.++.||+.||+|||++|++|+||+|+|||++.++. ++|+|||++..
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~----~~l~d~g~~~~ 149 (287)
T cd07840 75 IYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV----LKLADFGLARP 149 (287)
T ss_pred EEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC----EEEccccceee
Confidence 999999996 5888888665567999999999999999999999999999999999999997664 59999999985
Q ss_pred ccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC--------
Q 000726 1202 KRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-------- 1271 (1329)
Q Consensus 1202 ~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr-------- 1271 (1329)
..... ......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 150 YTKRNSADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred ccCCCcccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccc
Confidence 54332 12334567889999988642 34688999999999999999999999876654443332221000
Q ss_pred ---------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1272 ---------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1272 ---------------------~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
......++..+.+++.+||+.+|.+||++.+++.+.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~ 286 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence 0011123788999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=315.29 Aligned_cols=255 Identities=24% Similarity=0.309 Sum_probs=199.6
Q ss_pred cccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
...+|+..+.||+|+||.||++.+ +++.||||++..... .......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ------NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc------ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence 346799999999999999999987 478899999864321 112234567899999999999999999987643
Q ss_pred C----CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1118 P----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1118 ~----dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
. ....++||||+. ++|.+.+... +++..+..++.||+.||+|||++||+||||||+|||++.++. +||
T Consensus 88 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~----~kL 159 (353)
T cd07850 88 KSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKI 159 (353)
T ss_pred CCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC----EEE
Confidence 2 135799999994 6888777432 889999999999999999999999999999999999997764 599
Q ss_pred eecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-----
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN----- 1268 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~----- 1268 (1329)
+|||++.............++..|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+...
T Consensus 160 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 160 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred ccCccceeCCCCCCCCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99999986554433344567899999999984 45788999999999999999999999765543322222110
Q ss_pred -----------------CCCC-------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1269 -----------------TLRP-------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1269 -----------------~lr~-------------------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.... ..+...+..+.++|.+||+.||.+|||+.+++.+.|..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 0000 00113456789999999999999999999999998765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.06 Aligned_cols=246 Identities=24% Similarity=0.468 Sum_probs=189.4
Q ss_pred EecccCcEEEEEEEEC-Cce---EEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEE
Q 000726 1049 ELGSGTFGTVYHGKWR-GTD---VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~k-Gr~---VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
.||+|+||.||++++. +.. +++|.++... .......+.+|+.+++.++||||+++++.|.... ..++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~l 72 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI--PYLL 72 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-------ChHHHHHHHHHHHHHhccCCcchhheEEEecCCC--ccEE
Confidence 5999999999999763 333 4555554321 1123467889999999999999999999998754 7899
Q ss_pred EEEeccCCchhhhhhccc---ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1125 VTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~ke---k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++ .++|+|||++..
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~----~~~l~Dfg~~~~ 148 (268)
T cd05086 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL----TVKVGDYGIGPS 148 (268)
T ss_pred EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc----cEEecccccccc
Confidence 999999999999986532 3456777889999999999999999999999999999998765 469999999863
Q ss_pred ccC---cccccCCCCCCcccCccccccC-----CCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcC---
Q 000726 1202 KRN---TLVTGGVRGTLPWMAPELLNGS-----SSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT--- 1269 (1329)
Q Consensus 1202 ~~~---~~~ss~~~GTp~YmAPEvL~Gs-----~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~--- 1269 (1329)
... ........++..|+|||++... ...++.++|||||||++|||++ +..||......+.+..+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc
Confidence 211 1122345678899999998531 2245778999999999999997 677887766655555443332
Q ss_pred -CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1270 -LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1270 -lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.++..+..+++.+.+++.+|| .+|.+||++.+|++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 223344557889999999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=326.93 Aligned_cols=249 Identities=26% Similarity=0.332 Sum_probs=201.6
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
.|+..+++|.|+||.||+|... +..||||...... +.--+|+.+|+.+.|||||++.-+|....+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------------RYKNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 4778899999999999999984 5789999876431 1123689999999999999999888654443
Q ss_pred ---eEEEEEEeccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1121 ---TLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1121 ---~L~LVMEYm~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
++.|||||| ..+|.+.+.. ....++...+.-+..||++||+|||..|||||||||.|+|+|.+ ++.+|||
T Consensus 93 d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~---tg~LKic 168 (364)
T KOG0658|consen 93 DEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD---TGVLKIC 168 (364)
T ss_pred chhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC---CCeEEec
Confidence 677999999 5788888853 24668888888899999999999999999999999999999965 3568999
Q ss_pred ecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC-----
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----- 1269 (1329)
Q Consensus 1195 DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~----- 1269 (1329)
|||.|+............-|..|.|||.+.| ...|+.++||||.||++.||+-|++.|.+....+.+..+++-.
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifg-a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcC-ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 9999997665555555667899999999998 4568999999999999999999999999876655444333210
Q ss_pred ----------------------CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1270 ----------------------LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1270 ----------------------lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
...-.....++++.+|+.++|+.+|.+|.++.+++.|..
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 000022346899999999999999999999999987754
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.63 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=197.2
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||.|++|.||+|++. +..||||+++..... .....+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-------GTPSTAIREISLMKELKHENIVRLHDVIHTEN-- 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-------cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--
Confidence 4788999999999999999984 788999999754321 11234667999999999999999999998854
Q ss_pred eEEEEEEeccCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~ke--k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||++ ++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++. ++|+|||+
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~----~~l~d~g~ 146 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE----LKLADFGL 146 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc----EEEeecch
Confidence 8899999997 58888775443 46899999999999999999999999999999999999997764 59999999
Q ss_pred cccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC--------
Q 000726 1199 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-------- 1269 (1329)
Q Consensus 1199 Ar~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~-------- 1269 (1329)
+...... .......++..|++||++.+. ..++.++|||||||++|+|++|..||......+....+....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 147 ARAFGIPVNTFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhhcCCccccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 8743321 112234468889999998742 346789999999999999999999998766544433322110
Q ss_pred --------CCCC-----------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1270 --------LRPP-----------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1270 --------lr~~-----------ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
+... +...++..+.+++.+||+.+|.+||++.+++.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 282 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP 282 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 0000 0123467889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=303.69 Aligned_cols=256 Identities=24% Similarity=0.253 Sum_probs=195.8
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccccCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~e~~ 1118 (1329)
++|++.+.||+|+||.||+|.+ +++.||||+++..... +.....+.+|+.+++.+. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE------EGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc------cCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 3688999999999999999998 4788999998754221 112345778999999995 699999999887543
Q ss_pred C---CeEEEEEEeccCCchhhhhhcc----cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1119 G---GTLATVTEFMVNGSLRHVLLSK----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1119 d---g~L~LVMEYm~GGSL~d~L~~k----ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
. ...++||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++ ..+
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~---~~~ 150 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQK---GLL 150 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCC---CeE
Confidence 1 237999999975 788877543 23579999999999999999999999999999999999999722 247
Q ss_pred EEeecCCcccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC
Q 000726 1192 KVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1270 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l 1270 (1329)
||+|||++...... .......+++.|+|||++.+ ...++.++|||||||++|+|++|..||...........+.....
T Consensus 151 kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 151 KIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG-STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred EEeecccceecCCCccccCCcccccCCCChHHhhC-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998754221 11222346788999999864 23468899999999999999999999987655443332221100
Q ss_pred C--------------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1271 R--------------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1271 r--------------------------~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
. ......++..+.++|.+||+.+|.+||++.+++.+.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~ 293 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence 0 0001246788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.52 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=197.6
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEE
Q 000726 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1329)
Q Consensus 1050 LGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVME 1127 (1329)
||+|+||+||++.+. ++.||+|++...... .......+..|+.+|+.++||||+++++.+.... ..++|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-----KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD--DLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-----hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC--eEEEEEe
Confidence 689999999999874 788999998754221 1122345678999999999999999999987754 8999999
Q ss_pred eccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCcc
Q 000726 1128 FMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206 (1329)
Q Consensus 1128 Ym~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~ 1206 (1329)
|+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+|||++.++. ++|+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~----~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN----VRISDLGLAVELKGGK 149 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC----EEEccCcchhhhccCC
Confidence 999999999886543 36899999999999999999999999999999999999997664 5999999987554333
Q ss_pred cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc--CCCCCCCCCCcHHHHH
Q 000726 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--TLRPPVPGFCDSEWRL 1284 (1329)
Q Consensus 1207 ~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~--~lr~~ips~~S~eL~D 1284 (1329)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... ......+..+++.+.+
T Consensus 150 ~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKD 227 (277)
T ss_pred ccccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHH
Confidence 3334457889999999874 33788999999999999999999999765432111111111 1233445567899999
Q ss_pred HHHHhhcCCCCCCC-----CHHHHHHHHHHH
Q 000726 1285 LMEQCWAPDPVVRP-----SFTEIARRLRVM 1310 (1329)
Q Consensus 1285 LIkrCLqkDPeERP-----TaeELLq~Le~L 1310 (1329)
+|.+||+.+|.+|| ++.+++.+.|-.
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~ 258 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVREHPLFK 258 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence 99999999999999 888898887664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.15 Aligned_cols=256 Identities=23% Similarity=0.299 Sum_probs=195.5
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++.+.||+|+||.||+|.++ ++.||||.+....... .....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC------CchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 457999999999999999999984 7889999986542211 11234567999999999999999999876532
Q ss_pred ------CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEE
Q 000726 1119 ------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1119 ------dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VK 1192 (1329)
....++||||+. ++|..++......+++..++.++.||+.||.|||++|++|+||||+|||++.++ .+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~----~~k 159 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG----ILK 159 (310)
T ss_pred ccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC----cEE
Confidence 235699999995 588887766555789999999999999999999999999999999999999765 469
Q ss_pred EeecCCcccccCcc-----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 000726 1193 VGDFGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1193 LsDFGLAr~~~~~~-----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve 1267 (1329)
|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+|++|+.||...........+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~ 238 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcC-CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999997543211 1123456788999999874 23467899999999999999999999976654332211111
Q ss_pred --cCCC---------------CCC-------------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1268 --NTLR---------------PPV-------------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1268 --~~lr---------------~~i-------------ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.... ... ....+..+.+||.+||..||.+|||+.+++++.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~ 309 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence 0000 000 1123567889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=341.28 Aligned_cols=257 Identities=34% Similarity=0.587 Sum_probs=220.4
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEEC---Cc--eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR---GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~k---Gr--~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
-.|..+++.+.++||+|.||+|++|.|+ |+ .||||+++..... .....|++|+.+|.+|+|||+|+||
T Consensus 105 clIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-------~~mddflrEas~M~~L~H~hliRLy 177 (1039)
T KOG0199|consen 105 CLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-------AIMDDFLREASHMLKLQHPHLIRLY 177 (1039)
T ss_pred eeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-------hhHHHHHHHHHHHHhccCcceeEEe
Confidence 3577888899999999999999999995 33 4999999864322 1457899999999999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhc-ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCc
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~-kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~ 1190 (1329)
|++.+. .+.+|||+++.|+|.+.|++ ....|-......++.||+.||.||..++.|||||-+.|||+-.. .+
T Consensus 178 GvVl~q---p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp----rt 250 (1039)
T KOG0199|consen 178 GVVLDQ---PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP----RT 250 (1039)
T ss_pred eeeccc---hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc----ce
Confidence 999874 58899999999999999977 44568888889999999999999999999999999999999853 46
Q ss_pred EEEeecCCcccccC----cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 000726 1191 CKVGDFGLSKIKRN----TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1265 (1329)
Q Consensus 1191 VKLsDFGLAr~~~~----~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qI 1265 (1329)
|||||||+.+.... +.+.....-.+-|+|||.++ ...++.++|||+|||+||||++ |+.||.+.....+++.+
T Consensus 251 VKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr--h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i 328 (1039)
T KOG0199|consen 251 VKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR--HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI 328 (1039)
T ss_pred eeeecccceeccCCCCcceEecCCCcCcccccCHhHhc--cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc
Confidence 79999999985432 22233344567799999999 7889999999999999999999 99999999888877765
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1266 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1266 ve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
- .+-+++.+..|++++++++++||..+|.+||||..|.+.+-..
T Consensus 329 D-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 329 D-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred c-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 4 7788899999999999999999999999999999998555444
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.33 Aligned_cols=256 Identities=25% Similarity=0.293 Sum_probs=198.9
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.+.||+|++|.||+|.++ ++.||||.++..... +.....+.+|+.+++.++||||+++++++....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED------EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK- 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc------ccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-
Confidence 57899999999999999999984 678999998654221 122345778999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+. ++|..++.... ..+++..++.++.||+.||+|||+++|+|+||+|+||+++.++. .+||+|||+
T Consensus 75 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~---~~kl~dfg~ 149 (294)
T PLN00009 75 -RLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGL 149 (294)
T ss_pred -eEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC---EEEEccccc
Confidence 8999999995 57777764433 34678888999999999999999999999999999999986442 479999999
Q ss_pred cccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC------
Q 000726 1199 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR------ 1271 (1329)
Q Consensus 1199 Ar~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr------ 1271 (1329)
+...... .......+++.|+|||++.+ ...++.++|||||||++|+|++|+.||........+..+......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 150 ARAFGIPVRTFTHEVVTLWYRAPEILLG-SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred ccccCCCccccccCceeecccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9754322 11223346889999999874 344688999999999999999999999876554443332211000
Q ss_pred -----------------CC----CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1272 -----------------PP----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1272 -----------------~~----ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.. .....++.+.+++.+||+.+|++||++.+++.+.+-.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~ 288 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence 00 0123578899999999999999999999999886654
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=303.10 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=195.8
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccccCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~e~~ 1118 (1329)
++|+..+.||+|+||.||++.+. ++.||||.+...... .....+.+|+.++.++. |+||+++++++....
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~ 76 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG 76 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence 45666778999999999999984 688999998753211 23456788999999996 999999999887744
Q ss_pred CCeEEEEEEeccCCchhhh---hhc-ccccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1119 GGTLATVTEFMVNGSLRHV---LLS-KERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~---L~~-kek~Lse~qrlkIA~QIAsALaYLHs~-GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
..+++|||+. .++..+ +.. ....+++..+..++.+++.||+|||+. +|+||||||+|||++.++ .++|
T Consensus 77 --~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~----~~kl 149 (288)
T cd06616 77 --DCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG----NIKL 149 (288)
T ss_pred --cEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC----cEEE
Confidence 7889999985 454443 222 235689999999999999999999975 999999999999999765 4699
Q ss_pred eecCCcccccCcccccCCCCCCcccCccccccCC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcC--
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNNT-- 1269 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~-~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~-ell~qIve~~-- 1269 (1329)
+|||++.............++..|+|||++.+.. ..++.++|||||||++|+|++|+.||...... .....+....
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd06616 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP 229 (288)
T ss_pred eecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCC
Confidence 9999987543333333345888999999997431 35788999999999999999999999765421 1122222111
Q ss_pred -CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1270 -LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1270 -lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.....+..++..+.+||.+||+.+|.+|||+.+|+.+.+...
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 111122347889999999999999999999999999877643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.50 Aligned_cols=251 Identities=27% Similarity=0.330 Sum_probs=196.2
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCe
Q 000726 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~ 1121 (1329)
|++.+.||.|++|.||+|.+ .|+.||||++...... +.....+.+|+.+++.++||||+++++++.+.. .
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~--~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED------EGVPSTAIREISLLKELNHPNIVRLLDVVHSEN--K 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc------ccchhHHHHHHHHHHhcCCCCccCHhheeccCC--e
Confidence 56678999999999999987 4888999998754322 112245678999999999999999999998754 8
Q ss_pred EEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1122 LATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1122 L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.++||||+ +++|..++.... ..+++..++.++.|++.||+|||+++++|+||+|+||+++.++ .++|+|||++.
T Consensus 73 ~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~----~~~l~df~~~~ 147 (283)
T cd07835 73 LYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG----ALKLADFGLAR 147 (283)
T ss_pred EEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC----cEEEeeccccc
Confidence 99999999 568988885443 3689999999999999999999999999999999999999765 46999999987
Q ss_pred cccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC---------
Q 000726 1201 IKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL--------- 1270 (1329)
Q Consensus 1201 ~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l--------- 1270 (1329)
..... .......++..|+|||++.+. ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 148 AFGVPVRTYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred ccCCCccccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhh
Confidence 44321 111223468889999988742 3467899999999999999999999977654333222221100
Q ss_pred ------------------CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1271 ------------------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1271 ------------------r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.......++..+.+++.+||+.+|.+|||+.+++.+.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 282 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence 00112345688999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.47 Aligned_cols=251 Identities=28% Similarity=0.421 Sum_probs=206.3
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccccCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~e~~ 1118 (1329)
++|.+.+.||+|+||.||++.+ .+..||+|++...... .+.....+.+|+.+++++. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-----chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 4688999999999999999998 4788999998763221 1222356788999999998 999999999998754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+++++|.+++... ..+++..++.|+.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 76 --~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~----~~l~df~~ 148 (280)
T cd05581 76 --NLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH----IKITDFGT 148 (280)
T ss_pred --eEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC----EEecCCcc
Confidence 899999999999999988644 46999999999999999999999999999999999999997664 59999999
Q ss_pred cccccCcc---------------------cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC
Q 000726 1199 SKIKRNTL---------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1257 (1329)
Q Consensus 1199 Ar~~~~~~---------------------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~ 1257 (1329)
+....... ......++..|+|||++.+ ..++.++|||||||++++|++|..||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 87543221 1223457889999999874 447889999999999999999999998776
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCH----HHHHHHHH
Q 000726 1258 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSF----TEIARRLR 1308 (1329)
Q Consensus 1258 ~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTa----eELLq~Le 1308 (1329)
.......+.. .....+..+++.+.+++.+||+.+|.+||++ .+++++.+
T Consensus 227 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 227 EYLTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred HHHHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 5554444442 2334556678999999999999999999999 89887653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=287.71 Aligned_cols=248 Identities=30% Similarity=0.522 Sum_probs=205.1
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|++.+.||+|++|.||++.+. +..|+||.+...... +.....+.+|++++++++|+|++++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--
Confidence 4788899999999999999874 678999999764321 233467889999999999999999999988754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..++||||+++++|.+++... ..+++..++.++.|++.+|.|||++||+|+||+|+||+++.++ .++|+|||++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~----~~~l~d~~~~~ 147 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG----VVKLADFGVAT 147 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC----CEEEeccccce
Confidence 899999999999999988644 5689999999999999999999999999999999999999755 46999999998
Q ss_pred cccCccc-ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCc
Q 000726 1201 IKRNTLV-TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279 (1329)
Q Consensus 1201 ~~~~~~~-ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S 1279 (1329)
....... .....++..|+|||.+.+. .++.++|||+||+++|+|++|..||.............. ......+..++
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 224 (254)
T cd06627 148 KLNDVSKDDASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGIS 224 (254)
T ss_pred ecCCCcccccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCCCCCCCCC
Confidence 5443222 2334588899999998743 378899999999999999999999977654444433332 33345566788
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 000726 1280 SEWRLLMEQCWAPDPVVRPSFTEIARR 1306 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERPTaeELLq~ 1306 (1329)
..+.+++.+||..+|++||++.+++.+
T Consensus 225 ~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 225 PELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 999999999999999999999999865
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.57 Aligned_cols=254 Identities=30% Similarity=0.479 Sum_probs=207.9
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
...|+..+.||+|++|.||++.+. +..|++|+++.... ....+.+|+.+++.++|+||+++++.+....
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 88 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLVGD 88 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC
Confidence 345777788999999999999985 78899999975321 2356788999999999999999999998754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+++++|.+++......+++..++.++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||+
T Consensus 89 --~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~----~~l~d~~~ 162 (286)
T cd06614 89 --ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS----VKLADFGF 162 (286)
T ss_pred --EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC----EEECccch
Confidence 899999999999999999765447999999999999999999999999999999999999997664 59999998
Q ss_pred cccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC-CCCC
Q 000726 1199 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP-PVPG 1276 (1329)
Q Consensus 1199 Ar~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~-~ips 1276 (1329)
+...... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+....... ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd06614 163 AAQLTKEKSKRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPE 240 (286)
T ss_pred hhhhccchhhhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchh
Confidence 8643321 12223457889999999874 457889999999999999999999998766555444443332221 2223
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.++..+.++|.+||+.+|.+||++.+++.+.+...
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 37889999999999999999999999999887665
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=335.16 Aligned_cols=258 Identities=33% Similarity=0.595 Sum_probs=222.7
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC----Cc--eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR----GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k----Gr--~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
.+.++..++.+.||.|-||.||+|.+. |. .||||.-|..+..+ + ...|+.|..+|+.++|||||+++
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d----~---tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD----D---TEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh----h---HHHHHHHHHHHHhCCCcchhhee
Confidence 355666777889999999999999984 33 38999888655432 1 45799999999999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
|+|.+.+ +|||||+++-|.|..++......++......++.||+.||+|||+..++||||...|||+.+.. .|
T Consensus 458 Gv~~e~P---~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~----CV 530 (974)
T KOG4257|consen 458 GVCVEQP---MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ----CV 530 (974)
T ss_pred eeeeccc---eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc----ee
Confidence 9999764 8999999999999999988888899999999999999999999999999999999999998654 46
Q ss_pred EEeecCCcccccCcccc--cCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhc
Q 000726 1192 KVGDFGLSKIKRNTLVT--GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1268 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~~~s--s~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~ 1268 (1329)
||+|||+++........ +...-...|||||.+. ..+++.++|||-|||+|||++. |..||.+..+.+++.. +++
T Consensus 531 KLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESIN--fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-iEn 607 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYKASRGKLPIKWMAPESIN--FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-IEN 607 (974)
T ss_pred eecccchhhhccccchhhccccccceeecCccccc--hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-ecC
Confidence 99999999965543322 2223456799999998 7889999999999999999997 9999999888777654 567
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1269 ~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
+-++++|..|++.|+.|+.+||+.+|.+||+|.+|...|..+..
T Consensus 608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 78999999999999999999999999999999999999888765
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.35 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=201.8
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
.|.....||+|+||.||++.. ++..||||.+.... ......+.+|+.+++.++|+||+++++.+....
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-- 92 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--------QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-- 92 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--------HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC--
Confidence 344456799999999999987 47789999886421 122356789999999999999999999988754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..++||||+++++|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+||+++.++. ++|+|||++.
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~----~kL~dfg~~~ 166 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR----IKLSDFGFCA 166 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC----EEEccCcchh
Confidence 89999999999999988743 45889999999999999999999999999999999999997654 6999999987
Q ss_pred cccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC--CCCC
Q 000726 1201 IKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPGF 1277 (1329)
Q Consensus 1201 ~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~--ips~ 1277 (1329)
..... .......++..|+|||.+. ...++.++|||||||++|||++|+.||...........+.. ..... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 243 (292)
T cd06658 167 QVSKEVPKRKSLVGTPYWMAPEVIS--RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRVKDSHK 243 (292)
T ss_pred hcccccccCceeecCccccCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCccccccc
Confidence 43222 1223345889999999987 34578899999999999999999999987665544443322 12111 2234
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 1314 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~ 1314 (1329)
++..+.+++.+||..+|.+|||+.+++++.+......
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 6788999999999999999999999999876654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=300.12 Aligned_cols=256 Identities=27% Similarity=0.351 Sum_probs=196.8
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++.+.||+|+||.||++.++ ++.||||++......... ...+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF------PITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc------chhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 478999999999999999999984 778999998764322211 134568999999999999999999875433
Q ss_pred ------CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEE
Q 000726 1119 ------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1119 ------dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VK 1192 (1329)
...+++||||+. ++|...+......+++..+..++.||++||+|||++||+|+||||+|||++.++. ++
T Consensus 81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~----~~ 155 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI----LK 155 (311)
T ss_pred ccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC----EE
Confidence 235799999995 5677777655567999999999999999999999999999999999999997764 59
Q ss_pred EeecCCcccccCccc------------ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH
Q 000726 1193 VGDFGLSKIKRNTLV------------TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 1260 (1329)
Q Consensus 1193 LsDFGLAr~~~~~~~------------ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~e 1260 (1329)
|+|||++........ .....+++.|+|||++.+ ...++.++|||||||++|+|++|++||.......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC-CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999874332111 112346788999999864 3346889999999999999999999998765544
Q ss_pred HHHHHHhcCCC---------------------CCCC-------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1261 IIGGIVNNTLR---------------------PPVP-------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1261 ll~qIve~~lr---------------------~~ip-------s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
....+...... ...+ ....+.+.+++.+||+.+|.+|||+.+++.+.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~ 310 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence 33332211000 0000 123467889999999999999999999987653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=329.40 Aligned_cols=247 Identities=26% Similarity=0.329 Sum_probs=192.6
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
....|.+.+.||+|+||.||++.+. ++.||||.... ..+.+|+.+|++++|+|||++++++...
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 3457999999999999999999985 67799995421 2356799999999999999999998774
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
. ..++|||++ .++|..++......+++.+++.|+.||+.||.|||++||+||||||+||||+.++. +||+|||
T Consensus 233 ~--~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~----vkL~DFG 305 (461)
T PHA03211 233 G--LTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED----ICLGDFG 305 (461)
T ss_pred C--EEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC----EEEcccC
Confidence 4 889999999 57888888666667999999999999999999999999999999999999997654 6999999
Q ss_pred CcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--------hhHHHHHHH
Q 000726 1198 LSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH--------YGAIIGGIV 1266 (1329)
Q Consensus 1198 LAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~--------~~ell~qIv 1266 (1329)
+++...... ......||..|+|||++.+ ..++.++|||||||+||||++|..|+.... ...+...+.
T Consensus 306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~ 383 (461)
T PHA03211 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR 383 (461)
T ss_pred CceecccccccccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence 997543221 2234569999999999984 457889999999999999999876543211 111111111
Q ss_pred hcCC-------------------------CCCC--C-----CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1267 NNTL-------------------------RPPV--P-----GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1267 e~~l-------------------------r~~i--p-----s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
.... +... + ...+..+.+||.+||+.||.+|||+.|+|++.|.
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 1000 0000 0 0234578999999999999999999999998663
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.95 Aligned_cols=256 Identities=27% Similarity=0.367 Sum_probs=198.4
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
..++|++.+.||+|+||.||+|.++ ++.||||+++...... .....+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~ 78 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE------GFPITAIREIKILRQLNHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc------CchHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence 3467889999999999999999984 7889999997543221 1123566899999999999999999988764
Q ss_pred C--------CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCC
Q 000726 1118 P--------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1329)
Q Consensus 1118 ~--------dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~ 1189 (1329)
. .+.+++||||+++ ++...+......+++..++.++.||+.||+|||++||+|+||||+||+++.++
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~---- 153 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG---- 153 (302)
T ss_pred chhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----
Confidence 3 2378999999965 77777765555789999999999999999999999999999999999999765
Q ss_pred cEEEeecCCcccccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 000726 1190 ICKVGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1190 ~VKLsDFGLAr~~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve 1267 (1329)
.+||+|||++....... ......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||........+..+..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 154 QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred cEEeCcccccccccCCcccccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 46999999987543221 11223457789999988642 3467899999999999999999999976554433322221
Q ss_pred c---CCC---C----------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1268 N---TLR---P----------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1268 ~---~lr---~----------------------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
. ... + .....++..+.+++.+||+.+|.+||++.+++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 300 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP 300 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 1 000 0 01123578999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=335.29 Aligned_cols=255 Identities=26% Similarity=0.302 Sum_probs=209.0
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-C-----CceeeEeccc
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-H-----PNVVAFYGVV 1114 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-H-----PNIVKL~Gif 1114 (1329)
+|.+.+.||+|+||.|-+|.+ +++.||||+++.. ..+..+...|+.+|..|+ | -|+|+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 899999999999999999998 4778999999853 345566778999999997 4 3899999999
Q ss_pred ccCCCCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
.... ++|||+|.+ ..+|.+++... ...++...+..|+.||+.||.+||+.+|||+||||+||||..-+.. .+||
T Consensus 258 ~fr~--HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~--~vKV 332 (586)
T KOG0667|consen 258 YFRN--HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS--RIKV 332 (586)
T ss_pred cccc--ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC--ceeE
Confidence 9866 899999998 78999999654 3568999999999999999999999999999999999999876543 7899
Q ss_pred eecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-----
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN----- 1268 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~----- 1268 (1329)
+|||.++....... ....+..|.|||++.| ..|+.+.||||||||+.||++|.+.|++....+.+..|++-
T Consensus 333 IDFGSSc~~~q~vy--tYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY--TYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred EecccccccCCcce--eeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 99999997655443 4567889999999995 56889999999999999999999999887765544332210
Q ss_pred ---------------C------------------------------CCCCCC-----------CCCcHHHHHHHHHhhcC
Q 000726 1269 ---------------T------------------------------LRPPVP-----------GFCDSEWRLLMEQCWAP 1292 (1329)
Q Consensus 1269 ---------------~------------------------------lr~~ip-----------s~~S~eL~DLIkrCLqk 1292 (1329)
. ...-.| ......+.+++++||..
T Consensus 409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 0 000011 01235588999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1293 DPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1293 DPeERPTaeELLq~Le~L~aa~q 1315 (1329)
||.+|+|..++++|.+--.....
T Consensus 489 dP~~R~tp~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 489 DPAERITPAQALNHPFLTGTSLE 511 (586)
T ss_pred CchhcCCHHHHhcCccccccccc
Confidence 99999999999999988754444
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=309.60 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=196.4
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++.+.||+|+||.||+|.+ +++.||||+++... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPS 76 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-------cchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence 36799999999999999999987 47889999986421 1123456778999999999999999999875432
Q ss_pred ---CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1119 ---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1119 ---dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
...+++||||+. ++|...+. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~----~kl~d 149 (336)
T cd07849 77 FESFNDVYIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD----LKICD 149 (336)
T ss_pred ccccceEEEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC----EEECc
Confidence 135799999995 57777763 346899999999999999999999999999999999999997764 59999
Q ss_pred cCCcccccCcc----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh---c
Q 000726 1196 FGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN---N 1268 (1329)
Q Consensus 1196 FGLAr~~~~~~----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve---~ 1268 (1329)
||++....... ......++..|+|||.+.+ ...++.++|||||||++|+|++|+.||...........+.. .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~ 228 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN-SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99987543211 1123457899999998764 34578899999999999999999999976544322211110 0
Q ss_pred ------------C---------CCCC-----CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1269 ------------T---------LRPP-----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1269 ------------~---------lr~~-----ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
. .... .....+..+.++|.+||+.+|.+|||+.+++.+.+-.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 0 0000 0123467799999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=319.30 Aligned_cols=255 Identities=29% Similarity=0.350 Sum_probs=205.5
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCc-eeeEecccccC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN-VVAFYGVVQDG 1117 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPN-IVKL~Gif~e~ 1117 (1329)
...|..+++||+|+||+||+|+. +|+.||+|.++..... |.......+|+.+|+.|+|+| ||++++++...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 34566677899999999999988 4788999999875432 223345679999999999999 99999999875
Q ss_pred C----CCeEEEEEEeccCCchhhhhhccc---ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCc
Q 000726 1118 P----GGTLATVTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190 (1329)
Q Consensus 1118 ~----dg~L~LVMEYm~GGSL~d~L~~ke---k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~ 1190 (1329)
+ .+.+++||||+ ..+|..++.... ..++...+..+..||+.||+|||+++|+||||||+||||+.+|.
T Consensus 84 ~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~---- 158 (323)
T KOG0594|consen 84 NNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV---- 158 (323)
T ss_pred ccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc----
Confidence 4 24789999999 688999886655 35778889999999999999999999999999999999998764
Q ss_pred EEEeecCCccccc-CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 000726 1191 CKVGDFGLSKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1269 (1329)
Q Consensus 1191 VKLsDFGLAr~~~-~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~ 1269 (1329)
+||+|||+|+... .........+|.+|.|||++.|.. .|+..+||||+|||++||++++..|++....+.+..+..--
T Consensus 159 lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~-~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l 237 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGST-SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL 237 (323)
T ss_pred EeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCC-cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence 5999999999655 333345567899999999999853 48899999999999999999999999987766555443210
Q ss_pred C----------------CCCCC------------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1270 L----------------RPPVP------------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1270 l----------------r~~ip------------s~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
- ....+ ....++..+++.+||+.+|.+|.|+..++.|.
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~ 303 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP 303 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence 0 00111 11224788999999999999999999999983
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=299.96 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=191.4
Q ss_pred EecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHH---HHHhcCCCceeeEecccccCCCCeEE
Q 000726 1049 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE---ILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIe---ILk~LrHPNIVKL~Gif~e~~dg~L~ 1123 (1329)
.||+|+||.||++.+. ++.+|||.+......... .+ ..+.+|.. ++....||||+.+++.+.... ..+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GE---TLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLC 73 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch--HH---HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEE
Confidence 3899999999999884 788999999764332111 11 12233433 334457999999999988754 889
Q ss_pred EEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 000726 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1329)
Q Consensus 1124 LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~ 1203 (1329)
+||||+++++|..++... ..+++..+..++.|++.||.|||+++|+|+||||+|||++.++ .++|+|||++....
T Consensus 74 lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~----~~~l~dfg~~~~~~ 148 (279)
T cd05633 74 FILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG----HVRISDLGLACDFS 148 (279)
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC----CEEEccCCcceecc
Confidence 999999999999888543 4689999999999999999999999999999999999999765 46999999987443
Q ss_pred CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHhcCCCCCCCCCCcHH
Q 000726 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--AIIGGIVNNTLRPPVPGFCDSE 1281 (1329)
Q Consensus 1204 ~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~--ell~qIve~~lr~~ips~~S~e 1281 (1329)
... .....|+..|+|||.+.+ ...++.++|||||||++|+|++|..||...... ..... ........++..++..
T Consensus 149 ~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 225 (279)
T cd05633 149 KKK-PHASVGTHGYMAPEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTVNVELPDSFSPE 225 (279)
T ss_pred ccC-ccCcCCCcCccCHHHhcC-CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-HhhcCCcCCccccCHH
Confidence 222 223468999999999863 234688999999999999999999999654321 11111 1222334456678899
Q ss_pred HHHHHHHhhcCCCCCCC-----CHHHHHHHHHHHH
Q 000726 1282 WRLLMEQCWAPDPVVRP-----SFTEIARRLRVMS 1311 (1329)
Q Consensus 1282 L~DLIkrCLqkDPeERP-----TaeELLq~Le~L~ 1311 (1329)
+.++|.+||..||.+|| +++++++|.+...
T Consensus 226 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 226 LKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 99999999999999999 6999999876643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=302.42 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=202.1
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
..+|.+.+.||+|+||.||++.. .+..||+|.+.... ......+.+|+.+++.++||||+++++.+....
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--------QPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--------chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 46889999999999999999986 46789999985421 112345788999999999999999999998754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||+
T Consensus 90 --~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~----~~kL~dfg~ 161 (293)
T cd06647 90 --ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGF 161 (293)
T ss_pred --cEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC----CEEEccCcc
Confidence 78999999999999998853 3578899999999999999999999999999999999999765 469999998
Q ss_pred cccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-CCCCCCCC
Q 000726 1199 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPG 1276 (1329)
Q Consensus 1199 Ar~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~-~lr~~ips 1276 (1329)
+...... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+... ......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd06647 162 CAQITPEQSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239 (293)
T ss_pred eecccccccccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCcc
Confidence 8643322 22233458889999999874 45688999999999999999999999766543332222211 11122234
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.++..+.+++.+||+.+|.+||++.+++.+.+..
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~ 273 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 4678899999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=299.61 Aligned_cols=250 Identities=24% Similarity=0.411 Sum_probs=200.7
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
.|...+.||+|++|.||++.+ .++.+++|+++... ......+.+|+.+++.+.||||+++++++....
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-- 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-- 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--------hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC--
Confidence 455567899999999999987 36789999885321 112345778999999999999999999988754
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..++|+||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||+|+||+++.++ .++|+|||++.
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~----~~~l~d~g~~~ 163 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG----RVKLSDFGFCA 163 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC----cEEEcccccch
Confidence 88999999999999998865 4689999999999999999999999999999999999999766 45999999887
Q ss_pred cccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-CCCCCCCC
Q 000726 1201 IKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPPVPGFC 1278 (1329)
Q Consensus 1201 ~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l-r~~ips~~ 1278 (1329)
..... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+..... ....+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKV 241 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccC
Confidence 43322 12233458899999999874 4478899999999999999999999977665555544443321 11122337
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
+..+.+++.+||+.+|.+||++.+++++.+..
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 273 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHccCcccc
Confidence 78999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=307.14 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=198.3
Q ss_pred Eeccc--CcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEE
Q 000726 1049 ELGSG--TFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1049 vLGqG--aFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
.||+| +||+||++++ .++.||||++...... ....+.+.+|+.+++.++||||++++++|.... ..++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~~ 76 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT------EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLWV 76 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceEE
Confidence 46666 9999999988 5889999998753211 123467888999999999999999999998855 8899
Q ss_pred EEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 000726 1125 VTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~ 1203 (1329)
||||+.+++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++||+.+....
T Consensus 77 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~----~~~~~~~~~~~~~ 152 (328)
T cd08226 77 ISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL----VSLSGLSHLYSLV 152 (328)
T ss_pred EEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc----EEEechHHHhhhh
Confidence 999999999999886532 35889999999999999999999999999999999999997653 5999998653211
Q ss_pred Cc-c-------cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-----
Q 000726 1204 NT-L-------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL----- 1270 (1329)
Q Consensus 1204 ~~-~-------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l----- 1270 (1329)
.. . ......++..|+|||++.+....++.++|||||||++|+|++|..||.................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence 10 0 0011224567999999986555678999999999999999999999987654443322221110
Q ss_pred ----------------------------------------CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1271 ----------------------------------------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1271 ----------------------------------------r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
..+.+..++..+.+|+++||+.||++|||+.+++++.|-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 1111223567799999999999999999999999999987
Q ss_pred HHHhccC
Q 000726 1311 SAACQTK 1317 (1329)
Q Consensus 1311 ~aa~q~~ 1317 (1329)
....+.+
T Consensus 313 ~~~~~~~ 319 (328)
T cd08226 313 QVKEQTQ 319 (328)
T ss_pred HHHHhcc
Confidence 6666533
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=291.30 Aligned_cols=245 Identities=28% Similarity=0.384 Sum_probs=193.7
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHH-HhcCCCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL-SKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeIL-k~LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+.||+|+||.||+|.+ .++.||||++++.... .......+..|..++ ..+.|+||+++++++.... ..++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-----AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD--YLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-----HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC--eEEE
Confidence 4699999999999988 4788999998653211 112223344555444 4558999999999998754 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~ 1204 (1329)
||||+++++|..++... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++ .++|+|||++.....
T Consensus 75 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~----~~~l~dfg~~~~~~~ 149 (260)
T cd05611 75 VMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG----HLKLTDFGLSRNGLE 149 (260)
T ss_pred EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----cEEEeecccceeccc
Confidence 99999999999988543 4689999999999999999999999999999999999999765 469999999875432
Q ss_pred cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC--CCCCCCCcHHH
Q 000726 1205 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--PPVPGFCDSEW 1282 (1329)
Q Consensus 1205 ~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr--~~ips~~S~eL 1282 (1329)
.....++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+...... ......++..+
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEA 224 (260)
T ss_pred ---cccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHH
Confidence 2234578899999999853 3688999999999999999999999887766665554443322 22334578999
Q ss_pred HHHHHHhhcCCCCCCCCH---HHHHHHHHH
Q 000726 1283 RLLMEQCWAPDPVVRPSF---TEIARRLRV 1309 (1329)
Q Consensus 1283 ~DLIkrCLqkDPeERPTa---eELLq~Le~ 1309 (1329)
.+++.+||+.+|++||++ .+++.+.+-
T Consensus 225 ~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 225 VDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred HHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 999999999999999954 677777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=338.09 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=215.7
Q ss_pred ccCeeEEEEecccCcEEEEEEEECCce--EEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~kGr~--VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.+.|.++..||.|+||.||+|..+.+. .|-|++... .+.....|+-|++||..+.||+||++|+.|...+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--------seEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--------SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 345677788999999999999886433 577776432 2334567889999999999999999999887644
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
.++++.|||.||-....+..-+..+++.++..+++|++.||.|||++.|||||||+.|||++.+|.+ +|+|||.
T Consensus 103 --kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdi----rLADFGV 176 (1187)
T KOG0579|consen 103 --KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDI----RLADFGV 176 (1187)
T ss_pred --ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcE----eeecccc
Confidence 8999999999999999998888999999999999999999999999999999999999999988876 9999998
Q ss_pred ccc-ccCcccccCCCCCCcccCcccccc---CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC-CCCC
Q 000726 1199 SKI-KRNTLVTGGVRGTLPWMAPELLNG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPP 1273 (1329)
Q Consensus 1199 Ar~-~~~~~~ss~~~GTp~YmAPEvL~G---s~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~-lr~~ 1273 (1329)
+.. .........+.|||+|||||++.. ....|+.++||||||++|.||..+.+|-.......++..+.+.. ..+.
T Consensus 177 SAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl 256 (1187)
T KOG0579|consen 177 SAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL 256 (1187)
T ss_pred cccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc
Confidence 753 333334457889999999999742 24568889999999999999999999988877777776665443 3444
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1274 ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.|..++..|.+|+++||.+||..||++.+|++|.+.-
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 5778899999999999999999999999999988754
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=302.97 Aligned_cols=251 Identities=28% Similarity=0.425 Sum_probs=202.3
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCe
Q 000726 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~ 1121 (1329)
|...+.||+|+||+||+|++ .+..||||++...... .......+.+|+.+++.++|||++++++++.+.. .
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-----TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--T 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-----chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--E
Confidence 56677899999999999987 4788999998754221 2233456788999999999999999999998865 8
Q ss_pred EEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1122 L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
.++||||+. +++..++......+++..++.++.||+.+|.|||++||+|+||+|+||+++.++. +||+|||++..
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~----~kL~dfg~~~~ 170 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ----VKLADFGSASK 170 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC----EEEeecCCCcc
Confidence 899999995 6787777665667899999999999999999999999999999999999987653 69999999864
Q ss_pred ccCcccccCCCCCCcccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcH
Q 000726 1202 KRNTLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 1280 (1329)
Q Consensus 1202 ~~~~~~ss~~~GTp~YmAPEvL~G-s~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~ 1280 (1329)
... .....++..|+|||++.. ....++.++|||||||++|+|++|..||...........+............++.
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
T cd06633 171 SSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTD 247 (313)
T ss_pred cCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCH
Confidence 322 223568889999999853 1345788999999999999999999999877655555444433332223345678
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1281 EWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1281 eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
.+.+|+.+||+.+|.+||++.+++.+.+.
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~~~~ 276 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRHDFV 276 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 89999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=344.52 Aligned_cols=258 Identities=27% Similarity=0.390 Sum_probs=203.0
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
++|++.++||+|+||.||+|.+. ++.||||+++.... ..+....++.+|+.+++.++||||+++++++.+..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-----~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~- 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-----ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD- 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-----cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-
Confidence 57999999999999999999884 78899999875321 12344567899999999999999999999998754
Q ss_pred CeEEEEEEeccCCchhhhhhcc----------cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCC
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSK----------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~k----------ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~ 1189 (1329)
..++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 76 -~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--- 151 (932)
T PRK13184 76 -PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--- 151 (932)
T ss_pred -EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC---
Confidence 899999999999999887531 123566778899999999999999999999999999999997764
Q ss_pred cEEEeecCCcccccCc-------------------ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCC
Q 000726 1190 ICKVGDFGLSKIKRNT-------------------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250 (1329)
Q Consensus 1190 ~VKLsDFGLAr~~~~~-------------------~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk 1250 (1329)
++|+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 152 -vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~ 228 (932)
T PRK13184 152 -VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLS 228 (932)
T ss_pred -EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCC
Confidence 599999999754110 01123468999999999984 45788999999999999999999
Q ss_pred CCCCCCChhHHHHH-HHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHHHH
Q 000726 1251 EPYANMHYGAIIGG-IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRP-SFTEIARRLRVMSA 1312 (1329)
Q Consensus 1251 ~PF~~~~~~ell~q-Ive~~lr~~ips~~S~eL~DLIkrCLqkDPeERP-TaeELLq~Le~L~a 1312 (1329)
.||........... .............+++.+.+++.+||+.||.+|| +++++++.|+.+..
T Consensus 229 ~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 229 FPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred CCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99976544332211 1111111111235788999999999999999995 67778888877654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=295.26 Aligned_cols=251 Identities=27% Similarity=0.347 Sum_probs=199.7
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCe
Q 000726 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~ 1121 (1329)
|+..+.||+|++|.||++.+ .+..+++|.++..... ......+.+|+.+++.++|+||+++++++.... .
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES------EGIPKTALREIKLLKELNHPNIIKLLDVFRHKG--D 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc------chhHHHHHHHHHHHHHhcCCCcchHHHhhccCC--C
Confidence 45678899999999999988 4778999998764322 123456778999999999999999999998754 8
Q ss_pred EEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1122 L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
.++||||++ ++|..++......+++..++.++.||+.||.|||+++|+|+||||+||+++.++ .++|+|||.+..
T Consensus 73 ~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~----~~~l~df~~~~~ 147 (283)
T cd05118 73 LYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG----VLKLADFGLARS 147 (283)
T ss_pred EEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC----cEEEeeeeeeEe
Confidence 999999996 588888866556789999999999999999999999999999999999999765 469999999875
Q ss_pred ccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC---------
Q 000726 1202 KRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--------- 1271 (1329)
Q Consensus 1202 ~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr--------- 1271 (1329)
..... ......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||......+.+..+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 54332 22234578889999998742 35788999999999999999999999776654433332211000
Q ss_pred -------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1272 -------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1272 -------------------~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
......++..+.++|.+||++||.+||++.+++.+.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 0011235788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=304.84 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=205.2
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
...|...+.||+|+||.||+|.+ .+..||||.+...... .......+.+|+.+++.++|+|++++++++....
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-----ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence 34577778899999999999998 4678999988643111 1223456788999999999999999999988754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
..++||||+. +++.+.+......+++..+..++.|++.||.|||+++++|+||+|+|||++.++ .++|+|||+
T Consensus 89 --~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~kl~dfg~ 161 (308)
T cd06634 89 --TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGS 161 (308)
T ss_pred --eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC----cEEECCccc
Confidence 8899999995 688777765556789999999999999999999999999999999999998765 469999999
Q ss_pred cccccCcccccCCCCCCcccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 000726 1199 SKIKRNTLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277 (1329)
Q Consensus 1199 Ar~~~~~~~ss~~~GTp~YmAPEvL~G-s~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~ 1277 (1329)
+...... ....++..|+|||.+.+ ....++.++|||||||++|+|++|..||...........+............
T Consensus 162 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06634 162 ASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238 (308)
T ss_pred ceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCccc
Confidence 8754332 23457889999999853 1334678999999999999999999999776655544444433332223446
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
++..+.++|.+||+.+|.+||++.+++.+.+...
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 7888999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=304.33 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=199.9
Q ss_pred eEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeE
Q 000726 1045 EELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1045 ellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L 1122 (1329)
.....||+|+||.||++.+ .++.||||++..... .....+.+|+.+++.+.||||+++++++.... ..
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~ 93 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--------QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE--EL 93 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--------chHHHHHHHHHHHHhCCCCchhhhhhheeeCC--eE
Confidence 3344799999999999987 478899999864321 11245778999999999999999999988754 89
Q ss_pred EEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 000726 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
++||||+++++|..++.. ..+++..++.++.||+.||+|||+++|+|+||||+|||++.++. ++|+|||++...
T Consensus 94 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~----~kL~dfg~~~~~ 167 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR----VKLSDFGFCAQI 167 (297)
T ss_pred EEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc----EEEeechhHhhc
Confidence 999999999999887743 45899999999999999999999999999999999999997764 599999998743
Q ss_pred cCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-CCCCCCCCcH
Q 000726 1203 RNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPPVPGFCDS 1280 (1329)
Q Consensus 1203 ~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l-r~~ips~~S~ 1280 (1329)
... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..... .......++.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (297)
T cd06659 168 SKDVPKRKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISP 245 (297)
T ss_pred ccccccccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCH
Confidence 322 12234568899999999974 4578899999999999999999999987665554443332211 1122335678
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1281 EWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1281 eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.+.++|.+||+.+|.+||++.+++++.+...
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~ 276 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDHPFLLQ 276 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhChhhcc
Confidence 8999999999999999999999999876553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=306.49 Aligned_cols=261 Identities=26% Similarity=0.333 Sum_probs=200.9
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~ 1117 (1329)
.++|++.+.||+|+||.||+|.+. ++.+|||.+...... ......+.+|+.+++++ +||||++++++|...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN------ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc------chhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 457888899999999999999884 778999988643211 11124567899999999 999999999998765
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
.....++||||+. ++|..++... .+++..++.++.||+.||+|||++||+|+||||+|||++.++. +||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~----~kl~d~g 152 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR----VKLADFG 152 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc----EEEeecc
Confidence 4457899999996 6888887543 6889999999999999999999999999999999999997764 5999999
Q ss_pred CcccccCcc------cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC--
Q 000726 1198 LSKIKRNTL------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-- 1269 (1329)
Q Consensus 1198 LAr~~~~~~------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~-- 1269 (1329)
++....... ......++..|+|||.+.+ ...++.++|||||||++|+|++|+.||...........+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLG-STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeec-cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 987432211 1223457889999998864 2446789999999999999999999997654433222211110
Q ss_pred ------------------------CC---CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1270 ------------------------LR---PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1270 ------------------------lr---~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
.. ......++..+.++|.+||+.+|.+|||+.+++.+.+-......
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 00 01112367889999999999999999999999998665544333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=291.41 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=201.8
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|.+.+.||+|+||.||++.+. +..+++|+++......... .....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP---NETVQANQEAQLLSKLDHPAIVKFHASFLERD-- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCc---chHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--
Confidence 4788899999999999999885 4457777776533321111 11234667899999999999999999998754
Q ss_pred eEEEEEEeccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1121 TLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
..++||||+++++|..++.. ....+++..++.++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~-----~~~l~d~g 150 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-----LLKIGDFG 150 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC-----CEeecccC
Confidence 78999999999999988753 33568999999999999999999999999999999999999742 37999999
Q ss_pred CcccccC-cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 000726 1198 LSKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1198 LAr~~~~-~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips 1276 (1329)
++..... ........+++.|+|||.+. ...++.++|+||||+++|+|++|..||...........+.. ......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 227 (260)
T cd08222 151 VSRLLMGSCDLATTFTGTPYYMSPEALK--HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPE 227 (260)
T ss_pred ceeecCCCcccccCCCCCcCccCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCCcc
Confidence 9875432 22233455788999999987 34567889999999999999999999976655554444433 33444566
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.++.++.++|.+||..+|.+||++.+++++.|
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred hhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 78899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=302.68 Aligned_cols=260 Identities=28% Similarity=0.313 Sum_probs=205.7
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC--
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP-- 1118 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~-- 1118 (1329)
+|++.+.||+|++|.||+|.+. +..||||++..... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 4788999999999999999984 68899999875321 1223456888999999999999999999987642
Q ss_pred -CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1119 -GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1119 -dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
...+++||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+|+||||.|||++.++ .++|+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~----~~~L~dfg 148 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC----DLKICDFG 148 (330)
T ss_pred cccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----CEEEcccC
Confidence 236899999996 5888887543 3789999999999999999999999999999999999999775 46999999
Q ss_pred CcccccCcc----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC-
Q 000726 1198 LSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP- 1272 (1329)
Q Consensus 1198 LAr~~~~~~----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~- 1272 (1329)
++....... ......++..|+|||++.+.. .++.++|||||||++|+|++|..||......+....+.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS-RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeeccc-CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence 998654332 123345788999999998532 67889999999999999999999998776554443333211000
Q ss_pred ----------------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1273 ----------------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1273 ----------------------------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
......+..+.++|.+||+.+|.+||++.+++.+.|-......
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0112357889999999999999999999999999776654443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=293.97 Aligned_cols=251 Identities=28% Similarity=0.326 Sum_probs=194.8
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc---CCCceeeEecccccCC
Q 000726 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L---rHPNIVKL~Gif~e~~ 1118 (1329)
|++.+.||+|+||.||+++++ ++.||||+++..... ......+.+|+.+++++ .|+||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE------EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc------chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 577889999999999999984 788999999754321 11123455677777665 5999999999987654
Q ss_pred C---CeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1119 G---GTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1119 d---g~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
. ..++++|||+. ++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+|||++.++ .++|+
T Consensus 75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~----~~~l~ 149 (287)
T cd07838 75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG----QVKIA 149 (287)
T ss_pred CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC----CEEEe
Confidence 1 23899999996 57888775533 3689999999999999999999999999999999999999775 46999
Q ss_pred ecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC---
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 1271 (1329)
Q Consensus 1195 DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr--- 1271 (1329)
|||++.............++..|+|||++.+ ..++.++|||||||++|+|++|++||......+....+......
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 150 DFGLARIYSFEMALTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227 (287)
T ss_pred ccCcceeccCCcccccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence 9999976544333334457889999999984 45788999999999999999999999877665554444321100
Q ss_pred -------------------C---CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1272 -------------------P---PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1272 -------------------~---~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
. ......+..+.+++.+||+.||.+||++.+++.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~ 285 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence 0 00012357788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=296.54 Aligned_cols=250 Identities=24% Similarity=0.305 Sum_probs=192.7
Q ss_pred EecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEE
Q 000726 1049 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVT 1126 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVM 1126 (1329)
.||+|+||.||++.+ .++.||||++......... .+.........+.+++...||+|+++++++.... ..++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch--hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--EEEEEE
Confidence 389999999999987 4778999998764332111 1111111122334455568999999999998755 899999
Q ss_pred EeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCcc
Q 000726 1127 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206 (1329)
Q Consensus 1127 EYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~ 1206 (1329)
||+.+++|..++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++ .++|+|||++......
T Consensus 77 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~----~~kl~dfg~~~~~~~~- 150 (278)
T cd05606 77 DLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG----HVRISDLGLACDFSKK- 150 (278)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC----CEEEccCcCccccCcc-
Confidence 99999999988854 35689999999999999999999999999999999999999765 4699999998744322
Q ss_pred cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhcCCCCCCCCCCcHHHH
Q 000726 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY---GAIIGGIVNNTLRPPVPGFCDSEWR 1283 (1329)
Q Consensus 1207 ~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~---~ell~qIve~~lr~~ips~~S~eL~ 1283 (1329)
......|+..|+|||++.+ ...++.++|||||||++|+|++|+.||..... ...... ........+..++..+.
T Consensus 151 ~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~ 227 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TLTMAVELPDSFSPELR 227 (278)
T ss_pred CCcCcCCCcCCcCcHHhcC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH--hhccCCCCCCcCCHHHH
Confidence 1223468999999999873 22467899999999999999999999976532 222111 12233445666789999
Q ss_pred HHHHHhhcCCCCCCC-----CHHHHHHHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRP-----SFTEIARRLRVMS 1311 (1329)
Q Consensus 1284 DLIkrCLqkDPeERP-----TaeELLq~Le~L~ 1311 (1329)
+++.+||..+|.+|| ++.+++++.|...
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 228 SLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred HHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 999999999999999 9999998876643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=297.11 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=200.5
Q ss_pred CeeEEEEecccCcEEEEEEEE-----CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEeccccc
Q 000726 1043 DLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~-----kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e 1116 (1329)
.|++.+.||+|+||.||++.. +|..||+|+++..... ........+.+|+.+++.+ +|+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV----QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhh----hcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 378889999999999999986 4678999999753211 1112235577899999999 59999999999887
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.. ..++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+|||++.++ .+||+||
T Consensus 77 ~~--~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~----~~kl~df 149 (290)
T cd05613 77 DT--KLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG----HVVLTDF 149 (290)
T ss_pred CC--eEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC----CEEEeeC
Confidence 54 889999999999999988644 4688999999999999999999999999999999999999765 4699999
Q ss_pred CCcccccCc--ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHhcCC
Q 000726 1197 GLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTL 1270 (1329)
Q Consensus 1197 GLAr~~~~~--~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~----~ell~qIve~~l 1270 (1329)
|++...... .......|+..|+|||.+.+....++.++|||||||++|+|++|..||..... ......+.. .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~ 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--S 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--c
Confidence 998754322 12223458899999999875444567889999999999999999999964322 122222221 1
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHHH
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLRV 1309 (1329)
Q Consensus 1271 r~~ips~~S~eL~DLIkrCLqkDPeERP-----TaeELLq~Le~ 1309 (1329)
..+.+..++..+.+++.+||+.+|.+|| ++.+++.+.+-
T Consensus 228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 271 (290)
T cd05613 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271 (290)
T ss_pred CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccc
Confidence 2345566889999999999999999997 88998887553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=330.45 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=207.8
Q ss_pred cccccccCeeEEEEecccCcEEEEEEEEC-CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecc
Q 000726 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGV 1113 (1329)
Q Consensus 1036 l~iI~~edYellkvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gi 1113 (1329)
.-.+...+|++++.||+||.+.||++... .+.+|+|.+... ..+.....-|+.|+..|.+|+ |.+||++|+|
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~------~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY 428 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL------EADNQTLDGYRNEIALLNKLKGHDKIIQLYDY 428 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh------hcCHHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence 34577789999999999999999999875 355788776532 224556788999999999995 9999999998
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
-.. ++++|+||||- ..+|..+|..+...++...+..++.||+.|+.++|++||||.||||.|+|+- .+.+||
T Consensus 429 Ev~--d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-----kG~LKL 500 (677)
T KOG0596|consen 429 EVT--DGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-----KGRLKL 500 (677)
T ss_pred ecc--CceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-----eeeEEe
Confidence 777 56999999975 7899999987766666557888999999999999999999999999999996 346799
Q ss_pred eecCCcccccCccc---ccCCCCCCcccCccccccCCC---------CCChhhHHHHHHHHHHHHHhCCCCCCCCChh-H
Q 000726 1194 GDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSS---------KVSEKVDVFSFGIVLWEILTGEEPYANMHYG-A 1260 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~---ss~~~GTp~YmAPEvL~Gs~~---------~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~-e 1260 (1329)
+|||+|.......+ ....+||+.||+||.+..... ..++++||||||||||+|+.|+.||...... .
T Consensus 501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a 580 (677)
T KOG0596|consen 501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA 580 (677)
T ss_pred eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH
Confidence 99999987654432 235679999999999853322 2688999999999999999999999765432 3
Q ss_pred HHHHHHhcCCCCCCCCCCcH-HHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1261 IIGGIVNNTLRPPVPGFCDS-EWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1261 ll~qIve~~lr~~ips~~S~-eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
.+..+.+.....+++..-+. ++.++|+.||+.||.+||++.+||++...
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl 630 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFL 630 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccc
Confidence 33444444344444444333 39999999999999999999999987654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=293.14 Aligned_cols=250 Identities=28% Similarity=0.368 Sum_probs=196.1
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccccCCCC
Q 000726 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~e~~dg 1120 (1329)
|++.+.||+|++|.||+|.+. ++.||||.+...... .. .....+|+..+++++ |+||+++++++... .
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WE---ECMNLREVKSLRKLNEHPNIVKLKEVFREN--D 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hh---HHHHHHHHHHHHhccCCCCchhHHHHhhcC--C
Confidence 567889999999999999984 678999998754321 11 123456889999999 99999999999884 4
Q ss_pred eEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
..++||||+ +++|.+++.... ..+++..+..++.|++.+|.|||+++++|+||+|+||+++.++. ++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~----~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV----VKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC----EEEeecccc
Confidence 899999999 889988886544 46899999999999999999999999999999999999997654 599999999
Q ss_pred ccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-----------
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN----------- 1268 (1329)
Q Consensus 1200 r~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~----------- 1268 (1329)
.............++..|+|||++.+ ...++.++|+||||+++|+|++|+.||...........+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 147 REIRSRPPYTDYVSTRWYRAPEILLR-STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred eeccCCCCcCCCCCcccccCceeeec-CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 86554333344557889999999864 334688999999999999999999999766544332221110
Q ss_pred ------CCCC-----------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1269 ------TLRP-----------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1269 ------~lr~-----------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
.... ......+..+.+++.+||+.+|.+|||+.+++.+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 0000 001123578999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=306.74 Aligned_cols=256 Identities=25% Similarity=0.312 Sum_probs=198.5
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
.+|.+.+.||+|+||+||++.+ +++.||||.++..... ......+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN------RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc------cchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 4799999999999999999987 4788999998753211 1123456789999999999999999998865321
Q ss_pred ---CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1120 ---GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1120 ---g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
..+++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++++|+||||+||+++.++. +||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~----~kL~Df 152 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDF 152 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC----EEECcC
Confidence 35899999994 788887754 356899999999999999999999999999999999999997664 599999
Q ss_pred CCcccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH---------
Q 000726 1197 GLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV--------- 1266 (1329)
Q Consensus 1197 GLAr~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIv--------- 1266 (1329)
|++...... .......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+.
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 999854332 222334578899999998642 237889999999999999999999997654322111111
Q ss_pred --------------hcCC---C---CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1267 --------------NNTL---R---PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1267 --------------e~~l---r---~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.... . ......++..+.++|.+||+.+|.+|||+.+++++.+-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 0000 0 011234678899999999999999999999999996654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=306.65 Aligned_cols=259 Identities=25% Similarity=0.347 Sum_probs=201.8
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC--
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG-- 1117 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~-- 1117 (1329)
++|++.+.||+|+||.||++.+ ++..||||++...... ......+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV------PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc------ccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 6789999999999999999987 4788999998753211 12235567899999999999999999987643
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
....+++||||+. ++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~----~kl~dfg 152 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE----LRIGDFG 152 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc----EEecccc
Confidence 2347899999995 6888887543 45899999999999999999999999999999999999997764 5999999
Q ss_pred CcccccCcc-----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh-----
Q 000726 1198 LSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN----- 1267 (1329)
Q Consensus 1198 LAr~~~~~~-----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve----- 1267 (1329)
++....... ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||........+..+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~ 231 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence 987543211 11234688899999998642 3478899999999999999999999977654322211111
Q ss_pred ------------------c-CCCCCC-----CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1268 ------------------N-TLRPPV-----PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1268 ------------------~-~lr~~i-----ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
. ...... ....+..+.++|.+||+.+|.+||++.+++.+.|.....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0 001111 133578899999999999999999999999998886443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=300.88 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=194.6
Q ss_pred EEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEE
Q 000726 1046 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1329)
Q Consensus 1046 llkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LV 1125 (1329)
+.+.+|.|+++.||++..+++.||||+++.... .......+.+|+.+++.++|+||+++++++.... ..+++
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--~~~~~ 77 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--ELYVV 77 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEecccc------chhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--eEEEE
Confidence 344556666777777766789999999975421 1223456889999999999999999999998754 88999
Q ss_pred EEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 000726 1126 TEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204 (1329)
Q Consensus 1126 MEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~ 1204 (1329)
|||+++++|.+++... ...+++..+..++.|++.||+|||+++|+|+||||+|||++.++. +||+|||.+.....
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~----~kl~d~~~~~~~~~ 153 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK----VVLSGLRYSVSMIK 153 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc----eEEecCccceeecc
Confidence 9999999999988653 345889999999999999999999999999999999999997664 59999998863321
Q ss_pred cc--------cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC-----
Q 000726 1205 TL--------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR----- 1271 (1329)
Q Consensus 1205 ~~--------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr----- 1271 (1329)
.. ......++..|+|||++.+....++.++|||||||++|+|++|+.||..................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK 233 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence 11 11223467789999999754455788999999999999999999999876544332221111100
Q ss_pred ---------------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1272 ---------------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1272 ---------------------------~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.......+..+.+|+.+||+.||++|||+.+++++.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 0011123467889999999999999999999999988653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=327.83 Aligned_cols=262 Identities=31% Similarity=0.493 Sum_probs=219.4
Q ss_pred cccccccccCeeEEEEecccCcEEEEEEEECC-ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEec
Q 000726 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1329)
Q Consensus 1034 s~l~iI~~edYellkvLGqGaFGtVYKA~~kG-r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~G 1112 (1329)
..++.+.++.+.+.++||+|-||.|.+|+..+ ..||||.++... ......+|.+|+++|.+|+|||||+++|
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-------~~~~r~~F~kEIkiLsqLkhPNIveLvG 602 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-------TKNARNDFLKEIKILSRLKHPNIVELLG 602 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-------chhHHHHHHHHHHHHhccCCCCeeEEEe
Confidence 45677888999999999999999999999976 889999998542 3344678999999999999999999999
Q ss_pred ccccCCCCeEEEEEEeccCCchhhhhhcccccC-CHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL-DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1113 if~e~~dg~L~LVMEYm~GGSL~d~L~~kek~L-se~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
+|..++ .+++|+|||++|+|.+++...+.+. .......|+.||++||+||.+.+++||||.+.|+|++.++ ++
T Consensus 603 VC~~De--PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~----~i 676 (807)
T KOG1094|consen 603 VCVQDD--PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF----TI 676 (807)
T ss_pred eeecCC--chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc----cE
Confidence 998855 8999999999999999997765443 5667788999999999999999999999999999999654 56
Q ss_pred EEeecCCccc-ccC--cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh--CCCCCCCCChhHHHHHHH
Q 000726 1192 KVGDFGLSKI-KRN--TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT--GEEPYANMHYGAIIGGIV 1266 (1329)
Q Consensus 1192 KLsDFGLAr~-~~~--~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT--Gk~PF~~~~~~ell~qIv 1266 (1329)
||+|||+++. +.. ....+...-..+|||||.+. -+++++++|||+||++|||+++ ...||..++.++......
T Consensus 677 KiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsil--lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~ 754 (807)
T KOG1094|consen 677 KIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG 754 (807)
T ss_pred EecCcccccccccCCceeeecceeeeeeehhHHHHH--hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh
Confidence 9999999983 222 22223344568899999998 5679999999999999999876 788999988877665432
Q ss_pred h---cC---CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1267 N---NT---LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1267 e---~~---lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
. .. .-+..|..|+..+.++|.+||..|-.+||+|++|..+|+..
T Consensus 755 ~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 755 EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2 11 12345677999999999999999999999999999999865
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=294.19 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=198.6
Q ss_pred CeeEEEEecccCcEEEEEEEE-----CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEeccccc
Q 000726 1043 DLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~-----kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e 1116 (1329)
+|++.+.||+|++|.||++++ +++.||||+++..... ........+.+|+.++.++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH----hhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 478899999999999999876 3567999999753211 1223345678899999999 59999999999877
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.. ..++||||+.+++|..++... ..+++..+..++.|++.+|.|||+.+++|+||+|.||+++.++ .++|+||
T Consensus 77 ~~--~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~----~~~l~df 149 (288)
T cd05583 77 DT--KLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG----HVVLTDF 149 (288)
T ss_pred CC--EEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC----CEEEEEC
Confidence 54 889999999999999988543 4688999999999999999999999999999999999999765 4699999
Q ss_pred CCcccccCc--ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHhcCC
Q 000726 1197 GLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTL 1270 (1329)
Q Consensus 1197 GLAr~~~~~--~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~----~ell~qIve~~l 1270 (1329)
|++...... .......++..|+|||.+.+.....+.++||||||+++|+|++|..||..... ......+...
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 227 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-- 227 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--
Confidence 998753222 12223458899999999875443467899999999999999999999964321 2222222222
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1271 r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
..+.+..++..+.+++.+||+.+|++|||+.++.+.|..
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 234556678899999999999999999997666444443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=285.64 Aligned_cols=242 Identities=30% Similarity=0.418 Sum_probs=200.7
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEE
Q 000726 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1329)
Q Consensus 1050 LGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVME 1127 (1329)
||+|+||.||++.+. ++.+|+|+++..... .......+..|+.+++.++|+||+++++.+.... ..++|||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-----KRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE--KLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-----chHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC--eeEEEEe
Confidence 699999999999984 788999998765322 1223456788999999999999999999988754 8999999
Q ss_pred eccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCc-c
Q 000726 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT-L 1206 (1329)
Q Consensus 1128 Ym~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~-~ 1206 (1329)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 74 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~----~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 74 YAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH----IKLTDFGLAKELSSEGS 148 (250)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc----EEEeecCcceecccCCC
Confidence 99999999988544 36899999999999999999999999999999999999997664 599999998754332 2
Q ss_pred cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 000726 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLM 1286 (1329)
Q Consensus 1207 ~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLI 1286 (1329)
......++..|++||.+.+ ...+.++|+||||+++|+|++|..||...........+.. ....++...+..+.+++
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i 224 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLI 224 (250)
T ss_pred cccCCcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHH
Confidence 2334568889999999974 4468899999999999999999999987766555555544 34556677799999999
Q ss_pred HHhhcCCCCCCCCH---HHHHHHH
Q 000726 1287 EQCWAPDPVVRPSF---TEIARRL 1307 (1329)
Q Consensus 1287 krCLqkDPeERPTa---eELLq~L 1307 (1329)
.+||..||.+||++ .+++.+.
T Consensus 225 ~~~l~~~p~~R~~~~~~~~l~~~~ 248 (250)
T cd05123 225 SGLLQKDPTKRLGSGGAEEIKAHP 248 (250)
T ss_pred HHHhcCCHhhCCCcccHHHHHhCC
Confidence 99999999999999 7777654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=333.24 Aligned_cols=251 Identities=31% Similarity=0.482 Sum_probs=211.0
Q ss_pred EEecccCcEEEEEEEECCc--eEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEE
Q 000726 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~kGr--~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LV 1125 (1329)
-+||+|.||+||.|++..+ .+|||.+... +.+..+-+..|+.+-+.|+|.|||+++|.|.+ ++++-|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--------dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIF 650 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--------DSREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIF 650 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--------cchhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEE
Confidence 3799999999999998644 4788887532 22234456679999999999999999999876 5699999
Q ss_pred EEeccCCchhhhhhcccccC--CHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 000726 1126 TEFMVNGSLRHVLLSKERHL--DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1329)
Q Consensus 1126 MEYm~GGSL~d~L~~kek~L--se~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~ 1203 (1329)
||-++||+|..++..+=+++ .+..+-.+.+||++||.|||++.|+|||||-+||||+.- .+.+||+|||-++...
T Consensus 651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy---SGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY---SGVLKISDFGTSKRLA 727 (1226)
T ss_pred eecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec---cceEEecccccchhhc
Confidence 99999999999998776777 778888899999999999999999999999999999843 3468999999998543
Q ss_pred -CcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHhcCCCCCCCCCCcHH
Q 000726 1204 -NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRPPVPGFCDSE 1281 (1329)
Q Consensus 1204 -~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~e-ll~qIve~~lr~~ips~~S~e 1281 (1329)
-...+.++.||..|||||++......|+.++|||||||++.||.||++||-...... .+.++-.-...+++|..++.+
T Consensus 728 ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsae 807 (1226)
T KOG4279|consen 728 GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAE 807 (1226)
T ss_pred cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHH
Confidence 334455678999999999998778889999999999999999999999998765543 334444445678899999999
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1282 WRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1282 L~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.+.+|.+|+.++|.+||++.++|.......
T Consensus 808 ak~FilrcFepd~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 808 AKNFILRCFEPDPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred HHHHHHHHcCCCcccCccHHHhccCccccc
Confidence 999999999999999999999998765443
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=300.58 Aligned_cols=262 Identities=26% Similarity=0.332 Sum_probs=199.5
Q ss_pred cCee-EEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHH------HHHHHHHHHHHHHHhcCCCceeeEec
Q 000726 1042 EDLE-ELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQE------RLTLEFWREAEILSKLHHPNVVAFYG 1112 (1329)
Q Consensus 1042 edYe-llkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E------~~~keFlrEIeILk~LrHPNIVKL~G 1112 (1329)
++|. +.+.||.|+||+||+|.+. ++.||||+++............ .....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 4567999999999999874 7889999997643321110000 01235678999999999999999999
Q ss_pred ccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEE
Q 000726 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1113 if~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VK 1192 (1329)
++.... ..++||||+. ++|.+++.. ...+++.....++.||+.||.|||+.||+|+||+|+|||++.++ .++
T Consensus 88 ~~~~~~--~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~----~~k 159 (335)
T PTZ00024 88 VYVEGD--FINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG----ICK 159 (335)
T ss_pred EEecCC--cEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC----CEE
Confidence 998754 8999999995 688888753 34589999999999999999999999999999999999999766 469
Q ss_pred EeecCCcccccC---------------cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC
Q 000726 1193 VGDFGLSKIKRN---------------TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1257 (1329)
Q Consensus 1193 LsDFGLAr~~~~---------------~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~ 1257 (1329)
|+|||++..... ........++..|+|||.+.+. ..++.++|||||||++|+|++|..||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999875431 1111223467889999998753 346889999999999999999999998776
Q ss_pred hhHHHHHHHhcC---CCC-----------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1258 YGAIIGGIVNNT---LRP-----------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1258 ~~ell~qIve~~---lr~-----------------------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
....+..+.... ... .....++..+.+++.+||+.+|.+||++.+++.+.|...
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 554443332210 000 001234778999999999999999999999999888753
Q ss_pred H
Q 000726 1312 A 1312 (1329)
Q Consensus 1312 a 1312 (1329)
.
T Consensus 319 ~ 319 (335)
T PTZ00024 319 D 319 (335)
T ss_pred C
Confidence 3
|
|
| >cd06410 PB1_UP2 Uncharacterized protein 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=271.34 Aligned_cols=95 Identities=61% Similarity=1.053 Sum_probs=91.1
Q ss_pred EeecCCccccCCCCCCceeecCceEEEEecCCCChHHHHHHHHHHcCCce--EEEeeCCCCCCCceeeccChhHHHHHHH
Q 000726 189 LCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQTH--TIKYQLPGEDLDALVSVSCDEDLQNMME 266 (1329)
Q Consensus 189 mcSyGG~I~pr~~d~~l~YvGG~triv~V~r~~~f~~l~~kl~~~~~~~~--~lkYqLP~edLD~LisVt~DeDL~~m~~ 266 (1329)
||||||||+|||+||+|+|+||+|||++|+|++||+||+.||+++++... +||||||+||||+||||++||||+|||+
T Consensus 1 ~cs~GG~i~pr~~dg~l~Y~GG~tr~i~V~r~~s~~el~~kl~~~~~~~~~~~lky~Lp~edld~Lisv~~DeDl~~M~~ 80 (97)
T cd06410 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPDEDLDALISVSNDEDLKNMME 80 (97)
T ss_pred CcccCCEEeCcCCCCCEEEcCCceEEEEEcCCCCHHHHHHHHHHHhCCCCceEEEEEcCCCCcceeEEecCcHHHHHHHH
Confidence 89999999999999999999999999999999999999999999998655 9999999999999999999999999999
Q ss_pred HhhhhcccCCCCcEEEEe
Q 000726 267 ECNVLEDRGTQKPRMFLF 284 (1329)
Q Consensus 267 Eydr~~~~~~~~~R~flF 284 (1329)
||||+ +..+.|+|+|||
T Consensus 81 e~~~~-~~~~~rirvflf 97 (97)
T cd06410 81 EYDRL-SGGSARLRVFLF 97 (97)
T ss_pred hhccc-cCCCceEEEEEC
Confidence 99999 566779999998
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=300.20 Aligned_cols=256 Identities=24% Similarity=0.321 Sum_probs=201.4
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++.+.||+|+||.||++.+ .+..||||+++.... .......+.+|+.+|+.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 46799999999999999999987 478899999864321 1233456778999999999999999999887543
Q ss_pred C----CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1119 G----GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1119 d----g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
. ...++||||+ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~----~kl~ 160 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE----LKIL 160 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC----EEEe
Confidence 2 2468999999 7788887743 46899999999999999999999999999999999999997664 6999
Q ss_pred ecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC---
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 1271 (1329)
Q Consensus 1195 DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr--- 1271 (1329)
|||++...... .....+++.|+|||.+.+. ..++.++|+|||||++|+|++|..||...........+......
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 161 DFGLARQTDSE--MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ecccccccccC--ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99998754332 2234578899999998742 34788999999999999999999999866543333222211000
Q ss_pred --------------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1272 --------------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1272 --------------------------~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
......++..+.++|.+||+.||.+|||+.+++.+.+.-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 01123467789999999999999999999999988776544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=294.46 Aligned_cols=256 Identities=17% Similarity=0.184 Sum_probs=184.0
Q ss_pred cccccCeeEEEEecccCcEEEEEEEECCc-----eEEEEEEeccccCCCChHHHHH------HHHHHHHHHHHHhcCCCc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGT-----DVAIKRIKKSCFTGRSSEQERL------TLEFWREAEILSKLHHPN 1106 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~kGr-----~VAVKiLKks~~sd~s~e~E~~------~keFlrEIeILk~LrHPN 1106 (1329)
.+...+|++.+.||+|+||+||+|.+.+. .+|+|+..... .....+.. ......+...+..+.|+|
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~---~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN---ETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC---CchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 34557899999999999999999998543 46666543221 11111111 112334445566778999
Q ss_pred eeeEecccccCCC--CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccC
Q 000726 1107 VVAFYGVVQDGPG--GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 1184 (1329)
Q Consensus 1107 IVKL~Gif~e~~d--g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsd 1184 (1329)
|+++++++..... ...+++|+++ ..++...+.. ....++..+..|+.|++.||+|||+++|+||||||+|||++.+
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN 162 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 9999987654321 2446778876 3455555432 2346788889999999999999999999999999999999866
Q ss_pred CCCCCcEEEeecCCcccccCc--------ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCC
Q 000726 1185 DPIRPICKVGDFGLSKIKRNT--------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 1256 (1329)
Q Consensus 1185 Gni~~~VKLsDFGLAr~~~~~--------~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~ 1256 (1329)
+ .++|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||+||||++|..||...
T Consensus 163 ~----~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 163 N----RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred C----cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 5 4599999999753211 11223469999999999984 45789999999999999999999999876
Q ss_pred Ch-hHHH--------HHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1257 HY-GAII--------GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1257 ~~-~ell--------~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
.. .... ..+..... ....++..+.+++..||..+|.+||++.+|++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 237 GHNGNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccchHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 32 2211 11111111 1235688999999999999999999999998865
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=302.00 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=197.8
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
.+|++.+.||.|+||.||+|.++ +..||||.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--------chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 68999999999999999999884 77899999865421 123557789999999999999999987664321
Q ss_pred ------------CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCC
Q 000726 1120 ------------GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 1187 (1329)
Q Consensus 1120 ------------g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni 1187 (1329)
...++||||+. ++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-- 151 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-- 151 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC--
Confidence 25789999995 68887774 34588999999999999999999999999999999999998544
Q ss_pred CCcEEEeecCCcccccCccc----ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 000726 1188 RPICKVGDFGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 1263 (1329)
Q Consensus 1188 ~~~VKLsDFGLAr~~~~~~~----ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~ 1263 (1329)
..++|+|||++........ .....++..|+|||.+.+ ...++.++|||||||++|+|++|+.||..........
T Consensus 152 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 152 -LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred -ceEEECCcccceecCCccccccccccccccccccCHHHHhC-ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 3479999999875432211 122347888999998763 3457789999999999999999999997665443333
Q ss_pred HHHhcC-----------------------CCC-----CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1264 GIVNNT-----------------------LRP-----PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1264 qIve~~-----------------------lr~-----~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.+.... ... .....++.++.+++.+||+.||.+|||+.+++.+.|.-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 222110 000 011246788999999999999999999999998877753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=288.22 Aligned_cols=251 Identities=30% Similarity=0.382 Sum_probs=198.1
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCe
Q 000726 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~ 1121 (1329)
|+..+.||+|.+|.||+|+.. ++.||+|+++.... .+.....+..|+.+++.++|+||+++++++.... .
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE------EEGIPSTALREISLLKELKHPNIVKLLDVIHTER--K 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC--c
Confidence 566788999999999999984 78899999986431 1222355678999999999999999999998754 8
Q ss_pred EEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1122 L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
.++||||+. ++|.+++......+++..++.++.+++.||+|||++||+|+||+|+||+++.++ .++|+|||++..
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~----~~~l~d~g~~~~ 147 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG----VLKLADFGLARA 147 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC----CEEEecCCcccc
Confidence 999999996 689999876545799999999999999999999999999999999999999765 469999999875
Q ss_pred ccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC-----------
Q 000726 1202 KRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----------- 1269 (1329)
Q Consensus 1202 ~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~----------- 1269 (1329)
..... ......++..|+|||.+.+. ..++.++|||||||++|+|++|..||........+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 43322 22233467789999998742 357889999999999999999999998766544333222100
Q ss_pred -----CCC-----------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1270 -----LRP-----------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1270 -----lr~-----------~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
... ......+..+.+++.+||..+|.+||++.+++.+.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 000 000123678999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=327.97 Aligned_cols=253 Identities=29% Similarity=0.457 Sum_probs=213.2
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCe
Q 000726 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~ 1121 (1329)
|.-++.||.|+||.||-+++ +...||||.+.-. +. ........+++|+..|++++|||+|.+-|+|.... .
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsyS---GK--Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--T 100 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS---GK--QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--T 100 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeecccc---cc--ccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--h
Confidence 66677899999999999988 4667999987532 21 12334578899999999999999999999998754 7
Q ss_pred EEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1122 L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
.||||||| -|+-.+++.-..+++-+..+..|+.+.+.||+|||+.+.||||||+.|||+++.| .|||+|||.|.+
T Consensus 101 aWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g----~VKLaDFGSAsi 175 (948)
T KOG0577|consen 101 AWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG----LVKLADFGSASI 175 (948)
T ss_pred HHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC----eeeeccccchhh
Confidence 89999999 5777777766678899999999999999999999999999999999999999766 469999999987
Q ss_pred ccCcccccCCCCCCcccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcH
Q 000726 1202 KRNTLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 1280 (1329)
Q Consensus 1202 ~~~~~~ss~~~GTp~YmAPEvL~G-s~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~ 1280 (1329)
..+ .+.+.|||.|||||++.. ..+.|+-++||||||++..||...++|+.+++....+..|..+....-....++.
T Consensus 176 ~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~ 252 (948)
T KOG0577|consen 176 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD 252 (948)
T ss_pred cCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHH
Confidence 654 356789999999999863 2456888999999999999999999999999887777766655443333556899
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1281 EWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1281 eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.|+.|+..||++-|.+|||.++++.|....+
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 9999999999999999999999998876553
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=300.26 Aligned_cols=252 Identities=27% Similarity=0.358 Sum_probs=195.3
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
.+|...+.||+|+||.||+|.+ +++.||||+++..... +.....+.+|+.+++.++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS------EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc------ccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 5799999999999999999987 4788999998753211 1223457789999999999999999998865422
Q ss_pred ----CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1120 ----GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1120 ----g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
...++||||+. .+|..++ ...+++..+..++.|++.||+|||+++|+||||||+|||++.++. ++|+|
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~----~kL~d 160 (342)
T cd07879 89 GDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE----LKILD 160 (342)
T ss_pred CCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----EEEee
Confidence 24689999995 4666554 235889999999999999999999999999999999999997664 69999
Q ss_pred cCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC------
Q 000726 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT------ 1269 (1329)
Q Consensus 1196 FGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~------ 1269 (1329)
||++...... .....++..|+|||++.+ ...++.++|||||||++|||++|+.||........+..+....
T Consensus 161 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 161 FGLARHADAE--MTGYVVTRWYRAPEVILN-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred CCCCcCCCCC--CCCceeeecccChhhhcC-ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9998754322 223457889999999874 2346889999999999999999999998765443333222100
Q ss_pred -----------------C---CCC---CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1270 -----------------L---RPP---VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1270 -----------------l---r~~---ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
. +.. .....+..+.++|.+||+.||.+||++.+++.+.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~ 301 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchh
Confidence 0 000 0113567899999999999999999999999885543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=322.35 Aligned_cols=260 Identities=18% Similarity=0.276 Sum_probs=185.7
Q ss_pred ccCeeEEEEecccCcEEEEEEEECC---ceEEEEEEeccc---------cCCCChHHHHHHHHHHHHHHHHHhcCCCcee
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWRG---TDVAIKRIKKSC---------FTGRSSEQERLTLEFWREAEILSKLHHPNVV 1108 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~kG---r~VAVKiLKks~---------~sd~s~e~E~~~keFlrEIeILk~LrHPNIV 1108 (1329)
.++|++++.||+|+||+||+|.++. ..+++|.+.... ..............+.+|+.+|+.++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987642 222222111000 0000001122345678999999999999999
Q ss_pred eEecccccCCCCeEEEEEEeccCCchhhhhhccc----ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccC
Q 000726 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 1184 (1329)
Q Consensus 1109 KL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke----k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsd 1184 (1329)
++++++.... ..++||+++ .++|..++.... .......+..|+.||+.||.|||++||+||||||+|||++.+
T Consensus 227 ~l~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEA--NTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECC--eeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999998755 789999998 567777664322 223456677899999999999999999999999999999977
Q ss_pred CCCCCcEEEeecCCcccccCc--ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCC-CCCCC--hh
Q 000726 1185 DPIRPICKVGDFGLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP-YANMH--YG 1259 (1329)
Q Consensus 1185 Gni~~~VKLsDFGLAr~~~~~--~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~P-F~~~~--~~ 1259 (1329)
+. +||+|||++...... .......||..|+|||++.+ ..++.++|||||||+||||++|..+ |.... ..
T Consensus 304 ~~----vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 304 GK----IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CC----EEEEeCCCceecCcccccccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 64 599999999855332 12234569999999999984 4578899999999999999998754 43221 11
Q ss_pred HHHHHHHhcC--CCC-----------------------C-----CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1260 AIIGGIVNNT--LRP-----------------------P-----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1260 ell~qIve~~--lr~-----------------------~-----ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
..+..++... ... . ....++..+.++|.+||+.||.+|||+.|++.+.+.
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 1111111100 000 0 011245678888999999999999999999998774
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=300.28 Aligned_cols=257 Identities=24% Similarity=0.326 Sum_probs=202.2
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|++.+.||+|++|.||+|.+. +..||||++..... .......+.+|+.+++.+.||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ------SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc------hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 467999999999999999999984 67899998864321 1223355778999999999999999999876543
Q ss_pred C----CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1119 G----GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1119 d----g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
. ...++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++. ++|+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~----~kL~ 160 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE----LKIL 160 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC----EEEc
Confidence 1 2489999998 7799888853 46899999999999999999999999999999999999997664 6999
Q ss_pred ecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC---
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 1271 (1329)
Q Consensus 1195 DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr--- 1271 (1329)
|||++...... .....++..|+|||.+.+ ...++.++|||||||++|+|++|+.||...........+......
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhC-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 99998754332 223457889999999864 235688999999999999999999999776554433332221000
Q ss_pred -----------------------C---CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1272 -----------------------P---PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1272 -----------------------~---~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
. .....++..+.++|.+||+.+|.+|||+.+|+.+.|-....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0 01123578899999999999999999999999987765433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=309.00 Aligned_cols=256 Identities=30% Similarity=0.420 Sum_probs=218.2
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif 1114 (1329)
..+..++|..+++||+|.||+|-+++.+ ++.+|+|++++++...... ...-+.|-.+|+..+||.+..+--.|
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdE-----VAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDE-----VAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHH-----hhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 3567789999999999999999999874 7889999999987654322 23346788999999999999888778
Q ss_pred ccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
+..+ .+|+||||..||.|.-.|. +.+.+++.....+-.+|++||.|||+++||+||||.+|+|+|.+|++ ||+
T Consensus 238 Qt~d--rlCFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHI----Kit 310 (516)
T KOG0690|consen 238 QTQD--RLCFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHI----KIT 310 (516)
T ss_pred ccCc--eEEEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCce----Eee
Confidence 8755 9999999999999998885 45678999889999999999999999999999999999999998865 999
Q ss_pred ecCCcccc-cCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 000726 1195 DFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1195 DFGLAr~~-~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ 1273 (1329)
|||+++.. ........+||||.|+|||++. ...|+.++|+|.+||+||||++|+.||-+.+...++..|+...++
T Consensus 311 DFGLCKE~I~~g~t~kTFCGTPEYLAPEVle--DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~k-- 386 (516)
T KOG0690|consen 311 DFGLCKEEIKYGDTTKTFCGTPEYLAPEVLE--DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLK-- 386 (516)
T ss_pred ecccchhcccccceeccccCChhhcCchhhc--cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhcc--
Confidence 99999853 3344556899999999999998 566889999999999999999999999988887777777666543
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 1308 (1329)
Q Consensus 1274 ips~~S~eL~DLIkrCLqkDPeERP-----TaeELLq~Le 1308 (1329)
+|..++++.+.|+..+|.+||.+|. .+.||.++-.
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F 426 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF 426 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh
Confidence 5678899999999999999999994 5667666543
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=291.63 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=199.2
Q ss_pred EEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEE
Q 000726 1047 LKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~L 1124 (1329)
...||+|+||.||++.. ++..||||.+.... ......+.+|+.+++.++|+||+++++++.... ..++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 94 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWV 94 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--------hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC--EEEE
Confidence 35799999999999988 47889999875321 112345788999999999999999999998755 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~ 1204 (1329)
||||+++++|.+++.. ..+++..+..++.|++.+|+|||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~----~~l~dfg~~~~~~~ 168 (292)
T cd06657 95 VMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR----VKLSDFGFCAQVSK 168 (292)
T ss_pred EEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC----EEEcccccceeccc
Confidence 9999999999987743 35789999999999999999999999999999999999997653 69999999874432
Q ss_pred c-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC-CCCCCCCCCcHHH
Q 000726 1205 T-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPPVPGFCDSEW 1282 (1329)
Q Consensus 1205 ~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~-lr~~ips~~S~eL 1282 (1329)
. .......++..|+|||.+. ...++.++|+|||||++|+|++|..||...........+.... ........++..+
T Consensus 169 ~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (292)
T cd06657 169 EVPRRKSLVGTPYWMAPELIS--RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSL 246 (292)
T ss_pred ccccccccccCccccCHHHhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHH
Confidence 2 1223345889999999987 3456889999999999999999999998765544443332211 1111234568899
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1283 RLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1283 ~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
.+++.+||+.+|.+||++.+++.+-+.....
T Consensus 247 ~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 247 KGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 9999999999999999999999987765544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-31 Score=296.54 Aligned_cols=256 Identities=24% Similarity=0.305 Sum_probs=198.8
Q ss_pred cccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
..++|++.+.||+|+||.||++.+ +++.||||+++.... .......+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch------hhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 347899999999999999999986 478899999875311 122234577899999999999999999987543
Q ss_pred C----CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1118 P----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1118 ~----dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
. ....+++++++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++. ++|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~----~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE----LKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC----EEE
Confidence 2 13478888887 7888887743 35899999999999999999999999999999999999997764 699
Q ss_pred eecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC----
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT---- 1269 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~---- 1269 (1329)
+|||++...... .....++..|+|||.+.+ ...++.++|||||||++|+|++|+.||...........+....
T Consensus 162 ~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 162 LDFGLARHTDDE--MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred eccccccccccc--ccccccCCCccCHHHHhC-ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999998754322 223457889999999864 2456889999999999999999999997655433322221100
Q ss_pred --------------------CCC-----CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1270 --------------------LRP-----PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1270 --------------------lr~-----~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
..+ ......++.+.++|.+||+.||.+||++.+++.+.+-..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 000 001135778999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=287.34 Aligned_cols=242 Identities=22% Similarity=0.317 Sum_probs=187.5
Q ss_pred CeeEEEE--ecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccC
Q 000726 1043 DLEELKE--LGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1043 dYellkv--LGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~ 1117 (1329)
.|++.+. ||+|+||.||++.. .+..+|+|++....... .|+.....+ +||||+++++.+...
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444444 59999999999987 46789999987542210 012222222 699999999999875
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
. ..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++. .++|+|||
T Consensus 82 ~--~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~~~l~dfg 155 (267)
T PHA03390 82 K--GHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD---RIYLCDYG 155 (267)
T ss_pred C--eeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC---eEEEecCc
Confidence 5 899999999999999998654 37899999999999999999999999999999999999997662 46999999
Q ss_pred CcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH-HHHHh-cCCCCCCC
Q 000726 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII-GGIVN-NTLRPPVP 1275 (1329)
Q Consensus 1198 LAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell-~qIve-~~lr~~ip 1275 (1329)
++...... ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||......... ..+.. .......+
T Consensus 156 ~~~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T PHA03390 156 LCKIIGTP---SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI 230 (267)
T ss_pred cceecCCC---ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcc
Confidence 98754332 22458899999999984 45688999999999999999999999755433211 11111 12223344
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCC-HHHHHHHHH
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPS-FTEIARRLR 1308 (1329)
Q Consensus 1276 s~~S~eL~DLIkrCLqkDPeERPT-aeELLq~Le 1308 (1329)
..+++.+.++|.+||+.+|.+||+ +++++++.|
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~ 264 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence 568899999999999999999995 699998765
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=293.71 Aligned_cols=255 Identities=26% Similarity=0.317 Sum_probs=195.1
Q ss_pred CeeEEEEecccCcEEEEEEEEC----CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccC
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k----Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~ 1117 (1329)
+|++.+.||+|+||.||++.+. +..||||++..... .......+.+|+.+++++ .||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS------KKILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc------cchhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 4788999999999999999985 55799999864321 112235677899999999 599999999875432
Q ss_pred --CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1118 --PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1118 --~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
....++++|+|+ +++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 75 ~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~----~kl~D 148 (332)
T cd07857 75 PGNFNELYLYEELM-EADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE----LKICD 148 (332)
T ss_pred cccCCcEEEEEecc-cCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC----EEeCc
Confidence 123578899998 4788888753 456899999999999999999999999999999999999997764 69999
Q ss_pred cCCcccccCcc-----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc--
Q 000726 1196 FGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-- 1268 (1329)
Q Consensus 1196 FGLAr~~~~~~-----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~-- 1268 (1329)
||++....... ......|+..|+|||++.+ ...++.++|||||||++|+|++|..||........+..++..
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS-FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 99997533211 1223468899999998864 245788999999999999999999999765533322221110
Q ss_pred ------------------------CCCC---CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1269 ------------------------TLRP---PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1269 ------------------------~lr~---~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.... .....++..+.+++.+||+.+|.+|||+.+++.+.|..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 0000 01123578899999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-33 Score=325.72 Aligned_cols=253 Identities=31% Similarity=0.463 Sum_probs=208.9
Q ss_pred eEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeE
Q 000726 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1045 ellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L 1122 (1329)
++..+||+|+|-+||+|.+. |-.||--.++...+.. ......+|..|+++|+.|+|||||++|..|.+....++
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q----~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQ----SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhc----ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 34568999999999999884 6667655554433221 23345678999999999999999999999988777789
Q ss_pred EEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK--NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~--GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
-+|+|+|..|+|..|+.+ .+.++...+..|++||+.||.|||++ .|||||||.+||+|+.+ .+.|||+|+|+|+
T Consensus 119 n~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~---~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN---LGEVKIGDLGLAT 194 (632)
T ss_pred eeeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC---cCceeecchhHHH
Confidence 999999999999999964 45688999999999999999999988 59999999999999854 3578999999999
Q ss_pred cccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-CCCCCCCCc
Q 000726 1201 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPPVPGFCD 1279 (1329)
Q Consensus 1201 ~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l-r~~ips~~S 1279 (1329)
......... +.|||.|||||++. ..|.+.+||||||.+|+||+|+..||........+.+.+..+. ...+...-.
T Consensus 195 l~r~s~aks-vIGTPEFMAPEmYE---E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 195 LLRKSHAKS-VIGTPEFMAPEMYE---ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred Hhhccccce-eccCccccChHHHh---hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC
Confidence 877666554 78999999999997 3578999999999999999999999988776654444444444 333445558
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1280 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1280 ~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
+++++||.+||.. ..+|||+.|||.+....
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~ 300 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKDPFFD 300 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhChhhc
Confidence 9999999999999 99999999999876543
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=321.58 Aligned_cols=255 Identities=28% Similarity=0.456 Sum_probs=221.2
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
..-|.+.+.||+|.|++|.++++ +++.||||++.+... +......+.+|+++|+.|+|||||+++.+.....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l------n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL------NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc------ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 45688899999999999999998 589999999987543 2233344889999999999999999999998865
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
.+|+||||+.+|.+.+++...+. +.+..+..++.|+++|++|||+++|||||||++|||++.+-+ +||+|||+
T Consensus 129 --~lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn----ikIaDfgf 201 (596)
T KOG0586|consen 129 --TLYLVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN----IKIADFGF 201 (596)
T ss_pred --eeEEEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc----eeeecccc
Confidence 89999999999999999976665 455888889999999999999999999999999999996654 59999999
Q ss_pred cccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 000726 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1199 Ar~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~ 1278 (1329)
+..+.........||++.|.|||++.|.. ..++.+|+|+||++||-|+.|..||++....+.....+...++.+ -.+
T Consensus 202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp--~~m 278 (596)
T KOG0586|consen 202 STFFDYGLMLQTFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP--FYM 278 (596)
T ss_pred ceeecccccccccCCCCCccChHhhcCcc-cCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc--cee
Confidence 99888777888899999999999999865 457899999999999999999999998877776666666655544 456
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1279 S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
+.+..++|+++|.++|.+|++..++.++-|...
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 778999999999999999999999999888754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=294.80 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=207.8
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.|..++|++.+.||+|+|+.||+++. ++.-+|+|.+.-.. .+.....++|++..++++|||+++++++..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--------~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--------QEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--------hHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 67788999999999999999999886 57779999986431 122456789999999999999999999865
Q ss_pred cCC---CCeEEEEEEeccCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCCcceEeccCCCC
Q 000726 1116 DGP---GGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPI 1187 (1329)
Q Consensus 1116 e~~---dg~L~LVMEYm~GGSL~d~L~~---kek~Lse~qrlkIA~QIAsALaYLHs~G--IIHRDLKPeNILLDsdGni 1187 (1329)
.+. ....||++.|...|+|.+.+.. ++..+++.+++.|+.+|++||.+||... ++||||||.|||+.+.+
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-- 166 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-- 166 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC--
Confidence 332 2358999999999999988854 3457999999999999999999999998 99999999999999755
Q ss_pred CCcEEEeecCCcccccCc----------ccccCCCCCCcccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCC
Q 000726 1188 RPICKVGDFGLSKIKRNT----------LVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANM 1256 (1329)
Q Consensus 1188 ~~~VKLsDFGLAr~~~~~----------~~ss~~~GTp~YmAPEvL~G-s~~~~S~KSDVWSLGVLLyELLTGk~PF~~~ 1256 (1329)
.++|.|||.++...-. .......-|..|.|||.+.- .....++++|||||||+||.|+.|..||...
T Consensus 167 --~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 167 --LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred --ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 4599999998742111 11122346889999999963 2445789999999999999999999999653
Q ss_pred Ch--hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1257 HY--GAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1257 ~~--~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.. ..+...+....+..+....+++.+.++|+.||+.||.+||++.+++.++..+
T Consensus 245 ~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 245 YQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred hhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 21 1111122333344445556899999999999999999999999999998865
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=323.25 Aligned_cols=260 Identities=33% Similarity=0.507 Sum_probs=219.0
Q ss_pred cccccccCeeEEEEecccCcEEEEEEEEC---------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCC
Q 000726 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 1105 (1329)
Q Consensus 1036 l~iI~~edYellkvLGqGaFGtVYKA~~k---------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHP 1105 (1329)
.+.+..+.+.+.+.||+|+||.||+|... ...||||.++.... ....+.+..|+.+|+.+ .|+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~-------~~~~~~~~~El~~m~~~g~H~ 362 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS-------SSEKKDLMSELNVLKELGKHP 362 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC-------cHHHHHHHHHHHHHHHhcCCc
Confidence 56778888888889999999999998753 24599999986432 23356788999999998 699
Q ss_pred ceeeEecccccCCCCeEEEEEEeccCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCee
Q 000726 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIV 1170 (1329)
Q Consensus 1106 NIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~ke---------------k~Lse~qrlkIA~QIAsALaYLHs~GII 1170 (1329)
||+.++|+|.. .+.+++|+||+..|+|..+++... ..++..+.+.++.||+.||+||++..+|
T Consensus 363 niv~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v 440 (609)
T KOG0200|consen 363 NIVNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV 440 (609)
T ss_pred chhhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 99999999988 458999999999999999997665 3488999999999999999999999999
Q ss_pred ecCCCCcceEeccCCCCCCcEEEeecCCcccccCcccc--cCCC--CCCcccCccccccCCCCCChhhHHHHHHHHHHHH
Q 000726 1171 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT--GGVR--GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEI 1246 (1329)
Q Consensus 1171 HRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~s--s~~~--GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyEL 1246 (1329)
||||-+.|||+..+ ..+||+|||+|+........ ..-. -...|||||.+. ...|+.++||||||++||||
T Consensus 441 HRDLAaRNVLi~~~----~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~--~~~ft~kSDVWSfGI~L~Ei 514 (609)
T KOG0200|consen 441 HRDLAARNVLITKN----KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF--DRVFTSKSDVWSFGILLWEI 514 (609)
T ss_pred chhhhhhhEEecCC----CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc--cCcccccchhhHHHHHHHHH
Confidence 99999999999965 46899999999843322111 1112 234599999998 46789999999999999999
Q ss_pred Hh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1247 LT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1247 LT-Gk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
++ |..||.+......+...+..+.+++.|..|+.+++++|+.||+.+|++||+|.++.+.+...
T Consensus 515 fsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 515 FTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred hhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 99 99999987633333457888999999999999999999999999999999999999999984
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-31 Score=321.04 Aligned_cols=148 Identities=28% Similarity=0.471 Sum_probs=128.3
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
.++|.+.+.||+|+||+||+|.+. ++.||||+++..... .......+.+|+.+++.++||||++++.++....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-----NKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-----CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence 468999999999999999999986 788999999764321 2334466888999999999999999999887754
Q ss_pred CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCC
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGL 1198 (1329)
.+++||||+.+++|..++... ..+++..++.|+.||+.||.|||.++|+||||||+||||+.++ .+||+|||+
T Consensus 78 --~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g----~vkL~DFGl 150 (669)
T cd05610 78 --NVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG----HIKLTDFGL 150 (669)
T ss_pred --EEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC----CEEEEeCCC
Confidence 899999999999999988543 4688999999999999999999999999999999999998765 469999998
Q ss_pred cc
Q 000726 1199 SK 1200 (1329)
Q Consensus 1199 Ar 1200 (1329)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 75
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-31 Score=290.84 Aligned_cols=254 Identities=28% Similarity=0.365 Sum_probs=196.1
Q ss_pred cccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
..++|++.+.||.|+||.||++.+ +++.||||++.+..... .....+.+|+.+++.++||||++++++|...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP------VLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc------chhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 346799999999999999999987 47789999886543211 1234567899999999999999999988653
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
....++||||+ +++|..++.. ..+++..+..++.||+.||+|||+++|+|+||+|.|||++.++ .++|+|||
T Consensus 82 -~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~----~~~l~dfg 153 (328)
T cd07856 82 -LEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC----DLKICDFG 153 (328)
T ss_pred -CCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC----CEEeCccc
Confidence 23688999998 6788887743 4578888889999999999999999999999999999999765 46999999
Q ss_pred CcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh----------
Q 000726 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN---------- 1267 (1329)
Q Consensus 1198 LAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve---------- 1267 (1329)
++...... .....++..|+|||.+.+ ...++.++|||||||++|+|++|+.||...........+.+
T Consensus 154 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 154 LARIQDPQ--MTGYVSTRYYRAPEIMLT-WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cccccCCC--cCCCcccccccCceeeec-cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98754322 123457888999999863 24578899999999999999999999976543221111000
Q ss_pred --------------cCCCCCC-----CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1268 --------------NTLRPPV-----PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1268 --------------~~lr~~i-----ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
....... ...++..+.++|.+||+.+|++||++.+++.+.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~ 292 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence 0000011 123578899999999999999999999999887653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=307.47 Aligned_cols=246 Identities=27% Similarity=0.412 Sum_probs=211.3
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEECCce--EEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecc
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGV 1113 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~kGr~--VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gi 1113 (1329)
..+...+|.++.+||+|+||.|.++..+|+. +|||++++.+....+.... -+.|.++|+.. +-|.+++++.+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvec-----tm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVEC-----TMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccc-----eehhhhheecCCCCchHHHHHHH
Confidence 3677889999999999999999999998755 9999999887654332221 23466677765 57899999999
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
|++-+ .+|+||||+.||+|...+.+ -+.+.+..+..++.+|+-||-|||++|||+||||.+|||+|.+|++ ||
T Consensus 419 FQTmD--RLyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHi----Ki 491 (683)
T KOG0696|consen 419 FQTMD--RLYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHI----KI 491 (683)
T ss_pred hhhhh--heeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCce----Ee
Confidence 99865 99999999999999888854 4568888999999999999999999999999999999999988755 99
Q ss_pred eecCCcccc-cCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC
Q 000726 1194 GDFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1194 sDFGLAr~~-~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~ 1272 (1329)
+|||+++.. -...++.++|||+.|+|||++. .+.|+..+|+|||||+||||+.|++||++.+.+++.+.|.+...
T Consensus 492 ~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~--YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv-- 567 (683)
T KOG0696|consen 492 ADFGMCKENIFDGVTTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV-- 567 (683)
T ss_pred eecccccccccCCcceeeecCCCcccccceEE--ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--
Confidence 999999842 3344566799999999999998 66788999999999999999999999999999999999988765
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCC
Q 000726 1273 PVPGFCDSEWRLLMEQCWAPDPVVRP 1298 (1329)
Q Consensus 1273 ~ips~~S~eL~DLIkrCLqkDPeERP 1298 (1329)
..|..++.+..++.+..|.+.|.+|.
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCcccc
Confidence 45677899999999999999999995
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-33 Score=347.22 Aligned_cols=251 Identities=29% Similarity=0.444 Sum_probs=210.3
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCC
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg 1120 (1329)
+|+....||.|.||.||-|.. +|.-.|||.++..... ....+.+.+|..+|..|+|||+|++||+-.+.+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-- 1307 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-- 1307 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc------cccCcchHHHHHHHHhccCccccccCceeecHH--
Confidence 567778999999999999987 5778999998764322 334566778999999999999999999877655
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.++|.||||.+|+|.+.+. .++..++.....+..|++.|++|||+.|||||||||+|||++.+| .+|++|||.|.
T Consensus 1308 kv~IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g----~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG----LIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC----cEEeeccccee
Confidence 7899999999999999884 455567777778889999999999999999999999999999887 36999999998
Q ss_pred cccCcc-----cccCCCCCCcccCccccccCC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC
Q 000726 1201 IKRNTL-----VTGGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1201 ~~~~~~-----~ss~~~GTp~YmAPEvL~Gs~-~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~i 1274 (1329)
...+.. ......||+.|||||++.|.. .+-..+.|||||||++.||+||+.||...+..-.+---+..+-.+.+
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC
Confidence 544332 223567999999999998754 34466899999999999999999999988776655555666677888
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 000726 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306 (1329)
Q Consensus 1275 ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~ 1306 (1329)
|..++.+-.++|..||+.||.+|-++.||+++
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 98999999999999999999999888887765
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-33 Score=339.72 Aligned_cols=264 Identities=26% Similarity=0.329 Sum_probs=220.6
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.+..++|.++++||+|+||.|.+++++ ++.||+|++.+..+..+ ....-|+.|..+|...+.+.|+.++-.|+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr-----~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR-----AETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc-----hhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 456789999999999999999999985 56799999987433221 11245888999999999999999999999
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
+.. ++|+|||||+||+|..++...+ ++++..+..++..|+.||.-||+.|+|||||||+|||||..|+ +||+|
T Consensus 146 D~~--~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH----ikLAD 218 (1317)
T KOG0612|consen 146 DER--YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH----IKLAD 218 (1317)
T ss_pred Ccc--ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc----Eeecc
Confidence 865 9999999999999999997766 8999999999999999999999999999999999999998775 49999
Q ss_pred cCCccccc--CcccccCCCCCCcccCcccccc--CC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC
Q 000726 1196 FGLSKIKR--NTLVTGGVRGTLPWMAPELLNG--SS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1270 (1329)
Q Consensus 1196 FGLAr~~~--~~~~ss~~~GTp~YmAPEvL~G--s~-~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l 1270 (1329)
||.+-... .........|||.|++||++.. .. +.|+..+|+|||||++|||+.|..||-....-+.+..|+...-
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE 298 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh
Confidence 99886443 3334556779999999999962 23 5689999999999999999999999988777777777776644
Q ss_pred CCCCC--CCCcHHHHHHHHHhhcCCCCCCCC---HHHHHHHHHHHHHHh
Q 000726 1271 RPPVP--GFCDSEWRLLMEQCWAPDPVVRPS---FTEIARRLRVMSAAC 1314 (1329)
Q Consensus 1271 r~~ip--s~~S~eL~DLIkrCLqkDPeERPT---aeELLq~Le~L~aa~ 1314 (1329)
...+| ..++.++++||.+.+. +|+.|.. ++++..|++.....+
T Consensus 299 ~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 299 SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 44444 5589999999999886 5788876 999999987654433
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=297.20 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=206.6
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEeccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVV 1114 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif 1114 (1329)
.....+++.+..||.|+.|.||+++++ |.-.|||.+.... +....++++..+.++.+.. .|+||+++|+|
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-------Nkee~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-------NKEENKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-------CHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 344566777888999999999999985 5789999987532 2233467788888877664 89999999999
Q ss_pred ccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
.... .+++.||.| ...+..++..-..++++..+-++...++.||.||.. +||||||+||+|||+|..|++ ||
T Consensus 161 i~n~--dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gni----Kl 233 (391)
T KOG0983|consen 161 ITNT--DVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNI----KL 233 (391)
T ss_pred eeCc--hHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCE----Ee
Confidence 8855 678899998 445555565556779999999999999999999996 489999999999999998876 99
Q ss_pred eecCCcccccCcccccCCCCCCcccCccccccC-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcCCC
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNNTLR 1271 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs-~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~-ell~qIve~~lr 1271 (1329)
||||++.............|.+.|||||.+.-. ...|+.++||||||++|+||.||+.||.+...+ +.+..+++. ..
T Consensus 234 CDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~-eP 312 (391)
T KOG0983|consen 234 CDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE-EP 312 (391)
T ss_pred ecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-CC
Confidence 999999876655555556789999999999743 556899999999999999999999999986544 444444443 22
Q ss_pred CCCC--CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1272 PPVP--GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1272 ~~ip--s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
+-++ ...++.+.+|+..||++|+.+||.+.++++|..
T Consensus 313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 3233 347899999999999999999999999998754
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=309.49 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=209.4
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d 1119 (1329)
+-|.++.+||+|+||.||++.++ |..+|||.+... .-.+++.+|+.+++++..|++|++||.+....
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s- 101 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS- 101 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----------chHHHHHHHHHHHHHcCCchhhhhhhhhccCC-
Confidence 34667789999999999999884 888999988653 12467889999999999999999999877644
Q ss_pred CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.+|+|||||-.|++.+.+..+.+++++..+..+++..+.||.|||...-||||||+.|||++.+|. +||+|||.|
T Consensus 102 -DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~----AKLADFGVA 176 (502)
T KOG0574|consen 102 -DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI----AKLADFGVA 176 (502)
T ss_pred -ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch----hhhhhcccc
Confidence 799999999999999999989999999999999999999999999999999999999999997774 599999999
Q ss_pred ccccCc-ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-CCCCCCC
Q 000726 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPPVPGF 1277 (1329)
Q Consensus 1200 r~~~~~-~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~l-r~~ips~ 1277 (1329)
...... ...+.+.||+.|||||++.. -.|..++||||||++..||..|++||...+....+.-+-..+. ....|..
T Consensus 177 GQLTDTMAKRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 177 GQLTDTMAKRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEE 254 (502)
T ss_pred chhhhhHHhhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHh
Confidence 754332 23456789999999999984 4578899999999999999999999988776544332222111 1123556
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1278 ~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
++.++.+++++||.+.|++|-|+.++++|..
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence 7899999999999999999999999988864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=299.62 Aligned_cols=255 Identities=25% Similarity=0.318 Sum_probs=209.7
Q ss_pred cCeeEE-EEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccC
Q 000726 1042 EDLEEL-KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1042 edYell-kvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~ 1117 (1329)
++|++. ++||-|-.|.|..+.++ +..+|+|++... ....+|+++-... .|||||.++++|.+.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------------~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------------PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 344442 57999999999998874 788999998632 2345677766555 599999999998764
Q ss_pred CC--CeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1118 PG--GTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1118 ~d--g~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
-. .++.+|||.|+||.|...+..++ ..+++.++..|..||+.|+.|||+.+|.||||||+|+|+...+ .+..+||+
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~-~na~lKLt 206 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS-PNAPLKLT 206 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC-CCcceEec
Confidence 32 47889999999999999997664 5799999999999999999999999999999999999998776 34688999
Q ss_pred ecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHhcCC
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG----AIIGGIVNNTL 1270 (1329)
Q Consensus 1195 DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~----ell~qIve~~l 1270 (1329)
|||+|+.........+.|-|+.|.|||++. ...|+..+|+|||||++|-|++|.+||-..+.. .+...|....+
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg--~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhC--chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 999999766555556678899999999998 556888999999999999999999999665542 34455555555
Q ss_pred CCCCCC--CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1271 RPPVPG--FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1271 r~~ips--~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
..+-++ .+++..+++|+.+|..+|.+|.|+.+++.+.|....
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 544444 468999999999999999999999999999997654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=318.12 Aligned_cols=261 Identities=29% Similarity=0.400 Sum_probs=205.6
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC--
Q 000726 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP-- 1118 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~-- 1118 (1329)
-|..-+.||+|+||.||++++ +|+.||||.++.... .+......+|+++|++++|+|||+++++=.+..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-------~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-------LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG 86 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcc-------cchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence 456667899999999999997 489999999987532 122456789999999999999999999866544
Q ss_pred --CCeEEEEEEeccCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1119 --GGTLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1119 --dg~L~LVMEYm~GGSL~d~L~~ke--k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
...-.+|||||.+|+|...|...+ .-+++.+.+.++.+++.||.|||++|||||||||.||++-...+.....||+
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 345679999999999999996544 4599999999999999999999999999999999999997666566789999
Q ss_pred ecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-----HHHHHHHhc-
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-----AIIGGIVNN- 1268 (1329)
Q Consensus 1195 DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~-----ell~qIve~- 1268 (1329)
|||.|+..........+.||..|++||++.. ...|+..+|.|||||++|+++||..||...... ..+..+...
T Consensus 167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 167 DFGAARELDDNSLFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred cccccccCCCCCeeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence 9999998877777788899999999999984 356788899999999999999999999654333 222211111
Q ss_pred -----------------CCCCCCCCCCcHH----HHHHHHHhhcCCCCCCC--CHHHHHHHHHHHH
Q 000726 1269 -----------------TLRPPVPGFCDSE----WRLLMEQCWAPDPVVRP--SFTEIARRLRVMS 1311 (1329)
Q Consensus 1269 -----------------~lr~~ips~~S~e----L~DLIkrCLqkDPeERP--TaeELLq~Le~L~ 1311 (1329)
....+.+..++.. +..++..+|..+|.+|- .+.+....+..+.
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 1122333333333 44567788888999987 6666666555553
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=262.63 Aligned_cols=238 Identities=32% Similarity=0.448 Sum_probs=192.4
Q ss_pred CcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEEeccC
Q 000726 1054 TFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVN 1131 (1329)
Q Consensus 1054 aFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVMEYm~G 1131 (1329)
+||.||++.+. ++.+|+|++....... ....+.+|+..+++++|+||+++++++.... ..+++|||+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK-------KRERILREISILKKLKHPNIVRLYDVFEDED--KLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc-------HHHHHHHHHHHHHhCCCCcHHHHHhheeeCC--EEEEEEeCCCC
Confidence 58999999985 5889999987543211 0467889999999999999999999998754 89999999998
Q ss_pred CchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCcccccCC
Q 000726 1132 GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211 (1329)
Q Consensus 1132 GSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~ss~~ 1211 (1329)
++|..++..... +++..++.++.+++.+|.|||+.+++|+||+|.||+++.++ .++|+|||.+............
T Consensus 72 ~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 72 GDLFDLLKKRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG----HVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred CCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC----cEEEccccceeeeccccccccc
Confidence 899998855433 88999999999999999999999999999999999999775 4599999999866544334455
Q ss_pred CCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC--CcHHHHHHHHHh
Q 000726 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF--CDSEWRLLMEQC 1289 (1329)
Q Consensus 1212 ~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~--~S~eL~DLIkrC 1289 (1329)
.++..|++||.+. ...++.++|||+||+++|+|++|..||........................ ++..+.+++.+|
T Consensus 147 ~~~~~~~~pE~~~--~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 147 VGTPEYMAPEVLL--GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKL 224 (244)
T ss_pred cCCcCCCCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHH
Confidence 6888999999997 345678999999999999999999999873333333333333332222222 788999999999
Q ss_pred hcCCCCCCCCHHHHHHHH
Q 000726 1290 WAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1290 LqkDPeERPTaeELLq~L 1307 (1329)
|..+|.+||++.+++++.
T Consensus 225 l~~~p~~Rp~~~~~~~~~ 242 (244)
T smart00220 225 LVKDPEKRLTAEEALQHP 242 (244)
T ss_pred ccCCchhccCHHHHhhCC
Confidence 999999999999998753
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=275.52 Aligned_cols=225 Identities=21% Similarity=0.245 Sum_probs=178.7
Q ss_pred cCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEEecc
Q 000726 1053 GTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMV 1130 (1329)
Q Consensus 1053 GaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVMEYm~ 1130 (1329)
|.+|.||++.+ +++.||+|.++... .+.+|...+....||||+++++++.... ..++||||++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~ 68 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVSED--SVFLVLQHAE 68 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheecCC--eEEEEEecCC
Confidence 89999999998 47889999997531 1223444555667999999999998754 8999999999
Q ss_pred CCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCcccccC
Q 000726 1131 NGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGG 1210 (1329)
Q Consensus 1131 GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~ss~ 1210 (1329)
+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++. ++++|||.+....... ..
T Consensus 69 ~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~----~~l~df~~~~~~~~~~--~~ 141 (237)
T cd05576 69 GGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH----IQLTYFSRWSEVEDSC--DG 141 (237)
T ss_pred CCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC----EEEecccchhcccccc--cc
Confidence 99999988543 45899999999999999999999999999999999999997764 5999999876443321 23
Q ss_pred CCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 000726 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCW 1290 (1329)
Q Consensus 1211 ~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCL 1290 (1329)
..++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... ........++..++..+.++|.+||
T Consensus 142 ~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 142 EAVENMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred CCcCccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHc
Confidence 346778999999873 44678999999999999999999887543211 1111223456678899999999999
Q ss_pred cCCCCCCCCH-----HHHHHHH
Q 000726 1291 APDPVVRPSF-----TEIARRL 1307 (1329)
Q Consensus 1291 qkDPeERPTa-----eELLq~L 1307 (1329)
+.||.+||++ ++++.|.
T Consensus 214 ~~dp~~R~~~~~~~~~~~~~h~ 235 (237)
T cd05576 214 QFNPTERLGAGVAGVEDIKSHP 235 (237)
T ss_pred cCCHHHhcCCCccchHHHHcCC
Confidence 9999999986 6666553
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=310.65 Aligned_cols=249 Identities=30% Similarity=0.441 Sum_probs=209.2
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEE
Q 000726 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LV 1125 (1329)
++||.|-||+||-|.+ +|+.||||++.+..+..... ..+..|+.+|+.+.||.||.+...|++.+ .++.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe------sqlR~EVaILq~l~HPGiV~le~M~ET~e--rvFVV 641 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE------SQLRNEVAILQNLHHPGIVNLECMFETPE--RVFVV 641 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchH------HHHHHHHHHHHhcCCCCeeEEEEeecCCc--eEEEE
Confidence 6799999999999987 58999999999887764322 45678999999999999999999999876 89999
Q ss_pred EEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCc
Q 000726 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205 (1329)
Q Consensus 1126 MEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~ 1205 (1329)
||-+.|.-|...|......+++.....++.||+.||.|||-++|+|+||||+|||+.+..+. .++||||||+|+.+.+.
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~F-PQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPF-PQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCC-Cceeeccccceeecchh
Confidence 99996555555555556789999999999999999999999999999999999999987654 78999999999998888
Q ss_pred ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC--CCCCCCCcHHHH
Q 000726 1206 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--PPVPGFCDSEWR 1283 (1329)
Q Consensus 1206 ~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr--~~ips~~S~eL~ 1283 (1329)
.....+.||+.|+|||+++ ...|...-|+||.||++|--++|..||.... ++..+|-...+. +.....++....
T Consensus 721 sFRrsVVGTPAYLaPEVLr--nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLR--NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAI 796 (888)
T ss_pred hhhhhhcCCccccCHHHHh--hccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHH
Confidence 7778889999999999999 5667888999999999999999999997542 222333332222 223355789999
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1284 LLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1284 DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
+||..+|+..-.+|-+....+.|.|.
T Consensus 797 dlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhccchhh
Confidence 99999999999999999888877664
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=303.97 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=210.9
Q ss_pred cccccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecc
Q 000726 1036 LQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1329)
Q Consensus 1036 l~iI~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gi 1113 (1329)
.+.+....|+..++||+|+||.||-++. +|+-+|.|.+.+.....+ .-....+.|..+|.+++.+.||.+--.
T Consensus 179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr-----~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKR-----KGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred hhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHh-----hhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 3566778899999999999999998876 588899998865433211 122345789999999999999999777
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEE
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VK 1192 (1329)
|.+.+ .+||||..|.||+|.-++...+ ..+++..++.++.+|+.||.|||+++||+|||||+|||+|+.|++ .
T Consensus 254 feTkd--~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Ghv----R 327 (591)
T KOG0986|consen 254 FETKD--ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHV----R 327 (591)
T ss_pred ecCCC--ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCe----E
Confidence 77755 8999999999999999987665 458999999999999999999999999999999999999988865 9
Q ss_pred EeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHhc
Q 000726 1193 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG----AIIGGIVNN 1268 (1329)
Q Consensus 1193 LsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~----ell~qIve~ 1268 (1329)
|+|+|+|..+.......+..||.+|||||++.+ ..|+...|+|||||+||||+.|+.||...... ++-+.+...
T Consensus 328 ISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~ 405 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED 405 (591)
T ss_pred eeccceEEecCCCCccccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc
Confidence 999999998777666667789999999999994 44788899999999999999999999764332 222222222
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHH
Q 000726 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRL 1307 (1329)
Q Consensus 1269 ~lr~~ips~~S~eL~DLIkrCLqkDPeERP-----TaeELLq~L 1307 (1329)
....+...++++++|.+.+|++||.+|. .+.++.+|.
T Consensus 406 --~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 406 --PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred --hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence 2345577899999999999999999996 455666654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=324.84 Aligned_cols=250 Identities=31% Similarity=0.497 Sum_probs=188.6
Q ss_pred cCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc---
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD--- 1116 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e--- 1116 (1329)
.+|+.++.||+||||.||+++. +|+.||||.+.... .......+.+|+.+|++|+|||||++|..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-------SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 4677888999999999999988 59999999997532 34456778999999999999999998753221
Q ss_pred ----------------------------------------------------C---------------------------
Q 000726 1117 ----------------------------------------------------G--------------------------- 1117 (1329)
Q Consensus 1117 ----------------------------------------------------~--------------------------- 1117 (1329)
.
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence 0
Q ss_pred ---------------------------CC--------CeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHH
Q 000726 1118 ---------------------------PG--------GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162 (1329)
Q Consensus 1118 ---------------------------~d--------g~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALa 1162 (1329)
.+ ..+||-||||+..+|.+++......-.....|+++++|+.||+
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence 00 3578999999877777766433221157788999999999999
Q ss_pred HHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc-------------------CcccccCCCCCCcccCcccc
Q 000726 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-------------------NTLVTGGVRGTLPWMAPELL 1223 (1329)
Q Consensus 1163 YLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~-------------------~~~~ss~~~GTp~YmAPEvL 1223 (1329)
|+|++|||||||||.||+++++++ |||+|||+|+... +....++..||.-|+|||++
T Consensus 712 YIH~~giIHRDLKP~NIFLd~~~~----VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLDSRNS----VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHhCceeeccCCcceeEEcCCCC----eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999999999999999997765 5999999998510 11123456699999999999
Q ss_pred ccCCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHhhcCCCCCCCC
Q 000726 1224 NGSSS-KVSEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGIVNNTLRPP--VPGFCDSEWRLLMEQCWAPDPVVRPS 1299 (1329)
Q Consensus 1224 ~Gs~~-~~S~KSDVWSLGVLLyELLTGk~PF~~~~-~~ell~qIve~~lr~~--ips~~S~eL~DLIkrCLqkDPeERPT 1299 (1329)
.+... .|+.|+|+||||++|+||+. ||.... ....+..+....+..+ +....-+.-..+|.+|++.||.+|||
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC
Confidence 86432 68999999999999999984 565433 3344444443322222 01112244567999999999999999
Q ss_pred HHHHHH
Q 000726 1300 FTEIAR 1305 (1329)
Q Consensus 1300 aeELLq 1305 (1329)
+.|||.
T Consensus 865 A~eLL~ 870 (1351)
T KOG1035|consen 865 ATELLN 870 (1351)
T ss_pred HHHHhh
Confidence 999875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=314.12 Aligned_cols=264 Identities=33% Similarity=0.571 Sum_probs=223.3
Q ss_pred ccccccccCeeEEEEecccCcEEEEEEEE--CC----ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCcee
Q 000726 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKW--RG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 1108 (1329)
Q Consensus 1035 ~l~iI~~edYellkvLGqGaFGtVYKA~~--kG----r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIV 1108 (1329)
.+.+.+..+++..++||+|+||+||+|.| +| -+||||++..... .....+++.|+-+|.+|+||||+
T Consensus 689 ~lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-------~~~s~e~LdeAl~masldHpnl~ 761 (1177)
T KOG1025|consen 689 LLRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-------PKASIELLDEALRMASLDHPNLL 761 (1177)
T ss_pred heeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-------chhhHHHHHHHHHHhcCCCchHH
Confidence 44556666788889999999999999999 33 3599998865321 22346788999999999999999
Q ss_pred eEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCC
Q 000726 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188 (1329)
Q Consensus 1109 KL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~ 1188 (1329)
+++++|..+ .+.||++||+.|+|.++++.....+-....+.|..||++||.|||.++++||||-+.||||..-.
T Consensus 762 RLLgvc~~s---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~--- 835 (1177)
T KOG1025|consen 762 RLLGVCMLS---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN--- 835 (1177)
T ss_pred HHhhhcccc---hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC---
Confidence 999999875 48899999999999999988888899999999999999999999999999999999999998543
Q ss_pred CcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 000726 1189 PICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGG 1264 (1329)
Q Consensus 1189 ~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~q 1264 (1329)
++||.|||+++...... ...+..-.+.|||-|.+. ...+++++|||||||++||++| |..||.+....++- .
T Consensus 836 -hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~--~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-d 911 (1177)
T KOG1025|consen 836 -HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIR--IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-D 911 (1177)
T ss_pred -eEEEEecchhhccCcccccccccccccCcHHHHHHHhh--ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-H
Confidence 57999999999654332 222334567799999998 6789999999999999999999 99999998776654 4
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1265 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1265 Ive~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
+++.+.+++.|..++.++..+|.+||..|+..||+|+++...+..+....+
T Consensus 912 lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 912 LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 567777899999999999999999999999999999999988887755433
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=306.23 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=225.4
Q ss_pred ccccCeeEEEEecccCcEEEEEEEECCce--EEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~kGr~--VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
+..++++.+.-||-|+||.|=++..++.. +|+|++++....+. ....-+..|..+|..++.|.||++|-.|.+
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdt-----kQqeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDT-----KQQEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccch-----hHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 34455666677999999999999887655 89999987654432 222345679999999999999999999998
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.. ++|++||-|-||.|+..|..+ +.++......++..+++|++|||++|||+|||||+|++++.+| .+||.||
T Consensus 492 ~k--yvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G----y~KLVDF 564 (732)
T KOG0614|consen 492 SK--YVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG----YLKLVDF 564 (732)
T ss_pred ch--hhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC----ceEEeeh
Confidence 65 999999999999999999655 4688888888999999999999999999999999999999776 4599999
Q ss_pred CCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 000726 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1197 GLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips 1276 (1329)
|+|+.......+.++|||+.|.|||++. ...-+.++|.||||+++|||++|.+||.+.+.......|+..--...+|.
T Consensus 565 GFAKki~~g~KTwTFcGTpEYVAPEIIL--nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr 642 (732)
T KOG0614|consen 565 GFAKKIGSGRKTWTFCGTPEYVAPEIIL--NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR 642 (732)
T ss_pred hhHHHhccCCceeeecCCcccccchhhh--ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccc
Confidence 9999988888889999999999999998 45567899999999999999999999999999888888888777778888
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLRVMS 1311 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPT-----aeELLq~Le~L~ 1311 (1329)
.+.....+||+++...+|.+|.. +.+|.+|-|...
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 99999999999999999999964 789999988753
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=288.04 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=204.5
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccccCCCCeEEE
Q 000726 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+.||+|+++.|--+.. +|..+|||++.+.. -....++.+|++++..++ |+||++++.+|++.. ..||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYL 153 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--------GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYL 153 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEE
Confidence 4699999999987765 68999999997642 223467889999999995 999999999999865 8999
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~ 1204 (1329)
|||-|.||+|...+.+ .+.+++..+..++++|+.||.|||.+||.||||||+|||...-..+ .-+|||||.+..-...
T Consensus 154 VfEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~v-sPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKV-SPVKICDFDLGSGIKL 231 (463)
T ss_pred EEecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCc-Cceeeecccccccccc
Confidence 9999999999999864 4679999999999999999999999999999999999999765544 4579999999863211
Q ss_pred --------cccccCCCCCCcccCccccc---cCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh---------------
Q 000726 1205 --------TLVTGGVRGTLPWMAPELLN---GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--------------- 1258 (1329)
Q Consensus 1205 --------~~~ss~~~GTp~YmAPEvL~---Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~--------------- 1258 (1329)
.....+.+|+..|||||+.. +....|+.+.|.||||++||-||+|.+||.++-.
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 11123456888999999863 4456689999999999999999999999976422
Q ss_pred hHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1259 GAIIGGIVNNTLRPPVP--GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1259 ~ell~qIve~~lr~~ip--s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
..++..|-+..+..+-. ..++.+.++++..+|..++.+|.++.+++.++|.-+-
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 12344444444433322 3468999999999999999999999999998886543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=289.86 Aligned_cols=260 Identities=30% Similarity=0.530 Sum_probs=207.6
Q ss_pred cccccccCeeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHh--cCCCceeeEecc
Q 000726 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK--LHHPNVVAFYGV 1113 (1329)
Q Consensus 1036 l~iI~~edYellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~--LrHPNIVKL~Gi 1113 (1329)
++.....+.++.+.||+|.||.||+|.|+|..||||+|... + ...+.+|.++++. |+|+||+.+++.
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr--------d---E~SWfrEtEIYqTvmLRHENILgFIaa 273 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR--------D---ERSWFRETEIYQTVMLRHENILGFIAA 273 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccccCCceEEEEeccc--------c---hhhhhhHHHHHHHHHhccchhhhhhhc
Confidence 33445568899999999999999999999999999999632 1 2467788888875 599999999986
Q ss_pred cccC--CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC--------CeeecCCCCcceEecc
Q 000726 1114 VQDG--PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNL 1183 (1329)
Q Consensus 1114 f~e~--~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~--------GIIHRDLKPeNILLDs 1183 (1329)
-..+ .-.+++||++|-+.|||.++|.. ..++....++++..++.||+|||.. .|.|||||..||||..
T Consensus 274 D~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 274 DNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred cccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 5433 33579999999999999999954 5789999999999999999999952 4999999999999997
Q ss_pred CCCCCCcEEEeecCCcccccCc-----ccccCCCCCCcccCccccccCCC----CCChhhHHHHHHHHHHHHHhC-----
Q 000726 1184 KDPIRPICKVGDFGLSKIKRNT-----LVTGGVRGTLPWMAPELLNGSSS----KVSEKVDVFSFGIVLWEILTG----- 1249 (1329)
Q Consensus 1184 dGni~~~VKLsDFGLAr~~~~~-----~~ss~~~GTp~YmAPEvL~Gs~~----~~S~KSDVWSLGVLLyELLTG----- 1249 (1329)
+| .|.|+|+|+|...... ...+...||.+|||||++...-. .--..+||||||++|||++-.
T Consensus 352 n~----~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg 427 (513)
T KOG2052|consen 352 NG----TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG 427 (513)
T ss_pred CC----cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence 76 5699999999754432 23355679999999999964211 112479999999999999752
Q ss_pred -----CCCCCC-----CChhHHHHHHHhcCCCCCCCCCCc-----HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1250 -----EEPYAN-----MHYGAIIGGIVNNTLRPPVPGFCD-----SEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1250 -----k~PF~~-----~~~~ell~qIve~~lr~~ips~~S-----~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
+.||-. ...+++..-++.+.+++.+|..+. ..+.++|+.||..+|..|.|+--+.+.|..+..
T Consensus 428 i~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 428 IVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred EehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 456643 344566666777888888876542 345678999999999999999999999888763
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=304.07 Aligned_cols=242 Identities=28% Similarity=0.355 Sum_probs=196.6
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~ 1117 (1329)
.++|.+...+|.|+|+.|-.+.+ ++...+||++.+... .-.+|+.++... +||||+++++.+.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------------~~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------------DNQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------------ccccccchhhhhcCCCcceeecceecCC
Confidence 56788888899999999999888 467799999976511 112345455444 799999999999886
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec-cCCCCCCcEEEeec
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN-LKDPIRPICKVGDF 1196 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLD-sdGni~~~VKLsDF 1196 (1329)
. ..|+|||++.++-|.+.+..... +. ..+..|+.+|+.|+.|||.+||+||||||+|||++ +.| +++|+||
T Consensus 389 ~--~~~~v~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g----~lrltyF 460 (612)
T KOG0603|consen 389 K--EIYLVMELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG----HLRLTYF 460 (612)
T ss_pred c--eeeeeehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC----cEEEEEe
Confidence 5 89999999999988887754432 22 67778999999999999999999999999999995 444 4699999
Q ss_pred CCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 000726 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 1276 (1329)
Q Consensus 1197 GLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips 1276 (1329)
|.++..... ....+-|..|.|||++. ...+++++||||||++||+|++|+.||........+...+ ...++..
T Consensus 461 G~a~~~~~~--~~tp~~t~~y~APEvl~--~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---~~~~~s~ 533 (612)
T KOG0603|consen 461 GFWSELERS--CDTPALTLQYVAPEVLA--IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---QMPKFSE 533 (612)
T ss_pred chhhhCchh--hcccchhhcccChhhhc--cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh---cCCcccc
Confidence 999876655 33346788999999998 5678999999999999999999999997765552222222 2333447
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1277 ~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
.++..+++|+.+||+.||.+||++.+++.+.|.
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 889999999999999999999999999999998
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=283.72 Aligned_cols=265 Identities=26% Similarity=0.350 Sum_probs=206.6
Q ss_pred cCeeEEEEecccCcEEEEEEEEC------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
..|+.+..||+|+||.||+|..+ ...+|||.|+.+....+ .....+||+.+++.++||||+.+..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG------iS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG------ISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC------cCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 46888999999999999999653 23699999987643222 2245679999999999999999999998
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhc----ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcE
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~----kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
.. +..+++++||. ..+|+..++- +.+.++...+..|+.||+.|+.|||++=|+||||||.||||..+|...+.|
T Consensus 98 ~~-d~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 98 SH-DKKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred cc-CceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCee
Confidence 75 56899999998 5788888742 235688999999999999999999999999999999999999998888999
Q ss_pred EEeecCCcccccCcc----cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh---------
Q 000726 1192 KVGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--------- 1258 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~~----~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~--------- 1258 (1329)
||+|||+++.+.+.. ....+.-|.+|.|||.+.| ...|+.++||||.|||+.||++-++.|.+...
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG-a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG-ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcc-cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 999999999765432 2345567999999999998 46799999999999999999999888754211
Q ss_pred hHHHHHHHh---cC------------------------CCCCC--------CCCCcHHHHHHHHHhhcCCCCCCCCHHHH
Q 000726 1259 GAIIGGIVN---NT------------------------LRPPV--------PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303 (1329)
Q Consensus 1259 ~ell~qIve---~~------------------------lr~~i--------ps~~S~eL~DLIkrCLqkDPeERPTaeEL 1303 (1329)
.+.+..|++ .+ +...+ ...-++...+|+.+||..||.+|.|+++.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 111111111 00 00000 01124457889999999999999999999
Q ss_pred HHHHHHHHHHhc
Q 000726 1304 ARRLRVMSAACQ 1315 (1329)
Q Consensus 1304 Lq~Le~L~aa~q 1315 (1329)
+++.-.......
T Consensus 335 leh~yF~~d~lp 346 (438)
T KOG0666|consen 335 LEHPYFTEDPLP 346 (438)
T ss_pred hcccccccCCCC
Confidence 988766555444
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=306.37 Aligned_cols=255 Identities=29% Similarity=0.418 Sum_probs=210.9
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEeccccc-
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD- 1116 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e- 1116 (1329)
.+.|++.++||.|.+|.||+++. +++.+|||++...... ..++..|.++|+.+ .|||++.+|++|..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---------deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---------EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---------cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 35688999999999999999876 5888999998653211 13455688899887 69999999998863
Q ss_pred --CCCCeEEEEEEeccCCchhhhhhc-ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1117 --GPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1117 --~~dg~L~LVMEYm~GGSL~d~L~~-kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
..++.+|||||||.+||..+++.. .+..+.|..+..|++.++.||.|||.+.+||||||-.|||++.++. |||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~----VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE----VKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc----EEE
Confidence 234689999999999999999854 3567999999999999999999999999999999999999998875 499
Q ss_pred eecCCccccc-CcccccCCCCCCcccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 000726 1194 GDFGLSKIKR-NTLVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1269 (1329)
Q Consensus 1194 sDFGLAr~~~-~~~~ss~~~GTp~YmAPEvL~Gs---~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~ 1269 (1329)
+|||++.... .....++..||+.|||||++... ...|+.++|+||||++..||.-|.+|+..++....+..+-.++
T Consensus 165 vDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP 244 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 244 (953)
T ss_pred eeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC
Confidence 9999987543 33445677899999999999532 3457789999999999999999999999999877766654433
Q ss_pred C-CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1270 L-RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1270 l-r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
. ...-+..++..+.++|..||.+|-++||+..++++|..
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 2 22235678899999999999999999999999988753
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-31 Score=285.26 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=201.8
Q ss_pred cccccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEec
Q 000726 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYG 1112 (1329)
Q Consensus 1036 l~iI~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~G 1112 (1329)
+.....++++.+..||.|+||+|++-.++ |+..|||.++... .+...++++.|.++..+- +.||||++||
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-------~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-------IEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-------chHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 33444556666778999999999998885 7889999997532 244456788888876654 6999999999
Q ss_pred ccccCCCCeEEEEEEeccCCchhhhh---hc-ccccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEeccCCCC
Q 000726 1113 VVQDGPGGTLATVTEFMVNGSLRHVL---LS-KERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPI 1187 (1329)
Q Consensus 1113 if~e~~dg~L~LVMEYm~GGSL~d~L---~~-kek~Lse~qrlkIA~QIAsALaYLHs~-GIIHRDLKPeNILLDsdGni 1187 (1329)
.+.. ++..|+.||+| ..+|..+. +. +...+++..+-.|..-.+.||.||... .|||||+||+|||++..|.+
T Consensus 131 a~F~--EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFS--EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhc--CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCE
Confidence 8765 45789999999 46665433 11 235688888888888899999999965 79999999999999988865
Q ss_pred CCcEEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHH
Q 000726 1188 RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIV 1266 (1329)
Q Consensus 1188 ~~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~-ell~qIv 1266 (1329)
||||||++.........+...|...|||||.+......|+.++||||||++|||+.||+.||.....- +.+..++
T Consensus 208 ----KLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv 283 (361)
T KOG1006|consen 208 ----KLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV 283 (361)
T ss_pred ----eeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH
Confidence 99999999876665555556788999999999876667999999999999999999999999765432 2222333
Q ss_pred hcC-CCCCCCC---CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1267 NNT-LRPPVPG---FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1267 e~~-lr~~ips---~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
... .....+. .++..+..+|.-||.+|...||.+.+++++..-
T Consensus 284 ~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fy 330 (361)
T KOG1006|consen 284 IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFY 330 (361)
T ss_pred cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchh
Confidence 322 2222222 368899999999999999999999999887543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=292.15 Aligned_cols=267 Identities=26% Similarity=0.357 Sum_probs=211.2
Q ss_pred cccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccC
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~ 1117 (1329)
..++|-++..||+|+|+.||++-+ ..+.||||+-....... ....+...+-.++|..|-+.|.||.||++|++|.-.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wr-dEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWR-DEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchh-hHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 356788889999999999999977 46779999876543221 223345567788999999999999999999999765
Q ss_pred CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK--NIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~--GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
. ..+|.|+|||+|.+|..+|. ..+.+++..+..|+.||+.||.||... .|||-||||.|||+-. |.....+||.|
T Consensus 540 t-dsFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~-GtacGeIKITD 616 (775)
T KOG1151|consen 540 T-DSFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVN-GTACGEIKITD 616 (775)
T ss_pred c-ccceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEec-CcccceeEeee
Confidence 4 36889999999999998885 446789999999999999999999976 5999999999999963 44557789999
Q ss_pred cCCcccccCc--------ccccCCCCCCcccCcccccc--CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHH-
Q 000726 1196 FGLSKIKRNT--------LVTGGVRGTLPWMAPELLNG--SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG- 1264 (1329)
Q Consensus 1196 FGLAr~~~~~--------~~ss~~~GTp~YmAPEvL~G--s~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~q- 1264 (1329)
||+++..... ..+....||.+|++||.+.- ....++.|+||||+|||+|.++.|+.||........+.+
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 9999865432 23345679999999999853 256689999999999999999999999987654332221
Q ss_pred --HHh-cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1265 --IVN-NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1265 --Ive-~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
|++ .....+....++.+.++||++||+..-++|....+|..+.-.+
T Consensus 697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 111 1223334456789999999999999999999999987665443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=285.68 Aligned_cols=258 Identities=29% Similarity=0.422 Sum_probs=204.9
Q ss_pred ccCeeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHh--cCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK--LHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~--LrHPNIVKL~Gif~e~~ 1118 (1329)
...+++.++||+|.||.||+|+++++.||||+|.. .....|..|.++++. +.|+||+++++.-...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-----------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-----------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCH-----------HHHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 44567778999999999999999999999999963 224567888888775 58999999998755433
Q ss_pred --CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---------CeeecCCCCcceEeccCCCC
Q 000726 1119 --GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK---------NIVHFDLKCDNLLVNLKDPI 1187 (1329)
Q Consensus 1119 --dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~---------GIIHRDLKPeNILLDsdGni 1187 (1329)
...++||++|.+.|+|.++|.. ..++|....+|+..|++||+|||.. .|+|||||..||||..|+
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-- 353 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-- 353 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC--
Confidence 3468999999999999999954 4689999999999999999999963 599999999999999665
Q ss_pred CCcEEEeecCCcccccCcc---cccCCCCCCcccCccccccCC----CCCChhhHHHHHHHHHHHHHhCCCCCC------
Q 000726 1188 RPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS----SKVSEKVDVFSFGIVLWEILTGEEPYA------ 1254 (1329)
Q Consensus 1188 ~~~VKLsDFGLAr~~~~~~---~ss~~~GTp~YmAPEvL~Gs~----~~~S~KSDVWSLGVLLyELLTGk~PF~------ 1254 (1329)
++.|+|||+|....... ...+..||.+|||||++.|.- ...-.+.||||+|.+||||++.+.-+.
T Consensus 354 --TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~ 431 (534)
T KOG3653|consen 354 --TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE 431 (534)
T ss_pred --cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc
Confidence 57999999998654322 223456999999999997631 223357999999999999998654331
Q ss_pred -----------CCChhHHHHHHHhcCCCCCCCCCC-----cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1255 -----------NMHYGAIIGGIVNNTLRPPVPGFC-----DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1255 -----------~~~~~ell~qIve~~lr~~ips~~-----S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
....+++...++....|+.++..+ ...+.+.+..||..|++.|.|+.=+.+.++.+.....
T Consensus 432 Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 432 YQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred ccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 122345566677777777776542 4668899999999999999999999998888876553
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=275.97 Aligned_cols=255 Identities=22% Similarity=0.374 Sum_probs=206.8
Q ss_pred ccccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecc
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGV 1113 (1329)
Q Consensus 1037 ~iI~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gi 1113 (1329)
+.+...+|.++++||+|+|.+|.++++. .+-+|+|++|++.+.+.... .-...|..+..+. +||.+|-++.+
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedi-----dwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDI-----DWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccc-----hhHHhhHHHHHhccCCCeEEehhhh
Confidence 3456678999999999999999999885 45699999999887654322 2234566677665 79999999999
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
|++.. .+++|.||++||+|.-.+. +.+.++++++..+..+|+.||.|||++|||+||||.+|||+|..|++ ||
T Consensus 320 fqtes--rlffvieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghi----kl 392 (593)
T KOG0695|consen 320 FQTES--RLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHI----KL 392 (593)
T ss_pred hcccc--eEEEEEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCce----ee
Confidence 99866 9999999999999988775 44569999999999999999999999999999999999999988755 99
Q ss_pred eecCCccc-ccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCC--------CChhHHHHH
Q 000726 1194 GDFGLSKI-KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN--------MHYGAIIGG 1264 (1329)
Q Consensus 1194 sDFGLAr~-~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~--------~~~~ell~q 1264 (1329)
.|+|+++. ......++++|||+.|+|||+++|.. |+..+|+|+||++|+||+.|+.||+- .+.+.+++-
T Consensus 393 tdygmcke~l~~gd~tstfcgtpnyiapeilrgee--ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv 470 (593)
T KOG0695|consen 393 TDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV 470 (593)
T ss_pred cccchhhcCCCCCcccccccCCCcccchhhhcccc--cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence 99999984 44555677899999999999999755 56679999999999999999999952 123345555
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCC------CHHHHHHHH
Q 000726 1265 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRP------SFTEIARRL 1307 (1329)
Q Consensus 1265 Ive~~lr~~ips~~S~eL~DLIkrCLqkDPeERP------TaeELLq~L 1307 (1329)
+++...+. |..++-....+++..|.+||.+|. .+.++..|.
T Consensus 471 ilekqiri--prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ 517 (593)
T KOG0695|consen 471 ILEKQIRI--PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHA 517 (593)
T ss_pred Hhhhcccc--cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcch
Confidence 66665554 445666777899999999999984 456665443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=294.02 Aligned_cols=256 Identities=18% Similarity=0.169 Sum_probs=169.8
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
....++|++.+.||+|+||.||+|++. +..||||.++... ..+. +..| .+....+.+++.++
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~----~~~e--~l~~~~~~~~~~~~ 195 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEI----WMNE--RVRRACPNSCADFV 195 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHH----HHHH--HHHhhchhhHHHHH
Confidence 345678999999999999999999984 5679999875321 1111 1111 11222223333222
Q ss_pred cccc----cCCCCeEEEEEEeccCCchhhhhhccccc-------------------CCHHHHHHHHHHHHHHHHHHHHCC
Q 000726 1112 GVVQ----DGPGGTLATVTEFMVNGSLRHVLLSKERH-------------------LDRRKRLIIAMDAAFGMEYLHSKN 1168 (1329)
Q Consensus 1112 Gif~----e~~dg~L~LVMEYm~GGSL~d~L~~kek~-------------------Lse~qrlkIA~QIAsALaYLHs~G 1168 (1329)
..+. ......+++||||+.+++|.+++...... .....+..|+.||+.||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g 275 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG 275 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence 2211 12234789999999999999888543211 123345679999999999999999
Q ss_pred eeecCCCCcceEeccCCCCCCcEEEeecCCcccccC--cccccCCCCCCcccCccccccCCC------------------
Q 000726 1169 IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN--TLVTGGVRGTLPWMAPELLNGSSS------------------ 1228 (1329)
Q Consensus 1169 IIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~--~~~ss~~~GTp~YmAPEvL~Gs~~------------------ 1228 (1329)
|+||||||+|||++.+. ..+||+|||+++.... ........+++.|+|||.+.....
T Consensus 276 IiHRDLKP~NILl~~~~---~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~ 352 (566)
T PLN03225 276 IVHRDVKPQNIIFSEGS---GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 352 (566)
T ss_pred EEeCcCCHHHEEEeCCC---CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhc
Confidence 99999999999998532 2479999999975322 222344678999999997642221
Q ss_pred --CCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh--------------cCCCCC------CCCCCcHHHHHHH
Q 000726 1229 --KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN--------------NTLRPP------VPGFCDSEWRLLM 1286 (1329)
Q Consensus 1229 --~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve--------------~~lr~~------ips~~S~eL~DLI 1286 (1329)
.+..++|||||||+||||+++..++.... ..+...+. ...... +.........+||
T Consensus 353 ~~~~~~k~DVwSlGviL~el~~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi 430 (566)
T PLN03225 353 QLNLPDRFDIYSAGLIFLQMAFPNLRSDSNL--IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELL 430 (566)
T ss_pred cccCCCCcccHHHHHHHHHHHhCcCCCchHH--HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHH
Confidence 23456799999999999999776654321 11111111 000000 0011233456899
Q ss_pred HHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1287 EQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1287 krCLqkDPeERPTaeELLq~Le~L 1310 (1329)
.+||+.||.+|||+.++++|.+..
T Consensus 431 ~~mL~~dP~kR~ta~e~L~Hpff~ 454 (566)
T PLN03225 431 KSMMRFKGRQRISAKAALAHPYFD 454 (566)
T ss_pred HHHccCCcccCCCHHHHhCCcCcC
Confidence 999999999999999999998764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=287.08 Aligned_cols=263 Identities=19% Similarity=0.164 Sum_probs=185.8
Q ss_pred ccccCeeEEEEecccCcEEEEEEEE------------------CCceEEEEEEeccccCCCChHHHH----------HHH
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKW------------------RGTDVAIKRIKKSCFTGRSSEQER----------LTL 1090 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~------------------kGr~VAVKiLKks~~sd~s~e~E~----------~~k 1090 (1329)
...++|++.++||+|+||+||+|.+ .++.||||.++.... ...+. ...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~----~~~~~fl~e~~~~~~~~e 217 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ----GVRQDFLKTGTLAKGSAE 217 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch----hhHHHHHhhhhhhhcccc
Confidence 4678999999999999999999864 245799999864211 01111 112
Q ss_pred HHHHHHHHHHhcCCCce-----eeEecccccC------CCCeEEEEEEeccCCchhhhhhccc-----------------
Q 000726 1091 EFWREAEILSKLHHPNV-----VAFYGVVQDG------PGGTLATVTEFMVNGSLRHVLLSKE----------------- 1142 (1329)
Q Consensus 1091 eFlrEIeILk~LrHPNI-----VKL~Gif~e~------~dg~L~LVMEYm~GGSL~d~L~~ke----------------- 1142 (1329)
.+..|+.++.+++|.++ ++++++|... ..+..+|||||+++++|.+++....
T Consensus 218 ~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l 297 (507)
T PLN03224 218 TGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKI 297 (507)
T ss_pred hhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCch
Confidence 34457777888876654 6777776532 1246899999999999998885321
Q ss_pred ------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCcccccC--CCCC
Q 000726 1143 ------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGG--VRGT 1214 (1329)
Q Consensus 1143 ------k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~ss~--~~GT 1214 (1329)
..+++..++.++.|++.+|.|||+++|+||||||+|||++.++ .+||+|||++........... ..+|
T Consensus 298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~g~~t 373 (507)
T PLN03224 298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG----QVKIIDFGAAVDMCTGINFNPLYGMLD 373 (507)
T ss_pred hhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC----cEEEEeCcCccccccCCccCccccCCC
Confidence 1245677889999999999999999999999999999999765 469999999975432222122 2247
Q ss_pred CcccCccccccCC--------------------CCCChhhHHHHHHHHHHHHHhCCC-CCCCCChhH-----------HH
Q 000726 1215 LPWMAPELLNGSS--------------------SKVSEKVDVFSFGIVLWEILTGEE-PYANMHYGA-----------II 1262 (1329)
Q Consensus 1215 p~YmAPEvL~Gs~--------------------~~~S~KSDVWSLGVLLyELLTGk~-PF~~~~~~e-----------ll 1262 (1329)
+.|+|||.+.... +....+.||||+||+||+|+++.. ||....... .+
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~ 453 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW 453 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH
Confidence 8999999985321 111235799999999999999875 665321110 11
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCC---CCCCCHHHHHHHHHH
Q 000726 1263 GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDP---VVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1263 ~qIve~~lr~~ips~~S~eL~DLIkrCLqkDP---eERPTaeELLq~Le~ 1309 (1329)
..+....+..+.....++...+|+.+||..+| .+|+|+.|+++|.|.
T Consensus 454 r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 454 RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 11112223333344568899999999999866 689999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=231.84 Aligned_cols=211 Identities=43% Similarity=0.653 Sum_probs=178.3
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEE
Q 000726 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1329)
Q Consensus 1050 LGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVME 1127 (1329)
||+|.+|.||++... ++.++||++....... ....+.+|+.+++.+.|++|+++++++... ...+++||
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEe
Confidence 689999999999996 8889999997542211 345688999999999999999999999875 38999999
Q ss_pred eccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecc-CCCCCCcEEEeecCCcccccCcc
Q 000726 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL-KDPIRPICKVGDFGLSKIKRNTL 1206 (1329)
Q Consensus 1128 Ym~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDs-dGni~~~VKLsDFGLAr~~~~~~ 1206 (1329)
|+.+++|..++......+++..++.++.+++++|.+||+.|++|+||+|.||+++. ++ .++|+|||.+.......
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~----~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG----KVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC----cEEEecCCceEEccCCc
Confidence 99889999998654346899999999999999999999999999999999999997 44 46999999998554332
Q ss_pred -cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 000726 1207 -VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLL 1285 (1329)
Q Consensus 1207 -~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DL 1285 (1329)
......+...|++||.+... ...+.+.|+|+||+++++| ..+.++
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~ 193 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL---------------------------------PELKDL 193 (215)
T ss_pred chhhcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH---------------------------------HHHHHH
Confidence 12234478889999999742 2567899999999999998 568899
Q ss_pred HHHhhcCCCCCCCCHHHHHHHH
Q 000726 1286 MEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1286 IkrCLqkDPeERPTaeELLq~L 1307 (1329)
+.+|++.+|.+||++.+++++|
T Consensus 194 l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 194 IRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHhhCCcccCcCHHHHhhCC
Confidence 9999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=255.66 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=200.4
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCe
Q 000726 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~ 1121 (1329)
|...++||+|.+|+||+++.+ ++-||+|.++.... ++......++|+.+|+.++|.|||+++++..... .
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddd------degvpssalreicllkelkhknivrl~dvlhsdk--k 75 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--K 75 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC------CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc--e
Confidence 445578999999999999874 66799999986432 2333456789999999999999999999987644 8
Q ss_pred EEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1122 L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
+.+|+||| ..+|..+...-.+.++...+..++.|+++||.|+|++++.||||||.|.||+.+|.. ||+|||+++.
T Consensus 76 ltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngel----kladfglara 150 (292)
T KOG0662|consen 76 LTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGEL----KLADFGLARA 150 (292)
T ss_pred eEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcE----Eecccchhhh
Confidence 99999999 578888876667789999999999999999999999999999999999999988855 9999999986
Q ss_pred ccCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC-------
Q 000726 1202 KRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP------- 1272 (1329)
Q Consensus 1202 ~~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~------- 1272 (1329)
..-.. ......-|.+|.+|.++.|. .-|+...|+||-||++.|+.. |++.|++.+..+.+..+...--.+
T Consensus 151 fgipvrcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 151 FGIPVRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred cCCceEeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence 54332 33344578999999999874 457889999999999999986 888899988877766654321100
Q ss_pred --CCC------------------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1273 --PVP------------------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1273 --~ip------------------s~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
.++ ..+...-++++.++|.-+|.+|.++++.+++.
T Consensus 230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 000 01223356889999999999999999988764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=283.72 Aligned_cols=256 Identities=22% Similarity=0.333 Sum_probs=199.8
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~ 1115 (1329)
.+..+-|..++-||-|+||.|.++.. +...+|+|.+++... ..+....-.+.|..||+....+.||+||--|+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-----l~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-----LMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH-----HhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 35566789999999999999999876 344589999876532 22333445678999999999999999999999
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
+.+ .+|+||+|++||++..+|...+ .+++..+..++.++..|+++.|..|+|||||||+|||||.+|++ ||.|
T Consensus 700 Dkd--nLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHI----KLTD 772 (1034)
T KOG0608|consen 700 DKD--NLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHI----KLTD 772 (1034)
T ss_pred cCC--ceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCce----eeee
Confidence 865 9999999999999999987654 57888888888999999999999999999999999999988865 9999
Q ss_pred cCCcccc---------cC--c--------------------------------ccccCCCCCCcccCccccccCCCCCCh
Q 000726 1196 FGLSKIK---------RN--T--------------------------------LVTGGVRGTLPWMAPELLNGSSSKVSE 1232 (1329)
Q Consensus 1196 FGLAr~~---------~~--~--------------------------------~~ss~~~GTp~YmAPEvL~Gs~~~~S~ 1232 (1329)
|||++-. .+ . .....+.||+.|+|||++. ...++.
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~--r~g~~q 850 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA--RTGYTQ 850 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc--ccCccc
Confidence 9998621 00 0 0001234999999999998 556788
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC--CCCCCCCCCcHHHHHHHHHhhcCCCCCCC---CHHHHHHHH
Q 000726 1233 KVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT--LRPPVPGFCDSEWRLLMEQCWAPDPVVRP---SFTEIARRL 1307 (1329)
Q Consensus 1233 KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~--lr~~ips~~S~eL~DLIkrCLqkDPeERP---TaeELLq~L 1307 (1329)
.+|+|+.|||||||+.|++||-..+..+....++.+. +..+....++.+..++|.++.. +++.|. ...+|..|.
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHp 929 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHP 929 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCc
Confidence 9999999999999999999998877766555554443 3344456789999998876443 455663 344555544
Q ss_pred H
Q 000726 1308 R 1308 (1329)
Q Consensus 1308 e 1308 (1329)
+
T Consensus 930 f 930 (1034)
T KOG0608|consen 930 F 930 (1034)
T ss_pred c
Confidence 3
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-29 Score=279.04 Aligned_cols=253 Identities=24% Similarity=0.278 Sum_probs=199.2
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCC--C----ceeeEec
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH--P----NVVAFYG 1112 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrH--P----NIVKL~G 1112 (1329)
..+|.+...||+|+||.|-.+.++ +..||||+++. -.......+-|+++|.++.+ | -+|++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---------V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---------VDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---------HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 578999999999999999999874 56799999874 23344556679999999942 3 3788888
Q ss_pred ccccCCCCeEEEEEEeccCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCC-----
Q 000726 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP----- 1186 (1329)
Q Consensus 1113 if~e~~dg~L~LVMEYm~GGSL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGn----- 1186 (1329)
||.- .+.+|||+|.+ |-|+.++|... ..+++..++..|+.|++.+++|||+.+++|.||||+|||+.+...
T Consensus 159 wFdy--rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 159 WFDY--RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred hhhc--cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 8877 44899999998 77999999763 467999999999999999999999999999999999999953211
Q ss_pred -----------CCCcEEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCC
Q 000726 1187 -----------IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1255 (1329)
Q Consensus 1187 -----------i~~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~ 1255 (1329)
....++|+|||.|+...+.. .....|..|.|||++.| -+++.++||||+||||+|+++|...|..
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceeccc
Confidence 13458999999999766654 44668999999999994 5689999999999999999999999987
Q ss_pred CChhH---HHHHHHhcCC----------------CCC-----------------CC--------CCCcHHHHHHHHHhhc
Q 000726 1256 MHYGA---IIGGIVNNTL----------------RPP-----------------VP--------GFCDSEWRLLMEQCWA 1291 (1329)
Q Consensus 1256 ~~~~e---ll~qIve~~l----------------r~~-----------------ip--------s~~S~eL~DLIkrCLq 1291 (1329)
....+ +++.++.... +.. .| ...-.+|.+||++||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 66544 2222221100 000 00 0112458899999999
Q ss_pred CCCCCCCCHHHHHHHHHH
Q 000726 1292 PDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1292 kDPeERPTaeELLq~Le~ 1309 (1329)
.||.+|+|+.|++.|..-
T Consensus 392 fDP~~RiTl~EAL~HpFF 409 (415)
T KOG0671|consen 392 FDPARRITLREALSHPFF 409 (415)
T ss_pred cCccccccHHHHhcCHHh
Confidence 999999999999998764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-29 Score=298.55 Aligned_cols=245 Identities=31% Similarity=0.450 Sum_probs=186.7
Q ss_pred eEEEEecccCcEE-EEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccccCCCCeE
Q 000726 1045 EELKELGSGTFGT-VYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1045 ellkvLGqGaFGt-VYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~e~~dg~L 1122 (1329)
.-.+++|.|+.|+ ||+|.+.++.||||.+-.+ ...-..+|+.+|+.- .|||||++|+.-.+ ..++
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d--~qF~ 578 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE-----------FFDFAQREIQLLQESDEHPNVIRYYCSEQD--RQFL 578 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeCCceehHHHHhhH-----------hHHHHHHHHHHHHhccCCCceEEEEeeccC--CceE
Confidence 3345799999876 7999999999999988543 233456899999987 59999999876555 5599
Q ss_pred EEEEEeccCCchhhhhhcc--ccc-CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecc-CCCCCCcEEEeecCC
Q 000726 1123 ATVTEFMVNGSLRHVLLSK--ERH-LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL-KDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~d~L~~k--ek~-Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDs-dGni~~~VKLsDFGL 1198 (1329)
||+.|.| ..+|.+++... +.. ......+.++.|+++||+|||+.+||||||||+||||+. +++....++|+|||+
T Consensus 579 YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 579 YIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred EEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccc
Confidence 9999999 79999999763 111 111345678899999999999999999999999999986 233456899999999
Q ss_pred cccccC----cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCC
Q 000726 1199 SKIKRN----TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1199 Ar~~~~----~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~lr~~ 1273 (1329)
++.... .....+..||.+|+|||++... ....++|||||||++|+.++ |.+||......+ ..|+...+...
T Consensus 658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~ 733 (903)
T KOG1027|consen 658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLV 733 (903)
T ss_pred ccccCCCcchhhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCcccee
Confidence 985432 2234567799999999999843 34668999999999999999 599997643332 23333333221
Q ss_pred C-CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1274 V-PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1274 i-ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
. ......+..+||.+|+.++|..||++.+|+.|+
T Consensus 734 ~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 734 HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 1 111112789999999999999999999998764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=269.28 Aligned_cols=262 Identities=26% Similarity=0.424 Sum_probs=214.9
Q ss_pred ccccCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEe
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~kG-------r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~ 1111 (1329)
+...++++.-.+-+|.||.||.|.|+. +.|-||.++.. ..+.....++.|.-.|..+.|||+..+.
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-------AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-------ASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-------ccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 445667777889999999999998842 34777776642 2344456788999999999999999999
Q ss_pred cccccCCCCeEEEEEEeccCCchhhhhhc-------ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccC
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLS-------KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 1184 (1329)
Q Consensus 1112 Gif~e~~dg~L~LVMEYm~GGSL~d~L~~-------kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsd 1184 (1329)
+++.+.. ..-+.++.++.-|+|..++.. ..+.++..+...++.|++.||+|||++||||.||.+.|++||+.
T Consensus 354 ~V~ie~~-~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 354 GVSIEDY-ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EEEeecc-CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence 9887643 356778899988999999862 12457788899999999999999999999999999999999954
Q ss_pred CCCCCcEEEeecCCcccc--cCcc-cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhH
Q 000726 1185 DPIRPICKVGDFGLSKIK--RNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGA 1260 (1329)
Q Consensus 1185 Gni~~~VKLsDFGLAr~~--~~~~-~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~e 1260 (1329)
..+||+|-.+++.. .... .-........||+||.+. ...|+.++||||||++||||+| |+.||...++.+
T Consensus 433 ----LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~--n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 433 ----LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ--NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred ----eeEEeccchhccccCcccccccCCCCCCcccccCHHHHh--hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence 67899999988732 1111 111222456799999998 5668999999999999999999 999999887766
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1261 IIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1261 ll~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
+. ..++++++...|-+|+++|..+|..||+..|++||++++++.-|..++....
T Consensus 507 m~-~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 507 ME-HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred HH-HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 54 5678889999999999999999999999999999999999999999987654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-28 Score=266.61 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=201.7
Q ss_pred cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC-
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP- 1118 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~- 1118 (1329)
+.|....+||+|.||.||+|+.+ |+.||+|++..+. +.+.+-...++|+.+|..|+|+|++.++.+|....
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen------eKeGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN------EKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc------cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 45666778999999999999874 6778988764321 22333455679999999999999999999886432
Q ss_pred -----CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1119 -----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1119 -----dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
...+|+||.+| ..+|.-++......++...+.++..++..||.|+|++.|+|||+||+|+||+.+| ++||
T Consensus 91 p~~r~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg----ilkl 165 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG----ILKL 165 (376)
T ss_pred CcccccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc----eEEe
Confidence 24589999999 5789888877767899999999999999999999999999999999999999776 4699
Q ss_pred eecCCcccccCc-----ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH--
Q 000726 1194 GDFGLSKIKRNT-----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV-- 1266 (1329)
Q Consensus 1194 sDFGLAr~~~~~-----~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIv-- 1266 (1329)
+|||+++..... .......-|.+|.+||.+.| ...++.+.|||+-||+|.||+++.+-+.+.+....+..|.
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG-~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG-DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhc-ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 999999743221 12223446899999999997 5678999999999999999999999988876654433221
Q ss_pred -hcC----------------CC-CCCCC-------------CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1267 -NNT----------------LR-PPVPG-------------FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1267 -e~~----------------lr-~~ips-------------~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
... +. .+++. .-.++..+|+.++|..||.+|+++.+++.|-+....
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 110 00 11111 124567899999999999999999999988776544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=253.57 Aligned_cols=254 Identities=19% Similarity=0.264 Sum_probs=203.7
Q ss_pred cccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEeccccc
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 1116 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~e 1116 (1329)
..++|++.+++|+|-++.||.|.. +...++||+++.- ..+.+.+|+.+|..|. ||||+++++++.+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----------kkkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----------KKKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----------HHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 456899999999999999999985 5788999999853 1356889999999997 9999999999998
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.......||+||+.+.+...+. ..++...+..+..+++.||.|||++||+|||+||+|++||... ..++|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~---rkLrlIDW 177 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL---RKLRLIDW 177 (338)
T ss_pred ccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh---ceeeeeec
Confidence 8877889999999877765543 3577888899999999999999999999999999999999543 35799999
Q ss_pred CCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCC-ChhHHHH------------
Q 000726 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIG------------ 1263 (1329)
Q Consensus 1197 GLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~-~~~ell~------------ 1263 (1329)
|+|.++......+....+..|--||.+.. -..|+..-|+|||||+|..|+..+.||..- ++.+.+-
T Consensus 178 GLAEFYHp~~eYnVRVASRyfKGPELLVd-y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred chHhhcCCCceeeeeeehhhcCCchheee-chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 99998887776666667888999999974 345677899999999999999999888542 2211111
Q ss_pred ---------------HHHhcCC--------CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 000726 1264 ---------------GIVNNTL--------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1264 ---------------qIve~~l--------r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~a 1312 (1329)
.++.... ...-...++++..+|+.++|..|..+|+|+.|.+.|......
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 1111111 111122356899999999999999999999999998776543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=262.50 Aligned_cols=276 Identities=22% Similarity=0.251 Sum_probs=207.2
Q ss_pred cccccCCCCccccccccc-cCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHH
Q 000726 1024 VDLALGNFDISTLQIIKN-EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100 (1329)
Q Consensus 1024 ~d~al~~fDls~l~iI~~-edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk 1100 (1329)
.++..+.|....+..+.. .+|.+.++||+|-|++||+|.++ .+.||+|+.|. .+.+....+.|+.+|+
T Consensus 59 ~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---------AqhYtEaAlDEIklL~ 129 (590)
T KOG1290|consen 59 EDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---------AQHYTEAALDEIKLLQ 129 (590)
T ss_pred hhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---------hhHHHHHHHHHHHHHH
Confidence 455567777766666666 89999999999999999999884 57799999985 3455667788999999
Q ss_pred hcC-----C---CceeeEeccccc--CCCCeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHC-C
Q 000726 1101 KLH-----H---PNVVAFYGVVQD--GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSK-N 1168 (1329)
Q Consensus 1101 ~Lr-----H---PNIVKL~Gif~e--~~dg~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~-G 1168 (1329)
+++ | .+||+|++.|.. .+..++|+|+|++ |.+|..++.... +-++...+..|++||+.||.|||++ |
T Consensus 130 ~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg 208 (590)
T KOG1290|consen 130 QVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG 208 (590)
T ss_pred HHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC
Confidence 884 3 369999999863 3345899999999 899999986654 5689999999999999999999976 8
Q ss_pred eeecCCCCcceEeccC----------------------------------------------------------------
Q 000726 1169 IVHFDLKCDNLLVNLK---------------------------------------------------------------- 1184 (1329)
Q Consensus 1169 IIHRDLKPeNILLDsd---------------------------------------------------------------- 1184 (1329)
|||.||||+|||+-..
T Consensus 209 IIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l 288 (590)
T KOG1290|consen 209 IIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASL 288 (590)
T ss_pred ccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhh
Confidence 9999999999998110
Q ss_pred ----------------------CC--------------------------------------------------------
Q 000726 1185 ----------------------DP-------------------------------------------------------- 1186 (1329)
Q Consensus 1185 ----------------------Gn-------------------------------------------------------- 1186 (1329)
+.
T Consensus 289 ~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~ 368 (590)
T KOG1290|consen 289 AGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSP 368 (590)
T ss_pred cccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCc
Confidence 00
Q ss_pred --------------------CCCcEEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHH
Q 000726 1187 --------------------IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEI 1246 (1329)
Q Consensus 1187 --------------------i~~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyEL 1246 (1329)
....|||+|||-|++.....+. ...|..|.|||++.|. .|+..+||||++|++|||
T Consensus 369 ~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~--DIQTRQYRapEVllGs--gY~~~ADiWS~AC~~FEL 444 (590)
T KOG1290|consen 369 SSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTE--DIQTRQYRAPEVLLGS--GYSTSADIWSTACMAFEL 444 (590)
T ss_pred CCccccccccccCCCCCCCccceeEEEeeccchhhhhhhhch--hhhhhhccCcceeecC--CCCCchhHHHHHHHHHHh
Confidence 0123677788877765443322 3468899999999964 467889999999999999
Q ss_pred HhCCCCCCCCCh------hHHHHHHHhc------------CC---------------CC-------------CCCCCCcH
Q 000726 1247 LTGEEPYANMHY------GAIIGGIVNN------------TL---------------RP-------------PVPGFCDS 1280 (1329)
Q Consensus 1247 LTGk~PF~~~~~------~ell~qIve~------------~l---------------r~-------------~ips~~S~ 1280 (1329)
+||-..|..... ++.+..|++- .+ ++ ..+.....
T Consensus 445 aTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~ 524 (590)
T KOG1290|consen 445 ATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQ 524 (590)
T ss_pred hcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHH
Confidence 999999865321 1112111110 00 00 01111235
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1281 EWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1281 eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
++.+|+.-||+.+|++|||+.+.++|.|....+
T Consensus 525 ~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 525 QFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVA 557 (590)
T ss_pred HHHHHHHHHHhcCccccccHHHHhcCccccCCC
Confidence 578899999999999999999999999976433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=227.23 Aligned_cols=202 Identities=38% Similarity=0.597 Sum_probs=167.4
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCe
Q 000726 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~ 1121 (1329)
|.+.+.||.|++|.||++... +..+|||.+...... .....+.+|+..++.++|+|++++++++.... .
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFEDPE--P 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeecCC--c
Confidence 456788999999999999985 588999999764321 23467889999999999999999999987754 7
Q ss_pred EEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1122 L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
.++++||+++++|.+++......+++..++.++.+++.++.+||+.+++|+||+|.||+++.++ .++|+|||.+..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~----~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG----LVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----CEEEeeCceeeE
Confidence 8999999998899998865433388999999999999999999999999999999999999764 469999999886
Q ss_pred ccCcc--cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCC-CChh
Q 000726 1202 KRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN-MHYG 1259 (1329)
Q Consensus 1202 ~~~~~--~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~-~~~~ 1259 (1329)
..... ......++..|++||.+. ....++.++|||+||+++++|++|+.||.. ....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 54332 223345788899999984 345667799999999999999999999977 3443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=271.01 Aligned_cols=256 Identities=25% Similarity=0.321 Sum_probs=203.9
Q ss_pred ccccccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC------CCc
Q 000726 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH------HPN 1106 (1329)
Q Consensus 1035 ~l~iI~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr------HPN 1106 (1329)
.+..+.-.+|.+....|+|-|++|..|.++ |..||||++.. ++-+.+.=++|+++|++|+ --|
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---------NE~M~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---------NEVMHKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---------chHHhhhhhHHHHHHHHhhccCchhhhH
Confidence 455667789999999999999999999884 77899999974 3555677789999999996 247
Q ss_pred eeeEecccccCCCCeEEEEEEeccCCchhhhhhcccc--cCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccC
Q 000726 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER--HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 1184 (1329)
Q Consensus 1107 IVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek--~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsd 1184 (1329)
+++++..|...+ ++|||+|.+ ..+|.+.|...+. -|....+..++.|+..||.+|...||+|.||||.||||+..
T Consensus 496 clrl~r~F~hkn--HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 496 CLRLFRHFKHKN--HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHHhhhcc--eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC
Confidence 899999888865 899999988 7899999976553 46778889999999999999999999999999999999965
Q ss_pred CCCCCcEEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 000726 1185 DPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1264 (1329)
Q Consensus 1185 Gni~~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~q 1264 (1329)
- .++||||||.|........+ ...-+..|.|||++.|.. |+...|+||.||+||||.||+..|++.++..++..
T Consensus 573 k---~iLKLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~~--yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 573 K---NILKLCDFGSASFASENEIT-PYLVSRFYRAPEIILGLP--YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred c---ceeeeccCcccccccccccc-HHHHHHhccCcceeecCc--ccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 4 35899999999866544333 223456799999999755 56679999999999999999999998877665442
Q ss_pred HHhcC---------------------C----------------------CC--C----------CCC---CCcHHHHHHH
Q 000726 1265 IVNNT---------------------L----------------------RP--P----------VPG---FCDSEWRLLM 1286 (1329)
Q Consensus 1265 Ive~~---------------------l----------------------r~--~----------ips---~~S~eL~DLI 1286 (1329)
.++-. + .+ . ++. .....|.+|+
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 22100 0 00 0 000 0124578999
Q ss_pred HHhhcCCCCCCCCHHHHHHHHH
Q 000726 1287 EQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1287 krCLqkDPeERPTaeELLq~Le 1308 (1329)
.+||..||++|.|..++|+|..
T Consensus 727 dkml~LdP~KRit~nqAL~HpF 748 (752)
T KOG0670|consen 727 DKMLILDPEKRITVNQALKHPF 748 (752)
T ss_pred HHHhccChhhcCCHHHHhcCCc
Confidence 9999999999999999998864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=242.62 Aligned_cols=217 Identities=29% Similarity=0.453 Sum_probs=173.3
Q ss_pred ccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~ 1115 (1329)
+..+++.-+..||+|++|.|=+.++ .|+-.|||.++...- ....++.++|+.+..+. .+|.+|.+||.+.
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-------~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-------SQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-------hHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 4455666778899999999877666 688999999975432 22345677888887765 6999999999776
Q ss_pred cCCCCeEEEEEEeccCCchhhhh---hcccccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEeccCCCCCCcE
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVL---LSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L---~~kek~Lse~qrlkIA~QIAsALaYLHs~-GIIHRDLKPeNILLDsdGni~~~V 1191 (1329)
. .+.+++.||.| ..||..+- ..++..+++..+-+|+..++.||.|||++ .|||||+||.||||+.+|+ +
T Consensus 116 r--egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq----V 188 (282)
T KOG0984|consen 116 R--EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ----V 188 (282)
T ss_pred c--cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc----E
Confidence 5 45799999999 46665543 34677899999999999999999999986 7999999999999998875 5
Q ss_pred EEeecCCcccccCcccccCCCCCCcccCcccccc--CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhc
Q 000726 1192 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNG--SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNN 1268 (1329)
Q Consensus 1192 KLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~G--s~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~-ell~qIve~ 1268 (1329)
|+||||.+....+....+...|...|||||.+.. +...|+.|+||||||+++.||.+++.||+....+ +.+.++++.
T Consensus 189 KiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 189 KICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred EEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 9999999987665555554568889999999963 2447899999999999999999999999876443 455556554
Q ss_pred C
Q 000726 1269 T 1269 (1329)
Q Consensus 1269 ~ 1269 (1329)
.
T Consensus 269 p 269 (282)
T KOG0984|consen 269 P 269 (282)
T ss_pred C
Confidence 3
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=270.82 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=210.9
Q ss_pred ccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
-..++|+++.++|.|++|.||++++ +++..|||++|.+...+ ..-+.+|+-+++.++|||||.+++-+..
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--------~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--------FSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--------ccccccceeeeecCCCcChHHHHhhhhh
Confidence 3467899999999999999999998 47889999998764321 2345578889999999999999998877
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.. .++++||||.+|+|.+.-+ -..++++.++..++++.+.+|+|||++|-+|||||-.|||+++.|++ |++||
T Consensus 84 ~d--klwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDv----klaDf 156 (829)
T KOG0576|consen 84 RD--KLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDV----KLADF 156 (829)
T ss_pred hc--CcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCce----eeccc
Confidence 54 8999999999999988653 34679999999999999999999999999999999999999988875 99999
Q ss_pred CCcccccCc-ccccCCCCCCcccCccccc-cCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC-
Q 000726 1197 GLSKIKRNT-LVTGGVRGTLPWMAPELLN-GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP- 1273 (1329)
Q Consensus 1197 GLAr~~~~~-~~ss~~~GTp~YmAPEvL~-Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~- 1273 (1329)
|.+..+... .....+.||+.|||||+.. +..+.|...+|||++|++..|+-.-++|....+....+.-+.+..+.++
T Consensus 157 gvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~ 236 (829)
T KOG0576|consen 157 GVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT 236 (829)
T ss_pred CchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc
Confidence 998754332 2234678999999999973 3356688999999999999999988888777777666666665555433
Q ss_pred --CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1274 --VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1274 --ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
-+..+++.|.+|++.||.++|.+||+++.++.|.
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~ 272 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHP 272 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheece
Confidence 3445789999999999999999999998887653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-26 Score=250.50 Aligned_cols=252 Identities=26% Similarity=0.339 Sum_probs=194.0
Q ss_pred ccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~ 1118 (1329)
..+|.-++.+|.|+- .|..+-+ .+++||+|.+... +.. ....++..+|..++..++|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n-----~~~akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQN-----QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-ccc-----CccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 456777888999998 5666555 5899999988655 221 223456778999999999999999999986432
Q ss_pred ----CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1119 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1119 ----dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
....|+|||+| ..+|...+. -.++-..+..|+.|++.|+.|||+.||+||||||+||++..+. .+||+
T Consensus 89 ~l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~----~lKi~ 160 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC----TLKIL 160 (369)
T ss_pred cHHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh----heeec
Confidence 13578999999 678877775 3366777889999999999999999999999999999999654 56999
Q ss_pred ecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC-----
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----- 1269 (1329)
Q Consensus 1195 DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~----- 1269 (1329)
|||+|+........+....|..|.|||++.|.. +...+||||+||++.||++|+..|.+.+.-+.+.++.+..
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~--~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheeccC--CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 999998766664555667899999999999644 7889999999999999999999998755433322221110
Q ss_pred --------------------------------CCC-C--CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1270 --------------------------------LRP-P--VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1270 --------------------------------lr~-~--ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
..+ . .+..-...+++++.+||..+|++|.+++++|+|+--
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 000 0 000123457899999999999999999999998643
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-26 Score=248.98 Aligned_cols=250 Identities=27% Similarity=0.361 Sum_probs=188.8
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCC---CeE
Q 000726 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG---GTL 1122 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~d---g~L 1122 (1329)
+.||.|+||+||.+++ .|+.||+|.+..- ...-...+.+.+|+.+|...+|.|++..+++.+-..- ..+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnv------fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNV------FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchH------HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 4699999999999988 4899999988532 2233445788999999999999999999887664321 135
Q ss_pred EEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 000726 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
|.|+|+| ..+|...+. ..+.++...+.-+++||++||.|||+.+|.||||||.|.|++++ ..+||||||+++..
T Consensus 133 YV~TELm-QSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN----CvLKICDFGLARve 206 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN----CILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-Hhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC----ceEEeccccccccc
Confidence 6788888 456666553 45679999999999999999999999999999999999999965 46799999999965
Q ss_pred cCcccc--cCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHH---------------
Q 000726 1203 RNTLVT--GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI--------------- 1265 (1329)
Q Consensus 1203 ~~~~~s--s~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qI--------------- 1265 (1329)
...... ....-|..|.|||++.| ...|+.++||||.||++.||+..+..|.....-+.+.-+
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMG-aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMG-ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhc-chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 433221 11235788999999998 567899999999999999999988888665443322211
Q ss_pred --------HhcCCCCC-CC--------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1266 --------VNNTLRPP-VP--------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1266 --------ve~~lr~~-ip--------s~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
+....+.+ .+ ..-..+...++.+++..||+.|.+..+.+.++..-
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 11111111 11 11234567788899999999999999998876543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=260.82 Aligned_cols=206 Identities=27% Similarity=0.389 Sum_probs=166.7
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC---CCceeeEeccc
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVV 1114 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr---HPNIVKL~Gif 1114 (1329)
...+|..++.||.|+||.|++|.++ ...|+||.++++..-.+.=...+..-.+-.|+++|..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457999999999999999999995 456999999876432111001111223456999999997 99999999999
Q ss_pred ccCCCCeEEEEEEec-cCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1115 QDGPGGTLATVTEFM-VNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm-~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
++.. ++||+||-- ++-+|.+++.. ...+++..+..|++||+.|++|||++||||||||-+||.++.+| .+||
T Consensus 639 Eddd--~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g----~~kl 711 (772)
T KOG1152|consen 639 EDDD--YYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG----FVKL 711 (772)
T ss_pred ecCC--eeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC----eEEE
Confidence 9855 999999975 34488888853 45689999999999999999999999999999999999999776 4699
Q ss_pred eecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1254 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~ 1254 (1329)
+|||.+....... ...+.||..|.|||++.|..+ .+..-|||+||++||-++....||-
T Consensus 712 idfgsaa~~ksgp-fd~f~gtv~~aapevl~g~~y-~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSGP-FDVFVGTVDYAAPEVLGGEKY-LGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcCCC-cceeeeeccccchhhhCCCcc-CCCcchhhhhhheeeEEEeccCCCc
Confidence 9999987544433 345789999999999998655 4677899999999999998888874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-25 Score=270.83 Aligned_cols=205 Identities=19% Similarity=0.216 Sum_probs=148.9
Q ss_pred HhcCC-CceeeEecccccCC-----CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Q 000726 1100 SKLHH-PNVVAFYGVVQDGP-----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFD 1173 (1329)
Q Consensus 1100 k~LrH-PNIVKL~Gif~e~~-----dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRD 1173 (1329)
+.+.| +||++++++|..+. ...++++|||+ +++|.+++......+++.+++.++.||++||+|||++||+|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 34456 68888888772211 23577889987 7799999976566799999999999999999999999999999
Q ss_pred CCCcceEeccCCC---------------CCCcEEEeecCCcccccCc-----------------ccccCCCCCCcccCcc
Q 000726 1174 LKCDNLLVNLKDP---------------IRPICKVGDFGLSKIKRNT-----------------LVTGGVRGTLPWMAPE 1221 (1329)
Q Consensus 1174 LKPeNILLDsdGn---------------i~~~VKLsDFGLAr~~~~~-----------------~~ss~~~GTp~YmAPE 1221 (1329)
|||+||||+..+. ....+|++|||+++..... .......||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999964321 1235688888887632110 0001235789999999
Q ss_pred ccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHH
Q 000726 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFT 1301 (1329)
Q Consensus 1222 vL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTae 1301 (1329)
++.+ ..++.++|||||||+||||++|..|+.... ..+..+..... ++..........+++.+||+++|.+||++.
T Consensus 186 ~~~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ 260 (793)
T PLN00181 186 EDNG--SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL-PPQILLNWPKEASFCLWLLHPEPSCRPSMS 260 (793)
T ss_pred hhcc--CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc-ChhhhhcCHHHHHHHHHhCCCChhhCcChH
Confidence 9984 457899999999999999999988875422 11222211111 111112245567899999999999999999
Q ss_pred HHHHHHHHH
Q 000726 1302 EIARRLRVM 1310 (1329)
Q Consensus 1302 ELLq~Le~L 1310 (1329)
+++++.+..
T Consensus 261 eil~h~~~~ 269 (793)
T PLN00181 261 ELLQSEFIN 269 (793)
T ss_pred HHhhchhhh
Confidence 999988764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=213.03 Aligned_cols=165 Identities=24% Similarity=0.312 Sum_probs=128.3
Q ss_pred CchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCcccccCC
Q 000726 1132 GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211 (1329)
Q Consensus 1132 GSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~ss~~ 1211 (1329)
|+|.+++......+++..++.|+.||+.||.|||+++ ||+|||++.++. +|+ ||++....... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~----~~~--fG~~~~~~~~~----~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL----LKL--DGSVAFKTPEQ----S 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc----eee--ccceEeecccc----C
Confidence 6788888766677999999999999999999999998 999999997764 477 99987654322 2
Q ss_pred CCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcCCCC-----CCCCCCcH--HHH
Q 000726 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNNTLRP-----PVPGFCDS--EWR 1283 (1329)
Q Consensus 1212 ~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~-ell~qIve~~lr~-----~ips~~S~--eL~ 1283 (1329)
.||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+....... ..+...+. .+.
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence 58899999999984 45788999999999999999999999765432 2222222221111 11112233 699
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 000726 1284 LLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 1314 (1329)
Q Consensus 1284 DLIkrCLqkDPeERPTaeELLq~Le~L~aa~ 1314 (1329)
+++.+||..+|.+||++.+++++++......
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999886543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-22 Score=203.56 Aligned_cols=252 Identities=33% Similarity=0.470 Sum_probs=197.6
Q ss_pred eeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCC-ceeeEecccccCCCCeE
Q 000726 1044 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP-NVVAFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHP-NIVKL~Gif~e~~dg~L 1122 (1329)
|.+.+.||.|+||.||++.+. ..+++|.+........ .....+.+|+.+++.+.|+ +|+++++.+.... ..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFFQDEG--SL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEEecCC--EE
Confidence 678889999999999999988 7899999976543211 2456788999999999988 7999999995533 57
Q ss_pred EEEEEeccCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1123 ATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~d~L~~ke--k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
+++++++.++++.+++.... ..+.......++.|++.++.|+|..+++|||+||+|||++..+. .++++|||.+.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~---~~~l~dfg~~~ 150 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR---VVKLIDFGLAK 150 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC---eEEEeccCcce
Confidence 99999999999996664433 26889999999999999999999999999999999999997653 46999999997
Q ss_pred cccCcc-------cccCCCCCCcccCccccccCC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHhc
Q 000726 1201 IKRNTL-------VTGGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNN 1268 (1329)
Q Consensus 1201 ~~~~~~-------~ss~~~GTp~YmAPEvL~Gs~-~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~----~ell~qIve~ 1268 (1329)
...... ......|+..|++||.+.+.. .......|+|++|++++++++|..||..... ......+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 230 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence 443322 235667999999999998532 4678899999999999999999999877653 3333333332
Q ss_pred CCC---CCCCCCC----cHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 000726 1269 TLR---PPVPGFC----DSEWRLLMEQCWAPDPVVRPSFTEIARR 1306 (1329)
Q Consensus 1269 ~lr---~~ips~~----S~eL~DLIkrCLqkDPeERPTaeELLq~ 1306 (1329)
... ....... ...+.+++..|+..+|..|.+..+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 221 1111111 2578899999999999999998887765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-24 Score=231.31 Aligned_cols=258 Identities=24% Similarity=0.302 Sum_probs=189.6
Q ss_pred ccCeeEEEEecccCcEEEEEEEECC--ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecc-ccc
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGV-VQD 1116 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~kG--r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gi-f~e 1116 (1329)
.+.|.+.+.||+|.||.+.++++++ +.+++|.+....+. ..+|.+|...--.| .|.||+.-|+. |+.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---------~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---------QADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---------HHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 3568889999999999999999974 56999998765432 46788888765556 48999998875 444
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
. +.+.++|||++-|+|..-+.. ..+.+.....++.|+++||.|+|+++++|||||.+||||-..+. ..+|||||
T Consensus 94 ~--d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df--~rvKlcDF 167 (378)
T KOG1345|consen 94 S--DAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF--YRVKLCDF 167 (378)
T ss_pred C--ceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc--cEEEeeec
Confidence 3 388899999999999998854 34778888999999999999999999999999999999964432 26899999
Q ss_pred CCcccccCcccccCCCCCCcccCccccc---cCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhcCC
Q 000726 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLN---GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---YGAIIGGIVNNTL 1270 (1329)
Q Consensus 1197 GLAr~~~~~~~ss~~~GTp~YmAPEvL~---Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~---~~ell~qIve~~l 1270 (1329)
|+.+....... ...-+..|.+||.+. +......+..|||.||+++|.++||++||.... ...........+.
T Consensus 168 G~t~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 168 GLTRKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK 245 (378)
T ss_pred ccccccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence 99875433221 122355689999874 224446778999999999999999999996421 1111111122223
Q ss_pred CCCCCC---CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1271 RPPVPG---FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1271 r~~ips---~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
.+..|. ..++.+..+.++-|..++++|--..++.+.-...-..+.
T Consensus 246 ~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 246 NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 333332 357888889999999999999655555544444433333
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-22 Score=221.89 Aligned_cols=261 Identities=21% Similarity=0.243 Sum_probs=200.7
Q ss_pred CeeEEEEecccCcEEEEEEEECC---ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCC----CceeeEecccc
Q 000726 1043 DLEELKELGSGTFGTVYHGKWRG---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH----PNVVAFYGVVQ 1115 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~kG---r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrH----PNIVKL~Gif~ 1115 (1329)
+|.+.+.||+|+||.||++.... ..+|+|+......... ..+..|+.++..+.. +++..+++...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--------ccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 89999999999999999999854 3589998876432211 135567788888762 57888888774
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCC-CCCCcEEE
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PIRPICKV 1193 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdG-ni~~~VKL 1193 (1329)
....+.++||+.+ |.+|.++..... +.++...+..|+.|++.+|.+||+.|++||||||.|+++.... .....+.|
T Consensus 91 -~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 91 -STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred -CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence 2234889999988 899999875544 7899999999999999999999999999999999999998664 22346899
Q ss_pred eecCCcc--cccCc-------c-c-ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 000726 1194 GDFGLSK--IKRNT-------L-V-TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII 1262 (1329)
Q Consensus 1194 sDFGLAr--~~~~~-------~-~-ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell 1262 (1329)
.|||+++ .+... . . ...+.||..|+++.+..+ ...+.+.|+||+++++.||+.|..||.........
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 9999998 31111 1 1 234569999999999984 45688999999999999999999999776543222
Q ss_pred HHHHhc---CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1263 GGIVNN---TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1263 ~qIve~---~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
..+... ..........+..+.++...+-..+..++|.+..+...|+.......
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred HHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 222211 11111233456788899988888999999999999999999888763
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-22 Score=230.28 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=186.1
Q ss_pred cCeeEEEEecccCcEEEEEEEEC-----CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecccc
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1042 edYellkvLGqGaFGtVYKA~~k-----Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif~ 1115 (1329)
..|..+++||.|.|++||++.+. .+.||+|.+...... ..+..|+++|..+ .+.||+++.+++.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----------~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----------SRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----------hHHHHHHHHHHHhccchhhhcchhhhc
Confidence 45788899999999999998763 456999998754322 3477899999988 5999999999998
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
..+ ..++||||++.....++.. .++...+..+++.++.||+|+|.+|||||||||.|+|++.... .-.|+|
T Consensus 106 nnd--~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~---rg~LvD 176 (418)
T KOG1167|consen 106 NND--QVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ---RGVLVD 176 (418)
T ss_pred cCC--eeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC---CceEEe
Confidence 755 8999999998887777663 4678889999999999999999999999999999999986532 348999
Q ss_pred cCCcccccCc---------------c------------------------------cccCCCCCCcccCccccccCCCCC
Q 000726 1196 FGLSKIKRNT---------------L------------------------------VTGGVRGTLPWMAPELLNGSSSKV 1230 (1329)
Q Consensus 1196 FGLAr~~~~~---------------~------------------------------~ss~~~GTp~YmAPEvL~Gs~~~~ 1230 (1329)
||+|...... . ......||++|.|||++.... .-
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~-~Q 255 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP-RQ 255 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc-Cc
Confidence 9998611000 0 000133999999999998643 34
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCChh--HH-----------HH-------H--HHh-c-------------CC----
Q 000726 1231 SEKVDVFSFGIVLWEILTGEEPYANMHYG--AI-----------IG-------G--IVN-N-------------TL---- 1270 (1329)
Q Consensus 1231 S~KSDVWSLGVLLyELLTGk~PF~~~~~~--el-----------l~-------q--Ive-~-------------~l---- 1270 (1329)
+.++||||.|++++-++++..||.....+ .+ +. . +.+ . ..
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 77899999999999999999998443221 00 00 0 000 0 00
Q ss_pred --C--------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1271 --R--------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1271 --r--------~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
. .......+..+.+|+.+||..||.+|.|++++|+|..
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 0 0001123557899999999999999999999998764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.9e-21 Score=207.12 Aligned_cols=262 Identities=28% Similarity=0.441 Sum_probs=210.4
Q ss_pred ccccccccccCeeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEec
Q 000726 1033 ISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1329)
Q Consensus 1033 ls~l~iI~~edYellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~G 1112 (1329)
++....|...++.++-+|.+...|..|+|+|+|..+++|+++....+. +..+.|..|.-.|+-..||||+.+++
T Consensus 181 lsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~------risrdfneefp~lrifshpnilpvlg 254 (448)
T KOG0195|consen 181 LSRYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTA------RISRDFNEEFPALRIFSHPNILPVLG 254 (448)
T ss_pred cccccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcch------hhcchhhhhCcceeeecCCchhhhhh
Confidence 334445666777888889999999999999999999999998654432 33456778888888899999999999
Q ss_pred ccccCCCCeEEEEEEeccCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCCcceEeccCCCCCC
Q 000726 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRP 1189 (1329)
Q Consensus 1113 if~e~~dg~L~LVMEYm~GGSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~G--IIHRDLKPeNILLDsdGni~~ 1189 (1329)
.|...+ .+.++..||+-++|+..++... -.++..++.+++.+|++|++|||+.. |----|....|+||++-..
T Consensus 255 acnspp--nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlta-- 330 (448)
T KOG0195|consen 255 ACNSPP--NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTA-- 330 (448)
T ss_pred hccCCC--CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhh--
Confidence 999876 8899999999999999997654 34688899999999999999999864 3344688899999965322
Q ss_pred cEEEeecCCcccccCcccccCCCCCCcccCccccccCCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 000726 1190 ICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK-VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1268 (1329)
Q Consensus 1190 ~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~-~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~ 1268 (1329)
.+-.+|--++. ...+..-.+.||+||.+...... .-.++|+|||.++||||.|...||......+.-.++.-.
T Consensus 331 rismad~kfsf------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale 404 (448)
T KOG0195|consen 331 RISMADTKFSF------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE 404 (448)
T ss_pred heecccceeee------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc
Confidence 22333422221 11223346789999999743322 245799999999999999999999998887777777778
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 000726 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1269 ~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L 1310 (1329)
+++..+|...+..+..||.-|+..||.+||.|..++-.|+++
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 899999999999999999999999999999999999888875
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=198.91 Aligned_cols=258 Identities=21% Similarity=0.310 Sum_probs=202.5
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCC-CceeeEeccc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH-PNVVAFYGVV 1114 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrH-PNIVKL~Gif 1114 (1329)
.+....|.++++||.|+||.+|+|.. .|..||||+-...... ..+..|..+.+.|++ ..|..+..+.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----------pqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----------PQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----------cchhHHHHHHHHhccCCCCchhhhhc
Confidence 46677899999999999999999987 5899999987654322 235568888888875 5666666666
Q ss_pred ccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
.+.. +-.+||+++ |.+|.+++.-..+.++...++.++-|++.-++|+|.+++|||||||+|+|..-+-. ...+.|+
T Consensus 81 ~e~~--ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh-~~kl~LI 156 (341)
T KOG1163|consen 81 TEKD--YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRH-CNKLYLI 156 (341)
T ss_pred cccc--cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccc-cceEEEE
Confidence 6644 778999998 89999988777888999999999999999999999999999999999999975443 2457899
Q ss_pred ecCCcccccCc--------ccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH---HHH
Q 000726 1195 DFGLSKIKRNT--------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA---IIG 1263 (1329)
Q Consensus 1195 DFGLAr~~~~~--------~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~e---ll~ 1263 (1329)
|||+++.+... .......||.+|.+-....|. .-+.+.|+-|+|++|.++.-|..||.+..... ..+
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 99999854321 122345699999998877642 34788999999999999999999999876543 334
Q ss_pred HHHhcCCCCCC---CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1264 GIVNNTLRPPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1264 qIve~~lr~~i---ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.|.+.....++ -...|.++.-.+..|-..--++-|...-+.+.+..+.
T Consensus 235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 44444443333 2456889999999999999999999988777666554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.1e-20 Score=211.01 Aligned_cols=164 Identities=22% Similarity=0.143 Sum_probs=122.9
Q ss_pred cccCeeEEEEecccCcEEEEEEEEC---CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceee-Eecccc
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA-FYGVVQ 1115 (1329)
Q Consensus 1040 ~~edYellkvLGqGaFGtVYKA~~k---Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVK-L~Gif~ 1115 (1329)
....|.+.+.||+|+||+||+|.++ ++.||||++........ .......|.+|+++|+.++|+|+++ ++.+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~---~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS---KPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc---cHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3567999999999999999999873 56689998753211000 1223456889999999999999985 5432
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCC-CCcceEeccCCCCCCcEEEe
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDL-KCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDL-KPeNILLDsdGni~~~VKLs 1194 (1329)
+..++|||||++++|.. +.. .. ...++.+++++|.|||++||+|||| ||+|||++.++ .+||+
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~----~ikLi 154 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG----EAAVI 154 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC----CEEEE
Confidence 24789999999998863 211 11 1457889999999999999999999 99999998665 36999
Q ss_pred ecCCcccccCcc---------cccCCCCCCcccCccccc
Q 000726 1195 DFGLSKIKRNTL---------VTGGVRGTLPWMAPELLN 1224 (1329)
Q Consensus 1195 DFGLAr~~~~~~---------~ss~~~GTp~YmAPEvL~ 1224 (1329)
|||+|+...... ......+++.|+|||++.
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999998543221 112455788899999986
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-19 Score=199.68 Aligned_cols=262 Identities=20% Similarity=0.260 Sum_probs=205.5
Q ss_pred ccccCeeEEEEecccCcEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQ 1115 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~ 1115 (1329)
+..-.|++.++||+|.||+++.|+. ++.+||||.-..... +.++.-|...++.|. .++|..+|-+-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----------APQLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----------APQLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC----------cchHHHHHHHHHHHcCCCCCCceeeecc
Confidence 4455799999999999999999986 799999998654321 123445677777774 688988887766
Q ss_pred cCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCC-CCcEEEe
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI-RPICKVG 1194 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni-~~~VKLs 1194 (1329)
++. +-.||||++ |.+|.++..-.++.++...+..+|.||+.-++|+|.+.+|.|||||+|+||..-+.. ...+.++
T Consensus 95 eG~--~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 95 EGK--YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred ccc--hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence 654 667999998 899999887788999999999999999999999999999999999999999754422 2457999
Q ss_pred ecCCcccccCcc--------cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH---HH
Q 000726 1195 DFGLSKIKRNTL--------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI---IG 1263 (1329)
Q Consensus 1195 DFGLAr~~~~~~--------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~el---l~ 1263 (1329)
|||+|+.+.... ......||.+||+-....| ..-+.+.|+-|||.++++.|-|..||.+...+.. .+
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe 249 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE 249 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence 999999654432 2235669999999988884 4458899999999999999999999988755433 33
Q ss_pred HHHhcCCCCCC---CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1264 GIVNNTLRPPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1264 qIve~~lr~~i---ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
.|-+..-..++ -...|.++..-++..-..+-.+-|.++-+...+..+.....
T Consensus 250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 250 KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 33322222222 23468889999998888899999999998888887766544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-20 Score=223.83 Aligned_cols=260 Identities=25% Similarity=0.351 Sum_probs=192.2
Q ss_pred EEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEE
Q 000726 1046 ELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1329)
Q Consensus 1046 llkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~ 1123 (1329)
...++|.|++|.|+..... ...++.|.++.. .. ...........+..|..+-..+.|+|++..+..+.+.. ...
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~ 397 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GIL 397 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cch
Confidence 3457999999987776652 344555554422 11 11222233333777888888899999999888887654 344
Q ss_pred EEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 000726 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1329)
Q Consensus 1124 LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~ 1203 (1329)
.+||||+. +|..++... ..+....+..++.|++.|+.|||..||.|||||++|+|++.+| .+||+|||.+....
T Consensus 398 ~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g----~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG----ILKIIDFGAASVFR 471 (601)
T ss_pred hhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC----ceEEeecCcceeec
Confidence 45999998 999888543 4688888999999999999999999999999999999999776 46999999998532
Q ss_pred C-----cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH-HHHHhcCCC------
Q 000726 1204 N-----TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII-GGIVNNTLR------ 1271 (1329)
Q Consensus 1204 ~-----~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell-~qIve~~lr------ 1271 (1329)
. .....+++|+..|+|||++.+..+. ....||||.|+++..|++|+.||......+.. .........
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~yd-pr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYD-PRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccC-cchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 2 2445678899999999999865443 45799999999999999999999765443221 111100000
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcc
Q 000726 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 1316 (1329)
Q Consensus 1272 ~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q~ 1316 (1329)
..+...++..-+.+|.+||+.+|.+|.|+++|++.-|.-...|+.
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~ 595 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH 595 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence 011223567788899999999999999999999999988776663
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.3e-19 Score=198.75 Aligned_cols=262 Identities=25% Similarity=0.276 Sum_probs=182.9
Q ss_pred cccccCeeEEEEecccCcEEEEEEEECC---------c----------------------------eEEEEEEeccccCC
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG---------T----------------------------DVAIKRIKKSCFTG 1080 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~kG---------r----------------------------~VAVKiLKks~~sd 1080 (1329)
....++|++.+.||+|....||.+.... . +.|||.+..-...
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~- 231 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD- 231 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC-
Confidence 4556889999999999999999875420 0 2455654432211
Q ss_pred CChHHHHHHHHHHHHHH------H--------HHh--------cCCCceeeEeccccc----------------------
Q 000726 1081 RSSEQERLTLEFWREAE------I--------LSK--------LHHPNVVAFYGVVQD---------------------- 1116 (1329)
Q Consensus 1081 ~s~e~E~~~keFlrEIe------I--------Lk~--------LrHPNIVKL~Gif~e---------------------- 1116 (1329)
..+....+..-+|.. . .+. -+|||||++.++|.+
T Consensus 232 --s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 232 --SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred --CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 223333333333321 1 111 249999999987764
Q ss_pred ---CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1117 ---GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1117 ---~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
+....+|+||..+ ..+|..++.. ...+.....-|+.|+++|+.|||++||.|||||.+||||.-+.+.-.++.|
T Consensus 310 ~g~g~~~tlylvMkrY-~~tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRY-RQTLREYLWT--RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred cccCCCceEEEehhcc-hhhHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEE
Confidence 1124688999987 6899998854 345667777788999999999999999999999999999777667788999
Q ss_pred eecCCcccccCcc-------cccCCCCCCcccCccccccCCCCC----ChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 000726 1194 GDFGLSKIKRNTL-------VTGGVRGTLPWMAPELLNGSSSKV----SEKVDVFSFGIVLWEILTGEEPYANMHYGAII 1262 (1329)
Q Consensus 1194 sDFGLAr~~~~~~-------~ss~~~GTp~YmAPEvL~Gs~~~~----S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell 1262 (1329)
+|||.+-...... .....-|....||||+.....+.. -.|+|.|+.|.+.||+++...||-......+-
T Consensus 387 aDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~ 466 (598)
T KOG4158|consen 387 ADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD 466 (598)
T ss_pred cccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec
Confidence 9999875332210 111233677799999986433221 24899999999999999999998653222111
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 000726 1263 GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305 (1329)
Q Consensus 1263 ~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq 1305 (1329)
.....+...+.++..+++.+++++..+|+.||.+|++..-...
T Consensus 467 ~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 467 TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 1112233456778899999999999999999999987644433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-18 Score=188.91 Aligned_cols=178 Identities=11% Similarity=0.053 Sum_probs=134.0
Q ss_pred cccccCeeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHH------HHHHHHHHHhcCCCceeeEe
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE------FWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~ke------FlrEIeILk~LrHPNIVKL~ 1111 (1329)
.+-..+|+.+++||.|+||.||+...++..+|||++...... .+..... +.+|+..+.++.|++|..+.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-----~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-----TERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-----hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 455789999999999999999998777888999999765322 2232223 67899999999999999998
Q ss_pred cccccCC------CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCC
Q 000726 1112 GVVQDGP------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 1185 (1329)
Q Consensus 1112 Gif~e~~------dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdG 1185 (1329)
.++.... .+..+|||||++|.+|.++. .+++ ....+++.+|..||+.|++|||+||.||+++.+|
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC
Confidence 8755322 23578999999999998763 1232 2456899999999999999999999999998765
Q ss_pred CCCCcEEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHH
Q 000726 1186 PIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 1247 (1329)
Q Consensus 1186 ni~~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELL 1247 (1329)
++|+|||............ .++. ...+..++|+|+||+++..+.
T Consensus 173 -----i~liDfg~~~~~~e~~a~d-----------~~vl--er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -----LRIIDLSGKRCTAQRKAKD-----------RIDL--ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -----EEEEECCCcccccchhhHH-----------HHHH--HhHhcccccccceeEeehHHH
Confidence 5999999886543221110 0222 233456899999999987553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.3e-18 Score=177.34 Aligned_cols=145 Identities=21% Similarity=0.173 Sum_probs=107.0
Q ss_pred EEecccCcEEEEEEEE-CCceEEEEEEeccccCCCCh------------------HHHHHHHHHHHHHHHHHhcCCCcee
Q 000726 1048 KELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSS------------------EQERLTLEFWREAEILSKLHHPNVV 1108 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~-kGr~VAVKiLKks~~sd~s~------------------e~E~~~keFlrEIeILk~LrHPNIV 1108 (1329)
..||+|+||.||+|.+ +|+.||||+++......... ..........+|+.+|.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4699999999999988 58999999998754321110 0001112334699999999877764
Q ss_pred eEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHH-HHCCeeecCCCCcceEeccCCCC
Q 000726 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL-HSKNIVHFDLKCDNLLVNLKDPI 1187 (1329)
Q Consensus 1109 KL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYL-Hs~GIIHRDLKPeNILLDsdGni 1187 (1329)
....+... ..+|||||++++++...+. ....+++..+..++.|++.+|.|| |+.||+||||||+|||++. +
T Consensus 83 ~p~~~~~~----~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~-- 154 (190)
T cd05147 83 CPEPILLK----SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G-- 154 (190)
T ss_pred CCcEEEec----CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--
Confidence 33322211 2379999998876655432 235688999999999999999999 7999999999999999983 3
Q ss_pred CCcEEEeecCCcccc
Q 000726 1188 RPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1188 ~~~VKLsDFGLAr~~ 1202 (1329)
.++|+|||+|...
T Consensus 155 --~v~LiDFG~a~~~ 167 (190)
T cd05147 155 --KLYIIDVSQSVEH 167 (190)
T ss_pred --cEEEEEccccccC
Confidence 3699999998744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.6e-19 Score=217.38 Aligned_cols=244 Identities=20% Similarity=0.211 Sum_probs=174.8
Q ss_pred CeeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeE
Q 000726 1043 DLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L 1122 (1329)
++...+.||.+.|=+|.+|+++.-.|+||+|-+..-. -..+.+ .+-+.|++ ...++|||.+++.-+.... ...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~---~sL~~~-~qrL~~ik-~~l~~~pn~lPfqk~~~t~--kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPT---ISLRPF-KQRLEEIK-FALMKAPNCLPFQKVLVTD--KAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCC---CCchHH-HHHHHHHH-HHhhcCCcccchHHHHHhh--HHH
Confidence 6778889999999999999997666999999765311 111222 23344555 6667999999988776553 366
Q ss_pred EEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc-
Q 000726 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI- 1201 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~- 1201 (1329)
|+|-+|. ..+|.+.+..+ ..+...+...|+.|++.||.-+|..||||||||.+||||++- .++.|+||-..+.
T Consensus 97 ylvRqyv-khnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW----NW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW----NWLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHH-hhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee----chhhhhcccccCCc
Confidence 7788887 68999988544 346777778899999999999999999999999999999843 4679999987652
Q ss_pred c---cCcccc----cCCCCCCcccCccccccC--------C-CCCChhhHHHHHHHHHHHHHh-CCCCCCCCChh-----
Q 000726 1202 K---RNTLVT----GGVRGTLPWMAPELLNGS--------S-SKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG----- 1259 (1329)
Q Consensus 1202 ~---~~~~~s----s~~~GTp~YmAPEvL~Gs--------~-~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~----- 1259 (1329)
+ ++.... .+...-.+|+|||.+... . ...+++-||||+||+++||++ |++||.-...-
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~ 250 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG 250 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc
Confidence 1 111111 112233569999998531 1 125778999999999999998 78888431110
Q ss_pred --HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 000726 1260 --AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307 (1329)
Q Consensus 1260 --ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~L 1307 (1329)
...+..++ ...+..++.++..|++.||.+|.++++.|+.-
T Consensus 251 ~~~~~e~~Le--------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 251 NADDPEQLLE--------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred CccCHHHHHH--------hCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 00111111 11234689999999999999999999998873
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=171.44 Aligned_cols=147 Identities=19% Similarity=0.139 Sum_probs=109.1
Q ss_pred EEEecccCcEEEEEEEEC-CceEEEEEEeccccCCCC------------------hHHHHHHHHHHHHHHHHHhcCCCce
Q 000726 1047 LKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRS------------------SEQERLTLEFWREAEILSKLHHPNV 1107 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s------------------~e~E~~~keFlrEIeILk~LrHPNI 1107 (1329)
...||+|++|.||+|.+. |+.||||+++........ .........+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 357999999999999884 899999999875321100 0111112234579999999999987
Q ss_pred eeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCC
Q 000726 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDP 1186 (1329)
Q Consensus 1108 VKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGn 1186 (1329)
.....+... ..+|||||++++++..... ....++......++.|++.+|.+||. +||+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~- 154 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG- 154 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC-
Confidence 544433322 2379999998876544322 23457888899999999999999999 9999999999999998 44
Q ss_pred CCCcEEEeecCCccccc
Q 000726 1187 IRPICKVGDFGLSKIKR 1203 (1329)
Q Consensus 1187 i~~~VKLsDFGLAr~~~ 1203 (1329)
.++|+|||+++...
T Consensus 155 ---~~~liDFG~a~~~~ 168 (190)
T cd05145 155 ---KPYIIDVSQAVELD 168 (190)
T ss_pred ---CEEEEEcccceecC
Confidence 46999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.3e-19 Score=208.24 Aligned_cols=226 Identities=29% Similarity=0.411 Sum_probs=180.9
Q ss_pred EecccCcEEEEEEEE-----CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccccCCCCeE
Q 000726 1049 ELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~-----kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~e~~dg~L 1122 (1329)
.+|+|+||.|+++.- .+.-+|+|++++.....+... ....|..++..++ ||.+|+++-.++... .+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~------~t~~er~il~~~~~~~f~v~lhyafqt~~--kl 72 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT------HTKQERIILAFVHNTPFLVKLHYAFQTDG--KL 72 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc------ccccHHHHHhhccCCCceeeeeeeecccc--ch
Confidence 379999999997543 466799999987654332211 3345777888887 999999999888754 89
Q ss_pred EEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 000726 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
+++++++.++.|...+.... .+++.....+...++-+++++|+.+|+|||+|++||+++.+|++ ++.|||+.+..
T Consensus 73 ~l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi----~~tdfglske~ 147 (612)
T KOG0603|consen 73 YLILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHI----KLTDFGLSKEA 147 (612)
T ss_pred hHhhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCcc----ccCCchhhhHh
Confidence 99999999999988875443 45666666777899999999999999999999999999988865 99999999854
Q ss_pred cCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHH
Q 000726 1203 RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 1282 (1329)
Q Consensus 1203 ~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL 1282 (1329)
-..... |||..|||||++.| ...++|+||||++++||++|..||.. +....|... ....|......+
T Consensus 148 v~~~~~---cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~~~~p~~l~~~a 214 (612)
T KOG0603|consen 148 VKEKIA---CGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--ELEMPRELSAEA 214 (612)
T ss_pred Hhhhhc---ccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--ccCCchhhhHHH
Confidence 433322 89999999999983 36679999999999999999999987 444444443 345667788899
Q ss_pred HHHHHHhhcCCCCCCCCH
Q 000726 1283 RLLMEQCWAPDPVVRPSF 1300 (1329)
Q Consensus 1283 ~DLIkrCLqkDPeERPTa 1300 (1329)
.+++.+++..+|..|...
T Consensus 215 ~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 215 RSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHhhCHHHHhcc
Confidence 999999999999999644
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=186.11 Aligned_cols=237 Identities=18% Similarity=0.197 Sum_probs=149.7
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCC----------CceeeE
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH----------PNVVAF 1110 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrH----------PNIVKL 1110 (1329)
.+...+.||.|+++.||.+++. ++++|||++..... ......+++.+|.-....+.+ -.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~-----~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD-----ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST-----THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccc-----cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 4567889999999999999994 68999999976541 122234556666555544322 122222
Q ss_pred ecccc---------cCCCC------eEEEEEEeccCCchhhhhhc---cc---ccCCHHHHHHHHHHHHHHHHHHHHCCe
Q 000726 1111 YGVVQ---------DGPGG------TLATVTEFMVNGSLRHVLLS---KE---RHLDRRKRLIIAMDAAFGMEYLHSKNI 1169 (1329)
Q Consensus 1111 ~Gif~---------e~~dg------~L~LVMEYm~GGSL~d~L~~---ke---k~Lse~qrlkIA~QIAsALaYLHs~GI 1169 (1329)
++... ...+. ..+++|+-+ .++|..++.. .. ..+....++.+..|+++.+++||..|+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 22211 11110 235677766 6788776532 11 123444556677899999999999999
Q ss_pred eecCCCCcceEeccCCCCCCcEEEeecCCcccccCcccccCCCCCCcccCccccccC------CCCCChhhHHHHHHHHH
Q 000726 1170 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS------SSKVSEKVDVFSFGIVL 1243 (1329)
Q Consensus 1170 IHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs------~~~~S~KSDVWSLGVLL 1243 (1329)
+|+||+|+|+|++.+|. ++|+||+........... ...+..|.+||..... .-.++.+.|.|+||+++
T Consensus 167 VHgdi~~~nfll~~~G~----v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGG----VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp EEST-SGGGEEE-TTS-----EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCC----EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 99999999999998875 599999987755443332 2345779999987421 23468899999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCC
Q 000726 1244 WEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVR 1297 (1329)
Q Consensus 1244 yELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeER 1297 (1329)
|.|+++..||........... ....+. .+++.+++||.++|+.+|.+|
T Consensus 241 y~lWC~~lPf~~~~~~~~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGSTSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCccccccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999986543322111 112233 678999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.8e-17 Score=173.48 Aligned_cols=189 Identities=16% Similarity=0.024 Sum_probs=137.9
Q ss_pred EEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccccCCCCeEEE
Q 000726 1046 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1046 llkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~e~~dg~L~L 1124 (1329)
+...|++|+||+||++...+.+++.+.+....... ...+...+.+|+++|++|. |+++++++++. ..++
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~----~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~l 75 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWL----RGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHL 75 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhh----hhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEE
Confidence 34579999999999888778888888776543210 1122335789999999995 58899998861 4689
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCC-CCcceEeccCCCCCCcEEEeecCCccccc
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDL-KCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDL-KPeNILLDsdGni~~~VKLsDFGLAr~~~ 1203 (1329)
+|||+.|.+|...+.. ....++.|++.+|.+||++||+|||| ||+|||++.+|. ++|+|||++....
T Consensus 76 vmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~----i~LIDFG~A~~~~ 143 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS----PAVIDFQLAVRGN 143 (218)
T ss_pred EEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC----EEEEECCCceecC
Confidence 9999998888654311 11346789999999999999999999 799999987664 5999999998543
Q ss_pred Cccc--------------ccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCC
Q 000726 1204 NTLV--------------TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 1256 (1329)
Q Consensus 1204 ~~~~--------------ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~ 1256 (1329)
.... ..-...++.|+.|+.-.-....--.+.++++.|+-+|.++|+..++-..
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 3221 0011257778888765422222225789999999999999998886543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.3e-17 Score=202.09 Aligned_cols=206 Identities=31% Similarity=0.469 Sum_probs=153.4
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
-..++|..++.|-.|++|.||+++++ .+++|+|+-+... +|+ ||.. |.+
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l--------------------ilR-----nilt----~a~ 130 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL--------------------ILR-----NILT----FAG 130 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcccccch--------------------hhh-----cccc----ccC
Confidence 34568999999999999999999886 6678886543210 111 1211 111
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.+ +.| |++...+... ++++. +++.+++|||+-||+|||+||+|.||+.-|.+ |+.||
T Consensus 131 np----fvv------gDc~tllk~~-g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhi----KlTDf 187 (1205)
T KOG0606|consen 131 NP----FVV------GDCATLLKNI-GPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHI----KLTDF 187 (1205)
T ss_pred Cc----cee------chhhhhcccC-CCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccc----cccch
Confidence 11 112 5666555332 23332 23778999999999999999999999977755 99999
Q ss_pred CCcccccC----------------cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH
Q 000726 1197 GLSKIKRN----------------TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 1260 (1329)
Q Consensus 1197 GLAr~~~~----------------~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~e 1260 (1329)
|+.+.... ......++||+.|+|||++. -+.|+..+|||+||+++||.+.|+.||.+.+.++
T Consensus 188 gLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil--rqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 188 GLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL--RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred hhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh--hhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 99874211 11223568999999999998 5668899999999999999999999999999999
Q ss_pred HHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhcCCCCCCC
Q 000726 1261 IIGGIVNNTL-RPPVPGFCDSEWRLLMEQCWAPDPVVRP 1298 (1329)
Q Consensus 1261 ll~qIve~~l-r~~ips~~S~eL~DLIkrCLqkDPeERP 1298 (1329)
++..++.... .++-...+++++++++.++|+.+|..|-
T Consensus 266 lfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 266 LFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 8887765543 3333556789999999999999999994
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=165.48 Aligned_cols=142 Identities=22% Similarity=0.278 Sum_probs=112.2
Q ss_pred EEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEE
Q 000726 1048 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVME 1127 (1329)
+.||+|++|.||+|.+.+..|+||+...................+.+|+.++..+.|++|.....++.... ..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEEEE
Confidence 46999999999999999999999987654332211122223456788999999999998876666555433 6789999
Q ss_pred eccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1128 Ym~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
|++|++|.+++... .. .+..++.+++.+|.+||+.+++|+|++|.|||++ ++ .++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~----~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG----KIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC----CEEEEECCcccC
Confidence 99999999887432 12 7788999999999999999999999999999998 33 368999998764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=170.09 Aligned_cols=140 Identities=20% Similarity=0.204 Sum_probs=104.2
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-----CCCceeeEecccccCCC-C
Q 000726 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-----HHPNVVAFYGVVQDGPG-G 1120 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-----rHPNIVKL~Gif~e~~d-g 1120 (1329)
.+.||+|+||.||.....+. .+||++..... .....+.+|+.+++.+ .||||+++++++.+... +
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~--------~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGD--------GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cceecCCCceEEEECCCCcC-eEEEEEecccc--------chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 45799999999996222233 36887764311 1124678999999999 57999999999987532 3
Q ss_pred eEE-EEEEe--ccCCchhhhhhcccccCCHHHHHHHHHHHHHHH-HHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1121 TLA-TVTEF--MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM-EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1121 ~L~-LVMEY--m~GGSL~d~L~~kek~Lse~qrlkIA~QIAsAL-aYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.++ +|||| +.+++|.+++... .+++. ..++.+++.++ +|||+++|+||||||+|||++..+.....++|+||
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 434 78999 5578999999542 35555 34567888777 99999999999999999999876544557899995
Q ss_pred CCc
Q 000726 1197 GLS 1199 (1329)
Q Consensus 1197 GLA 1199 (1329)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-16 Score=161.78 Aligned_cols=138 Identities=22% Similarity=0.262 Sum_probs=105.5
Q ss_pred EecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEEe
Q 000726 1049 ELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1128 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVMEY 1128 (1329)
.||+|+||.||++.+.+..|+||++.................++.+|+.++..+.|+++.....++.... ..++||||
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEEEE
Confidence 3899999999999999999999997654322111112233456788999999998876544333333322 56899999
Q ss_pred ccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1129 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1129 m~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++ .++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~----~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD----KLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC----cEEEEECCCCcC
Confidence 999999887743211 7889999999999999999999999999998 33 469999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.9e-16 Score=184.52 Aligned_cols=209 Identities=34% Similarity=0.553 Sum_probs=163.8
Q ss_pred HHhcCCCceeeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCe-eecCCCCc
Q 000726 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNI-VHFDLKCD 1177 (1329)
Q Consensus 1099 Lk~LrHPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GI-IHRDLKPe 1177 (1329)
|+.+.|.|+.+++|.+.+++ .++.|.+||..|+|.+.+......+++.-...++++|+.||.|||.-.| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--EMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCC--ceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 35688999999999999875 8899999999999999998878889999999999999999999998866 99999999
Q ss_pred ceEeccCCCCCCcEEEeecCCcccccCc---ccccCCCCCCcccCccccccC--CC---CCChhhHHHHHHHHHHHHHhC
Q 000726 1178 NLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGS--SS---KVSEKVDVFSFGIVLWEILTG 1249 (1329)
Q Consensus 1178 NILLDsdGni~~~VKLsDFGLAr~~~~~---~~ss~~~GTp~YmAPEvL~Gs--~~---~~S~KSDVWSLGVLLyELLTG 1249 (1329)
|+++| ..+.+||+|||+....... .......-...|.|||.+.+. .. ..+.+.||||||++++|+++.
T Consensus 79 nClvd----~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 79 NCLVD----SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred cceee----eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999 4567899999998765321 111111234569999999853 11 147789999999999999999
Q ss_pred CCCCCCCCh----hHHHHHHHhcC---CCCCCCC--CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 000726 1250 EEPYANMHY----GAIIGGIVNNT---LRPPVPG--FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1250 k~PF~~~~~----~ell~qIve~~---lr~~ips--~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa 1313 (1329)
..||..... .+.+..+.... +++.+.. ...+.+..++++||..+|.+||++.++-..+..+...
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 999976322 23444433312 2333321 3456799999999999999999999998888877654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.8e-15 Score=186.48 Aligned_cols=247 Identities=20% Similarity=0.239 Sum_probs=176.5
Q ss_pred cccccCeeEEEEecccCcEEEEEEEE-CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC---CCceeeEecc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGV 1113 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~-kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr---HPNIVKL~Gi 1113 (1329)
.+..+.|.+.+.||+|+||.||+|.. +|+.||||+-+......- .=-.+++.+|+ -+.|..+...
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf-----------YI~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF-----------YICLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee-----------eehHHHHHhhchhhhcchHHHHHH
Confidence 45677899999999999999999987 588899999887654321 11122444444 2334444444
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccC---CCCCCc
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK---DPIRPI 1190 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsd---Gni~~~ 1190 (1329)
+.-.+ ..+||+||.+-|+|.+++. ..+.+++..+..|..||+..+++||..+|||+||||+|+||... ......
T Consensus 763 ~~~~~--~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 763 HVFQN--ASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred HccCC--cceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence 43333 5679999999999999996 55678999999999999999999999999999999999999521 111356
Q ss_pred EEEeecCCccc---ccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 000726 1191 CKVGDFGLSKI---KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1191 VKLsDFGLAr~---~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~qIve 1267 (1329)
++|+|||-+.. ..........++|-.+-.+|+.. +..++..+|.|.|+.+++-||.|+.-- ...
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~--grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~ 906 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE--GRPWTYQIDYFGLAATVHVMLFGKYME-----------VKN 906 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhc--CCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcC
Confidence 89999999863 33334456677899999999998 466899999999999999999985421 111
Q ss_pred cCCCC---CCCCCC-cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1268 NTLRP---PVPGFC-DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1268 ~~lr~---~ips~~-S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
..... .++... -.-+.+|...+|..|=..=|...+|...++.+.
T Consensus 907 g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 907 GSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred CcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 11110 011111 234667888888833333377777766666554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=182.30 Aligned_cols=142 Identities=24% Similarity=0.232 Sum_probs=111.2
Q ss_pred eeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEE
Q 000726 1044 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~ 1123 (1329)
|...+.||+|+||+||++.+.+..+++|+...................+.+|+.+++.++|++++..+.++.... ..+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--EKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CCE
Confidence 345678999999999999998877777765433222111112233456889999999999999988776665543 568
Q ss_pred EEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1124 LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
+||||+++++|.+++. ....++.+++.+|.|||+.||+||||||+|||++ ++ .++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~----~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD----RLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC----cEEEEeCccccc
Confidence 9999999999998874 3467899999999999999999999999999994 33 469999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-15 Score=163.35 Aligned_cols=148 Identities=20% Similarity=0.139 Sum_probs=109.6
Q ss_pred CeeEEEEecccCcEEEEEEE-E--CCceEEEEEEeccccCCCC----------------hHHHHHHHHHHHHHHHHHhcC
Q 000726 1043 DLEELKELGSGTFGTVYHGK-W--RGTDVAIKRIKKSCFTGRS----------------SEQERLTLEFWREAEILSKLH 1103 (1329)
Q Consensus 1043 dYellkvLGqGaFGtVYKA~-~--kGr~VAVKiLKks~~sd~s----------------~e~E~~~keFlrEIeILk~Lr 1103 (1329)
-|.+.+.||+|++|.||+|. + +|+.||||+++........ ...+.....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 3 6899999999864321100 011112234678999999997
Q ss_pred CC--ceeeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCCcceE
Q 000726 1104 HP--NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN-IVHFDLKCDNLL 1180 (1329)
Q Consensus 1104 HP--NIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~G-IIHRDLKPeNIL 1180 (1329)
+. .+.+++.+ . ..++||||+++.+|...+.. ...+.......++.||+.+|.+||.+| |+||||||+||+
T Consensus 109 ~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe---c---CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 53 33444442 1 34799999998888765432 234566677889999999999999999 999999999999
Q ss_pred eccCCCCCCcEEEeecCCcccc
Q 000726 1181 VNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1181 LDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
++ ++ .++|+|||.+...
T Consensus 182 i~-~~----~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DG----KVVIIDVSQSVEL 198 (237)
T ss_pred EE-CC----CEEEEEChhhhcc
Confidence 98 43 3699999998743
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.3e-15 Score=153.42 Aligned_cols=142 Identities=19% Similarity=0.064 Sum_probs=104.9
Q ss_pred eeEEEEecccCcEEEEEEEE-CCceEEEEEEeccccCCCCh-H-------------HHHHHHHHHHHHHHHHhcCCCc--
Q 000726 1044 LEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSS-E-------------QERLTLEFWREAEILSKLHHPN-- 1106 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~-kGr~VAVKiLKks~~sd~s~-e-------------~E~~~keFlrEIeILk~LrHPN-- 1106 (1329)
|.+.+.||+|+||.||++.+ +|+.||||+++......... . .......+.+|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66678899999999999988 58899999987542110000 0 0011224677899999998774
Q ss_pred eeeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCC
Q 000726 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 1186 (1329)
Q Consensus 1107 IVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGn 1186 (1329)
+...++. ...++||||+++++|...... .....++.+++.++.++|+.||+|+||||+||+++.++
T Consensus 97 v~~~~~~------~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~- 162 (198)
T cd05144 97 VPKPIDW------NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE- 162 (198)
T ss_pred CCceeec------CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-
Confidence 4444432 145899999999988765421 33457888999999999999999999999999998655
Q ss_pred CCCcEEEeecCCcccc
Q 000726 1187 IRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1187 i~~~VKLsDFGLAr~~ 1202 (1329)
.++|+|||++...
T Consensus 163 ---~~~liDfg~~~~~ 175 (198)
T cd05144 163 ---KIYIIDWPQMVST 175 (198)
T ss_pred ---cEEEEECCccccC
Confidence 4699999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.2e-15 Score=176.76 Aligned_cols=173 Identities=29% Similarity=0.390 Sum_probs=126.9
Q ss_pred CeEEEEEEeccCCchhhhhhcc--cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecC
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSK--ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1120 g~L~LVMEYm~GGSL~d~L~~k--ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFG 1197 (1329)
.+++|.|++|...+|.+|+..+ ....++...+.++.|++.++.| ++.+|+|+||.||+...+.. +||+|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q----~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ----LKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh----hhhhhhh
Confidence 3689999999999999999533 2456788889999999999999 99999999999999987664 5999999
Q ss_pred CcccccCcc-------cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcC
Q 000726 1198 LSKIKRNTL-------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1269 (1329)
Q Consensus 1198 LAr~~~~~~-------~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ell~qIve~~ 1269 (1329)
+........ ....-.||..||+||.+.| ..|+.++||||||++|+|++. =..++... ..+..+.+..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~ 476 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGI 476 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCC
Confidence 987543333 2234459999999999994 568999999999999999987 22222111 1111222222
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 000726 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305 (1329)
Q Consensus 1270 lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq 1305 (1329)
+.+.....+ +.-..|+.+++.+.|.+||++.+...
T Consensus 477 ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~ 511 (516)
T KOG1033|consen 477 IPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVAL 511 (516)
T ss_pred CChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhh
Confidence 222222222 33467999999999999996555443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-13 Score=130.56 Aligned_cols=130 Identities=23% Similarity=0.170 Sum_probs=106.5
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCC--CceeeEecccccCCCCeEEE
Q 000726 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH--PNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrH--PNIVKL~Gif~e~~dg~L~L 1124 (1329)
.+.||+|.++.||++...+..++||.++.... ...+.+|+.+++.+.| .++++++.++... +..++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~ 70 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGESD--GWSYL 70 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEE
Confidence 46799999999999999888999999865321 2457789999999976 5888888887764 47899
Q ss_pred EEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK---NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1125 VMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~---GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
+|||+.+..+..+ +......++.+++.+|++||.. +++|+||+|.|||++..+ .++++|||.+.
T Consensus 71 v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~----~~~l~Df~~~~ 137 (155)
T cd05120 71 LMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK----ILGIIDWEYAG 137 (155)
T ss_pred EEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc----EEEEEeccccc
Confidence 9999988777654 4556677889999999999985 799999999999998643 46999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2e-13 Score=148.48 Aligned_cols=144 Identities=15% Similarity=0.145 Sum_probs=105.0
Q ss_pred EEec-ccCcEEEEEEEECCceEEEEEEecccc-----CCCChHHHHHHHHHHHHHHHHHhcCCCce--eeEecccccCCC
Q 000726 1048 KELG-SGTFGTVYHGKWRGTDVAIKRIKKSCF-----TGRSSEQERLTLEFWREAEILSKLHHPNV--VAFYGVVQDGPG 1119 (1329)
Q Consensus 1048 kvLG-qGaFGtVYKA~~kGr~VAVKiLKks~~-----sd~s~e~E~~~keFlrEIeILk~LrHPNI--VKL~Gif~e~~d 1119 (1329)
..|| .|+.|+||.+...+..++||.+..... .............+.+|+.++..|.|++| ++.+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 3577 889999999988899999999965321 11111111223567889999999998775 667766443221
Q ss_pred --CeEEEEEEeccC-CchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1120 --GTLATVTEFMVN-GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1120 --g~L~LVMEYm~G-GSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
...++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||++||+|+||||.|||++.++ .++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~----~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG----KFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC----CEEEEEC
Confidence 123599999987 588877743 234443 356899999999999999999999999998765 4699999
Q ss_pred CCccc
Q 000726 1197 GLSKI 1201 (1329)
Q Consensus 1197 GLAr~ 1201 (1329)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.8e-13 Score=139.68 Aligned_cols=143 Identities=20% Similarity=0.094 Sum_probs=95.3
Q ss_pred EEEecccCcEEEEEEEEC-CceEEEEEEeccccCCCChHHH----------------HHHHHHHHHHHHHHhcCCCc--e
Q 000726 1047 LKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQE----------------RLTLEFWREAEILSKLHHPN--V 1107 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e~E----------------~~~keFlrEIeILk~LrHPN--I 1107 (1329)
.+.||+|+||.||+|.+. ++.||||+++............ ........|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999886 8899999987643221110000 00011134566666654332 4
Q ss_pred eeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCC
Q 000726 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDP 1186 (1329)
Q Consensus 1108 VKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGn 1186 (1329)
.+++++. ..++||||++++.+......... . ...+..++.+++.++.++|. .+|+|+||||+||+++ ++
T Consensus 82 ~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~- 151 (187)
T cd05119 82 PKPIDLN------RHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG- 151 (187)
T ss_pred CceEecC------CCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-
Confidence 4444431 35899999988544322111110 1 15677899999999999999 9999999999999999 44
Q ss_pred CCCcEEEeecCCcccc
Q 000726 1187 IRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1187 i~~~VKLsDFGLAr~~ 1202 (1329)
.++|+|||.+...
T Consensus 152 ---~~~liDfg~a~~~ 164 (187)
T cd05119 152 ---KVYIIDVPQAVEI 164 (187)
T ss_pred ---cEEEEECcccccc
Confidence 4599999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.2e-14 Score=174.59 Aligned_cols=259 Identities=24% Similarity=0.252 Sum_probs=193.9
Q ss_pred ccCeeEEEEecccCcEEEEEEEEC---CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEeccccc
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 1116 (1329)
Q Consensus 1041 ~edYellkvLGqGaFGtVYKA~~k---Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~e 1116 (1329)
...|.+.+.||+|+|+.|-+.... ...+|+|.+.... ...........|..+-+.+. |+|++.+++....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC------CccchhhhcCccccccccccccccccccCCccCC
Confidence 445777778999999999877653 2336666655432 12223344455777777776 9999999999887
Q ss_pred CCCCeEEEEEEeccCCchhhhh-hcccccCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVL-LSKERHLDRRKRLIIAMDAAFGMEYLH-SKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L-~~kek~Lse~qrlkIA~QIAsALaYLH-s~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
.. ..+++++|..++++...+ .......+......++.|+..++.|+| ..++.|+|+||+|.+++..+. ..+++
T Consensus 93 ~~--~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~---~l~~~ 167 (601)
T KOG0590|consen 93 PR--SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS---ALKIA 167 (601)
T ss_pred Cc--ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC---cccCC
Confidence 65 788999999999999888 433325666777788999999999999 999999999999999998873 34999
Q ss_pred ecCCcccccC----cccccCCCC-CCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH-HHHHhc
Q 000726 1195 DFGLSKIKRN----TLVTGGVRG-TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII-GGIVNN 1268 (1329)
Q Consensus 1195 DFGLAr~~~~----~~~ss~~~G-Tp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell-~qIve~ 1268 (1329)
|||+|..+.. .......+| ++.|+|||...+. .......|+||.|+++.-+++|..||......... ......
T Consensus 168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~ 246 (601)
T KOG0590|consen 168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN 246 (601)
T ss_pred CchhhccccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccccceeeccc
Confidence 9999986543 223345568 9999999999853 33467899999999999999999999765433211 111111
Q ss_pred CC--CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 000726 1269 TL--RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1269 ~l--r~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~ 1311 (1329)
.. .............+++.+++..+|..|.+.+++....|...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 11 23334556788899999999999999999999987777655
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.7e-11 Score=146.29 Aligned_cols=249 Identities=23% Similarity=0.207 Sum_probs=182.5
Q ss_pred cCeeEEEEecc--cCcEEEEEEEE----CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEeccc
Q 000726 1042 EDLEELKELGS--GTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVV 1114 (1329)
Q Consensus 1042 edYellkvLGq--GaFGtVYKA~~----kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gif 1114 (1329)
..+...+.+|. |.+|.||.+.. .+..+|+|.-+........ ...-++|+...+.+ .|+|.++.+..+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~------~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD------SKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc------cccccchhhcccccCccccccccCccc
Confidence 44566778999 99999999876 3667898874433221111 11223566666666 499999988888
Q ss_pred ccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHH----HHHHHHHCCeeecCCCCcceEeccCCCCCCc
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190 (1329)
Q Consensus 1115 ~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAs----ALaYLHs~GIIHRDLKPeNILLDsdGni~~~ 1190 (1329)
.... .+++-+|+| +.+|..+.......++...++.++.+..+ ||.++|...++|-|+||.||+...++ ..
T Consensus 188 e~~~--~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~---~s 261 (524)
T KOG0601|consen 188 EGSG--ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW---TS 261 (524)
T ss_pred ccCC--cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc---ce
Confidence 8754 889999988 68999988877777899999999999999 99999999999999999999999774 34
Q ss_pred EEEeecCCcccccCccccc------CCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 000726 1191 CKVGDFGLSKIKRNTLVTG------GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1264 (1329)
Q Consensus 1191 VKLsDFGLAr~~~~~~~ss------~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~~~~~~ell~q 1264 (1329)
++++|||+........... ...|...|++||.+.+ .++...|+|+||.++.+..++..+.....+.. +..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~ 337 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQ 337 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCC-ccc
Confidence 7999999988654433221 1247788999999974 36788999999999999998776654331111 111
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 000726 1265 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306 (1329)
Q Consensus 1265 Ive~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~ 1306 (1329)
+.......++-...+..+..++.+|++.+|..|++++.++.+
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 111122233333456677779999999999999999887654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.3e-10 Score=137.18 Aligned_cols=148 Identities=22% Similarity=0.204 Sum_probs=97.7
Q ss_pred EEecccCcEEEEEEEE-CCceEEEEEEeccccCCCC--------------------------hHHHHHH------HHHHH
Q 000726 1048 KELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS--------------------------SEQERLT------LEFWR 1094 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~-kGr~VAVKiLKks~~sd~s--------------------------~e~E~~~------keFlr 1094 (1329)
+.||.|++|.||+|+. +|+.||||+.+......-. ...+.+. ..|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4699999999999998 5899999998764211000 0000111 13556
Q ss_pred HHHHHHhcC----CCceeeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHH-HHHHHHHCCe
Q 000726 1095 EAEILSKLH----HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF-GMEYLHSKNI 1169 (1329)
Q Consensus 1095 EIeILk~Lr----HPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAs-ALaYLHs~GI 1169 (1329)
|+..+.++. |.+-+.+-.++.+. .+..+|||||++|.+|.+.........+ ...++..++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 666666652 33333333333221 1246899999999999887643222222 3345666665 4788999999
Q ss_pred eecCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 000726 1170 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1329)
Q Consensus 1170 IHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~ 1203 (1329)
+|+|++|.||+++.++. ++|+|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~----i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGK----IIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCc----EEEEeCCCeeECC
Confidence 99999999999987664 5999999987544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.2e-10 Score=116.47 Aligned_cols=127 Identities=18% Similarity=0.119 Sum_probs=93.0
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCce-eeEecccccCCCCeEEEE
Q 000726 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV-VAFYGVVQDGPGGTLATV 1125 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNI-VKL~Gif~e~~dg~L~LV 1125 (1329)
++.|+.|.++.||+++..+..|+||+...... ....+.+|+.+++.+.+.++ .+++.+... ..++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~----~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---------LLINRENEAENSKLAAEAGIGPKLYYFDPE----TGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---------cccCHHHHHHHHHHHHHhCCCCceEEEeCC----CCeEE
Confidence 45789999999999999999999998764321 01234578888888765443 345544332 34789
Q ss_pred EEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCe-----eecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNI-----VHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1126 MEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GI-----IHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
|||+++.++.... . ....++.+++.+|+.||..++ +|+|++|.||+++ ++ .++|+||+.+.
T Consensus 70 ~e~i~G~~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~----~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG----RLWLIDWEYAG 135 (170)
T ss_pred EEecCCCcccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC----eEEEEeccccc
Confidence 9999998876431 1 112356789999999999885 9999999999998 33 35899999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.5e-10 Score=136.63 Aligned_cols=151 Identities=20% Similarity=0.246 Sum_probs=93.3
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccC---------------------C--C---ChHHHHHHH-----
Q 000726 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFT---------------------G--R---SSEQERLTL----- 1090 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~s---------------------d--~---s~e~E~~~k----- 1090 (1329)
|.. +.||.|++|.||+|+++ |+.||||+.++.... . . ....+.+..
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 444 67999999999999983 899999999864210 0 0 000111222
Q ss_pred -HHHHHHHHHHhcC----CCceeeEecccccCCCCeEEEEEEeccCCchhhhh--hcccc---cCCHHHHHHHHHHHHHH
Q 000726 1091 -EFWREAEILSKLH----HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKER---HLDRRKRLIIAMDAAFG 1160 (1329)
Q Consensus 1091 -eFlrEIeILk~Lr----HPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L--~~kek---~Lse~qrlkIA~QIAsA 1160 (1329)
.+.+|+..+.++. +...+.+-.++.+- ....+||||||.|+.+.+.. ...+. .+....+..++.
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~----- 274 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT----- 274 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH-----
Confidence 2445555554442 33333333333221 12467999999999997642 21111 122222223333
Q ss_pred HHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 000726 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1329)
Q Consensus 1161 LaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~ 1203 (1329)
-+...|++|+|+||.||+++.+|.....++++|||++....
T Consensus 275 --Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 --QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred --HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 34568999999999999999887555678999999987543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.9e-09 Score=113.68 Aligned_cols=153 Identities=21% Similarity=0.202 Sum_probs=108.3
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEE
Q 000726 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVT 1126 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVM 1126 (1329)
+..|-||+-+.|+++.+.|+.+.||.-......-..-+......+.++|+.+|.++.--.|.-.--++.+.. .-.|+|
T Consensus 12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~--~~~i~M 89 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY--GGQIYM 89 (229)
T ss_pred ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC--CCeEEE
Confidence 456889999999999999999888865444333222233444567789999999886333322222233322 346799
Q ss_pred EeccC-CchhhhhhcccccCCHHH-HHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 000726 1127 EFMVN-GSLRHVLLSKERHLDRRK-RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1127 EYm~G-GSL~d~L~~kek~Lse~q-rlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
||+++ .++.+++......-.... ...++..|-+.+.-||.++|||+||..+||++..+++. ..+.|+|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~-~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQ-ITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCc-CceEEEeecchhcc
Confidence 99976 366677654433323333 36788899999999999999999999999999988754 56689999998643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.6e-09 Score=113.04 Aligned_cols=137 Identities=22% Similarity=0.242 Sum_probs=100.1
Q ss_pred EecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCc--eeeEecccccCCCCeEEEEE
Q 000726 1049 ELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQDGPGGTLATVT 1126 (1329)
Q Consensus 1049 vLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPN--IVKL~Gif~e~~dg~L~LVM 1126 (1329)
.+++|+-+.||.+.|.|.++.+|.-.+.......-...-...+-.+|+.+|.++.--. ...++++. .. ...|+|
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~--~~~I~m 78 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PD--NGLIVM 78 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CC--CCEEEE
Confidence 5789999999999998888888865554443222222233445678999999885333 33344433 22 457899
Q ss_pred EeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 000726 1127 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1127 EYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
||++|..|.+++... ...++..+-.-+.-||..||||+||.++||++...+ +.++|||++...
T Consensus 79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-----i~~IDfGLg~~s 141 (204)
T COG3642 79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-----IYFIDFGLGEFS 141 (204)
T ss_pred EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-----EEEEECCccccc
Confidence 999888888888543 245667777888899999999999999999998554 589999998743
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.95 E-value=9.7e-09 Score=110.32 Aligned_cols=143 Identities=18% Similarity=0.112 Sum_probs=97.0
Q ss_pred EEecccCcEEEEEEEEC--------CceEEEEEEeccccCCC--------C----------hHHHHHHHHHHHHHHHHHh
Q 000726 1048 KELGSGTFGTVYHGKWR--------GTDVAIKRIKKSCFTGR--------S----------SEQERLTLEFWREAEILSK 1101 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k--------Gr~VAVKiLKks~~sd~--------s----------~e~E~~~keFlrEIeILk~ 1101 (1329)
..||.|--+.||.|... +..+|||+++.....-. . ........-..+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 36899999999999754 36899999975432100 0 0011111223479999998
Q ss_pred cCC--CceeeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHH-HHCCeeecCCCCcc
Q 000726 1102 LHH--PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL-HSKNIVHFDLKCDN 1178 (1329)
Q Consensus 1102 LrH--PNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYL-Hs~GIIHRDLKPeN 1178 (1329)
+.. -++.+++++ . ..+|||||+.+..+..... +...++......+..+++.+|..| |+.||||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~L-kd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKL-KDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhh-hccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 853 345566654 2 3478999996543322111 122345556677889999999998 89999999999999
Q ss_pred eEeccCCCCCCcEEEeecCCcccc
Q 000726 1179 LLVNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1179 ILLDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
||++. + .++|+|||.+...
T Consensus 156 IL~~~-~----~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWHD-G----KVWFIDVSQSVEP 174 (197)
T ss_pred EEEEC-C----cEEEEECCCceeC
Confidence 99973 3 3599999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.7e-10 Score=133.43 Aligned_cols=257 Identities=21% Similarity=0.193 Sum_probs=178.4
Q ss_pred cccccCeeEEEEecccCcEEEEEEEEC---CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceeeEecc
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGV 1113 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~k---Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVKL~Gi 1113 (1329)
.....+|.++..||.|.|+.|++...+ +..+++|.+........ .+ ..-+.|+.+...+ .|.++++.+..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~--~d----i~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA--SD----IFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH--hh----hcchhhhhHhhHhhcccccCCCCCC
Confidence 344567899999999999999987653 56688887765433211 11 1123556566655 48888887766
Q ss_pred cccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEE
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKL 1193 (1329)
|..-. ..++-.|||+++++.... .-...+++..++.+..|++.++.++|+..++|+|+||.||++..+| +..++
T Consensus 335 W~~~r--~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~---~~~~~ 408 (524)
T KOG0601|consen 335 WSQLR--QGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG---FFSKL 408 (524)
T ss_pred ccccc--cccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch---hhhhc
Confidence 65533 567899999999877665 2234577888899999999999999999999999999999999765 46799
Q ss_pred eecCCcccccCcccccCCCCCCccc-CccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCC-CCChhHHHHHHHhcCCC
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA-NMHYGAIIGGIVNNTLR 1271 (1329)
Q Consensus 1194 sDFGLAr~~~~~~~ss~~~GTp~Ym-APEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~-~~~~~ell~qIve~~lr 1271 (1329)
+|||.++...-. ......+-++. ..|++.. .+.+..+.|+++||..+.+.+++...-. ......+ ..+.
T Consensus 409 ~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e-~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i-----~~~~- 479 (524)
T KOG0601|consen 409 GDFGCWTRLAFS--SGVFHHIDRLYPIAEILLE-DYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI-----RSGD- 479 (524)
T ss_pred ccccccccccee--cccccccccccccchhhcc-ccccccccccccccccccccccCcccCcccccceee-----eccc-
Confidence 999998631111 11122333344 2454443 5667789999999999999999865322 2211111 1111
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 000726 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1272 ~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~L~aa~q 1315 (1329)
.+........+..+.+.++..++..||.+.++..+.......|.
T Consensus 480 ~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~~~ 523 (524)
T KOG0601|consen 480 TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDSRP 523 (524)
T ss_pred ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhhccC
Confidence 12222334778888999999999999999999888877766553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.3e-09 Score=136.25 Aligned_cols=249 Identities=23% Similarity=0.246 Sum_probs=175.0
Q ss_pred ccccCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 I~~edYellkvLGqGaFGtVYKA~~k--Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e 1116 (1329)
...+.+.+.+-+-+|+++.++.+.-. |...++|+.+........ ......++-.++-...+|.++....-+..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~-----~~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN-----DYESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccc-----cccccCCccCccccCCCCceecccCCCCC
Confidence 45567777788889999999877653 333555554432211110 01122233333333456777765544333
Q ss_pred CCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeec
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 ~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDF 1196 (1329)
.. .++|+|+|..+++|...++..+ ..+..-....+..+..+++|||...+.|+|++|.|+|+..+|.. ++.||
T Consensus 876 rs--P~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~----~l~~~ 948 (1205)
T KOG0606|consen 876 RS--PLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHR----PLTDF 948 (1205)
T ss_pred CC--CcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCc----ccCcc
Confidence 32 6899999999999998886554 35555556666788899999999999999999999999988866 89999
Q ss_pred CCccc---c----cC-------------------------cccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHH
Q 000726 1197 GLSKI---K----RN-------------------------TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLW 1244 (1329)
Q Consensus 1197 GLAr~---~----~~-------------------------~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLy 1244 (1329)
|.... . .. ........+|+.|.+||.+.+. .....+|+|++|++++
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~ 1026 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLF 1026 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhh
Confidence 84321 0 00 0012234589999999999853 3456799999999999
Q ss_pred HHHhCCCCCCCCChhHHHHHHHhcCCC-CCCCCCCcHHHHHHHHHhhcCCCCCCCCHH
Q 000726 1245 EILTGEEPYANMHYGAIIGGIVNNTLR-PPVPGFCDSEWRLLMEQCWAPDPVVRPSFT 1301 (1329)
Q Consensus 1245 ELLTGk~PF~~~~~~ell~qIve~~lr-~~ips~~S~eL~DLIkrCLqkDPeERPTae 1301 (1329)
|.++|.+||...........+...... +..+...+....+++...+..++.+|-.+.
T Consensus 1027 e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999999998888877776655443 233456788899999999999999997665
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.6e-08 Score=103.05 Aligned_cols=143 Identities=24% Similarity=0.268 Sum_probs=102.2
Q ss_pred EEecccCcEEEEEEEECC-ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCC--ceeeEecccccCC-CCeEE
Q 000726 1048 KELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP--NVVAFYGVVQDGP-GGTLA 1123 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~kG-r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHP--NIVKL~Gif~e~~-dg~L~ 1123 (1329)
+.|+.|.++.||+++..+ ..++||+....... .....+.+|..+++.+.+. .+.+++.+..... .+..+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF 76 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence 568999999999998865 88999987643211 0123567889999998753 4566676665421 13568
Q ss_pred EEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 000726 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS------------------------------------- 1166 (1329)
Q Consensus 1124 LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs------------------------------------- 1166 (1329)
+||||++|.++...+.. ..++..+...++.+++++|++||+
T Consensus 77 ~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 77 YVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred EEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 99999999888775531 346666777777788888877773
Q ss_pred -------------------CCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1167 -------------------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1167 -------------------~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
..+||+|+++.|||++.++ ...+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~--~~~~~iID~e~~~~ 206 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE--PRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC--CcEEEEEecccccc
Confidence 2479999999999998641 12468999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=8.1e-08 Score=116.85 Aligned_cols=162 Identities=22% Similarity=0.282 Sum_probs=117.0
Q ss_pred CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEEeccCCchhhhhhcccc
Q 000726 1064 RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER 1143 (1329)
Q Consensus 1064 kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek 1143 (1329)
.+.+|.|..++...- .......+-++-|+.++||||++++..+.... .+|||+|-+ ..|..++...
T Consensus 36 ~~~~vsVF~~~~~~~--------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV--~Pl~~~lk~l-- 101 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERV--RPLETVLKEL-- 101 (690)
T ss_pred cCCceEEEEEeCCCc--------hhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeecc--ccHHHHHHHh--
Confidence 467888888875421 11233456677899999999999999988744 999999988 4566555432
Q ss_pred cCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCccc-ccCCCCCCcccCcc
Q 000726 1144 HLDRRKRLIIAMDAAFGMEYLH-SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV-TGGVRGTLPWMAPE 1221 (1329)
Q Consensus 1144 ~Lse~qrlkIA~QIAsALaYLH-s~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~-ss~~~GTp~YmAPE 1221 (1329)
.......-+.||+.||.||| +.+++|++|.-..|+|+..|.- ||++|.++........ .....--..|..|+
T Consensus 102 --~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeW----kLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 --GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEW----KLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcE----EEeeeEEEeccccCCcccccchhhhcccChh
Confidence 24555566789999999998 4579999999999999988865 9999998864332211 11111223467777
Q ss_pred ccccCCCCCChhhHHHHHHHHHHHHHhC
Q 000726 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTG 1249 (1329)
Q Consensus 1222 vL~Gs~~~~S~KSDVWSLGVLLyELLTG 1249 (1329)
.+... . ...|.|-|||++++++.|
T Consensus 176 ~~~~s--~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPS--E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCcc--c--cchhhhhHHHHHHHHhCc
Confidence 66521 1 347999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.4e-09 Score=120.12 Aligned_cols=197 Identities=21% Similarity=0.288 Sum_probs=133.7
Q ss_pred HHHhcCCCceeeEecccccCC---CCeEEEEEEeccCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHC--Ce
Q 000726 1098 ILSKLHHPNVVAFYGVVQDGP---GGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSK--NI 1169 (1329)
Q Consensus 1098 ILk~LrHPNIVKL~Gif~e~~---dg~L~LVMEYm~GGSL~d~L~~k---ek~Lse~qrlkIA~QIAsALaYLHs~--GI 1169 (1329)
-|-.+.|-|||+++.|+.+.. .....++.|||..|++..+|+.. ...+....-.+|+-||+.||.|||+- .|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 345567999999999987543 24678999999999999998643 34577777888999999999999986 59
Q ss_pred eecCCCCcceEeccCCCCCCcEEEeecCCcccc-----cCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHH
Q 000726 1170 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-----RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLW 1244 (1329)
Q Consensus 1170 IHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~-----~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLy 1244 (1329)
+|++|...-|++..+|- +|++---..... ..........+-++|.+||.-. ....+-.+|||+||....
T Consensus 200 ihgnlTc~tifiq~ngL----Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~--~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGL----IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT--TTNTTGASDIYKFGMCAL 273 (458)
T ss_pred ccCCcchhheeecCCce----EEecccCccccchhhhhhhHhhhhccccCCccccCCcCc--ccccccchhhhhhhHHHH
Confidence 99999999999996653 344321111110 0011112233668899999754 333456799999999999
Q ss_pred HHHhCCCCCCCCCh----hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1245 EILTGEEPYANMHY----GAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1245 ELLTGk~PF~~~~~----~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
||..+..--..... .+.+...+ -......-+.++.+|++.+|..||++.+++-|+-
T Consensus 274 emailEiq~tnseS~~~~ee~ia~~i--------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIANVI--------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhhhe--------eeccCccccCcCcccccCCCCCCcchhhhhcCce
Confidence 99887654222111 11111110 0011122345789999999999999999987653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.7e-07 Score=103.31 Aligned_cols=141 Identities=18% Similarity=0.098 Sum_probs=95.2
Q ss_pred EEEEEEECCceEEEEEEeccccCCCChHHHH------HHHHHHHHHHHHHhcCCCce--eeEecccccCC---CCeEEEE
Q 000726 1057 TVYHGKWRGTDVAIKRIKKSCFTGRSSEQER------LTLEFWREAEILSKLHHPNV--VAFYGVVQDGP---GGTLATV 1125 (1329)
Q Consensus 1057 tVYKA~~kGr~VAVKiLKks~~sd~s~e~E~------~~keFlrEIeILk~LrHPNI--VKL~Gif~e~~---dg~L~LV 1125 (1329)
.|+++++.|+.|.||......... ..+. -...+.+|...+.+|...+| +.++++..... ....+||
T Consensus 37 rvvr~~~~g~~~~vKr~~~~~~~~---~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFELAGKSYFLKWHRGTGWGE---IFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEEECCEEEEEEEecCCcHHH---HhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 366788888999999775432110 0000 01136788888888743332 23333332211 2257899
Q ss_pred EEeccCC-chhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccC---CCCCCcEEEeecCCcc
Q 000726 1126 TEFMVNG-SLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK---DPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1126 MEYm~GG-SL~d~L~~k-ek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsd---Gni~~~VKLsDFGLAr 1200 (1329)
||++++. +|.+++... ....+......++.+++..++-||..||+|+||++.|||++.+ +.....+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999876 788877432 2345566777899999999999999999999999999999852 2234568999999875
|
|
| >smart00666 PB1 PB1 domain | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.6e-08 Score=88.78 Aligned_cols=75 Identities=47% Similarity=0.754 Sum_probs=65.4
Q ss_pred CCceeecCceEEEEecCCCChHHHHHHHHHHcCC---ceEEEeeCCCCCCCceeeccChhHHHHHHHHhhhhcccCCCCc
Q 000726 203 GKLRYVGGETRIIRISRDISWQELTQKALAIYNQ---THTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKP 279 (1329)
Q Consensus 203 ~~l~YvGG~triv~V~r~~~f~~l~~kl~~~~~~---~~~lkYqLP~edLD~LisVt~DeDL~~m~~Eydr~~~~~~~~~ 279 (1329)
.+++| ||++|.+.|+++++|.+|+.++...++. .++|||+ .||-| +|++++|+||..|++.+.+.. ...+
T Consensus 4 vK~~~-~~~~~~~~~~~~~s~~dL~~~i~~~~~~~~~~~~l~Y~--Dedgd-~v~l~sd~Dl~~a~~~~~~~~---~~~l 76 (81)
T smart00666 4 VKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLTSDEDLEEAIEEYDSLG---SKKL 76 (81)
T ss_pred EEEEE-CCEEEEEEECCCCCHHHHHHHHHHHhCCCCCCeEEEEE--CCCCC-EEEecCHHHHHHHHHHHHHcC---CceE
Confidence 35677 8999999999999999999999999975 6899999 77777 999999999999999998654 3478
Q ss_pred EEEEe
Q 000726 280 RMFLF 284 (1329)
Q Consensus 280 R~flF 284 (1329)
|+++|
T Consensus 77 ~l~v~ 81 (81)
T smart00666 77 RLHVF 81 (81)
T ss_pred EEEeC
Confidence 88876
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=8.1e-07 Score=103.91 Aligned_cols=252 Identities=18% Similarity=0.212 Sum_probs=157.7
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhc-CCCceee----EecccccCCCCe
Q 000726 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVA----FYGVVQDGPGGT 1121 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~L-rHPNIVK----L~Gif~e~~dg~ 1121 (1329)
.+.||+|+.+.+|-.-.-+ ..+-|++..... .... +.+..|... .||-+-. ........+.+.
T Consensus 16 gr~LgqGgea~ly~l~e~~-d~VAKIYh~Ppp-----a~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVR-DQVAKIYHAPPP-----AAQA------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CccccCCccceeeecchhh-chhheeecCCCc-----hHHH------HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 4579999999999532222 234477765321 1111 112233333 4553322 222222222223
Q ss_pred -EEEEEEeccCCchhhhhhc------ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEe
Q 000726 1122 -LATVTEFMVNGSLRHVLLS------KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1122 -L~LVMEYm~GGSL~d~L~~------kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLs 1194 (1329)
+.++|..+.+..--..+.. .-....|.-.++.++.++.+.+-||..|.+-+|+.++|+|+.+++. |.|.
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~----V~LV 159 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK----VVLV 159 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce----EEEE
Confidence 7788888866522222211 1235789999999999999999999999999999999999997764 3677
Q ss_pred ecCCcccccCcccccCCCCCCcccCccccc-cC--CCCCChhhHHHHHHHHHHHHHhC-CCCCCCCChh----HHHH-HH
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLN-GS--SSKVSEKVDVFSFGIVLWEILTG-EEPYANMHYG----AIIG-GI 1265 (1329)
Q Consensus 1195 DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~-Gs--~~~~S~KSDVWSLGVLLyELLTG-k~PF~~~~~~----ell~-qI 1265 (1329)
|-.......+.....+..|...|++||.-. +. ....+...|.|.||+++++++.| ++||.+.... ...+ .|
T Consensus 160 dsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 160 DSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred cccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 654433334444444566889999999865 21 12235568999999999999985 9999764221 0000 01
Q ss_pred H----------hcCCCCC---C-CCCCcHHHHHHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHh
Q 000726 1266 V----------NNTLRPP---V-PGFCDSEWRLLMEQCWAPD--PVVRPSFTEIARRLRVMSAAC 1314 (1329)
Q Consensus 1266 v----------e~~lr~~---i-ps~~S~eL~DLIkrCLqkD--PeERPTaeELLq~Le~L~aa~ 1314 (1329)
. ..+++++ . -..+++.+..+..+|+... +.-|||++.++..|..+...+
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 1 1111111 1 1235788999999999764 457999999998888876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.59 E-value=4e-07 Score=97.24 Aligned_cols=132 Identities=24% Similarity=0.173 Sum_probs=80.5
Q ss_pred EEEEEEE-CCceEEEEEEeccccCC-----------C-------ChHHHHHHHHHHHHHHHHHhcCCC--ceeeEecccc
Q 000726 1057 TVYHGKW-RGTDVAIKRIKKSCFTG-----------R-------SSEQERLTLEFWREAEILSKLHHP--NVVAFYGVVQ 1115 (1329)
Q Consensus 1057 tVYKA~~-kGr~VAVKiLKks~~sd-----------~-------s~e~E~~~keFlrEIeILk~LrHP--NIVKL~Gif~ 1115 (1329)
.||.|.. .|..+|||+++.....- + ............+|...|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3898887 58899999997542210 0 011222334567899999999765 456666543
Q ss_pred cCCCCeEEEEEEecc--CCchhhhhhcccccCCHHHHHHHHHHHHHHHHH-HHHCCeeecCCCCcceEeccCCCCCCcEE
Q 000726 1116 DGPGGTLATVTEFMV--NGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY-LHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1116 e~~dg~L~LVMEYm~--GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaY-LHs~GIIHRDLKPeNILLDsdGni~~~VK 1192 (1329)
.-+|||||++ |..+..+. ... ++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.
T Consensus 80 -----~~~ivME~I~~~G~~~~~l~-~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-----~~~ 146 (188)
T PF01163_consen 80 -----RNVIVMEYIGEDGVPLPRLK-DVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-----KVY 146 (188)
T ss_dssp -----TTEEEEE--EETTEEGGCHH-HCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-----CEE
T ss_pred -----CCEEEEEecCCCccchhhHH-hcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-----eEE
Confidence 2378999998 55554433 211 1133445567778775554 679999999999999999865 369
Q ss_pred EeecCCcccc
Q 000726 1193 VGDFGLSKIK 1202 (1329)
Q Consensus 1193 LsDFGLAr~~ 1202 (1329)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.7e-06 Score=101.61 Aligned_cols=215 Identities=17% Similarity=0.159 Sum_probs=148.2
Q ss_pred cEEEEEEEE--CCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCC--CCeEEEEEEecc
Q 000726 1055 FGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP--GGTLATVTEFMV 1130 (1329)
Q Consensus 1055 FGtVYKA~~--kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~--dg~L~LVMEYm~ 1130 (1329)
..+.|++.. +|..|++|++...... ... ....-++.++++.|+|+|++..+|.... +..+++|++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~n------k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQ--STN------KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP 360 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccccc--Ccc------cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence 356788876 5888999999432211 110 1112356889999999999999887332 346899999997
Q ss_pred CC-chhhhhhc--------------ccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEee
Q 000726 1131 NG-SLRHVLLS--------------KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1131 GG-SL~d~L~~--------------kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsD 1195 (1329)
+. +|.++.+. .+...++..+|.++.|+..||.++|+.|...+-|.+.+||++.+- .++|+-
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~----RIriS~ 436 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM----RIRISG 436 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc----eEEEec
Confidence 65 66655432 123468899999999999999999999999999999999999442 467887
Q ss_pred cCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCC-CCCCChhHHHHHHHhcCCCCCC
Q 000726 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP-YANMHYGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1196 FGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~P-F~~~~~~ell~qIve~~lr~~i 1274 (1329)
.|.......... |.+.+ -.+-|.-.||.+++.|.||..- +........... .+
T Consensus 437 C~i~Dvl~~d~~-------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I 490 (655)
T KOG3741|consen 437 CGIMDVLQEDPT-------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RI 490 (655)
T ss_pred ccceeeecCCCC-------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------Hh
Confidence 777654433321 11221 2357999999999999998543 222211121111 12
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 000726 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1275 ps~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le 1308 (1329)
...++.++++++......++++ -++.+++.+.-
T Consensus 491 ~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~ 523 (655)
T KOG3741|consen 491 TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIG 523 (655)
T ss_pred hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHH
Confidence 3457888999999999888887 77777766543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=7.5e-07 Score=95.12 Aligned_cols=110 Identities=24% Similarity=0.163 Sum_probs=80.9
Q ss_pred HHHHHHHHHHHhcCCCc--eeeEecccccCC--CCeEEEEEEeccCC-chhhhhhcccccCCHHHHHHHHHHHHHHHHHH
Q 000726 1090 LEFWREAEILSKLHHPN--VVAFYGVVQDGP--GGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164 (1329)
Q Consensus 1090 keFlrEIeILk~LrHPN--IVKL~Gif~e~~--dg~L~LVMEYm~GG-SL~d~L~~kek~Lse~qrlkIA~QIAsALaYL 1164 (1329)
....+|...+..|.... ..+.+++..... ....+||+|++++. +|.+++..... ++......++.+++..++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 35667777777764322 334444443321 12458999999875 78887754222 56677788999999999999
Q ss_pred HHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1165 Hs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
|.+||+|+||++.|||++.++ ....+.|+||+-++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~-~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDD-GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCC-CceeEEEEcchhcee
Confidence 999999999999999999776 345789999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.9e-06 Score=95.52 Aligned_cols=141 Identities=25% Similarity=0.115 Sum_probs=101.2
Q ss_pred eEEEEecccCcEEEEEEEE-CCceEEEEEEeccccCCC--------------ChHHHHHHHHHHHHHHHHHhcCCC--ce
Q 000726 1045 EELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGR--------------SSEQERLTLEFWREAEILSKLHHP--NV 1107 (1329)
Q Consensus 1045 ellkvLGqGaFGtVYKA~~-kGr~VAVKiLKks~~sd~--------------s~e~E~~~keFlrEIeILk~LrHP--NI 1107 (1329)
.+...||-|--+.||.|.. +|.++|||.-+...++-+ ..+.........+|.++|.+|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4567899999999999998 499999998765433211 111122334567899999998755 66
Q ss_pred eeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCC
Q 000726 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 1187 (1329)
Q Consensus 1108 VKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni 1187 (1329)
.+.+++- ..++||||++|..|...- ++......++..|+.-+..+-..||||+|+.+-|||++.+|..
T Consensus 174 P~P~~~n------RHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 174 PKPIAWN------RHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCccccc------cceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence 6776642 568999999887665533 1233344455566666666668999999999999999988765
Q ss_pred CCcEEEeecCCccc
Q 000726 1188 RPICKVGDFGLSKI 1201 (1329)
Q Consensus 1188 ~~~VKLsDFGLAr~ 1201 (1329)
.++||--+..
T Consensus 242 ----~vIDwPQ~v~ 251 (304)
T COG0478 242 ----VVIDWPQAVP 251 (304)
T ss_pred ----EEEeCccccc
Confidence 9999987653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=6.6e-06 Score=89.99 Aligned_cols=145 Identities=17% Similarity=0.109 Sum_probs=100.8
Q ss_pred ecccCcEEEEEEEECCceEEEEEEeccccCC-CChHHHHHHHHHHHHHHHHHhcCCCc--eeeEecccc---cCCCCeEE
Q 000726 1050 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTG-RSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQ---DGPGGTLA 1123 (1329)
Q Consensus 1050 LGqGaFGtVYKA~~kGr~VAVKiLKks~~sd-~s~e~E~~~keFlrEIeILk~LrHPN--IVKL~Gif~---e~~dg~L~ 1123 (1329)
-|+||-+-|+.....|..+-||.-....... ..+. -...|.+|...|..|..-+ +.++. ++. ..-....+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~---g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPF---GRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCC---CchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 3568888889888888878888654221111 0011 1356889999999885322 33333 222 22223567
Q ss_pred EEEEeccC-Cchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1124 TVTEFMVN-GSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1124 LVMEYm~G-GSL~d~L~~ke-k~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
||+|-+.+ .+|.+++.... .+.+......++.+++.+++-||+.|+.|+|+++.|||++.+| ...++|+||.-++
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g--~~~v~lIDlEk~r 178 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG--KAEAGFLDLEKSR 178 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC--CeeEEEEEhhccc
Confidence 99998854 47777774432 3457777788999999999999999999999999999998766 3468999998765
|
|
| >PF00564 PB1: PB1 domain; InterPro: IPR000270 The Phox and Bem1p domain, is present in many eukaryotic cytoplasmic signalling proteins | Back alignment and domain information |
|---|
Probab=98.15 E-value=7.2e-06 Score=75.52 Aligned_cols=68 Identities=34% Similarity=0.565 Sum_probs=57.5
Q ss_pred ceEEEEecCCCChHHHHHHHHHHcCC---ceEEEeeCCCCCCCceeeccChhHHHHHHHHhhhhcccCCCCcEEEEe
Q 000726 211 ETRIIRISRDISWQELTQKALAIYNQ---THTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLF 284 (1329)
Q Consensus 211 ~triv~V~r~~~f~~l~~kl~~~~~~---~~~lkYqLP~edLD~LisVt~DeDL~~m~~Eydr~~~~~~~~~R~flF 284 (1329)
.+|++.+++.++|.+|+.++.+.++. .+.|+|+ .||- .+|+|++|+||..|++.+... +..++|+++.
T Consensus 12 ~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~Y~--D~dg-D~V~i~sd~Dl~~a~~~~~~~---~~~~lrl~v~ 82 (84)
T PF00564_consen 12 IRRIISLPSDVSFDDLRSKIREKFGLLDEDFQLKYK--DEDG-DLVTISSDEDLQEAIEQAKES---GSKTLRLFVQ 82 (84)
T ss_dssp EEEEEEECSTSHHHHHHHHHHHHHTTSTSSEEEEEE--ETTS-SEEEESSHHHHHHHHHHHHHC---TTSCEEEEEE
T ss_pred eEEEEEcCCCCCHHHHHHHHHHHhCCCCccEEEEee--CCCC-CEEEeCCHHHHHHHHHHHHhc---CCCcEEEEEE
Confidence 34469999999999999999999986 6788887 5554 799999999999999999986 3448888876
|
The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate.; GO: 0005515 protein binding; PDB: 1IPG_A 1IP9_A 2KFK_A 1WMH_A 1VD2_A 1WI0_A 1OEY_C 1PQS_A 1Q1O_A 1TZ1_A .... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.7e-06 Score=105.92 Aligned_cols=144 Identities=22% Similarity=0.292 Sum_probs=100.3
Q ss_pred HHHHHHHHHHHC-CeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCccc----------ccCCCCCCcccCccccc
Q 000726 1156 DAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV----------TGGVRGTLPWMAPELLN 1224 (1329)
Q Consensus 1156 QIAsALaYLHs~-GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~----------ss~~~GTp~YmAPEvL~ 1224 (1329)
+++.||.|+|+. ++||+.|.|++|.++..+.. ||+.|+++........ .........|.|||++.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~w----kl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDW----KLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcce----eeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 455999999975 79999999999999988755 9999998764322100 00112345699999998
Q ss_pred cCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHH--HHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHH
Q 000726 1225 GSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI--IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFT 1301 (1329)
Q Consensus 1225 Gs~~~~S~KSDVWSLGVLLyELLT-Gk~PF~~~~~~el--l~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTae 1301 (1329)
+ ...+.++|+|||||++|.+.. |+.-+........ ......+.........+++++++=+.+++..++..||++.
T Consensus 183 ~--~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~ 260 (700)
T KOG2137|consen 183 G--TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD 260 (700)
T ss_pred c--ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence 5 446788999999999999984 5554443322111 1111111112223467899999999999999999999777
Q ss_pred HHHH
Q 000726 1302 EIAR 1305 (1329)
Q Consensus 1302 ELLq 1305 (1329)
.++.
T Consensus 261 ~l~~ 264 (700)
T KOG2137|consen 261 LLLS 264 (700)
T ss_pred hhhc
Confidence 6644
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.8e-05 Score=83.71 Aligned_cols=135 Identities=25% Similarity=0.265 Sum_probs=95.8
Q ss_pred cCeeEEEEecccCc-EEEEEEEECCceEEEEEEeccccCCCCh------HH-------HHHHHHHHHHHHHHHhcC---C
Q 000726 1042 EDLEELKELGSGTF-GTVYHGKWRGTDVAIKRIKKSCFTGRSS------EQ-------ERLTLEFWREAEILSKLH---H 1104 (1329)
Q Consensus 1042 edYellkvLGqGaF-GtVYKA~~kGr~VAVKiLKks~~sd~s~------e~-------E~~~keFlrEIeILk~Lr---H 1104 (1329)
.+++.++.||.|.. |.||+++..|..+|||+++.-....... .. .....-|..|++...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68899999999999 9999999999999999954322211110 00 123346888988888875 4
Q ss_pred Cce--eeEecccccC----------------CCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH
Q 000726 1105 PNV--VAFYGVVQDG----------------PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 1166 (1329)
Q Consensus 1105 PNI--VKL~Gif~e~----------------~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs 1166 (1329)
.++ |+++||+.-. ......||.||++... .+... -+.+|.+-|..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHHH
Confidence 566 9999987311 1123568888875443 12222 24567788889999
Q ss_pred CCeeecCCCCcceEeccCCCCCCcEEEeecCCc
Q 000726 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1167 ~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLA 1199 (1329)
.||+-+|+++.|.. +| +|+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~---~G------~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR---GG------KLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc---CC------EEEecccC
Confidence 99999999999987 22 89999964
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00019 Score=87.57 Aligned_cols=147 Identities=19% Similarity=0.224 Sum_probs=90.5
Q ss_pred EEecccCcEEEEEEEEC-CceEEEEEEeccccC--------------------CC---Ch---HHHHHH------HHHHH
Q 000726 1048 KELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFT--------------------GR---SS---EQERLT------LEFWR 1094 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~s--------------------d~---s~---e~E~~~------keFlr 1094 (1329)
+.|+.++-|.||+|++. |+.||||+.++.... .. .. .-+.+. ..+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 46999999999999996 999999998653211 00 00 001111 12445
Q ss_pred HHHHHHhcC-----CCceeeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCe
Q 000726 1095 EAEILSKLH-----HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNI 1169 (1329)
Q Consensus 1095 EIeILk~Lr-----HPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GI 1169 (1329)
|+.-+.++. .+++ ++=.+|.+- .+...|+|||++|..+.+...-+...++...+.....++ -+..+=..|+
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-Eeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 555555542 2332 222222211 124579999999999888753333445533333222221 2334445899
Q ss_pred eecCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 000726 1170 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1170 IHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
+|.|.+|.||+++.+|.. .+.|||+....
T Consensus 287 fHaDpHpGNi~v~~~g~i----~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSDGRI----VLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecCCcE----EEEcCcceecC
Confidence 999999999999988654 89999997644
|
|
| >cd05992 PB1 The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Probab=97.98 E-value=3.2e-05 Score=70.82 Aligned_cols=73 Identities=37% Similarity=0.651 Sum_probs=56.5
Q ss_pred ceeecCceEEEEec-CCCChHHHHHHHHHHcCC---ceEEEeeCCCCCCCceeeccChhHHHHHHHHhhhhcccCCCCcE
Q 000726 205 LRYVGGETRIIRIS-RDISWQELTQKALAIYNQ---THTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPR 280 (1329)
Q Consensus 205 l~YvGG~triv~V~-r~~~f~~l~~kl~~~~~~---~~~lkYqLP~edLD~LisVt~DeDL~~m~~Eydr~~~~~~~~~R 280 (1329)
++|- |++|.+.|+ ++++|.+|+.++.+.++. .+.|+|. .||- .+|++++|+||..|++.+.+ ....++|
T Consensus 5 ~~~~-~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~y~--D~e~-d~v~l~sd~Dl~~a~~~~~~---~~~~~l~ 77 (81)
T cd05992 5 VKYG-GEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYP--DEDG-DLVTISSDEDLEEAIEEARR---SGSKKLR 77 (81)
T ss_pred EEec-CCCEEEEEecCCCCHHHHHHHHHHHhCCCCCcEEEEee--CCCC-CEEEeCCHHHHHHHHHHHhh---cCCccEE
Confidence 3444 556666776 999999999999999985 4566666 5555 68999999999999999976 3345777
Q ss_pred EEEe
Q 000726 281 MFLF 284 (1329)
Q Consensus 281 ~flF 284 (1329)
++++
T Consensus 78 l~v~ 81 (81)
T cd05992 78 LFVF 81 (81)
T ss_pred EEeC
Confidence 7764
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00013 Score=75.57 Aligned_cols=80 Identities=18% Similarity=0.192 Sum_probs=54.9
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCC--ceeeEecccccC-CCCeEE
Q 000726 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP--NVVAFYGVVQDG-PGGTLA 1123 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHP--NIVKL~Gif~e~-~dg~L~ 1123 (1329)
++.|+.|..+.||+....+..++||+.... .....+.+|..+++.+... .+.+++.+.... ..+..+
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 467999999999999998789999987531 2234566788888877432 245566533222 133578
Q ss_pred EEEEeccCCchhh
Q 000726 1124 TVTEFMVNGSLRH 1136 (1329)
Q Consensus 1124 LVMEYm~GGSL~d 1136 (1329)
++|+++++..+..
T Consensus 72 ~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 72 LLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEESSEEHHH
T ss_pred EEEEEeccccccc
Confidence 9999998887766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=6.9e-05 Score=91.39 Aligned_cols=149 Identities=16% Similarity=0.169 Sum_probs=94.8
Q ss_pred EEecccCcEEEEEEEEC-CceEEEEEEeccccCCCChH------------------------HHHH------HHHHHHHH
Q 000726 1048 KELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSE------------------------QERL------TLEFWREA 1096 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~e------------------------~E~~------~keFlrEI 1096 (1329)
+.||.-+.|.||+|+.+ |+.||||+-+...... -.. -++. ...|.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~-~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKL-IMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHH-HHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46999999999999984 7889999876532110 000 0011 12345555
Q ss_pred HHHHhc----CCCc------eeeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH
Q 000726 1097 EILSKL----HHPN------VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 1166 (1329)
Q Consensus 1097 eILk~L----rHPN------IVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs 1166 (1329)
+-..+. .|-+ |.++|--+.. ...|+||||+|..+.+.-.-....++...+..-+.++..-+ +=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHh
Confidence 444433 3545 4444443332 56899999999988766543444566664444333332222 224
Q ss_pred CCeeecCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 000726 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1329)
Q Consensus 1167 ~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~ 1203 (1329)
.|++|+|-.|-||+++.++.....+.+.|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 5899999999999999766556678999999987543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00031 Score=77.71 Aligned_cols=144 Identities=16% Similarity=0.129 Sum_probs=95.8
Q ss_pred cccccCeeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHH------HHHHHHHHhcC---CCcee
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEF------WREAEILSKLH---HPNVV 1108 (1329)
Q Consensus 1038 iI~~edYellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keF------lrEIeILk~Lr---HPNIV 1108 (1329)
.+...+|...+++-......|.+-..+|..+.+|..+... ...++....| .+++..+.++. -..+.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~-----~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~ 101 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREEN-----RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPA 101 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhh-----hhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccc
Confidence 4556788999999888888899988899999999887532 2233333333 23333333332 22222
Q ss_pred eEecccccCC---CCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCC
Q 000726 1109 AFYGVVQDGP---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 1185 (1329)
Q Consensus 1109 KL~Gif~e~~---dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdG 1185 (1329)
.++.+..... ....++||||++|..|.+... +++ .++..|.++|.-||+.|+.|+|..|.|++++.++
T Consensus 102 ~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 102 DPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred cceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc
Confidence 2222211110 124568999999988876531 222 2445677889999999999999999999999554
Q ss_pred CCCCcEEEeecCCcc
Q 000726 1186 PIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1186 ni~~~VKLsDFGLAr 1200 (1329)
++++||+..+
T Consensus 173 -----i~iID~~~k~ 182 (229)
T PF06176_consen 173 -----IRIIDTQGKR 182 (229)
T ss_pred -----EEEEECcccc
Confidence 5899998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.0002 Score=78.27 Aligned_cols=72 Identities=19% Similarity=0.260 Sum_probs=48.6
Q ss_pred EEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCc--eeeEecccccCCCCeEEEE
Q 000726 1048 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQDGPGGTLATV 1125 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPN--IVKL~Gif~e~~dg~L~LV 1125 (1329)
..||+|..+.||+. .+..+++|+..... . .....+|.++++.+..-. +.+.+.+..... ..++|
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-----~-----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~--~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-----D-----KETIKREFDASRKVFSLGIPTPHPFDLVEDGG--RLGLI 72 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-----C-----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCC--eeeee
Confidence 46899999999984 35677888875421 0 123467888888875333 355666655533 57889
Q ss_pred EEeccCCc
Q 000726 1126 TEFMVNGS 1133 (1329)
Q Consensus 1126 MEYm~GGS 1133 (1329)
||+++|.+
T Consensus 73 ~e~i~G~~ 80 (226)
T TIGR02172 73 YELIVGKR 80 (226)
T ss_pred eeecCCcc
Confidence 99998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00043 Score=77.73 Aligned_cols=145 Identities=20% Similarity=0.112 Sum_probs=91.8
Q ss_pred EEEecccCcEEEEEEEE-CCceEEEEEEeccccCCCC---------------hHHHHHHHH-HHHHHHHHHhcC--CCce
Q 000726 1047 LKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS---------------SEQERLTLE-FWREAEILSKLH--HPNV 1107 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~-kGr~VAVKiLKks~~sd~s---------------~e~E~~~ke-FlrEIeILk~Lr--HPNI 1107 (1329)
.-.|.+|--+.||+|.. .+..+|||+++........ ......... ..+|..-|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34678888899999876 5888999999864332111 001111111 235677777663 3344
Q ss_pred eeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCC
Q 000726 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDP 1186 (1329)
Q Consensus 1108 VKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGn 1186 (1329)
.+.+.+.. -.|||||+... ....=.-++..+.......+..++++.+.-|-. .+++|+||..-|||+. ++
T Consensus 133 P~Pi~~~~------nVLvMEfIg~~-g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~- 203 (268)
T COG1718 133 PEPIAFRN------NVLVMEFIGDD-GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG- 203 (268)
T ss_pred CCceeecC------CeEEEEeccCC-CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-
Confidence 45555443 36899999443 111000112223333566777888888887776 8999999999999999 33
Q ss_pred CCCcEEEeecCCccccc
Q 000726 1187 IRPICKVGDFGLSKIKR 1203 (1329)
Q Consensus 1187 i~~~VKLsDFGLAr~~~ 1203 (1329)
.+.|+||+-|....
T Consensus 204 ---~p~iID~~QaV~~~ 217 (268)
T COG1718 204 ---EPYIIDVSQAVTID 217 (268)
T ss_pred ---eEEEEECccccccC
Confidence 35899999987544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00072 Score=86.44 Aligned_cols=147 Identities=20% Similarity=0.264 Sum_probs=89.0
Q ss_pred EEEecccCcEEEEEEEECC----ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCce--eeEecccccCC-
Q 000726 1047 LKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNV--VAFYGVVQDGP- 1118 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~kG----r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNI--VKL~Gif~e~~- 1118 (1329)
++.|+.|.+..+|+..+.+ ..+++|+........ ....+.+|..+|+.+. |.++ .+++.+|.+..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-------~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-------SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-------cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 4578999999999987754 357777654321110 1235678999999985 6665 77787776531
Q ss_pred CCeEEEEEEeccCCchhhh-----------------------hhccc----------ccCC--HHHHHHHHH--------
Q 000726 1119 GGTLATVTEFMVNGSLRHV-----------------------LLSKE----------RHLD--RRKRLIIAM-------- 1155 (1329)
Q Consensus 1119 dg~L~LVMEYm~GGSL~d~-----------------------L~~ke----------k~Ls--e~qrlkIA~-------- 1155 (1329)
.+..++||||++|..+.+. |+.-. .+.. ..++..+..
T Consensus 116 ~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~ 195 (822)
T PLN02876 116 IGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGE 195 (822)
T ss_pred CCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcc
Confidence 2457899999987643211 11100 0000 112211111
Q ss_pred -------HHHHHHHHHHH-----------CCeeecCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 000726 1156 -------DAAFGMEYLHS-----------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1156 -------QIAsALaYLHs-----------~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
.+...+.+|.. ..+||+|+++.|||++.++. ..+-|.||.++..-
T Consensus 196 ~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~--~v~aVLDWE~a~~G 258 (822)
T PLN02876 196 GKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTED--RVIGILDWELSTLG 258 (822)
T ss_pred cCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCC--eEEEEEeeeccccC
Confidence 12334566643 24999999999999986432 24579999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00083 Score=72.90 Aligned_cols=139 Identities=20% Similarity=0.212 Sum_probs=93.6
Q ss_pred EEecccCcEEEEEEEECCceEEEEEEeccccCCCChH--------HHHHHHHHHHHHHHHHhcC------CCceeeEecc
Q 000726 1048 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSE--------QERLTLEFWREAEILSKLH------HPNVVAFYGV 1113 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e--------~E~~~keFlrEIeILk~Lr------HPNIVKL~Gi 1113 (1329)
..||+|+.-.||.-- ......||+.+.......... .....++..+|+.....+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 369999999999532 234578899876541100000 0011345566666666655 7889999999
Q ss_pred cccCCCCeEEEEEEeccCC------chhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCC
Q 000726 1114 VQDGPGGTLATVTEFMVNG------SLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 1187 (1329)
Q Consensus 1114 f~e~~dg~L~LVMEYm~GG------SL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni 1187 (1329)
.++.- -+.+|+|.+... +|.+++.. ..++. . +...+-+-..||-+++|+.+||+|+||++...+..
T Consensus 86 veT~~--G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNL--GLGLVVELIRDADGNISPTLEDYLKE--GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCC--ceEEEEEEEECCCCCcCccHHHHHHc--CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 98855 678999987543 67777733 23444 2 33344455678889999999999999999887766
Q ss_pred CCcEEEee
Q 000726 1188 RPICKVGD 1195 (1329)
Q Consensus 1188 ~~~VKLsD 1195 (1329)
...+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 54667777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd06407 PB1_NLP A PB1 domain is present in NIN like proteins (NLP), a key enzyme in a process of establishment of symbiosis betweeen legumes and nitrogen fixing bacteria (Rhizobium) | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00052 Score=65.09 Aligned_cols=71 Identities=23% Similarity=0.464 Sum_probs=60.3
Q ss_pred ecCceEEEEecCCCChHHHHHHHHHHcC----CceEEEeeCCCCCCCceeeccChhHHHHHHHHhhhhcccCCCCcEEEE
Q 000726 208 VGGETRIIRISRDISWQELTQKALAIYN----QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFL 283 (1329)
Q Consensus 208 vGG~triv~V~r~~~f~~l~~kl~~~~~----~~~~lkYqLP~edLD~LisVt~DeDL~~m~~Eydr~~~~~~~~~R~fl 283 (1329)
.||+++.+.|+.+++|.+|..++++.++ ..++|||. .|| .-.|+++||+||+.-++-|... ...++|+|+
T Consensus 7 ~~~d~~r~~l~~~~~~~~L~~~i~~r~~~~~~~~f~LkY~--Dde-gd~v~ltsd~DL~eai~i~~~~---~~~~v~l~v 80 (82)
T cd06407 7 YGEEKIRFRLPPSWGFTELKQEIAKRFKLDDMSAFDLKYL--DDD-EEWVLLTCDADLEECIDVYRSS---GSHTIRLLV 80 (82)
T ss_pred eCCeEEEEEcCCCCCHHHHHHHHHHHhCCCCCCeeEEEEE--CCC-CCeEEeecHHHHHHHHHHHHHC---CCCeEEEEe
Confidence 4889999999999999999999999987 36899998 666 8899999999999888877654 345788887
Q ss_pred e
Q 000726 284 F 284 (1329)
Q Consensus 284 F 284 (1329)
.
T Consensus 81 ~ 81 (82)
T cd06407 81 H 81 (82)
T ss_pred e
Confidence 4
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes like osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-inte |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00093 Score=72.20 Aligned_cols=75 Identities=23% Similarity=0.142 Sum_probs=49.3
Q ss_pred ecccCc-EEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC-CCceeeEecccccCCCCeEEEEEE
Q 000726 1050 LGSGTF-GTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLATVTE 1127 (1329)
Q Consensus 1050 LGqGaF-GtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr-HPNIVKL~Gif~e~~dg~L~LVME 1127 (1329)
|-.|.+ ..||+....+..+.||+..... ...+.+|+++++.+. +--+.+++.+.... +..++|||
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e 72 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTS 72 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEE
Confidence 444555 7889987767778888875321 123456888887773 33355667666543 35788999
Q ss_pred eccCCchhhh
Q 000726 1128 FMVNGSLRHV 1137 (1329)
Q Consensus 1128 Ym~GGSL~d~ 1137 (1329)
+++|.++...
T Consensus 73 ~i~G~~l~~~ 82 (244)
T cd05150 73 AVPGVPAAAL 82 (244)
T ss_pred eeCCccHhHh
Confidence 9998776543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.38 E-value=3.9e-05 Score=93.86 Aligned_cols=183 Identities=20% Similarity=0.193 Sum_probs=127.8
Q ss_pred eEEEEecccCcEEEEEEEECCce-EEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCc-eeeEecccccCCCCeE
Q 000726 1045 EELKELGSGTFGTVYHGKWRGTD-VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN-VVAFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1045 ellkvLGqGaFGtVYKA~~kGr~-VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPN-IVKL~Gif~e~~dg~L 1122 (1329)
...+.+++|+.+.++|.+...+. ...+.+... ....-++++|.+++||| .+..++-+.. +.+.
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~--E~~~ 309 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDYDG--EDYL 309 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-------------hhhHHHHHHHHHccCCCCcccccccCCc--cccc
Confidence 33456889999999987653222 223333211 12334678999999999 5555554444 4488
Q ss_pred EEEEEeccCC-chhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1123 ATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1123 ~LVMEYm~GG-SL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
+++|+++.++ +-...+...+..+...+...++..-++++++||+.--+|+| |||..... .+.+||+....
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~-----~~~~~~~v~~~ 380 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE-----VKLLDFAVPPQ 380 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc-----cccccccCCcc
Confidence 9999999776 33332323334455666667777888999999988778998 88877532 48999999876
Q ss_pred ccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCC
Q 000726 1202 KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253 (1329)
Q Consensus 1202 ~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF 1253 (1329)
+..........+++.|+|||+..+ ..+....|+|++|.--.+|.-|-+|-
T Consensus 381 L~~~~~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 381 LTRTMKPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCcccccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCC
Confidence 665545566789999999998873 45677899999998766776676664
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00068 Score=73.13 Aligned_cols=130 Identities=28% Similarity=0.336 Sum_probs=91.5
Q ss_pred eeEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCcee-eEecccccCCCCeE
Q 000726 1044 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV-AFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIV-KL~Gif~e~~dg~L 1122 (1329)
.+..+.|++|.+|.||+|.|+|..+|+|+-+... ....+..|+++|..+.-.++. ++|.+-. .
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----------~r~~l~kEakiLeil~g~~~~p~vy~yg~------~ 87 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----------PRRNLEKEAKILEILAGEGVTPEVYFYGE------D 87 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCc----------chhhHHHHHHHHHHhhhcCCCceEEEech------h
Confidence 4556789999999999999999999999876432 124577899999988765543 4444432 2
Q ss_pred EEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCC--cceEeccCCCCCCcEEEeecCCcc
Q 000726 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKC--DNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKP--eNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
++.|||+.|-.|...-... +..+ +..+++.---|-..||-|+.|.- +||++... .+.|+||.-|+
T Consensus 88 ~i~me~i~G~~L~~~~~~~----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-----~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-----DVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhcc----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCC-----cEEEEEccchh
Confidence 4569999888887655211 2233 33455565567778999999873 57777643 25899999987
Q ss_pred cc
Q 000726 1201 IK 1202 (1329)
Q Consensus 1201 ~~ 1202 (1329)
+.
T Consensus 155 ~k 156 (201)
T COG2112 155 FK 156 (201)
T ss_pred hc
Confidence 44
|
|
| >cd06405 PB1_Mekk2_3 The PB1 domain is present in the two mitogen-activated protein kinase kinases MEKK2 and MEKK3 which are two members of the signaling kinase cascade involved in angiogenesis and early cardiovascular development | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0024 Score=59.76 Aligned_cols=70 Identities=26% Similarity=0.442 Sum_probs=60.2
Q ss_pred cCceEEEEecCCCChHHHHHHHHHHcCCceEEEeeCCCCCCCceeeccChhHHHHHHHHhhhhcccCCCCcEEEEe
Q 000726 209 GGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLF 284 (1329)
Q Consensus 209 GG~triv~V~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LisVt~DeDL~~m~~Eydr~~~~~~~~~R~flF 284 (1329)
-||.||+.++|.+.|.||..|+...||..+.+-|-.-. -||.+.|.|||+.-|+-.|+ ...-+.+|+.|-
T Consensus 8 ~gEKRIi~f~RPvkf~dl~~kv~~afGq~mdl~ytn~e----L~iPl~~Q~DLDkAie~ld~--s~~~ksLRilL~ 77 (79)
T cd06405 8 NGEKRIIQFPRPVKFKDLQQKVTTAFGQPMDLHYTNNE----LLIPLKNQEDLDRAIELLDR--SPHMKSLRILLS 77 (79)
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeEEEeccc----EEEeccCHHHHHHHHHHHcc--CccccceeEeEe
Confidence 58999999999999999999999999999999997432 79999999999999999998 233346677663
|
The PB1 domain of MEKK2 (and/or MEKK3) interacts with the PB1 domain of another member of the kinase cascade Map2k5. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, f |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0016 Score=84.54 Aligned_cols=205 Identities=21% Similarity=0.189 Sum_probs=134.7
Q ss_pred HHHHHHHHHHHHhcCCCceeeEecccccCCC-C-eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH
Q 000726 1089 TLEFWREAEILSKLHHPNVVAFYGVVQDGPG-G-TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 1166 (1329)
Q Consensus 1089 ~keFlrEIeILk~LrHPNIVKL~Gif~e~~d-g-~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs 1166 (1329)
+.....|+..+.++.|+|++.++.|-.+... + .+.+..++|...++...+. .-..++....+.+..++..||+|+|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3444567888999999999999988655431 1 1223446677777777664 34567888888999999999999999
Q ss_pred CCeeecCCCCc---ceEeccCCCCCCcEEEe--ecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHH
Q 000726 1167 KNIVHFDLKCD---NLLVNLKDPIRPICKVG--DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGI 1241 (1329)
Q Consensus 1167 ~GIIHRDLKPe---NILLDsdGni~~~VKLs--DFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGV 1241 (1329)
....|.-|..+ +..++. ...+.++ ||+................+..|.++|.............|+|.+|.
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~----e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDG----EGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred hccceeEEecccccccccCc----cceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 85555444433 222222 2234555 88877654433332233345668888888755555666789999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 000726 1242 VLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1242 LLyELLTGk~PF~~~~~~ell~qIve~~lr~~ips~~S~eL~DLIkrCLqkDPeERPTaeELLq~Le~ 1309 (1329)
++..+..|..+-.... ....+ .+......+.+...+|+..+.++|++..+++.+...
T Consensus 381 l~~~~~~~~~i~~~~~---~~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA---VPVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred HHhhhhhcCccccccc---chhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence 9999988765422111 00000 111122267788899999999999999999887643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0039 Score=67.58 Aligned_cols=75 Identities=16% Similarity=0.188 Sum_probs=43.2
Q ss_pred EEecccCcE-EEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCC---ceeeEecccccCCC-CeE
Q 000726 1048 KELGSGTFG-TVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP---NVVAFYGVVQDGPG-GTL 1122 (1329)
Q Consensus 1048 kvLGqGaFG-tVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHP---NIVKL~Gif~e~~d-g~L 1122 (1329)
+.|+.|+.. .||+. +..+.+|+.+... ....+.+|.++|..+... -+.+++........ +..
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----------~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~ 69 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----------YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP 69 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----------hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence 457766665 58875 3457777654210 123567888888877531 23344443332211 245
Q ss_pred EEEEEeccCCchh
Q 000726 1123 ATVTEFMVNGSLR 1135 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~ 1135 (1329)
+++|++++|.++.
T Consensus 70 ~~l~~~i~G~~l~ 82 (235)
T cd05155 70 WSVYRWLEGETAT 82 (235)
T ss_pred eEEEEeecCCCCC
Confidence 7899999887664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd06408 PB1_NoxR The PB1 domain is present in the Epichloe festucae NoxR protein (NADPH oxidase regulator), a key regulator of NADPH oxidase isoform, NoxA | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0029 Score=60.87 Aligned_cols=60 Identities=17% Similarity=0.335 Sum_probs=53.4
Q ss_pred cCceEEEEecCCCChHHHHHHHHHHcC--CceEEEeeCCCCCCCceeeccChhHHHHHHHHhhhhc
Q 000726 209 GGETRIIRISRDISWQELTQKALAIYN--QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLE 272 (1329)
Q Consensus 209 GG~triv~V~r~~~f~~l~~kl~~~~~--~~~~lkYqLP~edLD~LisVt~DeDL~~m~~Eydr~~ 272 (1329)
+|++|++.|+.+|+|.+|..|+.+.|+ ..++|||+ .| ...|++++++||+-.+.-+...+
T Consensus 10 ~~Dv~~i~v~~~i~f~dL~~kIrdkf~~~~~~~iKyk--DE--GD~iti~sq~DLd~Ai~~a~~~~ 71 (86)
T cd06408 10 QDDTRYIMIGPDTGFADFEDKIRDKFGFKRRLKIKMK--DD--GDMITMGDQDDLDMAIDTARSEA 71 (86)
T ss_pred cCcEEEEEcCCCCCHHHHHHHHHHHhCCCCceEEEEE--cC--CCCccccCHHHHHHHHHHHHHHH
Confidence 788999999999999999999999997 57899999 44 78999999999999988776543
|
NoxA is essential for growth control of the fungal endophyte in plant tissue in the process of symbiotic interaction between a fungi and its plant host. The Epichloe festucae p67(phox)-like regulator, NoxR, dispensable in culture but essential in plants for the symbiotic interaction. Plants infected with a noxR deletion mutant show severe stunting and premature senescence, whereas hyphae in the meristematic tissues show increased branching leading to increased fungal colonization of pseudostem and leaf blade tissue. The PB1 domain is a modular domain mediating specific protein-protein interactions which a play role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.009 Score=64.08 Aligned_cols=74 Identities=16% Similarity=0.206 Sum_probs=46.0
Q ss_pred EEEecccCcEEEEEEEEC---CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCc-eeeEecccccCCCCeE
Q 000726 1047 LKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN-VVAFYGVVQDGPGGTL 1122 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~k---Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPN-IVKL~Gif~e~~dg~L 1122 (1329)
++.|..|-...+|+.... +..|++|+....... .....+|+.+++.+.... ..+++..+..
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---------~~d~~~E~~~~~~l~~~gl~P~v~~~~~~------ 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---------IIDRERELRIHKLLSKHGLAPKLYATFQN------ 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---------eecHHHHHHHHHHHHhCCCCCeEEEEeCC------
Confidence 456888889999998765 467889977532110 011235777777774322 3444443321
Q ss_pred EEEEEeccCCchh
Q 000726 1123 ATVTEFMVNGSLR 1135 (1329)
Q Consensus 1123 ~LVMEYm~GGSL~ 1135 (1329)
.+||||++|.++.
T Consensus 68 ~~l~e~i~G~~l~ 80 (235)
T cd05157 68 GLIYEFIPGRTLE 80 (235)
T ss_pred cEEEEeeCCCcCC
Confidence 3799999887653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.00041 Score=91.05 Aligned_cols=187 Identities=17% Similarity=0.127 Sum_probs=127.6
Q ss_pred EEEEECC---ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEEeccCCchh
Q 000726 1059 YHGKWRG---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLR 1135 (1329)
Q Consensus 1059 YKA~~kG---r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~ 1135 (1329)
++++|-+ ..+.+|+.+...+. ...+...+..+.|...++...|+++...+.-.........+.+++|+.+|.+.
T Consensus 1243 ~R~k~Lr~kid~Fk~~I~ke~d~e---~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1243 FRNKWLRSKIDWFKFSIYKEYDFE---NLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred eccchHhhhhceeEEEeehhhhHH---HHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence 5666632 23577777643221 11233334455666667778999999888777666666788999999999999
Q ss_pred hhhhccc---ccCCHHHHHHHHHHHHHHHHHHHHC-----CeeecCCCCcceEeccCCCCCCcEEEeecCCccccc-Ccc
Q 000726 1136 HVLLSKE---RHLDRRKRLIIAMDAAFGMEYLHSK-----NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTL 1206 (1329)
Q Consensus 1136 d~L~~ke---k~Lse~qrlkIA~QIAsALaYLHs~-----GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~-~~~ 1206 (1329)
..+.+.- ..+...-+...-.+.+.+..-+|.. -.+|++||+.|.+|..+.+. |++++|+.+... ...
T Consensus 1320 ~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v----~~gk~gLdKIknp~~s 1395 (2724)
T KOG1826|consen 1320 SIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNV----KLGKGGLDKIKNPVLS 1395 (2724)
T ss_pred HHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcc----cccccccccccCchHh
Confidence 9886532 2233332332223335555555543 27899999999999976654 999999999433 333
Q ss_pred cccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 000726 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1254 (1329)
Q Consensus 1207 ~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTGk~PF~ 1254 (1329)
..+...+++.|+.|++.. .-.++.++|+|..|+.+|....|..+|.
T Consensus 1396 f~Gl~l~sp~~v~qli~N--~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1396 FFGLELCSPIYVLQLIKN--EIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred hhhhhhCCHHHHHHHHHH--HHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 445566788999999987 4456778999999999999888887764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0072 Score=64.84 Aligned_cols=99 Identities=22% Similarity=0.142 Sum_probs=77.0
Q ss_pred HHHHHHHhcCC-CceeeEecccccCCCCeEEEEEEeccCCchhhhhh--cccccCCHHHHHHHHHHHHHHHHHHHH---C
Q 000726 1094 REAEILSKLHH-PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--SKERHLDRRKRLIIAMDAAFGMEYLHS---K 1167 (1329)
Q Consensus 1094 rEIeILk~LrH-PNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~--~kek~Lse~qrlkIA~QIAsALaYLHs---~ 1167 (1329)
.|.-+|+.+++ +++.+++|.|-. ++|.||...+++..... .+-...+|..+.+|+.++++.+.+|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 47778888876 699999999843 56999997666542110 011246899999999999999999997 3
Q ss_pred CeeecCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 000726 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1329)
Q Consensus 1168 GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~ 1202 (1329)
.+.-.|++++|+-|+.+|. +|+.|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~----lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGR----LKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCc----EEEEechhcchh
Confidence 4788999999999997765 599999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0098 Score=65.20 Aligned_cols=133 Identities=17% Similarity=0.123 Sum_probs=74.1
Q ss_pred ecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCce-eeEecccccCCCCeEEEEEEe
Q 000726 1050 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV-VAFYGVVQDGPGGTLATVTEF 1128 (1329)
Q Consensus 1050 LGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNI-VKL~Gif~e~~dg~L~LVMEY 1128 (1329)
+..|-...+|+....+..+++|+....... ......+|..+++.+....+ .+++.... -++||||
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~--------~~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~ 69 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKA--------LGVDRQREYQILQALSALGLAPKPILVNE------HWLLVEW 69 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccc--------ccCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEe
Confidence 556888889988877888889875432111 00123457777777753322 33343322 2589999
Q ss_pred ccCCchhhh-----------------hhcc---cccCCHHH-HHHHHHH---------HHHHHHHHHH--------CCee
Q 000726 1129 MVNGSLRHV-----------------LLSK---ERHLDRRK-RLIIAMD---------AAFGMEYLHS--------KNIV 1170 (1329)
Q Consensus 1129 m~GGSL~d~-----------------L~~k---ek~Lse~q-rlkIA~Q---------IAsALaYLHs--------~GII 1170 (1329)
++|..+... ++.. ...++... +..+..+ +...+..+-. ..+|
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 988765421 1111 11112111 1111111 1122222222 2589
Q ss_pred ecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1171 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1171 HRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
|+|+.|.|||++.++ +.|+||..+..
T Consensus 150 H~Dl~~~Nil~~~~~-----~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-----LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEeCCC-----CEEEeccccCc
Confidence 999999999998765 37999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.021 Score=63.43 Aligned_cols=139 Identities=19% Similarity=0.135 Sum_probs=79.3
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCc--eeeEeccccc----CCCC
Q 000726 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQD----GPGG 1120 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPN--IVKL~Gif~e----~~dg 1120 (1329)
++.|..|....+|+....+..+++|++... . ......|+.++..+.+.. +.+++..... ...+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~-----~------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV-----S------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC-----C------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 456888888899998777778999987531 1 123445666676664322 3444432110 1123
Q ss_pred eEEEEEEeccCCchhh----hh----------hcc--c--c------cCCHHHHH----------HHHHHHHHHHHHHHH
Q 000726 1121 TLATVTEFMVNGSLRH----VL----------LSK--E--R------HLDRRKRL----------IIAMDAAFGMEYLHS 1166 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d----~L----------~~k--e--k------~Lse~qrl----------kIA~QIAsALaYLHs 1166 (1329)
..++||+|++|..+.. .+ +.. . . ...+.... .....+..++.++.+
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 5688999998876532 00 100 0 0 00111100 011123334455543
Q ss_pred -------CCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1167 -------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1167 -------~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.++||+|+.|.|||++.++ .+.|+||+.+.
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~~~~----~~~iIDfe~a~ 204 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFDGDE----LSGVIDFYFAC 204 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEeCCc----eEEEeehhhhc
Confidence 4699999999999998643 34799999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.022 Score=63.78 Aligned_cols=74 Identities=19% Similarity=0.329 Sum_probs=45.0
Q ss_pred EEEecccCcEEEEEEEEC--------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCc-eeeEecccccC
Q 000726 1047 LKELGSGTFGTVYHGKWR--------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN-VVAFYGVVQDG 1117 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~k--------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPN-IVKL~Gif~e~ 1117 (1329)
++.|..|-...+|+.+.. ++.+++|++...... .....+|..+++.+.... ..+++.++..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---------LIDRERELVVFARLSERNLGPKLYGIFPN- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---------eechHHHHHHHHHHHhCCCCCceEEEeCC-
Confidence 345667888889988764 367899987543111 122345777777764322 2345555432
Q ss_pred CCCeEEEEEEeccCCchh
Q 000726 1118 PGGTLATVTEFMVNGSLR 1135 (1329)
Q Consensus 1118 ~dg~L~LVMEYm~GGSL~ 1135 (1329)
.+||||++|..+.
T Consensus 73 -----~~v~e~i~G~~l~ 85 (302)
T cd05156 73 -----GRIEEFIPSRTLT 85 (302)
T ss_pred -----CchhheeCCCcCC
Confidence 2589999887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.0032 Score=73.25 Aligned_cols=140 Identities=19% Similarity=0.057 Sum_probs=95.7
Q ss_pred eeEEEEecccCcEEEEEEEEC-CceEEEEEEeccccCCCCh--------------HHHHHHHHHHHHHHHHHhcC-CCc-
Q 000726 1044 LEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSS--------------EQERLTLEFWREAEILSKLH-HPN- 1106 (1329)
Q Consensus 1044 YellkvLGqGaFGtVYKA~~k-Gr~VAVKiLKks~~sd~s~--------------e~E~~~keFlrEIeILk~Lr-HPN- 1106 (1329)
+.+.+.||-|--+-||.+-+. |++.++|+-+...++-+.- +.........+|...|+.|. |-.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 567889999999999998884 8999999765433321111 12222345667888888885 322
Q ss_pred eeeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEeccCCC
Q 000726 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 1186 (1329)
Q Consensus 1107 IVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GIIHRDLKPeNILLDsdGn 1186 (1329)
+.+.+++. ..++|||++.+..|.....- .+... +...+..-+.-|..+|+||+|..--||+|++++.
T Consensus 174 VPkpiD~~------RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 174 VPKPIDHN------RHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCccccc------ceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 33444432 56889999988888765421 22333 3344555566788899999999999999997664
Q ss_pred CCCcEEEeecCCcc
Q 000726 1187 IRPICKVGDFGLSK 1200 (1329)
Q Consensus 1187 i~~~VKLsDFGLAr 1200 (1329)
++++||--..
T Consensus 241 ----i~vIDFPQmv 250 (465)
T KOG2268|consen 241 ----IVVIDFPQMV 250 (465)
T ss_pred ----EEEeechHhh
Confidence 4999998654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.032 Score=63.04 Aligned_cols=140 Identities=18% Similarity=0.134 Sum_probs=77.0
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCc--eeeEecccc----cCCCC
Q 000726 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQ----DGPGG 1120 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPN--IVKL~Gif~----e~~dg 1120 (1329)
++.++.|....+|+....+..+.+|++.... .. .....|.+++..|.... +.+++.... ....+
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~----~~------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV----KA------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC----CH------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 4567788778899887666678888875421 11 12234555666653222 334333211 11134
Q ss_pred eEEEEEEeccCCchhhh--------------hhccccc-----------CCHHHHH------------HHHHHHHHHHHH
Q 000726 1121 TLATVTEFMVNGSLRHV--------------LLSKERH-----------LDRRKRL------------IIAMDAAFGMEY 1163 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~--------------L~~kek~-----------Lse~qrl------------kIA~QIAsALaY 1163 (1329)
..+++|+|++|..+... ++..... ..|.... .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 67899999988643210 1110000 0011000 011123344555
Q ss_pred HHH-------CCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1164 LHS-------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1164 LHs-------~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
+.. .++||+|+.+.||+++.++ .+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~----~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDS----VKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCc----eEEEeeccccc
Confidence 542 5799999999999998654 34799999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.053 Score=64.41 Aligned_cols=144 Identities=21% Similarity=0.151 Sum_probs=92.6
Q ss_pred EEecccCcEEEEEEEE-CCceEEEEEEeccccCCCChH-----------------HHHHHHH-HHHHHHHHHhcCCCcee
Q 000726 1048 KELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSE-----------------QERLTLE-FWREAEILSKLHHPNVV 1108 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~-kGr~VAVKiLKks~~sd~s~e-----------------~E~~~ke-FlrEIeILk~LrHPNIV 1108 (1329)
.+|..|--+-||.+.- .|..+|||+++.+.+.-...+ ...+.+. ..+|+.-|++|+.-.|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4688899999999887 588899999987654321111 1112221 23567777777654432
Q ss_pred eEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEeccCCCC
Q 000726 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPI 1187 (1329)
Q Consensus 1109 KL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs-~GIIHRDLKPeNILLDsdGni 1187 (1329)
-.--+... ...|||+|+- .+=+-.=.-+...++...+..+-.+++.-|.-|-+ .++||.||.--|+|+..
T Consensus 230 ~PePIlLk----~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd---- 300 (520)
T KOG2270|consen 230 CPEPILLK----NHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD---- 300 (520)
T ss_pred CCCceeee----cceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC----
Confidence 22222211 3478999993 33222111234456777777777888888887765 47999999999999973
Q ss_pred CCcEEEeecCCccc
Q 000726 1188 RPICKVGDFGLSKI 1201 (1329)
Q Consensus 1188 ~~~VKLsDFGLAr~ 1201 (1329)
..+.|+|-+-+..
T Consensus 301 -G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 -GKLYIIDVSQSVE 313 (520)
T ss_pred -CEEEEEEcccccc
Confidence 2468999887653
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.077 Score=63.53 Aligned_cols=81 Identities=20% Similarity=0.085 Sum_probs=51.6
Q ss_pred EEEecccCcEEEEEEEECC--ceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcC---CCceeeEecccccCCCCe
Q 000726 1047 LKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1047 lkvLGqGaFGtVYKA~~kG--r~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~Lr---HPNIVKL~Gif~e~~dg~ 1121 (1329)
.+.||.|.+..||++...+ +.|.||.-.......+... .....++..|.+.|+.+. ..++.+++.+..+ .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~w-pl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~----~ 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESW-PLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEE----L 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccc-cccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCC----C
Confidence 4579999999999998853 3799998543221111100 111234556777777752 3457778776443 4
Q ss_pred EEEEEEeccCC
Q 000726 1122 LATVTEFMVNG 1132 (1329)
Q Consensus 1122 L~LVMEYm~GG 1132 (1329)
.++||||+++.
T Consensus 106 ~~lVME~L~~~ 116 (401)
T PRK09550 106 AVTVMEDLSDH 116 (401)
T ss_pred CEEEEecCCCc
Confidence 67999999764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.1 Score=58.91 Aligned_cols=30 Identities=27% Similarity=0.365 Sum_probs=24.5
Q ss_pred CCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1167 ~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.++||+|+.+.|||++.+. ..-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~----~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR----LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc----eEEEEeccccc
Confidence 4799999999999998432 34799999875
|
|
| >cd06404 PB1_aPKC PB1 domain is an essential modular domain of the atypical protein kinase C (aPKC) which in complex with Par6 and Par3 proteins is crucial for establishment of apical-basal polarity of animal cells | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.081 Score=50.85 Aligned_cols=72 Identities=21% Similarity=0.337 Sum_probs=57.1
Q ss_pred ecCceEEEEecCCCChHHHHHHHHHHcC----CceEEEeeCCCCCCCceeeccChhHHHHHHHHhhhhcccCCCCcEEEE
Q 000726 208 VGGETRIIRISRDISWQELTQKALAIYN----QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFL 283 (1329)
Q Consensus 208 vGG~triv~V~r~~~f~~l~~kl~~~~~----~~~~lkYqLP~edLD~LisVt~DeDL~~m~~Eydr~~~~~~~~~R~fl 283 (1329)
-+|+-+|..++.+++|.+|..|+..+|. ..+++||- .||-| +|++++|++|..-+..|..-. .+-+-+-+
T Consensus 7 y~gdi~it~~d~~~s~e~L~~~v~~~c~~~~~q~ft~kw~--DEEGD-p~tiSS~~EL~EA~rl~~~n~---~~~l~ihv 80 (83)
T cd06404 7 YNGDIMITSIDPSISLEELCNEVRDMCRFHNDQPFTLKWI--DEEGD-PCTISSQMELEEAFRLYELNK---DSELNIHV 80 (83)
T ss_pred ecCcEEEEEcCCCcCHHHHHHHHHHHhCCCCCCcEEEEEE--CCCCC-ceeecCHHHHHHHHHHHHhcC---cccEEEEe
Confidence 4667789999999999999999999995 57899998 44433 799999999998888887543 23555666
Q ss_pred ec
Q 000726 284 FS 285 (1329)
Q Consensus 284 F~ 285 (1329)
||
T Consensus 81 fp 82 (83)
T cd06404 81 FP 82 (83)
T ss_pred cC
Confidence 64
|
PB1 domain is a modular domain mediating specific protein-protein interaction which play roles in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, |
| >cd06401 PB1_TFG The PB1 domain found in TFG protein, an oncogenic gene product and fusion partner to nerve growth factor tyrosine kinase receptor TrkA and to the tyrosine kinase ALK | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.059 Score=51.55 Aligned_cols=53 Identities=26% Similarity=0.400 Sum_probs=44.2
Q ss_pred cCceEEEEecC-CCChHHHHHHHHHHcC------CceEEEeeCCCCCCCceeeccChhHHHHH
Q 000726 209 GGETRIIRISR-DISWQELTQKALAIYN------QTHTIKYQLPGEDLDALVSVSCDEDLQNM 264 (1329)
Q Consensus 209 GG~triv~V~r-~~~f~~l~~kl~~~~~------~~~~lkYqLP~edLD~LisVt~DeDL~~m 264 (1329)
|||.|.+.++. .++|.+|+..+..++. .++.|||.=+. ..||+||+++||.--
T Consensus 8 g~DiR~~~~~~~~~t~~~L~~~v~~~F~~~~~~~~~flIKYkD~d---GDlVTIts~~dL~~A 67 (81)
T cd06401 8 GDDIRRIPIHNEDITYDELLLMMQRVFRGKLGSSDDVLIKYKDED---GDLITIFDSSDLSFA 67 (81)
T ss_pred CCeEEEEeccCccccHHHHHHHHHHHhccccCCcccEEEEEECCC---CCEEEeccHHHHHHH
Confidence 99999999998 5899999999987775 36889998332 348999999999765
|
The PB1 domain is a modular domain mediating specific protein-protein interaction in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The PB1 domains of TFG represent a type I/II PB1 domain. The physiological function of TFG remains unknown. |
| >cd06396 PB1_NBR1 The PB1 domain is an essential part of NBR1 protein, next to BRCA1, a scaffold protein mediating specific protein-protein interaction with both titin protein kinase and with another scaffold protein p62 | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.074 Score=50.93 Aligned_cols=69 Identities=19% Similarity=0.322 Sum_probs=53.9
Q ss_pred cCceEEEEecC--CCChHHHHHHHHHHcC-CceEEEeeCCCCCCCceeeccChhHHHHHHHHhhhhcccCCCCcEEEEe
Q 000726 209 GGETRIIRISR--DISWQELTQKALAIYN-QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLF 284 (1329)
Q Consensus 209 GG~triv~V~r--~~~f~~l~~kl~~~~~-~~~~lkYqLP~edLD~LisVt~DeDL~~m~~Eydr~~~~~~~~~R~flF 284 (1329)
||+++...++. +.+|.+|...+.+.|+ ..++|||= .| =.--|.++||.||+.-+ |+..++...+|+++.
T Consensus 8 ~~d~~rf~~~~~~~~~~~~L~~ev~~rf~l~~f~lKYl--Dd-e~e~v~lssd~eLeE~~----rl~~~~~~~l~~~v~ 79 (81)
T cd06396 8 NGESQSFLVSDSENTTWASVEAMVKVSFGLNDIQIKYV--DE-ENEEVSVNSQGEYEEAL----KSAVRQGNLLQMNVY 79 (81)
T ss_pred CCeEEEEEecCCCCCCHHHHHHHHHHHhCCCcceeEEE--cC-CCCEEEEEchhhHHHHH----HHHHhCCCEEEEEEe
Confidence 56788899988 7799999999999998 56789996 43 34489999999986554 455555667888764
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The NBR1 protein contains a type I PB1 domain. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.16 Score=57.90 Aligned_cols=107 Identities=13% Similarity=0.029 Sum_probs=73.3
Q ss_pred eEEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCC---CceeeEecccccC-CCC
Q 000726 1045 EELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH---PNVVAFYGVVQDG-PGG 1120 (1329)
Q Consensus 1045 ellkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrH---PNIVKL~Gif~e~-~dg 1120 (1329)
.-.+.||.|..+.||.....+..+.||..+... . ...+.+|...|+.|.- -.+.++++++... ..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g 86 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARSFS-T---------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG 86 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEecccc-c---------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC
Confidence 345679999999999987655567788754310 1 1356788889988853 3577888776542 134
Q ss_pred eEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 1167 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~ 1167 (1329)
..+||||++++.++.+.. ........+..+++++|+-||+.
T Consensus 87 ~~~LVmE~i~G~~~~~~~------~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 87 PDVLLLERLRGVSVEAPA------RTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred CeEEEEeccCCEecCCCC------CCHHHHHHHHHHHHHHHHHHhCC
Confidence 679999999988876521 23334455667788888888874
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.18 Score=56.26 Aligned_cols=29 Identities=24% Similarity=0.362 Sum_probs=24.0
Q ss_pred CCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1167 ~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
.++||+|+.+.|||++. +. +.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~----i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE----VYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc----EEEEECcccc
Confidence 47999999999999986 32 4799999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.069 Score=65.51 Aligned_cols=155 Identities=19% Similarity=0.338 Sum_probs=93.2
Q ss_pred HHHHHHHHHHHhcCCCceeeEecccccCCCCeEEEEEEeccCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCe
Q 000726 1090 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNI 1169 (1329)
Q Consensus 1090 keFlrEIeILk~LrHPNIVKL~Gif~e~~dg~L~LVMEYm~GGSL~d~L~~kek~Lse~qrlkIA~QIAsALaYLHs~GI 1169 (1329)
.+++-...+++.+.|+|+...+.+...... ...+|||++ +.+|.+.+.... +-.. ++. .+++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~-r~IVV~e~~-~~Sled~~~~~~--l~~~-------s~~-------~~~~ 88 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHE-RVIVVMEHY-TMSLEDILKTGN--LKDE-------SLL-------AHGV 88 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccc-eEEEEehhh-ccchHHHHHhcc--cchh-------hhc-------cccc
Confidence 345566778999999999999988766543 588899998 789988874432 1111 111 1222
Q ss_pred eecCCCCcceEeccCCCCCCcEEEeecCCcccccCcccccCCCCCCcccCccccccCCCCCChhhHHHHHHHHHHHHHhC
Q 000726 1170 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249 (1329)
Q Consensus 1170 IHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~~~ss~~~GTp~YmAPEvL~Gs~~~~S~KSDVWSLGVLLyELLTG 1249 (1329)
.|- ||+ +.+| -++..+ |- ...+|+|||++|.++.++..|
T Consensus 89 ~~~-----~~~-----------~~td-~~~t~~-----------------~~-------~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 89 LHL-----NII-----------YITD-HFLTKY-----------------PS-------PIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred cee-----hhh-----------hccc-cccccC-----------------CC-------CCCcchhhhhHHHHHHHHHHh
Confidence 221 222 2333 111000 00 012489999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhcCCCC----------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHH
Q 000726 1250 EEPYANMHYGAIIGGIVNNTLRP----------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303 (1329)
Q Consensus 1250 k~PF~~~~~~ell~qIve~~lr~----------~ips~~S~eL~DLIkrCLqkDPeERPTaeEL 1303 (1329)
...+......+....+.+-.... .+...++..+.++...|+-..|..||...++
T Consensus 128 ~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 128 ISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred hHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 88876655544443332221111 0112345667788889999999888865444
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.14 Score=59.57 Aligned_cols=135 Identities=16% Similarity=0.208 Sum_probs=73.9
Q ss_pred EEecccCcEEEEEEEEC------CceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCCCce-eeEecccccCCCC
Q 000726 1048 KELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV-VAFYGVVQDGPGG 1120 (1329)
Q Consensus 1048 kvLGqGaFGtVYKA~~k------Gr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrHPNI-VKL~Gif~e~~dg 1120 (1329)
+.|-.|-.-.+|++.+. ++.|.+|+..... +... .-.+|..+++.+..-++ .++++.+..
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--------~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~---- 108 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--------ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN---- 108 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--------Ceee-chHHHHHHHHHHHHcCCCCceEEEECC----
Confidence 34555888889998763 2568888875421 1111 12457777777753333 345555533
Q ss_pred eEEEEEEeccCCchhhh-----------------hhccc----c-cCCHHHHHHHHHH-----------------HHHHH
Q 000726 1121 TLATVTEFMVNGSLRHV-----------------LLSKE----R-HLDRRKRLIIAMD-----------------AAFGM 1161 (1329)
Q Consensus 1121 ~L~LVMEYm~GGSL~d~-----------------L~~ke----k-~Lse~qrlkIA~Q-----------------IAsAL 1161 (1329)
..|++|+++.+|... ++... . ...+..+..+..+ +...+
T Consensus 109 --g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~ 186 (344)
T PLN02236 109 --GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEI 186 (344)
T ss_pred --ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHH
Confidence 248999977665421 01111 0 1112222222211 11122
Q ss_pred HHHH--------HCCeeecCCCCcceEeccCCCCCCcEEEeecCCcc
Q 000726 1162 EYLH--------SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1162 aYLH--------s~GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr 1200 (1329)
..|. ...+||+|+++.|||++... ..+.|+||..+.
T Consensus 187 ~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~---~~~~lID~Eya~ 230 (344)
T PLN02236 187 NLLEKELSGDDQEIGFCHNDLQYGNIMIDEET---RAITIIDYEYAS 230 (344)
T ss_pred HHHHHHhcccCCCceEEeCCCCcCcEEEeCCC---CcEEEEeehhcc
Confidence 2222 22589999999999998532 246999999875
|
|
| >cd06398 PB1_Joka2 The PB1 domain is present in the Nicotiana plumbaginifolia Joka2 protein which interacts with sulfur stress inducible UP9 protein | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.15 Score=49.72 Aligned_cols=70 Identities=19% Similarity=0.285 Sum_probs=53.2
Q ss_pred cCceEEEEecC-----CCChHHHHHHHHHHcC----CceEEEeeCCCCCCCceeeccChhHHHHHHHHhhhhcccCCCCc
Q 000726 209 GGETRIIRISR-----DISWQELTQKALAIYN----QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKP 279 (1329)
Q Consensus 209 GG~triv~V~r-----~~~f~~l~~kl~~~~~----~~~~lkYqLP~edLD~LisVt~DeDL~~m~~Eydr~~~~~~~~~ 279 (1329)
||++|-+.++. +++|.+|..|+.+.+. ..+.|+|. .| =..+|.++||+||..-|+..-+. .+...+
T Consensus 8 ~~~~rRf~l~~~~~~~d~~~~~L~~kI~~~f~l~~~~~~~l~Y~--De-dgd~V~l~~D~DL~~a~~~~~~~--~~~~~l 82 (91)
T cd06398 8 GGTLRRFTFPVAENQLDLNMDGLREKVEELFSLSPDADLSLTYT--DE-DGDVVTLVDDNDLTDAIQYFCSG--SRLNPL 82 (91)
T ss_pred CCEEEEEEeccccccCCCCHHHHHHHHHHHhCCCCCCcEEEEEE--CC-CCCEEEEccHHHHHHHHHHHhcc--CCCceE
Confidence 78899999985 7999999999999985 36789998 43 34599999999999888764332 222355
Q ss_pred EEEE
Q 000726 280 RMFL 283 (1329)
Q Consensus 280 R~fl 283 (1329)
|+++
T Consensus 83 rl~v 86 (91)
T cd06398 83 RIDV 86 (91)
T ss_pred EEEE
Confidence 6654
|
The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.37 Score=56.46 Aligned_cols=149 Identities=17% Similarity=0.177 Sum_probs=81.5
Q ss_pred EEEEecccCcEEEEEEEECCceEEEEEEeccccCCCChHHHHHHHHHHHHHHHHHhcCC--CceeeEecccccCCCCeEE
Q 000726 1046 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH--PNVVAFYGVVQDGPGGTLA 1123 (1329)
Q Consensus 1046 llkvLGqGaFGtVYKA~~kGr~VAVKiLKks~~sd~s~e~E~~~keFlrEIeILk~LrH--PNIVKL~Gif~e~~dg~L~ 1123 (1329)
+.+.+-.|..-.+|....+++.+.|. ..... . .-.......+|..+|+.+.- --+.+.+++|.++..+..+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~-~-----~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDTGQKYVLR-KPPRG-D-----PVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred eeeeccCCcccceEEEecCCceEEEe-cCCcc-c-----cchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 34445455555566665567777777 22100 0 01112344567778877642 2344566777665445778
Q ss_pred EEEEeccCCchhhhhhccc-----------------------------cc--CCHHHHHHHHH--------------HHH
Q 000726 1124 TVTEFMVNGSLRHVLLSKE-----------------------------RH--LDRRKRLIIAM--------------DAA 1158 (1329)
Q Consensus 1124 LVMEYm~GGSL~d~L~~ke-----------------------------k~--Lse~qrlkIA~--------------QIA 1158 (1329)
.||+|++|..+...+.... .+ ....++..+.. .+.
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 9999998742222111000 00 00001111111 122
Q ss_pred HHHHHHHHC--------CeeecCCCCcceEeccCCCCCCcEEEeecCCcccccCc
Q 000726 1159 FGMEYLHSK--------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205 (1329)
Q Consensus 1159 sALaYLHs~--------GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~~~~~ 1205 (1329)
....||+.+ .++|+|+.+.||+|+..+. +-+.||+++......
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~----~gVlDwe~~~lGDP~ 232 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP----TGVLDWELATLGDPL 232 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe----eEEEeccccccCCcH
Confidence 334455543 4899999999999997764 589999998765443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.28 Score=55.61 Aligned_cols=31 Identities=23% Similarity=0.340 Sum_probs=24.9
Q ss_pred CeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1168 GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
.+||+|+++.|||++.++. .+-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~---~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR---VTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC---EEEEECcHhccc
Confidence 4899999999999986432 356999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.29 Score=56.73 Aligned_cols=30 Identities=27% Similarity=0.295 Sum_probs=24.4
Q ss_pred eeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1169 IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1169 IIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
+||+||.+.|||++.++. .++|+||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~---~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEG---KLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCC---cEEEEcccccCC
Confidence 799999999999975432 369999998753
|
|
| >cd06397 PB1_UP1 Uncharacterized protein 1 | Back alignment and domain information |
|---|
Probab=93.82 E-value=0.17 Score=48.42 Aligned_cols=59 Identities=24% Similarity=0.385 Sum_probs=46.8
Q ss_pred cCceEEEEecCCCChHHHHHHHHHHcCC---ceEEEeeCCCCCCCceeeccChhHHHHHHHHhhh
Q 000726 209 GGETRIIRISRDISWQELTQKALAIYNQ---THTIKYQLPGEDLDALVSVSCDEDLQNMMEECNV 270 (1329)
Q Consensus 209 GG~triv~V~r~~~f~~l~~kl~~~~~~---~~~lkYqLP~edLD~LisVt~DeDL~~m~~Eydr 270 (1329)
||+||=+++++.-+|++|..||..++.- ++.|+|- .||= -+|++++|+||...+....+
T Consensus 8 ~g~~RRf~~~~~pt~~~L~~kl~~Lf~lp~~~~~vtYi--DeD~-D~ITlssd~eL~d~~~~~~~ 69 (82)
T cd06397 8 LGDTRRIVFPDIPTWEALASKLENLYNLPEIKVGVTYI--DNDN-DEITLSSNKELQDFYRLSHR 69 (82)
T ss_pred CCceEEEecCCCccHHHHHHHHHHHhCCChhHeEEEEE--cCCC-CEEEecchHHHHHHHHhccc
Confidence 5666667799999999999999999863 5789997 4432 58999999999987764443
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.33 E-value=0.42 Score=54.41 Aligned_cols=30 Identities=17% Similarity=0.136 Sum_probs=25.5
Q ss_pred CeeecCCCCcceEeccCCCCCCcEEEeecCCccc
Q 000726 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1168 GIIHRDLKPeNILLDsdGni~~~VKLsDFGLAr~ 1201 (1329)
++||+|+.++|||++.++. +.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~----~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG----GYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC----EEEEEhhhccc
Confidence 6999999999999987654 48899998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.53 E-value=0.45 Score=50.93 Aligned_cols=29 Identities=31% Similarity=0.379 Sum_probs=18.4
Q ss_pred CeeecCCCCcceEe-ccCCCCCCcEEEeecCCcc
Q 000726 1168 NIVHFDLKCDNLLV-NLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1168 GIIHRDLKPeNILL-DsdGni~~~VKLsDFGLAr 1200 (1329)
.++|+||.+.|||+ +.++ .++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~----~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDG----EVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSS----CEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCC----eEEEecHHHHh
Confidence 58999999999999 4444 36999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1329 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-45 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-45 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-41 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-40 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-40 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-35 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-32 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-32 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-32 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-31 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-31 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-31 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-31 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-31 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-31 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-31 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-31 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-31 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-31 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-31 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-31 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-31 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-31 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-31 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-31 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-31 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-30 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-30 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-30 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-30 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-30 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-30 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-30 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-30 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-30 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-30 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-30 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-30 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-30 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-30 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-30 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-30 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-29 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-29 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-29 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-29 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-29 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-29 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-29 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-29 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-29 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-29 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-29 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-29 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-29 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-29 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-29 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-29 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-29 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-29 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-29 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-29 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-29 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-29 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-29 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-29 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-29 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-29 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-29 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-29 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-29 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-29 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-29 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-29 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-28 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-28 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-28 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-28 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-28 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-28 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-28 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-28 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-28 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-28 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-28 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-28 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-28 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-28 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-28 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-28 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-28 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-28 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-28 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-28 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-28 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-28 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-28 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-28 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-28 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-28 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-28 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-28 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-28 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-28 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-28 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-27 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-27 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-27 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-27 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-27 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-27 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-27 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-27 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-27 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-27 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-27 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-27 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-27 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-27 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-27 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-27 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-27 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-27 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-27 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-27 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-27 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-27 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-27 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-27 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-27 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-27 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-27 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-27 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-27 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-27 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-27 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-27 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-27 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-27 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-27 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-27 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-27 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-27 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-27 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-27 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-27 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-27 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-26 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-26 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-26 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-26 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-26 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-26 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-26 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-26 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-26 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-26 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-26 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-26 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-26 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-26 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-26 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-26 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-26 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-26 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-26 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-26 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-26 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-26 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-26 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-26 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-26 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-26 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-26 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-26 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-26 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-26 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-26 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-26 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-25 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-25 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-25 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-25 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-25 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-25 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-25 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-25 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-25 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-25 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-25 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-25 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-25 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-25 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-25 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-25 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-25 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-25 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-25 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-25 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-25 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-25 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-25 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-25 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-25 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-25 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-25 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-25 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-25 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-25 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-25 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-24 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-24 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-24 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-24 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-24 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-24 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-24 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-24 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-24 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-24 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-24 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-24 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-24 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-23 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-23 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-23 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-23 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-23 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-23 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-23 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-23 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-23 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-23 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-23 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-23 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-23 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-23 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-23 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-23 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-23 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-23 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-23 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-23 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-23 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-23 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-23 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-23 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-23 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-23 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-23 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-23 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-23 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-23 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-23 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-23 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-23 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-23 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-22 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-22 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-22 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-22 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-22 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-22 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-22 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-22 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-22 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-22 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-22 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-22 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-22 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-22 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-22 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-22 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-22 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-21 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-21 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-21 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-21 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-21 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-21 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-21 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-21 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-21 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-21 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-21 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-21 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-21 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-21 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-21 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-21 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-21 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-21 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-21 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-21 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-21 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-21 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-21 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-21 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-21 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-21 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-21 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-20 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-20 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-20 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-20 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-20 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-20 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-20 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-20 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-19 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-19 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-19 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-19 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-19 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-19 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-19 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-19 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-19 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-18 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-18 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-18 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-18 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-17 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-17 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-16 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-15 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-14 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-14 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-14 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-14 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-14 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 9e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1329 | |||
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-127 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-124 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-124 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-123 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-116 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-114 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-114 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-101 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 7e-95 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-90 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-85 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-83 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-73 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-72 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-71 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-71 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-71 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-70 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 7e-70 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-69 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-69 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-69 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-68 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-68 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-68 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-68 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-68 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 4e-68 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 5e-68 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 7e-68 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-67 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-67 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-67 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-67 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-67 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-67 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-67 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 5e-67 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 6e-67 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 7e-67 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-66 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-66 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-66 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-66 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-66 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-66 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-65 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-65 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-65 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 4e-65 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-65 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-64 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 9e-64 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-63 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-63 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-63 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-63 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 9e-63 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-62 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-62 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-62 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 6e-62 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-61 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-61 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-60 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 8e-60 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 6e-59 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-53 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-51 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 6e-50 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-48 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-48 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-47 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-47 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-47 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-47 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 8e-47 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-46 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-46 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 8e-46 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-45 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-44 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-44 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 6e-44 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 7e-44 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 8e-43 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-42 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-40 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-40 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-39 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-39 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 5e-39 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-38 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-38 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-38 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-38 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-38 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-38 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 4e-38 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-37 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-37 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-37 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-37 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 5e-37 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-37 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 7e-37 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-36 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-36 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-36 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-36 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-36 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 6e-36 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-36 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-15 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-36 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-35 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-35 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-35 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 4e-35 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-35 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 9e-35 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-34 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-34 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-34 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-34 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-34 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-34 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-34 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-33 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-33 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 8e-33 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-32 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-32 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-32 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-32 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-32 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-32 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-32 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-32 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-31 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-31 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-31 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 5e-31 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 7e-31 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 8e-31 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-30 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-30 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-30 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 6e-30 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 7e-30 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-29 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-29 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 8e-29 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 9e-29 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-28 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-28 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-28 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-28 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-28 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-28 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-28 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-28 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-28 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-27 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-27 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-27 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-27 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 7e-26 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-25 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-25 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-25 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-25 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-25 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 7e-25 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 9e-25 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-24 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-24 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-24 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-24 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-24 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 4e-24 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 4e-24 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 5e-24 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 8e-24 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-23 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-23 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-23 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-23 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 5e-23 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 9e-23 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-22 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-22 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-22 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-22 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-22 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 6e-22 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 7e-22 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-21 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-21 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-21 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 6e-21 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 7e-21 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-20 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-20 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-20 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 6e-20 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 6e-20 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 9e-20 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-19 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-19 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-19 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-19 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 8e-19 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-18 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-18 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-18 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-17 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-17 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 7e-16 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-15 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 8e-15 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-14 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-13 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-10 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-10 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 7e-10 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-09 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 5e-09 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 5e-09 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-09 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-08 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 5e-06 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-05 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-04 |
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 393 bits (1011), Expect = e-127
Identities = 102/288 (35%), Positives = 151/288 (52%), Gaps = 14/288 (4%)
Query: 1030 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQER 1087
F S L + + ++E K++G G FG V+ G+ + VAIK + G + E+
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR 1147
EF RE I+S L+HPN+V YG++ + P V EF+ G L H LL K +
Sbjct: 67 FQ-EFQREVFIMSNLNHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAHPIKW 121
Query: 1148 RKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPIC-KVGDFGLSKIKRN 1204
+L + +D A G+EY+ ++N IVH DL+ N+ + D P+C KV DFGLS+ +
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH 181
Query: 1205 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--AII 1262
+ G+ G WMAPE + +EK D +SF ++L+ ILTGE P+ YG I
Sbjct: 182 S--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 1263 GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
I LRP +P C R ++E CW+ DP RP F+ I + L +
Sbjct: 240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 386 bits (994), Expect = e-124
Identities = 105/286 (36%), Positives = 158/286 (55%), Gaps = 19/286 (6%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I DL +++G+G+FGTV+ +W G+DVA+K + + F EF RE I
Sbjct: 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVN------EFLREVAI 87
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLIIAMD 1156
+ +L HPN+V F G V P L+ VTE++ GSL +L LD R+RL +A D
Sbjct: 88 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 1157 AAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG-GVRG 1213
A GM YLH++N IVH +LK NLLV+ + KV DFGLS++K +T ++ G
Sbjct: 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVD----KKYTVKVCDFGLSRLKASTFLSSKSAAG 201
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273
T WMAPE+L S +EK DV+SFG++LWE+ T ++P+ N++ ++ + R
Sbjct: 202 TPEWMAPEVLRDEPS--NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 259
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSH 1319
+P + + ++E CW +P RPSF I LR + + +
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-124
Identities = 95/279 (34%), Positives = 136/279 (48%), Gaps = 18/279 (6%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I +L + +G G FG VY W G +VA+K + + + +EA++
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARH----DPDEDISQTIENVRQEAKL 59
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ L HPN++A GV P L V EF G L VL + + + A+ A
Sbjct: 60 FAMLKHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIA 115
Query: 1159 FGMEYLHSKN---IVHFDLKCDNLLVN----LKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211
GM YLH + I+H DLK N+L+ D I K+ DFGL++ T
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1271
G WMAPE++ S S+ DV+S+G++LWE+LTGE P+ + A+ G+ N L
Sbjct: 176 -GAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
P+P C + LME CW PDP RPSFT I +L +
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 382 bits (983), Expect = e-123
Identities = 72/277 (25%), Positives = 118/277 (42%), Gaps = 18/277 (6%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I + L L +L G ++ G+W+G D+ +K +K ++ R S +F E
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSR------DFNEECPR 60
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDA 1157
L HPNV+ G Q P +T +M GSL +VL +D+ + + A+D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 1158 AFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
A GM +LH+ I L +++++ ++ + ++ G
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMT----ARISMADVKFSFQSP----GRMYAP 172
Query: 1216 PWMAPELLNGSSSKV-SEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274
W+APE L D++SF ++LWE++T E P+A++ I + LRP +
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311
P LM+ C DP RP F I L M
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 363 bits (933), Expect = e-116
Identities = 93/281 (33%), Positives = 146/281 (51%), Gaps = 22/281 (7%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I + + + +GSG+FGTVY GKW G DVA+K + + T + + F E +
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQ------AFKNEVGV 73
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L K H N++ F G LA VT++ SL H L + E + +K + IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTL 1215
GM+YLH+K+I+H DLK +N+ ++ + K+GDFGL+ K + G++
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDN----TVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 1216 PWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLRP- 1272
WMAPE++ S+ S + DV++FGIVL+E++TG+ PY+N+ + II + +L P
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 1273 --PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311
V C + LM +C RPSF I + ++
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 359 bits (924), Expect = e-114
Identities = 93/282 (32%), Positives = 140/282 (49%), Gaps = 27/282 (9%)
Query: 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+L +I +++E + +G G FG V KWR DVAIK+I+ E F
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE----------SESERKAFIV 50
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER--HLDRRKRLI 1152
E LS+++HPN+V YG + + V E+ GSL +VL E + +
Sbjct: 51 ELRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106
Query: 1153 IAMDAAFGMEYLHS---KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
+ + G+ YLHS K ++H DLK NLL+ + K+ DFG + + +
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV---LKICDFGTACDIQTHMTNN 163
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI-IGGIVNN 1268
+G+ WMAPE+ GS SEK DVFS+GI+LWE++T +P+ + A I V+N
Sbjct: 164 --KGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
RPP+ LM +CW+ DP RPS EI + + +
Sbjct: 220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 359 bits (924), Expect = e-114
Identities = 84/294 (28%), Positives = 119/294 (40%), Gaps = 27/294 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I E LE + +G G FG VYHG+W G +VAI+ I + E F RE
Sbjct: 30 IPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIE------RDNEDQLKAFKREVMA 82
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ H NVV F G P LA +T +L V+ + LD K IA +
Sbjct: 83 YRQTRHENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG------GVR 1212
GM YLH+K I+H DLK N+ + + DFGL I
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYDNGK-----VVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 1213 GTLPWMAPELLNGSSSKV-------SEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1265
G L +APE++ S S+ DVF+ G + +E+ E P+ AII +
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255
Query: 1266 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSH 1319
E ++ CWA + RP+FT++ L + + SH
Sbjct: 256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 312 bits (800), Expect = 1e-96
Identities = 83/323 (25%), Positives = 135/323 (41%), Gaps = 58/323 (17%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWRE 1095
+Q + ++ +K++G G +G V+ GKWRG VA+K + ++RE
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-----------SWFRE 79
Query: 1096 AEI--LSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
EI + H N++ F G G L +T++ NGSL L K LD + L
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSML 137
Query: 1152 IIAMDAAFGMEYLHSKN--------IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203
+A + G+ +LH++ I H DLK N+LV C + D GL+
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN----GTCCIADLGLAVKFI 193
Query: 1204 NT-----LVTGGVRGTLPWMAPELLNGSSSKVS----EKVDVFSFGIVLWEILTGEE--- 1251
+ + GT +M PE+L+ S ++ D++SFG++LWE+
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
Query: 1252 -------PYANM-----HYGAIIGGIVNNTLRPPVPGF-----CDSEWRLLMEQCWAPDP 1294
PY ++ Y + + LRP P C + LM +CWA +P
Sbjct: 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313
Query: 1295 VVRPSFTEIARRLRVMSAACQTK 1317
R + + + L MS + K
Sbjct: 314 ASRLTALRVKKTLAKMSESQDIK 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 306 bits (786), Expect = 7e-95
Identities = 90/291 (30%), Positives = 127/291 (43%), Gaps = 34/291 (11%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWRE 1095
I + DL + LG G FG R T + +K + + E +R F +E
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----DEETQR---TFLKE 57
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
+++ L HPNV+ F GV+ L +TE++ G+LR ++ S + +R+ A
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDK--RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAK 115
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---------- 1205
D A GM YLHS NI+H DL N LV V DFGL+++ +
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENK----NVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 1206 -----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YG 1259
V G WMAPE++NG S EKVDVFSFGIVL EI+ +
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSY--DEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
Query: 1260 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
G V L P C + + +C DP RPSF ++ L +
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 2e-85
Identities = 80/322 (24%), Positives = 127/322 (39%), Gaps = 58/322 (18%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
Q + + +G G FG V+ GKWRG +VA+K S +ER ++REA
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS--------SREER---SWFREA 85
Query: 1097 EI--LSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
EI L H N++ F G L V+++ +GSL L + +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIK 143
Query: 1153 IAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
+A+ A G+ +LH + I H DLK N+LV C + D GL+ +
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCIADLGLAVRHDS 199
Query: 1205 TLVTG-----GVRGTLPWMAPELLNGSSS----KVSEKVDVFSFGIVLWEILTG------ 1249
T GT +MAPE+L+ S + + ++ D+++ G+V WEI
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
Query: 1250 EEPYANMHYG---------AIIGGIVNNTLRPPVPGF-----CDSEWRLLMEQCWAPDPV 1295
E Y +Y + + LRP +P +M +CW +
Sbjct: 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 319
Query: 1296 VRPSFTEIARRLRVMSAACQTK 1317
R + I + L +S K
Sbjct: 320 ARLTALRIKKTLSQLSQQEGIK 341
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 2e-83
Identities = 76/317 (23%), Positives = 131/317 (41%), Gaps = 58/317 (18%)
Query: 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
++Q D+ L+ +G G +G V+ G W+G +VA+K SS E+ ++R
Sbjct: 1 SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIF--------SSRDEK---SWFR 49
Query: 1095 EAEI--LSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
E E+ L H N++ F + L +T + GSL L + LD
Sbjct: 50 ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSC 107
Query: 1151 LIIAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202
L I + A G+ +LH + I H DLK N+LV C + D GL+ +
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG----QCCIADLGLAVMH 163
Query: 1203 RNTLVTG-----GVRGTLPWMAPELLNGS----SSKVSEKVDVFSFGIVLWEILTGEE-- 1251
+ GT +MAPE+L+ + ++VD+++FG+VLWE+
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
Query: 1252 --------PYANMH-----YGAIIGGIVNNTLRPPVP-----GFCDSEWRLLMEQCWAPD 1293
P+ ++ + + + + RP +P + LM++CW +
Sbjct: 224 GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283
Query: 1294 PVVRPSFTEIARRLRVM 1310
P R + I + L +
Sbjct: 284 PSARLTALRIKKTLTKI 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 2e-73
Identities = 80/289 (27%), Positives = 134/289 (46%), Gaps = 27/289 (9%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQ 1085
+ + L+I+K + +++K LGSG FGTVY G W VAIK ++++ +S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPK 59
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 1145
E EA +++ + +P+V G+ + +T+ M G L + + ++
Sbjct: 60 ANK--EILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNI 114
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRN 1204
+ L + A GM YL + +VH DL N+LV K+ DFGL+K +
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAE 170
Query: 1205 TLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI 1261
G +P WMA E + + + DV+S+G+ +WE++T G +PY + I
Sbjct: 171 EKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228
Query: 1262 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
I+ R P P C + ++M +CW D RP F E+ M
Sbjct: 229 S-SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 1e-72
Identities = 95/279 (34%), Positives = 136/279 (48%), Gaps = 24/279 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ +EDL +++G G FG V+ G+ R T VA+K +++ + +F +EA
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-----LPPDLKA--KFLQEA 163
Query: 1097 EILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
IL + HPN+V GV Q P + V E + G L ++ L + L +
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQP---IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGT 1214
DAA GMEYL SK +H DL N LV K+ + K+ DFG+S+ G
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKN----VLKISDFGMSREEADGVYAASGGLRQ 276
Query: 1215 LP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1271
+P W APE LN + S + DV+SFGI+LWE + G PY N+ + R
Sbjct: 277 VPVKWTAPEALN--YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GR 333
Query: 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
P P C LMEQCWA +P RPSF+ I + L+ +
Sbjct: 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 2e-71
Identities = 84/280 (30%), Positives = 129/280 (46%), Gaps = 25/280 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
I ED+ + LG G FG VY G + +VA+K KK + + +F
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-----CTLDNKE--KFM 61
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
EA I+ L HP++V G++++ P + E G L H L + L ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP---TWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
++ M YL S N VH D+ N+LV + K+GDFGLS+ +
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE----CVKLGDFGLSRYIEDEDYYKASVT 174
Query: 1214 TLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1270
LP WM+PE +N + + DV+ F + +WEIL+ G++P+ + +I G++
Sbjct: 175 RLPIKWMSPESIN--FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-GVLEKGD 231
Query: 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
R P P C LM +CW DP RP FTE+ L +
Sbjct: 232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 5e-71
Identities = 89/284 (31%), Positives = 128/284 (45%), Gaps = 24/284 (8%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEF 1092
+I +DL L++LG G+FG V G+W VA+K +K + + + F
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD-----F 68
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
RE + L H N++ YGVV P + VTE GSL L + H
Sbjct: 69 IREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGG 1210
A+ A GM YL SK +H DL NLL+ +D + K+GDFGL + + +
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQ 181
Query: 1211 VRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267
+P W APE L + S D + FG+ LWE+ T G+EP+ ++ I+ I
Sbjct: 182 EHRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
Query: 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311
R P P C + +M QCWA P RP+F + L
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 6e-71
Identities = 90/280 (32%), Positives = 138/280 (49%), Gaps = 25/280 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
I+ E +E + +G G FG V+ G + VAIK K +S+ R +F
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-----TSDSVRE--KFL 64
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
+EA + + HP++V GV+ + P + + E G LR L ++ LD ++
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
A + + YL SK VH D+ N+LV+ D K+GDFGLS+ ++ +G
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 177
Query: 1214 TLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1270
LP WMAPE +N + + DV+ FG+ +WEIL G +P+ + +I G + N
Sbjct: 178 KLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-GRIENGE 234
Query: 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
R P+P C LM +CWA DP RP FTE+ +L +
Sbjct: 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 1e-70
Identities = 72/312 (23%), Positives = 121/312 (38%), Gaps = 54/312 (17%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
++ L+ L+ G FG V+ + VA+K Q++ + + E
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIF---------PIQDKQSWQNEYEVYS 71
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
L + H N++ F G + G L +T F GSL L K + + IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAET 129
Query: 1157 AAFGMEYLHSK----------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---R 1203
A G+ YLH I H D+K N+L+ K+ + + DFGL+ +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL--KNNLT--ACIADFGLALKFEAGK 185
Query: 1204 NTLVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMH--- 1257
+ T G GT +MAPE+L G+ ++D+++ G+VLWE+ +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 1258 ---YGAIIGG----------IVNNTLRPPVPGFCDSEWRL-----LMEQCWAPDPVVRPS 1299
+ IG +V+ RP + + + +E+CW D R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 1300 FTEIARRLRVMS 1311
+ R+ M
Sbjct: 306 AGCVGERITQMQ 317
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 7e-70
Identities = 92/277 (33%), Positives = 140/277 (50%), Gaps = 24/277 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+K E++ LKELGSG FG V GKW+G DVA+K IK+ S ++ EF++EA+
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-----SMSED----EFFQEAQ 55
Query: 1098 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
+ KL HP +V FYGV ++ P + VTE++ NG L + L S + L+ + L + D
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYP---IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
GM +L S +H DL N LV+ KV DFG+++ + V P
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDL----CVKVSDFGMTRYVLDDQYVSSVGTKFP 168
Query: 1217 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
W APE+ + K S K DV++FGI++WE+ + G+ PY ++ V+ R
Sbjct: 169 VKWSAPEVFH--YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-LKVSQGHRLY 225
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
P +M CW P RP+F ++ + +
Sbjct: 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-69
Identities = 92/298 (30%), Positives = 133/298 (44%), Gaps = 27/298 (9%)
Query: 1039 IKNEDLEELK-ELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
+K ++L ELG G FG+V G +R DVAIK +K+ G E
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADTE---EMM 58
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
REA+I+ +L +P +V GV Q L V E G L L+ K + +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 1211
+ GM+YL KN VH DL N+L+ + K+ DFGLSK ++ T
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----YAKISDFGLSKALGADDSYYTARS 171
Query: 1212 RGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1268
G P W APE +N K S + DV+S+G+ +WE L+ G++PY M ++ +
Sbjct: 172 AGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQ 228
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQVQNQ 1326
R P C E LM CW RP F + +R+R + +K GH +
Sbjct: 229 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHHH 286
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-69
Identities = 95/274 (34%), Positives = 132/274 (48%), Gaps = 24/274 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I +DL LKELG+G FG V +GKWRG DVAIK IK+ S ++ EF EA+
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-----SMSED----EFIEEAK 71
Query: 1098 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ L H +V YGV + P + +TE+M NG L + L ++ L + D
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRP---IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
MEYL SK +H DL N LVN + + KV DFGLS+ + T V P
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEYTSSVGSKFP 184
Query: 1217 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
W PE+L SK S K D+++FG+++WEI + G+ PY I LR
Sbjct: 185 VRWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLY 241
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P + +M CW RP+F + +
Sbjct: 242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 2e-69
Identities = 85/280 (30%), Positives = 136/280 (48%), Gaps = 24/280 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I +L ++E+GSG FG V+ G W VAIK I++ + +E +F EAE
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-----AMSEE----DFIEEAE 55
Query: 1098 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ KL HP +V YGV + P + VTEFM +G L L ++ L + +D
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAP---ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
GM YL ++H DL N LV + KV DFG+++ + T P
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQ----VIKVSDFGMTRFVLDDQYTSSTGTKFP 168
Query: 1217 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
W +PE+ + S+ S K DV+SFG+++WE+ + G+ PY N ++ ++ R
Sbjct: 169 VKWASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFRLY 225
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313
P + +M CW P RP+F+ + R+L ++ +
Sbjct: 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-68
Identities = 80/289 (27%), Positives = 134/289 (46%), Gaps = 27/289 (9%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQ 1085
+ + L+I+K + +++K LGSG FGTVY G W VAIK ++++ +S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPK 59
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 1145
E EA +++ + +P+V G+ + +T+ M G L + + ++
Sbjct: 60 ANK--EILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNI 114
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRN 1204
+ L + A GM YL + +VH DL N+LV K+ DFGL+K +
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAE 170
Query: 1205 TLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI 1261
G +P WMA E + + + DV+S+G+ +WE++T G +PY + I
Sbjct: 171 EKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228
Query: 1262 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
I+ R P P C + ++M +CW D RP F E+ M
Sbjct: 229 S-SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 1e-68
Identities = 90/299 (30%), Positives = 140/299 (46%), Gaps = 42/299 (14%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
I + L+ + +LG G FG+V ++ VA+K+++ S +Q+R +
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQR---D 70
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
F RE +IL LH +V + GV +L V E++ +G LR L LD + L
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT---LV 1207
+ + GMEYL S+ VH DL N+LV + K+ DFGL+K + + +V
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEA----HVKIADFGLAKLLPLDKDYYVV 186
Query: 1208 TGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH-----YG 1259
G P W APE L+ + S + DV+SFG+VL+E+ T ++ + G
Sbjct: 187 REP--GQSPIFWYAPESLS--DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242
Query: 1260 AIIGGIVNNTL--------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
+ L R P P C +E LM+ CWAP P RPSF+ + +L ++
Sbjct: 243 CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 2e-68
Identities = 87/296 (29%), Positives = 126/296 (42%), Gaps = 27/296 (9%)
Query: 1039 IKNEDLE-ELKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
+ + L E KELGSG FGTV G ++ VA+K +K + + E
Sbjct: 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN----EANDPALKD--ELL 66
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
EA ++ +L +P +V G+ + V E G L L + RH+ + + +
Sbjct: 67 AEANVMQQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNK-YLQQNRHVKDKNIIEL 122
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 1211
+ GM+YL N VH DL N+L+ + K+ DFGLSK
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQT 178
Query: 1212 RGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1268
G P W APE +N K S K DV+SFG+++WE + G++PY M + ++
Sbjct: 179 HGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEK 235
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQVQ 1324
R P C E LM CW D RP F + RLR + H H
Sbjct: 236 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH 291
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 4e-68
Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 33/290 (11%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQE 1086
I+NEDL + LG GTF ++ G R T+V +K + K+
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYS 56
Query: 1087 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 1146
F+ A ++SKL H ++V YGV G V EF+ GSL L + ++
Sbjct: 57 E---SFFEAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCIN 111
Query: 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR----PICKVGDFGLSKIK 1202
+L +A A M +L ++H ++ N+L+ ++ + P K+ D G+S
Sbjct: 112 ILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--- 168
Query: 1203 RNTLVTGGVRGTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGA 1260
L ++ +PW+ PE + N ++ D +SFG LWEI + G++P + +
Sbjct: 169 ITVLPKDILQERIPWVPPECIENP--KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
Query: 1261 IIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
+ + + P P +E L+ C +P RPSF I R L +
Sbjct: 227 KLQFYEDR-HQLPAP--KAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 4e-68
Identities = 80/287 (27%), Positives = 130/287 (45%), Gaps = 34/287 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
+ + + +G G FG VYHG A+K + + E +F
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIGEVS--QFL 74
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
E I+ HPNV++ G+ G+ V +M +G LR+ + ++ + + +
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT--LVTGG 1210
+ A GM+YL SK VH DL N +++ K KV DFGL++ + V
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKF----TVKVADFGLARDMYDKEYYSVHNK 189
Query: 1211 VRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH----YGAIIG 1263
LP WMA E L + K + K DV+SFG++LWE++T G PY +++ ++
Sbjct: 190 TGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
Query: 1264 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
G R P +C +M +CW P +RPSF+E+ R+ +
Sbjct: 248 GR-----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 4e-68
Identities = 91/276 (32%), Positives = 130/276 (47%), Gaps = 26/276 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
++ D+ +LG G +G VY G W+ VA+K +K+ + E E EF +EA
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVE----EFLKEA 60
Query: 1097 EILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IA 1154
++ ++ HPN+V GV ++ P +TEFM G+L L R L+ +A
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGT 1214
+ MEYL KN +H DL N LV + KV DFGLS++ T
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 1215 LP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1271
P W APE L +K S K DV++FG++LWEI T G PY + + + + R
Sbjct: 174 FPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR 230
Query: 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P C + LM CW +P RPSF EI +
Sbjct: 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 5e-68
Identities = 82/281 (29%), Positives = 126/281 (44%), Gaps = 34/281 (12%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ +G G FG VYHG++ AIK + + Q+ F RE
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-----EMQQVE--AFLREG 73
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ L+HPNV+A G++ G + +M +G L + S +R+ + + +
Sbjct: 74 LLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRN--TLVTGGVRG 1213
A GMEYL + VH DL N +++ KV DFGL++ I V
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESF----TVKVADFGLARDILDREYYSVQQHRHA 188
Query: 1214 TLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH----YGAIIGGIV 1266
LP W A E L + + + K DV+SFG++LWE+LT G PY ++ + G
Sbjct: 189 RLPVKWTALESLQ--TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR- 245
Query: 1267 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
R P P +C +M+QCW DP VRP+F + +
Sbjct: 246 ----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 7e-68
Identities = 92/274 (33%), Positives = 136/274 (49%), Gaps = 28/274 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ ++L+ L+ +G G FG V G +RG VA+K IK ++ Q F EA +
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQ-----AFLAEASV 67
Query: 1099 LSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
+++L H N+V GV+ ++ L VTE+M GSL L S+ R + L+ ++D
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKG--GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
MEYL N VH DL N+LV+ + + KV DFGL+ + + G LP
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLT---KE-ASSTQDTGKLP 177
Query: 1217 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
W APE L K S K DV+SFGI+LWEI + G PY + ++ V +
Sbjct: 178 VKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKGYKMD 234
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P C +M+ CW D +RPSF ++ +L
Sbjct: 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-67
Identities = 89/298 (29%), Positives = 126/298 (42%), Gaps = 38/298 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
I L K LG G FG+V G + VA+K +K SS++E EF
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL----DNSSQREIE--EFL 84
Query: 1094 REAEILSKLHHPNVVAFYGVV-QDGPGGTLAT--VTEFMVNGSLRHVLLS-----KERHL 1145
EA + HPNV+ GV + G + FM G L LL +H+
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRN 1204
+ L +D A GMEYL ++N +H DL N ++ V DFGLSK I
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM----TVCVADFGLSKKIYSG 200
Query: 1205 TLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH---- 1257
G +P W+A E L + K DV++FG+ +WEI T G PY +
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258
Query: 1258 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315
Y ++ G R P C E +M CW DP+ RP+F+ + +L + +
Sbjct: 259 YDYLLHGH-----RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-67
Identities = 89/295 (30%), Positives = 130/295 (44%), Gaps = 40/295 (13%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ +++ ++ LG G FG VY G+ G VA+K + + C SEQ+ L +
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDEL--D 79
Query: 1092 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLS------KERH 1144
F EA I+SK +H N+V GV Q P + E M G L+ L +
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLP---RFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 1145 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKR 1203
L L +A D A G +YL + +H D+ N L+ P R + K+GDFG+++ I R
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYR 195
Query: 1204 NTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH--- 1257
+ G LP WM PE + K D +SFG++LWEI + G PY +
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253
Query: 1258 -YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311
+ G R P C +M QCW P RP+F I R+ +
Sbjct: 254 VLEFVTSGG-----RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-67
Identities = 93/282 (32%), Positives = 128/282 (45%), Gaps = 26/282 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
I+ + K +GSG G V +G+ R VAIK +K +E++R +F
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-----TERQRR--DFL 98
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
EA I+ + HPN++ GVV G VTE+M NGSL L + + + + +
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 1211
GM YL VH DL N+LV+ +CKV DFGLS++
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL----VCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 1212 RGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1268
G +P W APE + S DV+SFG+V+WE+L GE PY NM +I V
Sbjct: 213 GGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI-SSVEE 269
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
R P P C LM CW D RP F++I L +
Sbjct: 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 2e-67
Identities = 88/274 (32%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+ E L+ ++ LG+G FG V+ G + G T VA+K +K+ S + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-----SMSPD----AFLAEAN 60
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++ +L H +V Y VV P + +TE+M NGSL L + +L+ +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GM ++ +N +H DL+ N+LV+ CK+ DFGL+++ + T P
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTL----SCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 1217 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
W APE +N + K DV+SFGI+L EI+T G PY M +I + R
Sbjct: 174 IKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMV 230
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P C E LM CW P RP+F + L
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 3e-67
Identities = 91/299 (30%), Positives = 135/299 (45%), Gaps = 41/299 (13%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ L+ L++LG G FG+V ++ VA+K+++ S +
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLR----D 57
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
F RE EIL L H N+V + GV L + E++ GSLR L + +D K L
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV-TG 1209
GMEYL +K +H DL N+LV ++ K+GDFGL+K + ++
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKVLPQDKEFFKV 173
Query: 1210 GVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT----------------GEE 1251
G P W APE L SK S DV+SFG+VL+E+ T G +
Sbjct: 174 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 1252 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
M +I + NN R P P C E ++M +CW + RPSF ++A R+ +
Sbjct: 232 KQGQMIVFHLIELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 3e-67
Identities = 91/291 (31%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
I + + LG G FG+V + + VA+K +K + + EF
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA----DIIASSDIE--EFL 73
Query: 1094 REAEILSKLHHPNVVAFYGVV-QDGPGGTLAT---VTEFMVNGSLRHVLLS-----KERH 1144
REA + + HP+V GV + G L + FM +G L LL+ +
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 1145 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKR 1203
L + + +D A GMEYL S+N +H DL N ++ V DFGLS KI
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM----TVCVADFGLSRKIYS 189
Query: 1204 NTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH--- 1257
G LP W+A E L + + DV++FG+ +WEI+T G+ PYA +
Sbjct: 190 GDYYRQGCASKLPVKWLALESLA--DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 1258 -YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
Y +IGG R P C E LM QCW+ DP RPSFT + L
Sbjct: 248 IYNYLIGGN-----RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 4e-67
Identities = 70/325 (21%), Positives = 110/325 (33%), Gaps = 69/325 (21%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ ++L+ L+ +G G +G VY G VA+K S + F E I
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVF--------SFANRQ---NFINEKNI 58
Query: 1099 --LSKLHHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
+ + H N+ F + V E+ NGSL L D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRL 116
Query: 1154 AMDAAFGMEYLHS---------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
A G+ YLH+ I H DL N+LV C + DFGLS
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG----TCVISDFGLSMRLTG 172
Query: 1205 T---------LVTGGVRGTLPWMAPELLNGSSS-----KVSEKVDVFSFGIVLWEIL--- 1247
GT+ +MAPE+L G+ + ++VD+++ G++ WEI
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 1248 TGEEPYANMH-----YGAIIGG----------IVNNTLRPPVPGFCDSEWRL------LM 1286
T P ++ + +G + RP P +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 1287 EQCWAPDPVVRPSFTEIARRLRVMS 1311
E CW D R + R+ +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELM 317
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 5e-67
Identities = 78/283 (27%), Positives = 122/283 (43%), Gaps = 27/283 (9%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
I K +L +LK LGSG FGTV+ G W V IK I+ S Q
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-----SGRQSFQ--A 61
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
+ L H ++V G+ L VT+++ GSL + L + L
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLL 118
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGG 1210
+ A GM YL +VH +L N+L+ +V DFG++ + +
Sbjct: 119 NWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS----QVQVADFGVADLLPPDDKQLLY 174
Query: 1211 VRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267
P WMA E ++ K + + DV+S+G+ +WE++T G EPYA + + ++
Sbjct: 175 SEAKTPIKWMALESIH--FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-DLLE 231
Query: 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
R P C + ++M +CW D +RP+F E+A M
Sbjct: 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 6e-67
Identities = 87/297 (29%), Positives = 134/297 (45%), Gaps = 37/297 (12%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ L+ +++LG G FG V ++ G VA+K +K S +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-----SGGNHIA--D 69
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
+E EIL L+H N+V + G+ + G + + EF+ +GSL+ L + ++ +++L
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 129
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV-TG 1209
A+ GM+YL S+ VH DL N+LV + K+GDFGL+K I+ + T
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH----QVKIGDFGLTKAIETDKEYYTV 185
Query: 1210 GVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH--------- 1257
P W APE L SK DV+SFG+ L E+LT + + M
Sbjct: 186 KDDRDSPVFWYAPECLM--QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243
Query: 1258 YGAIIGGIVNNTL----RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
+G + + NTL R P P C E LM +CW P R SF + +
Sbjct: 244 HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 7e-67
Identities = 96/316 (30%), Positives = 141/316 (44%), Gaps = 47/316 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ E + +ELG G+FG VY G +G T VAIK + ++ S +ER+ E
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----SMRERI--E 74
Query: 1092 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-- 1148
F EA ++ + + +VV GVV Q P + E M G L+ L S +
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQP---TLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 1149 ------KRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-K 1200
++I +A + A GM YL++ VH DL N +V K+GDFG++
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF----TVKIGDFGMTRD 187
Query: 1201 IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1257
I G +G LP WM+PE L + DV+SFG+VLWEI T E+PY +
Sbjct: 188 IYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 1258 ----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL-RVMSA 1312
++ G P C LM CW +P +RPSF EI + M
Sbjct: 246 NEQVLRFVMEGG-----LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
Query: 1313 ACQTKSHGHQVQNQVP 1328
+ S + +N++P
Sbjct: 301 GFREVSFYYSEENKLP 316
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-66
Identities = 88/373 (23%), Positives = 152/373 (40%), Gaps = 40/373 (10%)
Query: 953 PQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEG 1012
P + ++ I+ P E L + + E+ Y +G
Sbjct: 6 PMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIE-----ELSTSLYKKAGSENLYFQG 60
Query: 1013 RLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG-----TD 1067
+ + ++ L + + + + +G G FG VYHG
Sbjct: 61 A-NTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 119
Query: 1068 VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127
A+K + + E +F E I+ HPNV++ G+ G+ V
Sbjct: 120 CAVKSLNRIT-----DIGEVS--QFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLP 171
Query: 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 1187
+M +G LR+ + ++ + + + + A GM++L SK VH DL N +++ K
Sbjct: 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-- 229
Query: 1188 RPICKVGDFGLSK-IKRN--TLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIV 1242
KV DFGL++ + V LP WMA E L + K + K DV+SFG++
Sbjct: 230 --TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVL 285
Query: 1243 LWEILT-GEEPYANMH----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVR 1297
LWE++T G PY +++ ++ G R P +C +M +CW P +R
Sbjct: 286 LWELMTRGAPPYPDVNTFDITVYLLQGR-----RLLQPEYCPDPLYEVMLKCWHPKAEMR 340
Query: 1298 PSFTEIARRLRVM 1310
PSF+E+ R+ +
Sbjct: 341 PSFSELVSRISAI 353
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-66
Identities = 91/283 (32%), Positives = 137/283 (48%), Gaps = 27/283 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEF 1092
I + K +G+G FG VY G + VAIK +K +E++R+ +F
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-----TEKQRV--DF 93
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
EA I+ + H N++ GV+ + +TE+M NG+L L K+ + +
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVG 151
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ A GM+YL + N VH DL N+LVN +CKV DFGLS++ +
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNL----VCKVSDFGLSRVLEDDPEATYTT 207
Query: 1213 --GTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267
G +P W APE ++ K + DV+SFGIV+WE++T GE PY + ++ +N
Sbjct: 208 SGGKIPIRWTAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-KAIN 264
Query: 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
+ R P P C S LM QCW + RP F +I L +
Sbjct: 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-66
Identities = 93/299 (31%), Positives = 138/299 (46%), Gaps = 41/299 (13%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ L+ L++LG G FG+V ++ VA+K+++ S + E R +
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLR---D 88
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
F RE EIL L H N+V + GV L + E++ GSLR L + +D K L
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 148
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV-TG 1209
GMEYL +K +H DL N+LV ++ K+GDFGL+K + ++
Sbjct: 149 QYTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKVLPQDKEYYKV 204
Query: 1210 GVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT----------------GEE 1251
G P W APE L SK S DV+SFG+VL+E+ T G +
Sbjct: 205 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262
Query: 1252 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
M +I + NN R P P C E ++M +CW + RPSF ++A R+ +
Sbjct: 263 KQGQMIVFHLIELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-66
Identities = 97/334 (29%), Positives = 142/334 (42%), Gaps = 43/334 (12%)
Query: 1003 RIQESDYEEGRLDLP---TAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVY 1059
+Q +Y+ +L T P A IS L+ + +++ ++ LG G FG VY
Sbjct: 29 ELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVY 88
Query: 1060 HGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112
G+ G VA+K + + C SEQ+ L +F EA I+SK +H N+V G
Sbjct: 89 EGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDEL--DFLMEALIISKFNHQNIVRCIG 141
Query: 1113 VV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI------IAMDAAFGMEYLH 1165
V Q P + E M G L+ L + L +A D A G +YL
Sbjct: 142 VSLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLP--WMAPEL 1222
+ +H D+ N L+ P R + K+GDFG+++ I R G LP WM PE
Sbjct: 199 ENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 257
Query: 1223 LNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH----YGAIIGGIVNNTLRPPVPGF 1277
+ K D +SFG++LWEI + G PY + + G R P
Sbjct: 258 FM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-----RMDPPKN 310
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311
C +M QCW P RP+F I R+ +
Sbjct: 311 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 3e-66
Identities = 103/355 (29%), Positives = 158/355 (44%), Gaps = 36/355 (10%)
Query: 965 SQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESD-YEEGRLDLPTAGIPL 1023
+ S I+ P S +L NE + E+D Y E + T +P
Sbjct: 322 NGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS 381
Query: 1024 VDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCF 1078
I+ E +E + +G G FG V+ G + VAIK K
Sbjct: 382 TRD----------YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-- 429
Query: 1079 TGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 1138
+S+ R +F +EA + + HP++V GV+ + P + + E G LR L
Sbjct: 430 ---TSDSVRE--KFLQEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFL 481
Query: 1139 LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
++ LD ++ A + + YL SK VH D+ N+LV+ D K+GDFGL
Sbjct: 482 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGL 537
Query: 1199 SKIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYAN 1255
S+ ++ +G LP WMAPE +N + + DV+ FG+ +WEIL G +P+
Sbjct: 538 SRYMEDSTYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQG 595
Query: 1256 MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
+ +I G + N R P+P C LM +CWA DP RP FTE+ +L +
Sbjct: 596 VKNNDVI-GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 5e-66
Identities = 99/323 (30%), Positives = 154/323 (47%), Gaps = 31/323 (9%)
Query: 993 ESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGS 1052
E+L ++V H ++D RL P V + + + ++L+ L+ +G
Sbjct: 147 ENLM-QLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYR--SGWALNMKELKLLQTIGK 203
Query: 1053 GTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112
G FG V G +RG VA+K IK +++ F EA ++++L H N+V G
Sbjct: 204 GEFGDVMLGDYRGNKVAVKCIK----NDATAQ------AFLAEASVMTQLRHSNLVQLLG 253
Query: 1113 VV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMDAAFGMEYLHSKNIV 1170
V+ ++ L VTE+M GSL L S+ R + L+ ++D MEYL N V
Sbjct: 254 VIVEEKG--GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311
Query: 1171 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPELLNGSSS 1228
H DL N+LV+ + + KV DFGL+K + ++ G LP W APE L
Sbjct: 312 HRDLAARNVLVSEDN----VAKVSDFGLTK-EASSTQDT---GKLPVKWTAPEALR--EK 361
Query: 1229 KVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLME 1287
K S K DV+SFGI+LWEI + G PY + ++ + + P C +M+
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYDVMK 420
Query: 1288 QCWAPDPVVRPSFTEIARRLRVM 1310
CW D RP+F ++ +L +
Sbjct: 421 NCWHLDAATRPTFLQLREQLEHI 443
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-65
Identities = 92/304 (30%), Positives = 126/304 (41%), Gaps = 54/304 (17%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
I + ++ELG FG VY G G VAIK +K R E
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-----EGPLRE--E 58
Query: 1092 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
F EA + ++L HPNVV GVV +D P L+ + + +G L L+ + H D
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQP---LSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 1151 ---------------LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
+ + A GMEYL S ++VH DL N+LV K K+ D
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL----NVKISD 171
Query: 1196 FGLS-KIKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GE 1250
GL ++ LP WMAPE ++ G K S D++S+G+VLWE+ + G
Sbjct: 172 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG---KFSIDSDIWSYGVVLWEVFSYGL 228
Query: 1251 EPYANMH----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306
+PY I P P C + LM +CW P RP F +I R
Sbjct: 229 QPYCGYSNQDVVEMIRNRQ-----VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
Query: 1307 LRVM 1310
LR
Sbjct: 284 LRAW 287
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-65
Identities = 94/274 (34%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L +LG G FG V+ G W G T VAIK +K + E F +EA+
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPE----AFLQEAQ 231
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++ KL H +V Y VV + P + VTE+M GSL L + R +L+ +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GM Y+ N VH DL+ N+LV +CKV DFGL+++ + T P
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 1217 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
W APE + + K DV+SFGI+L E+ T G PY M ++ + R P
Sbjct: 345 IKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 401
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P C LM QCW +P RP+F + L
Sbjct: 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 4e-65
Identities = 102/344 (29%), Positives = 154/344 (44%), Gaps = 31/344 (9%)
Query: 993 ESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGS 1052
+L E+V+H +D L P + + + ++ + D+ +LG
Sbjct: 173 NTLA-ELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEM-ERTDITMKHKLGG 230
Query: 1053 GTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 1110
G +G VY G W+ VA+K +K+ + E E EF +EA ++ ++ HPN+V
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVE----EFLKEAAVMKEIKHPNLVQL 281
Query: 1111 YGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMDAAFGMEYLHSKN 1168
GV ++ P +TEFM G+L L R L+ +A + MEYL KN
Sbjct: 282 LGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 1169 IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPELLNGS 1226
+H +L N LV + KV DFGLS++ T P W APE L
Sbjct: 339 FIHRNLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA-- 392
Query: 1227 SSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLL 1285
+K S K DV++FG++LWEI T G PY + + + + R P C + L
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEKVYEL 451
Query: 1286 MEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQVQNQVPK 1329
M CW +P RPSF EI + M Q S +V+ ++ K
Sbjct: 452 MRACWQWNPSDRPSFAEIHQAFETM---FQESSISDEVEKELGK 492
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 4e-65
Identities = 88/282 (31%), Positives = 130/282 (46%), Gaps = 26/282 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
+ ++ K +G+G FG V G+ + VAIK +K +E++R +F
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-----TEKQRR--DFL 94
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
EA I+ + HPN++ GVV + VTE+M NGSL L + + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 1211
A GM+YL VH DL N+L+N +CKV DFGL ++
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNL----VCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 1212 RGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1268
G +P W +PE + K + DV+S+GIVLWE+++ GE PY M +I V+
Sbjct: 209 GGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDE 265
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
R P P C + LM CW D RP F +I L +
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 4e-65
Identities = 93/307 (30%), Positives = 132/307 (42%), Gaps = 55/307 (17%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
IK D+ +ELG G FG V+ + VA+K +K + R +
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------TLAARK--D 63
Query: 1092 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVL------------ 1138
F REAE+L+ L H ++V FYGV P L V E+M +G L L
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDP---LIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 1139 ---LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
+ L + L IA A GM YL S++ VH DL N LV + K+GD
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL----LVKIGD 176
Query: 1196 FGLSK-IKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GE 1250
FG+S+ + G LP WM PE ++ K + + DV+SFG++LWEI T G+
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVILWEIFTYGK 233
Query: 1251 EPYANMH----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306
+P+ + I G P C E +M CW +P R + EI +
Sbjct: 234 QPWFQLSNTEVIECITQGR-----VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKI 288
Query: 1307 LRVMSAA 1313
L + A
Sbjct: 289 LHALGKA 295
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-64
Identities = 78/305 (25%), Positives = 131/305 (42%), Gaps = 39/305 (12%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ L+++++LG G FG V + VA+K +K +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-------GPQHRSG 79
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
+ +E +IL L+H +++ + G +D +L V E++ GSLR L + + L
Sbjct: 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLL 137
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV-TG 1209
+ A GM YLH+++ +H DL N+L++ + K+GDFGL+K +
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR----LVKIGDFGLAKAVPEGHEYYRV 193
Query: 1210 GVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAII---- 1262
G P W APE L K DV+SFG+ L+E+LT + + +
Sbjct: 194 REDGDSPVFWYAPECLK--EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251
Query: 1263 -GGIVNNTL--------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313
G + L R P P C +E LM+ CW + RP+F + L+ +
Sbjct: 252 QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
Query: 1314 CQTKS 1318
Q ++
Sbjct: 312 YQGQA 316
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 9e-64
Identities = 95/304 (31%), Positives = 134/304 (44%), Gaps = 51/304 (16%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQER 1087
D + ++ D++ +G G FG V + + D AIKR+K+ +S+ +
Sbjct: 15 DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDH 69
Query: 1088 LTLEFWREAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVL------- 1138
+F E E+L KL HHPN++ G G L E+ +G+L L
Sbjct: 70 R--DFAGELEVLCKLGHHPNIINLLGACEHRGY---LYLAIEYAPHGNLLDFLRKSRVLE 124
Query: 1139 --------LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190
S L ++ L A D A GM+YL K +H DL N+LV +
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY----V 180
Query: 1191 CKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248
K+ DFGLS+ + + G LP WMA E LN S + DV+S+G++LWEI++
Sbjct: 181 AKIADFGLSRGQEVYVKKTM--GRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVS 236
Query: 1249 -GEEPYANMH----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
G PY M Y + G R P CD E LM QCW P RPSF +I
Sbjct: 237 LGGTPYCGMTCAELYEKLPQGY-----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 291
Query: 1304 ARRL 1307
L
Sbjct: 292 LVSL 295
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 1e-63
Identities = 91/274 (33%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L+ K+LG+G FG V+ + T VA+K +K S E F EA
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVE----AFLAEAN 235
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++ L H +V + VV P + +TEFM GSL L S E +LI +
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GM ++ +N +H DL+ N+LV+ +CK+ DFGL+++ + T P
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 1217 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
W APE +N + K DV+SFGI+L EI+T G PY M +I + R P
Sbjct: 349 IKWTAPEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 405
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P C E +M +CW P RP+F I L
Sbjct: 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 3e-63
Identities = 95/303 (31%), Positives = 134/303 (44%), Gaps = 54/303 (17%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
IK D+ ELG G FG V+ + VA+K +K++ SE R +
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESARQ--D 89
Query: 1092 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-- 1148
F REAE+L+ L H ++V F+GV + P L V E+M +G L L S
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRP---LLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146
Query: 1149 -----------KRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
+L+ +A A GM YL + VH DL N LV + K+GDF
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL----VVKIGDF 202
Query: 1197 GLSK-IKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEE 1251
G+S+ I G R LP WM PE +L K + + DV+SFG+VLWEI T G++
Sbjct: 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR---KFTTESDVWSFGVVLWEIFTYGKQ 259
Query: 1252 PYANMH----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P+ + I G P C E +M CW +P R S ++ RL
Sbjct: 260 PWYQLSNTEAIDCITQGR-----ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314
Query: 1308 RVM 1310
+ +
Sbjct: 315 QAL 317
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-63
Identities = 98/357 (27%), Positives = 148/357 (41%), Gaps = 28/357 (7%)
Query: 965 SQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLP--TAGIP 1022
S ++S T+ HP + ++L S+ + +P T+
Sbjct: 257 SSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFE 316
Query: 1023 LVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCF 1078
L + ++ L ELG G FG+V G +R DVAIK +K+
Sbjct: 317 SPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT- 375
Query: 1079 TGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 1138
++ T E REA+I+ +L +P +V GV Q L V E G L L
Sbjct: 376 ------EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFL 426
Query: 1139 LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
+ K + + + GM+YL KN VH +L N+L+ + K+ DFGL
Sbjct: 427 VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH----YAKISDFGL 482
Query: 1199 SKI--KRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1253
SK ++ T G P W APE +N K S + DV+S+G+ +WE L+ G++PY
Sbjct: 483 SKALGADDSYYTARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPY 540
Query: 1254 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
M G + + R P C E LM CW RP F + +R+R
Sbjct: 541 KKMK-GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 7e-63
Identities = 94/274 (34%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L +LG G FG V+ G W G T VAIK +K + E F +EA+
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPE----AFLQEAQ 314
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++ KL H +V Y VV + P + VTE+M GSL L + R +L+ +A
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GM Y+ N VH DL+ N+LV +CKV DFGL+++ + T P
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 1217 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 1273
W APE + + K DV+SFGI+L E+ T G PY M ++ + R P
Sbjct: 428 IKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 484
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P C LM QCW +P RP+F + L
Sbjct: 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 9e-63
Identities = 85/312 (27%), Positives = 125/312 (40%), Gaps = 62/312 (19%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
++E ++++G G FG V+ + G T VA+K +K+ S + +
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----SADMQA--D 96
Query: 1092 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-- 1148
F REA ++++ +PN+V GV P + + E+M G L L S H
Sbjct: 97 FQREAALMAEFDNPNIVKLLGVCAVGKP---MCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 1149 --------------------KRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 1187
+ IA A GM YL + VH DL N LV
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-- 211
Query: 1188 RPICKVGDFGLS-KIKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVL 1243
+ K+ DFGLS I +P WM PE + + + + DV+++G+VL
Sbjct: 212 --VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVL 266
Query: 1244 WEILT-GEEPYANMH----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRP 1298
WEI + G +PY M + G P C E LM CW+ P RP
Sbjct: 267 WEIFSYGLQPYYGMAHEEVIYYVRDGN-----ILACPENCPLELYNLMRLCWSKLPADRP 321
Query: 1299 SFTEIARRLRVM 1310
SF I R L+ M
Sbjct: 322 SFCSIHRILQRM 333
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 4e-62
Identities = 89/301 (29%), Positives = 126/301 (41%), Gaps = 52/301 (17%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
++L K LG G FG V T VA+K +K++ S E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-----SPSELR--DLLS 75
Query: 1095 EAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK------------ 1141
E +L +++HP+V+ YG QDGP L + E+ GSLR L
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 1142 -----------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190
ER L + A + GM+YL +VH DL N+LV
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR----K 188
Query: 1191 CKVGDFGLS-KIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 1247
K+ DFGLS + +G +P WMA E L + + DV+SFG++LWEI+
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIV 246
Query: 1248 T-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306
T G PY + + + R P C E LM QCW +P RP F +I++
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305
Query: 1307 L 1307
L
Sbjct: 306 L 306
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 5e-62
Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 47/296 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEF 1092
+ L K LG G FG V + G VA+K +K +E++ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDLS--DL 87
Query: 1093 WREAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK--------- 1141
E E++ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 1142 ------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
E + + + A GMEYL S+ +H DL N+LV + + K+ D
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN----VMKIAD 200
Query: 1196 FGLS-KIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEE 1251
FGL+ I G LP WMAPE L + + DV+SFG+++WEI T G
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 1252 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
PY + + + R P C +E ++M CW P RP+F ++ L
Sbjct: 259 PYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 5e-62
Identities = 87/296 (29%), Positives = 126/296 (42%), Gaps = 46/296 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
L K LG+G FG V G VA+K +K S + ER
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTERE--ALMS 75
Query: 1095 EAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK----------- 1141
E ++LS L +H N+V G GP +TE+ G L + L K
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGP---TLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 1142 ------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
E LD L + A GM +L SKN +H DL N+L+ I K+ D
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR----ITKICD 188
Query: 1196 FGLS-KIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEE 1251
FGL+ IK ++ LP WMAPE + + + + DV+S+GI LWE+ + G
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 1252 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
PY M + ++ R P +E +M+ CW DP+ RP+F +I + +
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 6e-62
Identities = 83/298 (27%), Positives = 122/298 (40%), Gaps = 45/298 (15%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ L+ K LG G FG V G VA+K +K+ + E
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----THSEHR--A 76
Query: 1092 FWREAEILSKL-HHPNVVAFYGVV--QDGPGGTLATVTEFMVNGSLRHVLLSK------- 1141
E +IL + HH NVV G GP L + EF G+L L SK
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGP---LMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 1142 --------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193
+ L + + A GME+L S+ +H DL N+L++ K+ + K+
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN----VVKI 189
Query: 1194 GDFGLS-KIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-G 1249
DFGL+ I ++ LP WMAPE + + + DV+SFG++LWEI + G
Sbjct: 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 1250 EEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
PY + + R P + E M CW +P RP+F+E+ L
Sbjct: 248 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-61
Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 47/296 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEF 1092
+ L K LG G FG V + G VA+K +K +E++ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDLS--DL 133
Query: 1093 WREAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK--------- 1141
E E++ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 1142 ------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
E + + + A GMEYL S+ +H DL N+LV + + K+ D
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN----VMKIAD 246
Query: 1196 FGLS-KIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEE 1251
FGL+ I G LP WMAPE L + + DV+SFG+++WEI T G
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGS 304
Query: 1252 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
PY + + + R P C +E ++M CW P RP+F ++ L
Sbjct: 305 PYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 5e-61
Identities = 87/300 (29%), Positives = 130/300 (43%), Gaps = 49/300 (16%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLT 1089
+ + L K LG G FG V + G T VA+K +K ++E++
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDLS- 119
Query: 1090 LEFWREAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK------ 1141
+ E E++ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 120 -DLISEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLQARRPPGLE 175
Query: 1142 ---------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192
E L + + A A GMEYL SK +H DL N+LV + + K
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN----VMK 231
Query: 1193 VGDFGLS-KIKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT 1248
+ DFGL+ I G LP WMAPE L + + + DV+SFG++LWEI T
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---IYTHQSDVWSFGVLLWEIFT 288
Query: 1249 -GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
G PY + + + R P C +E ++M CW P RP+F ++ L
Sbjct: 289 LGGSPYPGVPVEELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-60
Identities = 83/293 (28%), Positives = 129/293 (44%), Gaps = 44/293 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+L+ K LG+G FG V G VA+K +K + E+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-----HADEKE--ALMS 98
Query: 1095 EAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR---- 1148
E +I+S L H N+V G GP + +TE+ G L + L K R L+
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGP---VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 1149 --------KRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199
+ L+ + A GM +L SKN +H D+ N+L+ + K+GDFGL+
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH----VAKIGDFGLA 211
Query: 1200 -KIKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYA 1254
I ++ LP WMAPE + + + + DV+S+GI+LWEI + G PY
Sbjct: 212 RDIMNDSNYIVKGNARLPVKWMAPESIFDC---VYTVQSDVWSYGILLWEIFSLGLNPYP 268
Query: 1255 NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
+ + +V + + P F +M+ CWA +P RP+F +I L
Sbjct: 269 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 8e-60
Identities = 89/301 (29%), Positives = 126/301 (41%), Gaps = 51/301 (16%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
E+LE K LGSG FG V + G VA+K +K+ ER
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-----DSSERE--ALMS 97
Query: 1095 EAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK----------- 1141
E +++++L H N+V G GP + + E+ G L + L SK
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGP---IYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 1142 -----------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190
L L A A GME+L K+ VH DL N+LV +
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK----V 210
Query: 1191 CKVGDFGLS-KIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 1247
K+ DFGL+ I ++ LP WMAPE L + K DV+S+GI+LWEI
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSYGILLWEIF 268
Query: 1248 T-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306
+ G PY + A ++ N + P + E ++M+ CWA D RPSF +
Sbjct: 269 SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328
Query: 1307 L 1307
L
Sbjct: 329 L 329
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 6e-59
Identities = 77/262 (29%), Positives = 125/262 (47%), Gaps = 21/262 (8%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
E+G G+F TVY G +VA ++ + ++ ER + EAE+L L HP
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDR----KLTKSERQRFK--EEAEMLKGLQHP 85
Query: 1106 NVVAFYGVVQDGPGG--TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
N+V FY + G + VTE M +G+L+ L + + + + G+++
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQF 144
Query: 1164 LHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 1221
LH++ I+H DLKCDN+ + K+GD GL+ +KR + V GT +MAPE
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASFAKA-VIGTPEFMAPE 200
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV-PGFCDS 1280
+ K E VDV++FG+ + E+ T E PY+ A I V + ++P
Sbjct: 201 MYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 1281 EWRLLMEQCWAPDPVVRPSFTE 1302
E + ++E C + R S +
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKD 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-53
Identities = 67/265 (25%), Positives = 101/265 (38%), Gaps = 22/265 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ + L LG G++G V+ + + A+KR R + L E
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP---FRGPKDRARKL---AEVGSH 110
Query: 1100 SKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
K+ HP V ++G G L TE SL+ + L + D
Sbjct: 111 EKVGQHPCCVRLEQAWEEG--GILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
+ +LHS+ +VH D+K N+ + + CK+GDFGL G +M
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRG----RCKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278
APELL GS DVFS G+ + E+ E H G + L P
Sbjct: 224 APELLQGSYGT---AADVFSLGLTILEVACNMELP---HGGEGWQQLRQGYLPPEFTAGL 277
Query: 1279 DSEWRLLMEQCWAPDPVVRPSFTEI 1303
SE R ++ PDP +R + +
Sbjct: 278 SSELRSVLVMMLEPDPKLRATAEAL 302
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-51
Identities = 72/256 (28%), Positives = 114/256 (44%), Gaps = 19/256 (7%)
Query: 1050 LGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG GT+G VY G +AIK I + + L E + L H N+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPER------DSRYSQPLH--EEIALHKHLKHKNI 81
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--IAMDAAFGMEYLH 1165
V + G + G + E + GSL +L SK L ++ I G++YLH
Sbjct: 82 VQYLGSFSEN--GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLN 1224
IVH D+K DN+L+N + K+ DFG SK + T GTL +MAPE+++
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGV---LKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196
Query: 1225 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLRPPVPGFCDSEWR 1283
+ D++S G + E+ TG+ P+ + A + + + P +P +E +
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256
Query: 1284 LLMEQCWAPDPVVRPS 1299
+ +C+ PDP R
Sbjct: 257 AFILKCFEPDPDKRAC 272
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 6e-50
Identities = 68/279 (24%), Positives = 121/279 (43%), Gaps = 41/279 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D +E++ +GSG FG V+ K R G IKR+K + +E+ RE + L
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAE------REVKAL 58
Query: 1100 SKLHHPNVVAFYGVVQDG--------------PGGTLATVTEFMVNGSLRHVL-LSKERH 1144
+KL H N+V + G L EF G+L + +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 1145 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
LD+ L + G++Y+HSK +++ DLK N+ + + K+GDFGL +N
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV----KIGDFGLVTSLKN 174
Query: 1205 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1264
+GTL +M+PE ++ ++VD+++ G++L E+L +
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILAELLHVCDTAFETS------K 226
Query: 1265 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ + D + + L+++ + P RP+ +EI
Sbjct: 227 FFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-48
Identities = 66/285 (23%), Positives = 111/285 (38%), Gaps = 39/285 (13%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ EL+++GSG FG+V+ R G AIKR KK G EQ L RE
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP-LAGSVDEQNAL-----REVYA 63
Query: 1099 LSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRKRLIIA 1154
+ L H +VV ++ + + E+ GSL + R + + +
Sbjct: 64 HAVLGQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP---------------ICKVGDFGLS 1199
+ G+ Y+HS ++VH D+K N+ ++ + K+GD G
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-Y 1258
+ V G ++A E+L + + K D+F+ + + E N +
Sbjct: 182 TRISSPQV---EEGDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAEPLPRNGDQW 237
Query: 1259 GAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
I G + P +P E+ L++ PDP RPS +
Sbjct: 238 HEIRQGRL-----PRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-48
Identities = 66/284 (23%), Positives = 124/284 (43%), Gaps = 24/284 (8%)
Query: 1024 VDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGR 1081
VDL N ++ E L+++G G+FG K IK I S R
Sbjct: 11 VDLGTENLYFQSM-----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS----R 61
Query: 1082 SSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-LS 1140
S +ER RE +L+ + HPN+V + ++ G+L V ++ G L +
Sbjct: 62 MSSKEREESR--REVAVLANMKHPNIVQYRESFEEN--GSLYIVMDYCEGGDLFKRINAQ 117
Query: 1141 KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
K + L + ++++H + I+H D+K N+ + + ++GDFG+++
Sbjct: 118 KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTV----QLGDFGIAR 173
Query: 1201 I-KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 1259
+ + GT +++PE+ + K D+++ G VL+E+ T + +
Sbjct: 174 VLNSTVELARACIGTPYYLSPEICENKP--YNNKSDIWALGCVLYELCTLKHAFEAGSMK 231
Query: 1260 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
++ I++ + PPV + R L+ Q + +P RPS I
Sbjct: 232 NLVLKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-47
Identities = 61/292 (20%), Positives = 112/292 (38%), Gaps = 46/292 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D EE+ LG G FG V + AIK+I+ + + + E +L
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTIL----SEVMLL 56
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLAT-----------VTEFMVNGSLRHVLLSKERHLDRR 1148
+ L+H VV +Y + E+ NG+L ++ S+ + R
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT 1208
+ + + Y+HS+ I+H DLK N+ ++ + K+GDFGL+K +L
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNV----KIGDFGLAKNVHRSLDI 172
Query: 1209 GGVR---------------GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
+ GT ++A E+L+G+ +EK+D++S GI+ +E++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIYPFSTG 231
Query: 1254 ANMH--YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ + P + ++ DP RP +
Sbjct: 232 MERVNILKKLRSVSIE--FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-47
Identities = 85/299 (28%), Positives = 133/299 (44%), Gaps = 54/299 (18%)
Query: 1044 LEELKE----------LGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQ-ERLTLE 1091
L +L+E +G G FG VY G R G VA+KR S Q E
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT------PESSQGIE---E 81
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRR 1148
F E E LS HP++V+ G + + + ++M NG+L+ L + +
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNT 1205
+RL I + AA G+ YLH++ I+H D+K N+L L + P K+ DFG+SK T
Sbjct: 140 QRLEICIGAARGLHYLHTRAIIHRDVKSINIL--LDENFVP--KITDFGISKKGTELDQT 195
Query: 1206 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN---------- 1255
++ V+GTL ++ PE +++EK DV+SFG+VL+E+L
Sbjct: 196 HLSTVVKGTLGYIDPEYF--IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
Query: 1256 -----MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLM--EQCWAPDPVVRPSFTEIARRL 1307
H + IV+ L + +S + +C A RPS ++ +L
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-47
Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 45/290 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D E ++ LG G FG V+ K + D AIKRI+ + E R + RE + L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-----NRELARE--KVMREVKAL 57
Query: 1100 SKLHHPNVVAFYGVVQDGP----------GGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
+KL HP +V ++ + L + +L+ + + +R +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 1150 RLI--IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT-- 1205
+ I + A +E+LHSK ++H DLK N+ + D + KVGDFGL
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV----KVGDFGLVTAMDQDEE 173
Query: 1206 ------------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
TG V GT +M+PE ++G+S S KVD+FS G++L+E+L
Sbjct: 174 EQTVLTPMPAYARHTGQV-GTKLYMSPEQIHGNSY--SHKVDIFSLGLILFELLYP--FS 228
Query: 1254 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
M + + N PP+ ++++ +P P+ RP I
Sbjct: 229 TQMERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-47
Identities = 74/229 (32%), Positives = 116/229 (50%), Gaps = 27/229 (11%)
Query: 1027 ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQ- 1085
NFD + + N+ +G G FG VY G T VA+K++ ++E+
Sbjct: 23 VTNNFDERPISVGGNK-------MGEGGFGVVYKGYVNNTTVAVKKLAAM--VDITTEEL 73
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-- 1143
++ +F +E ++++K H N+V G DG L V +M NGSL L +
Sbjct: 74 KQ---QFDQEIKVMAKCQHENLVELLGFSSDG--DDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 1144 HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-- 1201
L R IA AA G+ +LH + +H D+K N+L L + K+ DFGL++
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL--LDEAFTA--KISDFGLARASE 184
Query: 1202 -KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
T++T + GT +MAPE L G +++ K D++SFG+VL EI+TG
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITG 230
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-47
Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 24/276 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E L +G+G++G + + + K + +E E+ L E +L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG----SMTEAEKQMLV--SEVNLL 59
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---LSKERHLDRRKRLIIAMD 1156
+L HPN+V +Y + D TL V E+ G L V+ + ++LD L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 1157 AAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGG 1210
++ H ++ ++H DLK N+ ++ K + K+GDFGL++I +T
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV----KLGDFGLARILNHDTSFAKT 175
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1270
GT +M+PE +N +EK D++S G +L+E+ P+ + G I
Sbjct: 176 FVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233
Query: 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306
+P E ++ + RPS EI
Sbjct: 234 -RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-46
Identities = 67/290 (23%), Positives = 124/290 (42%), Gaps = 23/290 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ K++G G F VY VA+K+++ + R +E ++L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ---IFDLMDAKARADCI--KEIDLL 86
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---LSKERHLDRRKRLIIAMD 1156
+L+HPNV+ +Y + L V E G L ++ ++R + R +
Sbjct: 87 KQLNHPNVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGTL 1215
+E++HS+ ++H D+K N+ + + K+GD GL + + + GT
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVV----KLGDLGLGRFFSSKTTAAHSLVGTP 200
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA--NMHYGAIIGGIVNNTLRPP 1273
+M+PE ++ + + K D++S G +L+E+ + P+ M+ ++ I PP
Sbjct: 201 YYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY-PP 257
Query: 1274 VP-GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQ 1322
+P E R L+ C PDP RP T + + M A + H
Sbjct: 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-46
Identities = 65/261 (24%), Positives = 110/261 (42%), Gaps = 30/261 (11%)
Query: 1048 KELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+G G+FG V+ K G A+K+++ E E + L P
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVE--------ELVACAGLSSP 110
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+V YG V++GP + E + GSL L+ + L + L A G+EYLH
Sbjct: 111 RIVPLYGAVREGP--WVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLH 167
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK------IKRNTLVTGGVRGTLPWMA 1219
++ I+H D+K DN+L++ + DFG + + ++ L + GT MA
Sbjct: 168 TRRILHGDVKADNVLLSSDG---SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPPVPGFC 1278
PE++ G KVD++S ++ +L G P+ G + I + +P C
Sbjct: 225 PEVVMGKPC--DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC 282
Query: 1279 DSEWRLLMEQCWAPDPVVRPS 1299
+++ +PV R S
Sbjct: 283 APLTAQAIQEGLRKEPVHRAS 303
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 8e-46
Identities = 70/306 (22%), Positives = 115/306 (37%), Gaps = 31/306 (10%)
Query: 1029 GNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQE 1086
+ + II N+ +++LG G F V + G A+KRI +Q+
Sbjct: 16 NLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH------EQQD 69
Query: 1087 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVL---LSK 1141
R + REA++ +HPN++ G + F G+L + + K
Sbjct: 70 REEAQ--READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK 127
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
L + L + + G+E +H+K H DLK N+L+ + + D G
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQP----VLMDLGSMNQ 183
Query: 1202 KRNTLVT----------GGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGE 1250
+ R T+ + APEL + S + E+ DV+S G VL+ ++ GE
Sbjct: 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
Query: 1251 EPY-ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309
PY G + V N L P S L+ DP RP + +L
Sbjct: 244 GPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
Query: 1310 MSAACQ 1315
+
Sbjct: 304 LQPPAP 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-45
Identities = 74/282 (26%), Positives = 124/282 (43%), Gaps = 24/282 (8%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYH-GKWRGTDVAIKRIKKSCFTGRSSEQERLTL 1090
+ +++ I+ LG G GT+ + G + DVA+KRI CF+
Sbjct: 14 EETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD-------- 65
Query: 1091 EFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
RE ++L + HPNV+ ++ +D E +L+ + K+ +
Sbjct: 66 ---REVQLLRESDEHPNVIRYFCTEKDR--QFQYIAIEL-CAATLQEYVEQKDFAHLGLE 119
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC-KVGDFGLSKI----KRN 1204
+ + G+ +LHS NIVH DLK N+L+++ + I + DFGL K + +
Sbjct: 120 PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 1205 TLVTGGVRGTLPWMAPELLNGSSSK-VSEKVDVFSFGIVLWEILT-GEEPYANMHYGAII 1262
GV GT W+APE+L+ + + VD+FS G V + +++ G P+
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN 239
Query: 1263 GGIVNNTLRPPVP-GFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ +L P D R L+E+ A DP RPS +
Sbjct: 240 ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-44
Identities = 80/213 (37%), Positives = 113/213 (53%), Gaps = 24/213 (11%)
Query: 1050 LGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 1108
LG G FG VY G+ GT VA+KR+K+ G E +F E E++S H N++
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG----EL---QFQTEVEMISMAVHRNLL 90
Query: 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH---LDRRKRLIIAMDAAFGMEYLH 1165
G L V +M NGS+ L + LD KR IA+ +A G+ YLH
Sbjct: 91 RLRGFCMTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 1166 SK---NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGTLPWMAP 1220
I+H D+K N+L L + VGDFGL+K+ ++T VT VRGT+ +AP
Sbjct: 149 DHCDPKIIHRDVKAANIL--LDEEFEA--VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 204
Query: 1221 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
E L S+ K SEK DVF +G++L E++TG+ +
Sbjct: 205 EYL--STGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-44
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 17/233 (7%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
Q N LG G V+ G+ + G AIK F + R
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQM----R 56
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLI 1152
E E+L KL+H N+V + + ++ + EF GSL VL L + LI
Sbjct: 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ D GM +L IVH ++K N++ + + + + K+ DFG ++ + +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 1213 GTLPWMAPELLNGSSSKV------SEKVDVFSFGIVLWEILTGEEPYANMHYG 1259
GT ++ P++ + + VD++S G+ + TG P+
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 6e-44
Identities = 62/286 (21%), Positives = 114/286 (39%), Gaps = 41/286 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+K LK++GSG V+ AIK + ++ + + E
Sbjct: 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS------YRNEIA 78
Query: 1098 ILSKLHHPN--VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
L+KL + ++ Y + V E N L L K+ +D +R
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWK 134
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--------IKRNTLV 1207
+ + +H IVH DLK N L+ + K+ DFG++ + +++ V
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 1208 TGGVRGTLPWMAPELLNGSS---------SKVSEKVDVFSFGIVLWEILTGEEPYANM-H 1257
GT+ +M PE + S SK+S K DV+S G +L+ + G+ P+ + +
Sbjct: 190 -----GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244
Query: 1258 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ + I++ P + + + +++ C DP R S E+
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 7e-44
Identities = 62/286 (21%), Positives = 114/286 (39%), Gaps = 41/286 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+K LK++GSG V+ AIK + ++ + + E
Sbjct: 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS------YRNEIA 59
Query: 1098 ILSKLHHPN--VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
L+KL + ++ Y + V E N L L K+ +D +R
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWK 115
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--------IKRNTLV 1207
+ + +H IVH DLK N L+ + K+ DFG++ + +++ V
Sbjct: 116 NMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 1208 TGGVRGTLPWMAPELLNGSS---------SKVSEKVDVFSFGIVLWEILTGEEPYANM-H 1257
GT+ +M PE + S SK+S K DV+S G +L+ + G+ P+ + +
Sbjct: 171 -----GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225
Query: 1258 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ + I++ P + + + +++ C DP R S E+
Sbjct: 226 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-43
Identities = 64/320 (20%), Positives = 122/320 (38%), Gaps = 41/320 (12%)
Query: 1005 QESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR 1064
+ + + R + + + D + + +K LK++GSG V+
Sbjct: 19 ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNE 78
Query: 1065 -GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQDGPGGT 1121
AIK + + Q + E L+KL + ++ Y
Sbjct: 79 KKQIYAIKYVNLE----EADNQTLDSYR--NEIAYLNKLQQHSDKIIRLYDYEITD--QY 130
Query: 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 1181
+ V E N L L K+ +D +R + + +H IVH DLK N L+
Sbjct: 131 IYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 188
Query: 1182 NLKDPIRPICKVGDFGLSK--------IKRNTLVTGGVRGTLPWMAPELLNGSS------ 1227
+ K+ DFG++ + +++ V G + +M PE + S
Sbjct: 189 V-----DGMLKLIDFGIANQMQPDTTSVVKDSQV-----GAVNYMPPEAIKDMSSSRENG 238
Query: 1228 ---SKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLRPPVPGFCDSEWR 1283
SK+S K DV+S G +L+ + G+ P+ + + + + I++ P + + +
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 298
Query: 1284 LLMEQCWAPDPVVRPSFTEI 1303
+++ C DP R S E+
Sbjct: 299 DVLKCCLKRDPKQRISIPEL 318
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 6e-42
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 17/226 (7%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
Q N LG G V+ G+ + G AIK F + R
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQM----R 56
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLI 1152
E E+L KL+H N+V + + ++ + EF GSL VL L + LI
Sbjct: 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ D GM +L IVH ++K N++ + + + + K+ DFG ++ + +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 1213 GTLPWMAPELLNGSSSKV------SEKVDVFSFGIVLWEILTGEEP 1252
GT ++ P++ + + VD++S G+ + TG P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 79/284 (27%), Positives = 129/284 (45%), Gaps = 39/284 (13%)
Query: 1037 QIIKNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTL 1090
+ ++ D E + ELG G FG VY K + T A K I+ +E L
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-------SEEELE- 61
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
++ E EIL+ HP +V G G L + EF G++ ++L +R L +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 119
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRN 1204
++ + +LHSK I+H DLK N+L+ L+ I ++ DFG+S KR+
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDI----RLADFGVSAKNLKTLQKRD 175
Query: 1205 TLVTGGVRGTLPWMAPELLNGSSSKVS---EKVDVFSFGIVLWEILTGEEPYANMHYGAI 1261
+ + GT WMAPE++ + K + K D++S GI L E+ E P+ ++ +
Sbjct: 176 SFI-----GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230
Query: 1262 IGGIVNNTLRPPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTE 1302
+ I + PP P E+R ++ +P RPS +
Sbjct: 231 LLKIAKS--DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-40
Identities = 74/287 (25%), Positives = 119/287 (41%), Gaps = 45/287 (15%)
Query: 1048 KELGSGTFGTVYH-GKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 1105
K LG G+ GTV G ++G VA+KR+ E ++L++ HP
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----------IALMEIKLLTESDDHP 69
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI------IAMDAAF 1159
NV+ +Y L E N +L+ ++ SK + K + A
Sbjct: 70 NVIRYYCSETTD--RFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC---------KVGDFGLSKIKRN-----T 1205
G+ +LHS I+H DLK N+LV+ + DFGL K +
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 1206 LVTGGVRGTLPWMAPELLNGSSS-----KVSEKVDVFSFGIVLWEILT-GEEPYA--NMH 1257
GT W APELL S++ +++ +D+FS G V + IL+ G+ P+
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 1258 YGAIIGGIVN-NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
II GI + + ++ +E L+ Q DP+ RP+ ++
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 76/269 (28%), Positives = 118/269 (43%), Gaps = 29/269 (10%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKS-CFTGRSSEQERLTLEFWREAEI 1098
ED E + LG G FG VY + + + +A+K + K+ Q R RE EI
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR------REVEI 62
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
S L HPN++ YG D + + E+ G++ L + ++R I A
Sbjct: 63 QSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGT 1214
+ Y HSK ++H D+K +NLL+ + K+ DFG S +R L GT
Sbjct: 121 -ALSYCHSKRVIHRDIKPENLLLGSAGEL----KIADFGWSVHAPSSRRTDLC-----GT 170
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274
L ++ PE++ G EKVD++S G++ +E L G+ P+ Y I
Sbjct: 171 LDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--F 226
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P F R L+ + +P RP E+
Sbjct: 227 PDFVTEGARDLISRLLKHNPSQRPMLREV 255
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-39
Identities = 69/273 (25%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 1047 LKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+ LG+G FG V + G VAIK+ ++ +ER E +I+ KL+H
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS---PKNRERWC----LEIQIMKKLNH 71
Query: 1105 PNVVAFYGVVQDGPGGTLAT----VTEFMVNGSLRHVLLSKERH--LDRRKRLIIAMDAA 1158
PNVV+ V E+ G LR L E L + D +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
+ YLH I+H DLK +N+++ K+ D G +K + GTL ++
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIH-KIIDLGYAKELDQGELCTEFVGTLQYL 190
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278
APELL K + VD +SFG + +E +TG P+ G V + +
Sbjct: 191 APELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 1279 DSEWRL-LMEQCWAPDPVVRPSFTEIARRLRVM 1310
D + P+ + ++ R L+ M
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM 281
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-39
Identities = 79/284 (27%), Positives = 126/284 (44%), Gaps = 34/284 (11%)
Query: 1032 DISTLQIIKNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ 1085
D ++ +D E+ L+E+G G+FG VY + VAIK++ ++G+ S +
Sbjct: 40 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNE 96
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 1145
+ + +E L KL HPN + + G T V E+ GS +L ++ L
Sbjct: 97 KWQDII--KEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYC-LGSASDLLEVHKKPL 151
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KR 1203
+ + A G+ YLHS N++H D+K N+L++ + K+GDFG + I
Sbjct: 152 QEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV----KLGDFGSASIMAPA 207
Query: 1204 NTLVTGGVRGTLPWMAPELLNGSSSKV-SEKVDVFSFGIVLWEILTGEEPYANMHYGAII 1262
N+ V GT WMAPE++ KVDV+S GI E+ + P NM+ + +
Sbjct: 208 NSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262
Query: 1263 GGIVNNTLRPPVPGFCDSEW----RLLMEQCWAPDPVVRPSFTE 1302
I N P W R ++ C P RP+
Sbjct: 263 YHIAQN----ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 302
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 48/286 (16%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+K +DLE + ELG G +G V G +A+KRI+ T S EQ+RL +
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR---ATVNSQEQKRLL----MDL 56
Query: 1097 EI-LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL---- 1151
+I + + P V FYG + G + E M + SL ++ +D+ + +
Sbjct: 57 DISMRTVDCPFTVTFYGALFR--EGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDI 110
Query: 1152 --IIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-----KIKR 1203
IA+ +E+LHSK +++H D+K N+L+N + K+ DFG+S + +
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQV----KMCDFGISGYLVDDVAK 166
Query: 1204 NTLVTGGVRGTLPWMAPELLNGSSSKV--SEKVDVFSFGIVLWEILTGEEPYANM-HYGA 1260
+ G P+MAPE +N ++ S K D++S GI + E+ PY +
Sbjct: 167 DIDA-----GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221
Query: 1261 IIGGIVNNTLRPPVPGFCDSEW----RLLMEQCWAPDPVVRPSFTE 1302
+ +V P P ++ QC + RP++ E
Sbjct: 222 QLKQVVEE----PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 39/274 (14%)
Query: 1041 NEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
E +L+++G G+FG V+ G VAIK I ++ + + +E +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE------EAEDEIE-DIQQEITV 73
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
LS+ P V +YG L + E++ GS +L + LD + I +
Sbjct: 74 LSQCDSPYVTKYYGSYLKD--TKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREIL 129
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVR 1212
G++YLHS+ +H D+K N+L++ + K+ DFG++ +IKRNT V
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLSEHGEV----KLADFGVAGQLTDTQIKRNTFV----- 180
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272
GT WMAPE++ S K D++S GI E+ GE P++ +H ++ I N
Sbjct: 181 GTPFWMAPEVI--KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN---N 235
Query: 1273 PVPGFCDSEW----RLLMEQCWAPDPVVRPSFTE 1302
P P + + + +E C +P RP+ E
Sbjct: 236 P-PTL-EGNYSKPLKEFVEACLNKEPSFRPTAKE 267
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 73/273 (26%), Positives = 122/273 (44%), Gaps = 36/273 (13%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ +++G G GTVY T VAI+++ +Q + L E +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-------QQPKKELII-NEILV 70
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ + +PN+V + G L V E++ GSL V+ E +D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECL 126
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVR 1212
+E+LHS ++H D+K DN+L+ + + K+ DFG + KR+T+V
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMV----- 177
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272
GT WMAPE++ + KVD++S GI+ E++ GE PY N + + I N
Sbjct: 178 GTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG--T 233
Query: 1273 PV---PGFCDSEWRLLMEQCWAPDPVVRPSFTE 1302
P P + +R + +C D R S E
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 73/269 (27%), Positives = 118/269 (43%), Gaps = 29/269 (10%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKS-CFTGRSSEQERLTLEFWREAEI 1098
+D + + LG G FG VY + + +A+K + KS Q R RE EI
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR------REIEI 67
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
S L HPN++ Y D + + EF G L L R ++R + A
Sbjct: 68 QSHLRHPNILRMYNYFHDR--KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD 125
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGT 1214
+ Y H + ++H D+K +NLL+ K + K+ DFG S ++R T+ GT
Sbjct: 126 -ALHYCHERKVIHRDIKPENLLMGYKGEL----KIADFGWSVHAPSLRRRTMC-----GT 175
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274
L ++ PE++ G + EKVD++ G++ +E L G P+ + + IVN L+
Sbjct: 176 LDYLPPEMIEGKTH--DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--F 231
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P F + L+ + P R +
Sbjct: 232 PPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 69/273 (25%), Positives = 121/273 (44%), Gaps = 36/273 (13%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
L+ ++G G+ G V + + + VA+K + +Q+R L F E I
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-------KQQRRELLF-NEVVI 95
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ H NVV Y G L + EF+ G+L ++ + L+ + +
Sbjct: 96 MRDYQHFNVVEMYKSYLVG--EELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVL 151
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVR 1212
+ YLH++ ++H D+K D++L+ L + K+ DFG KR +LV
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRV----KLSDFGFCAQISKDVPKRKSLV----- 202
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272
GT WMAPE+++ S + +VD++S GI++ E++ GE PY + + + ++ P
Sbjct: 203 GTPYWMAPEVISRSLY--ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--P 258
Query: 1273 PV---PGFCDSEWRLLMEQCWAPDPVVRPSFTE 1302
P R +E+ DP R + E
Sbjct: 259 PKLKNSHKVSPVLRDFLERMLVRDPQERATAQE 291
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 69/280 (24%), Positives = 117/280 (41%), Gaps = 32/280 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
EDL++L E+G G +G+V K G +A+KRI+ T EQ++L +
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLL----MDL 71
Query: 1097 EILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL---- 1151
+++ + P +V FYG + G E M + S K + +
Sbjct: 72 DVVMRSSDCPYIVQFYGALFR--EGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEI 126
Query: 1152 --IIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT 1208
I + + +L I+H D+K N+L++ I K+ DFG+S +++
Sbjct: 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNI----KLCDFGISGQLVDSIAK 182
Query: 1209 GGVRGTLPWMAPELLNGSSSKV--SEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGI 1265
G P+MAPE ++ S+S+ + DV+S GI L+E+ TG PY + + +
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242
Query: 1266 VNN---TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTE 1302
V L + + C D RP + E
Sbjct: 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-38
Identities = 48/242 (19%), Positives = 91/242 (37%), Gaps = 37/242 (15%)
Query: 1028 LGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 1087
+ ++ I ++ L G F + + A+K+ +KS + +
Sbjct: 30 INDYRI-------------IRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKS 76
Query: 1088 LTLEFW---------REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 1138
+ E +I++ + + + G++ + + + E+M N S+
Sbjct: 77 NNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY--DEVYIIYEYMENDSILKFD 134
Query: 1139 LSKERHLDRRKRLIIAMDAAF-------GMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPI 1190
I Y+H+ KNI H D+K N+L++ +
Sbjct: 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRV--- 191
Query: 1191 CKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
K+ DFG S+ + + G RGT +M PE + SS KVD++S GI L+ +
Sbjct: 192 -KLSDFGESEYMVDKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
Query: 1251 EP 1252
P
Sbjct: 250 VP 251
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 73/288 (25%), Positives = 117/288 (40%), Gaps = 51/288 (17%)
Query: 1042 EDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D E + +GSG V + VAIKRI Q + E +E + +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE------KCQTSMD-ELLKEIQAM 67
Query: 1100 SKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL------ 1151
S+ HHPN+V++Y VV L V + + GS+ ++ + + +
Sbjct: 68 SQCHHPNIVSYYTSFVV----KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 1152 -IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS----------- 1199
I + G+EYLH +H D+K N+L+ + ++ DFG+S
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSV----QIADFGVSAFLATGGDITR 179
Query: 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 1259
R T V GT WMAPE++ K D++SFGI E+ TG PY
Sbjct: 180 NKVRKTFV-----GTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPM 233
Query: 1260 AIIGGIVNN---TLRPPVPGFC-DSEW----RLLMEQCWAPDPVVRPS 1299
++ + N +L V ++ R ++ C DP RP+
Sbjct: 234 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-37
Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 28/272 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+K++D E++ ELG+G G V+ K G +A K I + + + ++ RE
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQII----REL 82
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++L + + P +V FYG G ++ E M GSL +L K + + +++
Sbjct: 83 QVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIA 139
Query: 1157 AAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFG----LSKIKRNTLVTGGV 1211
G+ YL K I+H D+K N+LVN + I K+ DFG L N+ V
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEI----KLCDFGVSGQLIDSMANSFV---- 191
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1271
GT +M+PE L G+ S + D++S G+ L E+ G P +
Sbjct: 192 -GTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ D + E+
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-37
Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 34/221 (15%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LGSG G V R T VAI+ I K F S+ + L E EIL KL+HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 1159
++ V E M G L D+ ++
Sbjct: 201 CIIKIKNFFDA---EDYYIVLELMEGGEL----------FDK----VVGNKRLKEATCKL 243
Query: 1160 -------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
++YLH I+H DLK +N+L++ ++ I K+ DFG SKI T + +
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLC 302
Query: 1213 GTLPWMAPELLNGSSSKV-SEKVDVFSFGIVLWEILTGEEP 1252
GT ++APE+L + + VD +S G++L+ L+G P
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-37
Identities = 50/231 (21%), Positives = 87/231 (37%), Gaps = 29/231 (12%)
Query: 1042 EDLEELKELGSG--TFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
E L +G G TV K G V ++RI + E +T E
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE-----ACSNEMVT-FLQGELH 78
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM-- 1155
+ +HPN+V + L VT FM GS + ++ +D L IA
Sbjct: 79 VSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYIL 134
Query: 1156 -DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVT 1208
++Y+H VH +K ++L+++ + + + ++ +
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKV----YLSGLRSNLSMISHGQRQRVVHD 190
Query: 1209 GGVR--GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1257
LPW++PE+L + K D++S GI E+ G P+ +M
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 69/276 (25%), Positives = 112/276 (40%), Gaps = 36/276 (13%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED + LG G+F VY + T +VAIK I K + + + E +I
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKK-----AMYKAGMVQRVQNEVKIH 65
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLAT----VTEFMVNGSLRHVLLSKERHLD-RRKRLIIA 1154
+L HP+++ Y +D + V E NG + L ++ + R +
Sbjct: 66 CQLKHPSILELYNYFED------SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-- 1212
GM YLHS I+H DL NLL+ I K+ DFGL+ L +
Sbjct: 120 QIIT-GMLYLHSHGILHRDLTLSNLLLTRNMNI----KIADFGLA----TQLKMPHEKHY 170
Query: 1213 ---GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1269
GT +++PE+ S+ + DV+S G + + +L G P+ + +V
Sbjct: 171 TLCGTPNYISPEIATRSAH--GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD 228
Query: 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
+P F E + L+ Q +P R S + +
Sbjct: 229 YE--MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-37
Identities = 79/274 (28%), Positives = 121/274 (44%), Gaps = 33/274 (12%)
Query: 1040 KNEDLEEL----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW 1093
K L E+ K+LGSG +G V + + T AIK I+K+ + S+ +
Sbjct: 31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK------LL 84
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-KRLI 1152
E +L L HPN++ Y +D L V E G L ++ + + + +I
Sbjct: 85 EEVAVLKLLDHPNIMKLYDFFEDKRNYYL--VMECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ + + YLH NIVH DLK +NLL+ K+ I K+ DFGLS + N
Sbjct: 143 KQVLSG--VTYLHKHNIVHRDLKPENLLLESKEKDALI-KIVDFGLSAVFENQKKMKERL 199
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272
GT ++APE+L K EK DV+S G++L+ +L G P+ I+ +
Sbjct: 200 GTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT- 255
Query: 1273 PVPGFCDSEWRL-------LMEQCWAPDPVVRPS 1299
F EW+ L++Q D R S
Sbjct: 256 ----FDSPEWKNVSEGAKDLIKQMLQFDSQRRIS 285
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-37
Identities = 65/221 (29%), Positives = 95/221 (42%), Gaps = 34/221 (15%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LGSG G V R T VAIK I K F S+ + L E EIL KL+HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 1159
++ V E M G L D+ ++
Sbjct: 76 CIIKIKNFFDA---EDYYIVLELMEGGEL----------FDK----VVGNKRLKEATCKL 118
Query: 1160 -------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
++YLH I+H DLK +N+L++ ++ I K+ DFG SKI T + +
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLC 177
Query: 1213 GTLPWMAPELLNGSSSKV-SEKVDVFSFGIVLWEILTGEEP 1252
GT ++APE+L + + VD +S G++L+ L+G P
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 43/280 (15%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E ++ +G+GT+G VY G+ T AIK + + E+E E +E +L K
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEE----EIKQEINMLKKY 77
Query: 1103 -HHPNVVAFYG----VVQDGPGGTLATVTEFMVNGSLRHVL-LSKERHLDRRKRLIIAMD 1156
HH N+ +YG G L V EF GS+ ++ +K L I +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGG 1210
G+ +LH ++H D+K N+L+ + K+ DFG+S +RNT +
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEV----KLVDFGVSAQLDRTVGRRNTFI--- 190
Query: 1211 VRGTLPWMAPELLNGSSSKVS---EKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1267
GT WMAPE++ + + K D++S GI E+ G P +MH + I
Sbjct: 191 --GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248
Query: 1268 NTLRPPVPGFCDSEW----RLLMEQCWAPDPVVRPSFTEI 1303
N P P +W + +E C + RP+ ++
Sbjct: 249 N---PA-PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL 284
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 66/267 (24%), Positives = 106/267 (39%), Gaps = 35/267 (13%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G F + T A K + KS + + E I L H
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQ 75
Query: 1106 NVVAFYGVVQDGPGGTLAT----VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
+VV F+G +D V E SL + ++ + R + G
Sbjct: 76 HVVGFHGFFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GC 128
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLP 1216
+YLH ++H DLK NL +N + K+GDFGL+ + G R GT
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEV----KIGDFGLA----TKVEYDGERKKVLCGTPN 180
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 1276
++APE+L+ S +VDV+S G +++ +L G+ P+ I N +P
Sbjct: 181 YIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPK 236
Query: 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ L+++ DP RP+ E+
Sbjct: 237 HINPVAASLIQKMLQTDPTARPTINEL 263
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 62/283 (21%), Positives = 114/283 (40%), Gaps = 43/283 (15%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ DLE L E+GSGT G V+ + G +A+K+++ +G E +R+ +
Sbjct: 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRIL----MDL 74
Query: 1097 EILSKLH-HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
+++ K H P +V +G + E M + + + R + +
Sbjct: 75 DVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTV 131
Query: 1156 DAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNTLVTG 1209
+ YL K ++H D+K N+L++ + I K+ DFG+S ++
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQI----KLCDFGISGRLVDDKAKDRSA-- 185
Query: 1210 GVRGTLPWMAPELLNGSSSKV---SEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGI 1265
G +MAPE ++ + DV+S GI L E+ TG+ PY N ++ +
Sbjct: 186 ---GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
Query: 1266 VNN---TLRPPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTE 1302
+ L + F ++ C D RP + +
Sbjct: 243 LQEEPPLLPGHMGFSGDFQS-----FVKDCLTKDHRKRPKYNK 280
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-36
Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 32/274 (11%)
Query: 1040 KNEDLEEL----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW 1093
+ + LG G+FG V K + T A+K I K ++ ++
Sbjct: 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-----LL 74
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-KRLI 1152
RE ++L +L HPN++ Y +D G V E G L ++S++R + R+I
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII 132
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ + + Y+H IVH DLK +NLL+ K I ++ DFGLS +
Sbjct: 133 RQVLSG--ITYMHKNKIVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASKKMKDKI 189
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272
GT ++APE+L+G EK DV+S G++L+ +L+G P+ GA I+ +
Sbjct: 190 GTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPF----NGANEYDILKKVEKG 242
Query: 1273 PVPGFCDSEWRL-------LMEQCWAPDPVVRPS 1299
F +W+ L+ + P +R S
Sbjct: 243 K-YTFELPQWKKVSESAKDLIRKMLTYVPSMRIS 275
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-36
Identities = 66/265 (24%), Positives = 107/265 (40%), Gaps = 27/265 (10%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G F + T A K + KS + + E I L H
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQ 101
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+VV F+G +D + V E SL + ++ + R + G +YLH
Sbjct: 102 HVVGFHGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYLH 158
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWMAP 1220
++H DLK NL +N + K+GDFGL+ + G R GT ++AP
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEV----KIGDFGLA----TKVEYDGERKKVLCGTPNYIAP 210
Query: 1221 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 1280
E+L+ S +VDV+S G +++ +L G+ P+ I N +P +
Sbjct: 211 EVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHINP 266
Query: 1281 EWRLLMEQCWAPDPVVRPSFTEIAR 1305
L+++ DP RP+ E+
Sbjct: 267 VAASLIQKMLQTDPTARPTINELLN 291
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-36
Identities = 77/275 (28%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
E + L++LG G++G+VY + T VAIK++ + E +E I
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-------VESDLQ---EIIKEISI 77
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ + P+VV +YG L V E+ GS+ ++ + + L + I
Sbjct: 78 MQQCDSPHVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL 135
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVR 1212
G+EYLH +H D+K N+L+N + K+ DFG++ KRNT++
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLNTEGHA----KLADFGVAGQLTDTMAKRNTVI----- 186
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272
GT WMAPE++ + D++S GI E+ G+ PYA++H I I N
Sbjct: 187 GTPFWMAPEVIQEIG--YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN---- 240
Query: 1273 PVPGFCDSE-W----RLLMEQCWAPDPVVRPSFTE 1302
P P F E W ++QC P R + T+
Sbjct: 241 PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-36
Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 10/173 (5%)
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK- 1200
+ L + + A GME+L S+ +H DL N+L++ K+ + K+ DFGL++
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN----VVKICDFGLARD 242
Query: 1201 IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1257
I ++ LP WMAPE + + + DV+SFG++LWEI + G PY +
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 1258 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
+ R P + E M CW +P RP+F+E+ L +
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 4e-15
Identities = 42/171 (24%), Positives = 61/171 (35%), Gaps = 21/171 (12%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+ L+ K LG G FG V G VA+K +K+ ++ E
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-----ATHSEH--RALMS 74
Query: 1095 EAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
E +IL + HH NVV G PGG L + EF G+L L SK R + +
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSK-----RNEFVPY 128
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
A + + DLK + V + LS ++
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 6e-36
Identities = 69/329 (20%), Positives = 122/329 (37%), Gaps = 55/329 (16%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ L + L G F VY + G + A+KR+ E+ R + +E
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAII---QEV 76
Query: 1097 EILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMV-----NGSLRHVLLSKERH--LDRR 1148
+ KL HPN+V F G + EF++ G L L E L
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136
Query: 1149 KRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206
L I ++++H + I+H DLK +NLL++ + I K+ DFG + +
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI----KLCDFGSATTISHYP 192
Query: 1207 VTGG-------------VRGTLPWMAPELLNGSSSK-VSEKVDVFSFGIVLWEILTGEEP 1252
T + PE+++ S+ + EK D+++ G +L+ + + P
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
Query: 1253 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312
+ IVN P + + L+ +P R S E+ +L+ ++A
Sbjct: 253 F----EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
Query: 1313 AC-------------QTKSHGHQVQNQVP 1328
A Q +G ++ P
Sbjct: 309 ARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 27/227 (11%)
Query: 1039 IKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEF 1092
K + +E+ +ELGSG F V + + T + A K IKK R +E
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE- 63
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
RE IL ++ H NV+ + V ++ L + E + G L L KE +
Sbjct: 64 -REVSILRQVLHHNVITLHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEE----- 115
Query: 1153 IAMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205
+A G+ YLH+K I HFDLK +N+++ K+ P K+ DFGL+ +
Sbjct: 116 ---EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 1206 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
+ + GT ++APE++N + + D++S G++ + +L+G P
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 41/235 (17%)
Query: 1038 IIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLE 1091
+ + E++++ +ELGSG F V + + T A K IKK R +E
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
RE IL ++ HPNV+ + V ++ L + E + G L D
Sbjct: 63 --REVSILKEIQHPNVITLHEVYENKTDVIL--ILELVAGGEL----------FDF---- 104
Query: 1152 IIAM------DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
+ +A G+ YLHS I HFDLK +N+++ ++ +P K+ DFGL
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 1199 S-KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
+ KI GT ++APE++N + + D++S G++ + +L+G P
Sbjct: 165 AHKIDFGNEFKNIF-GTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP 216
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-35
Identities = 44/292 (15%), Positives = 84/292 (28%), Gaps = 43/292 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
+ ++ + LG G F VY + +K K + E T
Sbjct: 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGT-- 115
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK----ERHLDR 1147
+ E L + FY V E G+L + + E+ + +
Sbjct: 116 --QLMERLKPSMQHMFMKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 1148 RKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC-------KVGDFGLSK 1200
+ AM + +E +H I+H D+K DN ++ + + D G S
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 1201 IKR----NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 1256
+ T+ T T + E+L+ + ++D F ++ +L G
Sbjct: 232 DMKLFPKGTIFT-AKCETSGFQCVEMLSNKPW--NYQIDYFGVAATVYCMLFGTYMKVKN 288
Query: 1257 HYGAIIGGIVNNTLRPPVPGFCDSE-WRLLMEQCWAPDPVVRPSFTEIARRL 1307
G + W ++ R+
Sbjct: 289 EGGECK-------PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-35
Identities = 73/279 (26%), Positives = 124/279 (44%), Gaps = 32/279 (11%)
Query: 1040 KNEDLEEL----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLE-- 1091
K + E ++LGSG +G V K + AIK IKKS F + +E
Sbjct: 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 1092 ---FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR 1148
+ E +L L HPN++ + V +D L VTEF G L ++++ + +
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL--VTEFYEGGELFEQIINRHKFDECD 147
Query: 1149 -KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207
++ + + + YLH NIVH D+K +N+L+ K+ + I K+ DFGLS
Sbjct: 148 AANIMKQILSG--ICYLHKHNIVHRDIKPENILLENKNSLLNI-KIVDFGLSSFFSKDYK 204
Query: 1208 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1267
GT ++APE+L ++ K DV+S G++++ +L G P+ G I+
Sbjct: 205 LRDRLGTAYYIAPEVLKKKYNE---KCDVWSCGVIMYILLCGYPPF----GGQNDQDIIK 257
Query: 1268 NTLRPPVPGFCDSEWRL-------LMEQCWAPDPVVRPS 1299
+ F ++W+ L++ D R +
Sbjct: 258 KVEK-GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT 295
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-35
Identities = 65/233 (27%), Positives = 102/233 (43%), Gaps = 47/233 (20%)
Query: 1039 IKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEF 1092
++ ++ + + LGSG F V+ K R T A+K IKKS SS
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS--------L 53
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
E +L K+ H N+V + + V + + G L DR I
Sbjct: 54 ENEIAVLKKIKHENIVTLEDIYEST--THYYLVMQLVSGGEL----------FDR----I 97
Query: 1153 IAM------DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199
+ DA+ ++YLH IVH DLK +NLL + I + DFGLS
Sbjct: 98 LERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKI-MITDFGLS 156
Query: 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
K+++N +++ GT ++APE+L S+ VD +S G++ + +L G P
Sbjct: 157 KMEQNGIMSTAC-GTPGYVAPEVLAQKP--YSKAVDCWSIGVITYILLCGYPP 206
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 40/220 (18%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ELG G F V + T + A K I + R + + REA I KL HP
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHP 65
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 1159
N+V + +Q+ V + + G L + I+A DA+
Sbjct: 66 NIVRLHDSIQEE--SFHYLVFDLVTGGEL----------FED----IVAREFYSEADASH 109
Query: 1160 -------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ Y HS IVH +LK +NLL+ K + K+ DFGL+ ++ G
Sbjct: 110 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFA 168
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
GT +++PE+L S+ VD+++ G++L+ +L G P
Sbjct: 169 GTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPP 206
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-34
Identities = 64/230 (27%), Positives = 110/230 (47%), Gaps = 27/230 (11%)
Query: 1036 LQIIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLT 1089
++ K + +E+ +ELGSG F V + + T + A K IKK R
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 1090 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
+E RE IL ++ HPN++ + V ++ L + E + G L L KE +
Sbjct: 62 IE--REVSILRQVLHPNIITLHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEE-- 115
Query: 1150 RLIIAMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202
+A G+ YLH+K I HFDLK +N+++ K+ P K+ DFGL+
Sbjct: 116 ------EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 1203 RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
+ + + GT ++APE++N + + D++S G++ + +L+G P
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP 217
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-34
Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 33/276 (11%)
Query: 1038 IIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLE 1091
+ E LG G+FG V K R T + A+K I K+ + +
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST------ 67
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-KR 1150
RE E+L KL HPN++ + +++D + V E G L ++ ++R + R
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYI--VGELYTGGELFDEIIKRKRFSEHDAAR 125
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGG 1210
+I + + + Y+H NIVH DLK +N+L+ K+ I K+ DFGLS +
Sbjct: 126 IIKQVFSG--ITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKD 182
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1270
GT ++APE+L G EK DV+S G++L+ +L+G P+ YG I+
Sbjct: 183 RIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPF----YGKNEYDILKRVE 235
Query: 1271 RPPVPGFCDSEWRL-------LMEQCWAPDPVVRPS 1299
F +WR L+ + P +R +
Sbjct: 236 TGK-YAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 69/235 (29%), Positives = 103/235 (43%), Gaps = 45/235 (19%)
Query: 1037 QIIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTL 1090
+ E LG G+FG V K R T + A+K I K+ + +
Sbjct: 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST----- 67
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
RE E+L KL HPN++ + +++D + V E G L D
Sbjct: 68 -ILREVELLKKLDHPNIMKLFEILEDS--SSFYIVGELYTGGEL----------FDE--- 111
Query: 1151 LIIA------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197
II DAA + Y+H NIVH DLK +N+L+ K+ I K+ DFG
Sbjct: 112 -IIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFG 169
Query: 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
LS + GT ++APE+L G+ + K DV+S G++L+ +L+G P
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE---KCDVWSAGVILYILLSGTPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 47/232 (20%)
Query: 1040 KNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFW 1093
D+ + +G G++G V +GT A K+I K + +R
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVDRF----K 54
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
+E EI+ L HPN++ Y +D + V E G L +R ++
Sbjct: 55 QEIEIMKSLDHPNIIRLYETFEDN--TDIYLVMELCTGGEL----------FER----VV 98
Query: 1154 A------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
DAA M Y H N+ H DLK +N L P P+ K+ DFGL+
Sbjct: 99 HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPL-KLIDFGLAA 157
Query: 1201 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
+ + GT +++P++L G + D +S G++++ +L G P
Sbjct: 158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGP---ECDEWSAGVMMYVLLCGYPP 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 50/236 (21%)
Query: 1040 KNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFW 1093
+++L ++LGSG FG V+ + R + + IK I K RS +
Sbjct: 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD----RSQVPME---QIE 68
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
E E+L L HPN++ + V +D + V E G L L+R I+
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDY--HNMYIVMETCEGGEL----------LER----IV 112
Query: 1154 A----------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
+ A M Y HS+++VH DLK +N+L P PI K+ DF
Sbjct: 113 SAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI-KIIDF 171
Query: 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
GL+++ ++ + GT +MAPE+ V+ K D++S G+V++ +LTG P
Sbjct: 172 GLAELFKSDEHSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ELGSG F V + +GT + A K IKK + R +E RE IL ++ HP
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE--REVNILREIRHP 68
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF------ 1159
N++ + + ++ L + E + G L L KE + +A
Sbjct: 69 NIITLHDIFENKTDVVL--ILELVSGGELFDFLAEKESLTED--------EATQFLKQIL 118
Query: 1160 -GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
G+ YLHSK I HFDLK +N+++ K+ P K+ DFG++ + GT ++
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
APE++N + + D++S G++ + +L+G P
Sbjct: 179 APEIVNYEP--LGLEADMWSIGVITYILLSGASP 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 70/330 (21%), Positives = 113/330 (34%), Gaps = 80/330 (24%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKS----------------------- 1076
D E ++ +G G FG V+ K + + AIKRI+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 1077 ---------------------------CFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109
T + + N V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--IAMDAAFGMEYLHSK 1167
P L + +L+ + + DR + I + A +E+LHSK
Sbjct: 126 QLQPSS--PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--------------KRNTLVTGGVRG 1213
++H DLK N+ + D + KVGDFGL TG V G
Sbjct: 184 GLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-G 238
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273
T +M+PE ++G++ S KVD+FS G++L+E+L II + N P
Sbjct: 239 TKLYMSPEQIHGNN--YSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRNLKF-PL 293
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ + ++++ +P P RP T+I
Sbjct: 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 40/220 (18%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ELG G F V + T + A K I + R + + REA I KL HP
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHP 88
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 1159
N+V + +Q+ V + + G L + I+A DA+
Sbjct: 89 NIVRLHDSIQEE--SFHYLVFDLVTGGEL----------FED----IVAREFYSEADASH 132
Query: 1160 -------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ Y HS IVH +LK +NLL+ K + K+ DFGL+ ++ G
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFA 191
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
GT +++PE+L S+ VD+++ G++L+ +L G P
Sbjct: 192 GTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPP 229
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-33
Identities = 36/296 (12%), Positives = 71/296 (23%), Gaps = 49/296 (16%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ L G V+ + A+K RS + ++L
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELER-----LHEATFAAARLLGE 122
Query: 1106 NVVAFYG------------------VVQDGPGGTLATVTEFMV-----------NGSLRH 1136
+ Q PG V +++ S
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 1137 VLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
+ I+ L SK +VH DNL + + +GD
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRL----MLGDV 238
Query: 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 1256
+ + E LN S++ + ++ + G+ ++ + P+ +
Sbjct: 239 SALWKVGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 1257 HYGAIIGGIVNNTLRPPVPGFCDSEW-------RLLMEQCWAPDPVVRPSFTEIAR 1305
G + P + L+ + D R E
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 57/245 (23%), Positives = 91/245 (37%), Gaps = 48/245 (19%)
Query: 1031 FDISTLQIIKNEDLEEL-----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSS 1083
L E+ KELG G F V + T + A K +KK
Sbjct: 13 LGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR 72
Query: 1084 EQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE 1142
E E +L P V+ + V ++ L + E+ G +
Sbjct: 73 A------EILHEIAVLELAKSCPRVINLHEVYENTSEIIL--ILEYAAGGEI-------- 116
Query: 1143 RHLDRRKRLIIA--------MDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPI 1187
+ D G+ YLH NIVH DLK N+L++ P+
Sbjct: 117 --FSL----CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPL 170
Query: 1188 RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 1247
I K+ DFG+S+ + + GT ++APE+LN ++ D+++ GI+ + +L
Sbjct: 171 GDI-KIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDP--ITTATDMWNIGIIAYMLL 227
Query: 1248 TGEEP 1252
T P
Sbjct: 228 THTSP 232
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 42/225 (18%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ +G G F V R T A+K + + FT + REA I L HP
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE---DLKREASICHMLKHP 86
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA----------M 1155
++V G L V EFM L I+
Sbjct: 87 HIVELLETYSSD--GMLYMVFEFMDGADL----------CFE----IVKRADAGFVYSEA 130
Query: 1156 DAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV 1207
A+ M Y H NI+H D+K +L+ K+ P+ K+G FG++ + + LV
Sbjct: 131 VASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV-KLGGFGVAIQLGESGLV 189
Query: 1208 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
GG GT +MAPE++ + VDV+ G++L+ +L+G P
Sbjct: 190 AGGRVGTPHFMAPEVVKREP--YGKPVDVWGCGVILFILLSGCLP 232
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-32
Identities = 69/232 (29%), Positives = 105/232 (45%), Gaps = 48/232 (20%)
Query: 1040 KNEDLEEL----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW 1093
+ L + ELG G VY K +GT A+K +KK+ +++ +
Sbjct: 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIV----R 96
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
E +L +L HPN++ + + ++ V E + G L DR I+
Sbjct: 97 TEIGVLLRLSHPNIIKLKEIFETP--TEISLVLELVTGGEL----------FDR----IV 140
Query: 1154 AM------DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
DAA + YLH IVH DLK +NLL P P+ K+ DFGLSK
Sbjct: 141 EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSK 199
Query: 1201 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
I + ++ V GT + APE+L G + +VD++S GI+ + +L G EP
Sbjct: 200 IVEHQVLMKTVCGTPGYCAPEILRGCA--YGPEVDMWSVGIITYILLCGFEP 249
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 56/251 (22%), Positives = 89/251 (35%), Gaps = 53/251 (21%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+G G++G V T AIK + K+ + + E ++ KLHHP
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE---RIKTEVRLMKKLHHP 88
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM---------- 1155
N+ Y V +D + V E G L L + + +
Sbjct: 89 NIARLYEVYEDE--QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 1156 ----------------------DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDP 1186
+ + YLH++ I H D+K +N L + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS-TNK 205
Query: 1187 IRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWMAPELLNGSSSKVSEKVDVFSFGI 1241
I K+ DFGLSK GT ++APE+LN ++ K D +S G+
Sbjct: 206 SFEI-KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 1242 VLWEILTGEEP 1252
+L +L G P
Sbjct: 265 LLHLLLMGAVP 275
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 58/318 (18%), Positives = 116/318 (36%), Gaps = 42/318 (13%)
Query: 955 SGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRL 1014
SG F++ +R I + + ++ QS + ++ + + +
Sbjct: 9 SGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKG 68
Query: 1015 DLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGT--DVAIKR 1072
+ + + + D + +G G V R T + A+K
Sbjct: 69 TENLYFQSMGPEDELPDWAAAKEFYQKYDPK--DVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 1073 IKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLATVTEFMVN 1131
++ + + E + RE IL ++ HP+++ + L V + M
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL--VFDLMRK 184
Query: 1132 GSLRHVLLSKERHLDRRKRLIIAM------DAAF-------GMEYLHSKNIVHFDLKCDN 1178
G L D + + + +LH+ NIVH DLK +N
Sbjct: 185 GEL----------FDY----LTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230
Query: 1179 LLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKV----SEKV 1234
+L++ I ++ DFG S + GT ++APE+L S + ++V
Sbjct: 231 ILLDDNMQI----RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEV 286
Query: 1235 DVFSFGIVLWEILTGEEP 1252
D+++ G++L+ +L G P
Sbjct: 287 DLWACGVILFTLLAGSPP 304
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-32
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQ-ERLTLEFWREAEILSKL-H 1103
+ LG G V + T + A+K I + S+E+ + L +E +IL K+
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA--MDAAFGM 1161
HPN++ + L V + M G L L K ++ R I+ ++ +
Sbjct: 83 HPNIIQLKDTYETNTFFFL--VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV---I 137
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 1221
LH NIVH DLK +N+L++ I K+ DFG S V GT ++APE
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNI----KLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 1222 LLNGSSSKV----SEKVDVFSFGIVLWEILTGEEP 1252
++ S + ++VD++S G++++ +L G P
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-32
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ELG G F V + A I + R ++ REA I L HP
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK------LEREARICRLLKHP 70
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 1159
N+V + + + G + + + G L + I+A DA+
Sbjct: 71 NIVRLHDSISEE--GHHYLIFDLVTGGEL----------FED----IVAREYYSEADASH 114
Query: 1160 GM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGV 1211
+ + H +VH +LK +NLL+ K + K+ DFGL+ ++ G
Sbjct: 115 CIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV-KLADFGLAIEVEGEQQAWFGF 173
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
GT +++PE+L + VD+++ G++L+ +L G P
Sbjct: 174 AGTPGYLSPEVLRKDP--YGKPVDLWACGVILYILLVGYPP 212
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 5e-32
Identities = 45/225 (20%), Positives = 93/225 (41%), Gaps = 37/225 (16%)
Query: 1042 EDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWRE 1095
++L E ++LG G FG V+ + K +K + ++Q + +E
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLV----KKE 51
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
IL+ H N++ + + + + EF+ + + + L+ R
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVM--IFEFISGLDIFERINTSAFELNER------- 102
Query: 1156 DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLV 1207
+ +++LHS NI HFD++ +N++ + I K+ +FG + ++K
Sbjct: 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS-STI-KIIEFGQARQLKPGDNF 160
Query: 1208 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
+ APE+ VS D++S G +++ +L+G P
Sbjct: 161 RLLF-TAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINP 202
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 51/221 (23%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 1039 IKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEF 1092
+K + + +ELGSG FG V+ + T K I ++ +
Sbjct: 44 VKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTV---- 95
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
E I+++LHHP ++ + +D L + EF+ G L + +++ + + +
Sbjct: 96 KNEISIMNQLHHPKLINLHDAFEDKYEMVL--ILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGV 1211
A G++++H +IVH D+K +N++ K + K+ DFGL+ K+ + +V
Sbjct: 154 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA-SSV-KIIDFGLATKLNPDEIVKVTT 211
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
T + APE+++ V D+++ G++ + +L+G P
Sbjct: 212 -ATAEFAAPEIVDREP--VGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 71/282 (25%), Positives = 114/282 (40%), Gaps = 36/282 (12%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFW------------ 1093
E+G G++G V T A+K + K ++ R
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 1094 ------REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---H 1144
+E IL KL HPNVV V+ D L V E + G + V + +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSED 137
Query: 1145 LDRRK-RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-K 1202
R + +I G+EYLH + I+H D+K NLLV I K+ DFG+S K
Sbjct: 138 QARFYFQDLIK-----GIEYLHYQKIIHRDIKPSNLLVGEDGHI----KIADFGVSNEFK 188
Query: 1203 RNTLVTGGVRGTLPWMAPELLNGSSSKVS-EKVDVFSFGIVLWEILTGEEPYANMHYGAI 1261
+ + GT +MAPE L+ + S + +DV++ G+ L+ + G+ P+ + +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 1262 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
I + L P + + L+ + +P R EI
Sbjct: 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 48/276 (17%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LK +G G F V + G +VAIK I K+ + ++L RE I+ L+H
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLF----REVRIMKILNH 73
Query: 1105 PNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDA 1157
PN+V + V++ T T + E+ G + L++ R R K R I++
Sbjct: 74 PNIVKLFEVIE-----TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS--- 125
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----G 1213
++Y H K IVH DLK +NLL++ I K+ DFG S N GG G
Sbjct: 126 --AVQYCHQKRIVHRDLKAENLLLDADMNI----KIADFGFS----NEFTVGGKLDAFCG 175
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMH--YGAIIGGIVNNT 1269
P+ APEL G +VDV+S G++L+ +++G P+ N+ ++ G
Sbjct: 176 APPYAAPELFQGKKY-DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--- 231
Query: 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
+P + ++ L+++ +P+ R + +I +
Sbjct: 232 ---RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 74/270 (27%), Positives = 112/270 (41%), Gaps = 37/270 (13%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G +G V R T VA+K + E + +E I L+H
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIK------KEICINKMLNHE 65
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 1161
NVV FYG ++G E+ G L + +R ++A G+
Sbjct: 66 NVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---GTLPWM 1218
YLH I H D+K +NLL++ +D + K+ DFGL+ + R + GTLP++
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNL----KISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTG----EEPYANMH-YGAIIGGIVNNTLRPP 1273
APELL +E VDV+S GIVL +L G ++P + Y P
Sbjct: 175 APELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---LNP 230
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
DS L+ + +P R + +I
Sbjct: 231 WKKI-DSAPLALLHKILVENPSARITIPDI 259
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-31
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 22/221 (9%)
Query: 1039 IKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEF 1092
IK++ + + +ELG+G FG V+ R T + A K + S++E +
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETV---- 201
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
+E + +S L HP +V + +D + + EFM G L + + + + +
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVM--IYEFMSGGELFEKVADEHNKMSEDEAVE 259
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGV 1211
G+ ++H N VH DLK +N++ K K+ DFGL+ + V
Sbjct: 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS--NELKLIDFGLTAHLDPKQSVKVTT 317
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
GT + APE+ G V D++S G++ + +L+G P
Sbjct: 318 -GTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSP 355
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 67/276 (24%), Positives = 111/276 (40%), Gaps = 45/276 (16%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
LG G++G V A+K +KK + + + +E ++L +L H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK----KEIQLLRRLRHK 66
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL-----------IIA 1154
NV+ V+ + + V E+ V G +L KR +I
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPE----KRFPVCQAHGYFCQLID 120
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-- 1212
G+EYLHS+ IVH D+K NLL+ + K+ G+++ R
Sbjct: 121 -----GLEYLHSQGIVHKDIKPGNLLLTTGGTL----KISALGVAEALHPFAADDTCRTS 171
Query: 1213 -GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMH--YGAIIGGIVN 1267
G+ + PE+ NG + KVD++S G+ L+ I TG P+ N++ + I G
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA 231
Query: 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+PG C L++ +P R S +I
Sbjct: 232 ------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-30
Identities = 51/274 (18%), Positives = 103/274 (37%), Gaps = 46/274 (16%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ G G +Y D V +K + +G + Q E + L
Sbjct: 85 KGCIAHGGLGWIY----LALDRNVNGRPVVLKGLV---HSGDAEAQAM----AMAERQFL 133
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLAT---VTEFMVNG-SLRHVLLSKERHLDRRKRLIIAM 1155
+++ HP++V + V+ V E+ V G SL+ + L + + +
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSK---GQKLPVAEAIAYLL 189
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
+ + YLHS +V+ DLK +N+++ ++ + K+ D G G + GT
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT-EEQL----KLIDLG---AVSRINSFGYLYGTP 241
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275
+ APE++ + + D+++ G L + G + G+ +
Sbjct: 242 GFQAPEIVRTGPTVAT---DIYTVGRTLAALTLDLPTRN----GRYVDGLPEDDPVLKTY 294
Query: 1276 GFCDSEWRLLMEQCWAPDPVVRP-SFTEIARRLR 1308
+ L+ + PDP R + E++ +L
Sbjct: 295 D----SYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 67/310 (21%), Positives = 121/310 (39%), Gaps = 52/310 (16%)
Query: 963 EGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEV---VNHRIQESDYEEGRLDLPTA 1019
G + ++ S + SRS + + S ++ +D+P
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 1020 GIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSC 1077
P + + + + + LG G FG V+ + T +A K IK
Sbjct: 70 PAPFDHRIVT---AKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR- 125
Query: 1078 FTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHV 1137
++E + E ++++L H N++ Y + L V E++ G L
Sbjct: 126 ---GMKDKEEV----KNEISVMNQLDHANLIQLYDAFESKNDIVL--VMEYVDGGEL--- 173
Query: 1138 LLSKERHLDRRKRLIIA-------MDAAF-------GMEYLHSKNIVHFDLKCDNLLVNL 1183
DR II +D G+ ++H I+H DLK +N+L
Sbjct: 174 -------FDR----IIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222
Query: 1184 KDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIV 1242
+D + I K+ DFGL++ K + GT ++APE++N VS D++S G++
Sbjct: 223 RDA-KQI-KIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDF--VSFPTDMWSVGVI 277
Query: 1243 LWEILTGEEP 1252
+ +L+G P
Sbjct: 278 AYMLLSGLSP 287
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 68/268 (25%), Positives = 111/268 (41%), Gaps = 33/268 (12%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH- 1103
LG G FGTV+ G VAIK I ++ G S + +T E +L K+
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP--LEVALLWKVGA 93
Query: 1104 ---HPNVVAFYGVVQDGPGGTLATVTEFMVNGS-LRHVLLSKER---HLDRRK-RLIIAM 1155
HP V+ + G L V E + L + K R ++A
Sbjct: 94 GGGHPGVIRLLDWFETQEGFML--VLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA- 150
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
+++ HS+ +VH D+K +N+L+ D R K+ DFG + + T GT
Sbjct: 151 ----AIQHCHSRGVVHRDIKDENILI---DLRRGCAKLIDFGSGALLHDEPYTDFD-GTR 202
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275
+ PE ++ + V+S GI+L++++ G+ P+ I+ ++ P
Sbjct: 203 VYSPPEWISRHQYH-ALPATVWSLGILLYDMVCGDIPFE--RDQEILEAELH------FP 253
Query: 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ L+ +C AP P RPS EI
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEI 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-30
Identities = 34/292 (11%), Positives = 82/292 (28%), Gaps = 49/292 (16%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTG--------------------RSSEQ 1085
LG + T + + ++ +Q
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVN-----GSLRHVLLS 1140
++ L F +++ ++ +D + + M + G + S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 1141 KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
+ L RL + + + LH +VH L+ +++++ + + + F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV----FLTGFEHLV 254
Query: 1201 IKRNTLVTGGVRGTLPWMAPELLNGSS---------SKVSEKVDVFSFGIVLWEILTGEE 1251
+ V + + PEL + + ++ D ++ G+V++ I +
Sbjct: 255 -RDGARVV--SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 1252 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P I + P R L+E R +
Sbjct: 312 PITKDAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQA 357
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-30
Identities = 60/270 (22%), Positives = 112/270 (41%), Gaps = 35/270 (12%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+ LGSG FG V+ + +V +K IKK ++ + E ILS++ H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGS-LRHVLLSKER---HLDRRK-RLIIAMDAAF 1159
N++ + ++ G V E +G L + R L R +++
Sbjct: 89 ANIIKVLDIFEN--QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS----- 141
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTL 1215
+ YL K+I+H D+K +N+++ I K+ DFG + L G + GT+
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFTI----KLIDFGSA----AYLERGKLFYTFCGTI 193
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275
+ APE+L G+ + E ++++S G+ L+ ++ E P+ + ++ P
Sbjct: 194 EYCAPEVLMGNPYRGPE-LEMWSLGVTLYTLVFEENPFCE--LEETVEAAIH------PP 244
Query: 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 1305
E L+ P P R + ++
Sbjct: 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 74/270 (27%), Positives = 112/270 (41%), Gaps = 37/270 (13%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G +G V R VA+K + E + +E I L+H
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIK------KEICINKMLNHE 65
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 1161
NVV FYG ++G E+ G L + +R ++A G+
Sbjct: 66 NVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---GTLPWM 1218
YLH I H D+K +NLL++ +D + K+ DFGL+ + R + GTLP++
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNL----KISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTG----EEPYANMH-YGAIIGGIVNNTLRPP 1273
APELL +E VDV+S GIVL +L G ++P + Y T P
Sbjct: 175 APELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNP 230
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
DS L+ + +P R + +I
Sbjct: 231 WKKI-DSAPLALLHKILVENPSARITIPDI 259
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+ +LG G TVY + VAIK I + +R F RE S+L H
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKR----FEREVHNSSQLSH 70
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
N+V+ V ++ V E+ + G +L + L + G+++
Sbjct: 71 QNIVSMIDVDEED--DCYYLVMEY-IEGPTLSE-YIESHGPLSVDTAINFTNQILDGIKH 126
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT--GGVRGTLPWMAPE 1221
H IVH D+K N+L++ + K+ DFG++K T +T V GT+ + +PE
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTL----KIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
G E D++S GIVL+E+L GE P+
Sbjct: 183 QAKGE--ATDECTDIYSIGIVLYEMLVGEPPF 212
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 59/240 (24%), Positives = 100/240 (41%), Gaps = 54/240 (22%)
Query: 1042 EDLEELKE--LGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
ED+ +L+E LG G V T + A+K I+K RS +RE E
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--------VFREVE 62
Query: 1098 ILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM- 1155
+L + H NV+ ++ V E M GS+ L I
Sbjct: 63 MLYQCQGHRNVLELIEFFEEED--RFYLVFEKMRGGSI----------LSH----IHKRR 106
Query: 1156 -----DAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203
+A+ + ++LH+K I H DLK +N+L + + P+ K+ DF L +
Sbjct: 107 HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPV-KICDFDLGSGIK 165
Query: 1204 NTLVTGGVR--------GTLPWMAPELLNGSSSKVS---EKVDVFSFGIVLWEILTGEEP 1252
+ G+ +MAPE++ S + S ++ D++S G++L+ +L+G P
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-29
Identities = 36/295 (12%), Positives = 79/295 (26%), Gaps = 42/295 (14%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSS--------EQERLTLEFW 1093
L LG + T + + ++ + RL
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 1094 REAEILSKLH---------HPNVVAFYGVVQDGPGGTLATVTEFM--VNGSLRHVL---- 1138
+ + L P V D + + + +L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 1139 --LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
S + L RL + + + LH +VH L+ +++++ + + + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV----FLTGF 255
Query: 1197 GLSKIKRNTLVT--GGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEE 1251
+ V+ G A +L + ++ D ++ G+ ++ I +
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 1252 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306
P + I + P P R L+E R +
Sbjct: 316 PNTDDAALGGSEWIFRSCKNIPQP------VRALLEGFLRYPKEDRLLPLQAMET 364
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 59/239 (24%), Positives = 96/239 (40%), Gaps = 56/239 (23%)
Query: 1039 IKNEDLEEL-------KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLT 1089
+K+ + K LG G+F + + A+K I K R +
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQ-- 53
Query: 1090 LEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR 1148
+E L HPN+V + V D V E + G L +R
Sbjct: 54 ----KEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVMELLNGGEL----------FER- 96
Query: 1149 KRLIIAM------DAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
I +A++ M ++H +VH DLK +NLL ++ I K+ D
Sbjct: 97 ---IKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEI-KIID 152
Query: 1196 FGLSKIKR--NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
FG +++K N + TL + APELLN + E D++S G++L+ +L+G+ P
Sbjct: 153 FGFARLKPPDNQPLKTPC-FTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 49/226 (21%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 1104
+++G G++ + T + A+K I KS E EIL + H
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------------EEIEILLRYGQH 75
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAA 1158
PN++ V DG + VTE M G L LD+ I+ +A+
Sbjct: 76 PNIITLKDVYDDGKYVYV--VTELMKGGEL----------LDK----ILRQKFFSEREAS 119
Query: 1159 F-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTG 1209
+EYLH++ +VH DLK N+L + ++ DFG +K R N L+
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1255
T ++APE+L D++S G++L+ +LTG P+AN
Sbjct: 180 PC-YTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFAN 222
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 51/238 (21%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 1104
+ LG G G V R T A+K + S + +E + +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------------KARQEVDHHWQASGG 81
Query: 1105 PNVVAFYGVVQDGPGGTLAT--VTEFMVNGSLRHVLLSKERHLDRRKRLIIA-------- 1154
P++V V ++ G + E M G L R I
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----------FSR----IQERGDQAFTE 127
Query: 1155 MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207
+AA M ++LHS NI H D+K +NLL K+ + K+ DFG +K +
Sbjct: 128 REAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL-KLTDFGFAKETTQNAL 186
Query: 1208 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1265
T ++APE+L K + D++S G++++ +L G P+ + AI G+
Sbjct: 187 QTPC-YTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 63/266 (23%), Positives = 105/266 (39%), Gaps = 31/266 (11%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LGSG FG+VY G VAIK ++K + + E +L K+
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP--MEVVLLKKVSS 105
Query: 1105 --PNVVAFYGVVQDGPGGTLATVTEFMVN-GSLRHVLLSKER---HLDRRK-RLIIAMDA 1157
V+ + L + E L + + L R ++
Sbjct: 106 GFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLE--- 160
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
+ + H+ ++H D+K +N+L+ D R K+ DFG + ++T+ T GT +
Sbjct: 161 --AVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYTDFD-GTRVY 214
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
PE + V+S GI+L++++ G+ P+ + II G V
Sbjct: 215 SPPEWIRYHRYH-GRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRGQVF------FRQR 265
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEI 1303
SE + L+ C A P RP+F EI
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEI 291
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 73/273 (26%), Positives = 113/273 (41%), Gaps = 37/273 (13%)
Query: 1045 EELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ +K++GSG FG K VA+K I++ E + RE L
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQ----REIINHRSL 73
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAA 1158
HPN+V F V+ LA + E+ G L + + R R + +++
Sbjct: 74 RHPNIVRFKEVILTP--THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS---- 127
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTLP 1216
G+ Y HS I H DLK +N L++ R K+ DFG SK + + GT
Sbjct: 128 -GVSYCHSMQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKS--TVGTPA 182
Query: 1217 WMAPELLNGSSSK--VSEKVDVFSFGIVLWEILTG----EEPYANMHYGAIIGGIVNNTL 1270
++APE+L + + DV+S G+ L+ +L G E+P Y I I++
Sbjct: 183 YIAPEVLLR---QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P E L+ + + DP R S EI
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEI 272
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 67/270 (24%), Positives = 117/270 (43%), Gaps = 41/270 (15%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
LG GTFG V G+ + G VA+K + + ++ RE + L HP
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIK----REIQNLKLFRHP 71
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 1161
+++ Y V+ V E++ G L + R RR + I++ +
Sbjct: 72 HIIKLYQVISTP--TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-----AV 124
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTLPW 1217
+Y H +VH DLK +N+L++ K+ DFGLS N + G G+ +
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNA----KIADFGLS----NMMSDGEFLRTSCGSPNY 176
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMH--YGAIIGGIVNNTLRPP 1273
APE+++G E VD++S G++L+ +L G P+ ++ + I GG+
Sbjct: 177 AAPEVISGRLYAGPE-VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY------ 229
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+P + + L+ DP+ R + +I
Sbjct: 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDI 259
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 77/269 (28%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED + K LG G+F TV + T AIK ++K + ++ +T RE +++
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVT----RERDVM 84
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKRLIIA-MDA 1157
S+L HP V Y QD L + NG L + K D R A + +
Sbjct: 85 SRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLK-YIRKIGSFDETCTRFYTAEIVS 141
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--------KRNTLVTG 1209
A EYLH K I+H DLK +N+L+N I ++ DFG +K+ + N+ V
Sbjct: 142 AL--EYLHGKGIIHRDLKPENILLNEDMHI----QITDFGTAKVLSPESKQARANSFV-- 193
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP-YANMHYGAIIGGIVNN 1268
GT +++PELL S+ S D+++ G ++++++ G P A Y I I+
Sbjct: 194 ---GTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKL 247
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVR 1297
P F + R L+E+ D R
Sbjct: 248 EYDFP-EKF-FPKARDLVEKLLVLDATKR 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 73/287 (25%), Positives = 125/287 (43%), Gaps = 51/287 (17%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
+ LG G V+ D VA+K + ++ S R F REA+ +
Sbjct: 17 GEILGFGGMSEVH----LARDLRDHRDVAVK-VLRADLARDPSFYLR----FRREAQNAA 67
Query: 1101 KLHHPNVVAFY--GVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDA 1157
L+HP +VA Y G + G V E+ V+G +LR ++ E + ++ + + DA
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEY-VDGVTLRD-IVHTEGPMTPKRAIEVIADA 125
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV----TGGVRG 1213
+ + H I+H D+K N++++ + + KV DFG+++ ++ T V G
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAV----KVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--------ANMHYGAIIGGI 1265
T +++PE G V + DV+S G VL+E+LTGE P+ A H
Sbjct: 182 TAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-------- 231
Query: 1266 VNNTLRPP---VPGFCDSEWRLLMEQCWAPDPVVRP-SFTEIARRLR 1308
V PP G ++ ++ + A +P R + E+ L
Sbjct: 232 VREDPIPPSARHEGL-SADLDAVVLKALAKNPENRYQTAAEMRADLV 277
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
+ +G G G VY D VA+K + ++ + + R REA
Sbjct: 39 RRLVGRGGMGDVY----EAEDTVRERIVALKLMSET-LSSDPVFRTR----MQREARTAG 89
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+L P+VV + + G L +NG L +L ++ L + + I
Sbjct: 90 RLQEPHVVPIHDFGEID--GQLYVDMRL-INGVDLAA-MLRRQGPLAPPRAVAIVRQIGS 145
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT--GGVRGTLPW 1217
++ H+ H D+K +N+LV+ D + DFG++ + +T G GTL +
Sbjct: 146 ALDAAHAAGATHRDVKPENILVSADDFA----YLVDFGIASATTDEKLTQLGNTVGTLYY 201
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
MAPE + S + + D+++ VL+E LTG PY
Sbjct: 202 MAPERFSESH--ATYRADIYALTCVLYECLTGSPPY 235
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 20/262 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E L+ +G G+FG V + T A+K + K R + R +E +I+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER--NEVRNVF---KELQIM 69
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKRLIIAMDAA 1158
L HP +V + QD + V + ++ G LR+ L + H +L I +
Sbjct: 70 QGLEHPFLVNLWYSFQDE--EDMFMVVDLLLGGDLRY-HLQQNVHFKEETVKLFIC-ELV 125
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
++YL ++ I+H D+K DN+L++ + + DF ++ + + GT P+M
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGHV----HITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 1219 APELLNGSSSKV-SEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV--P 1275
APE+ + S VD +S G+ +E+L G PY IV+ V P
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI-RSSTSSKEIVHTFETTVVTYP 240
Query: 1276 GFCDSEWRLLMEQCWAPDPVVR 1297
E L+++ P+P R
Sbjct: 241 SAWSQEMVSLLKKLLEPNPDQR 262
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 64/256 (25%), Positives = 103/256 (40%), Gaps = 54/256 (21%)
Query: 1034 STLQIIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQER 1087
S LQI KN +++ + LG G G V + T A+K ++
Sbjct: 50 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------- 98
Query: 1088 LTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT--VTEFMVNGSLRHVLLSKERH 1144
+ RE E+ + P++V V ++ G V E + G L
Sbjct: 99 --PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL---------- 146
Query: 1145 LDRRKRLIIA--------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189
R I +A+ M +YLHS NI H D+K +NLL K P
Sbjct: 147 FSR----IQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 202
Query: 1190 ICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
+ K+ DFG +K + T ++APE+L K + D++S G++++ +L G
Sbjct: 203 L-KLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCG 259
Query: 1250 EEPYANMHYGAIIGGI 1265
P+ + H AI G+
Sbjct: 260 YPPFYSNHGLAISPGM 275
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 76/270 (28%), Positives = 117/270 (43%), Gaps = 42/270 (15%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G+FG V VA+K I + +S R+ RE L L HP
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVE----REISYLKLLRHP 69
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 1161
+++ Y V+ + V E+ G L ++ K+R RR + II +
Sbjct: 70 HIIKLYDVITTP--TDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC-----AI 121
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTLPW 1217
EY H IVH DLK +NLL++ + K+ DFGLS N + G G+ +
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNV----KIADFGLS----NIMTDGNFLKTSCGSPNY 173
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMH--YGAIIGGIVNNTLRPP 1273
APE++NG E VDV+S GIVL+ +L G P+ + + + +
Sbjct: 174 AAPEVINGKLYAGPE-VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY------V 226
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+P F + L+ + DP+ R + EI
Sbjct: 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEI 256
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 31/222 (13%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E+L+++G GT+GTV+ K R T VA+KR++ + E + RE +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDA 1157
+L H N+V + V+ TL V EF + L+ S LD K + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTL--VFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNT-LVTGGV 1211
G+ + HS+N++H DLK NLL+N + K+ +FGL++ ++ + V
Sbjct: 113 --GLGFCHSRNVLHRDLKPQNLLINRNGEL----KLANFGLARAFGIPVRCYSAEVV--- 163
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
TL + P++L G + S +D++S G + E+ P
Sbjct: 164 --TLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 56/257 (21%), Positives = 97/257 (37%), Gaps = 32/257 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
++ +D E LK +G G F V K + T A+K + K R E F E
Sbjct: 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG-EVSC----FREER 112
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKRLIIAM 1155
++L + + QD L V E+ V G L +L + R +A
Sbjct: 113 DVLVNGDRRWITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA- 169
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-------IKRNTLVT 1208
+ ++ +H VH D+K DN+L++ I ++ DFG ++ V
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHI----RLADFGSCLKLRADGTVRSLVAV- 224
Query: 1209 GGVRGTLPWMAPELLNGSSSKVSEK-----VDVFSFGIVLWEILTGEEPYANMHYGAIIG 1263
GT +++PE+L D ++ G+ +E+ G+ P+ G
Sbjct: 225 ----GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280
Query: 1264 GIVNNTLRPPVPGFCDS 1280
IV+ +P +
Sbjct: 281 KIVHYKEHLSLPLVDEG 297
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 67/253 (26%), Positives = 111/253 (43%), Gaps = 31/253 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+K ED E +K +G G FG V + + T A+K + K RS + FW E
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS-DSAF----FWEER 120
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA-M 1155
+I++ + P VV + QD L V E+M G L + L+S ++ R A +
Sbjct: 121 DIMAFANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEV 177
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-------IKRNTLVT 1208
A + +HS +H D+K DN+L++ + K+ DFG ++ +T V
Sbjct: 178 VLAL--DAIHSMGFIHRDVKPDNMLLDKSGHL----KLADFGTCMKMNKEGMVRCDTAV- 230
Query: 1209 GGVRGTLPWMAPELLNGSSSKVS--EKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1266
GT +++PE+L + D +S G+ L+E+L G+ P+ I+
Sbjct: 231 ----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286
Query: 1267 NNTLRPPVPGFCD 1279
N+ P D
Sbjct: 287 NHKNSLTFPDDND 299
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 61/256 (23%), Positives = 104/256 (40%), Gaps = 32/256 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ ED E LK +G G FG V K + D A+K + K R+ E F E
Sbjct: 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA-ETAC----FREER 125
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++L + + QD L V ++ V G L L + + +
Sbjct: 126 DVLVNGDSKWITTLHYAFQDD--NNLYLVMDYYVGGDLLT-------LLSKFEDRLPEEM 176
Query: 1157 AAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLV 1207
A F ++ +H + VH D+K DN+L+++ I ++ DFG ++ T+
Sbjct: 177 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHI----RLADFGSCLKLMEDGTVQ 232
Query: 1208 TGGVRGTLPWMAPELLNGSSSKVSE---KVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1264
+ GT +++PE+L + D +S G+ ++E+L GE P+ G
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292
Query: 1265 IVNNTLRPPVPGFCDS 1280
I+N+ R P
Sbjct: 293 IMNHKERFQFPTQVTD 308
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 68/270 (25%), Positives = 116/270 (42%), Gaps = 41/270 (15%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
LG GTFG V GK G VA+K + + ++ RE + L HP
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIR----REIQNLKLFRHP 76
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 1161
+++ Y V+ + V E++ G L + R RR + I++ G+
Sbjct: 77 HIIKLYQVISTP--SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-----GV 129
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTLPW 1217
+Y H +VH DLK +N+L++ K+ DFGLS N + G G+ +
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNA----KIADFGLS----NMMSDGEFLRTSCGSPNY 181
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTG----EEPYANMHYGAIIGGIVNNTLRPP 1273
APE+++G E VD++S G++L+ +L G ++ + + I GI
Sbjct: 182 AAPEVISGRLYAGPE-VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF------Y 234
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P + + L++ DP+ R + +I
Sbjct: 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDI 264
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQE---RLTLEFWREA 1096
E E++ ++G G++G V+ + R T VAIK+ S + ++ L RE
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL------ESEDDPVIKKIAL---REI 53
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK-RLIIAM 1155
+L +L HPN+V V + L V E+ + ++ H L +R + + I
Sbjct: 54 RMLKQLKHPNLVNLLEVFRRK--RRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQ 110
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVR 1212
+ + H N +H D+K +N+L+ I K+ DFG ++ + V
Sbjct: 111 TLQ-AVNFCHKHNCIHRDVKPENILITKHSVI----KLCDFGFARLLTGPSDYY-DDEV- 163
Query: 1213 GTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
T W +PELL G ++ VDV++ G V E+L+G
Sbjct: 164 ATR-WYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 31/221 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ + +LG GT+G VY T+ VAIKRI+ E+E + RE +L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+L H N++ V+ L + E+ + L ++++D+ + + + +F
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHL--IFEYA-----ENDL---KKYMDKNPDVSMRVIKSF 137
Query: 1160 ------GMEYLHSKNIVHFDLKCDNLLVNLKDPI-RPICKVGDFGLSK---IKRNTLVTG 1209
G+ + HS+ +H DLK NLL+++ D P+ K+GDFGL++ I T
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-TH 196
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ TL + PE+L G S S VD++S + E+L
Sbjct: 197 EII-TLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 60/262 (22%), Positives = 93/262 (35%), Gaps = 75/262 (28%)
Query: 1034 STLQIIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQER 1087
S LQI KN +++ + LG G G V + T A+K ++
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------- 54
Query: 1088 LTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT--VTEFMVNGSLRHVLLSKERH 1144
+ RE E+ + P++V V ++ G V E + G L
Sbjct: 55 --PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL---------- 102
Query: 1145 LDRRKRLIIA--------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189
R I +A+ M +YLHS NI H D+K +NLL K P
Sbjct: 103 FSR----IQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 158
Query: 1190 ICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
+ K+ DFG A E K D++S G++++ +L G
Sbjct: 159 L-KLTDFGF--------------------AKETTGEKYDK---SCDMWSLGVIMYILLCG 194
Query: 1250 EEPYANMHYGAIIGGIVNNTLR 1271
P+ + H AI G+
Sbjct: 195 YPPFYSNHGLAISPGMKTRIRM 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 1050 LGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+G GT+G VY K + D A+K+I+ +++ RE +L +L HP
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG----------TGISMSACREIALLRELKHP 78
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIAMDAAF---- 1159
NV++ V + + ++ L H++ + + +L M +
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 1160 --GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNTLVTGGVR 1212
G+ YLH+ ++H DLK N+LV + P R K+ D G ++ +K + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 1213 GTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
T W APELL G + ++ +D+++ G + E+LT E
Sbjct: 198 -TF-WYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 233
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 53/228 (23%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD-VAIKRIKK-SCFTGRSSEQERLTLEFWREAEILSKL 1102
K +G+G+FG V+ K +D VAIK++ + F R E +I+ +
Sbjct: 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------------ELQIMRIV 89
Query: 1103 HHPNVVA----FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
HPNVV FY L V E++ ++ RH + K+ M
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRAS----RHYAKLKQ---TMPML 141
Query: 1159 F----------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRN 1204
+ Y+HS I H D+K NLL++ P + K+ DFG +KI + N
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD---PPSGVLKLIDFGSAKILIAGEPN 198
Query: 1205 T--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ + R APEL+ G ++ + +D++S G V+ E++ G+
Sbjct: 199 VSYICSRYYR------APELIFG-ATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 30/218 (13%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
E L+++G GT+G VY + G A+K+I+ E E + RE IL
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDAA 1158
+L H N+V Y V+ L V E + + L+ +L E L+ K ++ +
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVL--VFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLN- 111
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNT-LVTGGVR 1212
G+ Y H + ++H DLK NLL+N + + K+ DFGL++ +++ T +
Sbjct: 112 -GIAYCHDRRVLHRDLKPQNLLINREGEL----KIADFGLARAFGIPVRKYTHEIV---- 162
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
TL + AP++L G S K S +D++S G + E++ G
Sbjct: 163 -TLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKK-SCFTGRSSEQERLTLEFWREAEILSK 1101
+ K +G+G+FG VY K G VAIK++ + F R E +I+ K
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------------ELQIMRK 103
Query: 1102 LHHPNVVA----FYGVVQDGPGGTLATVTEFM---VNGSLRHVLLSKERHLDRRKRLIIA 1154
L H N+V FY + L V +++ V RH +K+ +L +
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM- 162
Query: 1155 MDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTG 1209
+ + Y+HS I H D+K NLL++ P + K+ DFG +K + R
Sbjct: 163 ----YQLFRSLAYIHSFGICHRDIKPQNLLLD---PDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ + + APEL+ G ++ + +DV+S G VL E+L G+
Sbjct: 216 YI-CSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-24
Identities = 67/273 (24%), Positives = 104/273 (38%), Gaps = 32/273 (11%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWR 1094
Q + + + LG G FG V + R T A K+++K R E L
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN----- 233
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA 1154
E +IL K++ VV+ + L V M G L+ H+ +
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETK--DALCLVLTLMNGGDLKF-------HIYHMGQAGFP 284
Query: 1155 MD-AAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206
A F G+E LH + IV+ DLK +N+L++ IR I D GL+
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIR-IS---DLGLAVHVPEGQ 340
Query: 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1266
G GT+ +MAPE++ S D ++ G +L+E++ G+ P+ +
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFS--PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398
Query: 1267 NNTLRPPV--PGFCDSEWRLLMEQCWAPDPVVR 1297
P + R L Q DP R
Sbjct: 399 RLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 72/215 (33%), Positives = 109/215 (50%), Gaps = 24/215 (11%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
E ++L+++G GT+G VY K G VA+KRI+ +E E + RE +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDAA 1158
+LHHPN+V+ V+ TL V EFM L+ VL + L K + +
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTL--VFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR- 130
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGTL 1215
G+ + H I+H DLK NLL+N + K+ DFGL++ I + V TL
Sbjct: 131 -GVAHCHQHRILHRDLKPQNLLINSDGAL----KLADFGLARAFGIPVRSYTHEVV--TL 183
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ AP++L G S K S VD++S G + E++TG+
Sbjct: 184 WYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 64/258 (24%), Positives = 112/258 (43%), Gaps = 20/258 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ + +K LG+G+FG V K + + A+K + K + + E TL E IL
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEH-TLN---EKRIL 95
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++ P +V +D L V E++ G + L + A
Sbjct: 96 QAVNFPFLVKLEFSFKDN--SNLYMVMEYVAGGEMFS-HLRRIGRFSEPHARFYAAQIVL 152
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
EYLHS ++++ DLK +NLL++ + I +V DFG +K + T + GT +A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYI----QVTDFGFAKRVKGR--TWTLCGTPEALA 206
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279
PE++ + VD ++ G++++E+ G P+ I IV+ +R P
Sbjct: 207 PEIILSKGYNKA--VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFS 262
Query: 1280 SEWRLLMEQCWAPDPVVR 1297
S+ + L+ D R
Sbjct: 263 SDLKDLLRNLLQVDLTKR 280
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQE---RLTLEFWREA 1096
E E L +G G++G V + + T VAIK+ S + + ++ + RE
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAM---REI 75
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIA 1154
++L +L H N+V V + L V EF+ + ++ L LD + ++ +
Sbjct: 76 KLLKQLRHENLVNLLEVCKKKKRWYL--VFEFV-DHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGV 1211
+ G+ + HS NI+H D+K +N+LV+ + K+ DFG ++ V
Sbjct: 133 IIN--GIGFCHSHNIIHRDIKPENILVSQSGVV----KLCDFGFARTLAAPGEVY-DDEV 185
Query: 1212 RGTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
T W APELL G K + VDV++ G ++ E+ GE
Sbjct: 186 -ATR-WYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E+L LG G F TVY + + T+ VAIK+IK RS ++ + RE ++L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLL 66
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDA 1157
+L HPN++ +L V +FM L ++ L K ++
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISL--VFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNT-LVTGGV 1211
G+EYLH I+H DLK +NLL++ + K+ DFGL+K + T V
Sbjct: 124 --GLEYLHQHWILHRDLKPNNLLLDENGVL----KLADFGLAKSFGSPNRAYTHQVV--- 174
Query: 1212 RGTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
T W APELL G + VD+++ G +L E+L
Sbjct: 175 --TR-WYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRV 210
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 31/265 (11%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D + LK LG GTFG V + + T A+K ++K + E E + +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTE----SRVL 59
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIAMDA 1157
HP + A Q L V E+ G L H LS+ER R R A +
Sbjct: 60 QNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFH--LSRERVFTEERARFYGA-EI 114
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----- 1212
+EYLHS+++V+ D+K +NL+++ I K+ DFGL K ++ G
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHI----KITDFGLCKEG----ISDGATMKTFC 166
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272
GT ++APE+L + + VD + G+V++E++ G P+ N + + I+ +R
Sbjct: 167 GTPEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR- 223
Query: 1273 PVPGFCDSEWRLLMEQCWAPDPVVR 1297
P E + L+ DP R
Sbjct: 224 -FPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 33/268 (12%)
Query: 1042 EDLEELKELGSGTFGTVY---HGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREA 1096
E E L+ LG G +G V+ T A+K +KK+ + + T E
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH-TKA---ER 72
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIA 1154
IL ++ HP +V Q G G L + E++ G L L +E +A
Sbjct: 73 NILEEVKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMQ--LEREGIFMEDTACFYLA 128
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-- 1212
+ + + +LH K I++ DLK +N+++N + + K+ DFGL K + G
Sbjct: 129 -EISMALGHLHQKGIIYRDLKPENIMLNHQGHV----KLTDFGLCKES----IHDGTVTH 179
Query: 1213 ---GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1269
GT+ +MAPE+L S + VD +S G +++++LTG P+ + I I+
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRA--VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237
Query: 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVR 1297
L +P + E R L+++ + R
Sbjct: 238 LN--LPPYLTQEARDLLKKLLKRNAASR 263
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 73/260 (28%), Positives = 130/260 (50%), Gaps = 24/260 (9%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D + L+ LG+G+FG V+ + R A+K +KK R + E T + E +L
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEH-TND---ERLML 60
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKRLIIAMDAA 1158
S + HP ++ +G QD + + +++ G L LL K + + A +
Sbjct: 61 SIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAA-EVC 116
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
+EYLHSK+I++ DLK +N+L++ I K+ DFG +K + T + GT ++
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHI----KITDFGFAKYVPDV--TYTLCGTPDYI 170
Query: 1219 APELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
APE+++ +K +D +SFGI+++E+L G P+ + + I+N LR P F
Sbjct: 171 APEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FPPF 225
Query: 1278 CDSEWRLLMEQCWAPDPVVR 1297
+ + + L+ + D R
Sbjct: 226 FNEDVKDLLSRLITRDLSQR 245
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 70/331 (21%), Positives = 132/331 (39%), Gaps = 34/331 (10%)
Query: 978 METHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQ 1037
M H + E + + + +L TA + +
Sbjct: 1 MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLT-----------GHAE 49
Query: 1038 IIKNEDLEELKELGSGTFGTVY---HGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEF 1092
+ E+ E LK LG+G +G V+ T A+K +KK+ ++ E T
Sbjct: 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH-TRT- 107
Query: 1093 WREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKR 1150
E ++L + P +V + Q L + +++ G L LS+ +
Sbjct: 108 --ERQVLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFT-HLSQRERFTEHEVQ 162
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVT 1208
+ + + +E+LH I++ D+K +N+L++ + + DFGLSK + T
Sbjct: 163 IYVG-EIVLALEHLHKLGIIYRDIKLENILLDSNGHV----VLTDFGLSKEFVADETERA 217
Query: 1209 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1268
GT+ +MAP+++ G S + VD +S G++++E+LTG P+ I
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277
Query: 1269 TLRPPV--PGFCDSEWRLLMEQCWAPDPVVR 1297
L+ P + + L+++ DP R
Sbjct: 278 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-23
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 21/219 (9%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ + + LG G FG V+ + + T A K++ K R Q + E +IL
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-----EKKIL 239
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLR---HVLLSKERHLD-RRKRLIIAM 1155
+K+H +V+ + L V M G +R + + R A
Sbjct: 240 AKVHSRFIVSLAYAFETK--TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA- 296
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGT 1214
G+E+LH +NI++ DLK +N+L++ +R I D GL+ +K T G GT
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR-IS---DLGLAVELKAGQTKTKGYAGT 352
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
+MAPELL G S VD F+ G+ L+E++ P+
Sbjct: 353 PGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGPF 389
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-22
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E +L +LG GT+ TVY GK + TD VA+K I R +E RE +L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLL 54
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDA 1157
L H N+V + ++ TL V E++ + L+ L ++ K + +
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTL--VFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQL-- 109
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGT 1214
G+ Y H + ++H DLK NLL+N + + K+ DFGL++ I T V T
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGEL----KLADFGLARAKSIPTKTYDNEVV--T 163
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
L + P++L G S+ S ++D++ G + +E+ TG
Sbjct: 164 LWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGR 198
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 79/266 (29%), Positives = 117/266 (43%), Gaps = 32/266 (12%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E LK LG GTFG V K + T A+K +KK + LT E +L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-----ENRVL 202
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIAMDA 1157
HP + A Q L V E+ G L H LS+ER R R A +
Sbjct: 203 QNSRHPFLTALKYSFQT--HDRLCFVMEYANGGELFFH--LSRERVFSEDRARFYGA-EI 257
Query: 1158 AFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---- 1212
++YLHS KN+V+ DLK +NL+++ I K+ DFGL K + G
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHI----KITDFGLCKEG----IKDGATMKTF 309
Query: 1213 -GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1271
GT ++APE+L + + VD + G+V++E++ G P+ N + + I+ +R
Sbjct: 310 CGTPEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 367
Query: 1272 PPVPGFCDSEWRLLMEQCWAPDPVVR 1297
P E + L+ DP R
Sbjct: 368 --FPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-22
Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 37/224 (16%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQE----RLTLEFWRE 1095
++L++LG+GT+ TVY G + T VA+K +K + E + RE
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK--------LDSEEGTPSTAI---RE 53
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
++ +L H N+V Y V+ TL V EFM + L+ + + + L + +
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTL--VFEFM-DNDLKK-YMDSRTVGNTPRGLELNL 109
Query: 1156 DAAF------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTL 1206
F G+ + H I+H DLK NLL+N + + K+GDFGL++ I NT
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQL----KLGDFGLARAFGIPVNTF 165
Query: 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ V TL + AP++L G S S +D++S G +L E++TG+
Sbjct: 166 SSEVV--TLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGK 206
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-22
Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 35/268 (13%)
Query: 1042 EDLEELKELGSGTFGTVY---HGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREA 1096
E LK LG G+FG V+ A+K +KK+ R E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKM-----ER 77
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIA 1154
+IL +++HP +V + Q G L + +F+ G L LSKE + +A
Sbjct: 78 DILVEVNHPFIVKLHYAFQTE--GKLYLILDFLRGGDLFTR--LSKEVMFTEEDVKFYLA 133
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-- 1212
+ A +++LHS I++ DLK +N+L++ + I K+ DFGLSK + +
Sbjct: 134 -ELALALDHLHSLGIIYRDLKPENILLDEEGHI----KLTDFGLSKES----IDHEKKAY 184
Query: 1213 ---GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1269
GT+ +MAPE++N S D +SFG++++E+LTG P+ + I+
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
Query: 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVR 1297
L +P F E + L+ + +P R
Sbjct: 243 LG--MPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 4e-22
Identities = 37/281 (13%), Positives = 76/281 (27%), Gaps = 57/281 (20%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
L G W+ D VA+ + + + + E LS
Sbjct: 36 LIFHGGVPPLQF----WQALDTALDRQVALTFVD-----PQGVLPDDVLQETLSRTLRLS 86
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
++ P V VV GG + V E++ GSL+ V + + A
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLV--VAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAA 141
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAP 1220
+ H + + V++ + + M
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVSIDGDV----VLAYPAT-------------------MPD 178
Query: 1221 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP----- 1275
+ + D+ G L+ +L P + + +T P+
Sbjct: 179 ---------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID 229
Query: 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 1316
+ + + D +R + T + + + A +T
Sbjct: 230 RDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRT 270
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-22
Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 53/235 (22%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW-----R 1094
E + E+G G +GTVY + + VA+K ++ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV--------PNGGGGGGGLPISTVR 60
Query: 1095 EAEILSKLH---HPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRR 1148
E +L +L HPNVV V V E + L +LD+
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----DQDL---RTYLDKA 112
Query: 1149 KRLIIAMDAA--------FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
+ + G+++LH+ IVH DLK +N+LV + K+ DFGL++
Sbjct: 113 PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV----KLADFGLAR 168
Query: 1201 I----KRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
I T +V TL + APE+L S + VD++S G + E+ +
Sbjct: 169 IYSYQMALTPVVV-----TLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRK 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-22
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E+L ++G GTFG V+ + R T VA+K++ +E+E + RE +IL
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 1100 SKLHHPNVVAFYGVV------QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRL 1151
L H NVV + + G++ V +F + L +L + KR+
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNT 1205
+ + G+ Y+H I+H D+K N+L+ + K+ DFGL++ +
Sbjct: 130 MQMLLN--GLYYIHRNKILHRDMKAANVLITRDGVL----KLADFGLARAFSLAKNSQPN 183
Query: 1206 LVTGGVRGTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
T V TL W PELL G +D++ G ++ E+ T
Sbjct: 184 RYTNRVV-TL-WYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 47/224 (20%), Positives = 91/224 (40%), Gaps = 42/224 (18%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D + +++LG G + V+ + V +K +K +++ RE +IL
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIK---REIKIL 84
Query: 1100 SKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIAMD 1156
L PN++ +V+D T A V E + N + + L+ D
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY-------------D 131
Query: 1157 AAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVT 1208
F ++Y HS I+H D+K N++++ + + D+GL++
Sbjct: 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI---DWGLAEFYHPGQEYN 188
Query: 1209 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1252
V + + PELL +D++S G +L ++ +EP
Sbjct: 189 VRV-ASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 2e-21
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 19/217 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D + +G G FG VY + T A+K + K + + E L L E +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALN---ERIML 243
Query: 1100 SKLH---HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
S + P +V L+ + + M G L + LS+ A +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHY-HLSQHGVFSEADMRFYAAE 300
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
G+E++H++ +V+ DLK N+L++ +R I D GL+ V GT
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVR-IS---DLGLACDFSKKKPHASV-GTHG 355
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
+MAPE+L D FS G +L+++L G P+
Sbjct: 356 YMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPF 391
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-21
Identities = 50/223 (22%), Positives = 88/223 (39%), Gaps = 33/223 (14%)
Query: 1045 EELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSS---EQERLTLEFWREAEI 1098
+ + SG++G V + G VAIKR+ + GR+ L RE +
Sbjct: 25 TVQRFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHL-DRRKRLIIA 1154
L+ HHPN++ + + VTE M L V+ + + + + +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM- 140
Query: 1155 MDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLS-KIKRNTLV 1207
+ G+ LH +VH DL N+L+ + DF L+ + +
Sbjct: 141 ----YHILLGLHVLHEAGVVHRDLHPGNILLADN------NDITICDFNLAREDTADANK 190
Query: 1208 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
T V + APEL+ ++ VD++S G V+ E+ +
Sbjct: 191 THYV-THRWYRAPELV-MQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 59/236 (25%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD------VAIKRI--KKSCFTGRSSEQERLTLEFWREA 1096
+LK LG G G V + D VAIK+I L RE
Sbjct: 14 MDLKPLGCGGNGLV----FSAVDNDCDKRVAIKKIVLTDPQSVKH-------AL---REI 59
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLAT------------VTEFMVNGSLRHVLLSKERH 1144
+I+ +L H N+V + ++ V E+M + +L +
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPL 117
Query: 1145 LDRRKRLIIAMDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGL 1198
L+ RL + + G++Y+HS N++H DLK NL +N +D K+GDFGL
Sbjct: 118 LEEHARLFM-----YQLLRGLKYIHSANVLHRDLKPANLFINTED-----LVLKIGDFGL 167
Query: 1199 SKI-----KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 1249
++I ++ G+ T + +P LL S + ++ +D+++ G + E+LTG
Sbjct: 168 ARIMDPHYSHKGHLSEGL-VTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 7e-21
Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 39/227 (17%)
Query: 1042 EDLEELKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ E + E+G G +G V+ K G VA+KR++ + +E + L RE +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 1099 LSKLH---HPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
L L HPNVV + V V E + L +LD+
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-----DQDL---TTYLDKVPEPG 116
Query: 1153 IAMDAA--------FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
+ + G+++LHS +VH DLK N+LV I K+ DFGL++I
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI----KLADFGLARIYSF 172
Query: 1205 TL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ +T V TL + APE+L S + VD++S G + E+ +
Sbjct: 173 QMALTSVVV-TLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRK 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 2e-20
Identities = 76/385 (19%), Positives = 137/385 (35%), Gaps = 59/385 (15%)
Query: 899 WSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSR 958
F+ D+ R V + D D + + ++ G + + + G
Sbjct: 227 TFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEY 286
Query: 959 INFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPT 1018
N + + E ++ ++ + D R+ L
Sbjct: 287 FNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRD----RMKL-- 340
Query: 1019 AGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKS 1076
D L LG G+FG V + +GTD A+K +KK
Sbjct: 341 -----------------------TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD 377
Query: 1077 CFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL- 1134
+ E E +L+ P + + Q L V E++ G L
Sbjct: 378 VVIQDD-DVECT----MVEKRVLALPGKPPFLTQLHSCFQ--TMDRLYFVMEYVNGGDLM 430
Query: 1135 RHVLLSKERHLD-RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193
H + + A + A G+ +L SK I++ DLK DN++++ + I K+
Sbjct: 431 YH--IQQVGRFKEPHAVFYAA-EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI----KI 483
Query: 1194 GDFGLSKIKRNTLVTGGVR-----GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248
DFG+ K + GV GT ++APE++ S VD ++FG++L+E+L
Sbjct: 484 ADFGMCKEN----IWDGVTTKTFCGTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLA 537
Query: 1249 GEEPYANMHYGAIIGGIVNNTLRPP 1273
G+ P+ + I+ + + P
Sbjct: 538 GQAPFEGEDEDELFQSIMEHNVAYP 562
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 76/269 (28%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+K ED K LG G+FG V+ +++ T+ AIK +KK + E E
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-DVECT----MVEK 68
Query: 1097 EILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLII 1153
+LS HP + + Q L V E++ G L H + D R
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYH--IQSCHKFDLSRATFYA 124
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR- 1212
A + G+++LHSK IV+ DLK DN+L++ I K+ DFG+ K + G +
Sbjct: 125 A-EIILGLQFLHSKGIVYRDLKLDNILLDKDGHI----KIADFGMCKEN----MLGDAKT 175
Query: 1213 ----GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1268
GT ++APE+L G S VD +SFG++L+E+L G+ P+ + I +
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHS--VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVR 1297
P + + E + L+ + + +P R
Sbjct: 234 NPF--YPRWLEKEAKDLLVKLFVREPEKR 260
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 53/252 (21%), Positives = 95/252 (37%), Gaps = 68/252 (26%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K LG+G+FG V G A+K++ + R RE +I+ L
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVL---------QDPRYKN---RELDIMKVL 57
Query: 1103 HHPNVVA----FYGVVQDGPGGTLAT--------------------------------VT 1126
H N++ FY + P +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 1127 EFM---VNGSLRHVLLSKERHLDRRKRLIIAMDAAF----GMEYLHSKNIVHFDLKCDNL 1179
E++ ++ L+ + S + I + + ++HS I H D+K NL
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYI-----YQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 1180 LVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFS 1238
LVN KD +C DFG +K + + + + + APEL+ G +++ + +D++S
Sbjct: 173 LVNSKDNTLKLC---DFGSAKKLIPSEPSVAYI-CSRFYRAPELMLG-ATEYTPSIDLWS 227
Query: 1239 FGIVLWEILTGE 1250
G V E++ G+
Sbjct: 228 IGCVFGELILGK 239
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-20
Identities = 62/278 (22%), Positives = 120/278 (43%), Gaps = 41/278 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ +D + L+ +G G++ V + + TD A+K +KK + + + E
Sbjct: 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE-DIDWV----QTEK 60
Query: 1097 EILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLII 1153
+ + +HP +V + Q L V E++ G L H + ++R L R
Sbjct: 61 HVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYVNGGDLMFH--MQRQRKLPEEHARFYS 116
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR- 1212
A + + + YLH + I++ DLK DN+L++ + I K+ D+G+ K + G
Sbjct: 117 A-EISLALNYLHERGIIYRDLKLDNVLLDSEGHI----KLTDYGMCKEG----LRPGDTT 167
Query: 1213 ----GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG---- 1264
GT ++APE+L G S VD ++ G++++E++ G P+ +
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 225
Query: 1265 -----IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVR 1297
I+ +R +P + +++ DP R
Sbjct: 226 YLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 261
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-20
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRI-KKSCFTGRSSEQERLTLEFWREAEILSK 1101
+ + G GTFGTV GK + G VAIK++ + F R L + + L+
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR-------EL---QIMQDLAV 75
Query: 1102 LHHPNVVA----FYGVVQDGPGGT-LATVTEFM---VNGSLRHVLLSKERHLDRRKRLII 1153
LHHPN+V FY + + L V E++ ++ R+ + ++ +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 1154 AMDAAF----GMEYLH--SKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKI-KRN 1204
F + LH S N+ H D+K N+LVN D K+ DFG +K +
Sbjct: 136 -----FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD-----GTLKLCDFGSAKKLSPS 185
Query: 1205 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ + + APEL+ G + + VD++S G + E++ GE
Sbjct: 186 EPNVAYI-CSRYYRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 9e-20
Identities = 67/245 (27%), Positives = 111/245 (45%), Gaps = 30/245 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ ++ E ++ LG G+FG V + + T A+K +KK + E E
Sbjct: 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD-DVECT----MTEK 74
Query: 1097 EILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLII 1153
ILS +HP + + Q L V EF+ G L H + K R D R R
Sbjct: 75 RILSLARNHPFLTQLFCCFQ--TPDRLFFVMEFVNGGDLMFH--IQKSRRFDEARARFYA 130
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR- 1212
A + + +LH K I++ DLK DN+L++ + K+ DFG+ K + GV
Sbjct: 131 A-EIISALMFLHDKGIIYRDLKLDNVLLDHEGHC----KLADFGMCKEG----ICNGVTT 181
Query: 1213 ----GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1268
GT ++APE+L + VD ++ G++L+E+L G P+ + + I+N+
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPA--VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
Query: 1269 TLRPP 1273
+ P
Sbjct: 240 EVVYP 244
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-19
Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 30/242 (12%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D L LG G+FG V + +GTD A+K +KK + E E +L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD-DVECT----MVEKRVL 74
Query: 1100 SK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIAMD 1156
+ P + + Q L V E++ G L H + + A +
Sbjct: 75 ALPGKPPFLTQLHSCFQ--TMDRLYFVMEYVNGGDLMYH--IQQVGRFKEPHAVFYAA-E 129
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---- 1212
A G+ +L SK I++ DLK DN++++ + I K+ DFG+ K + GV
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI----KIADFGMCKEN----IWDGVTTKTF 181
Query: 1213 -GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1271
GT ++APE++ S VD ++FG++L+E+L G+ P+ + I+ + +
Sbjct: 182 CGTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 239
Query: 1272 PP 1273
P
Sbjct: 240 YP 241
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 41/300 (13%)
Query: 1030 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQER 1087
N S+ K D LK +G G+FG V + + +V A+K ++K + E++
Sbjct: 26 NLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK-EEKH 84
Query: 1088 LTLEFWREAEILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHL 1145
+ E +L K + HP +V + Q L V +++ G L H L +ER
Sbjct: 85 -IMS---ERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDYINGGELFYH--LQRERCF 136
Query: 1146 D-RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
R R A + A + YLHS NIV+ DLK +N+L++ + I + DFGL K
Sbjct: 137 LEPRARFYAA-EIASALGYLHSLNIVYRDLKPENILLDSQGHI----VLTDFGLCKEN-- 189
Query: 1205 TLVTGGVR-----GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 1259
+ GT ++APE+L+ + VD + G VL+E+L G P+ + +
Sbjct: 190 --IEHNSTTSTFCGTPEYLAPEVLHKQPYDRT--VDWWCLGAVLYEMLYGLPPFYSRNTA 245
Query: 1260 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSH 1319
+ I+N L+ + + R L+E D +RL + KSH
Sbjct: 246 EMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDR---------TKRLGAKDDFMEIKSH 294
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-19
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+GSG +G+V K G VAIK++ + F + RE +L +
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAY-----RELLLLKHM 80
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
H NV+ V P +L V FM L+ ++ + + + + ++
Sbjct: 81 QHENVIGLLDVFT--PASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLV--- 132
Query: 1157 AAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGG 1210
+ G++Y+HS +VH DLK NL VN C K+ DFGL++ + TG
Sbjct: 133 --YQMLKGLKYIHSAGVVHRDLKPGNLAVNED------CELKILDFGLARHADAEM-TGY 183
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
V T + APE++ S ++ VD++S G ++ E+LTG+
Sbjct: 184 V-VTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 61/275 (22%), Positives = 119/275 (43%), Gaps = 41/275 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D + L+ +G G++ V + + TD A++ +KK + + + E +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE-DIDWV----QTEKHVF 106
Query: 1100 SK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIAMD 1156
+ +HP +V + Q L V E++ G L H + ++R L R A +
Sbjct: 107 EQASNHPFLVGLHSCFQTE--SRLFFVIEYVNGGDLMFH--MQRQRKLPEEHARFYSA-E 161
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---- 1212
+ + YLH + I++ DLK DN+L++ + I K+ D+G+ K + G
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHI----KLTDYGMCKEG----LRPGDTTSTF 213
Query: 1213 -GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG------- 1264
GT ++APE+L G S VD ++ G++++E++ G P+ +
Sbjct: 214 CGTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271
Query: 1265 --IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVR 1297
I+ +R +P + +++ DP R
Sbjct: 272 QVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 304
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-19
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 1047 LKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
L+ +GSG +G V G VAIK++ + F + RE +L + H
Sbjct: 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAY-----RELRLLKHMRH 83
Query: 1105 PNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
NV+ V P TL V FM L ++ ++ DR + L+ M
Sbjct: 84 ENVIGLLDVFT--PDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQM--L 138
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGTLP 1216
G+ Y+H+ I+H DLK NL VN C K+ DFGL++ + + TG V T
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNED------CELKILDFGLARQADSEM-TGYV-VTRW 190
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ APE++ + + ++ VD++S G ++ E++TG+
Sbjct: 191 YRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 61/231 (26%), Positives = 93/231 (40%), Gaps = 49/231 (21%)
Query: 1045 EELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
+ LG G +G V H G VAIK+I F R TL RE +IL
Sbjct: 14 QLKSLLGEGAYGVVCSATHKP-TGEIVAIKKI--EPFDKPLFAL-R-TL---REIKILKH 65
Query: 1102 LHHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
H N++ + + + + E M + H ++S + D + I
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFI----- 118
Query: 1159 F----GMEYLHSKNIVHFDLKCDNLLVN----LKDPIRPICKVGDFGLS-KIKRNTLVTG 1209
+ ++ LH N++H DLK NLL+N LK +C DFGL+ I +
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK-----VC---DFGLARIIDESAADNS 170
Query: 1210 GVRGTLPWM----------APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
G M APE++ +S+K S +DV+S G +L E+
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ L +GSG +G+V G VA+K++ + F +S + T RE +L +
Sbjct: 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PF--QSIIHAKRTY---RELRLLKHM 85
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
H NV+ V P +L VT M L +++ ++ D + LI +
Sbjct: 86 KHENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQI- 141
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGT 1214
G++Y+HS +I+H DLK NL VN C K+ DFGL++ + + TG V T
Sbjct: 142 -LRGLKYIHSADIIHRDLKPSNLAVNED------CELKILDFGLARHTADEM-TGYV-AT 192
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ APE++ + ++ VD++S G ++ E+LTG
Sbjct: 193 RWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 1047 LKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LK +GSG G V + +VAIK++ + F ++ + RE ++ ++H
Sbjct: 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PF--QNQTHAKRAY---RELVLMKCVNH 83
Query: 1105 PNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
N++ V P +L V E M + +L V+ + H +R L+ M
Sbjct: 84 KNIIGLLNVFT--PQKSLEEFQDVYIVMELM-DANLCQVIQMELDH-ERMSYLLYQM--L 137
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLS-KIKRNTLVTGGVRGTL 1215
G+++LHS I+H DLK N++V C K+ DFGL+ + ++T V T
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYV-VTR 190
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ APE++ E VD++S G ++ E++ G
Sbjct: 191 YYRAPEVI--LGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
L +G G +G V + VAIK+I S F ++ Q R TL RE +IL +
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQ-R-TL---REIKILLRF 82
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
H N++ +++ + V + M L +L ++ D + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQI--LR 139
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKI-----KRNTLVTGGVR 1212
G++Y+HS N++H DLK NLL+N C K+ DFGL+++ +T V
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTT------CDLKICDFGLARVADPDHDHTGFLTEYV- 192
Query: 1213 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
T + APE++ +S ++ +D++S G +L E+L+
Sbjct: 193 ATRWYRAPEIM-LNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-17
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ LK +GSG G V D VAIK++ + F ++ + RE ++ +
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY-----RELVLMKCV 118
Query: 1103 HHPNVVAFYGVVQDGPGGT----LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+H N+++ V + V E M + ++ E +R L+ M
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYLLYQMLC- 175
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGTLP 1216
G+++LHS I+H DLK N++V C K+ DFGL++ + + T
Sbjct: 176 -GIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ APE++ E VD++S G ++ E++ +
Sbjct: 229 YRAPEVI--LGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 7e-16
Identities = 50/251 (19%), Positives = 94/251 (37%), Gaps = 57/251 (22%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+G G++G VY + K +VAIK++ + F + R L RE IL++L
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MFEDLIDCK-R-IL---REITILNRL 82
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++ Y ++ V E + L+ + + + + I+ +
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL-----Y 136
Query: 1160 ----GMEYLHSKNIVHFDLKCDNLLVN----LKDPIRPICKVGDFGLS------------ 1199
G ++H I+H DLK N L+N +K +C DFGL+
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVK-----VC---DFGLARTINSEKDTNIV 188
Query: 1200 -KIKRNTLVTGGVRGTLPWM----------APELLNGSSSKVSEKVDVFSFGIVLWEILT 1248
++ N + + APEL+ ++ +D++S G + E+L
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL-LQENYTKSIDIWSTGCIFAELLN 247
Query: 1249 GEEPYANMHYG 1259
+ + N
Sbjct: 248 MLQSHINDPTN 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 56/254 (22%), Positives = 92/254 (36%), Gaps = 58/254 (22%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E +G+G++G V + VAIK+I R E RE IL++L
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI------LRVFEDLIDCKRILREIAILNRL 109
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+H +VV +V V E + + + + + + ++ +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL-----Y 163
Query: 1160 ----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLS-------------- 1199
G++Y+HS I+H DLK N LVN C KV DFGL+
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQD------CSVKVCDFGLARTVDYPENGNSQLP 217
Query: 1200 ----KIKRNTLVTGGVRGTLPWM----------APELLNGSSSKVSEKVDVFSFGIVLWE 1245
+ N + + + APEL+ +E +DV+S G + E
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI-LLQENYTEAIDVWSIGCIFAE 276
Query: 1246 ILTGEEPYANMHYG 1259
+L + H
Sbjct: 277 LLNMIKENVAYHAD 290
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-15
Identities = 64/242 (26%), Positives = 101/242 (41%), Gaps = 63/242 (26%)
Query: 1045 EELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E +K+LG G +G V + G VA+K+I F + Q R T RE IL++
Sbjct: 12 ELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKIFD-AFQNSTDAQ-R-TF---REIMILTE 64
Query: 1102 LH-HPNVVAFYGVVQDGPGGTLATVTEFM---VNGSLRHVLLSKERH------LDRRKRL 1151
L H N+V V++ + V ++M ++ +R +L L +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIK---- 120
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLS---------- 1199
++YLHS ++H D+K N+L+N + C KV DFGLS
Sbjct: 121 --------VIKYLHSGGLLHRDMKPSNILLNAE------CHVKVADFGLSRSFVNIRRVT 166
Query: 1200 --KIKRNTLVTGGVRGTLPWM----------APELLNGSSSKVSEKVDVFSFGIVLWEIL 1247
T P + APE+L S+K ++ +D++S G +L EIL
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCILGEIL 225
Query: 1248 TG 1249
G
Sbjct: 226 CG 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.5 bits (182), Expect = 4e-14
Identities = 48/280 (17%), Positives = 78/280 (27%), Gaps = 67/280 (23%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ E L+ +++G G FG V+ T VAIK I + ++ E E
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 1097 EILSKLH---------HPNVVAFYG--VVQDG--------------------------PG 1119
I +L + VQ
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDN 1178
L V EF G + +K L K I + + H DL N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKS--ILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 1179 LLVNLKDPIRPICKVG----------------DFGLSKIKRNTLVTGGVRGTLPWMAPEL 1222
+L+ + + D+ LS+++R+ G V M +L
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDL 248
Query: 1223 LNGSSSKVSEKVDVFSF-GIVLWEILTGEEPYAN---MHY 1258
G + D++ PY+N +HY
Sbjct: 249 FTGDGDY---QFDIYRLMKKENNNRWGEYHPYSNVLWLHY 285
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 48/220 (21%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 1047 LKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
+++LG G F TV W T VA+K ++ ++E E L+ +A+
Sbjct: 24 VRKLGWGHFSTV----WLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 1101 KLH--HPNVVAFYGVVQ-DGPGGT-LATVTEFMVNGSLRHVL-LSKER--HLDRRKRLII 1153
+ +++ GP G + V E + +L ++ + R L K+ I
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--I 136
Query: 1154 AMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDP--IRPICKVGDFGLSKIKRNTLVTGG 1210
+ G++Y+H + I+H D+K +N+L+ + D K+ D G +
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
T + +PE+L G+ D++S +++E++TG+
Sbjct: 197 Q--TREYRSPEVLLGA--PWGCGADIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 41/233 (17%)
Query: 1036 LQIIKNEDL----EELKELGSGTFGTVY--HGKWRGTDVAIKRIK-KSCFTGRSSEQERL 1088
+ ++ + E LK +G G+FG V + VA+K ++ + F Q
Sbjct: 87 YVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAE 142
Query: 1089 TLEFWREAEILSKL------HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-LSK 1141
E IL L + NV+ + E + + +L ++ +K
Sbjct: 143 ------EIRILEHLRKQDKDNTMNVIHMLENFTFR--NHICMTFELL-SMNLYELIKKNK 193
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
+ A ++ LH I+H DLK +N+L LK R KV DFG S
Sbjct: 194 FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENIL--LKQQGRSGIKVIDFGSSCY 251
Query: 1202 KRNTLVTGGV----RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ + T R APE++ G ++ +D++S G +L E+LTG
Sbjct: 252 EHQRVYTYIQSRFYR------APEVILG--ARYGMPIDMWSLGCILAELLTGY 296
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.0 bits (160), Expect = 7e-11
Identities = 78/647 (12%), Positives = 176/647 (27%), Gaps = 155/647 (23%)
Query: 611 HGDSEAEPTNFSYNGPSAIP----------QRYHSEQIPRE---QTE-KNRLSKSDDSFG 656
H D E + Y + + +P+ + E + + D G
Sbjct: 6 HMDFETGEHQYQYK--DILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSG 63
Query: 657 SQFLISQALSDGSKPIRESVDKLHSGN----MASETEQSVAPAKQQ----------YTNL 702
+ L LS + +++ V+++ N M+ + P+ Y +
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 703 QKVEDGHAQ-LRKHKEFADKINKINSNG--SEDGLQSSLGKSELTQVVPKSAD-----DC 754
Q + L+ + + + ++ DG+ S GK+ + V S D
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS-GKTWVALDVCLSYKVQCKMDF 182
Query: 755 EV--TKIRETVKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNG 812
++ ++ ++ E L + + + I A
Sbjct: 183 KIFWLNLKNCNSPETVL-EMLQKLLY----QIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 813 NDNKGQAQSL-----AQKENSVRAVSPG--------DSSIA-VVSPEGDILIDINDR--- 855
+K L Q + A + + +S I ++
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 856 FPRDFLSDIFTKA------RISENIAGVSPMHGD--GAVLSWNVENHDPRRWSYFRNLAQ 907
D + + K + + +P + W ++++
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIR-----DGLATWDNWKHVNC 352
Query: 908 DEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLK--PDGSVMPQSGSRINFDEGS 965
D+ + S L +E + L P + +P + + +
Sbjct: 353 DKLTTI-----------IESSLNVLEPAEYRKM-FDRLSVFPPSAHIPTILLSLIWFDVI 400
Query: 966 QRESSSIV----GPSTMETHPDYSRSELKG-----NESLQSEVVNHR-IQESDYEEGR-L 1014
+ + +V S +E P S + L++E HR I + Y +
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH-YNIPKTF 459
Query: 1015 DLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIK 1074
D P +D + +G +H +K
Sbjct: 460 DSDDLIPPYLDQYFYSH------------------IG-------HH------------LK 482
Query: 1075 KSCFTGRSSEQERLTLEF-WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGS 1133
R + + L+F + E K+ H + G L T+ +
Sbjct: 483 NIEHPERMTLFRMVFLDFRFLEQ----KIRHD------STAWNASGSILNTLQQLKF--- 529
Query: 1134 LRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK--NIVHFDLKCDN 1178
+ + + +R I+ + SK +++ L ++
Sbjct: 530 YKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAED 576
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 1e-08
Identities = 79/580 (13%), Positives = 163/580 (28%), Gaps = 155/580 (26%)
Query: 10 MDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGGVRPVLNYSI 69
MD + Q +Y ++ + E F + ++ D + +L
Sbjct: 7 MDFETGEHQYQYKDILSVFE------DAFVDNFDCK---DV--QDM-----PKSIL---- 46
Query: 70 QTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSESGSDITMLNA 129
+ EE M + + + V ++ VL I++ M
Sbjct: 47 -SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY-------KFLMSPI 98
Query: 130 AETGRAQELERKGPSGHEDRSYYDSM----RSVPR-----------TSSRNDMGRGTQGY 174
R + + DR Y D+ +V R R G
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 175 ASSG----ASDSSRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKA 230
SG A D K C KI + + + S + + +
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDFKIF---------W-------LNLKNCNSPETVLEML 202
Query: 231 LAIYNQTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFSSADLE 290
+ Q +D + D N+ + ++ R L S E
Sbjct: 203 QKLLYQ------------IDPNWTSRSDHS-SNIKLRIHSIQAE----LRR-LLKSKPYE 244
Query: 291 DTQLSLESMEGDSEIQYVVAVNCMDLGSR----------KNSIALASASENNLDELLGLR 340
+ L L +++ +++ N +L + + ++ A+ + +LD
Sbjct: 245 NCLLVLLNVQ-NAKA-----WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL 298
Query: 341 VEREAGHIAAELAGSGATNLAYNASSSTIQSSQPVLVS-------SGSGYESNLQPYQGQ 393
E + + +L + ++ P +S G N +
Sbjct: 299 TPDEVKSLLLKYLDCRPQDL-----PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD 353
Query: 394 RMQH-ISSTLYPADGLPPLDVKSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPIHGQL 452
++ I S+L + L P + + + + + IP
Sbjct: 354 KLTTIIESSL---NVLEPAE----------YRKMF----DRLSVFPPSA-HIP------- 388
Query: 453 NQQGGLAEEKMYSGFHADDSEACAQEVKQKID--SLADKIKESEKIR--SLDKEASTKEQ 508
+ S D ++ V K+ SL +K + I S+ E K +
Sbjct: 389 --------TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE 440
Query: 509 KIKRDHSLPKINEIDNIRRS-ENDHVVSSHSYVSSVSNYI 547
H I + NI ++ ++D ++ + + Y
Sbjct: 441 NEYALHR--SIVDHYNIPKTFDSDDLIPPY-----LDQYF 473
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 4e-05
Identities = 50/295 (16%), Positives = 88/295 (29%), Gaps = 71/295 (24%)
Query: 907 QDEFSRKDVSLMD-QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFD--E 963
+D F + D QD S L+ E +D+ + D SG+ F
Sbjct: 26 EDAF-VDNFDCKDVQDMP--KSILSKEE----IDHII--MSKD----AVSGTLRLFWTLL 72
Query: 964 GSQRESSSIVGPSTMETH-PDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIP 1022
Q +V E +Y L +++E + Y E R L
Sbjct: 73 SKQ---EEMVQKFVEEVLRINYKF--LM--SPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125
Query: 1023 LVDLALGNFDISTLQIIKNEDLEE-LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGR 1081
+++S LQ L + L EL + G G+ K+
Sbjct: 126 FAK-----YNVSRLQPYLK--LRQALLELRPAKNVLI-DGV-LGSG-------KTWVALD 169
Query: 1082 SSEQERLTLE-----FW------REA----EILSKLHHPNVVAFYGVVQDGPGGTLATVT 1126
++ + FW E+L KL + + + D +
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY-QIDPNWTSRSDHSSNIKLRIH 228
Query: 1127 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIV-HFDLKCDNLL 1180
+ LR LL + + L++ ++ + + F+L C LL
Sbjct: 229 S--IQAELRR-LLKSKPY---ENCLLVLLN-------VQNAKAWNAFNLSCKILL 270
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 43/171 (25%), Positives = 70/171 (40%), Gaps = 39/171 (22%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH- 1104
+++GSG+FG +Y G G +VAIK + + L E++I +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECV--------KTKHPQLH--IESKIYKMMQGG 64
Query: 1105 ---PNVVAF------YGVVQD--GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
P + +V + GP SL + R + L++
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELLGP--------------SLEDLFNFCSRKFSLKTVLLL 110
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
A +EY+HSKN +H D+K DN L+ L + + DFGL+K R+
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRD 160
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 44/169 (26%), Positives = 69/169 (40%), Gaps = 33/169 (19%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH- 1104
K++G G FG + GK + VAIK S +L LE +R + L
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLE-YRFYKQLGSGDGI 67
Query: 1105 PNVVAF------YGVVQD--GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
P V F +V + GP SL + +R + L+IA+
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGP--------------SLEDLFDLCDRTFSLKTVLMIAIQ 113
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP-ICKVGDFGLSKIKRN 1204
MEY+HSKN+++ D+K +N L+ + + DF L+K +
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 7e-10
Identities = 32/170 (18%), Positives = 55/170 (32%), Gaps = 25/170 (14%)
Query: 1048 KELGSGTFGTVYHG-KWRGTDVAIKRIKKSCFTGRSSEQ------------ERLTLEFWR 1094
+G G FG +Y V + + ++ W
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMV----NGSLRHVLLSKERHLDRRKR 1150
L L P G FM+ L+ + + + R+
Sbjct: 101 RTRKLKYLGVPKYWGS------GLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
L +++ +EY+H VH D+K NLL+N K+P + D+GL+
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP--DQVYLVDYGLAY 202
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 51/266 (19%), Positives = 90/266 (33%), Gaps = 75/266 (28%)
Query: 1047 LKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-- 1102
+++LG G F TV+ VA+K + KS + E +L +
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--------DEIRLLKSVRN 92
Query: 1103 ---HHPN---VVAFYGVVQ-DGPGGT-LATVTEFMVNG-SLRHVL-LSKERHLDRRKRLI 1152
+ PN VV + G GT + V E + G L + S + L
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKK 150
Query: 1153 IAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPI------------------------ 1187
I G++YLH+K I+H D+K +N+L+++ +
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 1188 ---------------------RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226
+ K+ D G + T + + E+L G
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIG- 267
Query: 1227 SSKVSEKVDVFSFGIVLWEILTGEEP 1252
S + D++S + +E+ TG+
Sbjct: 268 -SGYNTPADIWSTACMAFELATGDYL 292
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 38/254 (14%), Positives = 73/254 (28%), Gaps = 66/254 (25%)
Query: 978 METHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQ 1037
M H +S G E+L + + ++ LP G L D + + +
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMTTSLEA---------LP-TGTVLTDKSGRQWKL---- 46
Query: 1038 IIKNEDLEELKELGSGTFGTVYHG----------KWRGTDVAIK--RIKKSCFTGRSSEQ 1085
G +Y + ++K F ++ Q
Sbjct: 47 ---------KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ 97
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYG----------VVQDGPGGTLATVTEFMVNG--- 1132
+ + L + G +V G +L + V+
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA--LDVSPKHV 155
Query: 1133 -SLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191
S R VL R LD +E+LH VH ++ +N+ V+ +D +
Sbjct: 156 LSERSVLQVACRLLDA-------------LEFLHENEYVHGNVTAENIFVDPED--QSQV 200
Query: 1192 KVGDFGLSKIKRNT 1205
+ +G + +
Sbjct: 201 TLAGYGFAFRYCPS 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 39/173 (22%), Positives = 63/173 (36%), Gaps = 41/173 (23%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH- 1104
+ +G G+FG ++ G VAIK R S+ +L E L
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEP------RRSDAPQLR----DEYRTYKLLAGC 65
Query: 1105 ---PNVVAFYGVVQD---------GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
PNV ++G GP SL +L R + +
Sbjct: 66 TGIPNVY-YFGQEGLHNVLVIDLLGP--------------SLEDLLDLCGRKFSVKTVAM 110
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP-ICKVGDFGLSKIKRN 1204
A ++ +H K++V+ D+K DN L+ + + V DFG+ K R+
Sbjct: 111 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 5e-09
Identities = 57/233 (24%), Positives = 91/233 (39%), Gaps = 39/233 (16%)
Query: 1036 LQIIKNEDL----EELKELGSGTFGTVYHGKWRGTD--VAIKRIK-KSCFTGRSSEQERL 1088
+ E E +G G+FG V R VAIK IK K F ++ E
Sbjct: 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-NQAQIEVR 102
Query: 1089 TLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER----- 1143
LE + + K + +V L V E + + +L +L +
Sbjct: 103 LLELMNKHDTEMKYY---IVHLKRHFMFR--NHLCLVFEML-SYNLYDLL--RNTNFRGV 154
Query: 1144 HLDRRKRLIIAMDAAFGMEYLHSK--NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
L+ ++ A + +L + +I+H DLK +N+L L +P R K+ DFG S
Sbjct: 155 SLNLTRK--FAQQMCTALLFLATPELSIIHCDLKPENIL--LCNPKRSAIKIVDFGSSCQ 210
Query: 1202 KRNTLVTGGV----RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 1250
+ R +PE+L G +D++S G +L E+ TGE
Sbjct: 211 LGQRIYQYIQSRFYR------SPEVLLGM--PYDLAIDMWSLGCILVEMHTGE 255
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 7e-09
Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-H 1104
+++GSG+FG +Y G +VAIK + + L E++I L
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENV--------KTKHPQLL--YESKIYRILQGG 62
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
+ +G L V + + G SL + R L + L++A +E+
Sbjct: 63 TGIPNVRWFGVEGDYNVL--VMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205
+HSK+ +H D+K DN L+ L + + DFGL+K R+T
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKKYRDT 159
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 39/170 (22%), Positives = 61/170 (35%), Gaps = 28/170 (16%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEF------------- 1092
K++GSG FG +Y + A +K E L E
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKV-----EYQENGPLFSELKFYQRVAKKDCIK 97
Query: 1093 -WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKR 1150
W E + L L P G+ + V E + G L+ + + +
Sbjct: 98 KWIERKQLDYLGIPLFY-GSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTV 153
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
L + + +EY+H VH D+K NLL+ K+P + D+GLS
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP--DQVYLADYGLSY 201
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 56/260 (21%), Positives = 88/260 (33%), Gaps = 77/260 (29%)
Query: 1036 LQIIKNEDLEE----LKELGSGTFGTV---YHGKWRGTDVAIKRIK-KSCFTGRSSEQER 1087
L + L + LG G FG V K G VA+K +K + E R
Sbjct: 4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC----EAAR 59
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT---------VTEFMVNGSLRHVL 1138
E ++L L+ + + + VQ L V E ++ S +
Sbjct: 60 S------EIQVLEHLNTTDPNSTFRCVQ-----MLEWFEHHGHICIVFE-LLGLSTYDFI 107
Query: 1139 ---------LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN------- 1182
L R + ++ +++ +LHS + H DLK +N+L
Sbjct: 108 KENGFLPFRLDHIRKM--AYQICKSVN------FLHSNKLTHTDLKPENILFVQSDYTEA 159
Query: 1183 --------LKDPIRPICKVGDFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKV 1230
+ I P KV DFG + + T R APE++
Sbjct: 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR------APEVILA--LGW 211
Query: 1231 SEKVDVFSFGIVLWEILTGE 1250
S+ DV+S G +L E G
Sbjct: 212 SQPCDVWSIGCILIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 54/260 (20%), Positives = 85/260 (32%), Gaps = 77/260 (29%)
Query: 1036 LQIIKNEDLEE----LKELGSGTFGTVY----HGKWRGTDVAIKRIK-KSCFTGRSSEQE 1086
L + L+E + LG GTFG V H + + VA+K I+ + E
Sbjct: 9 LVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHAR-GKSQVALKIIRNVGKYR----EAA 63
Query: 1087 RLTLEFWREAEILSKL--------HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 1138
RL E +L K+ V G + E ++ + L
Sbjct: 64 RL------EINVLKKIKEKDKENKFL--CVLMSDWFNFH--GHMCIAFE-LLGKNTFEFL 112
Query: 1139 ---------LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN------- 1182
L RH+ +L A+ +LH + H DLK +N+L
Sbjct: 113 KENNFQPYPLPHVRHM--AYQLCHALR------FLHENQLTHTDLKPENILFVNSEFETL 164
Query: 1183 --------LKDPIRPICKVGDFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKV 1230
K +V DFG + + T R PE++
Sbjct: 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR------PPEVILE--LGW 216
Query: 1231 SEKVDVFSFGIVLWEILTGE 1250
++ DV+S G +L+E G
Sbjct: 217 AQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 48/262 (18%), Positives = 92/262 (35%), Gaps = 77/262 (29%)
Query: 1036 LQIIKNEDLEE----LKELGSGTFGTVY--HGKWRGTDVAIKRIK-KSCFTGRSSEQERL 1088
K L ++++G GTFG V A+K ++ +T ++
Sbjct: 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT----RSAKI 80
Query: 1089 TLEFWREAEILSKL-----HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL----- 1138
EA+IL K+ ++ N+V ++G + + E + SL ++
Sbjct: 81 ------EADILKKIQNDDINNNNIVKYHGKFMY--YDHMCLIFE-PLGPSLYEIITRNNY 131
Query: 1139 ----LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN------------ 1182
+ + ++ A++ YL ++ H DLK +N+L++
Sbjct: 132 NGFHIEDIKLYCI--EILKALN------YLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183
Query: 1183 ---------LKDPIRPICKVGDFGLSKIKRNTLVTGGV-----RGTLPWMAPELLNGSSS 1228
+ K+ DFG ++ + R APE++
Sbjct: 184 RVTDGKKIQIYRTKSTGIKLIDFG-CATFKSDYHGSIINTRQYR------APEVILN--L 234
Query: 1229 KVSEKVDVFSFGIVLWEILTGE 1250
D++SFG VL E+ TG
Sbjct: 235 GWDVSSDMWSFGCVLAELYTGS 256
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1329 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-74 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-69 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-67 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-67 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-66 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-63 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-62 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-58 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-58 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-57 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-56 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-56 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-53 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-50 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-49 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-46 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-45 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-18 | |
| d1ip9a_ | 85 | d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker' | 2e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (627), Expect = 5e-74
Identities = 90/283 (31%), Positives = 145/283 (51%), Gaps = 22/283 (7%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I + + + +GSG+FGTVY GKW G DVA+K + + T + + F E +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQ------AFKNEVGV 57
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L K H N++ F G LA VT++ SL H L E + K + IA A
Sbjct: 58 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---RNTLVTGGVRGTL 1215
GM+YLH+K+I+H DLK +N+ ++ + K+GDFGL+ +K + + G++
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTV----KIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 1216 PWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP- 1273
WMAPE++ + S + DV++FGIVL+E++TG+ PY+N++ I +V P
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 1274 ---VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313
V C + LM +C RP F +I + +++ +
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 5e-69
Identities = 94/272 (34%), Positives = 137/272 (50%), Gaps = 22/272 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ ++L+ L+ +G G FG V G +RG VA+K IK + + F EA +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQA----FLAEASV 53
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDA 1157
+++L H N+V GV+ + GG L VTE+M GSL L S+ R L L ++D
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
MEYL N VH DL N+LV+ + + KV DFGL+K +T TG + + W
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASSTQDTG--KLPVKW 166
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 1276
APE L K S K DV+SFGI+LWEI + G PY + ++ + + P
Sbjct: 167 TAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPD 223
Query: 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
C +M+ CW D +RPSF ++ +L
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 1e-67
Identities = 92/274 (33%), Positives = 128/274 (46%), Gaps = 22/274 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I +DL LKELG+G FG V +GKWR DVAIK IK+ S E EF EA+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------SMSED---EFIEEAK 51
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
++ L H +V YGV + +TE+M NG L + L ++ L + D
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGTL 1215
MEYL SK +H DL N LVN + + KV DFGLS+ + G + +
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 1274
W PE+L S K S K D+++FG+++WEI + G+ PY I LR
Sbjct: 166 RWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 222
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
P + +M CW RP+F + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 4e-67
Identities = 88/281 (31%), Positives = 127/281 (45%), Gaps = 24/281 (8%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEF 1092
+I +DL L++LG G+FG V G+W VA+K +K + + +F
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-----DF 58
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
RE + L H N++ YGVV P + VTE GSL L + H
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 115
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVT 1208
A+ A GM YL SK +H DL NLL+ +D + K+GDFGL + + ++
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV----KIGDFGLMRALPQNDDHYVMQ 171
Query: 1209 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267
+ W APE L S D + FG+ LWE+ T G+EP+ ++ I+ I
Sbjct: 172 EHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
Query: 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
R P P C + +M QCWA P RP+F + L
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 226 bits (577), Expect = 6e-67
Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 22/279 (7%)
Query: 1032 DISTLQIIKNEDLEE----LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQ 1085
D ++ +D E+ L+E+G G+FG VY + VAIK++ S Q
Sbjct: 1 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 1145
+ +E L KL HPN + + G T V E+ + + + + K + L
Sbjct: 61 D-----IIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHK-KPL 112
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205
+ + A G+ YLHS N++H D+K N+L++ + K+GDFG + I
Sbjct: 113 QEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMAPA 168
Query: 1206 LVTGGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1264
GT WMAPE++ + KVDV+S GI E+ + P NM+ + +
Sbjct: 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
Query: 1265 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
I N G +R ++ C P RP+ +
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 2e-66
Identities = 77/263 (29%), Positives = 123/263 (46%), Gaps = 21/263 (7%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
E+G G+F TVY G T VA ++ T ++ F EAE+L L HP
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR------FKEEAEMLKGLQHP 68
Query: 1106 NVVAFYGVVQDGP--GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
N+V FY + + VTE M +G+L+ L + + + + G+++
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 1164 LHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 1221
LH++ I+H DLKCDN+ + K+GD GL+ +KR + V GT +MAPE
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASF-AKAVIGTPEFMAPE 183
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP-VPGFCDS 1280
+ K E VDV++FG+ + E+ T E PY+ A I V + ++P
Sbjct: 184 MYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 1281 EWRLLMEQCWAPDPVVRPSFTEI 1303
E + ++E C + R S ++
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 5e-66
Identities = 92/294 (31%), Positives = 131/294 (44%), Gaps = 27/294 (9%)
Query: 1038 IIKNEDLEELK-ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEF 1092
+K ++L ELG G FG+V G +R DVAIK +K+ ++ T E
Sbjct: 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-------TEKADTEEM 56
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
REA+I+ +L +P +V GV Q L V E G L L+ K +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 113
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVT 1208
+ + GM+YL KN VH DL N+L+ R K+ DFGLSK
Sbjct: 114 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVN----RHYAKISDFGLSKALGADDSYYTAR 169
Query: 1209 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267
+ L W APE +N K S + DV+S+G+ +WE L+ G++PY M ++ I
Sbjct: 170 SAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
Query: 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGH 1321
R P C E LM CW RP F + +R+R + +K GH
Sbjct: 228 G-KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 5e-66
Identities = 82/273 (30%), Positives = 124/273 (45%), Gaps = 22/273 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+ E L+ ++ LG+G FG V+ G + T VA+K +K+ + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEAN 60
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAMD 1156
++ +L H +V Y VV P + +TE+M NGSL L + L K L +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGT 1214
A GM ++ +N +H DL+ N+LV+ CK+ DFGL+++ G +
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274
+ W APE +N + K DV+SFGI+L EI+T + + R
Sbjct: 174 IKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P C E LM CW P RP+F + L
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 3e-65
Identities = 77/274 (28%), Positives = 127/274 (46%), Gaps = 20/274 (7%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+I +L ++E+GSG FG V+ G W VAIK I++ + +F EA
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---------DFIEEA 51
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
E++ KL HP +V YGV + + V EFM +G L L ++ L + +D
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQ--APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGT 1214
GM YL ++H DL N LV + KV DFG+++ + G +
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 165
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274
+ W +PE+ + S + S K DV+SFG+++WE+ + + + + ++ R
Sbjct: 166 VKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
P + +M CW P RP+F+ + R+L
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 6e-65
Identities = 65/273 (23%), Positives = 114/273 (41%), Gaps = 24/273 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E L +G+G++G + + + K + T + E +L
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM------LVSEVNLL 57
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRKRLIIAMD 1156
+L HPN+V +Y + D TL V E+ G L V+ + +LD L +
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 1157 AAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGG 1210
++ H ++ ++H DLK N+ ++ K + K+GDFGL++ + +T
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV----KLGDFGLARILNHDTSFAKA 173
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1270
GT +M+PE +N +EK D++S G +L+E+ P+ + G I
Sbjct: 174 FVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK- 230
Query: 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+P E ++ + RPS EI
Sbjct: 231 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 4e-64
Identities = 73/264 (27%), Positives = 121/264 (45%), Gaps = 19/264 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E + LG G FG VY + + + +A+K + K+ E+ + + RE EI
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-----QLEKAGVEHQLRREVEIQ 60
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
S L HPN++ YG D + + E+ G++ L K D ++ + A
Sbjct: 61 SHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYR-ELQKLSKFDEQRTATYITELAN 117
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
+ Y HSK ++H D+K +NLL+ + K+ DFG S ++ + GTL ++
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAGEL----KIADFGWSVHAPSSR-RTTLCGTLDYLP 172
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279
PE++ G EKVD++S G++ +E L G+ P+ Y I + P F
Sbjct: 173 PEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVT 228
Query: 1280 SEWRLLMEQCWAPDPVVRPSFTEI 1303
R L+ + +P RP E+
Sbjct: 229 EGARDLISRLLKHNPSQRPMLREV 252
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 5e-64
Identities = 74/278 (26%), Positives = 121/278 (43%), Gaps = 25/278 (8%)
Query: 1037 QIIKNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTL 1090
+ ++ + E+ + ELG G FG VY + + T A K I SE+E
Sbjct: 3 HVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK------SEEELE-- 54
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
++ E +IL+ HPN+V L + EF G++ V+L ER L +
Sbjct: 55 DYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQI 112
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTG 1209
++ + YLH I+H DLK N+L L I K+ DFG+S R
Sbjct: 113 QVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDI----KLADFGVSAKNTRTIQRRD 168
Query: 1210 GVRGTLPWMAPELLNGSSSK---VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1266
GT WMAPE++ +SK K DV+S GI L E+ E P+ ++ ++ I
Sbjct: 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228
Query: 1267 NN-TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ P S ++ +++C + R + +++
Sbjct: 229 KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-63
Identities = 84/274 (30%), Positives = 122/274 (44%), Gaps = 27/274 (9%)
Query: 1044 LEELKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
LE+ KELGSG FGTV G ++ VA+K +K + L E EA ++
Sbjct: 10 LED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE------ANDPALKDELLAEANVM 62
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+L +P +V G+ + V E G L L + RH+ + + + +
Sbjct: 63 QQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNK-YLQQNRHVKDKNIIELVHQVSM 118
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVTGGVRGTL 1215
GM+YL N VH DL N+L+ + K+ DFGLSK + + +
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 1274
W APE +N K S K DV+SFG+++WE + G++PY M + + R
Sbjct: 175 KWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGC 231
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
P C E LM CW D RP F + RLR
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 8e-63
Identities = 79/287 (27%), Positives = 133/287 (46%), Gaps = 27/287 (9%)
Query: 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQER 1087
+ L+I+K + +++K LGSG FGTVY G W VAIK ++++ +
Sbjct: 1 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-------TSPK 53
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR 1147
E EA +++ + +P+V G+ T+ +T+ M G L + + ++
Sbjct: 54 ANKEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGS 110
Query: 1148 RKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRN 1204
+ L + A GM YL + +VH DL N+LV K+ DFGL+K+ +
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEK 166
Query: 1205 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIG 1263
G + + WMA E + + + DV+S+G+ +WE++T G +PY + I
Sbjct: 167 EYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 224
Query: 1264 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
I+ R P P C + ++M +CW D RP F E+ M
Sbjct: 225 -ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 4e-62
Identities = 89/306 (29%), Positives = 129/306 (42%), Gaps = 49/306 (16%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
E+LE K LGSG FG V + G VA+K +K+ ++ ER
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-----KADSSERE--A 86
Query: 1092 FWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH------ 1144
E +++++L H N+V G G + + E+ G L + L SK
Sbjct: 87 LMSELKMMTQLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 1145 ----------------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188
L L A A GME+L K+ VH DL N+LV
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK--- 201
Query: 1189 PICKVGDFGLSKI---KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWE 1245
+ K+ DFGL++ N +V G R + WMAPE L + K DV+S+GI+LWE
Sbjct: 202 -VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWE 258
Query: 1246 ILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIA 1304
I + G PY + A ++ N + P + E ++M+ CWA D RPSF +
Sbjct: 259 IFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 1305 RRLRVM 1310
L
Sbjct: 319 SFLGCQ 324
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 6e-62
Identities = 86/278 (30%), Positives = 132/278 (47%), Gaps = 25/278 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFW 1093
I+ E +E + +G G FG V+ G + + VAIK K + + +F
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-------TSDSVREKFL 56
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
+EA + + HP++V GV+ + P + + E G LR L ++ LD ++
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 1211
A + + YL SK VH D+ N+LV+ D K+GDFGLS+
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 169
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1270
+ + WMAPE +N + + DV+ FG+ +WEIL G +P+ + +IG I N
Sbjct: 170 KLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 226
Query: 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
R P+P C LM +CWA DP RP FTE+ +L
Sbjct: 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 7e-61
Identities = 89/280 (31%), Positives = 133/280 (47%), Gaps = 25/280 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEF 1092
I + K +G+G FG VY G + + VAIK +K +E++R+ +F
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-----YTEKQRV--DF 56
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
EA I+ + H N++ GV+ + +TE+M NG+L L K+ + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMI--ITEYMENGALDKFLREKDGEFSVLQLVG 114
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVT 1208
+ A GM+YL + N VH DL N+LVN +CKV DFGLS++ T T
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNL----VCKVSDFGLSRVLEDDPEATYTT 170
Query: 1209 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1268
G + + W APE ++ K + DV+SFGIV+WE++T E + +N+
Sbjct: 171 SGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
R P P C S LM QCW + RP F +I L
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 7e-61
Identities = 87/273 (31%), Positives = 123/273 (45%), Gaps = 22/273 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-VAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L +LG G FG V+ G W GT VAIK +K + F +EA+
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------AFLQEAQ 64
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLDRRKRLIIAMD 1156
++ KL H +V Y VV + P + VTE+M GSL + ++L + + +A
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGT 1214
A GM Y+ N VH DL+ N+LV +CKV DFGL+++ G +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274
+ W APE + + K DV+SFGI+L E+ T + V R P
Sbjct: 178 IKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
P C LM QCW +P RP+F + L
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (527), Expect = 1e-60
Identities = 86/277 (31%), Positives = 124/277 (44%), Gaps = 22/277 (7%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
++ D+ +LG G +G VY G W+ VA+K +K+ EF +EA
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------EFLKEA 64
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAM 1155
++ ++ HPN+V GV P +TEFM G+L L R + L +A
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN--TLVTGGVRG 1213
+ MEYL KN +H DL N LV + KV DFGLS++ G +
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273
+ W APE L + K S K DV++FG++LWEI T + + ++ R
Sbjct: 179 PIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
P C + LM CW +P RPSF EI + M
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (525), Expect = 4e-60
Identities = 95/296 (32%), Positives = 135/296 (45%), Gaps = 32/296 (10%)
Query: 1027 ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGR 1081
A+ F + I ++ + +G+G FG V G + VAIK +K
Sbjct: 15 AVREFA----KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----- 65
Query: 1082 SSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK 1141
+E++R +F EA I+ + HPNV+ GVV + +TEFM NGSL L
Sbjct: 66 YTEKQRR--DFLSEASIMGQFDHPNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQN 121
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
+ + + + A GM+YL N VH DL N+LVN +CKV DFGLS+
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL----VCKVSDFGLSRF 177
Query: 1202 ------KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYA 1254
G + + W APE + K + DV+S+GIV+WE+++ GE PY
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYW 235
Query: 1255 NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
+M +I I + R P P C S LM CW D RP F +I L M
Sbjct: 236 DMTNQDVINAIEQD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 2e-59
Identities = 92/298 (30%), Positives = 132/298 (44%), Gaps = 37/298 (12%)
Query: 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWRGT----DVAIKRIKKSCFTGRSSEQERLT 1089
+ ++ D++ +G G FG V + + D AIKR+K+ S + R
Sbjct: 2 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHR-- 55
Query: 1090 LEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------- 1139
+F E E+L KL HHPN++ G + G L E+ +G+L L
Sbjct: 56 -DFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 112
Query: 1140 ------SKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193
S L ++ L A D A GM+YL K +H DL N+LV + K+
Sbjct: 113 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKI 168
Query: 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEP 1252
DFGLS+ + + R + WMA E LN S + DV+S+G++LWEI++ G P
Sbjct: 169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTP 226
Query: 1253 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
Y M + + R P CD E LM QCW P RPSF +I L M
Sbjct: 227 YCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-59
Identities = 71/310 (22%), Positives = 125/310 (40%), Gaps = 62/310 (20%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+K++D E++ ELG+G G V+ + + +A K I + + + RE
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-------IKPAIRNQIIREL 55
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++L + + P +V FYG G ++ E M GSL +L K + + +++
Sbjct: 56 QVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIA 112
Query: 1157 AAFGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
G+ YL K+ I+H D+K N+LVN + I K+ DFG+S +++ V GT
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEI----KLCDFGVSGQLIDSMANSFV-GTR 167
Query: 1216 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY---------------------- 1253
+M+PE L G+ S + D++S G+ L E+ G P
Sbjct: 168 SYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 1254 --------------------ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPD 1293
M ++ IVN G E++ + +C +
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 1294 PVVRPSFTEI 1303
P R ++
Sbjct: 286 PAERADLKQL 295
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 3e-59
Identities = 69/267 (25%), Positives = 118/267 (44%), Gaps = 22/267 (8%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ +++G G GTVY G +VAI+++ + ++E E +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKEL----IINEILV 70
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ + +PN+V + G L V E++ GSL V+ E +D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECL 126
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPW 1217
+E+LHS ++H D+K DN+L+ + + K+ DFG I + GT W
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPG 1276
MAPE++ KVD++S GI+ E++ GE PY N + + I N T P
Sbjct: 183 MAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240
Query: 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ +R + +C D R S E+
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (518), Expect = 3e-59
Identities = 88/315 (27%), Positives = 140/315 (44%), Gaps = 51/315 (16%)
Query: 1030 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRS 1082
N + +L+ +N ++E ++++G G FG V+ + T VA+K +K+ S
Sbjct: 2 NPKLLSLEYPRN-NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----AS 56
Query: 1083 SEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE 1142
++ + +F REA ++++ +PN+V GV G + + E+M G L L S
Sbjct: 57 ADMQA---DFQREAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMS 111
Query: 1143 RH-----------------------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 1179
H L ++L IA A GM YL + VH DL N
Sbjct: 112 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171
Query: 1180 LVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDV 1236
LV + K+ DFGLS+ G + WM PE + ++ + + DV
Sbjct: 172 LVGENM----VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDV 225
Query: 1237 FSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPV 1295
+++G+VLWEI + G +PY M + +I + + P C E LM CW+ P
Sbjct: 226 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPA 284
Query: 1296 VRPSFTEIARRLRVM 1310
RPSF I R L+ M
Sbjct: 285 DRPSFCSIHRILQRM 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-58
Identities = 83/295 (28%), Positives = 119/295 (40%), Gaps = 38/295 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLE 1091
L K LG+G FG V VA+K +K S + ER
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTERE--A 72
Query: 1092 FWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK--------- 1141
E ++LS L +H N+V G G G +TE+ G L + L K
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 1142 --------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193
E LD L + A GM +L SKN +H DL N+L+ I IC
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDF 189
Query: 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP- 1252
G K N +V G R + WMAPE + + + DV+S+GI LWE+ +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSP 247
Query: 1253 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 1307
Y M + ++ R P +E +M+ CW DP+ RP+F +I + +
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 203 bits (518), Expect = 2e-58
Identities = 53/267 (19%), Positives = 110/267 (41%), Gaps = 18/267 (6%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ + L+ELGSG FG V+ + T K I ++ E I
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYT----VKNEISI 79
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+++LHHP ++ + +D + + EF+ G L + +++ + + + A
Sbjct: 80 MNQLHHPKLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
G++++H +IVH D+K +N++ K K+ DFGL+ + T +
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGLATKLNPDEIVKVTTATAEFA 195
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF- 1277
APE+++ V D+++ G++ + +L+G P+A + + F
Sbjct: 196 APEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 1278 -CDSEWRLLMEQCWAPDPVVRPSFTEI 1303
E + ++ +P R + +
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 3e-58
Identities = 78/274 (28%), Positives = 129/274 (47%), Gaps = 26/274 (9%)
Query: 1048 KELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ +G G FG VYHG D A+K + + G S+ F E I+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-------FLTEGIIMKDF 85
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HPNV++ G+ G + V +M +G LR+ + ++ + + + + A GM+
Sbjct: 86 SHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN-----TLVTGGVRGTLPW 1217
+L SK VH DL N +++ + KV DFGL++ + G + + W
Sbjct: 145 FLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 1276
MA E L K + K DV+SFG++LWE++T G PY +++ I ++ R P
Sbjct: 201 MALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPE 257
Query: 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310
+C +M +CW P +RPSF+E+ R+ +
Sbjct: 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 202 bits (515), Expect = 3e-58
Identities = 57/266 (21%), Positives = 106/266 (39%), Gaps = 18/266 (6%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ + +ELG+G FG V+ R T A K + S++E +E + +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKET----VRKEIQTM 77
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
S L HP +V + +D + + EFM G L + + + + +
Sbjct: 78 SVLRHPTLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 135
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
G+ ++H N VH DLK +N++ K K+ DFGL+ GT + A
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRSNE--LKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF-- 1277
PE+ G V D++S G++ + +L+G P+ + + + + F
Sbjct: 194 PEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ + + + DP R + +
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 4e-58
Identities = 72/268 (26%), Positives = 110/268 (41%), Gaps = 21/268 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED + ++ LG G +G V R T+ VA+K + R+ + +E I
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----RAVDCPE---NIKKEICIN 57
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
L+H NVV FYG + G E+ G L + + +
Sbjct: 58 KMLNHENVVKFYGHRR--EGNIQYLFLEYCSGGELFD-RIEPDIGMPEPDAQRFFHQLMA 114
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR---NTLVTGGVRGTLP 1216
G+ YLH I H D+K +NLL++ +D + K+ DFGL+ + R + + GTLP
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNL----KISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE-EPYANMHYGAIIGGIVNNTLRPPVP 1275
++APELL +E VDV+S GIVL +L GE
Sbjct: 171 YVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229
Query: 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
DS L+ + +P R + +I
Sbjct: 230 KKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 4e-57
Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 21/272 (7%)
Query: 1040 KNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW 1093
+ ED+ + LG+G F V + + T VAIK I K G+
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS-------ME 55
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
E +L K+ HPN+VA + + G G L + + + G L + ++ R +
Sbjct: 56 NEIAVLHKIKHPNIVALDDIYESG--GHLYLIMQLVSGGELFD-RIVEKGFYTERDASRL 112
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
++YLH IVH DLK +NLL D I + DFGLSK++ V G
Sbjct: 113 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI-MISDFGLSKMEDPGSVLSTACG 171
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273
T ++APE+L S+ VD +S G++ + +L G P+ + + + I+
Sbjct: 172 TPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 229
Query: 1274 VPGF--CDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P + + + DP R + +
Sbjct: 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 5e-57
Identities = 70/278 (25%), Positives = 116/278 (41%), Gaps = 21/278 (7%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ ED + K LG G+F TV + T AIK ++K R +E RE
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK-----RHIIKENKVPYVTRER 59
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
+++S+L HP V Y QD L + NG L + K D +
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLK-YIRKIGSFDETCTRFYTAE 116
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRG 1213
+EYLH K I+H DLK +N+L+N I ++ DFG +K+ + G
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHI----QITDFGTAKVLSPESKQARANSFVG 172
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273
T +++PELL + D+++ G ++++++ G P+ + I I+ L
Sbjct: 173 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYD 228
Query: 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311
P + R L+E+ D R E+ + +
Sbjct: 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 196 bits (498), Expect = 9e-57
Identities = 65/272 (23%), Positives = 116/272 (42%), Gaps = 17/272 (6%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ-ERLTLEFWREAEI 1098
E+ E + LG G V + T A+K I + S+E+ + L +E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 1099 LSKLH-HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
L K+ HPN++ + V + M G L L+++ L ++ I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFD-YLTEKVTLSEKETRKIMRAL 119
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
+ LH NIVH DLK +N+L++ I K+ DFG S V GT +
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNI----KLTDFGFSCQLDPGEKLREVCGTPSY 175
Query: 1218 MAPELLNGS----SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273
+APE++ S ++VD++S G++++ +L G P+ + ++ I++ +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235
Query: 1274 VPGFCD--SEWRLLMEQCWAPDPVVRPSFTEI 1303
P + D + L+ + P R + E
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-56
Identities = 51/266 (19%), Positives = 105/266 (39%), Gaps = 19/266 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E ++LG G FG V+ + K +K + ++Q +E IL
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVL----VKKEISIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ H N++ + + L + EF+ + + + L+ R+ +
Sbjct: 56 NIARHRNILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
+++LHS NI HFD++ +N++ + K+ +FG ++ + + + A
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRR--SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF-- 1277
PE+ VS D++S G +++ +L+G P+ II I+N F
Sbjct: 172 PEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEI 1303
E +++ + R + +E
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-56
Identities = 66/274 (24%), Positives = 121/274 (44%), Gaps = 15/274 (5%)
Query: 1038 IIKNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLE 1091
+ + E++++ +ELGSG F V + + T A K IKK SS + +
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTK--SSRRGVSRED 59
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
RE IL ++ HPNV+ + V ++ + + E + G L L KE +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211
+ G+ YLHS I HFDLK +N+++ ++ +P K+ DFGL+ +
Sbjct: 118 FLKQ-ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI--VNNT 1269
GT ++APE++N + + D++S G++ + +L+G P+ + + VN
Sbjct: 177 FGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ + + + DP R + +
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-56
Identities = 71/309 (22%), Positives = 120/309 (38%), Gaps = 54/309 (17%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
+ + +G G FG V+ GKWRG +VA+K +E + E
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS---------REERSWFREAEIYQTVM 53
Query: 1102 LHHPNVVAFYGVVQ--DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
L H N++ F +G L V+++ +GSL L + + +A+ A
Sbjct: 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTAS 111
Query: 1160 GMEYLHS--------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN-----TL 1206
G+ +LH I H DLK N+LV C + D GL+ + +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCIADLGLAVRHDSATDTIDI 167
Query: 1207 VTGGVRGTLPWMAPELLNGSSS----KVSEKVDVFSFGIVLWEILTG----------EEP 1252
GT +MAPE+L+ S + + ++ D+++ G+V WEI + P
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 1253 YANMHYG-----AIIGGIVNNTLRPPVPGFCDS-----EWRLLMEQCWAPDPVVRPSFTE 1302
Y ++ + + LRP +P S +M +CW + R +
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
Query: 1303 IARRLRVMS 1311
I + L +S
Sbjct: 288 IKKTLSQLS 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 192 bits (488), Expect = 2e-55
Identities = 62/275 (22%), Positives = 119/275 (43%), Gaps = 15/275 (5%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
++ E + LG G V+ + DVA+K ++ + L F REA+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-----LARDPSFYLRFRREAQN 60
Query: 1099 LSKLHHPNVVAFYGVVQD--GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
+ L+HP +VA Y + G V E++ +LR ++ E + ++ + + D
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIAD 119
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A + + H I+H D+K N++++ + ++ + ++ + T V GT
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--V 1274
+++PE G V + DV+S G VL+E+LTGE P+ ++ V PP
Sbjct: 180 YLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 1275 PGFCDSEWRLLMEQCWAPDPVVRP-SFTEIARRLR 1308
++ ++ + A +P R + E+ L
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-55
Identities = 81/300 (27%), Positives = 123/300 (41%), Gaps = 39/300 (13%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLT 1089
+ + L K LG G FG V + G D VA+K +K ++E++
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDLS- 63
Query: 1090 LEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---------- 1138
+ E E++ + H N++ G G L + E+ G+LR L
Sbjct: 64 -DLISEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 1139 -----LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193
+ E L + + A A GMEYL SK +H DL N+LV +D + I
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADF 179
Query: 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEP 1252
G T R + WMAPE L + + DV+SFG++LWEI T G P
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 1253 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312
Y + + ++ R P C +E ++M CW P RP+F ++ L + A
Sbjct: 238 YPGVPVEELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-53
Identities = 85/297 (28%), Positives = 124/297 (41%), Gaps = 41/297 (13%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
+ L+ K LG G FG V G D VA+K +K+ G + + R
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHR---A 62
Query: 1092 FWREAEILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH------ 1144
E +IL HH NVV G PGG L + EF G+L L SK
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 121
Query: 1145 ---------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
L + + A GME+L S+ +H DL N+L++ K+ + K+ D
Sbjct: 122 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN----VVKICD 177
Query: 1196 FGLSKI---KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEE- 1251
FGL++ + + G R L WMAPE + + + DV+SFG++LWEI +
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGAS 235
Query: 1252 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
PY + + R P + E M CW +P RP+F+E+ L
Sbjct: 236 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-53
Identities = 81/287 (28%), Positives = 121/287 (42%), Gaps = 30/287 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
+ E + +ELG G+FG VY G +G VAIK + ++ +S +ER+ E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-----ASMRERI--E 69
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---------LSKE 1142
F EA ++ + + +VV GVV G + E M G L+ L
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 1143 RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202
K + +A + A GM YL++ VH DL N +V ++ I G
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK-IGDFGMTRDIYET 186
Query: 1203 RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEE-PYANMHYGAI 1261
G + WM+PE L + DV+SFG+VLWEI T E PY + +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244
Query: 1262 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
+ ++ P C LM CW +P +RPSF EI ++
Sbjct: 245 LRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-53
Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 20/269 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED K LG G+FG V+ +++ T+ AIK +KK + E +L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC-----TMVEKRVL 56
Query: 1100 SK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
S HP + + Q L V E++ G L + + D + A +
Sbjct: 57 SLAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMY-HIQSCHKFDLSRATFYAAEII 113
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPW 1217
G+++LHSK IV+ DLK DN+L++ K+ DFG+ K T GT +
Sbjct: 114 LGLQFLHSKGIVYRDLKLDNILLDKDGH----IKIADFGMCKENMLGDAKTNTFCGTPDY 169
Query: 1218 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277
+APE+L G K + VD +SFG++L+E+L G+ P+ + I + P P +
Sbjct: 170 IAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRW 225
Query: 1278 CDSEWRLLMEQCWAPDPVVRPSFTEIARR 1306
+ E + L+ + + +P R R+
Sbjct: 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-50
Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 32/284 (11%)
Query: 1036 LQIIKN---EDLEELKE-LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLT 1089
LQI KN +D + + LG G G V + T A+K ++
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------- 48
Query: 1090 LEFWREAEILSKL-HHPNVVAFYGVVQDG--PGGTLATVTEFMVNGSLRHVLLSK-ERHL 1145
+ RE E+ + P++V V ++ L V E + G L + + ++
Sbjct: 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205
R+ I ++YLHS NI H D+K +NLL K P I K+ DFG +K +
Sbjct: 109 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP-NAILKLTDFGFAKETTSH 167
Query: 1206 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1265
T ++APE+L K + D++S G++++ +L G P+ + H AI G+
Sbjct: 168 NSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 225
Query: 1266 VNN------TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P E ++L+ +P R + TE
Sbjct: 226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-50
Identities = 59/261 (22%), Positives = 103/261 (39%), Gaps = 21/261 (8%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH- 1103
LGSG FG+VY G + VAIK ++K + E +L K+
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT--RVPMEVVLLKKVSS 66
Query: 1104 -HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
V+ + + + E +++ L +
Sbjct: 67 GFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPEL 1222
+ H+ ++H D+K +N+L++L R K+ DFG + ++T+ T GT + PE
Sbjct: 125 HCHNCGVLHRDIKDENILIDLN---RGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 180
Query: 1223 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 1282
+ V+S GI+L++++ G+ P+ + II G + SE
Sbjct: 181 IRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRG------QVFFRQRVSSEC 231
Query: 1283 RLLMEQCWAPDPVVRPSFTEI 1303
+ L+ C A P RP+F EI
Sbjct: 232 QHLIRWCLALRPSDRPTFEEI 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 176 bits (448), Expect = 4e-49
Identities = 59/261 (22%), Positives = 98/261 (37%), Gaps = 14/261 (5%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D + +G G FG VY + G A+K + K + + E L L ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI--KMKQGETLALNERIMLSLV 61
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
S P +V L+ + + M G L + L + R A
Sbjct: 62 STGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-IIL 118
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
G+E++H++ +V+ DLK N+L++ + ++ D GL+ GT +MA
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHV----RISDLGLACDFSKKK-PHASVGTHGYMA 173
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPGFC 1278
PE+L D FS G +L+++L G P+ T+ +P
Sbjct: 174 PEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 1279 DSEWRLLMEQCWAPDPVVRPS 1299
E R L+E D R
Sbjct: 233 SPELRSLLEGLLQRDVNRRLG 253
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 175 bits (444), Expect = 4e-49
Identities = 67/260 (25%), Positives = 126/260 (48%), Gaps = 20/260 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D + L+ LG+G+FG V+ + R G A+K +KK + E +L
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH-----TNDERLML 58
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
S + HP ++ +G QD + + +++ G L +L +R + + A +
Sbjct: 59 SIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCL 115
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
+EYLHSK+I++ DLK +N+L++ I K+ DFG +K + T + GT ++A
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHI----KITDFGFAKYVPDVTYT--LCGTPDYIA 169
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279
PE+++ ++ +D +SFGI+++E+L G P+ + + I+N P F +
Sbjct: 170 PEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFN 225
Query: 1280 SEWRLLMEQCWAPDPVVRPS 1299
+ + L+ + D R
Sbjct: 226 EDVKDLLSRLITRDLSQRLG 245
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (441), Expect = 6e-49
Identities = 59/278 (21%), Positives = 105/278 (37%), Gaps = 31/278 (11%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+++GSG+FG +Y G G +VAIK ++ + E++I +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQ----LHIESKIYKMMQG 61
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
+ G V E + SL + R + L++A +EY+
Sbjct: 62 GVGIPTIRWCGA-EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT--------LVTGGVRGTLP 1216
HSKN +H D+K DN L+ L + + DFGL+K R+ + GT
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT---LRPP 1273
+ + G + S + D+ S G VL G P+ + + + P
Sbjct: 179 YASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 1274 VPGFCD---SEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
+ C SE+ + C + +P ++ + + R
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 6e-48
Identities = 67/297 (22%), Positives = 112/297 (37%), Gaps = 46/297 (15%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
++ E + E+G G +G V+ + G VA+KR++ + +E + L RE
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTIREVA 59
Query: 1098 ILSKL---HHPNVVAFYGVVQDGP---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
+L L HPNVV + V L V E + ++ E +
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211
+ G+++LHS +VH DLK N+LV K+ DFGL++I + V
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG----QIKLADFGLARIYSFQMALTSV 175
Query: 1212 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1271
TL + APE+L S + VD++S G + E+ + + +G I++
Sbjct: 176 VVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233
Query: 1272 PP-------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
P D + L+ +C +P R S
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 168 bits (427), Expect = 4e-47
Identities = 50/280 (17%), Positives = 92/280 (32%), Gaps = 33/280 (11%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-H 1103
+ +G G+FG ++ G VAIK + + E L
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR----------RSDAPQLRDEYRTYKLLAG 59
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
+ Y Q+G + ++ SL +L R + + A ++
Sbjct: 60 CTGIPNVYYFGQEG---LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 1164 LHSKNIVHFDLKCDNLLVNLKD-PIRPICKVGDFGLSKIKRNTLV--------TGGVRGT 1214
+H K++V+ D+K DN L+ + + V DFG+ K R+ + + GT
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI------IGGIVNN 1268
+M+ G + S + D+ + G V L G P+ + IG +
Sbjct: 177 ARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308
T + E+ M P + +
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-46
Identities = 70/292 (23%), Positives = 114/292 (39%), Gaps = 43/292 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E+ ++++++G GT+G VY + + T VA+K+I+ +E E + RE +L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD------TETEGVPSTAIREISLL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+L+HPN+V V+ L V EF+ + + S +
Sbjct: 56 KELNHPNIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW-M 1218
G+ + HS ++H DLK NLL+N + I K+ DFGL++ + T W
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAI----KLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP----- 1273
APE+L G S VD++S G + E++T + + I P
Sbjct: 170 APEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 1274 ----------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
V D + R L+ Q DP R S
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 8e-46
Identities = 67/261 (25%), Positives = 109/261 (41%), Gaps = 19/261 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D + LK LG GTFG V + + T A+K ++K + E+ +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-----TVTESRVL 59
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
HP + A Q L V E+ G L LS+ER + +
Sbjct: 60 QNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFF-HLSRERVFTEERARFYGAEIVS 116
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWM 1218
+EYLHS+++V+ D+K +NL+++ I K+ DFGL K + GT ++
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHI----KITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278
APE+L + VD + G+V++E++ G P+ N + + I+ P
Sbjct: 173 APEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTL 228
Query: 1279 DSEWRLLMEQCWAPDPVVRPS 1299
E + L+ DP R
Sbjct: 229 SPEAKSLLAGLLKKDPKQRLG 249
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 5e-45
Identities = 67/288 (23%), Positives = 111/288 (38%), Gaps = 40/288 (13%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E+L LG G F TVY + + T+ VAIK+IK RS ++ + RE ++L +L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLG---HRSEAKDGINRTALREIKLLQEL 57
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HPN++ ++ V +FM + L + G+E
Sbjct: 58 SHPNIIGLLDAFGHK--SNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLE 114
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-GTLPWMAPE 1221
YLH I+H DLK +NLL++ + K+ DFGL+K + + T + APE
Sbjct: 115 YLHQHWILHRDLKPNNLLLDENGVL----KLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 1222 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF---- 1277
LL G+ VD+++ G +L E+L + I P +
Sbjct: 171 LLFGAR-MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 1278 ----------------------CDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ L++ + +P R + T+
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 8e-45
Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 21/268 (7%)
Query: 1042 EDLEELKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
E+ E LK LG+G +G V+ G G A+K +KK+ ++ E E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH----TRTER 79
Query: 1097 EILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
++L + P +V + Q L + +++ G L LS+ + I
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFT-HLSQRERFTEHEVQIYVG 136
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRG 1213
+ +E+LH I++ D+K +N+L++ + + DFGLSK + T G
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVV----LTDFGLSKEFVADETERAYDFCG 192
Query: 1214 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-- 1271
T+ +MAP+++ G S + VD +S G++++E+LTG P+ I L+
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252
Query: 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPS 1299
PP P + + L+++ DP R
Sbjct: 253 PPYPQEMSALAKDLIQRLLMKDPKKRLG 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 161 bits (407), Expect = 1e-44
Identities = 61/290 (21%), Positives = 105/290 (36%), Gaps = 41/290 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
E L+++G GT+G VY + G A+K+I+ E E + RE IL
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLE------KEDEGIPSTTIREISILK 55
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
+L H N+V Y V+ L ++ L+ +L E L+ + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVL---VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAP 1220
+ Y H + ++H DLK NLL+N + + K+ DFGL++ + W
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGEL----KIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 1221 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF--- 1277
+ S K S +D++S G + E++ G + + + I P +
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 1278 ------------------------CDSEWRLLMEQCWAPDPVVRPSFTEI 1303
D L+ + DP R + +
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-43
Identities = 61/296 (20%), Positives = 111/296 (37%), Gaps = 51/296 (17%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
L +G G +G V VAIK+I E + RE +IL +
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-------EHQTYCQRTLREIKILLRF 63
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT--VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
H N++ +++ + + ++ L +L K +HL G
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRG 121
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVTGGVRGTLP 1216
++Y+HS N++H DLK NLL+N + K+ DFGL+++ +T T
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDL----KICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--- 1273
+ APE++ S ++ +D++S G +L E+L+ + HY + I+ P
Sbjct: 178 YRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 1274 --------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ DS+ L+++ +P R +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 7e-43
Identities = 59/305 (19%), Positives = 105/305 (34%), Gaps = 55/305 (18%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E+L ++G GTFG V+ + R T VA+K++ +E+E + RE +IL
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME------NEKEGFPITALREIKIL 63
Query: 1100 SKLHHPNVVAFYGVVQDGP------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
L H NVV + + G++ V +F + + + + ++
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT----- 1208
M G+ Y+H I+H D+K N+L+ + K+ DFGL++ +
Sbjct: 124 QM-LLNGLYYIHRNKILHRDMKAANVLITRDGVL----KLADFGLARAFSLAKNSQPNRY 178
Query: 1209 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1268
TL + PELL G +D++ G ++ E+ T + I
Sbjct: 179 TNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 1269 TLRPP------------------------------VPGFCDSEWRLLMEQCWAPDPVVRP 1298
D L+++ DP R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 1299 SFTEI 1303
+
Sbjct: 298 DSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (400), Expect = 7e-43
Identities = 60/259 (23%), Positives = 110/259 (42%), Gaps = 20/259 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ + +K LG+G+FG V K + + A+K + K + + + E IL
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRIL 95
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++ P +V +D L V E++ G + L + A
Sbjct: 96 QAVNFPFLVKLEFSFKDNS--NLYMVMEYVAGGEMFS-HLRRIGRFSEPHARFYAAQIVL 152
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
EYLHS ++++ DLK +NLL++ + I+ V DFG +K + T + GT +A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQ----VTDFGFAKRVKGRTWT--LCGTPEALA 206
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 1279
PE++ ++ VD ++ G++++E+ G P+ I IV+ + P
Sbjct: 207 PEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFS 262
Query: 1280 SEWRLLMEQCWAPDPVVRP 1298
S+ + L+ D R
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 9e-42
Identities = 60/296 (20%), Positives = 100/296 (33%), Gaps = 51/296 (17%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
+ K +G+G+FG VY K + VAIK++ + RE +I+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------------KRFKNRELQIMR 68
Query: 1101 KLHHPNVVAFYGVVQDGP----GGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIA 1154
KL H N+V L V +++ R ++ L +
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGT 1214
+ Y+HS I H D+K NLL++ + K+ DFG +K +
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDT---AVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 1215 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP- 1273
+ APEL+ G ++ + +DV+S G VL E+L G+ + + I+ P
Sbjct: 186 RYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 1274 --------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
E L + P R + E
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 62/292 (21%), Positives = 109/292 (37%), Gaps = 43/292 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E+L+++G GT+GTV+ K R T VA+KR++ + E + RE +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD------DDDEGVPSSALREICLL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+L H N+V + V+ TL V EF ++ + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSFLF-QLLK 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
G+ + HS+N++H DLK NLL+N K+ +FGL++ + W
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNG----ELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 1220 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP-YANMHYGAIIGGIVNNTLRPPVPGF- 1277
P + + S +D++S G + E+ P + + I P +
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 1278 --------------------------CDSEWRLLMEQCWAPDPVVRPSFTEI 1303
++ R L++ +PV R S E
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 149 bits (376), Expect = 6e-40
Identities = 50/313 (15%), Positives = 109/313 (34%), Gaps = 58/313 (18%)
Query: 1030 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQER 1087
+++ ++ +D + +++LG G + V+ + V +K +K ++++
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKK 75
Query: 1088 LTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 1146
RE +IL L PN++ +V+D T A V E + N + + + L
Sbjct: 76 ----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLT 127
Query: 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206
+ ++Y HS I+H D+K N++++ + ++ D+GL++
Sbjct: 128 DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH---RKLRLIDWGLAEFYHPGQ 184
Query: 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1266
+ + PELL +D++S G +L ++ +EP+ + H +
Sbjct: 185 EYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243
Query: 1267 NNTLRPP------------------------------------VPGFCDSEWRLLMEQCW 1290
L E +++
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303
Query: 1291 APDPVVRPSFTEI 1303
D R + E
Sbjct: 304 RYDHQSRLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-38
Identities = 63/294 (21%), Positives = 108/294 (36%), Gaps = 51/294 (17%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+L+ +GSG +G V G VAIK++ + + E +RE +L +
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHM 74
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT----VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
H NV+ V T V FM + L K L + +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGEDRIQFLVYQML 131
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
G+ Y+H+ I+H DLK NL VN K+ DFGL++ + + T +
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQADSEMTG--YVVTRWYR 185
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP----- 1273
APE++ + ++ VD++S G ++ E++TG+ + + + I+ T PP
Sbjct: 186 APEVILNWM-RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 1274 ------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ L+E+ D R + E
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 7e-35
Identities = 55/265 (20%), Positives = 105/265 (39%), Gaps = 23/265 (8%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ LK +GSG G V D VAIK++ + +++ +RE ++ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKCV 73
Query: 1103 HHPNVVAFYGVVQDGP----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+H N+++ V + V E M + + + LD + +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQML 129
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
G+++LHS I+H DLK N++V K+ DFGL++ + + T +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 1219 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278
APE++ G E VD++S G ++ E++ + + Y ++ L P P F
Sbjct: 186 APEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ-LGTPCPEFM 242
Query: 1279 DSEWRLLMEQCWAPDPVVRPSFTEI 1303
+ +F ++
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKL 267
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 9e-35
Identities = 58/296 (19%), Positives = 110/296 (37%), Gaps = 49/296 (16%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E + L +GSG +G+V G VA+K++ + + +++ +RE +L
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR------TYRELRLL 71
Query: 1100 SKLHHPNVVAFYGVVQDGPG---GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
+ H NV+ V + ++ L + + K + L +
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQ 129
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
G++Y+HS +I+H DLK NL VN K+ DFGL++ + + T
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDDEMTG--YVATRW 183
Query: 1217 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--- 1273
+ APE++ ++ VD++S G ++ E+LTG + + + I+ P
Sbjct: 184 YRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 1274 --------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 1303
V + L+E+ D R + +
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (292), Expect = 1e-28
Identities = 43/224 (19%), Positives = 93/224 (41%), Gaps = 9/224 (4%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+ K+ +++LG G F TV+ K T VA+K ++ ++E E L+
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 1095 EAEI--LSKLHHPNVVAFYGVVQDGP--GGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
+A+ + +++ G + V E + L + + R +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 1151 LIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
I+ G++Y+H + I+H D+K +N+L+ + D + ++ L
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1253
T + +PE+L G + D++S +++E++TG+ +
Sbjct: 188 NSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLF 229
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.1 bits (202), Expect = 3e-18
Identities = 28/164 (17%), Positives = 52/164 (31%), Gaps = 30/164 (18%)
Query: 1048 KELGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTLE----------FWREA 1096
K +G G V++ + + +K K + + +++R + E
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
L KL V Y + A + E + L V + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN------AVLMELIDAKELYRVRVENPDE--------VLDM 111
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
+ + + IVH DL N+LV+ + + DF S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-----WIIDFPQSV 150
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 85 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 42.5 bits (100), Expect = 2e-05
Identities = 8/65 (12%), Positives = 24/65 (36%), Gaps = 5/65 (7%)
Query: 204 KLRYVGGETRIIRISRDISWQELTQKALAIYN-QTHTIKYQLPGEDLDALVSVSCDEDLQ 262
K Y + + + D +++EL K + ++ + + + D +
Sbjct: 16 KFYY-KDDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTK---LFDGSGEEIKTDSQVS 71
Query: 263 NMMEE 267
N+++
Sbjct: 72 NIIQA 76
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1329 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d1ip9a_ | 85 | Bud emergence mediator Bemp1 {Baker's yeast (Sacch | 98.01 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.76 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.57 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 97.46 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.3 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.26 | |
| d2c60a1 | 80 | Mitogen-activated protein kinase kinase kinase 3, | 97.08 | |
| d2nptb1 | 82 | Mitogen-activated protein kinase kinase kinase 2, | 96.96 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.92 | |
| d2bkfa1 | 85 | Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Hum | 96.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 94.71 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 91.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 90.23 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 88.72 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 86.9 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 85.47 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 84.95 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 84.41 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 83.17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.16 Aligned_cols=263 Identities=34% Similarity=0.555 Sum_probs=220.3
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC
Q ss_conf 01356671599884015838999999979208999972166679984789999999999999984699955267021115
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1037 ~~Is~eeYsllkvLGsGaFGtVYKAk~kGt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~e 1116 (1329)
|++..++|++.+.||+|+||.||+|++++ .||||+++...... .....|.+|+.++++++|||||++++++.+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP------QQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT------THHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CCCCCCCEEEEEEEEECCCCEEEEEEECC-EEEEEEEECCCCCH------HHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 13154518998898307885899999999-89999997346998------999999999999984799878645679715
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf 99971899998212883135441013457999999999999999999897990304798751575468998880899424
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 sseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDF 1196 (1329)
. .+++|||||++|+|.+++......+++..++.|+.||+.||+|||+++|+||||||+|||++.++. +||+||
T Consensus 76 ~---~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~----~Kl~DF 148 (276)
T d1uwha_ 76 P---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT----VKIGDF 148 (276)
T ss_dssp S---SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS----EEECCC
T ss_pred C---EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCC----EEECCC
T ss_conf 5---899999658998889998523578999999999999999988875099951614789979818997----887500
Q ss_pred CCCCCCCC---CCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 77522468---6323687798764472111368-8999905689999999999990999998988568999787258999
Q 000726 1197 GLSKIKRN---TLVTGGVRGTLPWMAPELLNGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1197 GLAkli~~---~~~ss~v~GT~~YlAPEvL~Gs-~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrl 1272 (1329)
|+|+.... ........||+.|+|||++.+. ...++.++|||||||++|||++|+.||...................
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 228 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 228 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC
T ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 22133355677631256655743179999950568999953151635999999997889989989699999999658889
Q ss_pred ----CCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf ----99998929999999992158999998999999999999997
Q 000726 1273 ----PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1273 ----eip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa 1313 (1329)
..+..+++.+.+||.+||+.+|.+|||+.+++++|+.+...
T Consensus 229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 860003655549999999997588976892999999999999970
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=371.65 Aligned_cols=256 Identities=21% Similarity=0.315 Sum_probs=221.3
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.++|++.+.||+|+||.||+|++. |+.||||++.... ......+.+|+.+|+.++|||||++++++.+..
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--------HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 657589889840768199999988999899999984524--------316999999999998679979992999999899
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 97189999821288313544101345799999999999999999989799030479875157546899888089942477
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGL 1198 (1329)
.+++|||||++|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++.+.+ ..+||+|||+
T Consensus 97 --~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~--~~vkL~DFG~ 172 (350)
T d1koaa2 97 --EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS--NELKLIDFGL 172 (350)
T ss_dssp --EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTS--CCEEECCCTT
T ss_pred --EEEEEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCC--CEEEEEECCH
T ss_conf --999999857998899999762378999999999999999999997569760001546736416889--8699954521
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC--CC
Q ss_conf 5224686323687798764472111368899990568999999999999099999898856899978725899999--99
Q 000726 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV--PG 1276 (1329)
Q Consensus 1199 Akli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrlei--p~ 1276 (1329)
+.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+.......+. ..
T Consensus 173 a~~~~~~~~~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 250 (350)
T d1koaa2 173 TAHLDPKQSVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 250 (350)
T ss_dssp CEECCTTSCEEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGG
T ss_pred HEECCCCCCCCEECCCCCCCCHHHHCC--CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 044256543200068624218899758--998726765546599999985989989979999999998478898942235
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 8929999999992158999998999999999999
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1277 ~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L 1310 (1329)
.++..+.+||.+||+.||.+|||+.++++|.|.-
T Consensus 251 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~ 284 (350)
T d1koaa2 251 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284 (350)
T ss_dssp GCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 8999999999997568966790899986291328
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.90 Aligned_cols=261 Identities=33% Similarity=0.503 Sum_probs=222.9
Q ss_pred CCCCCCCCCCCEEEEEEECCCCCEEEEEEEECC-------CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CC
Q ss_conf 631101356671599884015838999999979-------2089999721666799847899999999999999846-99
Q 000726 1033 ISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 1104 (1329)
Q Consensus 1033 ls~l~~Is~eeYsllkvLGsGaFGtVYKAk~kG-------t~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkL-rH 1104 (1329)
....|.+..++|++.+.||+|+||.||+|++.+ ..||+|.+.... .......+.+|+.++.++ +|
T Consensus 28 ~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~H 100 (325)
T d1rjba_ 28 YDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-------DSSEREALMSELKMMTQLGSH 100 (325)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCC
T ss_pred CCCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHHCCC
T ss_conf 8744657789939701983078819999998578855420499999966335-------878999999999999971589
Q ss_pred CCEEEEECCCCCCCCCEEEEEEEECCCCCHHHHHHCCC----------------------CCCCHHHHHHHHHHHHHHHH
Q ss_conf 95526702111599971899998212883135441013----------------------45799999999999999999
Q 000726 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----------------------RHLDRRKRLIIAMDAAFGME 1162 (1329)
Q Consensus 1105 PNIVKLlGif~esseg~L~LVMEYieGGSL~dlL~~ke----------------------k~LSe~qIlkIA~QIAsALa 1162 (1329)
||||++++++.+.. .+++|||||++|+|.+++.... ..+++..++.++.||+.||+
T Consensus 101 pnIv~l~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ 178 (325)
T d1rjba_ 101 ENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178 (325)
T ss_dssp TTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred CCEEEEEEEEEECC--EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
T ss_conf 96868778886299--5899997279995999998625777510221000012220012577899999999999999999
Q ss_pred HHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 9897990304798751575468998880899424775224686---3236877987644721113688999905689999
Q 000726 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSF 1239 (1329)
Q Consensus 1163 YLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGLAkli~~~---~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSL 1239 (1329)
|||+++|+||||||+|||++.++ .+||+|||+|+..... .......||+.|+|||++. ...++.++|||||
T Consensus 179 yLH~~~IiHRDlKp~Nill~~~~----~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwS~ 252 (325)
T d1rjba_ 179 FLEFKSCVHRDLAARNVLVTHGK----VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSY 252 (325)
T ss_dssp HHHHTTEEETTCSGGGEEEETTT----EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHH
T ss_pred HHHHCCEEECCCCHHCCCCCCCC----EEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHC--CCCCCCCEECCCH
T ss_conf 99739905052703214434598----28985142222045778615623435787657838872--7999963303000
Q ss_pred HHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 999999990-999998988568999787258999999989299999999921589999989999999999
Q 000726 1240 GIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1240 GVLLyELLT-Gk~PFs~~~~~eilqqIve~~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le 1308 (1329)
||++|||++ |..||.+......+..++....+++.+..+++.+.+||.+||+.+|.+|||+++|+++|.
T Consensus 253 Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 253 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 3999999838999999989899999998569989988767899999999975889668939999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=368.69 Aligned_cols=255 Identities=20% Similarity=0.320 Sum_probs=220.5
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.++|++.+.||+|+||.||+|.+. ++.||||+++... . .....+.+|+.+|+.++|||||++++++.+..
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----P---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----H---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-----H---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 403599899931778299999998999799999988726-----4---67999999999998679979891999999899
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 97189999821288313544101345799999999999999999989799030479875157546899888089942477
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGL 1198 (1329)
.+++|||||++|+|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++.... ..+||+|||+
T Consensus 100 --~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~--~~vkL~DFGl 175 (352)
T d1koba_ 100 --EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGL 175 (352)
T ss_dssp --EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTC--CCEEECCCTT
T ss_pred --EEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCC--CEEEEEECCC
T ss_conf --999999828998088889863899899999999999999999999779265131445531134678--8489952563
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC--CCC
Q ss_conf 522468632368779876447211136889999056899999999999909999989885689997872589999--999
Q 000726 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPG 1276 (1329)
Q Consensus 1199 Akli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrle--ip~ 1276 (1329)
|.............|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+.......+ ...
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 253 (352)
T d1koba_ 176 ATKLNPDEIVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253 (352)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT
T ss_pred CEECCCCCCEEECCCCCCCCCHHHHCC--CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 034378872010047645348999747--998976333898999999996889989979999999998478898930024
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 892999999999215899999899999999999
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1277 ~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
.+++++.+||.+||+.||.+|||+.++++|.|.
T Consensus 254 ~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~ 286 (352)
T d1koba_ 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286 (352)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 799999999999756996689189999609734
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.16 Aligned_cols=256 Identities=32% Similarity=0.608 Sum_probs=219.1
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEEC-CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC
Q ss_conf 35667159988401583899999997-92089999721666799847899999999999999846999552670211159
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1039 Is~eeYsllkvLGsGaFGtVYKAk~k-Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~es 1117 (1329)
+..++|++.+.||+|+||.||+|.+. +..||||+++..... ..+|.+|+.+++.++||||++++++|...
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCCCCCCCEECCC
T ss_conf 896995888898208882999999889999999998788676---------89999999999966899756535243159
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECC
Q ss_conf 99718999982128831354410134579999999999999999998979903047987515754689988808994247
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 seg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFG 1197 (1329)
. ..++||||+++|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++.++. +||+|||
T Consensus 73 ~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~----~Kl~DFG 146 (263)
T d1sm2a_ 73 A--PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV----IKVSDFG 146 (263)
T ss_dssp S--SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC----EEECSCC
T ss_pred C--CEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCC----EEECCCC
T ss_conf 9--337999836999189975201347889999999999999877653164310443153266668877----6865532
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 75224686--3236877987644721113688999905689999999999990-99999898856899978725899999
Q 000726 1198 LSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1198 LAkli~~~--~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLT-Gk~PFs~~~~~eilqqIve~~lrlei 1274 (1329)
+++..... .......||..|+|||++.+ ..++.++|||||||++|||++ |.+||...........+ ....+...
T Consensus 147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i-~~~~~~~~ 223 (263)
T d1sm2a_ 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYK 223 (263)
T ss_dssp ------------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH-HHTCCCCC
T ss_pred HHEECCCCCCEEECCEECCCCCCCHHHHCC--CCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HHCCCCCC
T ss_conf 100236887335043001766678578607--999840332105999999987898887789999999999-80688899
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 99892999999999215899999899999999999999
Q 000726 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1275 p~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~s 1312 (1329)
+..+++.+.+||.+||+.+|.+|||+.+++++|+.+..
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 54367999999999765797689199999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=365.99 Aligned_cols=259 Identities=36% Similarity=0.590 Sum_probs=219.8
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEEC--CC---EEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEC
Q ss_conf 135667159988401583899999997--92---0899997216667998478999999999999998469995526702
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GT---DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1329)
Q Consensus 1038 ~Is~eeYsllkvLGsGaFGtVYKAk~k--Gt---~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlG 1112 (1329)
.+..++|++.+.||+|+||.||+|.++ +. .||||.+.... .+...+.|.+|+.+|++++|||||++++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~g 94 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNVIHLEG 94 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred HHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCCCCEEE
T ss_conf 208004278569802788299999995799788999999978445-------9899999999999998579988861899
Q ss_pred CCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEE
Q ss_conf 11159997189999821288313544101345799999999999999999989799030479875157546899888089
Q 000726 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1113 if~esseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VK 1192 (1329)
++.+.. .+++|||||++|+|.+++......+++.+++.|+.||+.||.|||+++|+||||||+|||++.++. +|
T Consensus 95 ~~~~~~--~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~----~K 168 (299)
T d1jpaa_ 95 VVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV----CK 168 (299)
T ss_dssp EECSSS--SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC----EE
T ss_pred EEEECC--EEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCC----EE
T ss_conf 996288--779999722798530021045679999999999999999889885279835761504489889991----99
Q ss_pred EEECCCCCCCCCCCC------CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Q ss_conf 942477522468632------36877987644721113688999905689999999999990-99999898856899978
Q 000726 1193 VGDFGLSKIKRNTLV------TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1265 (1329)
Q Consensus 1193 LsDFGLAkli~~~~~------ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLT-Gk~PFs~~~~~eilqqI 1265 (1329)
|+|||+++....... .....+++.|+|||++. ...++.++|||||||++|||+| |..||......+....+
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i 246 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHH--CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 88844315756777765365025666883003878883--6997861214453578999986799999999999999999
Q ss_pred HHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 72589999999892999999999215899999899999999999999
Q 000726 1266 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1266 ve~~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~s 1312 (1329)
. ...+++.+..++..+.+||.+||+.+|.+|||+.++++.|+.+..
T Consensus 247 ~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 247 E-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp H-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred H-CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 7-378899974226999999999758797689299999999999841
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=367.63 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=218.2
Q ss_pred CCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCC
Q ss_conf 67159988401583899999997--9208999972166679984789999999999999984699955267021115999
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~esse 1119 (1329)
+.|+.++.||+|+||.||+|++. +..||||++..... ........+.+|+.+++.++|||||++++++.+..
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH- 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC-
T ss_conf 856762797018880999999989993999999844443-----58899999999999999778999823899999899-
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCCC
Q ss_conf 71899998212883135441013457999999999999999999897990304798751575468998880899424775
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGLA 1199 (1329)
.+++|||||.+++|..++. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||++
T Consensus 89 -~~~iv~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~----~Kl~DFG~a 162 (309)
T d1u5ra_ 89 -TAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL----VKLGDFGSA 162 (309)
T ss_dssp -EEEEEEECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE----EEECCCTTC
T ss_pred -EEEEEEEECCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCC----EEEEECCCC
T ss_conf -8899998069994578997-3799999999999999999999998689766678842179879997----898443653
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 224686323687798764472111368-8999905689999999999990999998988568999787258999999989
Q 000726 1200 KIKRNTLVTGGVRGTLPWMAPELLNGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1200 kli~~~~~ss~v~GT~~YlAPEvL~Gs-~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrleip~~v 1278 (1329)
...... ....||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+......+..+.........+..+
T Consensus 163 ~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (309)
T d1u5ra_ 163 SIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239 (309)
T ss_dssp BSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTS
T ss_pred CCCCCC---CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 346778---73134766368899834678886721454558999999987889999979999999998289998887888
Q ss_pred CHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 29999999992158999998999999999999
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1279 SeeL~dLIkkCLq~DPeERPSaeELLk~Le~L 1310 (1329)
++.+.+||.+||+.||.+|||+.++++|.|..
T Consensus 240 s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~ 271 (309)
T d1u5ra_ 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHC
T ss_conf 99999999997737965791899997199753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=368.46 Aligned_cols=259 Identities=33% Similarity=0.534 Sum_probs=219.0
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECC
Q ss_conf 10135667159988401583899999997--9208999972166679984789999999999999984699955267021
Q 000726 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1329)
Q Consensus 1036 l~~Is~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGi 1113 (1329)
-|++..++|++.+.||+|+||.||+|.++ ++.||||+++..... ..+|.+|+.+|+.++|||||+++++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~il~~l~HpnIv~~~~~ 81 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------VEEFLKEAAVMKEIKHPNLVQLLGV 81 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCH---------HHHHHHHHHHHHHCCCCCEECCCCC
T ss_conf 5174579939865982088808999999999969999997776103---------9999999999986799988267752
Q ss_pred CCCCCCCEEEEEEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEE
Q ss_conf 1159997189999821288313544101-345799999999999999999989799030479875157546899888089
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1114 f~esseg~L~LVMEYieGGSL~dlL~~k-ek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VK 1192 (1329)
|.+.. .+++|||||++|+|..++... ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++. +|
T Consensus 82 ~~~~~--~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~----~K 155 (287)
T d1opja_ 82 CTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL----VK 155 (287)
T ss_dssp ECSSS--SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC----EE
T ss_pred EEECC--EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCC----EE
T ss_conf 74578--5478763146760677753035541579999999999999788898789305760457689989992----89
Q ss_pred EEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 9424775224686--32368779876447211136889999056899999999999909999989885689997872589
Q 000726 1193 VGDFGLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1270 (1329)
Q Consensus 1193 LsDFGLAkli~~~--~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~l 1270 (1329)
|+|||+++..... .......|++.|+|||++.+ ..++.++|||||||++|||+++..||............+....
T Consensus 156 l~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~ 233 (287)
T d1opja_ 156 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 233 (287)
T ss_dssp ECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCCCEEECCCCCCEEECCCCCCCCCCCHHHHCC--CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 83244546537887221035566546669278727--9998104302178999999867998877425999999985588
Q ss_pred CCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 99999989299999999921589999989999999999999
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1271 rleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~ 1311 (1329)
+++.+..++..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 88887433099999999975779768939999999999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.74 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=218.9
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.++|++.+.||+|+||.||+++++ |+.||||++...... +.....+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC------HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 33379967983088919999999999979999998746579------799999999999999778999824899999178
Q ss_pred CCEEEEEEEECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECCCCCCCEEECCCCCCCCC
Q ss_conf 97189999821288313544101---345799999999999999999989799-----0304798751575468998880
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPIRPI 1190 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~k---ek~LSe~qIlkIA~QIAsALaYLHskG-----IIHRDLKPsNILIDsdGni~~~ 1190 (1329)
...+++|||||++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~---- 152 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---- 152 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC----
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCC----
T ss_conf 9989999956899938999985154578999999999999999999999971677887885867654257478885----
Q ss_pred EEEEECCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 89942477522468-63236877987644721113688999905689999999999990999998988568999787258
Q 000726 1191 CKVGDFGLSKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1269 (1329)
Q Consensus 1191 VKLsDFGLAkli~~-~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~ 1269 (1329)
+||+|||+++.... ........||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+....
T Consensus 153 vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 153 VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN--RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp EEECCHHHHHHC-----------CCCSCCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred EEEEECCCEEECCCCCCCCCCCCCCCCCCCHHHHC--CCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCC
T ss_conf 79800100032245777556677882327999983--9999938988752789999801889989989999999997189
Q ss_pred CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 999999989299999999921589999989999999999
Q 000726 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 1308 (1329)
Q Consensus 1270 lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le 1308 (1329)
. ..++..+++++.+||.+||+.||.+|||+.|+++|+|
T Consensus 231 ~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 231 F-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred C-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCCC
T ss_conf 9-8897435999999999976799557918999972981
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.97 Aligned_cols=260 Identities=33% Similarity=0.556 Sum_probs=218.8
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEEC-CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECC
Q ss_conf 110135667159988401583899999997-9208999972166679984789999999999999984699955267021
Q 000726 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1329)
Q Consensus 1035 ~l~~Is~eeYsllkvLGsGaFGtVYKAk~k-Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGi 1113 (1329)
.-|.+..++|++.+.||+|+||.||+|.++ +..||||+++..... ...|.+|+.++++++|||||+++++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------PDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCEECCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 7700388993886798107982899999999999999998647688---------8999999999986799988578731
Q ss_pred CCCCCCCEEEEEEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEE
Q ss_conf 11599971899998212883135441013-45799999999999999999989799030479875157546899888089
Q 000726 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1114 f~esseg~L~LVMEYieGGSL~dlL~~ke-k~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VK 1192 (1329)
+.+. .+++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+|||++.++. +|
T Consensus 77 ~~~~---~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~----~K 149 (272)
T d1qpca_ 77 VTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS----CK 149 (272)
T ss_dssp ECSS---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC----EE
T ss_pred ECCC---CEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCC----EE
T ss_conf 0459---7699999578982888875147898878899999999999999997489546756422515620244----04
Q ss_pred EEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHHHCC
Q ss_conf 9424775224686--32368779876447211136889999056899999999999909-99998988568999787258
Q 000726 1193 VGDFGLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG-EEPYANMHYGAIIGGIVNNT 1269 (1329)
Q Consensus 1193 LsDFGLAkli~~~--~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTG-k~PFs~~~~~eilqqIve~~ 1269 (1329)
|+|||+|+..... .......|++.|+|||++.+ ..++.++|||||||++|||+|+ .+||........... +...
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~-i~~~ 226 (272)
T d1qpca_ 150 IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERG 226 (272)
T ss_dssp ECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTT
T ss_pred ECCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHHC--CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHHC
T ss_conf 23410147735886442035677444458289837--99982456452579999999689888888899999999-9706
Q ss_pred CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 99999998929999999992158999998999999999999997
Q 000726 1270 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1270 lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa 1313 (1329)
.++..+..++..+.+|+.+||+.+|.+|||+.++++.|+.+...
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 88889655719999999997588976893999999986113213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.19 Aligned_cols=264 Identities=33% Similarity=0.546 Sum_probs=221.8
Q ss_pred CCCCCCEEEEEE-ECCCCCEEEEEEEEC----CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEC
Q ss_conf 135667159988-401583899999997----920899997216667998478999999999999998469995526702
Q 000726 1038 IIKNEDLEELKE-LGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1329)
Q Consensus 1038 ~Is~eeYsllkv-LGsGaFGtVYKAk~k----Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlG 1112 (1329)
.+..++|.+.+. ||+|+||.||+|.++ +..||||+++... ......+|.+|+.+|++++|||||++++
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~g 76 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIG 76 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC-------CHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 654447188784873060809999999608976899999988203-------9789999999999998679988806865
Q ss_pred CCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEE
Q ss_conf 11159997189999821288313544101345799999999999999999989799030479875157546899888089
Q 000726 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1113 if~esseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VK 1192 (1329)
++... .+++|||||++|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+|
T Consensus 77 ~~~~~---~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~----~~K 149 (285)
T d1u59a_ 77 VCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----YAK 149 (285)
T ss_dssp EEESS---SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT----EEE
T ss_pred EECCC---EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCC----CEE
T ss_conf 60368---07999980789968997521256999999999999999987899868810576764660454688----542
Q ss_pred EEECCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHH
Q ss_conf 9424775224686----3236877987644721113688999905689999999999990-9999989885689997872
Q 000726 1193 VGDFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1193 LsDFGLAkli~~~----~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLT-Gk~PFs~~~~~eilqqIve 1267 (1329)
|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......+....+ .
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i-~ 226 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-E 226 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-H
T ss_pred ECCCHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHC--CCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHH-H
T ss_conf 0331342115543432113562113743358688727--999954123220178999993899999997999999999-8
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCC
Q ss_conf 589999999892999999999215899999899999999999999711678
Q 000726 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKS 1318 (1329)
Q Consensus 1268 ~~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa~st~s 1318 (1329)
...+++.+..+++++.+||.+||+.+|.+||||.++++.|+..........
T Consensus 227 ~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~ 277 (285)
T d1u59a_ 227 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277 (285)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHCC
T ss_conf 189999997678999999999757797689099999999999999854111
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.59 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=215.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.++|++.+.||+|+||.||+|.++ |+.||||+++...... ...+.+|+.+++.++||||+++++++.+..
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHH--------HHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 105388789812858299999998999899999984301727--------999999999998679998805857798899
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 97189999821288313544101345799999999999999999989799030479875157546899888089942477
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGL 1198 (1329)
.+++|||||++|+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 91 --~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~----vkl~DFG~ 162 (293)
T d1yhwa1 91 --ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGF 162 (293)
T ss_dssp --EEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC----EEECCCTT
T ss_pred --EEEEEEEECCCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCC----EEECCCHH
T ss_conf --98999970379808988641--59999999999999999999999879722677688868878996----86425156
Q ss_pred CCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC-CCCCCCCC
Q ss_conf 52246-86323687798764472111368899990568999999999999099999898856899978725-89999999
Q 000726 1199 SKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPG 1276 (1329)
Q Consensus 1199 Akli~-~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~-~lrleip~ 1276 (1329)
++... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+... ......+.
T Consensus 163 a~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T d1yhwa1 163 CAQITPEQSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (293)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGG
T ss_pred HEEECCCCCCCCCCCCCCCCCCHHHHCC--CCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 4132136664444444777368266447--99880120313729999980488998997999999999857999888855
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 8929999999992158999998999999999999
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1277 ~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L 1310 (1329)
.++..+.+||.+||+.||.+|||+.|+++|.|.-
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~ 274 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf 3799999999998669966890999996499657
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.76 Aligned_cols=254 Identities=28% Similarity=0.465 Sum_probs=218.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.++|++.+.||+|+||.||+|+++ ++.||+|++.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-----KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
T ss_conf 53769988985177858999999899949999998168856-----7689999999999998568888885999999899
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 97189999821288313544101345799999999999999999989799030479875157546899888089942477
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGL 1198 (1329)
.+++|||||++|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++. +||+|||+
T Consensus 80 --~~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~----~kl~DFG~ 152 (263)
T d2j4za1 80 --RVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE----LKIADFGW 152 (263)
T ss_dssp --EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC----EEECCCCS
T ss_pred --EEEEEEEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCC----EEECCCCE
T ss_conf --98999850479858988750-489999999999999999999999889465220234414668998----71155563
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 52246863236877987644721113688999905689999999999990999998988568999787258999999989
Q 000726 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1199 Akli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrleip~~v 1278 (1329)
+........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... ..++..+
T Consensus 153 a~~~~~~~~-~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~ 227 (263)
T d2j4za1 153 SVHAPSSRR-TTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFV 227 (263)
T ss_dssp CSCCCCCCC-EETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTS
T ss_pred EEECCCCCC-CCCCCCCCCCCHHHHCC--CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC--CCCCCCC
T ss_conf 354488852-35578876349999758--998931440467599999832999988899999999997189--9998668
Q ss_pred CHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 299999999921589999989999999999999
Q 000726 1279 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1279 SeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~ 1311 (1329)
++.+.+|+.+||+.||.+|||+.++++|.|.-.
T Consensus 228 s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 228 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 999999999976479768909999971907078
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.86 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=226.1
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.++|++.+.||+|+||.||+|+++ |+.||||++++........ ......+.+|+.+|+.++|||||++++++.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHH--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 567798279811789599999999999899999987566321340--689999999999998679989993889999799
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 97189999821288313544101345799999999999999999989799030479875157546899888089942477
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGL 1198 (1329)
.+++|||||++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.....+||+|||+
T Consensus 87 --~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 87 --DVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp --EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred --EEEEEEECCCCCCCCCHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHH
T ss_conf --899999867786431001035-64215578999999999987666254221133301279825898666469643344
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC--CCC
Q ss_conf 522468632368779876447211136889999056899999999999909999989885689997872589999--999
Q 000726 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPG 1276 (1329)
Q Consensus 1199 Akli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrle--ip~ 1276 (1329)
+.............|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.......+ .+.
T Consensus 164 a~~~~~~~~~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 164 AHKIDFGNEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp CEECTTSCBCSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHCC--CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCHHCC
T ss_conf 210577763122477774309999818--999976652214099999970889988999999999998168888701047
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 8929999999992158999998999999999999
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1277 ~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L 1310 (1329)
.++..+.+||.+||+.||.+|||++++++|.|.-
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 275 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 8899999999998638966891999996190418
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.27 Aligned_cols=255 Identities=26% Similarity=0.391 Sum_probs=217.5
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.+.|++++.||+|+||.||+|++. +..||||+++..... ....+.+|+.+|+.++|||||++++++.+..
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--------ELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--------GGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHH--------HHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
T ss_conf 03759847993077819999999999939999998728999--------9999999999998679999884988980099
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 97189999821288313544101345799999999999999999989799030479875157546899888089942477
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGL 1198 (1329)
.+++|||||++|+|..++......+++..+..++.||+.||.|||+++|+||||||+|||++.++. +||+|||+
T Consensus 83 --~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~----~Kl~DFG~ 156 (288)
T d2jfla1 83 --NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD----IKLADFGV 156 (288)
T ss_dssp --EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC----EEECCCTT
T ss_pred --EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCC----EEEEECHH
T ss_conf --589999627998188999862899999999999999999999999889887140700314878999----89971612
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC-CCC
Q ss_conf 522468-6323687798764472111368---89999056899999999999909999989885689997872589-999
Q 000726 1199 SKIKRN-TLVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPP 1273 (1329)
Q Consensus 1199 Akli~~-~~~ss~v~GT~~YlAPEvL~Gs---~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~l-rle 1273 (1329)
|..... ........||+.|+|||++.+. ...++.++|||||||++|+|++|+.||......+.+..+..... ...
T Consensus 157 a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (288)
T d2jfla1 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236 (288)
T ss_dssp CEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS
T ss_pred HHCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCC
T ss_conf 30357786410010256264799998320257888880665787899999982088999998999999999707998777
Q ss_pred CCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 999892999999999215899999899999999999
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1274 ip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
.+..+++++.+||.+||+.||.+|||+.|+++|.|.
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf 656699999999999766996689199999629231
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=366.12 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=220.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.+.|++.+.||+|+||.||+|+++ ++.||||++....... ....+.+|+.+|+.++||||+++++++.+..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-------KEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH-------HHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 666699889940658399999999999899999981577312-------8999999999998679989991989999899
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 97189999821288313544101345799999999999999999989799030479875157546899888089942477
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGL 1198 (1329)
.+++|||||++++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+.... ....+||+|||+
T Consensus 81 --~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~-~~~~vkl~DFG~ 156 (307)
T d1a06a_ 81 --HLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGL 156 (307)
T ss_dssp --EEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCC--
T ss_pred --EEEEEEECCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCC-CCCEEEEECCCE
T ss_conf --88898852689848886530-36788789999999999998752413055687046300110468-882499831543
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC--CCC
Q ss_conf 522468632368779876447211136889999056899999999999909999989885689997872589999--999
Q 000726 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPG 1276 (1329)
Q Consensus 1199 Akli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrle--ip~ 1276 (1329)
+............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......+ ...
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234 (307)
T ss_dssp ----------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT
T ss_pred EEECCCCCEEEEEEECCCCCCCHHHCC--CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
T ss_conf 587258970440032842259188737--999807873451599999985979999989999999986168777876666
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 892999999999215899999899999999999
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1277 ~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
.+++.+.+||.+||+.||.+|||+.|+++|.|.
T Consensus 235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 235 DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 789999999999760897579189998629844
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.85 Aligned_cols=258 Identities=25% Similarity=0.343 Sum_probs=219.4
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC
Q ss_conf 35667159988401583899999997--9208999972166679984789999999999999984699955267021115
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 Is~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~e 1116 (1329)
...++|++.+.||+|+||.||+|+++ ++.||||++.+.... .+.....+.+|+.++++++||||+++++++.+
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 79 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-----KENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred CCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCC-----CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 8998778988985087909999999899979999998657755-----77789999999999987688886179999998
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf 99971899998212883135441013457999999999999999999897990304798751575468998880899424
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 sseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDF 1196 (1329)
.. .+++|||||++|+|.+++... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++. +||+||
T Consensus 80 ~~--~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~----vkl~DF 152 (288)
T d1uu3a_ 80 DE--KLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH----IQITDF 152 (288)
T ss_dssp SS--EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC----EEECCC
T ss_pred CC--EEEEEEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCE----EEECCC
T ss_conf 99--889999704898777765315-99999999999999999997621650884767741236688853----886032
Q ss_pred CCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 77522468---632368779876447211136889999056899999999999909999989885689997872589999
Q 000726 1197 GLSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 1273 (1329)
Q Consensus 1197 GLAkli~~---~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrle 1273 (1329)
|+|+.... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... ..
T Consensus 153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~~ 228 (288)
T d1uu3a_ 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YD 228 (288)
T ss_dssp TTCEECC----------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--CC
T ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCEEECC--CCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--CC
T ss_conf 10242256776433355567755258440026--898966623045699999803889989959999999997189--99
Q ss_pred CCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 999892999999999215899999899999999999999
Q 000726 1274 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1274 ip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~s 1312 (1329)
++..+++.+.+||.+||+.||.+|||++|++.+.+....
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~H 267 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCC
T ss_conf 985479999999999855797689197897377898769
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.98 Aligned_cols=260 Identities=35% Similarity=0.594 Sum_probs=218.7
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECC------CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 1356671599884015838999999979------2089999721666799847899999999999999846999552670
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1038 ~Is~eeYsllkvLGsGaFGtVYKAk~kG------t~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLl 1111 (1329)
++..++|++.++||+|+||.||+|.+++ ..||||+++... .+....+|++|+.++++++|||||+++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~il~~l~H~nIv~~~ 75 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------TEKQRVDFLGEAGIMGQFSHHNIIRLE 75 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 5788996861598117790999999968998787999999988445-------968999999999999856898783236
Q ss_pred CCCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCE
Q ss_conf 21115999718999982128831354410134579999999999999999998979903047987515754689988808
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1112 Gif~esseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~V 1191 (1329)
+++.+.. .+++||||+.++++...+......+++.+++.++.||+.||.|||+++|+||||||+|||++.++. +
T Consensus 76 g~~~~~~--~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~----~ 149 (283)
T d1mqba_ 76 GVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV----C 149 (283)
T ss_dssp EEECSSS--SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC----E
T ss_pred EEEECCC--CEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCE----E
T ss_conf 7783388--038999721357402221023454208999999999998541212123425765644278889984----9
Q ss_pred EEEECCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHH
Q ss_conf 99424775224686----32368779876447211136889999056899999999999909-99998988568999787
Q 000726 1192 KVGDFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG-EEPYANMHYGAIIGGIV 1266 (1329)
Q Consensus 1192 KLsDFGLAkli~~~----~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTG-k~PFs~~~~~eilqqIv 1266 (1329)
||+|||+++..... .......||+.|+|||++. ...++.++|||||||++|||+++ .+|+......+.. ..+
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~-~~i 226 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-KAI 226 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHH
T ss_pred EECCCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHC--CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHH-HHH
T ss_conf 9845510300357876526742677773434888870--4999973556344898999996798865568999999-998
Q ss_pred HCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 25899999998929999999992158999998999999999999997
Q 000726 1267 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1267 e~~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa 1313 (1329)
....+++.+..++..+.+||.+||+.+|.+||++.++++.|+.+...
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 63578998504579999999997767976893999999999998669
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.73 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=220.3
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC
Q ss_conf 35667159988401583899999997--9208999972166679984789999999999999984699955267021115
Q 000726 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1039 Is~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~e 1116 (1329)
+..++|++++.||+|+||.||+|+++ +..||||++++..... ......+.+|+.+|+.++||||+++++++.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-----~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-----KDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCC-----HHHHHHHHHHHHHHHHCCCCCEEEEEEEECC
T ss_conf 84474289889831768499999998999899999981565449-----7999999999999986799988778764035
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf 99971899998212883135441013457999999999999999999897990304798751575468998880899424
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 sseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDF 1196 (1329)
.. .+++|||||++|+|..++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+ ||+||
T Consensus 77 ~~--~~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~v----kl~DF 149 (337)
T d1o6la_ 77 HD--RLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHI----KITDF 149 (337)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE----EECCC
T ss_pred CC--CCCCCEECCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCE----EEEEC
T ss_conf 64--21110003579860555532-5677599999999999652113431596224647778476589988----88205
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 7752246-863236877987644721113688999905689999999999990999998988568999787258999999
Q 000726 1197 GLSKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275 (1329)
Q Consensus 1197 GLAkli~-~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrleip 1275 (1329)
|+|+... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+.... ..++
T Consensus 150 G~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p 225 (337)
T d1o6la_ 150 GLCKEGISDGATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFP 225 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCC
T ss_pred CCCCCCCCCCCCCCCCEECHHHHHHHHCCC--CCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--CCCC
T ss_conf 652003567862055100889966665048--988833310223067889987899999969999999985289--9898
Q ss_pred CCCCHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHH
Q ss_conf 98929999999992158999998-----99999999999
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLRV 1309 (1329)
Q Consensus 1276 ~~vSeeL~dLIkkCLq~DPeERP-----SaeELLk~Le~ 1309 (1329)
..+++++.+||.+||++||.+|+ +++++++|.|.
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f 264 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred CCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCC
T ss_conf 668999999998666389344225652349999729150
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.30 Aligned_cols=254 Identities=28% Similarity=0.360 Sum_probs=211.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.++|++.+.||+|+||.||+|+++ ++.||||++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC-------HHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC
T ss_conf 74608998972174809999999999979999998456641-------27999999999998579988846965404674
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 97189999821288313544101345799999999999999999989799030479875157546899888089942477
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGL 1198 (1329)
.+++|||||++|+|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||+
T Consensus 77 --~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~----~KL~DFG~ 149 (271)
T d1nvra_ 77 --IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN----LKISDFGL 149 (271)
T ss_dssp --EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC----EEECCCTT
T ss_pred --EEEEEEECCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCC----EEECCCHH
T ss_conf --36798864589808999753-799999999999999999999999759835754689978878998----79832314
Q ss_pred CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCCCCCC
Q ss_conf 522468---632368779876447211136889999056899999999999909999989885689-9978725899999
Q 000726 1199 SKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI-IGGIVNNTLRPPV 1274 (1329)
Q Consensus 1199 Akli~~---~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~ei-lqqIve~~lrlei 1274 (1329)
|+.... .......+||+.|+|||++.+.. .++.++|||||||++|+|++|+.||........ .............
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 228 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSS-BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTT
T ss_pred HEEECCCCCCCCCCCEEECCCCCCHHHHCCCC-CCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf 22404688653111325574742872861899-99971016173799999982997888898599999998638887886
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 99892999999999215899999899999999999
Q 000726 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1275 p~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
...+++.+.+|+.+||+.||.+|||+.++++|.|.
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf 263 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 44699999999999767996689099999619845
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.13 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=211.1
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCC
Q ss_conf 135667159988401583899999997--920899997216667998478999999999999998469995526702111
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1329)
Q Consensus 1038 ~Is~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ 1115 (1329)
.+..++|++.+.||+|+||.||+|++. +..||+|+++..... .....+.+|+.+|+.++|||||+++++|.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-------AIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT-------THHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CCCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCH-------HHHHHHHHHHHHHHHCCCCCCCCEEEEEE
T ss_conf 78756888978971277809999999899969999998754097-------89999999999998679999994999999
Q ss_pred CCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCCCCCCEEECCCCCCCCCEEEE
Q ss_conf 599971899998212883135441013457999999999999999999897-9903047987515754689988808994
Q 000726 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1116 esseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHs-kGIIHRDLKPsNILIDsdGni~~~VKLs 1194 (1329)
+.. .+++|||||++++|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++. +||+
T Consensus 75 ~~~--~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~----vkl~ 147 (322)
T d1s9ja_ 75 SDG--EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLC 147 (322)
T ss_dssp CSS--EEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC----EEEC
T ss_pred ECC--EEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCC----EEEE
T ss_conf 899--999999767998689987424-999999999999999999999998599971445779946878998----9995
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH------------
Q ss_conf 24775224686323687798764472111368899990568999999999999099999898856899------------
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII------------ 1262 (1329)
Q Consensus 1195 DFGLAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eil------------ 1262 (1329)
|||+|....... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 148 DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 224 (322)
T d1s9ja_ 148 DFGVSGQLIDSM-ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224 (322)
T ss_dssp CCCCCHHHHHHT-C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred ECCCCCCCCCCC-CCCCCCCCCCCCCHHHCC--CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 487762567886-211137714119468758--99894888998999999999888998998878999999887517754
Q ss_pred ------------------------------HHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf ------------------------------97872589999999892999999999215899999899999999999999
Q 000726 1263 ------------------------------GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1263 ------------------------------qqIve~~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~s 1312 (1329)
..+.............+.++.+|+.+||+.||.+|||++|+++|.|.-..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf 57742123332211112223541347788766502687667644489999999999868994679089999609864769
Q ss_pred HHC
Q ss_conf 711
Q 000726 1313 ACQ 1315 (1329)
Q Consensus 1313 a~s 1315 (1329)
...
T Consensus 305 ~~~ 307 (322)
T d1s9ja_ 305 DAE 307 (322)
T ss_dssp HHS
T ss_pred CCC
T ss_conf 823
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.30 Aligned_cols=252 Identities=35% Similarity=0.577 Sum_probs=219.0
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEC-CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 5667159988401583899999997-920899997216667998478999999999999998469995526702111599
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1040 s~eeYsllkvLGsGaFGtVYKAk~k-Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
..++|++.+.||+|+||.||+|+++ +..||||+++..... ..+|++|+.++++++||||++++++|.+..
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---------HHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 96997996898207883999999889989999998747577---------899999999999668986015889985078
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 97189999821288313544101345799999999999999999989799030479875157546899888089942477
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGL 1198 (1329)
.+++||||+++|+|..++......+++..++.|+.||++||.|||+++|+||||||+|||++.++. +||+|||+
T Consensus 73 --~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~----~kl~DfG~ 146 (258)
T d1k2pa_ 73 --PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV----VKVSDFGL 146 (258)
T ss_dssp --SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC----EEECCCSS
T ss_pred --CEEEEEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCC----EEECCCHH
T ss_conf --169999704899388864102467768999999999999999875468434665413588769984----79886144
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 52246863--236877987644721113688999905689999999999990-999998988568999787258999999
Q 000726 1199 SKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 1275 (1329)
Q Consensus 1199 Akli~~~~--~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLT-Gk~PFs~~~~~eilqqIve~~lrleip 1275 (1329)
+....... ......++..|+|||++.+ ..++.++||||||+++|||+| |+.||......+....+. ...++..+
T Consensus 147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p 223 (258)
T d1k2pa_ 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRP 223 (258)
T ss_dssp CCBCSSSSCCCCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCC
T ss_pred HEECCCCCCEEECCCCCCCCCCCCHHHCC--CCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHH-HCCCCCCC
T ss_conf 20235787225246578877578078637--9988521033643246739755999988999999999998-07978996
Q ss_pred CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 9892999999999215899999899999999999
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1276 ~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
..++..+.+||.+||+.+|.+|||+.+++++|.+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 5465999999999766897689399999987418
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.11 Aligned_cols=261 Identities=30% Similarity=0.573 Sum_probs=219.8
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEEC--CC----EEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEE
Q ss_conf 10135667159988401583899999997--92----0899997216667998478999999999999998469995526
Q 000726 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR--GT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109 (1329)
Q Consensus 1036 l~~Is~eeYsllkvLGsGaFGtVYKAk~k--Gt----~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVK 1109 (1329)
++.++.++|++++.||+|+||.||+|.+. ++ .||+|.++... .....++|.+|+.++++++|||||+
T Consensus 3 ~~~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~ 75 (317)
T d1xkka_ 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCR 75 (317)
T ss_dssp SEECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEE
T ss_conf 243888999783198208992999999958998898999999965134-------9799999999999998679988815
Q ss_pred EECCCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCC
Q ss_conf 70211159997189999821288313544101345799999999999999999989799030479875157546899888
Q 000726 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1329)
Q Consensus 1110 LlGif~esseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~ 1189 (1329)
++++|.+. ..+++++++.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++
T Consensus 76 l~g~~~~~---~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~---- 148 (317)
T d1xkka_ 76 LLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---- 148 (317)
T ss_dssp EEEEEESS---SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT----
T ss_pred EEEEEECC---CEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCC----
T ss_conf 89999619---83699984268740101113345799999999999999999999876950476212031167998----
Q ss_pred CEEEEECCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Q ss_conf 0899424775224686---3236877987644721113688999905689999999999990-99999898856899978
Q 000726 1190 ICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1265 (1329)
Q Consensus 1190 ~VKLsDFGLAkli~~~---~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLT-Gk~PFs~~~~~eilqqI 1265 (1329)
.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||+| |.+||......+....
T Consensus 149 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~- 225 (317)
T d1xkka_ 149 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI- 225 (317)
T ss_dssp EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH-
T ss_pred CEEEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHHHHC--CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-
T ss_conf 758602552223354445322365105864467088746--99983565440799999999779999999998999999-
Q ss_pred HHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 725899999998929999999992158999998999999999999997
Q 000726 1266 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1266 ve~~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa 1313 (1329)
+....+++.+..++..+.+|+.+||+.+|.+|||+.+++.+|+.+...
T Consensus 226 i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 975998999855689999999984789934691999999999998758
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=356.96 Aligned_cols=259 Identities=23% Similarity=0.287 Sum_probs=209.7
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC
Q ss_conf 5667159988401583899999997--92089999721666799847899999999999999846999552670211159
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 s~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~es 1117 (1329)
..++|++.+.||+|+||.||+|++. |..||||++.+..... ...+........++.+++.++|||||++++++.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~--~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--HTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCH--HHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
T ss_conf 7776851018842889099999999999799999984587542--66799999999999998508998588999999989
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECC
Q ss_conf 99718999982128831354410134579999999999999999998979903047987515754689988808994247
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 seg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFG 1197 (1329)
. .+++|||||++++|..++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||
T Consensus 80 ~--~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~----iKl~DFG 152 (364)
T d1omwa3 80 D--KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH----VRISDLG 152 (364)
T ss_dssp S--EEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC----EEECCCT
T ss_pred C--EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCC----EEEEEEC
T ss_conf 9--889999914898389998732-55327899999999999999999779622044422167858896----7982201
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HHCCCCCCCCC
Q ss_conf 75224686323687798764472111368899990568999999999999099999898856899978-72589999999
Q 000726 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI-VNNTLRPPVPG 1276 (1329)
Q Consensus 1198 LAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqI-ve~~lrleip~ 1276 (1329)
+|+...... ....+||+.|+|||++.. ...++.++|||||||++|+|++|+.||............ .........+.
T Consensus 153 la~~~~~~~-~~~~~GT~~y~APE~~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 230 (364)
T d1omwa3 153 LACDFSKKK-PHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230 (364)
T ss_dssp TCEECSSSC-CCSCCSCGGGCCHHHHST-TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS
T ss_pred EEEECCCCC-CCCCCCCCCCCHHHHHHC-CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 023337886-433113455421687603-899984410467789999998599988889989999999860468887887
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHH
Q ss_conf 89299999999921589999989-----9999999999
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLRV 1309 (1329)
Q Consensus 1277 ~vSeeL~dLIkkCLq~DPeERPS-----aeELLk~Le~ 1309 (1329)
.+++.+.+||.+||+.||.+||| ++++++|.|.
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f 268 (364)
T d1omwa3 231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268 (364)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred CCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCC
T ss_conf 78999999999985669888088743579999749102
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.54 Aligned_cols=255 Identities=19% Similarity=0.240 Sum_probs=220.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.++|++.+.||+|+||.||+|.+. ++.||||+++... . . ...+.+|+.+|+.++||||+++++++.+..
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~-~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----T-D---QVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----H-H---HHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-----C-C---HHHHHHHHHHHHHCCCCCCCEEEEEEEECC
T ss_conf 010588789831778399999998999699999975786-----6-5---999999999998579979890989998899
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 97189999821288313544101345799999999999999999989799030479875157546899888089942477
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGL 1198 (1329)
.+++|||||++++|.+++......+++.+++.|+.||+.||.|||+++|+||||||+|||++.++. ..+||+|||+
T Consensus 75 --~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~--~~ikl~DFG~ 150 (321)
T d1tkia_ 75 --ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS--STIKIIEFGQ 150 (321)
T ss_dssp --EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC--CCEEECCCTT
T ss_pred --EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCC--EEEEECCCCH
T ss_conf --889999538998088998753899999999999999999999998769975135544434437885--1899764411
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC--CC
Q ss_conf 5224686323687798764472111368899990568999999999999099999898856899978725899999--99
Q 000726 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV--PG 1276 (1329)
Q Consensus 1199 Akli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrlei--p~ 1276 (1329)
+.............+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.......+. ..
T Consensus 151 ~~~~~~~~~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (321)
T d1tkia_ 151 ARQLKPGDNFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred HHCCCCCCCCCCCCCCCCCCCCHHCCC--CCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHCC
T ss_conf 100346775321223322234021048--777840113027999999982899999989999999998389998802236
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 8929999999992158999998999999999999
Q 000726 1277 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1277 ~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L 1310 (1329)
.++.++.+||.+||..||.+|||+.++++|.|.-
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf 7899999999998669966890999996399656
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=351.41 Aligned_cols=262 Identities=24% Similarity=0.271 Sum_probs=225.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHH-HHHHHHHHHHHHHHHHHCC-CCCEEEEECCCCC
Q ss_conf 66715998840158389999999--792089999721666799847-8999999999999998469-9955267021115
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSE-QERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 1116 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~--kGt~VAVKiIKks~~sd~s~e-dE~~~keFlREIeILkkLr-HPNIVKLlGif~e 1116 (1329)
.++|++.+.||+|+||+||+|++ +++.||||++++......... .+.....+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf 99971899998212883135441013457999999999999999999897990304798751575468998880899424
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 sseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDF 1196 (1329)
.. .+++|||||++++|.+++... ..+++.+++.++.||+.||.|||+++|+||||||+|||++.++.. ||+||
T Consensus 82 ~~--~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~----kl~DF 154 (277)
T d1phka_ 82 NT--FFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI----KLTDF 154 (277)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE----EECCC
T ss_pred CC--CEEEEEECCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCE----EECCC
T ss_conf 76--059999768986689999865-999999999999999999999987599432346254898689983----87124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 77522468632368779876447211136----88999905689999999999990999998988568999787258999
Q 000726 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNG----SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1197 GLAkli~~~~~ss~v~GT~~YlAPEvL~G----s~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrl 1272 (1329)
|++.............||..|+|||++.+ ....++.++||||+||++|+|++|+.||...........+.......
T Consensus 155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 155 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred HHEEECCCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 03167268872134524678889888605344567889923318565602310322888988999999999998189888
Q ss_pred CC--CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 99--99892999999999215899999899999999999
Q 000726 1273 PV--PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1273 ei--p~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
+. ...+++++.+|+.+||+.+|.+|||+.++++|.|.
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~ 273 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 985434689999999999765896689199999739787
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=355.23 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=216.5
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.++|++++.||+|+||.||+|+++ |+.||||++++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-----RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECC
T ss_conf 54708888972076808999999899979999998457754-----8899999999999998636967533035685288
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 97189999821288313544101345799999999999999999989799030479875157546899888089942477
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGL 1198 (1329)
.+++|||||.+++|..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++. +||+|||+
T Consensus 78 --~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~----vkL~DFG~ 150 (316)
T d1fota_ 78 --QIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH----IKITDFGF 150 (316)
T ss_dssp --EEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC----EEECCCSS
T ss_pred --EEEEEEEECCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCC----EEEECCCC
T ss_conf --00567650378632234322-221110079999999987655412476770556810503868998----89831752
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 52246863236877987644721113688999905689999999999990999998988568999787258999999989
Q 000726 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1199 Akli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrleip~~v 1278 (1329)
|+...... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..... ..+..+
T Consensus 151 a~~~~~~~--~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 224 (316)
T d1fota_ 151 AKYVPDVT--YTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--RFPPFF 224 (316)
T ss_dssp CEECSSCB--CCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--CCCTTS
T ss_pred CEEECCCC--CCCCCCCCCCCHHHHCC--CCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC--CCCCCC
T ss_conf 16712456--43457634359999838--9998043046533368999759899999699999999970898--899778
Q ss_pred CHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHH
Q ss_conf 29999999992158999998-----99999999999
Q 000726 1279 DSEWRLLMEQCWAPDPVVRP-----SFTEIARRLRV 1309 (1329)
Q Consensus 1279 SeeL~dLIkkCLq~DPeERP-----SaeELLk~Le~ 1309 (1329)
++++.+++.+||+.||.+|+ +++++++|.|.
T Consensus 225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred CHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCC
T ss_conf 999999999995449976664310219999819351
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.75 Aligned_cols=256 Identities=33% Similarity=0.534 Sum_probs=212.0
Q ss_pred CCEEEE-EEECCCCCEEEEEEEEC----CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC
Q ss_conf 671599-88401583899999997----9208999972166679984789999999999999984699955267021115
Q 000726 1042 EDLEEL-KELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1042 eeYsll-kvLGsGaFGtVYKAk~k----Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~e 1116 (1329)
..+.+. +.||+|+||.||+|.++ ++.||||+++.... ......+|.+|+.+|++++|||||+++++|..
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~ 79 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN------DPALKDELLAEANVMQQLDNPYIVRMIGICEA 79 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES
T ss_pred HHCEECCCCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC
T ss_conf 537001878345878299999981697385999999880108------98999999999999986799898527777505
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf 99971899998212883135441013457999999999999999999897990304798751575468998880899424
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 sseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDF 1196 (1329)
. ..++||||+++|+|.+++.. ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++. +||+||
T Consensus 80 ~---~~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~----~kl~DF 151 (277)
T d1xbba_ 80 E---SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY----AKISDF 151 (277)
T ss_dssp S---SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE----EEECCC
T ss_pred C---CEEEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCC----CCCCCH
T ss_conf 9---77999974788968999752-257899999999999999976687479556777611310235675----123413
Q ss_pred CCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 775224686----3236877987644721113688999905689999999999990-99999898856899978725899
Q 000726 1197 GLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1271 (1329)
Q Consensus 1197 GLAkli~~~----~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLT-Gk~PFs~~~~~eilqqIve~~lr 1271 (1329)
|+++..... .......||+.|+|||++. ...++.++|||||||++|||++ |..||......+....+ ....+
T Consensus 152 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i-~~~~~ 228 (277)
T d1xbba_ 152 GLSKALRADENYYKAQTHGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGER 228 (277)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCC
T ss_pred HHHHHCCCCCCCCCCCCCCCCCCEECCCHHHC--CCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHH-HCCCC
T ss_conf 45331343234432244567784203916653--7999843443034031328965899999998999999999-82899
Q ss_pred CCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 9999989299999999921589999989999999999999971
Q 000726 1272 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 1314 (1329)
Q Consensus 1272 leip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa~ 1314 (1329)
++.+..++..+.+||.+||+.||.+|||+.+++..|+.+...+
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHHC
T ss_conf 9998656799999999975889768909899999852887504
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=357.78 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=216.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.++|++++.||+|+||.||+|+++ |+.||||++.+.... .......+.+|+.+|+.++||||+++++++.+..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-----KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCC
T ss_conf 23708988961176808999999899989999998267745-----8899999999999999748772740344443222
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 97189999821288313544101345799999999999999999989799030479875157546899888089942477
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGL 1198 (1329)
.+++||||+.+++|..++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||+
T Consensus 115 --~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~----ikL~DFG~ 187 (350)
T d1rdqe_ 115 --NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY----IQVTDFGF 187 (350)
T ss_dssp --EEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC----EEECCCTT
T ss_pred --CCCCCCCCCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCC----EEEEECEE
T ss_conf --223222233466226667515-89899999999999999899998599861767999936077897----88610103
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 52246863236877987644721113688999905689999999999990999998988568999787258999999989
Q 000726 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 1278 (1329)
Q Consensus 1199 Akli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrleip~~v 1278 (1329)
|+...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..... ..+..+
T Consensus 188 a~~~~~~~--~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 261 (350)
T d1rdqe_ 188 AKRVKGRT--WTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--RFPSHF 261 (350)
T ss_dssp CEECSSCB--CCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTC
T ss_pred EEECCCCC--CCCCCCCCCCCHHHHCC--CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC--CCCCCC
T ss_conf 33225666--43367635678899717--9988533114500789999758899899599999999861798--897668
Q ss_pred CHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHH
Q ss_conf 29999999992158999998-----99999999999
Q 000726 1279 DSEWRLLMEQCWAPDPVVRP-----SFTEIARRLRV 1309 (1329)
Q Consensus 1279 SeeL~dLIkkCLq~DPeERP-----SaeELLk~Le~ 1309 (1329)
++++.+||.+||+.||.+|+ |++++++|.|.
T Consensus 262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred CHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCC
T ss_conf 999999999983409986065534549999719051
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.00 Aligned_cols=264 Identities=30% Similarity=0.488 Sum_probs=219.8
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEEC-------CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCC
Q ss_conf 110135667159988401583899999997-------92089999721666799847899999999999999846-9995
Q 000726 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 1106 (1329)
Q Consensus 1035 ~l~~Is~eeYsllkvLGsGaFGtVYKAk~k-------Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkL-rHPN 1106 (1329)
.-|.+.+++|++.+.||+|+||.||+|.+. ++.||||+++... .......+.+|...+.++ +|+|
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~e~~~l~~~~~h~~ 78 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLN 78 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC-------CCHHHHHHHHHHHHHHHHCCCCE
T ss_conf 25261679979844984167839999998677755578399999986001-------71789999999999886149984
Q ss_pred EEEEECCCCCCCCCEEEEEEEECCCCCHHHHHHCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Q ss_conf 526702111599971899998212883135441013---------------45799999999999999999989799030
Q 000726 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 1171 (1329)
Q Consensus 1107 IVKLlGif~esseg~L~LVMEYieGGSL~dlL~~ke---------------k~LSe~qIlkIA~QIAsALaYLHskGIIH 1171 (1329)
|+.+++++... ...+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+++|+|
T Consensus 79 iv~~~~~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivH 157 (299)
T d1ywna1 79 VVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 157 (299)
T ss_dssp BCCEEEEECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEEEEECCC-CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 99741154047-97579999845899299999853666665322202332146899999999999999999887379717
Q ss_pred CCCCCCCEEECCCCCCCCCEEEEECCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 479875157546899888089942477522468---63236877987644721113688999905689999999999990
Q 000726 1172 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248 (1329)
Q Consensus 1172 RDLKPsNILIDsdGni~~~VKLsDFGLAkli~~---~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLT 1248 (1329)
|||||+|||++.++. +||+|||+|+.... ........||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 158 rDlKp~NILl~~~~~----~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 158 RDLAARNILLSEKNV----VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp SCCCGGGEEECGGGC----EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHT
T ss_pred CCCCCCCEEECCCCC----EEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHC--CCCCCCCCEEEHHHHHHHHHH
T ss_conf 867731065779982----89845752001135665222475166721020368646--889966322136789999986
Q ss_pred C-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 9-999989885689997872589999999892999999999215899999899999999999999
Q 000726 1249 G-EEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 1312 (1329)
Q Consensus 1249 G-k~PFs~~~~~eilqqIve~~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~s 1312 (1329)
+ .+||............+....+++.+..+++.+.+||.+||+.||.+|||+.+++++|+.+..
T Consensus 232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 232 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp TSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 88999989998999999996389888886578999999999767796679199999999979986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.68 Aligned_cols=251 Identities=30% Similarity=0.475 Sum_probs=206.5
Q ss_pred EEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC--CC
Q ss_conf 159988401583899999997--92089999721666799847899999999999999846999552670211159--99
Q 000726 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG--PG 1119 (1329)
Q Consensus 1044 YsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~es--se 1119 (1329)
|++.++||+|+||.||+|.+. +..||+|.+...... +.....+.+|+.+|++++|||||++++++.+. ..
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCC
T ss_conf 88516970082849999999999959999998512279------899999999999998579998506999984033458
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCEEECC-CCCCCCCEEEEEC
Q ss_conf 7189999821288313544101345799999999999999999989799--030479875157546-8998880899424
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNL-KDPIRPICKVGDF 1196 (1329)
Q Consensus 1120 g~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskG--IIHRDLKPsNILIDs-dGni~~~VKLsDF 1196 (1329)
..+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++ .+||+||
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~----~~Kl~DF 159 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG----SVKIGDL 159 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS----CEEECCT
T ss_pred CEEEEEEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCC----CEEEEEC
T ss_conf 8899999578989489997513-5546999999999999999999978997996876743511667999----8898005
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHCCCCCCCC
Q ss_conf 775224686323687798764472111368899990568999999999999099999898856899-9787258999999
Q 000726 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII-GGIVNNTLRPPVP 1275 (1329)
Q Consensus 1197 GLAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eil-qqIve~~lrleip 1275 (1329)
|+++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+ ..+.........+
T Consensus 160 Gla~~~~~~~-~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 160 GLATLKRASF-AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235 (270)
T ss_dssp TGGGGCCTTS-BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred CCCEECCCCC-CCCCCCCCCCCCHHHHCC---CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCC
T ss_conf 7654236876-677553813008988478---999867110079999999878899987655999999997389986567
Q ss_pred CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 9892999999999215899999899999999999
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1276 ~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
..+++++.+||.+||+.||++|||+.|+++|.|.
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~f 269 (270)
T d1t4ha_ 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269 (270)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf 5578999999999763797589299999677540
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.76 Aligned_cols=261 Identities=33% Similarity=0.573 Sum_probs=221.0
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECC-----CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 01356671599884015838999999979-----2089999721666799847899999999999999846999552670
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1329)
Q Consensus 1037 ~~Is~eeYsllkvLGsGaFGtVYKAk~kG-----t~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLl 1111 (1329)
+++.+++|++.+.||+|+||.||+|.+.. ..||||.++... .+.....|.+|+.++++++||||++++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~ 74 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLI 74 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 9768899698779930788299999993699644999999936566-------879999999999999868999985698
Q ss_pred CCCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCE
Q ss_conf 21115999718999982128831354410134579999999999999999998979903047987515754689988808
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1112 Gif~esseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~V 1191 (1329)
+++.+ ..+++||||+++|+|..++......+++..++.++.||+.||.|||+++|+||||||+|||++.++. +
T Consensus 75 ~~~~~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~----~ 147 (273)
T d1mp8a_ 75 GVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC----V 147 (273)
T ss_dssp EEECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE----E
T ss_pred EEEEC---CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCC----E
T ss_conf 89953---7479999840698077654224789999999999999987752302267441410265532067896----7
Q ss_pred EEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHC
Q ss_conf 9942477522468--63236877987644721113688999905689999999999990-99999898856899978725
Q 000726 1192 KVGDFGLSKIKRN--TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1268 (1329)
Q Consensus 1192 KLsDFGLAkli~~--~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLT-Gk~PFs~~~~~eilqqIve~ 1268 (1329)
||+|||+++.... ........||+.|+|||++. ...++.++|||||||++|||++ |.+||......+....+..
T Consensus 148 Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~--~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~- 224 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN- 224 (273)
T ss_dssp EECC-------------------CCGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-
T ss_pred EECCCHHHEECCCCCCEECCCEECCCCCCHHHHHC--CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-
T ss_conf 87650342133677623305400583103266751--699887452444247899998269999888999999999981-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 8999999989299999999921589999989999999999999971
Q 000726 1269 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 1314 (1329)
Q Consensus 1269 ~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa~ 1314 (1329)
..+.+.+..+++.+.+||.+||+.||.+|||+.+|+++|+.+....
T Consensus 225 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 225 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf 8999898777999999999976879768929999999999997786
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.28 Aligned_cols=259 Identities=34% Similarity=0.549 Sum_probs=215.4
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEEC-CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCC
Q ss_conf 10135667159988401583899999997-92089999721666799847899999999999999846999552670211
Q 000726 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1329)
Q Consensus 1036 l~~Is~eeYsllkvLGsGaFGtVYKAk~k-Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif 1114 (1329)
-|.+..++|++.+.||+|+||.||+|.++ +..||||+++..... ...|.+|+.++++++|||||++++++
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---------~~~~~~E~~~l~~l~h~nIv~~~g~~ 81 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVV 81 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CEECCHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf 607477997984699307980999999999999999998804488---------89999999999866667886899998
Q ss_pred CCCCCCEEEEEEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEE
Q ss_conf 1599971899998212883135441013-457999999999999999999897990304798751575468998880899
Q 000726 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1115 ~esseg~L~LVMEYieGGSL~dlL~~ke-k~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKL 1193 (1329)
.+. .+++||||+++|+|..++.... ..+++.+++.++.||+.||+|||.++|+||||||+|||++.++. +||
T Consensus 82 ~~~---~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~----~kl 154 (285)
T d1fmka3 82 SEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV----CKV 154 (285)
T ss_dssp CSS---SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC----EEE
T ss_pred ECC---CEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCC----EEE
T ss_conf 239---7599999447994354200003553059999999999999999875411433531230799989992----998
Q ss_pred EECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHHCCC
Q ss_conf 424775224686--32368779876447211136889999056899999999999909999-989885689997872589
Q 000726 1194 GDFGLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP-YANMHYGAIIGGIVNNTL 1270 (1329)
Q Consensus 1194 sDFGLAkli~~~--~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~P-Fs~~~~~eilqqIve~~l 1270 (1329)
+|||+++..... .......|++.|+|||++. ...++.++|||||||++|||++|..| +......+.+.. +....
T Consensus 155 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~-i~~~~ 231 (285)
T d1fmka3 155 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGY 231 (285)
T ss_dssp CCCCTTC--------------CCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTC
T ss_pred CCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHH--CCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHH-HHHCC
T ss_conf 442555425688733524545566545808983--799891774132358999998689999988889999999-98268
Q ss_pred CCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 9999998929999999992158999998999999999999997
Q 000726 1271 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1271 rleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa 1313 (1329)
+.+.+..++..+.+||.+||+.+|++||++.+|+..|+.+...
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 9999832379999999997566975891999999987666238
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.14 Aligned_cols=257 Identities=35% Similarity=0.603 Sum_probs=222.6
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC
Q ss_conf 01356671599884015838999999979208999972166679984789999999999999984699955267021115
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1037 ~~Is~eeYsllkvLGsGaFGtVYKAk~kGt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~e 1116 (1329)
|.+..++|++.+.||+|+||.||+|.++++.||||+++... ....|.+|+.++++++||||+++++++.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 71 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred CCCCHHHEEEEEEEECCCCEEEEEEEECCEEEEEEEECCHH----------HHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 95578994885798207980899999999099999988577----------79999999999986789898549878872
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEE
Q ss_conf 99971899998212883135441013-45799999999999999999989799030479875157546899888089942
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1117 sseg~L~LVMEYieGGSL~dlL~~ke-k~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsD 1195 (1329)
.. ..+++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+|||++.++. +||+|
T Consensus 72 ~~-~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~----~kl~d 146 (262)
T d1byga_ 72 EK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV----AKVSD 146 (262)
T ss_dssp C---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC----EEECC
T ss_pred CC-CCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCC----EEECC
T ss_conf 38-92899996369998999987457888899999999999985232113376553666567601468997----76324
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 47752246863236877987644721113688999905689999999999990-99999898856899978725899999
Q 000726 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1196 FGLAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLT-Gk~PFs~~~~~eilqqIve~~lrlei 1274 (1329)
||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++ |++||......+....+ ....+++.
T Consensus 147 fg~s~~~~~~~--~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-~~~~~~~~ 221 (262)
T d1byga_ 147 FGLTKEASSTQ--DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDA 221 (262)
T ss_dssp CCC--------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-TTTCCCCC
T ss_pred CCCCEECCCCC--CCCCCCCCCCCHHHHHC--CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HCCCCCCC
T ss_conf 56003447877--65566646778178727--988858877757999999997899999999999999999-80899999
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 998929999999992158999998999999999999997
Q 000726 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1275 p~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa 1313 (1329)
+..+++.+.+||.+||+.||.+|||+.+++++|+.++..
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 765799999999997566976893999999999999867
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.57 Aligned_cols=264 Identities=33% Similarity=0.523 Sum_probs=222.8
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEEC--CC--EEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCEEE
Q ss_conf 110135667159988401583899999997--92--089999721666799847899999999999999846-9995526
Q 000726 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWR--GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVA 1109 (1329)
Q Consensus 1035 ~l~~Is~eeYsllkvLGsGaFGtVYKAk~k--Gt--~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkL-rHPNIVK 1109 (1329)
..+.|.+++|++.++||+|+||.||+|.++ +. .||||.++.... ......|.+|+.+|..+ +||||++
T Consensus 3 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~~HpnIv~ 75 (309)
T d1fvra_ 3 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIIN 75 (309)
T ss_dssp CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCC
T ss_pred CCCCCCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCC-------HHHHHHHHHHHHHHHHCCCCCCEEE
T ss_conf 899668799688779820788289999998999699999999782338-------5799999999999986228998836
Q ss_pred EECCCCCCCCCEEEEEEEECCCCCHHHHHHCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCC
Q ss_conf 70211159997189999821288313544101---------------345799999999999999999989799030479
Q 000726 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK---------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDL 1174 (1329)
Q Consensus 1110 LlGif~esseg~L~LVMEYieGGSL~dlL~~k---------------ek~LSe~qIlkIA~QIAsALaYLHskGIIHRDL 1174 (1329)
+++++.+.. .+++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+||||
T Consensus 76 ~~~~~~~~~--~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDl 153 (309)
T d1fvra_ 76 LLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 153 (309)
T ss_dssp EEEEEEETT--EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EEEEEECCC--EEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 788884187--369999802898699998640355555123101234578999999999999999987663089545550
Q ss_pred CCCCEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCC
Q ss_conf 8751575468998880899424775224686323687798764472111368899990568999999999999099-999
Q 000726 1175 KCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE-EPY 1253 (1329)
Q Consensus 1175 KPsNILIDsdGni~~~VKLsDFGLAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk-~PF 1253 (1329)
||+|||++.++. +||+|||+++............|+..|+|||.+. ...++.++|||||||++|||++|. +||
T Consensus 154 kp~NIL~~~~~~----~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDvwSfGvil~ell~~~~~p~ 227 (309)
T d1fvra_ 154 AARNILVGENYV----AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPY 227 (309)
T ss_dssp SGGGEEECGGGC----EEECCTTCEESSCEECCC----CCTTTCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCEEEECCCCC----EEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHC--CCCCCCCCEEEHHHHHHHHHHHCCCCCC
T ss_conf 520489868876----3874344322444223455301377555538752--6999962215313889999983689999
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 8988568999787258999999989299999999921589999989999999999999971
Q 000726 1254 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 1314 (1329)
Q Consensus 1254 s~~~~~eilqqIve~~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa~ 1314 (1329)
......+....+. ...+++.+..+++.+.+||.+||+.||++|||+.+++++|+.+....
T Consensus 228 ~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 228 CGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp TTCCHHHHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCCHHHHHHHHH-HCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 9999999999998-26888887667899999999976789668949999999999998618
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.82 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=207.4
Q ss_pred CCCEEEEE-EECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCEEEEECCCCC
Q ss_conf 66715998-8401583899999997--92089999721666799847899999999999999846-99955267021115
Q 000726 1041 NEDLEELK-ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 1116 (1329)
Q Consensus 1041 ~eeYsllk-vLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkL-rHPNIVKLlGif~e 1116 (1329)
.++|.+.. .||+|+||.||+|++. ++.||||+++.. ..+.+|+.++.++ +||||+++++++.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-------------HHHHHHHHHHHHHCCCCCCCEEEEEEEE
T ss_conf 148798107965454869999998899989999998974-------------7799999999986699997829899950
Q ss_pred --CCCCEEEEEEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEE
Q ss_conf --99971899998212883135441013-457999999999999999999897990304798751575468998880899
Q 000726 1117 --GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1117 --sseg~L~LVMEYieGGSL~dlL~~ke-k~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKL 1193 (1329)
..+..+++|||||++|+|.+++.... ..+++.+++.|+.||+.||.|||+++|+||||||+|||++..+. ...+||
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~-~~~~Kl 155 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP-NAILKL 155 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSST-TCCEEE
T ss_pred CCCCCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC-CCCCCC
T ss_conf 3468978999997789984999998627877579999999999999999999769864441002201135555-663113
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC----C
Q ss_conf 424775224686323687798764472111368899990568999999999999099999898856899978725----8
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN----T 1269 (1329)
Q Consensus 1194 sDFGLAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~----~ 1269 (1329)
+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+... .
T Consensus 156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~ 233 (335)
T d2ozaa1 156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233 (335)
T ss_dssp CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCCHHHCC--CCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCC
T ss_conf 54551233368886432267756379277748--9888888887645167788658899889887788999999985388
Q ss_pred CCCCCC--CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 999999--98929999999992158999998999999999999
Q 000726 1270 LRPPVP--GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1270 lrleip--~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L 1310 (1329)
...+.+ ..+++++.+||.+||+.||.+|||+.++++|.|..
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHH
T ss_conf 8889854346999999999997569965790999997098761
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.68 Aligned_cols=259 Identities=34% Similarity=0.573 Sum_probs=224.1
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECC-----CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEC
Q ss_conf 1356671599884015838999999979-----20899997216667998478999999999999998469995526702
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1329)
Q Consensus 1038 ~Is~eeYsllkvLGsGaFGtVYKAk~kG-----t~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlG 1112 (1329)
.|..++|++.+.||+|+||.||+|+++. ..||||+++..... .+....+|.+|+.+++.++||||+++++
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPEAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 88648919978980388839999999889990799999999835557-----9899999999999998689999878987
Q ss_pred CCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEE
Q ss_conf 11159997189999821288313544101345799999999999999999989799030479875157546899888089
Q 000726 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1113 if~esseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VK 1192 (1329)
++.+. ..++||||++++++.+.+......+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+|
T Consensus 79 ~~~~~---~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~----~vk 151 (273)
T d1u46a_ 79 VVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVK 151 (273)
T ss_dssp EECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT----EEE
T ss_pred EEEEC---CHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCC----CEE
T ss_conf 77401---00114654238612544421268999999999999999999875217875205668881565565----433
Q ss_pred EEECCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHH
Q ss_conf 94247752246863----236877987644721113688999905689999999999990-9999989885689997872
Q 000726 1193 VGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1193 LsDFGLAkli~~~~----~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLT-Gk~PFs~~~~~eilqqIve 1267 (1329)
|+|||+++...... ......++..|+|||++.+ ..++.++||||||+++|||++ |..||......+....+..
T Consensus 152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~ 229 (273)
T d1u46a_ 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229 (273)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred ECCCHHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHC--CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
T ss_conf 2561155530358875265476325731079999837--99994215661489999999689999999699999999984
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 5899999998929999999992158999998999999999999
Q 000726 1268 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1268 ~~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L 1310 (1329)
...+++.+..++..+.+|+.+||+.||.+|||+.+|++.|...
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf 7999998544539999999997688966792999999999964
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=349.38 Aligned_cols=257 Identities=32% Similarity=0.544 Sum_probs=217.7
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECC-------CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEE
Q ss_conf 1356671599884015838999999979-------208999972166679984789999999999999984699955267
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 1110 (1329)
Q Consensus 1038 ~Is~eeYsllkvLGsGaFGtVYKAk~kG-------t~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKL 1110 (1329)
++..++|++.+.||+|+||.||+|++++ +.||||+++... ......+|.+|+.+++.++||||+++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~il~~l~h~niv~~ 81 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVKL 81 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC-------CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 38988938867982078839999998887657788299999988210-------85799999999999996689976552
Q ss_pred ECCCCCCCCCEEEEEEEECCCCCHHHHHHCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 02111599971899998212883135441013-----------------------4579999999999999999998979
Q 000726 1111 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-----------------------RHLDRRKRLIIAMDAAFGMEYLHSK 1167 (1329)
Q Consensus 1111 lGif~esseg~L~LVMEYieGGSL~dlL~~ke-----------------------k~LSe~qIlkIA~QIAsALaYLHsk 1167 (1329)
+++|.... ..+++|||+++++|.+++.... ..+++..++.|+.|++.||+|||++
T Consensus 82 ~~~~~~~~--~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~ 159 (301)
T d1lufa_ 82 LGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 159 (301)
T ss_dssp EEEECSSS--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEECCCC--CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC
T ss_conf 46660598--0389998158992999998527554210000111001210346788989999999999999985541357
Q ss_pred CEEECCCCCCCEEECCCCCCCCCEEEEECCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 9030479875157546899888089942477522468---6323687798764472111368899990568999999999
Q 000726 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLW 1244 (1329)
Q Consensus 1168 GIIHRDLKPsNILIDsdGni~~~VKLsDFGLAkli~~---~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLy 1244 (1329)
+|+||||||+|||++.++. +||+|||+++.... ........+++.|+|||++. ...++.++|||||||++|
T Consensus 160 ~ivHrDlKp~NILld~~~~----~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~t~ksDVwS~Gvvl~ 233 (301)
T d1lufa_ 160 KFVHRDLATRNCLVGENMV----VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLW 233 (301)
T ss_dssp TCCCSCCSGGGEEECGGGC----EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH--HCCCCHHHHHHHHHHHHH
T ss_pred CEEEEEECCCCEEECCCCC----EEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHC--CCCCCHHHHHCCCHHHHH
T ss_conf 8685488401168989992----8983314421136776411157777676767989972--688980563025236299
Q ss_pred HHHHCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 999099-999898856899978725899999998929999999992158999998999999999999
Q 000726 1245 EILTGE-EPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1245 ELLTGk-~PFs~~~~~eilqqIve~~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L 1310 (1329)
||+++. +||......+....+.. ..+++.+..+++++.+||.+||+.+|.+||||.+|+++|+.+
T Consensus 234 ell~~~~~p~~~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 234 EIFSYGLQPYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHCCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 998068999999899999999973-997888732529999999997488965793999999999984
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.89 Aligned_cols=265 Identities=31% Similarity=0.485 Sum_probs=225.9
Q ss_pred CCCCCCCCCCEEEEEEECCCCCEEEEEEEEC-------CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCC
Q ss_conf 3110135667159988401583899999997-------92089999721666799847899999999999999846-999
Q 000726 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 1105 (1329)
Q Consensus 1034 s~l~~Is~eeYsllkvLGsGaFGtVYKAk~k-------Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkL-rHP 1105 (1329)
...|.+..++|++.+.||+|+||.||+|++. ++.||||+++... .......|.+|+.+++.+ +||
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~~~~~l~~Hp 87 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-------HLTEREALMSELKVLSYLGNHM 87 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCT
T ss_pred CCCCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCC
T ss_conf 402637789969854982068829999998066447788699999987424-------8779999999999987626999
Q ss_pred CEEEEECCCCCCCCCEEEEEEEECCCCCHHHHHHCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 5526702111599971899998212883135441013-----------------45799999999999999999989799
Q 000726 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-----------------RHLDRRKRLIIAMDAAFGMEYLHSKN 1168 (1329)
Q Consensus 1106 NIVKLlGif~esseg~L~LVMEYieGGSL~dlL~~ke-----------------k~LSe~qIlkIA~QIAsALaYLHskG 1168 (1329)
|||++++++.+.. .+++|||||++++|..++.... ..+++..++.++.||+.||+|||+++
T Consensus 88 nIv~~~g~~~~~~--~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ 165 (311)
T d1t46a_ 88 NIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165 (311)
T ss_dssp TBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEEEEEEEECC--EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 8878998983199--78999973799879999985356654444453322233458899999999999999999887579
Q ss_pred EEECCCCCCCEEECCCCCCCCCEEEEECCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 030479875157546899888089942477522468---63236877987644721113688999905689999999999
Q 000726 1169 IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWE 1245 (1329)
Q Consensus 1169 IIHRDLKPsNILIDsdGni~~~VKLsDFGLAkli~~---~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyE 1245 (1329)
++||||||+|||++.++. ++++|||.++.... ........|++.|+|||++. ...++.++|||||||++||
T Consensus 166 ivHrDLKp~NIl~~~~~~----~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DIwS~G~~l~e 239 (311)
T d1t46a_ 166 CIHRDLAARNILLTHGRI----TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWE 239 (311)
T ss_dssp CCCSCCSGGGEEEETTTE----EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHH
T ss_pred EEECCCCCCCCCCCCCCC----CCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHC--CCCCCCCCCCCCHHHHHHH
T ss_conf 266624102100002575----2102340102336788615862013596876778861--7999974001025899999
Q ss_pred HHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 990-99999898856899978725899999998929999999992158999998999999999999997
Q 000726 1246 ILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1246 LLT-Gk~PFs~~~~~eilqqIve~~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa 1313 (1329)
|++ |.+||........+..++....++..+..++..+.+||.+||+.||.+|||+.+|++.|+.....
T Consensus 240 llt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 985899887789989999999866898898543659999999997577965792999999999876534
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.40 Aligned_cols=252 Identities=29% Similarity=0.452 Sum_probs=212.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHH-HCCCCCEEEEECCCCCCC
Q ss_conf 6715998840158389999999--7920899997216667998478999999999999998-469995526702111599
Q 000726 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS-KLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1042 eeYsllkvLGsGaFGtVYKAk~--kGt~VAVKiIKks~~sd~s~edE~~~keFlREIeILk-kLrHPNIVKLlGif~ess 1118 (1329)
++|++.+.||+|+||+||+|++ +++.||||++++.... .+.....+..|..++. .++||||+++++++.+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~-----~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC
T ss_conf 9718865894087828999999999989999998055533-----84899999999999998479996878988970498
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 97189999821288313544101345799999999999999999989799030479875157546899888089942477
Q 000726 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1329)
Q Consensus 1119 eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGL 1198 (1329)
.+++|||||++|+|..++.. ...+++.+++.++.||+.||.|||+++|+||||||+|||++.++.. ||+|||+
T Consensus 77 --~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~----kl~DFG~ 149 (320)
T d1xjda_ 77 --NLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHI----KIADFGM 149 (320)
T ss_dssp --EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE----EECCCTT
T ss_pred --CEEEEEEECCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCE----ECCCCCH
T ss_conf --31677750379808998640-4789999999999999999999986893403476540444489963----0155530
Q ss_pred CCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 52246-86323687798764472111368899990568999999999999099999898856899978725899999998
Q 000726 1199 SKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 1277 (1329)
Q Consensus 1199 Akli~-~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrleip~~ 1277 (1329)
++... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.... +..+..
T Consensus 150 a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~ 225 (320)
T d1xjda_ 150 CKENMLGDAKTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRW 225 (320)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTT
T ss_pred HHHCCCCCCCCCCCCCCCCCCCHHHHCC--CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--CCCCCC
T ss_conf 2323566533454578777689999827--998832320112278989873889999989999999997189--989756
Q ss_pred CCHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Q ss_conf 929999999992158999998999-99999999
Q 000726 1278 CDSEWRLLMEQCWAPDPVVRPSFT-EIARRLRV 1309 (1329)
Q Consensus 1278 vSeeL~dLIkkCLq~DPeERPSae-ELLk~Le~ 1309 (1329)
+++.+.+||.+||+.||.+||++. ++++|.|.
T Consensus 226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff 258 (320)
T d1xjda_ 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258 (320)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred CCHHHHHHHHHHCCCCCCCCCCHHHHHHHCCHH
T ss_conf 799999999996544898783889999809013
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=343.02 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=218.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.++|++.+.||+|+||.||+|++. ++.||||+++..... .......|.+|+.+++.++||||+++++++....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC
T ss_conf 62069868996089929999999999989999998556646-----9899999999999998569998873114354326
Q ss_pred C--CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf 9--71899998212883135441013457999999999999999999897990304798751575468998880899424
Q 000726 1119 G--GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1119 e--g~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDF 1196 (1329)
. ..+++||||+++++|..++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.. +++||
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~----~l~d~ 155 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAV----KVMDF 155 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCE----EECCC
T ss_pred CCCCEEEEEEECCCCCEEHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCC----EEEHH
T ss_conf 8876699999778898710112035-899999999999999999999985795276346755665754320----10034
Q ss_pred CCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 77522468----63236877987644721113688999905689999999999990999998988568999787258999
Q 000726 1197 GLSKIKRN----TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1272 (1329)
Q Consensus 1197 GLAkli~~----~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrl 1272 (1329)
|.+..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCC--CCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 443221235443333464257624369999839--999966320265289999976979989969999999998469999
Q ss_pred C--CCCCCCHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf 9--9998929999999992158999998-9999999999999
Q 000726 1273 P--VPGFCDSEWRLLMEQCWAPDPVVRP-SFTEIARRLRVMS 1311 (1329)
Q Consensus 1273 e--ip~~vSeeL~dLIkkCLq~DPeERP-SaeELLk~Le~L~ 1311 (1329)
+ ....+++.+.++|.+||++||.+|| ++++++..|..++
T Consensus 234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf 710034789999999999866797677739999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.09 Aligned_cols=261 Identities=31% Similarity=0.527 Sum_probs=222.1
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECC---------CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCC
Q ss_conf 01356671599884015838999999979---------2089999721666799847899999999999999846-9995
Q 000726 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 1106 (1329)
Q Consensus 1037 ~~Is~eeYsllkvLGsGaFGtVYKAk~kG---------t~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkL-rHPN 1106 (1329)
|.+..++|++.+.||+|+||.||+|++.+ ..||||+++... .+....++.+|...+.++ +|||
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHHCCCCE
T ss_conf 72258996970098516782899999857875556675499999988112-------86889999999999998139996
Q ss_pred EEEEECCCCCCCCCEEEEEEEECCCCCHHHHHHCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Q ss_conf 526702111599971899998212883135441013---------------45799999999999999999989799030
Q 000726 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 1171 (1329)
Q Consensus 1107 IVKLlGif~esseg~L~LVMEYieGGSL~dlL~~ke---------------k~LSe~qIlkIA~QIAsALaYLHskGIIH 1171 (1329)
||+++++|.+.. .+++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++|+|
T Consensus 81 Iv~~~~~~~~~~--~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivH 158 (299)
T d1fgka_ 81 IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 158 (299)
T ss_dssp BCCEEEEECSSS--SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEECCCCCCCCC--EEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
T ss_conf 973465220188--689999736999099999860677643222334574346799999999999999998766379786
Q ss_pred CCCCCCCEEECCCCCCCCCEEEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 47987515754689988808994247752246863---236877987644721113688999905689999999999990
Q 000726 1172 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 1248 (1329)
Q Consensus 1172 RDLKPsNILIDsdGni~~~VKLsDFGLAkli~~~~---~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLT 1248 (1329)
|||||+|||++.++. +||+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|||++
T Consensus 159 rDiKp~NiLl~~~~~----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 159 RDLAARNVLVTEDNV----MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFT 232 (299)
T ss_dssp SCCSGGGEEECTTCC----EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHT
T ss_pred EEECCCCEEECCCCC----EEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCC--CCCCCHHHHHHHHHHHHHHCC
T ss_conf 302210224547897----67622111011355555431466788846632667517--988825554775888887401
Q ss_pred -CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf -99999898856899978725899999998929999999992158999998999999999999997
Q 000726 1249 -GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 1313 (1329)
Q Consensus 1249 -Gk~PFs~~~~~eilqqIve~~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa 1313 (1329)
|.+||........... +....+++.+..+++.+.+||.+||+.+|.+|||+.+|++.|+.+.+.
T Consensus 233 ~g~~p~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 233 LGGSPYPGVPVEELFKL-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp TSCCSSTTCCHHHHHHH-HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHH-HHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 79898999999999999-972888898743529999999997667976793999999999888604
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.75 Aligned_cols=267 Identities=25% Similarity=0.305 Sum_probs=211.4
Q ss_pred EEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCCCEEE
Q ss_conf 9988401583899999997--92089999721666799847899999999999999846999552670211159997189
Q 000726 1046 ELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1329)
Q Consensus 1046 llkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~esseg~L~ 1123 (1329)
.+++||+|+||+||+|+++ ++.||||+++...... ..+.....+.+|+.+++.++|||||++++++.+.. .++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCE
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---HHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC--CEE
T ss_conf 5638512728299999999999699999984202124---56799999999999998679999868985422587--402
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCCCCCCC
Q ss_conf 99982128831354410134579999999999999999998979903047987515754689988808994247752246
Q 000726 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1329)
Q Consensus 1124 LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGLAkli~ 1203 (1329)
+||||+.++++.... .....+++..+..++.||+.||.|||+++|+||||||+|||++.++.. ||+|||++....
T Consensus 77 ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~----KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVL----KLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE----EECCCGGGSTTT
T ss_pred EHHHHHCCHHHHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCC----CCCCCCCCCCCC
T ss_conf 204553450776554-126677899999999999999988631635503577625885377841----146576100057
Q ss_pred C-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC----------
Q ss_conf 8-63236877987644721113688999905689999999999990999998988568999787258999----------
Q 000726 1204 N-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP---------- 1272 (1329)
Q Consensus 1204 ~-~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrl---------- 1272 (1329)
. ........||+.|+|||++.+ ...++.++|||||||++|+|++|.+||......+.+..+......+
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTT-CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred CCCCCCCCEECCHHHCCHHHHCC-CCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHC
T ss_conf 87554330204733363999726-77888056436304289999859699999999999999998518997254521000
Q ss_pred -----------C-----CCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf -----------9-----99989299999999921589999989999999999999971167889855579999
Q 000726 1273 -----------P-----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQVQNQVPK 1329 (1329)
Q Consensus 1273 -----------e-----ip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa~st~s~e~~V~~qiPK 1329 (1329)
. .....++.+.+|+.+||+.||.+|||+.|+++|.|. .....+...+++|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f------~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF------SNRPGPTPGCQLPR 297 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG------TSSSCCCCSSSSCC
T ss_pred CCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH------CCCCCCCCCCCCCC
T ss_conf 21344303478988678565689999999999763894569089999679965------78999989888999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.54 Aligned_cols=258 Identities=29% Similarity=0.487 Sum_probs=211.1
Q ss_pred EEEEEECCCCCEEEEEEEECC-----CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCC
Q ss_conf 599884015838999999979-----208999972166679984789999999999999984699955267021115999
Q 000726 1045 EELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1045 sllkvLGsGaFGtVYKAk~kG-----t~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~esse 1119 (1329)
.+.++||+|+||+||+|.+.. ..||||.++... ......+|.+|+.++++++||||+++++++... +
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~ 101 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-E 101 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-------CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-T
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-C
T ss_conf 26669813688099999997799879999999988436-------978999999999999867899986786789806-9
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCCC
Q ss_conf 71899998212883135441013457999999999999999999897990304798751575468998880899424775
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGLA 1199 (1329)
+.+++|||||++++|.+++......+++..++.++.|++.||.|||+.+|+||||||+|||++.++ .+||+|||++
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~----~~kL~DFG~~ 177 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF----TVKVADFGLA 177 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC----CEEECSSGGG
T ss_pred CCEEEEEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCC----CEEEECCCCH
T ss_conf 943899987406741442101345404899999999988765200336762577668757677999----8899106523
Q ss_pred CCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 224686-----323687798764472111368899990568999999999999099999898856899978725899999
Q 000726 1200 KIKRNT-----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 1274 (1329)
Q Consensus 1200 kli~~~-----~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrlei 1274 (1329)
+..... .......|+..|+|||.+. ...++.++||||||+++|||+++..||............+....++..
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~ 255 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC
T ss_pred HHCCCCCCCCCEECCCCCCCCCCCCHHHHH--CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC
T ss_conf 225566555310025655564556768874--379997457466199999999789999888999999999980898899
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCC
Q ss_conf 998929999999992158999998999999999999997116
Q 000726 1275 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 1316 (1329)
Q Consensus 1275 p~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa~st 1316 (1329)
+..+++.+.+||.+||+.||.+||++.+++++|+.+......
T Consensus 256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHH
T ss_conf 644759999999997688976893999999999999975201
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.43 Aligned_cols=261 Identities=32% Similarity=0.508 Sum_probs=219.8
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEEC-------CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 110135667159988401583899999997-------9208999972166679984789999999999999984699955
Q 000726 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107 (1329)
Q Consensus 1035 ~l~~Is~eeYsllkvLGsGaFGtVYKAk~k-------Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNI 1107 (1329)
.-|++.+++|++.+.||+|+||.||+|.++ ++.||||+++... .......|.+|+.++++++||||
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-------~~~~~~~~~~E~~il~~l~h~nI 85 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHV 85 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------CHHHHHHHHHHHHHGGGCCCTTB
T ss_pred CCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCE
T ss_conf 10042689918835982078818999998786447789689999987012-------86899999999999997699988
Q ss_pred EEEECCCCCCCCCEEEEEEEECCCCCHHHHHHCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCC
Q ss_conf 26702111599971899998212883135441013---------457999999999999999999897990304798751
Q 000726 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDN 1178 (1329)
Q Consensus 1108 VKLlGif~esseg~L~LVMEYieGGSL~dlL~~ke---------k~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsN 1178 (1329)
+++++++.... ..++||||+++|+|..++.... ..+++..++.++.|+++||.|||.++|+||||||.|
T Consensus 86 v~~~~~~~~~~--~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~N 163 (308)
T d1p4oa_ 86 VRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 163 (308)
T ss_dssp CCEEEEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred EEEEEEEECCC--CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCC
T ss_conf 41254784288--1067776048998899987503321134446887999999999999999998764796543286775
Q ss_pred EEECCCCCCCCCEEEEECCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHC-CCCCC
Q ss_conf 575468998880899424775224686---32368779876447211136889999056899999999999909-99998
Q 000726 1179 LLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG-EEPYA 1254 (1329)
Q Consensus 1179 ILIDsdGni~~~VKLsDFGLAkli~~~---~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTG-k~PFs 1254 (1329)
||++.++. +||+|||+++..... .......+++.|+|||.+.+ ..++.++||||||+++|||+++ .+||.
T Consensus 164 iLld~~~~----~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 164 CMVAEDFT----VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp EEECTTCC----EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred EEECCCCE----EEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCC--CCCCCCCCCCCHHHHHHHHHHCCCCCCC
T ss_conf 40359964----99942454202357763031340231632378888736--9988333444378999999968999999
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 988568999787258999999989299999999921589999989999999999999
Q 000726 1255 NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1255 ~~~~~eilqqIve~~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~ 1311 (1329)
.....+....+.. ..+++.+..++..+.++|.+||+.+|.+|||+.+|+++|+...
T Consensus 238 ~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 238 GLSNEQVLRFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 9899999999980-8888886335399999999975779658939999999978761
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.84 Aligned_cols=255 Identities=27% Similarity=0.335 Sum_probs=206.0
Q ss_pred CCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCC
Q ss_conf 67159988401583899999997--9208999972166679984789999999999999984699955267021115999
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~esse 1119 (1329)
++|++++.||+|+||.||+|++. ++.||||+++..... +.....+.+|+.++++++||||+++++++.+..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~- 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET------EGVPSTAIREISLLKELNHPNIVKLLDVIHTEN- 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCC-
T ss_conf 9977651772376809999999999979999998022257------589999999999998679983887445332243-
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCCC
Q ss_conf 71899998212883135441013457999999999999999999897990304798751575468998880899424775
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGLA 1199 (1329)
.+++||||+.++.+..........+++..++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||++
T Consensus 75 -~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~----~kl~DFG~a 149 (298)
T d1gz8a_ 75 -KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA----IKLADFGLA 149 (298)
T ss_dssp -EEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC----EEECSTTHH
T ss_pred -CEEEEEEECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCC----CEECCCCCC
T ss_conf -203788623774455544202568888999999999999999865288992135711401134676----210357861
Q ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC-------
Q ss_conf 2246-86323687798764472111368899990568999999999999099999898856899978725899-------
Q 000726 1200 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR------- 1271 (1329)
Q Consensus 1200 kli~-~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lr------- 1271 (1329)
+... .........|++.|+|||++... ..++.++|||||||++|+|++|+.||........+..+......
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 150 RAFGVPVRTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp HHHCCCSBCTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred EECCCCCCCCEEECCCCEEEEHHHHCCC-CCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCC
T ss_conf 3436886410010365215411221366-577742210333313427966879989889999999999832898333144
Q ss_pred ---------CCC-----------CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf ---------999-----------99892999999999215899999899999999999
Q 000726 1272 ---------PPV-----------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1272 ---------lei-----------p~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
... ...++.++.+|+.+||+.||.+|||+.|+++|.|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff 286 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 4222421243454322220444166789999999999763995579189999678701
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.35 Aligned_cols=257 Identities=25% Similarity=0.317 Sum_probs=207.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC---CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHH---CCCCCEEEEECCC
Q ss_conf 667159988401583899999997---9208999972166679984789999999999999984---6999552670211
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK---LHHPNVVAFYGVV 1114 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k---Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkk---LrHPNIVKLlGif 1114 (1329)
.++|++++.||+|+||+||+|++. ++.||||+++......... ..+.+|+.+++. ++||||++++++|
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~------~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP------LSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB------CTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHH------HHHHHHHHHHHHHHHCCCCCCCEEEEEE
T ss_conf 5897988899215586999999988899899999980232451679------9999999999987425898802366322
Q ss_pred CCC---CCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCE
Q ss_conf 159---99718999982128831354410134579999999999999999998979903047987515754689988808
Q 000726 1115 QDG---PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1115 ~es---seg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~V 1191 (1329)
... ....++++|||+.++.+..........+++..++.++.|++.||.|||+++|+||||||+|||++.++..
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~---- 155 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI---- 155 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE----
T ss_pred CCCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCE----
T ss_conf 1466666746999997405871444443037899989999999999999999975889835798627898589975----
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC-
Q ss_conf 9942477522468632368779876447211136889999056899999999999909999989885689997872589-
Q 000726 1192 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL- 1270 (1329)
Q Consensus 1192 KLsDFGLAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~l- 1270 (1329)
||+|||++.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+.....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 156 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EECCHHHHHHHCCCCCCCCCCCCHHHCCCCHHCC--CCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCC
T ss_conf 4210001011002345777654851148310017--98881110003289999998787998998989999999984079
Q ss_pred ------------------------CCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf ------------------------999999892999999999215899999899999999999
Q 000726 1271 ------------------------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1271 ------------------------rleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
........++.+.+||.+||+.||.+|||+.|+++|.|.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff 296 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred CCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 961105321111033302234564544044589999999999874896679189999669634
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.79 Aligned_cols=252 Identities=24% Similarity=0.235 Sum_probs=201.7
Q ss_pred CEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC---
Q ss_conf 7159988401583899999997--92089999721666799847899999999999999846999552670211159---
Q 000726 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG--- 1117 (1329)
Q Consensus 1043 eYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~es--- 1117 (1329)
+|+..++||+|+||+||+|++. ++.||||+++.... .+.+|+.+|+.++||||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH------------HHHHHHHHHHHCCCCCCCCEEEEEEECCCC
T ss_conf 76751698217683999999999997999999881606------------899999999866898987387899744765
Q ss_pred -CCCEEEEEEEECCCCCHHHHHH--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEE
Q ss_conf -9971899998212883135441--0134579999999999999999998979903047987515754689988808994
Q 000726 1118 -PGGTLATVTEFMVNGSLRHVLL--SKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1118 -seg~L~LVMEYieGGSL~dlL~--~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLs 1194 (1329)
...++++|||||+++.+..... .....+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+
T Consensus 89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~---~~kl~ 165 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA---VLKLC 165 (350)
T ss_dssp CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC---CEEEC
T ss_pred CCCEEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCC---CEEEE
T ss_conf 773189999841688607888863103689999999999999999999998668764578860378735897---11673
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC-----
Q ss_conf 247752246863236877987644721113688999905689999999999990999998988568999787258-----
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----- 1269 (1329)
Q Consensus 1195 DFGLAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~----- 1269 (1329)
|||++.............|+..|+|||.+.+ ...++.++|||||||++|||++|+.||........+..+....
T Consensus 166 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp CCTTCEECCTTSCCCSCCSCTTSCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCCCHHHCCCCCCCCCCCCCCCCCCHHHHHC-CCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHH
T ss_conf 3660544047765320025555568277640-468882100024652778550287998987999999999997489817
Q ss_pred ----------CCC------------CCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf ----------999------------99998929999999992158999998999999999999
Q 000726 1270 ----------LRP------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1270 ----------lrl------------eip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L 1310 (1329)
... ......++.+.+||.+||+.||.+|||+.|+++|.|.-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 307 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf 765430621011035544567444431568999999999997658955792999996698452
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.06 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=207.4
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC
Q ss_conf 5667159988401583899999997--92089999721666799847899999999999999846999552670211159
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1329)
Q Consensus 1040 s~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~es 1117 (1329)
..++|++++.||+|+||+||+|.++ ++.||||+++.... .+.....+.+|+.+|+.++|||||+++++|...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 89 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC
T ss_conf 47718998898017781999999999998999999852225------969999999999999866898754799986357
Q ss_pred C----CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEE
Q ss_conf 9----971899998212883135441013457999999999999999999897990304798751575468998880899
Q 000726 1118 P----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1329)
Q Consensus 1118 s----eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKL 1193 (1329)
. ...+++||||+ +.+|...+. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.. |+
T Consensus 90 ~~~~~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~----kl 162 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL----KI 162 (346)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE----EE
T ss_pred CCCCCCCEEEEEEECC-CCCHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCC----CC
T ss_conf 6555541599998405-521899987--4022699999999999999999873787645668511112100122----11
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC--
Q ss_conf 424775224686323687798764472111368899990568999999999999099999898856899978725899--
Q 000726 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-- 1271 (1329)
Q Consensus 1194 sDFGLAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lr-- 1271 (1329)
+|||++....... ....|++.|+|||++.+. ..++.++|||||||++|+|++|+.||........+..+......
T Consensus 163 ~Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 163 LDFGLARQADSEM--TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp CCCTTCEECCSSC--CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CCCCCEECCCCCC--CCCCCCCCCCCHHHHCCC-CCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 3431022068763--102455333588998178-7899650103003899999978699888976899999985037884
Q ss_pred ---------------------------CCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf ---------------------------999998929999999992158999998999999999999
Q 000726 1272 ---------------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1272 ---------------------------leip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L 1310 (1329)
.......++.+.+||.+||..||.+|||+.++++|.|.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~ 305 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf 888865300034433115786665566775568999999999997729955792999996396237
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.10 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=204.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCC--
Q ss_conf 671599884015838999999979208999972166679984789999999999999984699955267021115999--
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG-- 1119 (1329)
Q Consensus 1042 eeYsllkvLGsGaFGtVYKAk~kGt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~esse-- 1119 (1329)
++|.+.+.||+|+||.||+|+++|..||||+++... ... ..+..|+..+..++||||+++++++.+...
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-------~~~--~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-------ERS--WFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-------HHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred CEEEEEEEEEECCCEEEEEEEECCEEEEEEEECCCC-------HHH--HHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
T ss_conf 689998898207881999999999899999987200-------467--99999999996279986832688998379860
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCEEECCCCCCCEEECCCCCCCCCE
Q ss_conf 71899998212883135441013457999999999999999999897--------9903047987515754689988808
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS--------KNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1120 g~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHs--------kGIIHRDLKPsNILIDsdGni~~~V 1191 (1329)
..+++|||||++|+|..++.. ..+++..++.++.+++.||.|||. ++|+||||||+|||++.++. +
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~----~ 147 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT----C 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC----E
T ss_pred EEEEEEEECCCCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCC----E
T ss_conf 489999964669898999865--8999899999999999999998876652046898661531731357868877----6
Q ss_pred EEEECCCCCCCCCCC-----CCCCCCCCCCCCCCCCCCCCCC----CCCHHHHHHHHHHHHHHHHHCCCCCCCC------
Q ss_conf 994247752246863-----2368779876447211136889----9990568999999999999099999898------
Q 000726 1192 KVGDFGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSS----KVSEKVDVFSFGIVLWEILTGEEPYANM------ 1256 (1329)
Q Consensus 1192 KLsDFGLAkli~~~~-----~ss~v~GT~~YlAPEvL~Gs~~----~~SeKSDVWSLGVLLyELLTGk~PFs~~------ 1256 (1329)
||+|||++....... ......||+.|+|||++.+... .++.++|||||||+||||++|..||...
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 88763866234677762001355250354767822105654546777675012201599999996289988766311241
Q ss_pred ---------CHHHHHHHHHHCCCCCCCCCC-----CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCC
Q ss_conf ---------856899978725899999998-----9299999999921589999989999999999999971167
Q 000726 1257 ---------HYGAIIGGIVNNTLRPPVPGF-----CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 1317 (1329)
Q Consensus 1257 ---------~~~eilqqIve~~lrleip~~-----vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa~st~ 1317 (1329)
..............++.++.. ....+.+|+.+||+.||.+|||+.+|++.|..+......+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred HHHCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCCC
T ss_conf 012255643099999987502468887765577689999999999976069858959999999999888865998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=331.38 Aligned_cols=254 Identities=26% Similarity=0.335 Sum_probs=206.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEEC-CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCCC
Q ss_conf 67159988401583899999997-92089999721666799847899999999999999846999552670211159997
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1042 eeYsllkvLGsGaFGtVYKAk~k-Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~esseg 1120 (1329)
++|+++++||+|+||+||+|+++ ++.||||+++..... +.....+.+|+.+|+.++||||+++++++....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-- 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED------EGIPSTTIREISILKELKHSNIVKLYDVIHTKK-- 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG------GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCC--
T ss_conf 996343187227781899999689999999998123268------589999999999998679986876601204677--
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCCCC
Q ss_conf 18999982128831354410134579999999999999999998979903047987515754689988808994247752
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1121 ~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGLAk 1200 (1329)
..+++|+++.++.+.. +......+++..+..++.||+.||.|||+++|+||||||+|||++.++.. ||+|||.+.
T Consensus 74 ~~~i~~e~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~----kl~DfG~a~ 148 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKL-LDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL----KIADFGLAR 148 (286)
T ss_dssp CEEEEEECCSEEHHHH-HHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE----EECCTTHHH
T ss_pred CEEEEEEEEHHHHHHH-HHHHCCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCE----EECCCCCCE
T ss_conf 3158997400456789-98604775144568999999999998605748826787750568689978----732366430
Q ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC--------
Q ss_conf 2468-6323687798764472111368899990568999999999999099999898856899978725899--------
Q 000726 1201 IKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-------- 1271 (1329)
Q Consensus 1201 li~~-~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lr-------- 1271 (1329)
.... ........+++.|+|||.+.+. ..++.++|||||||++|||++|+.||......+.+..+......
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 149 AFGIPVRKYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HHCC---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ECCCCCCCCCEECCCCHHHHHHHHHCC-CCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCC
T ss_conf 114676541010243110137887178-8888410021117589999779799898898999999998638997110421
Q ss_pred -------------------CCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf -------------------99999892999999999215899999899999999999
Q 000726 1272 -------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1272 -------------------leip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
.......++.+.+|+.+||+.||.+|||+.|+++|.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f 284 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf 233322143333356764666512589999999999866896689099998569220
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=326.83 Aligned_cols=251 Identities=20% Similarity=0.267 Sum_probs=204.6
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCEEEEECCCCC
Q ss_conf 5667159988401583899999997--920899997216667998478999999999999998469-9955267021115
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 1116 (1329)
Q Consensus 1040 s~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLr-HPNIVKLlGif~e 1116 (1329)
..++|++++.||+|+||+||+|++. ++.||||+++... ..++.+|+.+|+.+. ||||+++++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHHCCCCCCCCEEEEEEEE
T ss_conf 9867189789831748199999988999799999988899-----------99999999999851579987679999981
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf 99971899998212883135441013457999999999999999999897990304798751575468998880899424
Q 000726 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1329)
Q Consensus 1117 sseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDF 1196 (1329)
.....+++|||||.+++|.... +.+++..+..++.||+.||.|||++||+||||||+|||++.++. .+||+||
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~---~vkl~DF 174 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR---KLRLIDW 174 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT---EEEECCG
T ss_pred CCCCCEEEEEEECCCCCHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCC---EEEECCC
T ss_conf 6877126888631798589974----68999999999999999998876433443456441237748998---3664156
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHH--------
Q ss_conf 77522468632368779876447211136889999056899999999999909999989885689-997872--------
Q 000726 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI-IGGIVN-------- 1267 (1329)
Q Consensus 1197 GLAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~ei-lqqIve-------- 1267 (1329)
|++.............+|+.|+|||.+.+. ..++.++|||||||++|+|++|+.||........ ...+..
T Consensus 175 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 175 GLAEFYHPGQEYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp GGCEECCTTCCCCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHH
T ss_conf 542664688744432248642476102688-8888452323354555876048899988760189999999987884155
Q ss_pred -----C----------------------CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf -----5----------------------89999999892999999999215899999899999999999
Q 000726 1268 -----N----------------------TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1268 -----~----------------------~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
. .........+++++.+||.+||+.||.+|||++|+++|.|.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf 555422544474300000333433112115521124489999999999866995689089999649355
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.79 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=202.9
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC--CCCEEEEECCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469--9955267021115
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH--HPNVVAFYGVVQD 1116 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLr--HPNIVKLlGif~e 1116 (1329)
.++|++.+.||+|+||.||+|++. +..||||++++.......... ...++.+|+.++++++ ||||+++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~--~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP--NGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECT--TCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
T ss_conf 88379967984087839999999999979999998568844334556--7999999999999743589881279999830
Q ss_pred CCCCEEEEEEEECCC-CCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEE
Q ss_conf 999718999982128-8313544101345799999999999999999989799030479875157546899888089942
Q 000726 1117 GPGGTLATVTEFMVN-GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1117 sseg~L~LVMEYieG-GSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsD 1195 (1329)
.. ..++||||+.+ +++.+++. ....+++..++.++.||+.||.|||+++|+||||||+|||++.+. ..+||+|
T Consensus 81 ~~--~~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~---~~vkl~D 154 (273)
T d1xwsa_ 81 PD--SFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR---GELKLID 154 (273)
T ss_dssp SS--EEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT---TEEEECC
T ss_pred CC--EEEEEEEECCCCCHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC---CEEEECC
T ss_conf 99--68999983368622899986-158999999999999999999999877975566761114774478---8489775
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 47752246863236877987644721113688999905689999999999990999998988568999787258999999
Q 000726 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 1275 (1329)
Q Consensus 1196 FGLAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrleip 1275 (1329)
||++....... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.... .+... ...++
T Consensus 155 FG~a~~~~~~~-~~~~~GT~~y~aPE~~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~~~~~ 224 (273)
T d1xwsa_ 155 FGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QVFFR 224 (273)
T ss_dssp CTTCEECCSSC-BCCCCSCGGGSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CCCCS
T ss_pred CCCCEECCCCC-CCCCCCCCCCCCHHHHCCCC-CCCCCCCCCCCEEEEHHHHHCCCCCCCCH------HHHHC--CCCCC
T ss_conf 46535324445-56656587747999984899-78865332554034536756889988736------77615--44778
Q ss_pred CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 9892999999999215899999899999999999
Q 000726 1276 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1276 ~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
..+++++.+||.+||+.||.+|||++|+++|.|.
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 258 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 7799999999999760897589399998539866
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.19 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=201.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCC
Q ss_conf 67159988401583899999997--9208999972166679984789999999999999984699955267021115999
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~esse 1119 (1329)
++|++++.||+|+||+||+|.++ ++.||||++.+.. .......+++|+.+|+.++||||+++++++.....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-------CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC
T ss_conf 98599789940648099999999999499999980310-------95899999999999997689898858889950564
Q ss_pred --CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECC
Q ss_conf --718999982128831354410134579999999999999999998979903047987515754689988808994247
Q 000726 1120 --GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1120 --g~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFG 1197 (1329)
...+++++++.+++|.+++.. ..+++..++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~----~kl~DfG 154 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD----LKICDFG 154 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC----EEECCCT
T ss_pred CCCCEEEEEEEECCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCC----EEECCCC
T ss_conf 55414999996259865664405--89999999999999999999999789867778764378879997----7875457
Q ss_pred CCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC----
Q ss_conf 752246863----236877987644721113688999905689999999999990999998988568999787258----
Q 000726 1198 LSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT---- 1269 (1329)
Q Consensus 1198 LAkli~~~~----~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~---- 1269 (1329)
++....... ......|++.|+|||++.. ...++.++||||+||++|+|++|+.||................
T Consensus 155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233 (345)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT-BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CEEECCCCCCCCEEECCCCCCCEECHHHHHHC-CCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf 05650477764101011026520003878604-78887410100467013377669799788888999998765206997
Q ss_pred --------------------CCCC-----CCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf --------------------9999-----9998929999999992158999998999999999999
Q 000726 1270 --------------------LRPP-----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1270 --------------------lrle-----ip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L 1310 (1329)
.... .....+..+.+|+.+||+.||.+|||+.++++|.|.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~ 299 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf 566423433222202446775577877783789999999999997648956790899986198655
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.38 Aligned_cols=257 Identities=23% Similarity=0.273 Sum_probs=203.3
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.++|++.+.||+|+||+||+|+++ ++.||||++......+. ...++.+|+.+|+.++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG------FPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS------SCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHH------HHHHHHHHHHHHHHHCCCCCCCEEEEEECCC
T ss_conf 2798899997227482999999989997999999842224637------8999999999999835999660676540246
Q ss_pred ------CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEE
Q ss_conf ------97189999821288313544101345799999999999999999989799030479875157546899888089
Q 000726 1119 ------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1119 ------eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VK 1192 (1329)
...+++||||+.++.+. ........+++..++.++.|++.||.|||+++|+||||||+|||++.++. +|
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~----~k 157 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LK 157 (318)
T ss_dssp --------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC----EE
T ss_pred CCCCCCCCEEEEEEECCCCCCCC-HHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCC----EE
T ss_conf 54444576389998535787410-12220344330899999999999998852299885676722203668996----87
Q ss_pred EEECCCCCCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 9424775224686-----32368779876447211136889999056899999999999909999989885689997872
Q 000726 1193 VGDFGLSKIKRNT-----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1267 (1329)
Q Consensus 1193 LsDFGLAkli~~~-----~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve 1267 (1329)
|+|||++...... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCC-CCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 631350022355444321135660249787428997079-9989178700678646617448799899899999999998
Q ss_pred CCCC--CCCC----------------------------CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 5899--9999----------------------------9892999999999215899999899999999999
Q 000726 1268 NTLR--PPVP----------------------------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1268 ~~lr--leip----------------------------~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
.... .... ...++.+.+||.+||+.||++|||++|+++|.|.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 418998255344320344433201334455503340444599899999999873896589099999749501
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=318.94 Aligned_cols=259 Identities=22% Similarity=0.264 Sum_probs=203.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEE-ECCCCCC
Q ss_conf 667159988401583899999997--9208999972166679984789999999999999984699955267-0211159
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF-YGVVQDG 1117 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKL-lGif~es 1117 (1329)
.++|++.+.||+|+||.||+|++. ++.||||++...... .++.+|+.+++.++|++++.. ..++.+.
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----------CCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC----------HHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 88899968985078809999999889989999997210058----------88999999999703899601799999519
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECC
Q ss_conf 99718999982128831354410134579999999999999999998979903047987515754689988808994247
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1329)
Q Consensus 1118 seg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFG 1197 (1329)
. ..++||||+ ++++...+......+++..++.++.|++.||.|||+++|+||||||+|||++..+. ...++|+|||
T Consensus 76 ~--~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~-~~~vkl~DFG 151 (299)
T d1ckia_ 76 D--YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK-GNLVYIIDFG 151 (299)
T ss_dssp T--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGG-TTCEEECCCS
T ss_pred C--EEEEEEEEC-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCC-CCEEEEECCC
T ss_conf 8--778999873-87133324430688768999999999999999999799442667876606433577-7615650467
Q ss_pred CCCCCCCC--------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---H
Q ss_conf 75224686--------323687798764472111368899990568999999999999099999898856899978---7
Q 000726 1198 LSKIKRNT--------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI---V 1266 (1329)
Q Consensus 1198 LAkli~~~--------~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqI---v 1266 (1329)
+|+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+ .
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~ 229 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred CCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHC--CCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf 513425544554100013577678735329999918--998983218861778999984987665530577999999852
Q ss_pred HC---CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 25---89999999892999999999215899999899999999999999711
Q 000726 1267 NN---TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 1315 (1329)
Q Consensus 1267 e~---~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa~s 1315 (1329)
.. .........+++++.+++.+||+.+|.+||++.++.+.|+.+.....
T Consensus 230 ~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCC
T ss_conf 3567898357534788999999999843995579199999999999999769
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.16 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=205.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC-
Q ss_conf 667159988401583899999997--92089999721666799847899999999999999846999552670211159-
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG- 1117 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~es- 1117 (1329)
.++|+++++||+|+||+||+|++. |..||||+++.... .+....++.+|+.+++.++||||++++++|...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 3775998896217585999999999998999999882336------9799999999999998648987648998970256
Q ss_pred ---CCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEE
Q ss_conf ---99718999982128831354410134579999999999999999998979903047987515754689988808994
Q 000726 1118 ---PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1329)
Q Consensus 1118 ---seg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLs 1194 (1329)
....+++|||||.+ ++...+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.. +++
T Consensus 90 ~~~~~~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~----kl~ 161 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL----KIL 161 (355)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE----EEC
T ss_pred CCCCCCEEEEEEECCCH-HHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCE----EEE
T ss_conf 43457626999841446-7787650---389999999999999999988652211245677632113654431----320
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC------
Q ss_conf 24775224686323687798764472111368899990568999999999999099999898856899978725------
Q 000726 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN------ 1268 (1329)
Q Consensus 1195 DFGLAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~------ 1268 (1329)
|||+++............+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||...........+...
T Consensus 162 df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp CCCC---------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CHHHHHCCCCCCCCCCCCCCCCCCCHHHHCC--CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 1023211466655332214655558133147--77787743335662578986598998889778899999972058987
Q ss_pred ----------------CCCCC------------CC------CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
Q ss_conf ----------------89999------------99------989299999999921589999989999999999999
Q 000726 1269 ----------------TLRPP------------VP------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 1311 (1329)
Q Consensus 1269 ----------------~lrle------------ip------~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~ 1311 (1329)
..... .+ ...+..+.+||.+||..||++|||++|+++|.|.-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 99987656677776417543566642126433354321013337999999999987699457908999966942087
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.50 Aligned_cols=255 Identities=23% Similarity=0.292 Sum_probs=205.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 667159988401583899999997--920899997216667998478999999999999998469995526702111599
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~ess 1118 (1329)
.++|++++.||+|+||+||+|++. ++.||||++++... .......+.+|+.+|+.++||||+++++++....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 9871888898317883999999999997999999882002------8689999999999998668987425999996346
Q ss_pred ---CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEE
Q ss_conf ---97189999821288313544101345799999999999999999989799030479875157546899888089942
Q 000726 1119 ---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1329)
Q Consensus 1119 ---eg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsD 1195 (1329)
+...+++|+++.+++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.. |++|
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~----kl~d 164 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL----KILD 164 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE----EECC
T ss_pred CCCCCCEEEEEEEECCCCHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCC----CCCC
T ss_conf 456686499999625886232002--2453099999999999999999973887651667763345543220----0132
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC--
Q ss_conf 477522468632368779876447211136889999056899999999999909999989885689997872589999--
Q 000726 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP-- 1273 (1329)
Q Consensus 1196 FGLAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~~lrle-- 1273 (1329)
||++...... .....|+..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.........+........
T Consensus 165 fg~a~~~~~~--~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 165 FGLARHTDDE--MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp C----CCTGG--GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCHHCCCCCC--CCCCCCCCCCCCCHHHCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHH
T ss_conf 1000125754--4443454355583553377-567855124320589999976889978898899999999730799757
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf ---------------------------9998929999999992158999998999999999999
Q 000726 1274 ---------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1274 ---------------------------ip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L 1310 (1329)
....+++.+.+||.+||+.||.+|||+.|+++|.|.-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf 7320010244544430355787555662678999999999997758834593899985599548
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.58 Aligned_cols=261 Identities=26% Similarity=0.382 Sum_probs=212.2
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEE-----CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-CCEEEEE
Q ss_conf 13566715998840158389999999-----79208999972166679984789999999999999984699-9552670
Q 000726 1038 IIKNEDLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH-PNVVAFY 1111 (1329)
Q Consensus 1038 ~Is~eeYsllkvLGsGaFGtVYKAk~-----kGt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrH-PNIVKLl 1111 (1329)
.+..++|++.+.||+|+||+||+|.. +|+.||||++++...... ......+.+|+.++++++| |||++++
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~----~~~~~~~~~E~~il~~l~h~pnIv~~~ 95 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----AKTTEHTRTERQVLEHIRQSPFLVTLH 95 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----ESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred CCCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCC----HHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 3451025999898328783999999876588794899999836772101----689999999999998646798399962
Q ss_pred CCCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCE
Q ss_conf 21115999718999982128831354410134579999999999999999998979903047987515754689988808
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1329)
Q Consensus 1112 Gif~esseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~V 1191 (1329)
+++.+.. .++++|||+.+++|..++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++. +
T Consensus 96 ~~~~~~~--~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~----v 168 (322)
T d1vzoa_ 96 YAFQTET--KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH----V 168 (322)
T ss_dssp EEEEETT--EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC----E
T ss_pred EEECCCC--CEEEEEECCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCC----E
T ss_conf 0002487--300123123411799998730-45437888888999999998851499896547732012469998----8
Q ss_pred EEEECCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC-
Q ss_conf 994247752246--86323687798764472111368899990568999999999999099999898856899978725-
Q 000726 1192 KVGDFGLSKIKR--NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN- 1268 (1329)
Q Consensus 1192 KLsDFGLAkli~--~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~eilqqIve~- 1268 (1329)
||+|||++.... .........|++.|++||.+.+....++.++|||||||+||+|++|..||...........+...
T Consensus 169 kL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~ 248 (322)
T d1vzoa_ 169 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 248 (322)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred EEEECCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHC
T ss_conf 87413202220344443221222333331068760577688713251777799999976899988887777999999833
Q ss_pred -CCCCCCCCCCCHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHH
Q ss_conf -899999998929999999992158999998-----99999999999
Q 000726 1269 -TLRPPVPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLRV 1309 (1329)
Q Consensus 1269 -~lrleip~~vSeeL~dLIkkCLq~DPeERP-----SaeELLk~Le~ 1309 (1329)
....+++..++..+.+||.+||++||.+|| |++|+++|.|.
T Consensus 249 ~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 249 LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHH
T ss_conf 56899886547999999999974458988199974509999749723
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=311.80 Aligned_cols=262 Identities=19% Similarity=0.224 Sum_probs=209.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-CCEEEEECCCCCC
Q ss_conf 667159988401583899999997--9208999972166679984789999999999999984699-9552670211159
Q 000726 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH-PNVVAFYGVVQDG 1117 (1329)
Q Consensus 1041 ~eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrH-PNIVKLlGif~es 1117 (1329)
.++|++.+.||+|+||.||+|++. ++.||||++...... ..+.+|+..++.+.| +|++.+++++.+.
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 73 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFGQEG 73 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC----------HHHHHHHHHHHHHCCCCCCCEEEEEEECC
T ss_conf 98069979984178829999999889979999997502582----------99999999999964899987799996018
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCC-CCCCEEEEEC
Q ss_conf 997189999821288313544101345799999999999999999989799030479875157546899-8880899424
Q 000726 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP-IRPICKVGDF 1196 (1329)
Q Consensus 1118 seg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGn-i~~~VKLsDF 1196 (1329)
. ..++||||+ +++|..++......+++..+..++.|++.+|.|||++||+||||||+|||++.... ....++|+||
T Consensus 74 ~--~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 74 L--HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp T--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred C--CCEEEEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCC
T ss_conf 8--117999964-8887999975203110689999999999999999977966266771315234754344795687236
Q ss_pred CCCCCCCCC--------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH
Q ss_conf 775224686--------323687798764472111368899990568999999999999099999898856---899978
Q 000726 1197 GLSKIKRNT--------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGI 1265 (1329)
Q Consensus 1197 GLAkli~~~--------~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~---eilqqI 1265 (1329)
|+|+..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred CEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCC--CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
T ss_conf 6057714676654111024676277510267989648--88886999898319999998698767885302199999999
Q ss_pred HHC---CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCC
Q ss_conf 725---8999999989299999999921589999989999999999999971167
Q 000726 1266 VNN---TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 1317 (1329)
Q Consensus 1266 ve~---~lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~L~sa~st~ 1317 (1329)
... .....+...+++++.+++..|+..+|.+||+++.+.+.|..+.......
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCC
T ss_conf 7056799958965799899999999984399300859999999999999975999
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.12 Aligned_cols=254 Identities=26% Similarity=0.301 Sum_probs=203.3
Q ss_pred CCEEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCC
Q ss_conf 67159988401583899999997--9208999972166679984789999999999999984699955267021115999
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1329)
Q Consensus 1042 eeYsllkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNIVKLlGif~esse 1119 (1329)
++|++++.||+|+||+||+|++. ++.||||+++..... +....++.+|+.+++.++||||+++++++.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~- 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHSDK- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCC-
T ss_conf 9978626971286819999999999969999998032178------689999999999998567578882135444443-
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEEEEECCCC
Q ss_conf 71899998212883135441013457999999999999999999897990304798751575468998880899424775
Q 000726 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1329)
Q Consensus 1120 g~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VKLsDFGLA 1199 (1329)
..++|++++.+++|..++. ..+.+++..++.++.|++.||+|||+++|+||||||+|||++.++. +||+|||.+
T Consensus 75 -~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~----~kl~DFG~a 148 (292)
T d1unla_ 75 -KLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE----LKLANFGLA 148 (292)
T ss_dssp -EEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC----EEECCCTTC
T ss_pred -CEEEEEEECCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCC----EEEEECCHH
T ss_conf -1158863023322211212-3565403678999999999987743399860014676121133782----665204601
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCC--------
Q ss_conf 224686-32368779876447211136889999056899999999999909999989-88568999787258--------
Q 000726 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN-MHYGAIIGGIVNNT-------- 1269 (1329)
Q Consensus 1200 kli~~~-~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~-~~~~eilqqIve~~-------- 1269 (1329)
...... .......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.. ....+....+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred HCCCCCCCCCEEECCCCCHHHHHHHCCC-CCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf 1046887510010344310146675069-888804440265418899851899998899999999999861189973551
Q ss_pred -------------------CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf -------------------9999999892999999999215899999899999999999
Q 000726 1270 -------------------LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 1309 (1329)
Q Consensus 1270 -------------------lrleip~~vSeeL~dLIkkCLq~DPeERPSaeELLk~Le~ 1309 (1329)
.........++.+.+|+.+||+.||.+|||++|+++|.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred HHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 34432221133444544310433065689999999999864996689099999649534
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-42 Score=283.28 Aligned_cols=258 Identities=20% Similarity=0.234 Sum_probs=191.3
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----------CCC
Q ss_conf 566715998840158389999999--7920899997216667998478999999999999998469-----------995
Q 000726 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-----------HPN 1106 (1329)
Q Consensus 1040 s~eeYsllkvLGsGaFGtVYKAk~--kGt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLr-----------HPN 1106 (1329)
...+|+++++||+|+||+||+|++ +|+.||||++++. ......+.+|+.+++.++ |+|
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC---------CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCC
T ss_conf 478579989975077818999999999979999998343---------13368999999999984014555554227676
Q ss_pred EEEEECCCCCCCCCEEEEEEEECCCCCHHHHH--HCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCCCCCCEEECC
Q ss_conf 52670211159997189999821288313544--1013457999999999999999999897-99030479875157546
Q 000726 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNL 1183 (1329)
Q Consensus 1107 IVKLlGif~esseg~L~LVMEYieGGSL~dlL--~~kek~LSe~qIlkIA~QIAsALaYLHs-kGIIHRDLKPsNILIDs 1183 (1329)
|+++++++........+++|+++......... ......+++..+..++.||+.||.|||+ .+|+||||||+|||++.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred EEEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEEC
T ss_conf 47899876312565202343200035420000012234678689999999999999888764058646567705705630
Q ss_pred CCCC--CCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH--
Q ss_conf 8998--880899424775224686323687798764472111368899990568999999999999099999898856--
Q 000726 1184 KDPI--RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-- 1259 (1329)
Q Consensus 1184 dGni--~~~VKLsDFGLAkli~~~~~ss~v~GT~~YlAPEvL~Gs~~~~SeKSDVWSLGVLLyELLTGk~PFs~~~~~-- 1259 (1329)
++.. ...++++|||.+...... .....|++.|+|||++. ...++.++|||||||++++|++|+.||......
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLL--GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHH--TCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCCCCCCCEEEEEECCCCCCCCCC--CCCCCCCCCCCCHHHCC--CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 576564430567531442123445--42236652105713214--66777643201237899999878899898755432
Q ss_pred ----HHHHHHHH---C-------------------CC------------------CCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf ----89997872---5-------------------89------------------9999998929999999992158999
Q 000726 1260 ----AIIGGIVN---N-------------------TL------------------RPPVPGFCDSEWRLLMEQCWAPDPV 1295 (1329)
Q Consensus 1260 ----eilqqIve---~-------------------~l------------------rleip~~vSeeL~dLIkkCLq~DPe 1295 (1329)
........ . .. ........+..+.+|+.+||..||.
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHH
T ss_conf 10268999999983799878862453220001320122024323577644421000156743589999999998779945
Q ss_pred CCCCHHHHHHHHHHH
Q ss_conf 998999999999999
Q 000726 1296 VRPSFTEIARRLRVM 1310 (1329)
Q Consensus 1296 ERPSaeELLk~Le~L 1310 (1329)
+|||++|+|+|.|.-
T Consensus 318 ~Rpta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 318 KRADAGGLVNHPWLK 332 (362)
T ss_dssp TCBCHHHHHTCGGGT
T ss_pred HCCCHHHHHCCCCCC
T ss_conf 790899996693407
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=8.5e-23 Score=159.90 Aligned_cols=171 Identities=16% Similarity=0.010 Sum_probs=118.0
Q ss_pred EEEEEEECCCCCEEEEEEEE-CCCEEEEEEEECCCCCCCC----------HHHHHHHHHHHHHHHHHHHCCCCCEEEEEC
Q ss_conf 15998840158389999999-7920899997216667998----------478999999999999998469995526702
Q 000726 1044 LEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS----------SEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1329)
Q Consensus 1044 YsllkvLGsGaFGtVYKAk~-kGt~VAVKiIKks~~sd~s----------~edE~~~keFlREIeILkkLrHPNIVKLlG 1112 (1329)
+.+.+.||+|+||.||+|.+ +|..||||+++........ .........+.+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred CCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCCCCCEE
Q ss_conf 11159997189999821288313544101345799999999999999999989799030479875157546899888089
Q 000726 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1329)
Q Consensus 1113 if~esseg~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHskGIIHRDLKPsNILIDsdGni~~~VK 1192 (1329)
+.. .+++|||+++..+.. ++......++.|++.++.|||++||+|+||||+|||++.++ ++
T Consensus 82 ~~~------~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-----~~ 142 (191)
T d1zara2 82 WEG------NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-----IW 142 (191)
T ss_dssp EET------TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-----EE
T ss_pred ECC------CEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECCC-----EE
T ss_conf 628------889999504565420--------01578999999999999998268889836890361142898-----99
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 942477522468632368779876447------211136889999056899999999
Q 000726 1193 VGDFGLSKIKRNTLVTGGVRGTLPWMA------PELLNGSSSKVSEKVDVFSFGIVL 1243 (1329)
Q Consensus 1193 LsDFGLAkli~~~~~ss~v~GT~~YlA------PEvL~Gs~~~~SeKSDVWSLGVLL 1243 (1329)
|+|||+|......... .|.. .+.+. ..+..++|+||+.--+
T Consensus 143 liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~---r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR-------EILERDVRNIITYFS---RTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHH-------HHHHHHHHHHHHHHH---HHHCCCCCHHHHHHHH
T ss_pred EEECCCCCCCCCCCCH-------HHHHHHHHHHHHHHC---CCCCCCCCHHHHHHHH
T ss_conf 9877884308998709-------999877999999975---7899844689999987
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=1.2e-06 Score=57.00 Aligned_cols=140 Identities=16% Similarity=0.042 Sum_probs=83.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCEEEEECCCCCCCCC
Q ss_conf 67159988401583899999997920899997216667998478999999999999998469-99552670211159997
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGG 1120 (1329)
Q Consensus 1042 eeYsllkvLGsGaFGtVYKAk~kGt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLr-HPNIVKLlGif~esseg 1120 (1329)
+.|+..+..+.++...||+....+..+.||+........ ...+.+|...+..+. +--+.+++.+.... +
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~ 83 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHD--G 83 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--T
T ss_pred HCEEEEECCCCCCCCCEEEEEECCCEEEEEECCCCCCCC--------HHHHHHHHHHHHHHHCCCCCCCEEEEEECC--C
T ss_conf 352799767899877189999089869999848876532--------556999999999876069987289997508--9
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q ss_conf 1899998212883135441013457999999999999999999897----------------------------------
Q 000726 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS---------------------------------- 1166 (1329)
Q Consensus 1121 ~L~LVMEYieGGSL~dlL~~kek~LSe~qIlkIA~QIAsALaYLHs---------------------------------- 1166 (1329)
..++||+++++.++....... ... ..++.+++..++.||+
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~---~~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDE---QSP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTC---SCH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred CEEEEEEECCCCCCCCCCCCC---CCH---HHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 649999860433435433440---269---99999899999998556842143576446565557789987765555430
Q ss_pred -------------------------CCEEECCCCCCCEEECCCCCCCCCEEEEECCCCCC
Q ss_conf -------------------------99030479875157546899888089942477522
Q 000726 1167 -------------------------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1167 -------------------------kGIIHRDLKPsNILIDsdGni~~~VKLsDFGLAkl 1201 (1329)
..++|+|+.+.|||++.++ ...|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~----~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK----VSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE----EEEECCCTTCEE
T ss_pred CCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCC----EEEEEECHHCCC
T ss_conf 33232005799999999844986781789860047642364996----599960231441
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.01 E-value=2.4e-05 Score=48.72 Aligned_cols=71 Identities=11% Similarity=0.181 Sum_probs=58.2
Q ss_pred CCCEEEEEEECCCCCCCCCCCCCCEEECCCEEEEEECCCCCHHHHHHHHHHHCC-CCEEEEEECCCCCCCCEEECCCHHH
Q ss_conf 998189995209800238999981221696279971589995999999997809-9508996079999772341268367
Q 000726 182 SSRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYN-QTHTIKYQLPGEDLDALVSVSCDED 260 (1329)
Q Consensus 182 ~~~~vklmcSyGG~I~pr~~d~~l~YvGG~triv~V~r~~~f~~l~~kl~~~~~-~~~~lkYqLP~edLD~LisV~~DeD 260 (1329)
+..+||..+.|+ ++++++.|+.+++|.+|+.++.+.+. ..+.|||+ .|| +-+|+++||+|
T Consensus 9 ~~~~ikVKv~~~----------------~D~~~~~l~~~it~~dL~~kI~~rf~~~~~~lkY~--Ded-gd~v~i~sD~D 69 (85)
T d1ip9a_ 9 GLKTTKIKFYYK----------------DDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTK--LFD-GSGEEIKTDSQ 69 (85)
T ss_dssp CCCCEEEEECBT----------------TCCEEEEECSCCCHHHHHHHHHHHHTSSCEEEEEC--CSS-SCCSCCCSHHH
T ss_pred CCCCEEEEEEEC----------------CCEEEEEECCCCCHHHHHHHHHHHHCCCCEEEEEE--CCC-CCEEEEECHHH
T ss_conf 998799999989----------------92999993799889999999999858783689999--689-99789837899
Q ss_pred HHHHHHHHHHH
Q ss_conf 99999996310
Q 000726 261 LQNMMEECNVL 271 (1329)
Q Consensus 261 L~~m~~Eydr~ 271 (1329)
|..+|++..++
T Consensus 70 l~~ai~~~~kl 80 (85)
T d1ip9a_ 70 VSNIIQAKLKI 80 (85)
T ss_dssp HHHHHHTTCCE
T ss_pred HHHHHHHCCCE
T ss_conf 99999722828
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.76 E-value=9.6e-05 Score=44.90 Aligned_cols=136 Identities=18% Similarity=0.088 Sum_probs=73.8
Q ss_pred EECCCCC-EEEEEEEEC-CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC--CCCEEEEECCCCCCCCCEEEE
Q ss_conf 8401583-899999997-920899997216667998478999999999999998469--995526702111599971899
Q 000726 1049 ELGSGTF-GTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH--HPNVVAFYGVVQDGPGGTLAT 1124 (1329)
Q Consensus 1049 vLGsGaF-GtVYKAk~k-Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLr--HPNIVKLlGif~esseg~L~L 1124 (1329)
.+..|.. ..||+.... +..+.+|........ .+.+|...++.+. .-.+.+++.+..+. +..++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-----------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-----------ELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS-----------CHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEE
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCHH-----------HHHHHHHHHHHHHHCCCCCCCEEEECCCC--CCEEE
T ss_conf 767865477589999389878999958966776-----------89999999999986599988613222456--61599
Q ss_pred EEEECCCCCHHHHH-----------------HCC---CCC--CCHHHHHHHH--------------------HHHHHHHH
Q ss_conf 99821288313544-----------------101---345--7999999999--------------------99999999
Q 000726 1125 VTEFMVNGSLRHVL-----------------LSK---ERH--LDRRKRLIIA--------------------MDAAFGME 1162 (1329)
Q Consensus 1125 VMEYieGGSL~dlL-----------------~~k---ek~--LSe~qIlkIA--------------------~QIAsALa 1162 (1329)
||++++|.++.... +.. ... ........-. ......+.
T Consensus 84 v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 84 LLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp EEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred EEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf 98744135543221268999999999999873688544887554124688999999875411011340112137999999
Q ss_pred HHHHC-------CEEECCCCCCCEEECCCCCCCCCEEEEECCCCCC
Q ss_conf 98979-------9030479875157546899888089942477522
Q 000726 1163 YLHSK-------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1163 YLHsk-------GIIHRDLKPsNILIDsdGni~~~VKLsDFGLAkl 1201 (1329)
.+... .++|+|+.+.|||++.+. .+.|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~----~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGR----FSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTE----EEEECCCTTCEE
T ss_pred HHHHHCCCCCCCEEEECCCCCCCEEEECCC----EEEEEECHHCCC
T ss_conf 998718765795678678887635773796----589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.57 E-value=0.0008 Score=39.03 Aligned_cols=83 Identities=17% Similarity=0.052 Sum_probs=46.1
Q ss_pred EEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCEEEEECCCCCCCCCE
Q ss_conf 988401583899999997--920899997216667998478999999999999998469---995526702111599971
Q 000726 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVVQDGPGGT 1121 (1329)
Q Consensus 1047 lkvLGsGaFGtVYKAk~k--Gt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLr---HPNIVKLlGif~esseg~ 1121 (1329)
.+.||.|....||+.... ++.+.||.-.......+.... ....+...|...|+.+. ...+++++.+..+ .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~-~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~----~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWP-LTIDRARIESSALIRQGEHVPHLVPRVFYSDTE----M 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCC-CCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT----T
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCC-CCHHHHHHHHHHHHHHHHHCCCCCCEEEEECCC----C
T ss_conf 99807985276899995799848999617713034677788-877899999999998650579885528998598----8
Q ss_pred EEEEEEECCCCCH
Q ss_conf 8999982128831
Q 000726 1122 LATVTEFMVNGSL 1134 (1329)
Q Consensus 1122 L~LVMEYieGGSL 1134 (1329)
.++|||++.+..+
T Consensus 106 ~~lvmE~L~~~~~ 118 (392)
T d2pula1 106 AVTVMEDLSHLKI 118 (392)
T ss_dssp TEEEECCCTTSEE
T ss_pred CEEEEECCCCCCC
T ss_conf 7798713577653
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=97.46 E-value=1.9e-05 Score=49.31 Aligned_cols=54 Identities=20% Similarity=0.305 Sum_probs=49.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 136689952117988652487699998899989999757565755457899832898
Q 000726 920 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPS 976 (1329)
Q Consensus 920 qls~~LP~~Lg~Ls~Lt~LdLS~N~LS~~Gs~IP~sg~l~nL~~lSLtdNs~LcgPs 976 (1329)
++++.||+.|++|+.|+.|+|++|+|+ |. ||..+.+.++..+.+.+|+.+||..
T Consensus 255 ~l~g~iP~~l~~L~~L~~L~Ls~N~l~--g~-iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 255 RIYGTLPQGLTQLKFLHSLNVSFNNLC--GE-IPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp CCEECCCGGGGGCTTCCEEECCSSEEE--EE-CCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred EECCCCCHHHHCCCCCCEEECCCCCCC--CC-CCCCCCCCCCCHHHHCCCCCCCCCC
T ss_conf 066608768847999998979588351--66-8986667998978868895001989
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.30 E-value=0.0032 Score=35.20 Aligned_cols=77 Identities=14% Similarity=0.245 Sum_probs=46.5
Q ss_pred CCEEEEEEECCCCCEEEEEEEECC---------CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCEEEEE
Q ss_conf 671599884015838999999979---------20899997216667998478999999999999998469-99552670
Q 000726 1042 EDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFY 1111 (1329)
Q Consensus 1042 eeYsllkvLGsGaFGtVYKAk~kG---------t~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLr-HPNIVKLl 1111 (1329)
+++++ +.|+.|-.-.+|++.... ..|.++++-.. . .. ....+|..+++.+. +.-..+++
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~--~~------idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TE------SHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CH------HHHHHHHHHHHHHHHTTSSSCEE
T ss_pred CCEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC--C--HH------HHHHHHHHHHHHHHHCCCCCEEE
T ss_conf 01699-99178533434899968877544578981799965996--1--16------58999999999997579998089
Q ss_pred CCCCCCCCCEEEEEEEECCCCCHH
Q ss_conf 211159997189999821288313
Q 000726 1112 GVVQDGPGGTLATVTEFMVNGSLR 1135 (1329)
Q Consensus 1112 Gif~esseg~L~LVMEYieGGSL~ 1135 (1329)
+++.+ ++|++|+++..+.
T Consensus 112 ~~~~~------g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 112 GIFSG------GRLEEYIPSRPLS 129 (395)
T ss_dssp EEETT------EEEECCCCEEECC
T ss_pred EECCC------CEEEEEECCCCCC
T ss_conf 98189------5699973455488
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.26 E-value=0.0017 Score=36.92 Aligned_cols=134 Identities=11% Similarity=-0.010 Sum_probs=68.0
Q ss_pred CCCEEEEEEEE-CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCE--EEEECC---CCCCCCCEEEEEE
Q ss_conf 58389999999-79208999972166679984789999999999999984699955--267021---1159997189999
Q 000726 1053 GTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV--VAFYGV---VQDGPGGTLATVT 1126 (1329)
Q Consensus 1053 GaFGtVYKAk~-kGt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLrHPNI--VKLlGi---f~esseg~L~LVM 1126 (1329)
+..-.||++.. .|..+++|+......+ ..++..|...+..|....+ +..+.. ......+..+.++
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s---------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~ 103 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 103 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEE
T ss_conf 6120269998389997999984787788---------9999999999999985599878752068980566534799998
Q ss_pred EECCCCCHHHH--------------HHC--------CCCCCCH-------------------HHHHHHHHHHHHHHHHHH
Q ss_conf 82128831354--------------410--------1345799-------------------999999999999999989
Q 000726 1127 EFMVNGSLRHV--------------LLS--------KERHLDR-------------------RKRLIIAMDAAFGMEYLH 1165 (1329)
Q Consensus 1127 EYieGGSL~dl--------------L~~--------kek~LSe-------------------~qIlkIA~QIAsALaYLH 1165 (1329)
+++.|..+... ++. .....+. .....+...+...+..+.
T Consensus 104 ~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 183 (325)
T d1zyla1 104 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 183 (325)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EECCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 65277688999999999989999998863035786556778978876656899987476998898999999999999999
Q ss_pred H-------CCEEECCCCCCCEEECCCCCCCCCEEEEECCCCCC
Q ss_conf 7-------99030479875157546899888089942477522
Q 000726 1166 S-------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1329)
Q Consensus 1166 s-------kGIIHRDLKPsNILIDsdGni~~~VKLsDFGLAkl 1201 (1329)
. .++||+|+.+.|||++.+ . .++||+-+..
T Consensus 184 ~~~~~~~p~~liHgDlh~~NvL~~~~--~----~~IDFdd~~~ 220 (325)
T d1zyla1 184 AHWREDFTVLRLHGDCHAGNILWRDG--P----MFVDLDDARN 220 (325)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEESSS--E----EECCCTTCCE
T ss_pred HHCCCCCCCEEECCCCCCCCEEEECC--C----EEEECHHCCC
T ss_conf 84545687120247888042878389--3----5886520146
|
| >d2c60a1 d.15.2.2 (A:43-122) Mitogen-activated protein kinase kinase kinase 3, MEKK 3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 3, MEKK 3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.08 E-value=0.0025 Score=35.93 Aligned_cols=70 Identities=20% Similarity=0.432 Sum_probs=59.9
Q ss_pred CCCEEEEEECCCCCHHHHHHHHHHHCCCCEEEEEECCCCCCCCEEECCCHHHHHHHHHHHHHHCCCCCCCCEEEEE
Q ss_conf 6962799715899959999999978099508996079999772341268367999999963100259998289981
Q 000726 209 GGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLF 284 (1329)
Q Consensus 209 GG~triv~V~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LisV~~DeDL~~m~~Eydr~~~~~~~~~R~flF 284 (1329)
-||.||+.++|.+.|-+|..|+...||..+.+-|- + -..+|.++|.+||+.-++..||-..- ..+|+.|.
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~--n--~El~IPl~~Q~DLDkAvellDrs~~~--ksLrilL~ 79 (80)
T d2c60a1 10 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM--N--NELSILLKNQDDLDKAIDILDRSSSM--KSLRILLL 79 (80)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHSSCCEEEEE--C--SSCEEECCSHHHHHHHHHHHHHCSSC--CSEEEEEE
T ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCCEEEEEEE--C--CEEEEECCCHHHHHHHHHHHCCCCCC--CEEEEEEE
T ss_conf 37068995278842999999999985983646775--6--71788525677789999987169663--30699973
|
| >d2nptb1 d.15.2.2 (B:42-123) Mitogen-activated protein kinase kinase kinase 2, MEKK 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 2, MEKK 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.96 E-value=0.0022 Score=36.20 Aligned_cols=70 Identities=20% Similarity=0.398 Sum_probs=60.2
Q ss_pred CCCEEEEEECCCCCHHHHHHHHHHHCCCCEEEEEECCCCCCCCEEECCCHHHHHHHHHHHHHHCCCCCCCCEEEEE
Q ss_conf 6962799715899959999999978099508996079999772341268367999999963100259998289981
Q 000726 209 GGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLF 284 (1329)
Q Consensus 209 GG~triv~V~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LisV~~DeDL~~m~~Eydr~~~~~~~~~R~flF 284 (1329)
-||.||+.++|.+.|.+|..|+...||....+-|- + -.-+|.++|.+||+.-++..||-..-+ .+|+.|.
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~--n--~EL~IPl~~Q~DLDkAvellDrs~~~k--sLrilL~ 79 (82)
T d2nptb1 10 RGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT--N--NELVIPLTTQDDLDKAVELLDRSIHMK--SLKILLV 79 (82)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHTSCEEEEEE--E--TTEEEECCCHHHHHHHHHHHHHCSSCC--SEEEEEE
T ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCCEEEEEEE--C--CEEEEECCCHHHHHHHHHHHCCCCCCC--CEEEEEE
T ss_conf 37068995278843899999999985984668885--6--768886256777899999871696634--2689999
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.92 E-value=0.0077 Score=32.75 Aligned_cols=144 Identities=13% Similarity=0.062 Sum_probs=70.9
Q ss_pred CEEEEEEECCCCCEEEEEEEECCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----CCCEEEEE-CCCCC
Q ss_conf 7159988401583899999997920899997216667998478999999999999998469-----99552670-21115
Q 000726 1043 DLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-----HPNVVAFY-GVVQD 1116 (1329)
Q Consensus 1043 eYsllkvLGsGaFGtVYKAk~kGt~VAVKiIKks~~sd~s~edE~~~keFlREIeILkkLr-----HPNIVKLl-Gif~e 1116 (1329)
++.-.+.|..|..-+.|+...++..+.+|++...... .++..|+.++..|. .|..+... |....
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~----------~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~ 88 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK----------NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 88 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC---C----------CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred CCEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCH----------HHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCE
T ss_conf 8568523788852673899978972899980789998----------899999999875430255545564104897621
Q ss_pred CCCCEEEEEEEECCCCCHHHH--------------HHC--------CCC------------------CCCHHHHHHHHHH
Q ss_conf 999718999982128831354--------------410--------134------------------5799999999999
Q 000726 1117 GPGGTLATVTEFMVNGSLRHV--------------LLS--------KER------------------HLDRRKRLIIAMD 1156 (1329)
Q Consensus 1117 sseg~L~LVMEYieGGSL~dl--------------L~~--------kek------------------~LSe~qIlkIA~Q 1156 (1329)
...+....++.++.+...... ++. ... ..........+..
T Consensus 89 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 168 (316)
T d2ppqa1 89 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP 168 (316)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred EEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHH
T ss_conf 34125502453114655333204678888899876454443202453101110120024567777653114127999999
Q ss_pred HHHHHHHHH----HCCEEECCCCCCCEEECCCCCCCCCEEEEECCCCC
Q ss_conf 999999989----79903047987515754689988808994247752
Q 000726 1157 AAFGMEYLH----SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1329)
Q Consensus 1157 IAsALaYLH----skGIIHRDLKPsNILIDsdGni~~~VKLsDFGLAk 1200 (1329)
+...+.... ..|+||+|+.+.||+++.+. ..-++||+.+.
T Consensus 169 ~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~----v~gvIDF~~~~ 212 (316)
T d2ppqa1 169 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDE----LSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTE----EEEECCCTTCE
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCC----CEEEECCCCCC
T ss_conf 987642048554545033378636564020454----12674222123
|
| >d2bkfa1 d.15.2.2 (A:1-85) Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.59 E-value=0.0041 Score=34.51 Aligned_cols=78 Identities=13% Similarity=0.314 Sum_probs=56.9
Q ss_pred CEEEEEEECCCCCCCCCCCCCCEEECCCEEE--EEECCCCCHHHHHHHHHHHCC-CCEEEEEECCCCCCCCEEECCCHHH
Q ss_conf 8189995209800238999981221696279--971589995999999997809-9508996079999772341268367
Q 000726 184 RKVKFLCSFGGKILPRPSDGKLRYVGGETRI--IRISRDISWQELTQKALAIYN-QTHTIKYQLPGEDLDALVSVSCDED 260 (1329)
Q Consensus 184 ~~vklmcSyGG~I~pr~~d~~l~YvGG~tri--v~V~r~~~f~~l~~kl~~~~~-~~~~lkYqLP~edLD~LisV~~DeD 260 (1329)
+.|.+..+|||. |+- +++++..+|.+|..++...++ .++.|||. . |-+-.|.++||+|
T Consensus 3 p~vtvKvtf~~d----------------t~RF~ls~~~~~~~~~L~~~i~~rf~l~~~~lkY~--D-dd~e~v~l~~d~d 63 (85)
T d2bkfa1 3 PQVTLNVTFKNE----------------IQSFLVSDPENTTWADIEAMVKVSFDLNTIQIKYL--D-EENEEVSINSQGE 63 (85)
T ss_dssp CCEEEEEEETTE----------------EEEEEESCGGGCCHHHHHHHHHHHHTCSSEEEEEE--C-TTSCEEEECSHHH
T ss_pred CCEEEEEEECCC----------------EEEEEECCCCCCCHHHHHHHHHHHCCCCCCEEEEE--C-CCCCEEEEECHHH
T ss_conf 608999998784----------------58999648877769999999998669664138987--5-9999899806888
Q ss_pred HHHHHHHHHHHCCCCCCCCEEEEE
Q ss_conf 999999963100259998289981
Q 000726 261 LQNMMEECNVLEDRGTQKPRMFLF 284 (1329)
Q Consensus 261 L~~m~~Eydr~~~~~~~~~R~flF 284 (1329)
|+.-++ +.......+|++++
T Consensus 64 l~E~~~----~a~~~~~~irl~v~ 83 (85)
T d2bkfa1 64 YEEALK----MAVKQGNQLQMQVH 83 (85)
T ss_dssp HHHHHH----HHHHTTTEEEEEEE
T ss_pred HHHHHH----HHHCCCCEEEEEEE
T ss_conf 999999----98668988999996
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=94.71 E-value=0.015 Score=30.85 Aligned_cols=67 Identities=12% Similarity=0.071 Sum_probs=46.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCC
Q ss_conf 689952117988652487699998899989999757565755457899832898--78889999622013685
Q 000726 923 LGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPS--TMETHPDYSRSELKGNE 993 (1329)
Q Consensus 923 ~~LP~~Lg~Ls~Lt~LdLS~N~LS~~Gs~IP~sg~l~nL~~lSLtdNs~LcgPs--sls~~P~lsKs~LaGN~ 993 (1329)
+.||+.++.|++|+.++++.|+|+ .+|....+.++..+.+.+|.+...+. .....+.+....+.+|.
T Consensus 33 ~~lp~~~~~l~~L~~L~l~~N~i~----~l~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~ 101 (124)
T d1dcea3 33 RALPPALAALRCLEVLQASDNALE----NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 101 (124)
T ss_dssp CCCCGGGGGCTTCCEEECCSSCCC----CCGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred CCCHHHHHHHHCCCCCCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCC
T ss_conf 865215655431354532432112----357412335557688889865888882565379999999897996
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.45 E-value=0.076 Score=26.42 Aligned_cols=51 Identities=10% Similarity=-0.078 Sum_probs=26.6
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCC
Q ss_conf 136689952117988652487699998899989999-7575657554578998328
Q 000726 920 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQS-GSRINFDEGSQRESSSIVG 974 (1329)
Q Consensus 920 qls~~LP~~Lg~Ls~Lt~LdLS~N~LS~~Gs~IP~s-g~l~nL~~lSLtdNs~Lcg 974 (1329)
++++..|..|+.++.|+.|+|+.|+|+ .||.. ..+.++..+.+.+|+-.|.
T Consensus 159 ~l~~~~~~~~~~l~~L~~L~Ls~N~L~----~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 159 NLTELPAGLLNGLENLDTLLLQENSLY----TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC----CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCC----CCCHHHCCCCCCCEEEECCCCCCCC
T ss_conf 652237200134212423430139785----5686677788899998369998788
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.23 E-value=0.095 Score=25.82 Aligned_cols=67 Identities=9% Similarity=0.021 Sum_probs=43.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCC
Q ss_conf 68995211798865248769999889998999975756575545789983289878-889999622013685
Q 000726 923 LGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTM-ETHPDYSRSELKGNE 993 (1329)
Q Consensus 923 ~~LP~~Lg~Ls~Lt~LdLS~N~LS~~Gs~IP~sg~l~nL~~lSLtdNs~LcgPssl-s~~P~lsKs~LaGN~ 993 (1329)
+.||..+..+++|+.|+||+|+|+ .++....+.++..+.+..|.....+... ...+.++...+.+|.
T Consensus 31 ~~i~~~~~~l~~L~~L~Ls~N~i~----~l~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~ 98 (162)
T d1a9na_ 31 PVIENLGATLDQFDAIDFSDNEIR----KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 98 (162)
T ss_dssp CSCCCGGGGTTCCSEEECCSSCCC----EECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCC
T ss_pred CCCCCCCCCCCCCCEEECCCCCCC----CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEECCCC
T ss_conf 865762004145998989799787----64774457613064310213457776322334534434203000
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=88.72 E-value=0.22 Score=23.49 Aligned_cols=64 Identities=13% Similarity=0.068 Sum_probs=48.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 8995211798865248769999889998999-975756575545789983289878889999622013685
Q 000726 924 GFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ-SGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNE 993 (1329)
Q Consensus 924 ~LP~~Lg~Ls~Lt~LdLS~N~LS~~Gs~IP~-sg~l~nL~~lSLtdNs~LcgPssls~~P~lsKs~LaGN~ 993 (1329)
.+| .++.|..|+.+++++|+|+ .+|. .+.+.++..+.+.+|.+...+. ....+.+....+..|.
T Consensus 12 ~l~-~l~~l~~L~~L~ls~N~l~----~lp~~~~~l~~L~~L~l~~N~i~~l~~-~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 12 VLC-HLEQLLLVTHLDLSHNRLR----ALPPALAALRCLEVLQASDNALENVDG-VANLPRLQELLLCNNR 76 (124)
T ss_dssp SCC-CGGGGTTCCEEECCSSCCC----CCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSC
T ss_pred CCC-CCCCCCCCCEEECCCCCCC----CCHHHHHHHHCCCCCCCCCCCCCCCCC-CCCCCCCCEEECCCCC
T ss_conf 871-0105898898979787168----652156554313545324321123574-1233555768888986
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.90 E-value=0.31 Score=22.58 Aligned_cols=63 Identities=10% Similarity=-0.044 Sum_probs=25.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 52117988652487699998899989999--75756575545789983289878889999622013685
Q 000726 927 SPLTNIEEGATVDYSYPPLKPDGSVMPQS--GSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNE 993 (1329)
Q Consensus 927 ~~Lg~Ls~Lt~LdLS~N~LS~~Gs~IP~s--g~l~nL~~lSLtdNs~LcgPssls~~P~lsKs~LaGN~ 993 (1329)
..|..+++|+.|++++|+|+ .|+.. ..+.++..+.+.+|.+...|...-....+....+.+|.
T Consensus 50 ~~f~~l~~L~~L~Ls~N~l~----~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np 114 (156)
T d2ifga3 50 RDLRGLGELRNLTIVKSGLR----FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNP 114 (156)
T ss_dssp GGSCSCCCCSEEECCSSCCC----EECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSC
T ss_pred HHHCCCCCCCCCEEECCCCC----CCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCCCCCCCCCCCCCC
T ss_conf 12256666672162021247----742011124554333322678785157456335321243357986
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.47 E-value=0.44 Score=21.60 Aligned_cols=52 Identities=6% Similarity=-0.020 Sum_probs=40.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCC
Q ss_conf 13668995211798865248769999889998999975-756575545789983289
Q 000726 920 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGS-RINFDEGSQRESSSIVGP 975 (1329)
Q Consensus 920 qls~~LP~~Lg~Ls~Lt~LdLS~N~LS~~Gs~IP~sg~-l~nL~~lSLtdNs~LcgP 975 (1329)
+++..-|..|..++.|+.|+|++|+|+ .+|.... ..++..+.+.+|+..|.-
T Consensus 67 ~l~~i~~~~f~~l~~L~~L~Ls~N~l~----~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 67 GLRFVAPDAFHFTPRLSRLNLSFNALE----SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp CCCEECTTGGGSCSCCCEEECCSSCCS----CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CCCCCCCCCCCCCCCCCCEECCCCCCC----CCCHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf 247742011124554333322678785----15745633532124335798633881
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=84.95 E-value=0.65 Score=20.50 Aligned_cols=69 Identities=6% Similarity=-0.093 Sum_probs=32.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCC
Q ss_conf 36689952117988652487699998899989999--7575657554578998328987-8889999622013685
Q 000726 921 DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQS--GSRINFDEGSQRESSSIVGPST-METHPDYSRSELKGNE 993 (1329)
Q Consensus 921 ls~~LP~~Lg~Ls~Lt~LdLS~N~LS~~Gs~IP~s--g~l~nL~~lSLtdNs~LcgPss-ls~~P~lsKs~LaGN~ 993 (1329)
+....+..+..++.|+.|+|++|+|+ .||.. .-+.++..+.+.+|.+...+.. ....+.++...+.+|.
T Consensus 66 i~~~~~~~~~~~~~L~~L~Ls~N~l~----~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~ 137 (192)
T d1w8aa_ 66 LTGIEPNAFEGASHIQELQLGENKIK----EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP 137 (192)
T ss_dssp CCCBCTTTTTTCTTCCEEECCSCCCC----EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCC
T ss_pred CCCCCCCCCCCCCCCCEEEECCCCCC----CCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCC
T ss_conf 21212122211222210100355344----3497998079746552457745353597785687533420003644
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=84.41 E-value=0.22 Score=23.48 Aligned_cols=45 Identities=13% Similarity=0.041 Sum_probs=19.0
Q ss_pred CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCC-CCCCCCCCCCCCCCCCCC
Q ss_conf 995211798865248769-999889998999-975756575545789983
Q 000726 925 FSSPLTNIEEGATVDYSY-PPLKPDGSVMPQ-SGSRINFDEGSQRESSSI 972 (1329)
Q Consensus 925 LP~~Lg~Ls~Lt~LdLS~-N~LS~~Gs~IP~-sg~l~nL~~lSLtdNs~L 972 (1329)
||+.|++|+.|+.|+|+. |+|. |. ||. .+.+.++..+.+..|...
T Consensus 68 lp~~l~~L~~L~~L~Ls~~N~l~--g~-iP~~i~~L~~L~~L~Ls~N~l~ 114 (313)
T d1ogqa_ 68 IPSSLANLPYLNFLYIGGINNLV--GP-IPPAIAKLTQLHYLYITHTNVS 114 (313)
T ss_dssp CCGGGGGCTTCSEEEEEEETTEE--SC-CCGGGGGCTTCSEEEEEEECCE
T ss_pred CCHHHHCCCCCCCCCCCCCCCCC--CC-CCCCCCCCCCCCHHHHCCCCCC
T ss_conf 98478467533520202654333--00-2431145420011020356434
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=83.17 E-value=0.93 Score=19.51 Aligned_cols=41 Identities=7% Similarity=-0.130 Sum_probs=20.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 117988652487699998899989999757565755457899832
Q 000726 929 LTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIV 973 (1329)
Q Consensus 929 Lg~Ls~Lt~LdLS~N~LS~~Gs~IP~sg~l~nL~~lSLtdNs~Lc 973 (1329)
+..|++|+.|++++|.|+ .++..+.+.++.++.+.+|.+..
T Consensus 64 l~~l~~L~~L~L~~n~i~----~l~~~~~l~~L~~L~l~~n~i~~ 104 (210)
T d1h6ta2 64 IQYLPNVTKLFLNGNKLT----DIKPLANLKNLGWLFLDENKVKD 104 (210)
T ss_dssp GGGCTTCCEEECCSSCCC----CCGGGTTCTTCCEEECCSSCCCC
T ss_pred HHHCCCCCEEECCCCCCC----CCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 764899898769896025----86011358621201433333212
|